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PREDICTION OF EARLY POST
OPERATIVE MORTALITY IN
DECEASED DONOR LIVER
TRANSPLANTATION BY USING
CLINICAL PROFILE
Arunkumar Krishnan
Stanley Medical College, Chennai, India
Background: Liver transplant often results in hemody-
namic and biochemical changes in the immediate post-
operative period, often causing concern to the treating
physician. To study the pre-operative clinical profile,
the hematological and biochemical changes in the
immediate post-operative period up to 7 days following
DDLT patients.
Patients and Methods: A detailed assessment of the
patient’s pre-operative clinical diagnosis, presence of
co-morbid illness and postoperative hematological, bio-
chemical, microbiological and clinical events was made
between survivors and those who died. Various param-
eters were compared between two groups to understand
the various that determined early postoperative out-
come in DDLT patients.
Results: A total of 35 patients, categorized into group I-
26 patients (Survivors) and group II-9(mortality). There
was no difference in the fluctuation of hemoglobin levels
between the two groups (104%). Early leukocytosis
and persistent azotemia predicted early morbidity and
mortality. A significant fall of platelet count predicted
mortality. Transaminases showed a significant rise
between the 2nd and 3rd postoperative days and stabilized
and showed a downwards trends by the 7th–9th postop-
erative days in both group. Hypernatremia predicated
early mortality. Cause of death was intra-operative
events like cardiac arrhythmias, and in ischemic cardiac
events(3),pulmonary thromboembolism(1),and hepatic
artery thrombosis(1),sepsis and multi-organ failure(4).
Two patients required renal replacement therapy for
resistance renal failure in group II.
Conclusion: Pre-operative co-morbid illness, postopera-
tive worsening azotemia, persistent leukocytosis, and
sepsis and cardiac events in the immediate postopera-
tive period predicts an outcome post DDLT.
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IS ALCOHOLIC PANCREATITIS AND
LIVER DISEASE ARE FRIENDS OR
FOES?
Arunkumar Krishnan
Stanley Medical College, Chennai, India
Background: Alcohol is known cause for chronic liver
disease and chronic pancreatitis. The two diseases often
do not co-exist. This study compares the similarities
and dissimilarities on a case to case basis between
alcohol related acute recurrent pancreatitis and alcohol
related chronic liver disease with an intention to iden-
tify risk factors predisposing an individual to one dis-
ease but not to the other.
Methods: Consecutive patients presenting with US/
CECT proven pancreatitis, liver disease or a combina-
tion were included in the study. Controls were men
who consuming alcohol for more than 5 years, but had
normal liver and pancreas on biochemical and radio-
logical evaluation. Female gender, pancreatitis and liver
disease due to other etiological factors or alcohol con-
sumption less than 5 years were excluded from the
study. Patients were categorized as GpI: Alcoholic
related pancreatitis, GpII: Alcoholic liver disease,
GpIII: combination of pancreatic and alcohol related
liver disease. Patient details included were age, baseline
demographic characteristics, literacy status, per capita
income, details of alcohol consumption, smoking and
diet details. Pertaining to the disease, information on
age of onset of disease, the duration of disease and
date/month of diagnosis were recorded. All patients
had liver function tests, baseline amylase and lipase
estimation, ultrasound and CECT. Likewise definite
evidence of chronic pancreatitis on CECT was consid-
ered mandatory for inclusion in the study.
Results: There were 53 controls. There were 59 patients
with pancreatitis (GpI), 97 with liver disease (GpII), 7
with both liver and pancreatic disease (GpIII). The
demographic profile, socioeconomic status, pan chewing,
diet pattern and smoking pattern in the three groups
were similar. Age of first consumption of alcohol was
also similar in all the 3 groups. The mean age of presen-
tation in the three groups was 37.4  10.2, 44.6  9.4,
and 45.3  6.9 years respectively. Current alcohol con-
sumption was more in Gp I (71.2%) compared to Gp II
(50.5%), and Gp III (57.1%) (p < 0.05). The mean dura-
tion of alcohol consumption was 13.1, 16.5 and 15.4
years respectively. The average current consumption of
alcohol per week was similar in all, i.e. Gp II (765.3 g),
Gp I and III (653 g each). Average consumption and
duration of consumption of alcohol was not significantly
different in all the 3 groups.
Conclusion: Unlike the western reports, the age of
presentation for both alcoholic liver disease and pan-
creatic disease is similar i.e. 13  2 years. What predis-
poses an individual to develop liver or pancreatic
disease is probably genetically determined.
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SUCCESSFUL TREATMENT OF
MALIGNANT BILIARY-CUTANEOUS
FISTULA USING A T-TUBE
Sung Kyun Park
Incheon St. Mary’s Hospital, bupyung-dong, bupyung-gu,
Incheon, South Korea
Background and aims: Biliary-cutaneous fistulas are
uncommon but can be a source of significant morbidity
after hepato-biliary surgery. Residual malignancy may
be associated with the development of postoperative fis-
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tula. Conservative treatment and invasive treatment
including surgery is considered. We report a case of
post operative biliary-cutaneous fistula which was suc-
cessfully treated by resection of fistula tract including
wide excision of hepaticojejunostomy site with T-tube
insertion.
Methods: Right hepatectomy with Roux-en-Y hepati-
cojejunostomy was performed for a 78-year-old man
with Klatskin tumor Bismuth type IIIA. Postoperative 4
weeks, bilious discharge was found in the wound and CT
showed biliary-cutaneous fistula. The liver function sus-
tained normal so we decided to observe. To 1 month
after the development of fistula, closure of the fistula was
not found so we performed percutaneous transhepatic
biliary drainage but closure did not occur. Thus, we per-
formed resection of fistula tract including wide excision
around the hepaticojejunostomy site and T-tube inser-
tion. Malignancy was found in the fistula tract, and T-
tube was removed after 2 months. No recurrence was
found for 12 months after the first operation.
Results: Postoperative biliary-cutaneous fistula was
successfully treated with resection of fistula tract
including wide excision of hepaticojejunostomy site and
T-tube insertion.
Conclusions: There may be possibility of malignancy in
cases of biliary-cutaneous fistula which is not success-
fully treated with conservative treatment, so wide exci-
sion of hepaticojejunostomy site should be included in
the surgery for postoperative biliary-cutaneous fistula
and this treatment strategy may increase the curative
potential.
225
INITIAL POSTOPERATIVE DECEASES
CLINICAL OUTLINE IN DECEASE
DONOR LIVER TRANSPLANT
RECIPIENTS: A PRELIMINARY
REPORT
Arunkumar Krishnan
Stanley Medical College, Chennai, India
Background and Aim: Liver transplant often results in
hemodynamic and biochemical changes in the immedi-
ate postoperative period, often causing concern to the
treating physician. Aim of the study to determine the
pre-operative clinical profile, the hematological and
biochemical changes in the immediate postoperative
period up to 7 days following DDLT patients.
Method: A detailed assessment of the patients pre
operative clinical diagnosis, presence of co-morbid ill-
ness and postoperative hematological, biochemical,
microbiological and clinical events was made between
survivors and those who died. Various parameters were
compared between two groups to understand the vari-
ous that determined early postoperative outcome in
DDLT patients.
Results: A total of 34 patients, categorized into
groupI-26 patients (Survivors) and groupII-8(mortal-
ity). There was no difference in the fluctuation of
hemoglobin levels between the two groups (10  4%).
Early leukocytosis predicted early morbidity and
mortality between 2groups. This difference was statisti-
cally significant (p < 0.01). Serum urea showed a signif-
icant elevation in GpII than GpI (p < 0.01). Serum
creatinine increased in both groups, but it is much
higher in GpII compare to GpI (p < 0.05). The serum
platelet count in groupI was 350000  180000 platelets/
mL, whereas in groupII it had reduced to
80000  120000 platelets/ mL(p < 0.001). PT was
correlated well with outcome, although the trend was
the same in both groups. INR was also significantly
higher in GpII patients. Transaminases showed a sig-
nificant rise between the 2nd and 3rd postoperative
days and stabilized and showed a downwards trends by
the 7th–9th postoperative days in both group. Cause of
death was intra-operative events like cardiac arrhyth-
mias, and in ischemic cardiac events (2), pulmonary
thromboembolism (1), and hepatic artery thrombosis
(1), sepsis and multiorgan failure (4). Two patients
required renal replacement therapy for resistance renal
failure in groupII.
Conclusion: Pre-operative co-morbid illness, postopera-
tive worsening azotemia, persistent leukocytosis, and
sepsis and cardiac events in the immediate postopera-
tive period predicts an outcome post DDLT.
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RISK FACTORS FOR EARLY
OCCURRENCE OF LUNG METASTASIS
IN PATIENTS WITH
HEPATOCELLULAR CARCINOMA
AFTER TRANSARTERIAL
CHEMOEMBOLIZA
Yong-Bo Yang1, Yu-Fang Chen1, Ning-Yang Jia1,
Dong Chen1, Xing-An Long1, Hong Meng2 and
Hong-Yan Cheng1
1Department of Radiology, Eastern Hepatobiliary
Surgery Hospital, Second Military Medical University,
225 Changhai Rd, Shanghai 200438, China;
2Department of Health Statistics, Second Military
Medical University, 800 Xiangyin Rd, Shanghai 200433,
China
Aim: To analyze the risk factors for early occurrence
of lung metastasis in patients with hepatocellular carci-
noma (HCC) after transarterial chemoembolization
(TACE).
Methods: 202 patients diagnosed as HCC without pre-
vious treatment and detected lung metastases after trea-
ted with TACE were studied retrospectively. Patient’s
laboratory tests and imaging around TACE, parame-
ters in TACE, and time and location of lung metastasis
were obtained. Time to progression (TTP) was defined
from the time for first TACE to diagnosis of lung
metastases. Calculate the incidence of lung metastases
by Kaplan-Meier method for each factor and compare
the difference between groups of each factor by Log-
rank test. All factors entered into COX regression
model for univariate analysis and followed by multivar-
iate analysis.
Results: Before the occurrence of lung metastases, 44
patients also accepted local or comprehensive treatment
after TACE, the rest 158 patients had no other treat-
ment. 69 patients (34.2%) manifested unilateral lung
metastasis while 133 patients (65.8%) bilateral. The
median TTP, from first TACE to lung metastasis, was
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4 months (95% CI: 3.3–4.7), ranging from 1 month to
57 months. Take all factors into consideration, tumor
thrombosis grade in patients(p = 0.011), the degree of
AFP change in 1 month(p = 0.002), times of TACE
(P < 0.001) and adopting other treatment after TACE
(P < 0.001) were significant independent risk factors
for lung metastasis in patients with HCC after TACE
by COX univariate and multivariate analysis.
Conclusion: To patients with high grade of tumor
thrombosis in the preoperative imaging and signifi-
cantly increased or strong positive AFP 1 month later,
lung metastases tended to occur significantly earlier.
Nevertheless, repeated TACE and integrated other
local treatment if the hepatic function remained pre-
served, can significantly postpone the occurrence of
lung metastasis.
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PALLIATIVE HEPATOJEJUNOSTOMY
IN INOPERABLE
HILARMALIGNANCIES PRESENTING
WITH OBSTRUCTIVE JAUNDICE.
Arif Rashid Khawaja
24, E-1, Gulberg III, Lahore, Pakistan
Purpose: Decompression of the biliary system
Material/Methods: 14 patients with irresectable malig-
nant tumors of the liver hilum.
Results: All patients had more than 70% reduction in
serum bilirubin level on day 5 of the operation. The
technique is simple and safe in experienced hands and
provides excellent symptomatic relief.
Conclusion: As majority of patients are unable to afford
internal stents, this procedure is cost effective with mini-
mal morbidity if patients are selected properly.
Malignant biliary obstruction at the level of the liver
hilum causes mechanical cholestasis leading to severe
jaundice. This leads to symptoms like pruritis, recurrent
cholangitis and malaise. As most of these patients pres-
ent late, and are deemed inoperable, relieving jaundice
improves their quality of life. Most of the palliative
decompression is achieved either by internal stenting
procedures or external diversion using a percutaneous
transhepatic approach. Both methods have disadvan-
tages including frequent need for reintervention either
because of displacement, blockage due to tumor
growth, stent infections and recurrent cholangitis.
In this study, I report my experience with peripheral
hepatojejunostomy for decompression of the biliary
system in 11 patients with irresectable malignant
tumors of the liver hilum. This technique does not use
mucosa-to-mucosa anastamosis, but rather a jejunala-
nastamosis to a peripheral cut surface of the liver,
exposing the dilated bile ducts. All patients had more
than 70% reduction in serum bilirubin level on day 5
of the operation. The technique is simple and safe in
experienced hands and provides excellent symptomatic
relief.
As majority of patients are unable to afford internal
stents, this procedure is cost effective with minimal
morbidity if patients are selected properly.
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LIVER SURGERY AT JINNAH
HOSPITAL; INNOVATIONS MATCHING
THE FACILITIES
Arif Rashid Khawaja
24, E-1, Gulberg III, Lahore, Pakistan
Purpose: Liver Surgery has been accepted as a highly
specialized surgery and the world over, Hepato- Pan-
creato- Biliary (HPB) is now a recognized specialty of
General Surgery. Liver surgery has gone through the
embryonic phase and now the mortality and morbidity
has been brought down to 4% and 10% respectively is
specialist Centres.
Liver Surgery requires both the expertise and the tech-
nical support to reduce the morbidity and mortality of
patients. With the Purpose of new liver resecting
devices like CUSA, Tissue Link, water-jet, Habib’s Ra-
diofrequency Instruments, the operative blood loss has
been reduced considerably. Also the use of Fixed
Abdominal Retractor Systems and vascular staples the
operating time has been reduced and facilitated safe
liver resections. The use of Argon Gas has reduced the
risk of post- operative hemorrhage. The post- operative
monitoring of patients in an ICU also ensures smooth
recovery and early management of any post-operative
complication. I present my series of 19 major and
minor resections at Surgical Unit II that were carried
out during the last 18 months.
Methods: At Jinnah Hospital, none of these facilities
were available and therefore innovations were required
to do resections that were safe, cost effective and fitted
the available resources. “Kelly Classy” instead of
CUSA was used to resect the liver; Simple abdominal
retractors were fixed to the available bars to retract the
rib cage and liver was packed to avoid post- operative
bleeding that were removed 48–72 hours after initial
surgery. After the initial 2 liver resections, none of the
patients were transferred to ICU and were extubated
after the operation. The innovative techniques, total
cost of the operation, blood loss, morbidity and mor-
tality would be presented.
Results: There was no operative mortality. One patient
with cirrhosis died of liver failure and one patient died
with sepsis secondary to peritonitis due to perforated
appendix. The first two patients were sent to ICU, but
later on the patients were managed in the HDU of the
ward. The mean blood loss was 700 ml. The mean
LOS (Length of stay) was 9 days. The total cost of
sutures used during surgery was Rs.7600. Overall, the
results were comparable to other units in the develop-
ing countries.
Conclusions: Liver surgery can be performed safely
even in the constrained environment, provided it is
done and managed in a unit with special interest.
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ASSESSMENT OF AN OPTIMAL
PROGNOSTIC SYSTEM FOR
PREDICTING MORTALITY IN
PATIENTS AWAITING LIVER
TRANSPLANTATION: CHILD-PUGH
VERSUS MELD
ArunKumar Krishnan
Stanley Medical College, Chennai, India
Background: Decompensated cirrhosis is associated
with a poor prognosis and liver transplantation pro-
vides the only curative treatment option with excellent
long-term results. The Model for End-Stage Liver Dis-
ease (MELD) score is now used for allocation in liver
transplantation (LT) waiting lists, replacing the Child-
Turcotte-Pugh (CTP) score. However, the optimal
strategy based on scoring systems and/or waiting time
is still under debate. Aim of the study to compare the
CTP scores and MELD score for 3, 6 months survival
in cirrhotic patients waiting for liver transplant.
Methods: We investigated 216 consecutive patients
listed for single-organ liver transplantation for nonful-
minant liver disease between April 2010 and June 2011.
To assess the ability of MELD and CTP score predict-
ing the risk of death, the study was performed by range
by using c-statistic for area under the receiver operating
characteristic curve.
Results: 56 patients died during the observation period.
The mean CTP score at baseline, 3, 6 months was 7.4,
7.67 and 8.1 respectively for patients in the waiting list
7.63, 8.9 and 9.48 respectively for patients who died on
waiting. The Mean MELD at 3, 6 months was 12.2,
13.37 and 16.99 respectively for patients in the waiting
list and 14.8, 19.25 and 21.57 respectively for patients
who died on waiting. The sensitivity and specificity to
identify mortality or severe deterioration for CTP was
83.9% and 89.5%, respectively; for MELD 88.6%,
91%, respectively. In stratified analysis there were sig-
nificant ( < 0.001) differences between MELD and CTP
for the c-statistic in patients with low and intermediate
range MELD scores at 3 and no significant difference
in 6 months.
Conclusion: MELD has a better performance over the
CTP score in determination of priorities for organ allo-
cation. The outcome with lower range MELD cannot
be reliably predicted only with their MELD scores, and
alternative prognostic markers should be used in con-
junction to enhance the predictive accuracy. Because in
patients with a longer time on waiting list CTP may
serve as an additional factor for assessment of patient
prognosis. So, prognostic markers like ascites and hyp-
onatremia should be added with MELD to enhance the
predictive accuracy
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PROGNOSTIC SIGNIFICANCE OF
PREOPERATIVE PERIPHERAL BLOOD
MONOCYTE RATIO IN PATIENTS
WITH HEPATOCELLULAR
CARCINOMA
Seung Duk Lee
National Cancer Center, Republic of Korea, Goyang-si,
South Korea
Background: Leukocyte subsets in peripheral blood,
which include neutrophils, lymphocytes, and mono-
cytes, have not been well-established as prognostic fac-
tors in patients with hepatocellular carcinoma (HCC).
Method: Consecutive patients who underwent curative
hepatic resection for HCC at the National Cancer Cen-
tre, Republic of Korea, from April 2001 to December
2008 were enrolled in this study. Clinicopathologic fac-
tors, survivals, and prognostic factors were analysed
with respect to preoperative lymphocyte subsets, espe-
cially monocyte ratio.
Results: The 603 patients had a median follow-up of
40.0 months and a 5-year overall survival rate of
67.7%. In univariate analysis, preoperative lymphocyte
ratio  35% and monocyte ratio > 7% were signifi-
cantly poor prognostic factors. In multivariable analy-
sis, preoperative monocyte ratio > 7%, satellite nodule,
and microvascular invasion were independent risk fac-
tors for cancer-specific survival and disease-free surviv-
als (hazard ratio of monocyte ratio > 7%: 1.77,
p = 0.02 and 1.57, p = 0.006, respectively). Considering
the monocyte ratio with preoperative a-fetoprotein
level, patients with both abnormal a-fetoprotein level
( > 12 ng/mL) and monocyte ratio > 7% showed sig-
nificantly worse cancer-specific and disease-free surviv-
als than other groups (p < 0.001). The cirrhotic
patients with monocyte ratio > 7% showed significantly
poor cancer-specific and disease-free survivals
compared to the noncirrhotic patients (p = 0.033
and < 0.001, respectively).
Conclusions: The preoperative monocyte ratio > 7% of
peripheral blood is an independent risk factor for can-
cer-specific and disease-free survivals after hepatic
resection for HCC. The preoperative monocyte ratio
might be considered as a novel biomarker for HCC.
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PALLIATIVE
PANCREATICODUODENECTOMY IN
PANCREATIC AND PERIAMPULLARY
ADENOCARCINOMAS
Yi Ming Shyr
10 F 201 Section 2 Shih-Pai Road, Taipei, Taiwan
Background: This study aims to clarify the role of a
palliative pancreaticoduodenectomy in both pancreatic
and periampullary adenocarcinomas.
Methods: Data on patients with periampullary adeno-
carcinoma who underwent surgery between January,
1997 and December, 2009 were analyzed. Survival out-
comes were compared between resections and bypass
operations, and between curative (R0) and palliative
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resections, with a microscopically (R1) and a grossly
(R2) positive resection margin.
Results: There were 595 surgical patients, including
47.4% curative resections (R0) and 17.8% palliative
resections (R1 + R2). The positive margin rate after a
pancreaticoduodenectomy was 8.0% for a R1 and
19.3% for a R2. For periampullary adenocarcinomas,
there was a significant survival difference between the
R0, palliative, and no resection groups. However,
there was no significant survival difference between
the R0 curative resections and the palliative pancreati-
coduodenectomies for pancreatic head adenocarci-
noma. Note that the survival outcome after either a
curative or a palliative pancreaticoduodenectomy was
still better than the survival outcome of a bypass
operation.
Conclusion: There was a survival benefit after a pan-
creaticoduodenectomy regardless of the resection
margin or primary origin of the periampullary adeno-
carcinoma, as compared to a bypass operation. The
resection margin after a pancreaticoduodenectomy did
not play a role in the survival outcome in pancreatic
head adenocarcinoma. Therefore, we recommend that
pancreaticoduodenectomies should be attempted when-
ever possible.
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PANCREATIC AND PERIAMPULLARY
MIXED TUMORS
Yi Ming Shyr
10 F 201 Section 2 Shih-Pai Road, Taipei, Taiwan
Background: There is no data regarding the tumor inci-
dence by histological type and biological behavior in
terms of number of malignancy inside the mixed
tumors, tumor location, and histopathology. With anal-
ysis of the pooled data, we tried to clarify the charac-
teristics and survival outcomes of the pancreatic and
periampullary mixed tumors.
Methods: Data of mixed tumors in the pancreas and
periampullary region from our prospectively-collected
computer database and cases reported in the English
literature were included for analysis together.
Results: There were 43 mixed tumors. The mixed
tumor composed of adenocarcinoma and neuroendo-
crine neoplasm was most common (42%). Thirty-two
(74%) mixed tumors were malignant, and 28% were
composed of double malignancies. The most common
histolopathological diagnosis was neuroendocrine neo-
plasm (43%) including 36% neuroendocrine tumor and
7% neuroendocrine carcinoma. The median tumor size
was 3 cm, and larger in the benign group (6.3 vs.
2.5 cm, p = 0.038). There was no significant survival
difference between malignant mixed tumors with dou-
ble vs. single malignancy, pancreatic vs. non-pancreatic
origin, and adenocarcinoma vs. non-adenocarcinoma.
Conclusions: Neuroendocrine neoplasms are the most
common histolopathological diagnosis in pancreatic
and periampullary mixed tumors. There is no signifi-
cant survival difference in terms of number of malig-
nancy, tumor location and histolopathology.
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XANTHOGRANULOMATOUS
CHOLECYSTITIS PRESENTING AS
HEMOBILIA
Jungchul Kim
Gwangju, South Korea
Background and aims: Hemobilia is a rare condition
defined as bleeding into the biliary tree from an abnor-
mal communication between a blood vessel and bile
duct. Most common causes of hemobilia are iatrogenic
trauma, accidental trauma, gall stones, tumors, inflam-
matory disorders, and vascular disorders. Among these,
iatrogenic trauma to the liver and biliary tree is the
major cause of hemobilia. In contrast, non-traumatic
hemobilia due to gallstone, inflammation, and vascular
malformations are extremely rare. Here we reported a
case with Xanthogranulomatous cholecystitis presenting
as hemobilia.
Methods: A 70-year-old man was sent to the emer-
gency department at our hospital with a complaint of
right upper quadrant abdominal pain for 1 day. Vital
sign was stable and past history included diabetes mell-
itus and previous endoscopic retrograde cholangiopan-
creatography(ERCP) history due to common bile duct
stone 3 years ago. At that time he was treated by endo-
scopic sphincterotomy with CBD stone removal. There
were icteric sclera, right upper quadrant abdominal ten-
derness and positive Murphy’s sign on physical exami-
nation. Laboratory data on admission showed white
blood cell (13000/mm3), hemoglobin (14.9 g/dL), plate-
let (173000/mm3). Liver function tests showed that total
bilirubin (5.4 mg/dL), alkaline phosphates (159I U/L),
aspartate aminotransferase (AST) (287I U/L), alanine
aminotrasferase (ALT) (159I U/L), r-glutamyl traspep-
tidase (r-GTP) (391I U/L), and C-reactive protein
(CRP) (9.8 mg/dL) were elevated. Coagulation tests
were normal. Abdominal computed tomography (CT)
scan showed marked thickening of the gallbladder wall
with 2.8 cm sized radiopaque stone and biliary dilata-
tion with distal CBD stones. Based on these findings,
ERCP was done for CBD stone removal. ERCP
showed that there was no CBD stone and there was he-
matome resulting in CBD obstruction. After hemotome
removal, old blood colored bile was actively draining.
Then, we performed emergence open cholecystectomy
and choledocholithotomy with T-tube drainage, intra-
operative cholangiography.
Results: At laparotomy, gallbladder was severely
inflamed and adherent to omentum, small bowel, and
colon and there were maximum 3 cm sized multiple
black colored stones and pus-like fluid in gallbladder
with edematous wall thickening. And there was no
CBD stone and no abnormality at intraoperative chol-
angiography. A histological examination indicated
xanthgranulomatous cholecystitis based on the findings
of a granulomatous lesion in the gallbladder wall. The
patient was discharged 2 weeks following surgery with-
out any problems.
Conclusions: Xanthogranulomatous cholecystitis
patient has a history suggestive of an episode of acute
cholecystitis. Also it can be presenting as hemobilia.
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PERIBILIARY CYST IN HEALTHY
YOUNG PATIENT
Hyunjong Kim
Gwangju, South Korea
Background and aims: Peribiliary cysts originate from
cystic dilatation of the peribiliary glands. Almost all
the peribiliary cysts are found in patients with
advanced liver disease and particularly with disturbance
of the portal venous system, as almost all patients have
severe portal hypertension. Peribilary cysts should be
distinguished from premalignant conditions, such as
Caroli’s disease, localized primary sclerosing cholangi-
tis, mucinous cystic neoplasm (MCN) and intraductal
papillary neoplasm of the bile duct (IPNB). Herein, we
report a case of peribiliary cyst resembling unilobar
Caroli’s disease in a healthy young patient.
Methods: A 31-year-old man was referred to our hospi-
tal for further evaluation of the presence of hepatic
mass, detected on ultrasonogram (US) performed for
routine screening examination. The patient was asymp-
tomatic. He had no history of liver disease or alcohol
abuse. All the routine laboratory tests including liver
function tests and tests for tumor markers yielded nor-
mal findings. An ultrasonogram showed about 3 cm
sized multiseptated cystic mass in the right hepatic
lobe. An abdominal computed tomography (CT) scan
and a magnetic resonance cholangiopancreatography
(MRCP) demonstrated a 2.8 x 2.2 cm sized multilocu-
lar irregular cystic mass in segment VI. The mass was
located at a distance from hepatic hilum. The findings
suggested unilobar Caroli’s disease or biliary cystic neo-
plasm, such as mucinous cystic neoplasm or intraductal
papillary neoplasm of the bile duct. Concern regarding
the potential risk of malignancy in the context of sus-
pected Caroli’s disease, mucinous cystic neoplasm, and
intraductal papillary neoplasm of the bile duct were
discussed with the patient, who consequently opted for
surgical resection.
Results: A right hemihepatectomy was performed. At
laparotomy, multiple cystic lesions were found sur-
rounding segment VI bile duct. The patient was dis-
charged 2 weeks following surgery without any
complications. Histological examination of the resected
specimen showed multiple cysts distributed along the
major segmental portal tracts of the segment VI. On
microscopic examination, numerous peribiliary cysts
lined by cubic or flattened epithelium were seen around
normal appearing intrahepatic bile ducts. There was no
evidence of dysplasia.
Conclusions: Peribilary cysts can occur in normal liver
and can mimic the condition of unilobar Caroli’s
disease. Accurate identification of peribiliary cysts and
differentiation from other potentially premalignant or
malignant cystic lesions is mandatory.
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THE EFFECT OBSERVATION OF
ULTRASOUND-GUIDED
PERCUTANEOUS PUNCTURE
TREATMENT IN LOCALIZED
EFFUSION AFTER HEPATECTOMY
Yin-Xia Li and Jia Guo
The ultrasound department of Eastern Hepatobiliary
Surgery Hospital, Shanghai, China
Background the localized effusion is a common compli-
cation after liver resection, and ultrasound-guided
percutaneous puncture drainage treatment is a effective
way for decreasing the effusion.
Objective: To observe the clinical effect of ultrasound-
guided percutaneous puncture in localized effusion after
liver resection.
Methods: Review the clinical data of 83 patients after
hepatectomy concurrent localized effusion and all of
them received ultrasound-guided percutaneous puncture
treatment, the curative effect evaluation index is tem-
perature and white blood cell count change before and
after puncture treatment, besides, discusses the influ-
ence of the part, scope, character of located effusion on
temperature and white blood cell count before the
puncture treatment.
Results: The 83 patients successfully received puncture
treatment 100 times, the temperature and white blood
cell count before puncture treatment compared with
after treatment 1, 3, 5 days, the difference have statisti-
cal significance (p < 0.05), and after 1 day compared
with 3 day, 3 days compared with 5 day, there were
not significant statistical difference(P > 0.05); The loca-
tion, scope and character of located effusion had not
significant influence on temperature and white blood
cell count before the puncture treatment(P > 0.05).
Conclusion: Localized effusion occurrence has relations
with liver resection surgery and patients own conditions,
patients fever and white blood cell count anomaly before
puncture treatment have no obvious relation with The
location, scope and character of the effusion; Ultrasound-
guided puncture drainage treatment can fast effectively
solve the effusion complication after liver resection, and
has advantage of simple operation and less complications
occurrence. Thus it is worthy of clinic application.
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CLINICAL SIGNIFICANCE OF
METASTASIS-RELATED LONG
NONCODING RNA IN
HEPATOCELLULAR CARCINOMA
Wei-Xing Guo
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background: Although a great improvement has been
made in recent years, the mechanisms of hepatocarcino-
genesis still remain unclear. Emerging studies have
shown that long noncoding RNAs (lncRNAs are
involved in the process of tumorigenesis.
Methods: Using gene-expression profiling, we assessed
the differentially expressed lncRNAs between CSQT-2
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and Hep3B cell lines. A total of 651 HCC patients,
three independent cohorts, were analyzed to further test
lncRNAs association with the process of hepatocarci-
nogenesis through quantitative reverse-transcriptase-
polymerase-chain-reaction assays (qRT-PCR) and in-
situ-hybridization (ISH). As different metastasis stages
of HCC in vivo, 241 patients with different stages of
portal vein tumor thrombus (PVTT) were set as testing
cohort to determine the relationship between lncRNAs
and metastasis of HCC. 372 HCC patients were valida-
tion cohort to analyze the prediction role of lncRNAS
for prognosis of HCC patients no matter whether they
have PVTT or not. In addition, 38 HCC patients who
had received systemic therapy to sorafenib after under-
gone hepatectomy were analyzed to evaluate the differ-
ence lncRNA level response to therapy with sorafenib.
Results: A long nocoding RNA-BX648637 was mark-
edly upregulated in highly metastasis HCC cell line-
CSQT-2 than that in Hep3B, thus termed as metastasis
relation long nocoding RNA (MeRL). A RNA duplex
was formed, which increased stability and expression of
ICAM1 (Intercellular adhesion molecule-1), between
MeRL and ICAM1. In 245 PVTT patients, qRT-PCR
revealed that both MeRL and ICAM1 were higher
expression in PVTT tissue than that in its paired paren-
chyma tumor (tumor,T). Patients with high tumoral
MeRL and ICAM1 expression showed significantly
higher type of PVTT (p = 0.0168 and p = 0.0322) than
those with low expression. In 372 HCC patients,
including 281 patients without PVTT and 91 with
PVTT, there were also high expression levels of MeRL
and ICAM1 in tumor tissue than in its paired peritu-
moral (PT) tissues. Patients whose tumors had high
MeRL had shorter overall survival (p < 0.001) and dis-
ease-free survival (p < 0.001). And they also had bigger
tumor size (p < 0.001), high TNM stage (p = 0.001)
and high rates of intrahepatic metastasis (P < 0.001).
Moreover, analysis of results from 38 HCC patients
indicated that the treatment effective of sorafenib were
better in patients with low tumoral MeRL expression
than those with high (p = 0.043).
Conclusions: The expression levels of lncRNAs differ
between in tumor tissues and in its paired peritumoral
tumor tissues. The MeRL expression level is correlated
with survival of HCC patients and response to adju-
vant therapy with sorafenib.
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PATHOBIOLOGICAL FEATURES OF
HEPATOCELLULAR CARCINOMA
Wen-Ming Cong1 and Meng-Chao Wu2
1Department of Pathology; 2Department of Surgery,
Eastern Hepatobiliary Surgery Hospital, Second
Military Medical University, Shanghai, China
Background and aim: The traditional model of mor-
phological diagnosis on the liver and intrahepatic bili-
ary tumors (LIBTs) can no longer meet the needs of
modern oncology surgery. We aim to explore the estab-
lishment of pathobiological diagnostic mode and tech-
nology system of LIBT.
Method: To systematically summarize the pathological
features of 40656 LIBTs, which were surgically resected
during the period between 1982.1- 2011.12. in Eastern
Hepatobiliary Surgery Hospital, Shanghai, and mean-
while to carry out the screening of tumor molecular
diagnostic markers, new diagnostic projects as well as
applicable diagnostic technical methods.
Results: Based on the analysis of the characteristics of
our large series LIBTs and a systematic literature
review, we propose a new surgicopathological classifica-
tion of LIBTs comprising three types: tumor-like LIB-
Ts, benign LIBTs, and malignant LIBTs, six subtypes:
lesions derived from hepatocytes; cholangiocytes; vascu-
lar, lymphoid and hemopoietic tissues; muscular,
fibrous and adipose tissues; neural and neuroendocrine
tissues; and miscellaneous tissues, consisting of more
than 100 kinds of LIBTs, which is more than the num-
bers of 30 kind of tumor lesions proposed by WHO’s
classification. We also set up an archival paraffin-
embedded tissue based microdissection technology for
detecting genetic alterations of LIBTs, including the
screening of a sensitive and specific immunohistochemi-
cal spectrum; genomic instability of focal nodular
hyperplasia and hepatocellular adenoma; the risk of
recurrence and metastasis of hepatocellular carcinoma
(HCC) after resection; the clonal origins of recurrent
HCC(RHCC), and so-called dual-phenotype HCC
(DPHCC) that displays typical morphological features
to strongly coexpress both hepatocyte and cholangio-
cyte markers within the same tumor cells, etc. There-
fore, a pathobiological diagnostic mode with the
characteristics of LIBTs is primarily established in our
Department. During this period of time, we also put
forward some new concepts such as HCC beyond 3 cm
can be used as a predictor of relatively benign behavior
and a turning point of biological transformation; there
were 6 sub-molecular clonal patterns of RHCC, sug-
gesting different clonal origins; patients with DPHCC
have poor outcomes than those with classical HCC,
suggesting a new entity or a new subtype of HCC, etc.
Conclusions: Pathobiological features of LIBTs consti-
tute an important foundation for clinical diagnosis and
treatment. More attention should be paid to the upda-
tion of tradition pathological diagnostic mode and
provision the new index system for clinical treatment
programs.
272
PANCREAS TRANSPLANT AT TAIPEI
VETERANS GENERAL HOSPITAL
Yi-Ming Shyr
10 F 201 Section 2 Shih-Pai Road, Taipei, Taiwan
Background: Insulin-dependent diabetes mellitus
(IDDM) or Type 1 diabetes eventually leads to
nephropathy, neuropathy, retinopathy and angiopathy
after 10–30 years. Currently, pancreas transplant is the
treatment of choice in tight control of blood sugar for
IDDM patients, and further to stabilize, prevent or
even to reverse the diabetic complications. According
to the International Pancreas Transplant Registry
(IPTR) and United Network for Organ Sharing
(UNOS), over 25,000 cases of pancreas transplant have
been performed worldwide, with an increase of more
than 1,600 – 1,800 cases per year, mainly in the USA.
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The 1-year pancreas graft survival rate is 86.0% and 5-
year is 69.8%, very close to those of kidney transplant.
Among the whole pancreas transplants, 80% are simul-
taneous pancreas-kidney transplant (SPK), 15% pan-
creas after kidney transplant (PAK), and 5% pancreas
transplant alone (PTA).
Materials: From 2003 to 2012, there were 77 pancreas
transplants performed for 74 patients at Taipei Veter-
ans General Hospital, with 29 SPK, 8 PAK, 36 PTA
and 4 PBK.
Results: The blood sugar usually returned to normal
level within 5 hours (median) after revascularization of
the pancreas grafts. The fasting blood sugar maintained
within normal range thereafter throughout the whole
clinical course in most cases. The technical success rate
was 95.5%. There were 8 graft loss, due to acute rejec-
tion in 1, chronic rejection in 2, technique failure in 3
and 2 died with functioning graft, and 4 of them
received another successful re-transplant. All SPK
patients are free from dialysis, but 1 primary non func-
tion of kidney graft. Post-transplant infection disease
included 5 CMV gastroenterocolitis, 1 CMV pneumo-
nia, 4 UTI (urinary Tract Infection), 2 BK virus infec-
tion,3 herpes zoster infection, 1 pseudomembraneous
colitis, 2 varicella zoster infection, 1 skin infection with
MRSA and cryptococcus, 2 bacterial pneumonia, 1 sep-
sis.
Conclusion: Pancreas transplant provided an ideal insu-
lin-free solution for DM, especially IDDM. Pancreas
transplant could be performed with similar successful
rate of kidney transplant if they were done simulta-
neously.
273
LYMPHADENOPATHIC KAPOSI’S
SARCOMA MIMICKING PTLD AFTER
PANCREAS TRANSPLANT
Yi-Ming Shyr
10 F 201 Section 2 Shih-Pai Road, Taipei, Taiwan
Background: Kaposi’s sarcoma currently comprises
more than 5% of all de novo neoplasms in this group.
The average time to development of Kaposi sarcoma
following transplantation is 15-30 months. Human her-
pesvirus 8 (HHV-8) genomic sequences have been iden-
tified by polymerase chain reaction in more than 90%
Kaposi sarcomas.
Materials: From 2003 to 2012, Kaposi’s sarcoma was
identified for study from 73 patients with 77 pancreas
transplants performed at Taipei Veterans General Hos-
pital. Literature review was also done.
Results: Only one case of Kaposi’s sarcoma was identi-
fied, with an incidence of 1.5%. The patient suffered
from varicellar zoster Infection (chicken pox) 11
months after pancreas transplant alone (PTA). Four
months later (15 months after PTA), lymphadenopathy
with enlargement of multiple lymph nodes in neck,
around celiac trunk, along the superior mesenteric
artery and abdominal aorta, which mimicked post-
transplant lymphoproliferative disorder (PTLD). The
biopsy for pathology turned out to be Kaposi’s sar-
coma. HHV-8 viral gene was detected by the molecular
(PCR) assay. The lymphadenopathic Kaposi’s sarcoma
regressed 3 months after treatment by adding sirolimus,
reducing the dose of tacrolumus and discontinuing my-
cophenolate mofetil. There has been no evidence of
tumor recurrence for almost 3 years, and he has been
enjoying an insulin-free life with euglycemia for more
than 3 years.
Conclusion: This is an unusual HHV-8 associated Ka-
posi’s sarcoma mimicking PTLD presenting as lymph-
adenopathic form, instead of usual cutaneous form.
Sirolimus is recommended for the treatment of Kapos-
i’s sarcoma, in addition to reduction, cessation or mod-
ification of immunosuppressive regimen.
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APPLICATION OF THREE-
DIMENSIONAL VISUALIZATION
TECHNOLOGY IN PRECISE
DIAGNOSIS AND TREATMENT FOR
HEPATOLITHIASIS
Chi-Hua Fang
Department of Hepatobiliary Surgery, Zhujiang
Hospital, The Southern Medical University, Guangzhou,
China
Background: Hepatolithiasis (HL) is a prevalent disease
in Southeast Asia. Its treatment mainly relies on surgi-
cal intervention. Nevertheless, the calculi are deeply
buried in hepatic parenchyma and usually intangible
and the position of the biliary stricture are highly vari-
ant, which causes difficulties in the diagnosis and treat-
ment.
In recent years, the application of three-dimensional
(3D) techniques in biliary surgery, currently remains
largely in the stage of laboratory researches. In this
study, we try to assess the value of 3D technology in
guiding the surgeries for patients with hepatolithiasis.
Objective: To assess the value of three-dimensional(3D)
visualization technique in preoperative diagnosis, pre-
operative evaluation and surgical guidance for hepato-
lithiasis.
Methods: The 64-slice spiral CT data of 124 hepatolith-
iasis cases were imported in a self-designed medical
image processing system for 3D reconstruction of the
intrahepatic bile duct. The preoperative diagnosis and
pathological classification were derived from the recon-
structed model, with which the feasibility and safety of
the surgical plan were assessed by simulation of the
surgical procedures estimated by blood loss, blood
transfusion volume and short- and long-term complica-
tions.
Results: When the model setting was configured to ren-
der the liver translucent, the system clearly displayed
the site and number of the bile duct calculi as well as
the expansion or narrowing of the intrahepatic bile
duct. Postoperative cholangiography with a T-shaped
tube had the final residual stone rate of 0.3%. 22.6%
of the patients had the right, middle, and left hepatic
vein draining independently into the inferior vena cava
(IVC). 67.7% of the patients showed that the middle
hepatic vein(MHV)and the left hepatic vein(LHV)
shared a common trunk. 9.7% of the patients were free
of the LHV. The normal type of the PV was found in
67.7% of the patients, but the variant type was 32.3%,
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including that type I variation was found in 8.9%, type
II variation was 7.3%, type III variation was 12.1%
and other variations were 4.0%. A total consistency
(100%) was found between the surgical findings and
the preoperative findings based on the 3D model, and
also between the actual surgical procedures and the
preoperative simulation in 124 cases. The total inci-
dence of short-term complications was 13.7%, and the
total incidence of long-term complications was 5.6%.
Conclusions: The 3D visualization system allows accu-
rate preoperative diagnosis and precise surgical opera-
tion to avoid the surgical risk in biliary surgery, and
can be of value as a new diagnostic and treatment
modality.
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PERCUTANEOUS TRANSHEPATIC
INJECTION OF HISTOACRYL INTO
THE PSEUDOANEURYSM SAC IS
EFFECTIVE IN TREATMENT OF
HEMOBILIA CAUSED BY
INTRAHEPATIC PSEUDOANEURYSM
In-Seok Choi
Gasoowon-Dong, Seo-Gu, 685, Daejeon, South Korea
Introduction: Hemobilia caused by hepatic artery
pseudoaneurysm is uncommon but potentially lethal.
Intrahepatic arterial pseudoaneurysms are usually
caused by trauma or iatrogenic injury to the liver and
biliary tree. Transcatheter embolization of hepatic
pseudoaneurysms is an effective method of treatment.
However, if transcatheter embolization is not feasible, a
percutaneous transhepatic injection of histoacryl into
the pseudoaneurysm sac with sonographic or CT guid-
ance can be used as an alternative approach.
Case report: Case1: A 73-year old male with a history
of surgery for right trisectionectomy due to hilar cho-
langiocarcinoma (Klatskin tumor type IV) 28days ago,
bleeding was occurred through left PTBD. A 0.8 cm-
sized intrahepatic pseudoaneurysm was found at left
PTBD inserted site in CT scan. We performed a selec-
tive angio-embolization of the pseudoaneurysm through
the left hepatic artery. However, during the procedure,
a tearing of the intima of the proper hepatic artery was
occurred. Transcatheter embolization was not feasible.
So, we directly injected histoacryl into the pseudoaneu-
rysm sac with sonographic guidance. After well control
of pseudoaneurysm by injection of histoacryl, the
patient was recovered completely and seems to be in
excellent condition, 3 month after treatment
Case 2: A 73-year old female with a history of surgery
for gastric cancer(LADG, B-II) 1month ago, was found
duodenal stump leakage, so PCD was inserted through
Seg 6 of liver. Intrahepatic psuedoanuerysm was found
at intrahepatic drainage site. Coil embolization has
been attempted, but it has not been successful due to
collateral vessels. So, we treated same method like
above case. After the treatment, the patient was in sta-
ble condition during 4 month.
Discussion: Transcatheter embolization is a standard
method of treatment of hemobilia caused by intrahe-
patic arterial pseudoaneurysm. However the percutane-
ous transhepatic injection of histoacryl into the
pseudoaneurysm sac was found to be feasible and effec-
tive for pseudoaneurysms after transcatheter emboliza-
tion was failed
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PERCUTANEOUS TRANSHEPATIC
CHOLEDOCHOSCOPE FOR REMOVAL
OF INTRA-HEPATIC DUCTAL STONES
Irene Lo
Queen Elizabeth Hospital, Hong Kong S.A.R., China
Objective: Intrahepatic stones as a result of Recurrent
Pyogenic Cholangitis (RPC) are prevalent in Asia.
Treatment of hepatolithiasis is challenging especially
when there is a wide distribution of stones inside both
liver lobes. Percutaneous transhepatic choledochoscopic
approach under local anesthesia allows clearance of int-
rahepatic (IHD) stones without the need of hepatic
resection. We evaluate our results and outcome on this
treatment modality.
Method: This is a retrospective study from 2001 till
2010. Patients suffered from IHD stones who received
stones clearance by percutaneous transhepatic choledo-
choscope were included. Electrohydraulic Lithotripsy
(EHL), endoscopic basket and balloon dilatation are
tools for stones clearance. The distribution of IHD
stones; the mean number of endoscopic sessions
required; the time interval to achieve complete stones
clearance; successful rate; complications rate and recur-
rent rate are determined.
Results: 117 patients who had IHD stones were treated
by percutaneous transhepatic choledochoscope from
year 2001 till 2010. Mean age was 61. Distribution of
IHD stones included: 42.6% at left lobe; 20.9% at right
lobe and 36.4% in both lobes. 31% had bile duct stric-
ture from RPC while 4.7% had iatrogenic bile duct
stricture. To achieve complete stone clearance, median
number of endoscopic sessions required was 3.6 times
and median time duration required was 14.4 weeks.
Overall complications rate was 3.5%. They included
sepsis (2.2%); haemobilia (1.1%) and bile leak (0.2%).
No procedure related mortality. Successful rate in com-
plete clearance of stones was 86.8%. The overall mean
follow up time after complete stones clearance was 57
months. Overall IHD stones recurrent rate was 13.2%
at a mean time interval of 35.7 months. We observed a
2.6% incidence rate of cholangiocarcinoma transforma-
tion.
Conclusion: Percutaneous choledochoscope is a mini-
mal invasive and safe local anesthetic procedure for
IHD stones clearance. It allows a satisfactory stones
clearance in short term but the long term recurrent rate
is still high when compared to that of liver resection.
However, in patients with wide spread IHD stones or
in elderly patients who have short life expectancy and
high anesthetic risk, percutaneous choledochoscopic
removal of stones is still a treatment option. In selected
patients, a combined approach can help to improve
long term outcome.
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PERCUTANEOUS TRANSHEPATIC
CHOLEDOCHOSCOPE FOR REMOVAL
OF COMMON BILE DUCT (CBD)
STONES WHEN ERCP IS NOT
APPLICABLE
Irene Lo
Queen Elizabeth Hospital, Hong Kong S.A.R., China
Objective: CBD stones can be managed by ERCP effi-
ciently but not in patients who have distorted gastro-
duodenal anatomy. Besides exploration of CBD
(ECBD) under general anesthesia (GA), percutaneous
transhepatic approach under local anesthesia (LA)
offers an alternative way to clear CBD stones by using
choledochoscope. We evaluate our result and outcome
of this percutaneous approach.
Method: This is a retrospective study from 2001 till
2010. Patients who had cholangitis due to obstructing
CBD stones but failed ERCP received Percutaneous
Biliary Drainage (PTBD). PTBD tract was dilated
subsequently to enable the passage of a choledocho-
scope. Electrohydraulic Lithotripsy (EHL) and endo-
scopic basket are tools for stones clearance. Patients
with intrahepatic ductal stones (IHD) simultaneously
were excluded. Reasons for unsuccessful ERCP; num-
ber of endoscopic sessions required; time interval to
achieve complete CBD stones clearance; successful
rate; complications rate and recurrent rate are deter-
mined.
Results: 53 patients who received CBD stones clear-
ance by percutaneous transhepatic choledochoscope
were identified from 2001 till 2010. Mean age was 77.5.
Seventeen out of 53 (32%) had gallstones simulta-
neously but cholecystectomy and ECBD were not per-
formed due to patients’ high anaesthetic risk or
patients refused open surgery. Reasons for unsuccessful
ERCP included post gastrectomy status (70%) and
pyloric stenosis (17%). To achieve complete stones
clearance, median number of endoscopic sessions
required was 2; median time interval required was 10
weeks. Complications rate was 7.5%. No procedure
related mortality. Successful rate of complete stones
clearance was 96.2%. Mean follow up time after com-
plete removal of stones was 38 months. Seven out of 53
(13.2%) had CBD stones recurrence at a mean time
interval of 26.6 months. In stones recurrent group,
none of them had simultaneous gallstones. All the pre-
viously untreated gallstones remained asymptomatic
within follow up period.
Conclusion: In the presence of cholangitis due to
obstructing CBD stones and when ERCP is not appli-
cable, percutaneous transhepatic drainage followed by
choledochoscopic removal of CBD stones under LA is
a safe, minimally invasive and an effective alternative
approach besides exploration of CBD under GA. Pres-
ence of untreated gall stones in this study was not a
factor for recurrent CBD stones after percutaneous
clearance.
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LONG-TERM RESULTS WITH
PROXIMAL SPLENORENAL SHUNT
FOR PREVENTION OF REBLEEDING IN
PATIENTS WITH EHO
Mangla V1, Pal S2, George J2, Dash NR2, Sahni P2,
Acharya SK3, Chattopadhyay TK1 and Nundy S4
1Department of HPB Surgery, Institute of Liver and
Biliary Sciences, New Delhi, India; 2Department of GI
Surgery and Liver Transplantation, All India Institute of
Medical Sciences, New Delhi, India; 3Department of
Gastroenterology and Human Nutrition, All India
Institute of Medical Sciences, New Delhi, India;
4Department of Surgical Gastroenterology and Liver
Transplantation, Sir Ganga Ram Hospital, New Delhi,
India
Background and Aims: Extrahepatic portal venous
obstruction (EHO) is a common cause of portal hyper-
tension in India. It affects the young, has normal liver
function and death is usually due to variceal bleeding.
We analysed the short- and long-term results of proxi-
mal splenorenal shunt (PSRS) in patients with EHO.
Methods: From 1976 to 2010, 731 (511 male; 70%)
patients with EHO who had a history of variceal bleed-
ing with or without growth retardation and/or symp-
tomatic hypersplenism underwent a proximal
splenorenal shunt. Forty (5%) of these were emergency
procedures. The relevant data was extracted from a
prospectively maintained database. An attempt was
made from January 2009 to November 2011 to obtain
up-to-date follow up information on all these patients.
Patient characteristics, short-term results (postoperative
hospital stay, morbidity and mortality), postoperative
outcome, long-term complications and their manage-
ment were analyzed.
Results: The mean age, symptom duration and epi-
sodes of variceal bleeding were 17.6, 6.6 and 3.4 years,
respectively. 268 (36.7%) patients had received endo-
therapy prior to surgery. The incidence of fundal vari-
ces and congestive gastropathy was significantly higher
(p<0.001) in patients who had prior endotherapy.
Although 55% patients had hypersplenism, only 8%
were symptomatic. Overall 8 (1.1%) patients died, 5
(0.7%) after elective and 3 (7.5%) after emergency pro-
cedures. Postoperative morbidity was 10.3%, 9.3%
after elective and 27.8% after emergency procedures.
Mean (SD) postoperative hospital stay was 7.5 (4.6)
days. Reversal of hypersplenism occurred in all
patients. Of the 73% patients followed up for an aver-
age of 70.1 (range 1–364) months, rebleeding occurred
in 50 (9.5%). Need for further endotherapy was obvi-
ated in 89.9%. Liver function remained normal in all
and none developed post-splenectomy infection or
encephalopathy. The estimated 15-year overall and
bleed-free survival was 97.0% and 95.8%, respectively.
Conclusion: In patients with EHO, proximal splenore-
nal shunt provides safe, effective and durable control
of variceal bleeding. In the long-term, PSRS obviates
the need for further endotherapy or blood transfusions
in nearly 90% and ensures a 15-year overall survival of
>95% in these patients.
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MANNOSE-BINDING LECTIN-2 GENE
POLYMORPHISMS ASSOCIATE WITH
THE DEVELOPMENT OF LIVER
DISEASES AFTER HEPATITIS B VIRUS
INFECTION
Xing Gu
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background and aims: Mannose-binding lectin-2
(MBL-2) is an important immunomodulatory factor
that is involved in complement activation and oncogen-
esis. Genetic polymorphisms of MBL-2 were found to
be responsible for MBL-2 functionality, low serum lev-
els and also many disease developments. The aim of
our study was to elucidate the role of MBL-2 geno-
types in the development of liver diseases after HBV
infection. Methods In our study we investigated the
association of single nucleotide polymorphisms (SNPs)
in the first exon (rs7096206) and promoter region
(rs1800450) of the MBL-2 with susceptibility to liver
diseases after HBV infection. We detected the geno-
types of these two polymorphisms in 335 hepatitis B
virus (HBV)-related HCC patients, 97 HBV-related
liver cirrhosis, 133 non-HCC/cirrhosis patients with
HBV infection and 175 healthy controls. Further strati-
fication analysis was also performed according to
patients’ clinic pathologic characteristics, including
TNM stage and Child-Pugh grades.
Results: The prevalence of GG genotype and G allele
of rs1800450 polymorphism was significantly higher
among liver cirrhosis patients compared with healthy
controls. Furthermore, combined with rs7096206 poly-
morphism, AC haplotype is significantly less frequent
in HCC and liver cirrhosis patients. Regretfully, we did
not find the association between these polymorphisms
and patients’ clinic pathologic characteristics.
Conclusions: These results suggest that mannose-bind-
ing lectin-2 polymorphisms seem to be involved in the
development of HBV-induced cirrhosis and hepatocar-
cinogenesis in Chinese population.
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AN EVALUATION OF 11C-ACETATE &
18F-FDG DUAL TRACER PET-CT SCAN
IN DETECTING HEPATOCELLULAR
CARCINOMA
Chiu-Chuen Chan
Flat A, 18/F, Tower 2, Roca Center, 466 King&#039;s
Road, North Point, Hong Kong S.A.R., China
Background: 18F-FDG PET-CT scan is limited by its
high false-negative rate (sensitivity: 60.9%) in detecting
hepatocellular carcinoma (HCC) due to the fact that
HCC cells can have net glycolysis similar to or even
lower than that of normal liver tissue.
Objective: To evaluate the efficacy of 11C-Acetate &
18F-FDG dual tracer PET-CT scan (dual PET scan) in
detecting primary or recurrent HCC.
Method: We retrospectively reviewed dual PET scan
performed for our patients from October 2010 to
October 2011 in 30 suspicious lesions reported by con-
trast CT scan of liver. All the patients were subse-
quently followed up for at least six months.
Results: 30 suspicious lesions were scanned in that per-
iod but 7 were excluded from the study because of their
lack of pathological diagnosis to support the positive
diagnosis of HCC shown by the dual PET scan. The
patients’ age ranged from 46 to 82 with a mean of 64.
All of them were hepatitis B carrier. Male to female
ratio was two to one. Half of them were suspected to
have primary HCC while the others were investigated
for recurrent HCC. There were 15 positive scans and
they were all supported by pathological prove. Two
lesions were reported as negative and they were closely
followed up afterwards for more than 6 months and
supplemented with either ultrasound or CT scan to
confirm their “disease negative” state. For the three
false positive cases, two were operated on which
showed negative pathology results, for the third one
because of its diffuse peculiar Acetate uptake, close fol-
low-up for more than 6 months with repeated CT scan
showed resolution of the suspicious lesion. Two of the
three false negative cases were countered-proved by
positive pathology after resection base on worsening
clinical grounds and the last one was treated by TACE
after follow-up CT scan showed increase in size of the
lesion.
Compared to traditional 18F-FDG PET-CT scan, the
dual PET scan exhibited good results with sensitivity of
83.8% and specificity of 40%. The positive predictive
value was 83.3% and the negative predictive value was
40%.
Conclusion: The dual PET-CT scan can be a useful
adjunct to the traditional imaging methods such as CT
in diagnosing and managing HCC.
331
ROBOTIC ASSISTED SPLEEN-
PRESERVING DISTAL
PANCRETECTOMY
Man-Fung Ho
4/F, Clinical Sciences Building, Prince of Wales
Hospital, Shatin, Hong Kong, Hong Kong S.A.R., China
Aim: To report on technical issue and outcome of
patient having robotic assisted spleen preserving distal
pancreatectomy
Results: The recent introduction of robotics into pan-
creatic surgery has equipped surgeons with even better
tools since the era of minimally invasive surgery began.
Unique advantages of robotic system also applies to
pancreatic resection and allow better dissection, hence
spleen preservation. We described our experience on
spleen-preserving distal pancreatectomy for treatment
of a patient with branch type intraductal papillary
mucinous neoplasm (IPMN) over tail of pancreas.
Patient presented with abdominal pain and CT found a
benign or borderline malignant lesion radiologically.
Robot assisted spleen preserving distal pancreatectomy
was done without resection of splenic vessels. Vascular
branches supplying distal pancreas was divided between
ligatures. Operative time was 458 minutes and blood
lost was 300 ml. Post operatively the patient recovered
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well and discharged day 4 after surgery. Patient was
clinically followed up once as was well since operation.
Conclusion: Robotic spleen-preserving distal pancrea-
tectomy is feasible and safe to perform in our experi-
ence. The advantage of robotic system allows surgeon
to perform more meticulous dissection and potential
advantage on spleen preservation. However, whether
this confers to any clinical benefit is still a question to
answer.
336
OCT4 AND BIRC5 COLLUDE TO
PROMOTE CANCER CELL
PROLIFERATION VIA THE MEDIATOR
CCND1 AND EDUCE POOR
PROGNOSIS IN LIVER CANCER
Chang-Qing Su
No.225 Changhai Road, Shanghai, China
Background: The OCT4 and BIRC5 genes are prefer-
entially expressed in human cancer cells and mediate
cancer cell survival and tumor maintenance. However,
the molecular mechanism that regulates OCT4 and
BIRC5 is not well characterized and requires further
study.
Methods: The expression of OCT4 and BIRC5 was
detected in 7 hepatocellular carcinoma (HCC) cell lines
and 49 HCC specimens, the regulatory mechanism
between OCT4 and BIRC5 and their correlation with
the disease-free survival (DFS) and overall survival
(OS) of HCC patients were analyzed.
Results: OCT4 indirectly enhances the activity of the
BIRC5 promoter and regulates BIRC5 expression in
hepatocellular carcinoma (HCC). CCND1 expression
and promoter activity were strictly consistent with
OCT4 expression levels in HCC cells. An octamer
motif for OCT4 in the CCND1 promoter may have
directly and partly participated in the regulation of
CCND1 promoter activity, suggesting that the OCT4-
mediated overexpression of CCND1 increases BIRC5
expression by activating the BIRC5 promoter. Co-sup-
pression of OCT4 and BIRC5 induces cancer cell apop-
tosis and cell cycle arrest, thereby efficiently inhibiting
the proliferative activity of cancer cells. HCC patients
with OCT4 and BIRC5 co-expression had poorer
disease-free survival (DFS) and poorer overall survival
(OS) than patients who were negative for both OCT4
and BIRC5.
Conclusion: OCT4 and BIRC5 act in collusion to pro-
mote cancer recurrence, resulting in the poor prognosis
of HCC patients. These data suggest that both OCT4
and BIRC5 are potentially beneficial for HCC progno-
sis evaluation and may become targets of HCC treat-
ment.
338
EXTRAHEPATIC BILE DUCT
RESECTION FOR PROXIMAL BILE
DUCT CANCER IN HIGH-RISK
PATIENTS
Rawisak Chanwat
Rama VI Rd., Bangkok, Thailand
Background: Standard operative procedures in the
treatment of proximal bile duct cancer are bile duct
resection plus hepatectomy. Bile duct resection alone is
indicated only when the tumor is a localized type with-
out invasion and spreading. It is also an option for
high-risk patients.
Objective: The purpose of this report was to study the
surgical treatment effect and outcome of proximal bile
duct cancer in high-risk patients.
Methods: Retrospective analysis was conducted for 3
patients who were treated with bile duct resection alone
for bile duct cancer.
Results: This procedure was performed on 3 patients
aged over 70 years with Bismuth type I bile duct cancer.
A tumor-free bile duct resection margin and negative
regional lymph nodes were obtained in all 3 patients.
No complication occurred. Two patients are doing well
without recurrence at 20 and 8 months respectively. One
is alive at 16 months with lymph node metastasis.
Conclusion: Extrahepatic bile duct resection can be an
alternative radical treatment for proximal bile duct can-
cer in selected patients.
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SELECTIVE GLISSONIAN PEDICLE
CONTROL: A USEFUL TECHNIQUE IN
LAPAROSCOPIC LIVER RESECTION
Rawisak Chanwat
Rama VI Rd., Bangkok, Thailand
Background: Laparoscopic liver resections are becom-
ing a common procedure and bleeding remains the
major concern during parenchymal transection. Prin-
gle’s maneuver can be performed but ischemic reperfu-
sion injury can lead to postoperative morbidity.
Selective hemi hepatic inflow control can reduce the
severity of visceral congestion and total liver ischemia.
Objective: The purpose of this report was to describe
our experience with laparoscopic selective Glissonian
pedicle control for minor hepatic resection.
Methods: Ten patients submitted to laparoscopic liver
resection in our institute due to malignant lesion.
Results: The technique was successfully performed with-
out complication. The tumor size was 4.3 cm (range, 2.5
–8.0 cm). Mean operative time consumed to achieve
complete control of right or left pedicle was 26.5 min
(range, 18–46 min). Mean intraoperative blood loss was
150 ml (range, 50–300 ml) and no blood transfusion was
needed. The postoperative course of the patients was
uneventful and they were discharged an average of 4.8
days (range, 3–7 days) after the operation.
Conclusion: Safe laparoscopic liver surgery requires
knowledge of the regular techniques of vascular occlu-
sion for on-demand use when necessitated to reduce
blood loss.
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DIAGNOSTIC VALUE OF SERUM N-
GLYCOMICS IN
CHOLANGIOCARCINOMA
Meng Fang
225 Changhai Road, Shanghai, China
Background and aims: Cholangiocarcinoma (CC) is a
primary malignancy of the epithelial lining of the bili-
ary tree. Early stage CC often goes undetected, so most
patients are diagnosed at an advanced or disseminated
stage with a poor prognosis. Imaging techniques are
still the most important diagnostic tools, and carbohy-
drate antigen 19-9 (CA19-9) is the most common used
serum biomarker in laboratory test to identify CC. A
more sensitive and specific non-invasive serological
marker is required for the early diagnosis of CC, and
the present study is to assess the diagnostic value of N-
glycan in CC.
Methods: N-glycome of glycoprotein was profiled using
DNA sequencer-assisted fluorophore - assisted carbo-
hydrate electrophoresis (DSA-FACE) technique in a
total of 249 cases of serum, including 88 cases of CC,
28 cases of cyst of bile duct, 44 cases of calculus of bile
duct, as well as 89 cases of healthy control. The diag-
nostic effect of N-glycans were evaluated by the recei-
ver operating characteristic curve (ROC) analysis and
indicated by area under the curve (AUC).
Results: A total of 12 main N-glycan peaks were ana-
lyzed in the profiles, and structures of all these peaks
were identified previously. When compared with
healthy controls, serum N-glycan profiles in cyst
patients showed no significant changes, while peak1
(agalacto core-a-1,6-fucosylated biantennary glycan)
and peak2 (agalacto core-a-1,6-fucosylated bisecting bi-
antennary glycan) raised significantly in patients with
calculosis. Three fucosylated triantennary glycans
peak9, peak 10 and peak11 increased dramatically in
CC cases compared to that in other three groups (p
< 0.001). Meanwhile, these three peaks showed elevated
levels in CC with lymphatic metastasis compared with
CC without lymphatic metastasis. Peak10 was most
effective among N-glycan peaks in distinguishing CC
from other three groups upon ROC analysis. We estab-
lished a mathematical N-glycan based model combined
with CA19-9 as CA19-99p10, and the combined math-
ematical model improved diagnostic value to identify
CC. To differentiate CC from healthy controls, the
AUC of combined model, peak10 and CA19-9 was
0.943, 0.922 and 0.936, respectively. Similarly, the com-
bined model has more effective diagnostic value to dis-
tinguish CC from cyst cases and calculus cases than
peak10 or CA19-9 alone, as the AUC were 0.930 vs.
0.905 vs. 0.920, and 0.871 vs. 0.850 vs. 0.835, respec-
tively.
Conclusions: N-glycans are promising to be non-inva-
sive biomarkers for CC. The diagnostic model based
on N-glycans and CA19-9 could improve the efficacy in
CC diagnosis and progression monitoring.
348
ACUTE BILIARY PANCREATITIS –
DIAGNOSIS, MANAGEMENT AND
OUTCOME, SINGLE CENTER
EXPERIENCE
Vijay Borgaonkar
Seth Nandala Dhoot Hospital, Aurangabad,
Maharashtra, India
Till recently, two most common causes of acute pancre-
atitis were thought to be alcohol and idiopathic. With
better understanding of the subject more number of
patients of acute pancreatitis with biliary etiology are
detected. With more detailed investigations number of
idiopathic acute pancreatitis are declining. Biliary
sludge and microlithiasis has been proved to be the one
of the prominent etiological factors. In a case of severe
acute pancreatitis biliary etiology should be considered
in the presence of rise in serum bilirubin and alkaline
phosphatase level, presence of multiple small calculi
with sludge in the gall bladder and/or dilatation of the
common bile duct with presence of sludge or calculi.
Endoscopic ultrasound (EUS) is the best diagnostic
tool to detect micro lithiasis or calculi in common bile
duct. Since EUS services and expertise is not available
in all the centers, diagnosis can be entertained on
abdominal ultrasonography and biochemical tests. This
is a single center experience in the management of
severe acute biliary pancreatitis at Seth Nandalal
Dhoot Hospital, Aurangabad, India from 2009 to 2012.
During this period total 148 patients were treated for
severe acute pancreatitis. Out of these 22 were found to
be biliary pancreatitis. Of these 13 patients underwent
ERCP and papillotomy was performed. Four of these
patients also had to undergo biliary duct stenting. All
the patients of biliary pancreatitis were advised chole-
cystectomy in the same hospital admission. Open chole-
cystectomy was done in 5 patients along with
pancreatic necrosectomy while 15 patients underwent
laparoscopic cholecystectomy.
Conclusion: Patients of acute biliary pancreatitis need
to be recognized and diagnosed immediately on admis-
sion. E .R. C. P. and endoscopic interventional proce-
dures should be timely done. If not diagnosed and
treated promptly they carry high morbidity and mortal-
ity. Cholecystectomy is recommended in the same hos-
pital stay to prevent recurrence. Laparoscopic
cholecystectomy is feasible in majority of the patients.
349
HYPERPARATHYROIDISM – A RARE
CAUSE OF ACUTE PANCREATITIS
Vijay Borgaonkar
Seth Nandala Dhoot Hospital, Aurangabad,
Maharashtra, India
Introduction: Hyperparathyroidism is considered to be
a rare cause of pancreatitis. Various mechanisms have
been described for hyperparathyroidism leading to
acute pancreatitis. One of them is conversion of inac-
tive trypsinogen to active one by hypercalcemia. Rou-
tinely in acute pancreatitis hypocalcemia is observed.
Raised serum calcium levels in the setting of acute
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pancreatitis should raise the suspicion of hyperparathy-
roidism. In the management of these cases treatment of
hyperparathyroidism should be considered promptly
and in the initial stage of management.
Case report: 66 years old, diabetic lady, thin built,
emaciated, presented with acute abdominal pain in epi-
gastric region with tachycardia, tachypnea and tender-
ness, guarding all over the abdomen. She had repeated
attacks of similar pain since last 6 months. There was
no history of alcohol abuse and patient had no history
of endocrine disease. Investigations revealed raised
serum amylase, lipase. Serum calcium was raised. USG
and CT abdomen revealed signs of acute pancreatitis
with bilateral urolithiasis.
Patient was put on standard treatment of severe acute
pancreatitis but did not show much clinical recovery in
first week. In view this clinical situation Parathormone
(PTH) level was estimated and found to be raised.
Patient underwent 99m Tc MIBI Nuclear scan which
revealed parathyroid adenoma. Parathyroid adenoma
was localized at lower pole of left thyroid. After resus-
citation patient was offered surgery for parathyroid
adenoma. Parathyroid adenoma was excised. Serum
calcium and PTH levels dropped after surgery and
patient had a steady improvement.
Discussion: Hyperparathyroidism is a rare cause for
acute pancreatitis however it should be promptly sus-
pected in a setting of hypercalcemia with acute pancre-
atitis. Various mechanisms have been described for
hyperparathyroidism producing acute pancreatitis. One
of them is activation of trypsinogen by hypercalcemic
status. PTH itself has been suggested as a cause of pan-
creatitis. It may inhibit pancreatic blood circulation
directly or hypercalcemia might affect blood vessels as
well as pancreatic duct leading to narrowing of ducts
and vessels. Some authors have described that PTH
may act as a toxin and produce local thrombo end
arteritis and necrosis of pancreatic tissue.
Our case supports relationship between parathyroid
adenoma and pancreatitis. There was no other demon-
strable cause for pancreatitis and symptoms resolved
with good clinical improvement after removal of para-
thyroid adenoma.
351
AN EVALUATION OF 11C-ACETATE
AND 18F-FDG DUAL TRACER PET-CT
SCAN IN DETECTING
HEPATOCELLULAR CARCINOMA
Chiu-Chuen Chan
Flat A, 18/F, Tower 2, Roca Center, 466 King’s Road,
North Point, Hong Kong S.A.R., China
Background: 18F-FDG PET-CT scan is limited by its
high false-negative rate (sensitivity: 60.9%) in detecting
hepatocellular carcinoma (HCC) due to the fact that
HCC cells can have net glycolysis similar to or even
lower than that of normal liver tissue.
Objective: To evaluate the efficacy of 11C-acetate and
18F-FDG dual tracer PET-CT scan (dual PET scan) in
detecting primary or recurrent HCC.
Method: We retrospectively reviewed dual PET scan
performed for our patients from October 2010 to
October 2011 in 30 suspicious lesions reported by con-
trast CT scan of liver. All the patients were subse-
quently followed up for at least 6 months.
Results: 30 suspicious lesions were scanned in that per-
iod but 7 were excluded from the study because of their
lack of pathological proof to support the positive diag-
nosis of HCC shown by the dual PET scan. The
patients’ age ranged from 46 to 82 with a mean of 64.
All of them were hepatitis B carriers. Male to female
ratio was two to one. Half of them were suspected to
have primary HCC while the others were investigated
for recurrent HCC. There were 15 positive scans and
they were all supported by pathological proof. Two
lesions were reported as negative and they were closely
followed up afterwards for more than 6 months and
supplemented with either ultrasound or CT scan to
confirm their “disease negative” state. For the three
false positive cases, two were operated on which
showed negative pathology results, for the third one
because of its diffuse peculiar acetate uptake, close fol-
low-up for more than 6 months with repeated CT scan
showed resolution of the suspicious lesion. Two of the
three false negative cases were countered-proved by
positive pathology after resection base on worsening
clinical grounds and the last one was treated by TACE
after follow-up CT scan showed increase in size of the
lesion.
Compared to traditional 18F-FDG PET-CT scan, the
dual PET scan exhibited good results with sensitivity of
83.8% and specificity of 40%. The positive predictive
value was 83.3% and the negative predictive value was
40%.
Conclusion: The dual PET-CT scan can be a useful
adjunct to the traditional imaging methods such as CT
in diagnosing and managing HCC.
357
JAUNDICE AND LIFE-THREATENING
HEMOBILIA – A RARE PRESENTATION
OF ADULT CHOLEDOCHAL CYSTS
Peng Soon Koh
Department of Surgery, Faculty of Medicine, University
of Malaya, Lembah Pantai, Kuala Lumpur, Malaysia
Background: Haemobilia with jaundice as a result of
cholestasis and bleeding from a choledochal cyst is
uncommon. Ascertaining the diagnosis is often chal-
lenging and a delay in diagnosis can have significant
consequences with haemodynamic instability and
potential mortality. Although surgery remains the
definitive treatment modality, interventional radiology
for haemostasis is increasingly recognised as an option.
Methods: Due to this rare presentation, we present a
case series of two patients presented to our institution
from 2007 to 2012 with jaundice and hemobilia associ-
ated with a choledochal cyst and the challenges associ-
ated with its clinical diagnosis and management.
Results: Case one – -a 37-year-old lady presented to us
with upper gastrointestinal bleeding (UGIB) for one
day associated with high grade fever and symptoms of
obstructive jaundice for 1-month. She was haemody-
namically unstable on arrival. Initial diagnosis of
ascending cholangitis with underlying upper gastroin-
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testinal bleeding was made. She had CT scan, OGDS,
ERCP and angiogram done which revealed a diagnosis
of a bleeding choledochal cyst. The bleeding was suc-
cessfully arrested following angiographic embolization
of the gastroduodenal artery which we postulate to
have been eroded by gallstone.
Case two – a 71-year-old male who was incidentally
found to be jaundiced during a procedure for transure-
thral resection of prostate (TURP) in a private centre
and had ERCP performed revealing blood clots in
common bile duct and a bleeder. An ERCP was
repeated in our centre showed a choledochal cyst with
an active bleeder which underwent an urgent endovas-
cular embolization. As patient had a recurrent bleed a
few days later, emergency surgery was performed. The
choledochal cyst was excised and under-running of
bleeder done with successful arrest of further haemor-
rhage.
Conclusion: A good multidisciplinary team approach
involving the surgeons, gastroenterologist and interven-
tional radiologist ensures good optimal outcome to pre-
vent mortality in this extremely rare presentation. Such
presentation should be considered as a differential diag-
nosis in patient with jaundice and haemobilia as it can
be fatal, thereby, warranting immediate and urgent
attention as seen in the above cases.
363
EN BLOC SIMULTANEOUS PANCREAS
AND KIDNEY COMPOSITE GRAFT
TRANSPLANT WITH LIMITED
VASCULAR ACCESS
Shin-E Wang
10 F 201 Section 2 Shih-Pai Road, Taipei, Taiwan
Purpose: Limited vascular access could be encountered
in an obese or re-transplant patient. We described mod-
ifications that facilitated an en bloc simultaneous pan-
creas and kidney (SPK) composite graft transplant in
an obese type 2 diabetic patient with renal failure under
hemodialysis.
Materials and methods: At the back-table, the superior
mesenteric artery and splenic artery of the pancreas
graft were reconstructed with a long “Y” iliac artery
graft. The smaller left renal artery is anastomosed end-
to-side to the larger and longer common limb of the
arterial Y graft and the shorter portal vein is anasto-
mosed end-to-side to the longer graft left renal vein.
Thus, this en bloc composite graft allowed to facilitate
“real” SPK transplant using single common graft artery
and vein for anastomosis to one recipient arterial and
venous site. The en bloc pancreas and kidney compos-
ite graft was implanted by suturing the graft left renal
vein to IVC and graft common iliac artery the recipient
distal aorta. Exocrine drainage was provided by anasto-
mosis of the graft duodenum to a roux-en-y jejunum
limb in a side-to-side fashion. Immunosuppressants
included basiliximab, tacrolimus, mycophenolate mof-
etiland methylprednisolone.
Results: The operative time was 7 h with cold ischemic
time of 6 h and 25 min and warm ischemic time of
47 min. The patient was discharged on postoperative
day 20, with a serum creatinine level of 1.4 ng/mL and
a blood glucose level of 121 mg/dL. He has not had
any rejection episodes or postoperative complications
in the following 12 months after the en bloc SPK trans-
plant.
Conclusion: En bloc pancreas and kidney composite
graft might be an option for patients with limited vas-
cular access. This technique (1) facilitates “real” simul-
taneous pancreas and kidney (SPK) transplant with
only single common artery and vein for implanting the
composite graft; (2) minimizes dissection of vessels and
conserves recipient vessels.
365
GEMCITABINE PLUS NAB-
PACLITAXEL SHOWS A SIGNIFICANT
ANTITUMOR ACTIVITY IN
RESECTABLE PANCREATIC CANCER,
ASSESSED BY ELASTOGRAPHY
Emilio Vicente
Madrid, Spain
Introduction: For pancreatic cancer, complete macro-
scopic resection in combination with chemo-radiother-
apy is the only potentially curative treatment. Despite
this, overall survival is still poor, maybe because the
reduced absorption of the chemotherapy, affected by
the stromal surrounding the pancreas. Nab-paclitaxel
demonstrates clinical activity when administered in
combination with gemcitabine in advanced pancreatic
cancer, maybe disrupting the pancreatic cancer stroma.
Aim: This study was designed to determine the efficacy
of this combination in patients with operable pancreatic
adenocarcinoma, analysing moreover the efficacy of
preoperative elastography to assess it.
Methods: From a prospective database, from Septem-
ber 2011 to February 2012 patients with resectable to
borderline resectable pancreatic cancer were identified.
All of them underwent neoadjuvant treatment with
gemcitabine (1000 mg/m2 days 1, 8 and 15) and nab-
paclitaxel (125 mg/m2 days 1, 8 and 15) for two cycles
prior to surgery. All tumors were monitored with elas-
tography twice: before and after the two cycles. After
surgery all the specimens were evaluated to assay tumor
regression rate (TRR) (Ryan score).
Results: Among 15 patients included, 6 were excluded:
3 patients showed a progression disease (hepatic metas-
tases) and finally not operated; other 3 for the pathol-
ogy report of neuroendocrine tumor. One patient had a
complete pathological response (TRR 0) and seven
patients had near complete responses tumor (TRR 1).
Only one patient had no pathological response (TRR
3). Specimen TRR 3 was poorly differentiated, while
the remaining were well (n = 4; 50%) and moderately
differentiated (n = 4; 50%). The rest of the studied
variables (tumor size, affected lymph nodes, T invasion
and lymphovascular/perineural invasion) were similar
between the two groups. Specimen TRR 3 showed a
decline of only 6% of tissue stoma with elastography;
the remaining 8 TRR 0-1 specimens showed a decrease
significantly higher decline with an average of 71%
(range: 11.4290.19%) (p = 0.003).
Conclusions: Neoadjuvant treatment with infusion of
gemcitabine plus nab-paclitaxel induced a high rate of
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pathologic response in patient with pancreatic adeno-
carcinoma. Furthermore, it can be easy monitored by
the no invasive elastography. These results merits fur-
ther studies.
366
ARTERIAL BLOOD SUPPLY OF
HEPATOCELLULAR CARCINOMA IS
ASSOCIATED WITH EFFICACY OF
SORAFENIB
Jing Li
Eastern Hepatobiliary Surgery Hospital, Second
Military Medical University, Shanghai, China
Background and aims: The relationship between prog-
nosis of patients treated with sorafenib and parameters
of computed tomography (CT) and magnetic resonance
imaging (MRI) has been reported. This study aimed to
identify predictive factors for survival placing emphasis
on the correlation of imaging findings and survival.
Methods: From April 2009 to December 2010, 38 HCC
patients treated with sorafenib were included in this
study. HCCs were classified as good arterial supply and
poor arterial supply according to the enhancement
intensity on CT scan or MRI. Clinical data were col-
lected and survival time was analyzed.
Results: Among the 38 patients, the median survival
time (MST) was 10.7 months (95% CI, 8.7–12.7) and
the 1-year overall survival (OS) was 41.0%. On univari-
ate analysis, patients with good arterial supply of
tumors had longer survival time compared with that of
patients with poor arterial supply of tumors
(p = 0.002), and only arterial supply of the tumors
remained statistically predictive for overall survival on
multivariate analysis (HR 0.22, 95% CI, 0.07–0.67,
p = 0.008).
Conclusion: Arterial blood supply is an independent
predictor for survival in patients treated with sorafenib,
and patients with good arterial supply of tumors bene-
fit more than those with poor arterial supply of
tumors.
367
NURSING OF ADVERSE EFFECTS IN
PATIENTS TREATED WITH LIVER
RESECTION PLUS SORAFENIB FOR
HEPATOCELLULAR CARCINOMA
Jing Li
Eastern Hepatobiliary Surgery Hospital, Second
Military Medical University, Shanghai, China
Background and aims: The combination of surgical
resection and sorafenib therapy becomes interested by
clinical physicians. This study aims to observe the
adverse effects in patients with hepatocellular carci-
noma treated by liver resection plus sorafenib, and
search for the nursing options.
Methods: From April 2009 to December 2010, all
patients with hepatocellular carcinoma treated by liver
resection plus sorafenib were prospectively included in
the study. Adverse effects were observed and nursing
options were given.
Results: A total of five patients were included in the
study, the mean age was 38.6  13.4 years. All the five
patients had different degrees of adverse effects, of
which 5(100%) had diarrhea, 3(60%) had hand-foot
skin reaction, 1(20%) had hypertension and 1(20%)
had alopecia. All patients had diarrhea within 1 month
after operation. No patients had grade 3/4 adverse
events. Given nursing interventions and some medica-
tions, none of patients suffered dose reduction or treat-
ment discontinuation.
Conclusions: The incidence of diarrhea was high in
patients treated with liver resection plus sorafenib.
Given psychological and symptomatic nursing guid-
ance, all the adverse effects can be tolerable.
368
A HEPATO-PANCREATO-BILIARY
DEPARTMENT MODEL TO IMPROVE
THE ROBOTIC SYSTEM
Emilio Vicente
Madrid, Spain
Background: Robotic surgery has emerged as one of
the most promising surgical advances since its introduc-
tion. Despite its worldwide acceptance in many differ-
ent surgical specialties, high level experience surgical
centers are still lacking.
Reasons of it can be found in only few numbers of
robotic centers that currently exist in the world, in the
low interest of most surgeons still more attracted by
laparoscopic surgery and finally in the high cost of it.
Aim: This report aims to describe the organizational
system we have developed progressively in our center in
order to improve the use and the efficacy of robotic
System.
Methods: Our center is a no public university hospital
which has a single robotic system that can be used
simultaneously any day of the week by the general sur-
geon, urologist and gynaecologist staff. Almost all days
of the week the robotic area is used by general surgery
department. The department of general surgery consists
of eight surgeons with two surgeons who have extensive
experience in oncological abdominal surgery. There are
not specific sub-speciality areas and generally high com-
plexity surgical procedures are commonly performed by
the two experienced surgeons. The first 65 cases were
performed exclusively by the two experienced surgeons
with three more surgeons that joined the Robotic Sys-
tem 6 months ago.
Abdominal disease subsidiary of robotic surgery are
performed under the medical insurance coverage thanks
to an agreement resulting in a slight lower salary for
the surgeon.
Results: Since the first robotic surgery performed
2 years ago in our department, a total of 81 robotic
surgical procedures have been performed, 36 of them in
the first 6 month of this year, most of them for oncol-
ogy diseases.
We harvested a 5% of conversion rate with an overall
morbidity of 19% and without post-operative mortal-
ity.
Conclusions: The organizational model previously
described is facilitating the constant and progressive
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development of the robotic surgery. A broad and flexi-
ble availability of the robotic system, a progressive
increase of surgeons joining this approach, the absence
of sub-specialty areas and the insurances agreements
with the hospital has facilitated the development of the
robotic system in our center.
375
HEPATOPANCREATO
DUODENECTOMY WITH PORTAL VEIN
RECONSTRUCTION USING LEFT
RENAL VEIN IN ADVANCED BILE
DUCT CANCER
In Seok Choi
Daejeon, South Korea
Introduction: An aggressive surgical management of the
advanced bile duct cancer has improved survival signifi-
cantly in recent years. In the advanced bile duct cancer,
hepatopancreatoduodenectomy (HPD) is necessary to
accomplish curative complete resection, even though
high rates of morbidity and mortality still remain. We
reported our experience with HPD with portal vein
reconstruction using left renal vein in advanced bile
duct cancer and discuss the clinical significance of this
challenging case.
Case report: A 47-year-old male was admitted in
Konyang University Hospital with a chief complaint of
jaundice. CT showed with 7 cm sized mass located at
S4,5a with GB and duodenal invasion, and invaded to
right and confluent portal vein, right hepatic artery, as
well as metastatic lymph nodes in the hepatoduodenal
ligaments. MRCP showed that mass forming and peri-
ductal infiltrative type Klatskin tumor (type IIIa)
invaded GB and duodenum. So, right hepatectomy
with S4a segmentectomy and caudate lobectomy with
portal vein reconstruction using left renal vein, and
pancreatoduodenectomy with radical lymph node dis-
section was performed.
Estimated blood loss was 1000 mL and operative time
was 12 h 10 min. Diet was stated at POD 6 and dis-
charged at POD 18 without complications. The patient
was received 7-cycle chemotherapy and doing well 7-
month after surgery.
Conclusion: Hepatopancreatoduodenectomy with
simultaneous resection and reconstruction of the portal
vein using left renal vein is technically demanding.
However, this surgery may offers a better chance of
long-term survival in selected patients.
376
INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASM OF THE BILE
DUCT WITH INTRAHEPATIC RUPTURE
In Seok Choi
Daejeon, South Korea
Introduction: Mucin producing intraductal papillary
neoplasm of the bile duct(IPMN-B) has previously been
reported in various terms including intraductal papil-
lary neoplasia of the liver, mucin-hypersecreting biliary
papillomatosis, and mucin-producing cholangiocarcino-
ma. At present, no definitive terminology or definition
has been decided by World Health Organization,
because it has a similar histopathologic features of in-
traductal papillary mucinous neoplasm of the pancreas
(IPMN-P), the term of “intraductal papillary mucinous
neoplasms of the bile duct” is frequently used. Espe-
cially malignant IPMN-B is referred as intraductal
growth type of intrahepatic cholangiocarcinoma (ICC),
which is a rare disease and reveal a more favorable
prognosis than other types of ICC such as mass-form-
ing type and periductal-infiltrating type. Therefore
through precise preoperative diagnosis and wide com-
plete resection of the lesions, a more favorable progno-
sis can be expected.
Case presentation: A 52-year male patient was admitted
for RUQ pain during 4 days through ER. He had no
special past medical and social history. He had right
shoulder pain and febrile sensation. Vital sign was 100/
72 mmHg, 30 beats/min, 25 Resp. rates, 37.2 °C. His
physical examination showed mile tenderness of RUQ
abdomen and enlarged palpable liver. Initial laboratory
values revealed WBC 14,700, Hg 11.7, Plt 132,000, and
AST/ALT of 1,880/1,770 IU/L, TB 2.23 mg/dL, AFP
of 1.47 ng/mL, ca19-9 of 16.2 U/mL, and anti-HBV
AB(+). Initial ABDO CT was shown subcapsular he-
mobilia in right liver with dilated S2,3,4 bile duct with
internal enhancing mass in left bile duct, so diagnosed
malignant IPMN-B with intrahepatic rupture. PET-CT
was shown no distant metastasis and the high FDG
uptake in the tumor within left bile duct. The S4 bile
duct with mass was attached to midportion of middle
hepatic vein, so we performed a modified left hepatec-
tomy with segmental resection of middle-hepatic vein
and reconstruction with gore-tex(8 mm). Operation
time was 7 h 30 min and blood loss was 350 cc. The
histopathologic examination for resected specimen
showed well differentiated, 6 9 4 9 2.5 cm sized, intra-
ductal papillary carcinoma of the bile duct. There was
no metastasis of regional lymph node. The patient had
no postoperative complications and was discharged.
Conclusion: Mucin producing intraductal papillary
neoplasm of the bile duct(IPMN-B) reveal a more
favorable prognosis than other types of ICC, Therefore
through precise preoperative diagnosis and wide com-
plete resection of the lesions, a more favorable progno-
sis can be expected.
377
OPEN LIVER RESECTION WITH
THUNDERBEAT (R) IN A PIG MODEL:
AN INITIAL EXPERIENCE
Xiao-Yan Wang
Singapore
Introduction: Intraoperative massive hemorrhage is the
most serious complication in liver surgery and it will
affect the post surgery morbidity and mortality. To
avoid intraoperative bleeding, several devices for paren-
chymal resection have been developed. In recent years,
a new instrument for coagulation or sealing the vessels,
THUNDERBEAT(R) (Olympus(R)) was developed. It
works by integrating the frictional heat energy ultra-
sonically and bipolar heat energy electrically. By this
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mechanism, the device could seal large vessels up to
7 mm in diameter compared to conventional ultrasonic
energy device. The combination of these two types of
energy enables THUNDERBEAT(R) to increase the
speed of transaction by increasing tissue temperature.
This study demonstrates the safety of the THUNDER-
BEAT(R) in liver resection.
Methods: Two Yorkshire pigs underwent open liver
resection removing 75% of the liver. THUNDER-
BEAT(R) was used during liver transection. Post
resection, we evaluate the presence of bile leak and
hemorrhage. Hemoglobin level was checked immedi-
ately post operation and 24 h later. Blood lost was
recorded for both surgeries.
Results: Blood lost in the first pig was approximately
250 mL. The second pig was 200 mL. Post operation
Hb level is 6.7 g/dL in the first pig and 24 h post oper-
ation the Hb is 8.2 g/dL. Post operation Hb level is
8.0 g/dL in the second pig and 24 h post operation the
Hb is 8.2 g/dL. At the post-mortem, there was no
bleeding and bile leakage in both pigs.
Conclusion: Liver resection can be safely done by using
THUNDERBEAT(R) and with no significant blood
loss during the surgery.
378
UPDATE ON DIAGNOSTIC
APPLICATION OF CONTRAST
ENHANCED ULTRASOUND FOR THE
LIVER
Lei Cheng
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Contrast enhanced ultrasound (CEUS) has been con-
sidered a new diagnostic method with positive effects
on the diagnosis of the liver for decades. Recent years,
owing to technical advantages including 3D-CEUS,
new agents and software for qualification analysis,
CEUS has been demonstrated highly accurate and sen-
sitive. Amount of studies have indicated it is not infe-
rior to contrast-enhanced computed tomography (CT)
and magnetic resonance imaging (MRI) in some aspect.
This review focuses on the recent advances of CEUS
for the diagnosis of liver diseases.
379
LAPAROSCOPIC CHOLECYSTECTOMY
FOR THE PATIENTS WITH LIVER
CIRRHOSIS IN OUR HOSPITAL
Tomofumi Orokawa
Chibana 6-25-5, Okinawa, Japan
Background: Laparoscopic cholecystectomy (LSC) has
been formalized and become the first choice of chole-
cystectomy. Indication of LSC has been expanding for
previously contraindicated cases. It has also increased
enforcement to liver cirrhotic cases. We reported the
LSC for liver cirrhotic cases in our hospital.
Methods: Between April 2004 to December 2011, 1576
patients were underwent LSC in our hospital. Liver cir-
rhotic cases were 17. Eight patients were Child A, eight
patients were Child B, one patient was Child C .Clini-
copathological data were analyzed in each groups. The
comparison between two groups was significant with
p < 0.05 by Mann–Whitney U test and the v2 test.
Results: The median operative time of LSC for the
patients of liver cirrhosis was 97 min. The median
operative time of all cases of LSC was 147 min. There
were significantly different between two groups. The
median postoperative hospital stay of LSC for the
patients of cirrhosis was 4 days. The median postopera-
tive hospital stay of all LSC cases was 2 days. They
were significantly different between two groups. The
median postoperative hospital stay of Child B and C
group was 10 days. The median postoperative hospital
stay of Child A group was 2.5 days. There were signifi-
cantly different between two groups.
Conclusions: Laparoscopic cholecystectomy in patients
with liver cirrhosis is possible to enforcement, but there
is a possibility that operation time and post-operative
hospital stay is prolonged.
380
PANCREATICODUODENECTOMY FOR
PANCREATIC AND PERIAMPULLARY
LESIONS IN THE YOUNG
Shin-E Wang
10 F 201 Section 2 Shih-Pai Road, Taipei, Taiwan
Background and aims: This study is to investigate post-
surgical outcomes after pancreaticoduodenectomy and
assess the biological behavior of periampullary malig-
nancies, specifically in the younger patients <60 years
old.
Methods: Demographics, clinical presentations, surgical
risks, pathological characteristics of the tumor, and sur-
vival outcomes were evaluated between young and old
patients.
Results: There were 585 PD patients, 172 patients were
younger than 60 years of age. Compared with the older
population, there were more neuroendocrine neoplasms
(7.6% vs. 1.9%), and less ampullary adenocarcinoma
(23.8% vs. 32%) and distal common bile duct adeno-
carcinoma (2.9% vs. 8.5%) in younger patients. In the
younger aged patients, lower surgical mortality (2.3%
vs. 8%), shorter hospital stays (21 days vs. 27 days)
and a less advanced stage of cancer (11.4% vs. 19.4%)
were found. The 5-year survival rate was found to be
superior in the young as compared with older patients
in periampullary malignancies (29.5% vs. 25.1%) and
pancreatic head adenocarcinoma (13.5% vs. 7.7%).
Conclusions: PD does not carry more surgical morbid-
ity or post-operative complications in the young,
whereas it is associated with less surgical mortality
when compared with the old. After pancreaticoduoden-
ectomy, younger aged patients have a better 5-year
survival in periampullary malignancy and pancreatic
head adenocarcinoma.
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SEGMENT 6 PRESERVING
HEPATECTOMY FOR CENTRALLY
LOCATED HEPATOCELLULAR
CARCINOMA
Chih-Chi Wang
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung,
Taiwan
Background and aims: In order to preserve liver func-
tion and reduce risk of hepatic failure, extended central
hepatectomy (ECH) (resection of Couinaud’s segments
4, 5, 7 and 8) was proposed for management of cen-
trally located hepatocellular carcinoma (HCC) invading
or in the vicinity of right hepatic vein (RHV) and mid-
dle hepatic vein (MHV). Thick inferior RHV (IRHV),
present only in 20–24% of cases, is sufficient for drain-
age of segment 6 (S6). However, if it is absent, venous
outflow from S6 should be reconstructed. Here, we dis-
cuss our surgical technique of extended central hepatec-
tomy.
Methods: Between 2008 and 2012, five patients with
centrally located HCC invading or in the vicinity of
RHV and MHV underwent ECH. Thick IRHV
(>5 mm in diameter) was preserved during dissection.
Intermittent vascular inflow occlusion with alternate
clamping of the right/left Glissonian pedicles was used.
When congestion/cyanosis of S6 was noticed after tran-
section of RHV, confirmed by intraoperative Doppler
ultrasonography (IODUS), interposition graft for S6
outflow reconstruction has been used. Graft patency
was confirmed by IODUS.
Results: They were all males with mean age of
57 years. Mean future remnant liver volume after
extended right lobectomy on preoperative computed
tomography volumetry for segments 2 + 3 was 27.7%
while on segment 6 preservation it was 44.7%. Mean
tumor diameter was 7.36 cm. ECH was performed in
all cases. Thick IRHV was found in one case. Conges-
tion of segment 6 after RHV division was noted in four
cases. Outflow reconstruction was performed with Gor-
tex graft (8 mm) between RHV stump in S6 and RHV
stump (three cases) or MHV stump (one case) on the
IVC side. Mean parenchymal transection time was
126 min. Only one case needed intraoperative blood
transfusion. Postoperative complications were bile leak
(one case), pleural effusion (two cases), ascites (one
case). Gortex graft patency rate was 75% at 1 month.
There were no perioperative mortalities.
Conclusions: Extended central hepatectomy is a safe
alternative for extended hepatic resection in selected
patients with the aim of preservation of functional liver
parenchyma. Segment 6 outflow reconstruction, if
needed, is feasible with sound patency rate.
382
RESECTION FOR SECONDARY
MALIGNANCY OF THE PANCREAS
Shin-E Wang
10 F 201 Section 2 Shih-Pai Road, Taipei, Taiwan
Background and aims: This study tried to clarify the
role of pancreatic resection in treatment of secondary
malignancy with metastasis or local invasion to pan-
creas in terms of surgical risk and survival benefit.
Methods: Data of secondary malignancy of the pan-
creas from our 19 patients and cases reported in the
English literature were pooled together for analysis.
Results: There were 329 cases of resected secondary
malignancy of the pancreas, including 241 metastasis
and 88 local invasion. The most common primary
tumor metastatic to the pancreas and amenable to
resection was RCC (73.9%). More than half (52.3%)
of the primary cancers with local invasion to the pan-
creas were colon cancer, and nearly half (40.9%) were
stomach cancer. The median metastatic interval was
84 months (7 years) for overall primary tumors and
108 months (9 years) for RCC. The 5-year survival for
secondary malignancy of the pancreas after resection
was 61.1% for metastasis and 58.9% for local invasion,
with 72.8% for RCC metastasis, 69.0% for colon can-
cer, and 43.8% for stomach cancer with local invasion
to the pancreas.
Conclusions: Pancreatic resection should not be pre-
cluded for secondary malignancy of the pancreas since
long-term survival could be achieved with acceptable
surgical risk in selected patients.
385
REVIEW OF CLINICAL
CHARACTERISTICS INTRAHEPATIC
BILIARY CYSTADENOMA AND
CYSTADENOCARCINOMA
Bin Wu
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background and aims: As rare cystic neoplasms of the
liver, biliary cystadenoma and cystadenocarcinoma are
hard to diagnose before pathological examination for
similar clinical and radiological characteristics. We aim
to discuss the diagnosis and treatment of two diseases.
Methods: Patients who underwent liver resection
between January 2001 and December 2011 at EHBH
with biliary cystadenoma (36 cases) and biliary cystade-
nocarcinoma (15 cases) were reviewed.
Results: No significant differences were founded in age,
gender, symptom duration, serum CA199, tumor size
between biliary cystadenoma and cystadenocarcinoma.
Biliary cystadenoma and cystadenocarcinoma were
found 13/6/16, 11/2/2 cases in the left, media and right
lobe of liver respectively, with significant difference
(p = 0.003). Enhanced mural nodule and multiple septa
in radiological features tended to be more common in
biliary cystadenocarcinoma, but statistical significance
is 0.061 and 0.040, respectively. Only 4 of 15 patients
of biliary cystadenocarcinoma received radical resec-
tion.
Conclusions: Biliary cystadenocarcinoma is more fre-
quently occurred in left lobe in liver, and have lower
Hb lever than biliary cystadenoma.It shows more fre-
quently hilar lymph node enlargement, multilocular
lesion and enhanced mural nodule. Most patients with
biliary cystadenocarcinoma cannot be achieved by radi-
cal resection when clinical symptom occurred.
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395
HSULF-1 GENE EXHIBITS
ANTICANCER EFFICACY THROUGH
NEGATIVELY REGULATING VEGFR-2
SIGNALING IN HUMAN CANCERS
Wei-Dan Ji
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Road, Shanghai, China
Background: Human sulfatase 1 (hSulf-1) is a heparin-
degrading endosulfatase that desulfates cell surface hep-
aran sulfate proteoglycans (HSPGs) in extracellular
matrix and negatively modulates heparin-binding
growth factor and cytokine signaling in cell prolifera-
tion. But hSulf-1 function is complicated, and its
molecular mechanism has not been well known.
Methods: Expression of hSulf-1 and vascular endothe-
lial growth factor receptor (VEGFR-2) were detected
by immunohistochemistry in 87 cases of clinical cancer
specimens. To further investigate the functions of
hSulf-1 gene in regulating the VEGFR signaling, a ser-
ies of vectors expressing hSulf-1, hSulf-1 small hairpin
RNA (shRNA) and VEGFR-2 shRNA were generated.
In ovarian cancer cell line SKOV3 and hepatocellular
carcinoma (HCC) cell line BEL-7404, we reactivated
hSulf-1 expression by infection of adenovirus carrying
the hSulf-1 gene (Ad5-hSulf1). HSulf-1 shRNA and
VEGFR-2 shRNA was transfected into the Ad5-hSulf1
infected cancer cells respectively. The expression of
hSulf-1 and p-VEGFR2Tyr1175 were detected by
Western blotting and the cell viability were evaluated
by MTT-assay. To evaluate the effect of hSulf-1 on
tumor growth, we treated human cancer xenografts in
nude mice with Ad5-hSulf1. The microvessel density
(MVD) was performed by CD31 immunohistochemis-
try and the expression of hSulf-1 and p-VEG-
FR2Tyr1175 were examined by western blotting and
immunohistochemistry.
Results: We demonstrated that hSulf-1 expression was
downregulated in 87 cases of cancer specimens com-
pared with their adjacent normal tissues. There is an
obvious decrease of p-VEGFR2Tyr1175 level in the
hSulf-1-positive HCC than hSulf-1-negative HCC
(p < 0.05). hSulf-1 re-expression could downregulate
the VEGFR-2 phosphorylation and inhibit cancer cell
proliferation both in SKOV3 and BEL-7404. When
hSulf-1 expression was re-inhibited by hSulf-1 shRNA,
the content of p-VEGFR2Tyr1175 recovered nearly to
normal levels. The viability of BEL-7404 after transfec-
tion of VEGFR-2 shRNA was further decreased in the
context of hSulf-1 effect. In human cancer xenografts,
tumor growth was inhibited markedly after injections
of Ad5-hSulf1, with the tumor inhibition rates of
46.19% and 49.56% in SKOV3 and BEL-7404 models.
The MVD in tumor tissues were 24.67  6.51 and
52.33  12.34 in the Ad5-hSulf1 and control groups.
hSulf-1 expression significantly reduced tumor micro-
vessel density and also downregulated the expression of
p-VEGFR2Tyr1175 and p-AKTThr308.
Conclusions: The results demonstrated that hSulf-1 re-
expression both in ovarian and HCC cells induces anti-
tumor efficacy by attenuating the phosphorylation of
VEGFR-2 and suppressing angiogenesis. Therefore,
hSulf-1-mediated antiproliferation and antiangiogenesis
could be a reasonable approach for cancer therapy.
399
HEPATIC ANGIOMYOLIPOMA:
RADIOLOGIC-PATHOLOGIC
CORRELATION AND CLINICAL
FEATURES IN 178 CASES
Xiao-Yu Yang
EHBH, Shanghai, China
Aim: To review the main clinical, radiological and
pathological features of hepatic angiomyolipoma
(HAML).
Methods: We retrospectively analyzed the radiologic-
pathologic correlation and clinical features of 178
patients who underwent surgical resection for HAML.
Results: 43 males and 135 females with a median age
of 43.5 years (range: 17–76 years) were enrolled in the
study. Out of the 178 patients, 148 (83%) were hospi-
talized for medical examinations. Routine blood tests,
including those for a-fetoprotein (AFP), carcinoembry-
onic antigen (CEA), and carbohydrate antigen determi-
nant (CA19-9), were normal. Liver function was
classified as Child-Pugh A for all patients. Sixteen
patients were positive for hepatitis B surface antigen
(HBsAg), while two had liver cirrhosis. 75 lesions were
located in the right hepatic lobe, 42 in the left hepatic
lobe, and 12 in the hepatic caudal lobe. All patients
underwent examination by ultrasound sonography
(US), and additional examinations by computed
tomography (CT) and magnetic resonance (MR) were
carried out for 115 and 81 patients, respectively. Vari-
ous diseases including HAML, liver cancer, liver hem-
angioma, hepatic lipoma, hepatic hamartoma, focal
nodular hyperplasia and liver adenoma, were diag-
nosed, each with different radiological appearances. All
the patients underwent liver resection (96 right hepatic
lobectomy, 41 left hepatic lobectomy, and nine caudal
lobe hepatic lobectomy). Several sampled tissues were
positive for HBsAg (93/102, 91.2%), b-catenin (122/
167, 73.1%), myoglobin (105/156, 67.3%), HMB-45
(119/163, 73.0%), D2-40 (143/156,91.7%), and vimentin
(162/169, 95.9%).
Conclusion: The diagnosis of HAML remains difficult
and mainly relies on pathological findings. Although
HMB-45 is considered the main histopathological bio-
marker for HAML, b-catenin, myoglobin, D2-40 and
vimentin may be also helpful in the diagnostic process.
When the diagnosis of HAML is suspicious or hypoth-
esized, surgical resection remains the recommended
strategy due to the difficulty in diagnosis preoperatively
and the potentially invasive growth of the lesion.
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405
SURGICAL TREATMENT OF
BRONCHOBILIARY FISTULA DUE TO
RADIOFREQUENCY ABLATION OF
RECURRED HEPATOCELLULAR
CARCINOMA
Dong Hun Kim
Samsung Medical Center, Sungkyunkwan University
School of Medicine, Seoul, South Korea
Bronchobiliary fistula (BBF) is a extremely rare compli-
cation of radiofrequency ablation (RFA), in which
there is a abnormal communication between the biliary
tract and the bronchial trees. The definite procedure
such as surgery for this BBF should be considered only
when the non-invasive interventions failed. In this
report, we describe the surgical management for BBF
complicated by an abscess which encountered after
RFA in a 52-year-old woman with recurred hepatocel-
lular carcinoma (HCC). She had undergone central bi-
sectionectomy for HCC 7 years ago and been treated
with sixth transarterial chemoembolization and first
RFA for recurred HCC after that. After occurred a
liver abscess and BBF in the posterior section of the
liver, patient was received posterior sectionectomy and
hepaticojejunostomy, drainage of the lung abscess, dia-
phragmatic resection and repair because it was impossi-
ble to drain abscess radiologically. Symptomatic
improvement was achieved by operative treatment, and
pleural effusion and pneumonic consolidation was
obliterated on a 2-month follow-up image.
411
ANALYSIS OF THE RELATIONSHIPS
BETWEEN CLINICOPATHOLOGIC
FACTORS AND SURVIVAL IN
GALLBLADDER CANCER FOLLOWING
A SURGICAL RESECTION
Xin-Wei Yang
Changhai Road 225, Shanghai 200438, China, Shanghai,
China
Background: This study elucidated the relationships
between various clinicopathologic factors and the out-
come of patients with gallbladder cancer (GBC) treated
by surgical resection with curative intent.
Methods: Between January 2003 and January 2011, 76
patients with GBC underwent surgical resection with
curative intent in our hospital. We then conducted a
retrospective analysis of clinicopathologic data. Thir-
teen clinicopathological variables were selected for uni-
variate and multivariate analysis to evaluate their
influence on the outcome.
Results: The actuarial 1-, 3-, and 5-year survival rates
in the 76 resected cases were 56.6%, 32.7%, and
23.8%, respectively. The univariate analysis revealed
that curative resection (p < 0.001), lymph node metas-
tasis (p < 0.001), AJCC stage (p = 0.030), tumor loca-
tion (p = 0.008), histologic differentiation (p = 0.028),
intraoperative blood loss (p = 0.011), and preoperative
jaundice (p = 0.012) were significant risk factors for
survival. Multivariate analysis revealed that noncura-
tive resection and tumor location on gallbladder neck
were significant risk factors for poor outcome.
Conclusions: Curative surgical resection remains the
only effective approach to the treatment of GBC. This
series confirms that jaundice is a poor prognostic fac-
tor. However, the presence of jaundice does not pre-
clude resection, especially in highly selected patients
(when R0 resection is achievable).
413
IMPACTS OF CIGARETTE SMOKING
ON POSTOPERATIVE MORBIDITY AND
OUTCOMES OF PATIENTS AFTER
HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA
Xu-Feng Zhang
No. 277 West Yanta Road, Xi’an Jiaotong University,
Xi’an, Shanxi Province China
Background: Cigarette smoking is recognized as a risk
factor for hepatocellular carcinoma (HCC) develop-
ment. However, its potential influence on postoperative
morbidity and outcome after curative liver resection for
HCC remains unknown. The objective of this study is
to investigate whether preoperative smoking has any
impact on postoperative morbidity and survival after
surgery for HCC.
Patients and methods: The data of 397 patients under-
going curative liver resection for HCC in our unit was
collected and analyzed.
Results: The overall morbidity rate was 40.1% (159 of
397). There were 20 risk factors increasing postopera-
tive morbidity by univariate analysis. However, by fur-
ther multivariate analysis, only liver cirrhosis, smoking
status, pack-years (PY) of smoking and preoperative
platelet count were identified as independent risk factor
affecting postoperative morbidity (p < 0.05). The med-
ian overall survival in non-smokers, former smokers
and current smokers was 35.3 months, 42 months and
31.3 months, respectively, which was not significantly
different grossly, although former smokers seemed to
have better prognosis than current smokers (p = 0.015),
while the median disease-free survival was 30.4 months,
27 months and 24.6 months in the three groups, respec-
tively, which was significantly worse in current smokers
than that in non-smokers (p = 0.029). Compared to
non-smokers, current smokers had higher proportion
of alcohol abuse and tumor capsule formation, but
lower platelet count (p < 0.05, respectively).
Conclusions: Cigarette smoking increases postoperative
morbidity in patients with HCC after surgery. Current
smoking was a risk factor associated with tumor recur-
rence after surgery.
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415
CLINICOPATHOLOGICAL FEATURES
AND SURGICAL OUTCOME OF
INTRADUCTAL PAPILLARY
CHOLANGIOCARCINOMA
Sungho Jo
119, Dandae-ro, Dongnam-gu, Cheonan, South Korea
Background and aims: Despite a marked clarification
for intraductal papillary neoplasm of the bile duct over
recent several years, intraductal papillary cholangiocar-
cinoma (IPC) still remains unknown. This study was
performed to evaluate clinicopathological features and
prognosis with comparison to flat-type cholangiocarci-
noma (FTC).
Methods: Between July 1995 and December 2011, a
total of 80 patients underwent surgical resections for
intrahepatic and extrahepatic cholangiocarcinoma at
Dankook University Hospital. The patients were
divided into two groups according to the final patho-
logic diagnosis; IPC and FTC group. The clinicopatho-
logical characteristics and long-term outcome were
compared between both groups.
Results: A total of 11 patients (13.8%) received a cura-
tive intent surgery for IPC. Mean age of the patients with
IPC was 57.7 (38–72 years) and male patients were dom-
inant. Of them, two patients underwent surgery for
recurrent lesions in regional lymph node and remnant
distal bile duct, respectively, and are now in disease-free
status. One patient was postoperative mortality and two
patients died of recurrent disease about 1 and 4 years
after surgery. There were no statistical differences in age,
gender, tumor location, hospital mortality, and disease-
free survival between the groups. However, surgical radi-
cality, stage, and overall survival were better in the IPC
group. The overall 3-year and 5-year survival rates of the
patients with IPC were 81.8% and 68.2%.
Conclusions: The patients with IPC showed an excel-
lent prognosis compared to the patients with FTC. In
addition, an aggressive surgery for recurrent IPC could
prolong survival in selected cases.
416
INTERNAL VERSUS EXTERNAL
DRAINAGE WITH
PANCREATICOJEJUNOSTOMY AFTER
PANCREATICODUODENECTOMY:
RESULTS OF A PROSPECTIVE
RANDOMIZED TRIAL
Masaji Tani, Manabu Kawai, Seiko Hirono, Ken-ichi
Okada, Motoki Miyazawa, Atsushi Shimizu, Masaki
Ueno, Shinya Hayami and Hiroki Yamaue
122-12 Tsuhada, Wakayama, Wakayama, Japan
Background and aims: Pancreatic fistula can develop to
a fatal complication. This study compared postopera-
tive hospital stay and complications in patients with an
external or internal drainage tube in pancreaticojejun-
ostomy after pancreaticoduodenectomy.
Summary background data: Complications of pancrea-
ticoduodenectomy affect the postoperative course, and
a stent is often placed across the pancreaticojejunosto-
my to reduce complications. However, no study has
previously compared pancreatic stent types with regard
to postoperative course.
Methods: We conducted a prospective randomized trial
with 100 patients who underwent pancreaticoduodenec-
tomy. We compared the effects of external and internal
drainage tubes on postoperative course during the per-
iod from April 2005 to August 2007.
This study has been registered at ClinicalTrials.gov
using the Protocol Registration System (NCT
00628186).
Results: The median postoperative hospital stay was
21 days (range: 8–163 days) in the internal drainage
group, significantly shorter than the median stay of
24 days (range: 21–88 days) in the external drainage
group (p = 0.016). The incidences of pancreatic fistula
by International Study Group on Pancreatic Fistula
criteria were 20% and 26% in the external and internal
drainage groups, respectively. The incidence of pancre-
atic fistula classified as either grade B or grade C was
6% in both groups. The incidence of delayed gastric
emptying was also similar in both groups.
Conclusions: Internal drainage with pancreaticojejunos-
tomy significantly shortened postoperative stay after
pancreaticoduodenectomy and was associated with the
same incidence of complications compared with exter-
nal drainage. Thus, internal drainage with pancreat-
icojejunostomy should be recommended for
management after pancreaticoduodenectomy.
419
SANN-JOONG-KUEY-JIAN-TANG
COULD INHIBIT HEPATIC CANCER
HEP-G2 CELLS BY INCREASING TNF-Α
BUT DECREASING TCTP EXPRESSION
IN VITRO
Meng-Yi Yan1, Yao-Li Chen1, Su-Yu Chien4, Shou-Jen
Kuo1,3, Dar-Ren Chen1,3, Chun-Yuan Cheng1 and
Chin-Cheng Su1,2,3
1Department of Surgery, Changhua Christian Hospital,
No. 135, Nan-Hsiao Street, Changhua City, Changhua
County 500-06, Taiwan; 2Department of Pharmacy,
Changhua Christian Hospital, No. 135, Nan-Hsiao
Street, Changhua City, Changhua County 500-06,
Taiwan; 3Comprehensive Breast Cancer Center,
Changhua Christian Hospital, No. 135, Nan-Hsiao
Street, Changhua City, Changhua County 500-06,
Taiwan; 4Tumor Research Center of Integrative
Medicine, Changhua Christian Hospital, No. 135,
Nan-Hsiao Street, Changhua City, Changhua County
500-06, Taiwan
Background and aims: In 2008, the estimated death of
liver malignant tumor is 47,830 in male; hepatic cancer
is in the second position of the causes of cancer related
death worldwide. Due to current chemotherapeutic
medicines for hepatic cancers are unsatisfactory. Hepa-
tic cancer remains a challenging disease and need to
identify new treatments. Sann-Joong-Kuey-Jian-Tang
(SJKJT), a traditional medicinal prescription, has been
used to treat tumor and lymph node lesions, and exhib-
its cytotoxic activity in many cancer cell lines. In our
previous studies showed that SJKJT could inhibit colon
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cancer colo 205 cells through inducing apoptosis by up
regulate the protein expressions of Fas, TNF-a, Cas-
pase-8 and Caspase-3 in vivo and in vitro. SJKJT are
widely accepted as an option for the treatment of many
human cancers. However, the effects and molecular
mechanisms of SJKJT in human hepatocellular carci-
noma have not been clearly elucidated. In the present
study we evaluated the efficacy of SJKJT in human
hepatic cellular carcinoma Hep-G2 cells.
Methods: The cytotoxicity of SJKJT in hep-G2 cells
was measured by MTT assay. The cell cycles were ana-
lyzed by FACS. The protein expressions of hep-G2
cells were treated with SJKJT were evaluated by wes-
tern blotting. The protein expression of Caspase-3 was
also detected by immunofluorescence staining.
Results: The results showed that SJKJT could inhibit
hep-G2 cells with time and dose dependent. During
SJKJT treatment for 48 and 72 h, the half-maximum
inhibitory concentration (IC50) was 1.48 and 0.94 mg/
mL, respectively. The FACS results showed when
increase the dose of SJKJT could increase the percent-
ages of sub-G1 phase. The immunofluorescence stain
showed hep-G2 treated with SJKJT increase the expres-
sion of Caspase-3. The western blot results showed the
protein expressions of TNF-a, Caspase-8, Caspase- 3
and Bax were up regulated, but the TCTP and Mcl-1
were decreased in hep-G2 cells were treated with
SJKJT.
Conclusions: SJKJT could inhibit human hepatic cellu-
lar carcinoma Hep-G2 cells through inducing apopto-
sis. One of the molecular mechanisms may be through
increasing TNF-a.
425
RECENT TREND OF
HEPATOCELLULAR CARCINOMA IN
ELDERLY PATIENTS UNDERWENT
HEPATECTOMY
Masaki Ueno
811-1 Kimiidera, Wakayama, Japan
Background and aims: Recently the number of Hepato-
cellular carcinoma (HCC) in elderly patients is increas-
ing. Although, in 1990s, hepatectomy for the elderly
HCC were recognized as a high-risk group for postop-
erative morbidity, recent advantages of surgical tech-
nique and perioperative management have reduced
postoperative morbidities and mortality in the elderly
patients. The aim of this study was investigating the
recent trend and the postoperative outcome of hepato-
cellular carcinoma in the elderly patients after 2001.
Methods: From clinical records, retrospectively, 255
patients who initially underwent a hepatectomy for
HCC from January 2001 to December 2010 at Wakay-
ama Medical University Hospital were identified and
reviewed. Of them, three patients who required bile
duct reconstructions or additional simultaneous surgical
procedures other than cholecystectomy were excluded
from this study. In this study, age over than 75 years
old was defined as the elderly patients. Clinical charac-
teristics were compared between the elderly and youn-
ger patients. Risk factors for postoperative
complications (Grade 3, 4 of Clavien’s classification)
were identified by logistic regression analyses. Survival
curve was analyzed by Kaplan–Meier method. Prog-
nostic factors for survival were also assessed using Cox
proportional hazards model.
Results: The population of the elderly patients was
annually increased and 66 patients (26%) were recog-
nized in this study. Incidence of HCC without underly-
ing viral hepatitis was significantly high in elderly
patient. However, the Child-Pugh score was similar
between these two groups. Although the incidence of
ischemic cardiovascular event was significantly high in
elderly patients, the distribution of ASA score 3 was
not differ between these two groups. The tumor status
including tumor size, number, vascular invasion, and
serum AFP level was not significantly different between
the two groups. The independent risk factors [odds
(95% confidence interval)] for postoperative complica-
tions were ASA score 3 [4.6(2.0–10.4)], blood transfu-
sion [2.4 (1.0–5.8)], operation time [1.4 (1.1–1.8)].
Survival after hepatectomy was similar between these
two groups and independent prognostic factors for
elderly HCC patients were only the factor of vascular
invasion.
Conclusions: The incidence of HCC in elderly patients
was increasing. In the elderly HCC patients, the etiol-
ogy of background liver disease was different to the
younger and non-viral liver disorder was dominant in
the elderly. Aging itself was not a risk factor for post-
operative complications and survival outcome. There-
fore, equal efficacy and safety of surgical treatment
between the elderly and the younger patients for HCC
were proved.
431
SURGICAL TREATMENT OF
HEPATOBLASTOMA INVADING
INFERIOR VENA CAVA
Ai-Jun Li
EHBH 225 Changhai Road, Shanghai, China
Background: Hepatoblastoma (HB) accounts for
approximately 1% of all paediatric malignancies.
Although rare, HB is the most common primary malig-
nant hepatic tumor in children, with an annual inci-
dence of 0.5–1.5 per million in the paediatric
population. A majority of cases occur between the ages
of 6 months and 3 years. Worldwide, there are two dif-
ferent strategies regarding the treatment of paediatric
HB. The North American groups support immediate
surgery for localised tumors, whereas Europe favours
pre-operative chemotherapy in all cases, followed by
surgery. Hepatic resection is the main treatment modal-
ity for hepatic tumors in childhood. Advances in diag-
nostic technique, preoperative preparation, surgical
technique, and postoperative management increased the
success rate. The aim of this study is to report our
experience in hepatic lobectomy, which is relatively rare
procedure in hepatoblastoma invading inferior vena
cava.
Study design: Medical records of 20 patients with he-
patoblastoma invading inferior vena cava, who under-
went hepatic lobectomy between January 2000 and
June 2010 were reviewed retrospectively. Age, gender,
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diagnosis, physical examination findings, results of pre-
operative laboratory investigations, radiological exami-
nation, resectability criteria, postoperative pathological
results, incisions, operation technique, intraoperative
transfusions, drains used, antibiotic prophylaxes, and
intraoperative and postoperative complications were
evaluated for all patients.
Results: Right lobectomy (n = 9), left lobectomy
(n = 2), extended left lobectomy (n = 1), and extended
right lobectomy (n = 5) and middle lobectomy (n = 3)
were performed. Pathological examination of resected
tumors revealed hepatoblastoma (n = 20), which were
13 cases of fetal, 5 cases of embryonal, 2 cases of
mixed. Patients were observed in the intensive care unit
for 3.4  0.3 days. Postoperative complications were
sepsis, jaundice and intra-abdominal abscess (n = 1),
fever (n = 3), and subdiaphragmatic abscess with pleu-
ral effusion (n = 1).
Conclusions: Hepatic lobectomy is a major operation,
which is feasible yielding curative results in children.
The tumor is adjacent to major vessels, they may be
resected and reconstructed. Safe hepatic resections with
acceptable blood loss can be performed by a technique
relying on good anatomic dissection and surgical con-
trol. The diagnosis of HB is mainly based on histology.
More than 90% of the epithelial type, fetal survival
rate is high.
433
ULTRASOUND DIAGNOSIS OF
PRIMARY HEPATIC MALIGNANT
FIBROUS HISTIOCYTOMA
Lei Cheng
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background and aims: To describe and analyze ultra-
sound appearances of primary hepatic malignant
fibrous histiocytoma (MFH) of the liver.
Methods: A retrospective analysis of clinical data and
ultrasonic images was performed on 16 patients with
pathologically proven hepatic MFH.
Results: There were 5 females and 11 males in the
study. The age ranged from 41 to 66 years old, with an
average of 51.6 years old. Ultrasound: of the 16
patients, all the tumors were single, which including 9
tumors were located in the right lobe of the liver, 6
tumors were located in the left lobe, 1 tumor were
located in caudate lobe of the liver. The tumor sizes
were found to be larger than 10.0 cm in 3 cases, ranged
from 5.0 cm to 10.0 cm in 10 cases, less than 5.0 cm in
3 cases. The majority of the tumors showed hypoechoic
(11 cases), a small part as a hyperechoic (3 cases), a hy-
perechoic (1 case) or clutter echo (1 case). Tumor inter-
nal echo were heterogeneous, including 1 case of
honeycomb, 2 cases of multiple nodular fusion. Most
tumors and the surrounding boundaries were unclear
(11 cases) with silent halos around the tumors. The
color Doppler flow imaging (CDFI) results showed no
significant difference in blood flow signal. According to
CT or MRI, the main signal intensity of large mass
were hypointensive on T1WI and hyperintensive on
T2WI. Dynamic enhancement scanning revealed, 6
cases of uneven enhance in arterial phase, 1 case of
portal vein phase uneven enhancement, 3 cases of por-
tal vein phase decline, 4 cases delayed decline, 2 cases
of delay in low signal. Laboratory biochemical exami-
nation indicated normal AFP in 14 cases, and two
other cases were 20.9 lg/L, 21.4 lg/L, 16 cases of nor-
mal CEA, 13 cases of normal CA199 and poor liver
function in 4 cases. The pathologic results identified 15
cases of primary hepatic malignant fibrous histiocytom-
a and 1 case of primary intrahepatic bile duct malig-
nant fibrous histiocytoma.
Conclusions: It is difficult to make right clinical diagno-
sis of hepatic MFH. The ultrasonic manifestations of
primary hepatic MFH varied from case to case. Final
diagnosis is generally entrusted to pathological assess-
ment of surgically resected or biopsy samples. Ultra-
sound examination should be combined with clinical
and imaging material, comprehensive analysis, for the
diagnosis of malignant liver tumors.
442
PROGNOSTIC FACTORS AND
OUTCOME OF CHINESE PATIENTS
WITH HCC AND CRLM UNDERWENT
HEPATECTOMY IN A SINGLE
REGIONAL CENTER
Ting Kong Ling Steven
Surgery Department, Tuen Mun Hospital, Tuen Mun,
Hong Kong, China
Background and Aims: Hepatectomy for patients with
hepatocellular carcinoma (HCC) and colorectal liver
metastases (CRLM) carries high mortality despite
advances in early diagnosis and treatment modalities.
Moreover, the ‘true’ mortality may be under-estimated
with current definition of 30 days mortality after sur-
gery. Our study was designed to evaluate the periopera-
tive results in a single regional center and the
prognostic factors, also to better define perioperative
mortality.
Methods: The study recruited 144 patients with HCC
and CRLM who underwent hepatectomy at the
author’s hospital between 2009 and 2011. Their clinico-
pathological characteristics, surgical management, peri-
operative morbidity and mortality were assessed.
Survival was assessed at 30, 90, 180 days post-opera-
tively.
Results: Postoperative mortality at 30, 90, 180 days
were 2.1%, 2.8% and 4.9% respectively (figure1), while
were 3.0%, 6.1% and 9.1% when cases of major hepa-
tectomy recruited only (figure2). Differences in 30- and
180-day mortality were both significant (p < 0.05), with
57% more deaths occurred after 30-day period (fig-
ure3). Morbidity rates were 19.9% and 28.1% in over-
all and major hepatectomy group respectively. Cox
multivariate analysis indicated that age, prothrombin
time, albumin level, tumor number, intra-operative
blood loss, requirement of transfusion and presence of
complications (pneumonia and liver failure) were inde-
pendent prognostic factors for mortality (p < 0.05).
Mean of intra-operative blood loss was in improving
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trend (697 mL in 2009, 653 mL in 2010 and 457 mL in
2011), therefore the transfusion rate was also reduced
(18.9% in 2009, 16.1% in 2010 and 8.3% in 2011).
Conclusions: The 180 days mortality after hepatectomy
was 4.9% and 9.1% in overall and major hepatectomy
group respectively in our center. Reporting deaths that
occur within 30 days of surgery underestimates and
misleads the hepatectomy mortality. Age, prolonged
prothrombin time (> 12.6 sec), low albumin level
(< 35 g/L), multiplicity of tumor, intra-operative blood
loss amount, need of transfusion, presence of compli-
cated pneumonia and liver failure were the risk factors
that may impact mortality.
444
SEROTONIN PROMOTES THE
PROLIFERATION OF SERUM-
DEPRIVED HEPATOCELLULAR
CARCINOMA CELLS VIA
UPREGULATION OF FOXO3A
Ting-Bo Chao
88 Jiefang Road Hangzhou, China
Background and aims: Peripheral serotonin is involved
in tumorigenesis and induces a pro-proliferative effect
in hepatocellular carcinoma (HCC) cells; however, the
intracellular mechanisms by which serotonin exerts a
mitogenic effect remain unclear. In this research, we
examined whether FOXO3a, a transcription factor at
the interface of crucial cellular processes, plays a role
downstream of serotonin in HCC cells.
Methods and results: The cell viability and expression
of FOXO3a was assessed in three HCC cell lines
(HuH7, HepG2 and Hep3B) during serum deprivation
in the presence or absence of serotonin. Serum free
media significantly inhibited HCC proliferation and
lead to reduced expression of FOXO3a. Serotonin
reversed the serum-deprivation-induced inhibition of
cell proliferation and upregulated FOXO3a in HuH7
cells; however, serotonin had no effect on the prolifera-
tion of serum-deprived HepG2 or Hep3B cells. Conse-
quently, we demonstrated that serotonin promoted the
proliferation of HuH7 cells by increasing the expression
of FOXO3a. Knockdown of FOXO3a enhanced the
ability of serum deprivation to inhibit HCC prolifera-
tion. We also provide preliminary evidence that differ-
ent expression levels of the 5-HT2B receptor (5-
HT2BR) may contribute to the distinct effects of sero-
tonin in different serum-deprived HCC cells.
Conclusions: This study demonstrates that serotonin
promotes the proliferation of serum-deprived HCC cells
via upregulation of FOXO3a, in the presence of suffi-
cient levels of the serotonin receptor 5-HT2BR. Drugs
targeting the serotonin-5-HT2BR-FOXO3a pathway
may provide a novel target for anticancer therapy.
445
PERCUTANEOUS RADIOFREQUENCY
ABLATION VERSUS REPEAT
HEPATECTOMY FOR RECURRENT
HEPATOCELLULAR CARCINOMA: A
PROSPECTIVE RCT STUDY
Ji-Cheng Duan
Department of Laparoscopy, Eastern Hepatobiliary
Surgery Hospital, Second Military Medical University,
Shanghai, China
Objective: Percutaneous radiofrequency ablation
(PRFA) is known to be as effective as hepatectomy for
small hepatocellular carcinoma (HCC) in the long-term.
We wished to ascertain how it is for recurrent small
HCC.
Methods: From January 2009 to November 2011, a
series of sixty-one patients were included in the study
according to the criteria: each patient had one recurrent
HCC, less than 5 cm in diameter. Twenty-six of the 61
patients were treated with PRFA and the other 35 were
treated with repeat hepatectomy.
Results: The interval from first surgery to recurrent
for repeat hepatectomy and PRFA groups were
(1,239.60  1,017.00) d and (903.42  975.11) d
respectively (P = 0.066). The tumor-free time after
repeat hepatectomy and PRFA were (310.23  159.50)
d and (278.27  123.29) d respectively (P = 0.584).
Size of tumor in repeat hepatectomy and PRFA were
(7.34  3.16) cm2 and (5.59  3.40) cm2 (P = 0.215),
the total expenditure for each patient of the two
groups were (26,150.66  7,923.60) yuan and
(21,135.00  1,156.76) yuan (RMB), and the time of
hospitalization for each of the two groups were
(15.29  4.28) d and (7.46  2.20) d (p<0.001). Con-
clusion: PRFA is proved to be as effective as repeat
hepatectomy in the treatment of recurrent small HCC,
and superior to repeat hepatectomy as it is less inva-
sive.
448
A NEW CLASSIFICATION SYSTEM FOR
PORTAL-SUPERIOR MESENTERIC
VEIN RESECTION AND
RECONSTRUCTION AND ITS CLINICAL
SIGNIFICANCE FOR PROGNOSIS
Ting-Bo Liang
88 Jiefang Road Hangzhou China
Background and aims: Advanced liver cancer, perihilar
cholangiocarcinoma and pancreatic cancer may invade
the portal vein (PV), superior mensenteric vein (SMV),
and splenic vein (SV), which was considered as a con-
traindication in the past. Nowadays, portal-superior
mesenteric vein (PV/SMA) resection and reconstruction
(PSRR) is more and more used. PSRR varies with
resection locations, and no classification system for
PSRR has been reported. Here, we propose the first
classification system for PSRR and report the prelimin-
ary clinical significance for prognosis.
Methods: Totally 39 patients who had pancreatic can-
cer, liver cancer or cholangiocarcinoma underwent
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PSRR from July 2008 to September 2012. We classified
the PSRR to four types and five subtypes (IR, IL, II,
III, IV) based on our clinical experience and PV/SMV
anatomy. The association among PSRR type, post-
operative mortality, morbidity, hospital stay, age, sex,
anastomotic time, pre-operative bilirubin level were
analysed.
Results: PSRR type and anastomotic time are two
main predictable factors for prognosis. Long anasto-
motic time attributes to higher morbidity (P = 0.034)
and higher grade of complications (p = 0.013). PSRR
types were not significant associated with anastomotic
time (p = 0.39), though subtype IL seemed more tricky
and time-consuming in some cases. Different PSRR
types do not have significant difference in morbidity
(p = 0.33) but subtype IL has higher grade of complica-
tions (p = 0.0018, compared with other subtypes).
Conclusions: The new classification system for PSRR
may be helpful for hepato-pancreato-biliary surgeon
training, and along with anastomotic time, offers a pre-
dictable factor for prognosis after operation. Care
should be taken when subtype IL is used or/and long
anastomotic time is needed in surgical treatment of
liver cancer and prihilar holangiocarcinoma.
454
INFLUENCE OF VISCERAL OBESITY
TO POSTOPERATIVE PULMONARY
COMPLICATIONS (PPCS) AFTER
PANCREATICODUODENECTOMY.
Atsushi Shimizu
811-1, Kimiidera, Wakayama Japan
Background and aims: Postoperative pulmonary com-
plication (PPCs) was common and lethal complications
in all digestive surgery. Obesity is thought to be risk
factor for PPCs after surgery, whereas, in far studies
Body mass index (BMI) was not associated with
increasing PPCs. On the other hand, visceral obesity is
thought to be involved with high abdominal pressure,
resulting a risk factor for PPCs, but these studies did
not assess for distribution of visceral fat. We conduct
that this study is to determine whether PPCs are associ-
ated with obesity defined by BMI and visceral fat area
(VFA) or not.
Methods: 317 patients, undergoing pancreaticoduoden-
ectomy in Wakayama Medical University Hospital
between February 2003 and December 2009 were
enrolled in the present study. VFA was measured using
a preoperative cross-sectional CT scan at the level of
the umbilicus by FatScan software version 3.0 (N2 sys-
tems Inc., Japan).
Results: In result, PPCs were occurred in 14 patients
(4.4%) and median VFA of patients with PPCs was
135.7 cm2, significantly higher than without PPCs (75.9
cm2, p = 0.0058), however there was identical in BMI.
Then BMI and VFA were categorized into two groups;
high-BMI and low-BMI (cut-off value 25.0 kg/m2),
high-VFA and low-VFA group (cut-off value 130 cm2),
and a multivariate logistic analysis of risk factor for
PPCs was done. Consequently, only high-VFA was pre-
dicted the independent risk factor influencing PPCs
(p = 0.0390, odds ratio 4.246, 95% confidence interval
1.076-16.759).
Conclusion: In conclusion, preoperative VFA measure-
ments using CT scan may be more useful for the pre-
diction of the development to PPCs than BMI
calculation.
459
COLLATERAL VESSEL HARVESTED
FROM SURFACE OF RESECTED
SPLEEN USED AS INTERPOSITION
GRAFT IN PROXIMAL SPLENORENAL
SHUNT
P. K. Sinha, A. Garg, V. Mangla and T. K.
Chattopadhyay
Institute of Liver and Biliary Sciences, New Delhi, India
Background, aim and Methods: Proximal splenorenal
shunt (PSRS) is the preferred treatment in patients with
extrahepatic portal venous obstruction for prevention
of variceal re-bleeding. It improves portal biliopathy.
Nearly 10% patients have thrombosis of both splenic
and superior mesenteric vein precluding use of these
vessels for creating a porto-systemic shunt. There are
situations where mobilization of splenic vein is not pos-
sible because of a friable splenic vein or replacement of
splenic vein by large thin walled collaterals. We present
our experience of two cases where splenic vein could
not be mobilized from the pancreas for above men-
tioned reasons. Collateral on the surface of resected
spleen was harvested and used as interposition graft
between the left renal vein and the splenic vein. This
helped us avoid the need for harvesting the autologous
internal jugular vein or using a synthetic graft for cre-
ating the porto-systemic shunt.
Results: Both the patients did well in the postoperative
period and are on follow up with no evidence of shunt
thrombosis.
Conclusion: Use of a collateral vessel harvested from
the surface of resected spleen is an alternative to autol-
ogous internal jugular vein or synthetic graft in patients
undergoing splenectomy with proximal splenorenal
shunt.
460
CTACE VERSUS DEBTACE
TREATMENT FOR INTERMEDIATE/
ADVANCED HCC: A SINGLE-CENTER
RETROSPECTIVE FIVE-YEAR
SURVIVAL ANALYSIS.
Marco Massani
IV Dpt Surgery Regional Hospital Treviso, Treviso,
Italy
We present our experience in the non surgical treat-
ment for HCC comparing two different technique: con-
ventional vs. DebTace. All the patients have at least
12 month of follow up. Results are discussed pointing
out the role of DebTACE in disease free more than in
overall survival.
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461
DETECTION OF CANCER STEM CELLS
IN HEPATOCELLULAR CARCINOMA:
EXPRESSION OF CRIPTO-1 AND
PROGNOSTIC RELEVANCE AS
BIOMARKER FOLLOWING SURGICAL
RESECTION
Marco Massani
IV Department of Surgery Regional Hospital Treviso,
Treviso, Italy
Aim of our study was to evaluate if it’s possible obtain-
ing a specific marker useful for predicting HCC ag-
gressivenss.
467
LB-100 ENHANCES THE THERAPEUTIC
EFFECTS OF CHEMOTHERAPEUTIC
DRUGS FOR HEPATOCELLULAR
CARCINOMA
Ting-Bo Liang
88 Jiefang Road Hong Kong S.A.R., China
Background and aims : Hepatocellular carcinoma
(HCC) is one of the most malignant diseases and there
are no satisfactory internal treatments to date. For the
patients who do not have the opportunity to recept
“curative resection”, chemotherapy is an important
treatment. However, the effects of chemotherapy for
HCC is not yet good enough to inhibit progression of
HCC. Here, we report LB-100, a PP2A inhibitor,
works as a promising chemotherapeutic drug sensitizing
agent to inhibit HCC in vitro and in vivo.
Methods: We used cell counting kit-8 (CCK-8) to eval-
uate the effects of LB-100 together with cisplatin and
doxorubicin in four HCC cell lines HepG2, Hep3B,
Huh-7 and SUN-449. We used flow cytometry to ana-
lyze the cell cycle of HCC cells being treated by these
drugs. We also constructed nude mouse model of HCC
and treated them with 2 mg/kg of LB-100 or/and
2 mg/kg doxorubicin i.p. qod for 16 days. Relative
tumor volume was defined as times of tumor volume
increased based on the volume on the first day of treat-
ment.
Results: The cytotoxic effects of cisplatin and doxoru-
bicin were significantly enhanced by LB-100, while LB-
100 itself hardly showed influence on the viability of
these HCC cells except Hep3B, on which LB-100
showed dose-dependent cytotoxic effects. The propor-
tion of cells on S/G2 phase was significantly increased
by LB-100. LB-100 greatly enhanced the effects of
doxorubicin for HCC inhibition in vivo.
Conclusions: LB-100 is a promising cisplatin and doxo-
rubicin sensitizing agent to inhibit progression of HCC
in vitro and in vivo. The mechanism of its effects may
be that LB-100 drives HCC cells from G0 phase to S/
G2 phase, in which HCC cells are more sensitive to
chemotherapeutic drugs.
471
USE OF STERNOTOMY FOR REMOVAL
OF AN INTRA-THORACIC
HEPATOCELLULAR CARCINOMA: A
CASE REPORT
John Wong
Department of Surgery, Prince of Wales Hospital,
Shatin, NT, Hong Kong S. A. R., China
Background and aim: Median sternotomy is rarely
employed for resection of hepatocellular carcinoma
(HCC). It has only been reported for resection of
advanced HCC with tumor thrombus extending into
the supra-hepatic inferior vena cava (IVC). We report
on the technical issue and outcome of a patient with
huge HCC protruding into the right thoracic cavity
where successful hepatectomy was performed through a
laparotomy combined with median sternotomy.
Methods and Results: A 39-year-old gentleman with
hepatitis B associated Child’s A cirrhosis presented
with a 19 cm right lobe HCC. All major vessels were
patent, but the middle hepatic vein and IVC were com-
pressed by the tumor. Attempt to shrink down the
tumor before resection failed despite repeated sessions
of transarterial therapy, and subsequently the tumor
increased to 24 cm in size with significant protrusion
into the right thoracic cavity. The retro-hepatic and
supra-hepatic IVC was compressed and pushed to the
midline. He underwent a right hepatectomy through a
roof-top incision with upper midline extension to a
median sternotomy in order to gain control of the sup-
rahepatic IVC. The diaphragm was splitted at midline
anteriorly. The diaphragmatic pericardium and right
mediastinal pleura were opened for isolation of intra-
pericardial IVC. Liver transection was then performed
in the standard way with prior hilar dissection. The
specimen was removed en bloc with part of the dia-
phragm. The diaphragmatic defect was closed primarily
without tension. The operative time was 8.5 hours, with
3,600 mL of blood loss. Pleural drain and pericardial
drain were placed for 4 days. He had an uneventful
recovery and was discharged on day 14. Pathological
examination revealed a right hepatectomy specimen of
3,474 g. The moderately to poorly differentiated HCC
measured 24 cm in maximum diameter, with micro-
scopic vascular invasion. The tumor was partially
enclosed by a fibrous capsule. There was no satellite
nodule. Resection margin measured about 1 cm. The
adherent diaphragmatic tissue showed inflammation
with no evidence of malignant infiltration.
Conclusion: Selective use of median sternotomy pro-
vides good access for supra-hepatic IVC control and
enables safe resection of huge liver tumor protruding
into the thoracic cavity. The approach also facilitates
the application of venous bypass in case resection of
part of the IVC and vascular reconstruction is neces-
sary. Furthermore, it is a viable alternative to the right
thoraco-abdominal approach, of which is associated
with very high rate of chest complications and post-
operative pain as a result of rib cutting.
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475
RISK FACTORS OF HOSPITAL
MORTALITY AFTER RE-LAPAROTOMY
FOR POST-HEPATECTOMY
HEMORRHAGE FOR PATIENTS WITH
HEPATOCELLULAR CARCINOMA
Tian Yang
Eastern Hepatobiliary Surgery Hospital, Second
Military Medical University, Shanghai, China
Objective: To identify risk factors of hospital mortality
after re-laparotomy for post-hepatectomy hemorrhage
(PHH) in patients with hepatocellular carcinoma
(HCC).
Summary background data: PHH requiring re-laparot-
omy is a life-threatening condition associated with
high-risk hospital mortality. However, risk factors of
hospital mortality have not yet been investigated.
Methods: Perioperative data of 258 patients with HCC
who underwent re-laparotomy for PHH from 1997 to
2011 were reviewed and evaluated by univariate and
multivariate analyses to identify risk factors of hospital
mortality in these patients. The time periods of hepa-
tectomy during 1997~2004 and during 2005~2011 repre-
sent the earlier and later period, respectively.
Results: The overall occurrence rate of re-laparotomy
for PHH was 8.9& (9.6& and 8.4& in the earlier and
later period, respectively;p = 0.300). The median time
gap between hepatectomy and re-laparotomy was 9 (0.5
~ 165) hours. Hospital death occurred in 43 of all 258
patients 16 ~ 40 days after re-laparatomy, and the
overall mortality rate in these patients was 16.7%
(20.0% and 14.6% in the earlier and later period,
respectively;p < 0.001). Multivariate analysis showed
that the earlier period of hepatectomy (p = 0.041), inef-
fective hemostasis during re-laparotomy due to coagul-
opathy (P = 0.035), time gap between hepatectomy and
re-laparotomy  9 h (p = 0.038), postoperative liver
failure (P < 0.001), and postoperative acute renal fail-
ure requiring hemodialysis (P = 0.025) were indepen-
dent risk factors for hospital mortality.
Conclusions: Hospital mortality in patients undergoing
re-laparotomy for PHH was considerably high but has
reduced in recent years. The indications and timing of
re-laparotomy for PHH are very important for hepatic
surgery in such patients. More attention should be paid
to patients who develop postoperative liver failure and/
or serious acute renal failure.
478
DEVELOPMENT OF A NEWLY
DESIGNED BILIARY INTERNAL
FISTULA TUBE FOR ENDOSCOPIC
TRANSLUMINAL BILIARY DRAINAGE
Masayasu Aikawa
1397-1 Yamane, Hidaka, Saitama, Japan
Background: A transluminal biliary drainage has
recently been performed as an alternative procedures of
endoscopic retrograde biliary drainage and percutane-
ous transhepatic biliary drainage. However, the proce-
dure has the risk for the difficulty to exchange the
drainage tube, if biliary-enteric fistula remains incom-
plete. Aim: We have developed a biliary internal fistula
tube (BIFT) which has been constructed with a conven-
tional biliary stent tube and a bioabsorbable polymer
seat (BAPS). In this study we attempted to investigate
the difference between the BIFT and conventional tube
(CT) in biliary-enteric fistula formation. Materials: The
BIFT is a 7.5Fr conventional biliary stent tube
wrapped with the BAPS, which is 0.5 mm thickness.
The BAPS is an ideal scaffold for tissue regeneration
with porous property to allow easy penetration of cells.
Method: BIFT group (n = 2): The pigs were laparo-
tomized to expose the extrahepatic bile duct (EHBD).
Next, the duodenal side of the EHBD below a junction
of a cystic duct was ligated. The 5 cm BIFT was placed
between gallbladder(GB) and duodenum(DU). CT
group (n = 2): The 5 cm CT was placed between GB
and DU in a similar manner of the BIFT group. In
both group these pigs were sacrificed and re-laparotom-
ized at 2 weeks and at 6 weeks after the placement.
Results: All operated pigs survived until sacrifice. BIFT
group: At 2 weeks after the placement. The BIFT
became surrounded by connective tissue between GB
and DU. The part of the BAPS remained, but the con-
ventional biliary stent tube has gone. In microscopically
the connective tissue had a lot of inflammatory cells
and the trace of the BAPS. At 6 weeks after the place-
ment, the distance between GB and DU was shortened.
A biliary-enteric fistula, which had 1.5 cm bore diame-
ter and 2 cm length, was constructed between GB and
DU. CT group: At 2 weeks after the placement, the
exposed CT was found between GB and DU. At
6 weeks after the placement, the CT became sur-
rounded by connective tissue, and the distance between
GB and DU came closer to each other. However, the
connective tissue between GB and DU was fragile and
easy to be divided. The lumen of the CT has biliary
sludge and almost became obstructed.
Conclusion: The placement of the BIFT induced rapid
and good fistulization, and has the potential for appli-
cation as a novel device for transluminal biliary drain-
age avoiding the need for exchange of tubes.
479
A CLINICAL CASE SERIES OF SINGLE-
PORT LAPAROSCOPIC
HEPATECTOMY
Masayasu Aikawa
1397-1 Yamane, Hidaka, Saitama, Japan
Background: The recent use of single-port access sur-
gery in cholecystectomy and other abdominal surgeries
has confirmed its safety and validity as a treatment
option. However, there are few reports regarding the
use of complete single-port access surgeries in hepatec-
tomy for neoplasms.
Method: Between January 2008 and March 2012, 63
LHs were performed in our hospital (Saitama Medical
University International Medical Center, Saitama,
Japan). We performed single-port laparoscopic hepatec-
tomy (SLH) in 10 patients, among whom 7 patients
had hepatocellular carcinoma, 2 had metastatic liver
tumor, 1 had endocrine liver tumor, and 1 had heman-
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gioma. Further, 7 patients were classified in the Child-
Pugh category A, 2 were in category B, and 1 was in
category C. The tumors were located in the S2 in 1
patient, S3 in 2 patients, S4 in 2 patients, S5 in 1
patient, and S8 in 2 patients. The patients were eligible
for SLH if they had solitary tumors measuring 3 cm or
less on the caudal surface of the liver. In an abdominal
approach, a SILSTM Port (Covidien, Mansfield, MA,
USA) was inserted through a 20 -mm incision on the
upper median umbilical site. In hepatectomy, 2 devices
are typically used in order to shorten the operative
time. The parallel approach method is used to operate
these devices. One device is the Bipolar LAP forceps
unit (Erbe Elektromedizin GmbH, Tuebingen, Ger-
many), which is connected to the electrosurgical unit
VIO300D (Erbe Elektromedizin GmbH, Tuebingen,
Germany) for low-voltage coagulation. The other
device is the disposable suction irrigation system LA-
GIS (Lagis Enterprise Co., Ltd, Taichung, Taiwan),
which is useful for irrigation, suction, and retraction of
the liver.
Results: No patient developed intraoperative complica-
tions that required additional port access and conver-
sion to laparotomy. Operative time was 148 min (141-
235 min). The postoperative course of the patients was
uneventful, and they were discharged at an average of
6.2 days (3-11 days) after the operation. Approximately
2 weeks after discharge, the patients did not experience
wound pain or liver dysfunction.
Conclusion: SLH is a safe and feasible procedure for a
specific group of candidates, including patients with
high-grade liver dysfunction.
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GALLBLADDER POLYPS: WHEN TO
OPERATE
Kitty Lo
Department of Surgery, Queen Elizabeth Hospital, 30
Gascoigne Road, Kowloon, Hong Kong
Background and aims: Gallbladder polyp is a common
finding on ultrasonography (USG), yet its management
is still controversial. It has been recommended that
cholecystectomy be performed for gallbladder polyps
larger than 10 mm in size because of association with
gallbladder cancer. The aim of this study is to look at
the natural history and histological characteristics of
USG detected gallbladder polyps, and to propose opti-
mal management of these lesions.
Methods: Patients with USG detected gallbladder pol-
yps who subsequently underwent cholecystectomy were
identified retrospectively. Patients with USG findings
suspicious of cancer of the gallbladder were excluded.
Histological analysis was performed for all patients.
Results: From 1998 to 2012, 82 patients with USG
detected gallbladder polyps who subsequently under-
went cholecystectomy were identified. The median age
was 51.1 years (range 28 to 82 years). 48 (58.5%) were
female. 39 (47.6%) had multiple polyps. 11 (13.4%)
had concomitant gallstones. 33 of the patients had
serial USG performed, with a median interval of 15
months between USG (range 1 to 109 months).
Increase in size was noted in 11 (33.3%). 41 (50%) had
cholecystectomy performed due to symptoms, 33
(40.2%) due to concern for possible malignancy. Histo-
logical examination post cholecystectomy found only 1
patient (1.2%) with malignant polyp, who had adeno-
carcinoma. It measured 2.1 cm on USG. Neoplastic
polyp (adenoma) was found in 19 patients (23.2%). Of
the 27 patients with gallbladder polyp < 0.5 cm, only 1
(3.7%) had adenoma. Of the 24 patients with gallblad-
der polyp 0.5-0.99 cm, 2 (8.3%) had adenoma. Of the
16 patients with gallbladder polyp 1.0-1.49 cm, 6
(37.5%) had adenoma. Of the 8 patients with gallblad-
der polyp 1.5-1.99 cm, 4 (50%) had adenoma. Of the 4
patients with gallbladder polyp 2.0-2.49 cm, 3 (75%)
had adenoma. Of the 3 patients with gallbladder polyp
2.5 cm or above, all (100%) had adenoma. The rest of
the patients were found to have non-neoplastic lesions.
Out of all 82 patients, 12 (14.6%) had cholesterol
polyp, 13 (15.9%) had cholesterolosis, 3 (3.7%) had
hyperplastic polyp, 2 (2.4%) had papillary hyperplasia,
2 (2.4%) had adenomyomatosis and 30 (36.6%) had
only chronic cholecystitis.
Conclusion: Risk of gallbladder malignancy resulting
from gallbladder polyp is low. The risk of finding neo-
plastic gallbladder polyp increases with size. Small gall-
bladder polyps < 1 cm may be monitored by serial
USG. Cholecystectomy is recommended for gallbladder
polyps > 1 cm.
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DIABETES MELLITUS IN PANCREATIC
CANCER
L. K. Clement Chia, V. G. Shelat, Sameer P.
Junnarkar, W. L. Winston Woon and J. K. Low
Department of General Surgery, Tan Tock Seng
Hospital, 11 Jalan Tan Tock Seng, Singapore, Singapore
Background and aims: Diabetes mellitus (DM) is widely
considered to be associated with pancreatic cancer.
Pancreatic cancer has a dismal prognosis because can-
cer-specific symptoms occur only at an advanced stage.
We conducted a retrospective study to examine the
relationship of new onset DM with pancreatic cancer
and whether this group of patients have early curative
disease that can be identified for screening.
Methods: To determine the incidence of new onset dia-
betes (< 2 years duration from diagnosis of pancreatic
cancer), we retrospectively reviewed the medical records
of 151 patients (86 men and 65 women; mean age 62
(range 29-88) years who had pancreatic cancer and
underwent surgery between Jan 2006 to Aug 2012 in
Tan Tock Seng Hospital. DM was defined as fasting
blood glucose > 7.0 mmol/L.
Results: Of the 151 patients, 51 (33%) had DM of
which 11 (7%) had new onset DM. Among the 11 with
new onset DM, 9 were asymptomatic (no cancer-spe-
cific symptoms), at DM onset. In these 11 patients, the
median duration of DM prior to pancreatic cancer
diagnosis was 2 months (range 1-23) months. Post-
operatively, out of the 11 patients with new onset DM,
8 had early stage 1 or 2 disease, 1 had stage 3 disease
and 2 had metastatic stage 4 disease.
Conclusion: Diabetes is common in pancreatic cancer.
Our data suggests that the incidence of new onset DM
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in pancreatic cancer is 7%. The majority of new onset
DM occurs when the cancer is asymptomatic and at an
early stage disease, providing a window of opportunity
for screening to detect early curative pancreatic cancer.
486
TECHNIQUES AND INDICATIONS OF
PANCREAS SPARING DISTAL
DUODENECTOMY
Priyanka A. Sali, A. S. Rajegowda, Rajiv Shah and
P. Jagannath
Lilavati Hospital and Research Centre, A-791, Bandra
Reclamation, Bandra West, Mumbai-400050, India
Background and Aims: Infra ampullary pancreas spar-
ing duodenectomy is an attractive alternative to classi-
cal pancreaticoduodenectomy whenever feasible for
benign as well as malignant conditions. It avoids dissec-
tion and morbidities of duct to mucosa anastomoses. It
also conserves the pancreas. We highlight that pancreas
sparing distal duodenectomy is appropriate and onco-
logically adequate treatment for malignancies involving
D3, 4 (below the ampulla) without the risks of classical
pancreaticoduodenectomy.
Methods: Pancreas sparing distal duodenectomy
involves careful separation of D3 from the underlying
head of pancreas, complete mobilization of the liga-
ment of Treitz and resection of the involved distal D2
and D3. Intestinal continuity is established with end to
end or end to side duodeno-jejunal anastomosis. Duo-
denal adenocarcinoma and NET are rare malignancies
of the digestive system that would otherwise be treated
by pancreaticoduodenectomy. Three cases of duodenal
cancer that were successfully treated with infra ampul-
lary pancreas sparing duodenectomy are discussed. All
these patients presented with upper abdominal discom-
fort with weight loss and iron deficiency anemia. Imag-
ing and endoscopic studies for case 1 showed D3,4
involvement. Ampulla was identified free. An infra
ampullary pancreas sparing duodenectomy was done.
Histology confirmed moderately differentiated adeno-
carcinoma. Case 2 imaging showed a mass lesion in
close proximity to the pancreatic head. Since this
patient had undergone a right nephrectomy, extensive
adhesions were present behind the hepatic flexure and
around the duodenum. An infra-ampullary pancreas
sparing duodenectomy with excision of the mass was
done. Histology confirmed 4 foci of small primaries
(neuroendocrine tumor) in the duodenum and the mass
being the metastatic lymph node. Case 3 was detected
with adenocarcinoma involving D3, D4 and DJ junc-
tion. He was explored outside where a bypass was done
and was given on cycles of chemotherapy. Infra-ampul-
lary pancreas sparing duodenectomy with total excision
of epiploic nodes was done.
Results: The patients tolerated the procedure well and
had a smooth recovery. Histology of all showed clear
margins. The median follow up period is 6 months.
Conclusions: Though technically challenging, infra-
ampullary pancreas sparing duodenectomy can be con-
sidered for malignancies of the distal duodenum below
the ampulla without compromising on margins and
avoiding pancreatic anastomoses.
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HBV-DNA MAY PREDICT THE
OVERALL SURVIVAL IN PATIENTS
WITH HEPATITIS B VIRUS-RELATED
HCC TREATED BY SORAFENIB
Hong-Fei Zhu, Liang Huang and Jing Li
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background and aims: High serum load of hepatitis B
virus (HBV) deoxyribonucleic acid (DNA) is a strong
risk factor of hepatocellular carcinoma (HCC) develop-
ment and is strongly associated with recurrence of
HCC. Herein we aimed to explore potential correla-
tions between the HBV load and prognosis of patients
with HBV-related HCC treated with sorafenib.
Methods: One hundred and forty-seven consecutive
patients with HBV-related HCC who were treated with
sorafenib were enrolled in this study. Serum HBV
DNA level, together with other clinical variables, was
selected for univariate and multivariate analysis to eval-
uate their influence on prognosis.
Results: Median patient age was 52 years, and 91.2%
were men. There were 59 patients with intermediate
HCC (BCLC stage B) and 88 patients with advanced
HCC (BCLC stage C) with a median overall survival
(OS) of 13.0 months (95% CI, 8.7-17.3) and
8.0 months (95% CI, 6.0-10.0) (p = 0.002). Patients
with undetectable HBV DNA levels ( 1000 UI/mL)
had greater median OS than those with detectable
HBV DNA levels [13.0 months (95% CI, 9.4-16.6) vs
7.0 months (95% CI, 3.9-10.1), p = 0.006]. When strati-
fied by BCLC stage, both BCLC stage B and BCLC
stage C patients with undetectable HBV DNA levels
showed better prognosis than patients with detectable
HBV DNA levels (p = 0.041 and 0.046, respectively).
In multivariate analysis, BCLC stage (HR, 0.524; 95%
CI, 0.343-0.802; p = 0.003) and HBV viral load (HR,
1.757; 95%CI, 1.175-2.628; p = 0.006) were prognostic
factors of survival.
Conclusions: Baseline hepatitis B viral load was associ-
ated with the prognosis of patients with HBV-related
HCC who underwent the treatment of sorafenib.
494
LAPAROSCOPIC
PERIESOPHAGOGASTRIC
DEVASCULARIZATION AND
SPLENECTOMY IN THE
MANAGEMENT OF PORTAL
HYPERTENSION
Wei-Dong Wang, Jie Lin, Xiao-Wu Chen, Zhi-Qiang
Wu, Qing-Bo Liu and Wei He
Department of Hepatobiliary Surgery, The First People’s
Hospital of Shun De, FoShang, China
Background and aims: Devascularization has been
widely used in the management of portal hypertension.
Laparoscopic periesophagogastric devascularization
and splenectomy for portal hypertension resulting from
liver cirrhosis is being adopted. We performed this
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study to investigate the safety, feasibility, and effective-
ness of this laparoscopic procedure.
Methods: A retrospective analysis was conducted on 41
patients with portal hypertension resulting from liver
cirrhosis who underwent laparoscopic periesophagoga-
stric devascularization and splenectomy between May
2007 and June 2011. After splenectomy was performed,
devascularization was accomplished, completely freeing
6 to 8 cm of the distal esophagus. The evaluation
included clinical characteristics, laboratory data, endo-
scopic findings, operative morbidity and mortality, and
4 years of follow up outcomes.
Results: The operation was completed successfully in
all the patients, except that conversion was required in
one patient. Mean operation-time was 252 min (range,
170-430 min); Mean blood loss was 502 mL (range,
100-1200 mL). The Mean weight of removed spleen
was 832(range, 422-2000 g). Thrombocytopenia in the
patients with hypersplenism was significantly improved
at postoperative day 7. Liver function remained stable
postoperatively. The operative mortality was 2.4%.
22.0% of the patients experienced other postoperative
complications such as pleural effusion, pulmonary
infection and injury to the pancreas. During follow-up
(3-52 months), endoscopic findings demonstrated signif-
icant regression in variceal grade. 7.5% of the patients
experienced recurrent bleeding and grade II encepha-
lopathy developed in one patient. Two patients were
found with portal vein thrombosis. The major cause of
death was HCC. The overall cumulative survival rate
was 93.6% at 1 year, 81.1% at 2 years, and 72.1% at
3 years,respectively.
Conclusions: Laparoscopic periesophagogastric devas-
cularization and splenectomy is a feasible, safe and
effective procedure for portal hypertension resulting
from liver cirrhosis. We believe it is a good treatment
option in the management of portal hypertension.
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LAPAROSCOPIC RADICAL
CHOLECYSTECTOMY FOR T1B AND T2
STAGE GALLBLADDER CARCINOMA:
SURVIVAL OUTCOME IN
COMPARISON WITH OPEN RADICAL
CHOLECYSRECTOMY
Chun-Sheng Hou, zhi Xu, li-Xin Wang, Xiao-Feng
Ling and Dian-Rong Xiu
Department of General Surgery, Peking University Third
Hospital, Beijing, China
Background and aims: The role of laparoscopic radical
cholecystectomy for early stage gallbladder carcinoma
remains uncertain. This study investigated the feasibil-
ity of laparoscopic radical cholecystectomy for T1b and
T2 stage gallbladder carcinoma, compared the survival
results of laparoscopic vs. open radical cholecystectomy
for patiens with T1b or T2 stage gallbladder carci-
noma.
Method: Fifteen cases of patients with T1b (n = 4) or
T2 (n = 11) stage gallbladder carcinoma were treated
with laparoscopic radical cholecystectomy from August
2006 to May 2012. The surgical results were analysed
and the survial rates of this group were compared with
20 cases of patients with T1b (n = 4) or T2 (n = 16)
stage gallbladder carcinoma treated with open radical
cholecystectomy.
Results: The patients underwent laparoscopic cholecys-
tectomy firstly, after frozen pathology examination
reveal T1b or T2 stage gallbladder carcinoma, laparo-
scopic regional lymphadenectomy of the hepatoduode-
nal ligament and wedge resection of the gallbladder
bed were performed. The median operative time was
230 minutes, and the median blood loss was 150 mL.
The median number of retrieved lymph nodes was 4.
The complication rate was 7% and the median postop-
erative hospital stay was 5 days. The median follow-up
time was 26 months, During the follow-up period,
which ranged from 3 to 68 months, three patients died
of tumor recurrence at 25,26, and 30 months respec-
tively. The 1, 3, 5 years survival rate of laparoscopic
radical cholecystectomy group were 100%, 68%, and
68%. The 1, 3, 5 years survival rate of open radical
cholecystectomy group were 100%, 79%, and 60%. A
comparision of survival rates between the two groups
demonstrated no signifucant difference (Log-
Rankv2 = 0.016, p = 0.900).
Conclusion: Laparoscopic radical cholecystectomy is
feasible and safe with similar survival rate as open radi-
cal cholecystectomy in patients with T1b and T2 stage
gallbladder carcinoma.
Fig. 1 Lparoscopic view of the operative field after
completion of node dissection.
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THE ASSOCIATION BETWEEN
CENTRAL VENOUS PRESSURE AND
BLOOD LOSS DURING LIVER
RESECTION IN RELATION TO INTRA-
OPERATIVE BLOOD TRANSFUSION
M. G. Anthony, J. K. Low, W. Woon and
S. P. Junnarkar
Division of Hepatobiliary and Pancreatic Surgery,
Department of General Surgery, Tan Tock Seng
Hospital, 11 Jalan Tan Tock Seng, Singapore
Aims: This study aims to evaluate the association of
central venous pressure (CVP) with intra-operative
blood loss and blood transfusion during liver resection.
We postulate that during liver resection, the CVP is
kept at a fairly high level and the impact of this is
increased intra-operative blood loss that consequently
results in increased blood transfusion.
Methodology: We performed a retrospective review of
the 43 liver resection operations performed over a per-
iod of one year (2011). Electronic patient records, case
notes and intra-operative anaesthetic records were thor-
oughly examined. Parameters examined include esti-
mated blood loss, intra-operative CVP and, in those
patients who received blood transfusion, the volume
given as well as pre- and post-operative haemoglobin
(Hb) levels.
Results: For the 43 patients analyzed, the median CVP
was 8 (4-14) mmHg. In the subgroup of patients with a
CVP range of between 8.5-14 mmHg, the estimated
blood loss was more than 1500 ml. A total number of
19 cases were transfused intra-operatively. In 12 of
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them, post- operative Hb was higher than the pre-
operative Hb, averaging around 63% of over-transfu-
sion. Only in 5 cases, the pre-operative Hb was noted
to be higher than the post-operative Hb. The table
(table 1) below illustrates the relationship between esti-
mated intra-operative blood loss and the range of CVP
Conclusion: There is an association between lower
intra-operative CVP and less estimated blood loss with
a reduction in the need for intra-operative blood trans-
fusion. In several cases, the post-operative Hb levels
are noted to be higher than pre-operative Hb levels.
This may reflect an element of over transfusion or over
estimation of the intra-operative blood loss. Literature
search was carried out and it largely revealed that
intra-op CVP during liver resection should ideally be
kept less than 5mm Hg in order to reduce blood loss as
well as to reduce intra and post operative blood trans-
fusion
505
THERMAL ABLATION VERSUS
REPEATED HEPATIC RESECTION FOR
RECURRENT INTRAHEPATIC
CHOLANGIOCARCINOMA
Shao-Jun Zhang, Peng Hu, Neng Wang, Qiang Shen,
Aixue Sun and Guo-Jun Qian
Eastern Hepatobiliary Surgery Hospital, ShangHai,
China
Background and aims: Effective treatment for recurrent
intrahepatic cholangiocacinoma (RICC) is still critical
question. Repeated hepatic resection(HR) and thermal
ablation therapy(TAT) were being increasingly used to
treat RICC. This study is aimed to compare the effi-
cacy and safety of repeated HR and TAT for RICC.
Methods: 109 patients with RICC after curative resec-
tion were retrospectively studied. 32 patients with 44
tumors were treated by repeated HR and 77 patients
with 133 tumors were treated by TAT. The effective-
ness and prognosis of two groups are compared.
Results: There was no significant difference between
the two groups in the overall survival rates after initial
HR (p=0.266) and after repeated HR or TAT
(p = 0.996) and there was no significant difference
between the two groups in the disease-free survival
rates (p = 0.692). The1-,2- and 3-year overall survival
rate after initial HR were 90.6%, 80.7% and 47.8% in
repeated HR group and 88.3%, 63.4%, and 30.6% in
TAT group. The 1-,2- and 3-year overall survival rate
after repeated HR and TAT were 83.8%, 38.0%, and
17.1% and 69.8%, 37.3%, and 20.5%, respectively. In
patients with recurrent tumors > 3 cm, overall survival
rate was higher in repeated HR group than TAT group
(p = 0.037). The number of recurrent tumors and recur-
rence interval were significant prognostic factors for
overall survival. Major complication incidence rate was
statistically higher in repeated HR group than that in
TAT group (15/32 vs. 4/77, p < 0.001).
Conclusion: Repeated HR and TAT are both efficacy
treatment for RICC. TAT has a similar efficacy com-
pared with repeated HR, but when tumor is bigger
than 3 cm repeated HR may be a better choice. TAT
can provide an opportunity to effectively treat with
RICC especially for patients who are not suitable for
surgical resection.
506
PROGNOSTIC SIGNIFICANCE OF
GROSS TUMOR PATTERN IN THE
PATIENTS WITH SINGLE HCC OVER
5 CM AFTER CURATIVE RESECTION
[PLEASE CHECK FOR THE EDITS
MADE IN THE TITLE.]
D. H. Han1,2, G. H. Choi1,2, K. S. Kim1,2,
J. S. Choi1,2, Y. N. Park2,4, S. U. Kim1,3,
J. Y. Park1,3, D. Y. Kim1,3 and S. H. Ahn1,3
1Department of Surgery; 2Yonsei Liver Cancer
Special Clinic; 3Department of Internal Medicine;
4Pathology, Yonsei University College of Medicine,
Seoul, Korea
Background & aims: The morphologic growth patterns
have been reported to be a significant prognostic factor
for hepatocellular carcinoma (HCC) after curative liver
resection. The present study investigated the relation-
ship between gross pattern of HCC and tumor size as a
prognostic factor for the patients with single HCC after
curative liver resection.
Methods: From January 1996 to December 2007, 610
patients underwent curative resection for HCC at
Yonsei University Health System, Seoul, Korea.
Among them, 535 patients with single tumor were
included in the current study. First, the prognostic fac-
tors for disease (DFS) and overall survival (OS) were
investigated for 535 patients. Second, the patients were
divided according to tumor size by 5 cm and DFS
and OS were analyzed according to 14 clinicopatho-
logic factors.
Results: The gross pattern of tumor was the significant
prognostic factors for DFS and OS in univariate analy-
sis (p = 0.013 and 0.007) but not in multivariate analy-
sis. The gross pattern of tumor was not the significant
prognostic factors for DFS and OS in the patients with
tumor size below 5cm (p = 0.240 and 0.246). According
to comparison of clinicopathologic features between
single nodular pattern with other gross patterns in the
patients with HCC over 5cm, microvascular invasion
(p < 0.001), gross vascular invasion (p < 0.001), and
poorly differentiated histologic grade (p = 0.010) were
more in the patients with non-single nodular gross pat-
tern. Gross pattern was the significant prognostic factor
for both DFS and OS in multivariate analysis for the
patients with tumor size over 5cm (p = 0.012 and
0.003).
Conclusions: Gross pattern of HCC was a significant
prognostic factor for long-term survival of HCC after
curative liver resection when the size of tumor was
more than 5cm. Thus, the patients with single nodular
gross pattern even the tumor size over 5cm may be the
good candidate for surgical treatment for HCC.
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SHORT-TERM AND LONG-TERM
SURGICAL OUTCOME OF LEFT-SIDE
PREDOMINANT HILAR
CHOLANGIOCARCINOMA
Dai Hoon Han, Sung Hoon Choi, Gi Hong Choi,
Kyung Sik Kim, Jin Sub Choi and Woo Jung Lee
Department of Surgery, Yonsei University College of
Medicine, Seoul, Korea
Backgrounds & aims: Achieving negative surgical mar-
gin by radical surgical resection including right- (RH)
or left-sided hepatectomy (LH) with caudate lobectomy
has been recognized as a standard treatment option for
hilar cholangiocarcinoma (HCCA). However, anatomi-
cal variation and short extrahepatic part of right hepa-
tic duct usually makes LH technically difficult. The
current study attempted to evaluate the perioperative
and long-term surgical outcomes of LH compared to
RH.
Methods: From April 2001 to August 2012, a total of
147 patients underwent surgical resection to treat
HCCA at Yonsei University Health System, Korea.
Among them, 103 patients took RH (group A; n = 65)
and LH (group B; n = 38) including caudate lobec-
tomy.
Results: There were no significant differences in periop-
erative outcomes between group A and B: postopera-
tive complication rate (34, 52.3% Vs 20, 52.6%;
p = 0.975), postoperative mortality (12, 18.5% Vs 2,
5.3%;p = 0.0059), and R0 resection rate (55, 84.6% Vs
35, 92.1%). Especially, postoperative ascites, which was
related to liver dysfunction, was more in RH (18.5%
Vs 0%) although postoperative bile leakage was more
in LH (7.7% Vs 28.9%). There were no significant dif-
ferences in long term surgical outcomes between two
groups. The median disease-free survival of the patients
under RH and LH were 24  3.69 and 17  2.09
(p = 0.468). The overall survival of the patients under
RH and LH were 28  12.27 and 21  2.06
(p = 0.620). Although the perioperative mortality rates
of LH were not significantly lower than those of RH
(p = 0.059), those were comparably lower (5.3% Vs
18.5%).
Conclusions: In this study, there were no significant dif-
ferences in R0 resection rate and long survival between
LH and RH although postoperative bile leakages were
more in LH while ascites were more in RH. Therefore,
aggressive left hepatectomy should be performed when
LH can be indicated as an alternative option for RH to
treat HCCA considering the location of tumor and
remnant liver volume after aggressive surgery.
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PREDICTION OF 1-YEAR SURVIVAL
AFTER KASAI OPERATION USING
BACK PROPAGATION NEURAL
NETWORK
Qiao Wang1, Lu-Nan Yan1, Fu-Yu Li2, Zhi-Cheng
Xu2, Xiao-Ping Jiang2 and Shu-Guang Jin2
1Department of Surgery, West China Hospital, Sichuan
University; 2Department of Pediatric Surgery, West
China Hospital, Sichuan University, Chengdu, China
Background: Kasai operation is the putative first line
treatment for infant patients with biliary atresia (BA).
Yet its outcome remains unsatisfying. Predictors devel-
oped by linear mathematic techniques, for poor out-
come after Kasai operation failed to achieve sufficient
accuracy. Back propagation neural network (BPNN) is
an efficient non-linear method to form a comprehensive
prognostic model.
Method: 33 patients with BA who underwent Kasai
operation as the primary treatment in our center during
Jan. 2008-Jan 2011 (mean age 3.2 months) were
included. Records of these patients were retrospectively
reviewed. By forwarding selection, Age, bilirubin, INR,
Albumin, creatinine, PELD score and anatomical pat-
tern of the patients were selected as input neurons.
After the training of the network, 4 hidden neurons
were proved to be the most efficient pattern for the net-
work. We randomly selected 23 patients to form the
training set and the other 10 patients were recruited as
training set to test the accuracy of the model. All input
parameters were further analyzed to identify their
weight in the model.
Result: The follow-up duration ranged 12-48.5 months.
One-year survival of the patients was 60.6%. The net-
work showed prediction accuracy for patient survival
and death were 83.3% and 100% respectively with
overall accuracy of 90%. Result of the cross-correlation
function showed age and anatomical pattern had signif-
icant influence on the output of the network.
Conclusion: BPNN is an efficient technique to predict
the one year survival of the patients with BA after
Kasai operation. Age and anatomical pattern were
dominant parameters to predict the prognosis after Ka-
sai operation
509
APPLICATION OF A “COMMON BILE
DUCT WINDOW” IN LAPAROSCOPIC
CHOLECYSTECTOMY
Hui Ye, Dai-An Deng, Ning Li and Wen-Zhu Lu
Department of Surgery, West China Hospital, Sichuan
University, Chengdu, China
Objective: To develop a new technique for bile duct
injury prevention in laparoscopic cholecystectomy.
Methods: Fifty-five patients who underwent laparo-
scopic cholecystectomy at our hospital from June 1,
2011 to October 31, 2011 were studied. The concept of
a “common bile duct window (CBD window)” was uti-
lized during laparoscopic cholecystectomy. The rates of
appearance of a “CBD window” and of a hepatic duct
/ common bile duct in the hepatic hilum – “CBD
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window” line – were observed intraoperatively. The
relationship among the hepatic duct / common bile
duct, cystic duct and hepatic hilum – “CBD window”
line – were analyzed.
Results: The rate of appearance of a “ CBD window”
was 92.7% (51/55); 98% (50/51) of the hepatic duct/com-
mon bile duct was in the hepatic hilum – “CBD win-
dow” line – and could be exposed, and the cystic duct
was located on the right side of this line. In the case of
acute cholecystitis, the “ CBD window” can still be visu-
alized in most patients, even if significant inflammatory
changes have occurred in the hepatoduodenal ligament.
Conclusion: The relationship among the hepatic duct,
common bile duct and cystic duct can be better deter-
mined by using the “ CBD window” as an anatomical
landmark to dissect the hepatic duct / common bile
duct. The application of a “ CBD window” can reduce
the incidence of bile duct injury during laparoscopic
cholecystectomy.
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META-ANALYSIS OF SURVIVAL AND
DISEASE RECURRENCE FOR SMALL
HEPATOCELLULAR CARCINOMA
AFTER RADIOFREQUENCY ABLATION
AND SURGICAL RESECTION
Peng Hu1, Shao-Jun Zhang2, Ai-Xue Sun1 and
Guo-Jun Qian2
1School of clinical medicine, Soochow University,
Suzhou; 2Department of Minimally InvasiveI, Eastern
Hepatobiliary Surgery Hospital, The second Military
Medical University, Shanghai China
Background: Radiofrequency ablation (RFA) has
emerged as a popular therapy for small hepatocellular
carcinoma. This review compared the survival and dis-
ease recurrence rates after surgical resection or RFA.
Method: A systematic review was conducted using
MEDLINE, Embase, Pubmed,Cochrane Central Regis-
ter of Controlled Trails, Cochrane Database of System-
atic reviews, Cochrane Methodology Register and the
Database of Abstracts of Reviews of Effects from Jan-
uary 2000 until June 2012 .
Results: These studies included a total of 18 articles: 4
RCTs and 14 NRCTs. The 3, 5 years overall survival
rates of RES was higher than the RFA group.
RFA had a higher rate of local recurrence. But the com-
plication rates of RFA were lower than the RES group.
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ANALYSIS OF RISK FACTORS OF
INTRA-ABDOMINAL COMPLICATIONS
AFTER
PANCREATICODUODENECTOMY
BASED ON AN UNIFORM DEFINITION
Wei-Dong Xiao, Yong Li, Jun Cai, Xue-Ming Li and
Yong-Huan Yu
Department of General Surgery, The First Affiliated
Hospital of Nanchang University, Nanchang, China
Background and aims: To investigate the intra-abdomi-
nal complications (IACs) and its main risk factors after
pancreaticoduodenectomy (PD) based on an uniform
definition. Methods:A retrospective analysis was made
on 295 cases who underwent PD from Janunary 2001
to July 2010. The diagnosis of IACs was based on an
uniform definition suggested by International Study
Group of Pancreatic Surgery and Pancreatic Surgery
Group of Chinese Medical Association Surgery Branch,
and the risk factors of IACs were analyzed by multi-
variate logistic regression analysis.
Results: The overall rate of IACs was 45.4%. The over-
all mortality was 3.4% and the re-laparotomy rate was
5.1%. The IACs included 49 (16.6%) cases of delayed
gastric emptying, 37 (12.5%) pancreatic fistula, 18
(6.1%) hemorrhage, 16 (6.1%) intra-abdominal infec-
tion, 8 (3.4%) incision infection or dehiscence, 4 (1.4%)
bile leakage, 1 (1.4%) gastrointestinal fistula and 1
(1.4%) ileus. In multivariate analysis, pancreatic duct
diameter (OR = 3.310) and parenchyma texture
(OR = 2.278) were independent risk factors for pancre-
atic fistula, pancreatic fistula (OR = 2.945) and high
serum bilirubin level (OR = 1.062) were independent risk
factors for hemorrhage, pancreatic fistula (OR = 2.104)
and intra-abdominal infection (OR = 1.326) were inde-
pendent risk factors for B/C grade delayed gastric emp-
tying, and digestive tract fistula (OR = 1.965) was
independent risk factor for intra-abdominal infection.
Conclusions: The usage of uniform definition is useful
for the diagnosis and treatment of complications after
PD, and benefit for academic exchange. Effective
prevention aimed at its risk factors is helpful to
decrease IACs after PD.
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CLINICAL ANALYSIS OF 21 CASES OF
RARE HEPATIC BENIGN TUMORS
Wei-Dong Xiao, Yong Li, Wei Hu, Jun Cai, Xue-Ming
Li and Ren-Hua Wan
Department of General Surgery, the First Affiliated
Hospital, Nanchang University, Nanchang, Jiangxi,
China
Background and aims: To investigate the diagnosis and
treatment of rare hepatic benign tumors.
Methods: The clinical data of 21 patients with rare
hepatic benign tumor in our hospital from May 2004
to March 2011 were retrospectively analyzed, including
5 cases of inflammatory pseudotumor, 4 focal nodular
hyperplasia, 3 hepatocellular adenoma, 3 inflammatory
granuloma, 2 angiomyolipoma, 2 hepatic tuberculomas,
1 leiomyoma and 1 hamartoma.
Results: The accuracy of image examination (BUS, CT
and MRI) for differential diagnosis between benign
and magignant hepatic tumor was 47.6%. Two patients
were performed left lateral lobectomy, 2 left hemihepa-
tectomy, and 17 local liver resection. The mean operat-
ing time was 135  55 min (rang, 60~270 min). 18
patients had no intraoperative blood transfusion, the
other 3 cases were received blood transfusion with
1800 mL, 600mL and 950mL, respectively. The mor-
bidity was 4.8%, and there was no reoperation and
death. The mean length of postoperative hospital stay
was 10.3  4.4 d (rang, 5~26 d). All patients had no
recurrence in the follow-up period.
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Conclusions: Combined with various kinds of image
examination could improve the diagnosis accuracy of
rare hepatic benign tumor, but the qualitative diagnosis
is still difficult before operation. For most of rare hepa-
tic benign tumor patients with symptoms or suspicion
of malignancy or risk of malignant change, hepatec-
tomy is the most effective therapeutic method.
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EN BLOC
PANCREATICODUODENECTOMY FOR
LOCALLY ADVANCED GASTRIC OR
COLONIC CARCINOMA:REPORT OF 15
CASES
Wei-Dong Xiao, Yong Li, Jun Cai, Xue-Ming Li,
Zhi-Gang Jie, Yong-Huan Yu and Tai-Yuan Li
Department of General Surgery, The First Affiliated
Hospital, Nanchang University, Nanchang, China
Background and aims: To investigate the feasibility and
efficacy of combined with pancreaticoduodenectomy
(PD) for locally advanced gastric or colonic carcinoma.
Methods: The clinical data of 15 patients with locally
advanced gastric or colonic carcinoma invading pancre-
aticoduodenal region undergoing en bloc PD between
May 2004 to December 2010 were retrospectively ana-
lyzed, including 12 cases of primary or recurrent gastric
carcinoma and 3 colonic carcinoma.
Results: The median operating time was 6 h (rang,
4~12 h) and the median length of postoperative hospi-
tal stay was 21 d (rang, 7~63 d). The morbidity was
46.7%, the re-operation rate and the mortality were
6.7%. Median survival was 23 months and 1, 2, 3-year
survival rate were 62.2%, 44.4%, 22.2%, respectively.
Conclusions: En bloc PD could be considered as one of
the therapeutic options for local advanced gastric or
colonic carcinoma with pancreaticoduodenal region
involvement and could improve the survival time. The
strict mastery of operation indications, meticulous oper-
ative technique, radical resection and intensive postop-
erative management are the keys to the prognosis.
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CLINICAL ANALYSIS OF 328
CONSECUTIVE
PANCREATICODUODENECTOMIES
Yong Li, Wei-Dong Xiao, Jun Cai, Yong-Huan Yu,
An-Tao Wu and Xue-Ming Li
Department of General Surgery, the First Affiliated
Hospital, Nanchang University, Nanchang, China
Background and aims: To explore the morbidity and
mortality and the long-term survival after pancreatico-
duodenectomy (PD).
Methods: The clinical data of 328 consecutive patients
undergoing PD between January 2001 and January
2011 were retrospective analyzed.
Results: The morbidity was 34.1% (112/328). Delayed
gastric emptying (16.5%), pancreatic fistula (11.9%),
hemorrhage (7.0%), intra-abdominal infection (5.2%)
and pulmonary infection (4.9%) were the 5 most com-
mon postoperative complications. The re-laparotomy
rate was 6.1% and the mortality was 3.0%. The 1-, 3-
and 5-year survival rate of periampullary carcinoma
were 79.1%, 51.5% and 33.8%, respectively; the med-
ian survival time was 38 months. Patients with negative
lymph node status had a median survival of 47 months,
and their 1-, 3-, and 5-year survival rate were 81.7%,
57.6% and 40.6%, respectively. Patients with positive
lymph node status had a median survival of 24 months,
and their 1-, 3-, and 5-year survival rate were 72.1%,
36.4% and 16.8%, respectively. The long-term survival
of patients with negative lymph node was significantly
better than those with positive lymph node (p = 0.003).
The 1-, 3-, 5-year survival rate of pancreatic carcinoma
were 67.6%, 29.1% and 9.7%, respectively; the median
survival time was 16 months. The 3-year survival rate
of patients with positive lymph node status was 0. The
1-, 2-, 3-year survival rate of nonperiampullary primary
carcinoma were 71.4%, 39.6% and 19.8%, respectively;
the median survival time was 21 months.
Conclusions: The strict mastery of indication for
extended PD, meticulous operative technique, careful
observation and timely aggressive management in the
postoperative period are the keys to reduce morbidity
and mortality after PD. The lymph node status is the
important factor of prognosis of periampullary and
pancreatic carcinoma. PD should be considered for
locally advanced nonperiampullary tumors with the
advantage of improving the survival time.
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POST PANCREATICODUODENECTOMY
HAEMORRHAGE: REPORT OF 23
CASES
Yong Li, Wei-Dong Xiao, Jun Cai, Yong-Huan Yu,
An-Tao Wu and Xue-Ming Li
Department of General Surgery, The First Affiliated
Hospital of Nanchang University, Nanchang, China
Background and aims: To explore the cause, prevention
and treatment of post pancreaticoduodenectomy haem-
orrhage.
Methods: The clinical data of 279 patients undergoing
PD between January 2001 and April 2010 were retro-
spective analyzed. The diagnosis of haemorrhage was
according to the definition and classification of post-
pancreatectomy (PPH) proposed by international study
group of pancreatic surgery (ISGPS).
Results: PPH occurred in 18 patients (6.5%, 18/279),
including 6 intraluminal and 12 extraluminal PPH.
Early haemorrhage was recorded in 6 patients, and late
haemorrhage in 12 patients. 5 patients were mild and
13 severe PPH. According to the clinical grading of IS-
GPS, 11 belongs to Grade B and 7 belongs to Grade
C. The median time of onset was 5.5 days. Ten
(55.6%, 10/18) patients underwent reoperation. The
overall mortality was 22.2% (4/18).
Conclusions: Timely and decisive reoperation is an
important method to management of PPH. The meticu-
lous operative technique, complete hemostasis, preven-
tion of pancreatic fistula and intra-abdominal infection
are the keys to reduce PPH.
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LYMPH NODE RATIO OF PANCREATIC
CANCER HAS LIMITED PROGNOSTIC
RELEVANCE
M. J. Kang, J.-Y. Jang, J. W. Park, W. Kwon,
Y. R. Chang and S.–W. Kim
Department of Surgery, Seoul National University
College of Medicine, Seoul, Korea
Background: Metastatic lymph node ratio has been
suggested as a prognostic factor of pancreatic cancer.
However, some reported for other malignancies that
patients with a small number of metastatic lymph
nodes have comparable survival with node negative
patients. The aim of this study was to evaluate the
prognostic impact of metastatic lymph node ratio of
pancreatic cancer.
Methods: Data were collected from 717 patients who
underwent surgery for pancreatic head cancer at Seoul
National University Hospital. Long-term prognosis was
analyzed according to lymph node ratio (LNR) and
absolute positive lymph node number.
Results: The study subjects were at mean age of
59.7 years (male: female = 1.8:1) with median follow
up of 10.6 months (range, 0.2-176.4). Curative intended
resection rate was 55.5% (n = 398). After curative
intended resection, types of operation included Whip-
ple’s operation (n = 203, 51.0%), pylorus-preserving
pancreatoduodenectomy (n = 179, 45.0%), and total
pancreatectomy (n = 16, 4.0%), and portal vein resec-
tion was performed in 17.6% (n = 70). After curative
intended resection, lymph node metastasis was identi-
fied in 57.3% (n = 228) of the patients and total
retrieved lymph node was at mean of 19.5. Mean posi-
tive lymph node was 1.9 and mean lymph node ratio
(LNR) was 0.11. Patients with LNR higher than 0.2
had higher T stage (p = 0.024) but R0 resection rate or
portal vein resection rate was comparable with those
with LNR less than 0.2. Overall median survival of the
patients after curative intended resection was
18.4 months and patients without lymph node metasta-
sis had higher survival outcome than those with lymph
node metastasis (median survival 25.5 vs. 14.8 months,
p < 0.001). Patients with only 1 positive lymph node
had poor prognosis than those without lymph node
metastasis (median survival 17.3 vs. 25.5 months,
p = 0.001). Patients with 1 positive lymph node had
comparable survival outcome with those with 2 positive
lymph nodes or with more than 3 positive lymph nodes
(median survival 17.3, 15.5, 13.6 months, p = 0.195).
For node positive patients, survival outcome was com-
parable in patients with LNR < 0.2, 0.2  LNR < 0.4,
0.4  LNR (p = 0.085)
Conclusion: Only 1 positive lymph node metastasis sig-
nificantly worsens the prognosis of patients with pan-
creatic cancer. When lymph node metastasis is present,
number of metastatic lymph node or LNR has limited
prognostic relevance.
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HEPATIC HEMANGIOMA: CLINICAL
EXPERIENCE IN A SINGLE CENTER
WITH 820 CASES
Zhi-Ying Yang, Xin-Ting Sang, Yong-Liang Sun,
Hai-Dong Tan, Tian-Yi Chi, Xin Lu and
Shou-Xian Zhong
Department of Hepatobiliary Surgery, China-Japan
Friendship Hospital, Beijing, China
Background & Aims: Clinical features of hepatic hem-
angioma are not well defined, and indications for dif-
ferent therapeutic options remain controversial. The
aim of this study was to investigate the features of the
disease and to evaluate the indications for respective
therapeutic options.
Methods: The study involves retrospective review of
both inpatients and outpatients with liver hemangioma
from January 2006 to December 2010.
Results: The mean age of all the 820 patients at diag-
nosis was 43.9  9.8 years with a female: male ratio
of 2.76:1. Symptoms were present in 20.1% of
patients, and increased with tumor size, with left and
caudate lobe hemangiomas becoming symptomatic at
a relatively smaller size. Altogether 264 inpatients
underwent surgery, included 131 enucleations, 117
hepatectomies and 16 laparoscopic hepatectomies.
There were no significant difference between enucle-
ation and hepatectomy subgroup on patient’s age,
female to male ratio and tumor size. Enucleation
showed advantages over hepatectomy in terms of in-
traoperative blood loss and postoperative hospital
stay. However, postoperative complications were simi-
lar between the two subgroups (11.6%VS 13.7%,
P = 0.597) and a postoperative mortality was reported
in one patient (1.2%) of hepatectomy subgroup. Of
the 47 cases who underwent transcatheter arterial
embolization, treatment was unsuccessful in 42.1%,
including 7.9% who had complications needing further
intervention.
Conclusions: We propose that there should be strict
indications for the surgical treatment of hepatic heman-
giomas. Enucleation has advantages over hepatectomy.
Transcatheter arterial embolization should only be used
in strictly selected situations.
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UP-REGULATION OF FAM189B
CONTRIBUTES TO HUMAN
HEPTOCELLULAR CARCINOMA
PROLIFERATION VIA MODULATING
WWOX SIGNALING
Hai Zhang1, Yu-Ping Wang2,3, Jian Shen1, Yun
Wang1, Yuan Tian1, Chang-Jun Huang1, Ze-Guang
Han2 and Xiang-Cheng Li1
1Liver Transplantation Center, First Affiliated Hospital
of Nanjing Medical University, Key Laboratory of
Living Donor Liver Transplantation, Ministry of Public
Health, Nanjing 210029, People’s Republic of China;
2Shanghai-MOST Key Laboratory for Disease and
Health Genomics, Chinese National Human Genome
Center at Shanghai, Shanghai 200120, People’s Republic
of China; 3Department of Medical Biochemistry and
Molecular Biology, School of Basic Medical Sciences,
Lanzhou University, Gansu 730,000, People’s Republic of
China
Background and aims: Hepatocellular carcinoma
(HCC) is one of the most fatal tumor globally. Up to
date, no effective treatment has been explored for HCC
patients, especially for advanced ones. Family with
sequence similarity 189B (FAM189B), a putative onco-
gene selected by microarray, was found to be signifi-
cantly up-regulated in HCC specimens. Whether
genetic alterations of FAM189B are involved in the
oncogenesis of HCC is unknown.
Methods: In present study, the expression of
FAM189B was detected by using reverse transcription-
polymerase chain reaction and immunohistochemistry
assay. Then, siRNA and recombinant plasmid were
used to knockdown and overexpression FAM189B,
respectively. Cell viability was measured by CCK-8,
colony formation assay and soft agar colony formation
assay, successively. Cell cycle and apoptosis was
assessed by flow cytometry. The potential pathways
involved in cellular proliferation was explored by Wes-
tern blot, Co-IP and immunofluorescence.
Results: Over expression of FAM189B enhaced HCC-
derived Focus and Huh7 cell viability, colony forma-
tion in soft agar in vitro and tumorigenicity in vivo. By
contrast, FAM189B knockdown via RNAi markedly
suppressed these phenotypes, as documented in YY-
8103 and WRL-68 HCC cell lines. Mechanistic analyses
indicated that FAM189B could physically associate
with WW domain oxidoreductase (WWOX) and modu-
late WWOX tyrosine phosphorylation. Ectopic overex-
pression of FAM189B inhibit WWOX-p53 signaling
pathway via reducing phosphorylation of WWOX at
Tyr-33 residue in Focus. Conversely, FAM189B silenc-
ing activated the tyrosine-33 phosphorylation of
WWOX, induced WWOX-p53 mediated mitochondrial
aopotosis in WRL-68. In addition, FAM189B upregu-
lation could block WWOX-cyclin D1 pathway via
WWOX (Tyr-287) dephophorylation in Huh7, which
stimulated cell cycle progression. While, tyrosine-287
residue phosphorylation of WWOX by FAM189B
silencing may potentially caused WWOX-cyclin D1 si-
galing activation, leading to cell cycle arrest in YY-
8103. Together, our findings suggest that cytoplasm
protein FAM189B could contribute to HCC tumori-
genesis by regulating cell proliferation via modulating
WWOX signaling.
Conclusions: FAM189B contributes to the tumorigene-
sis of HCC and potentially represent a new target of
HCC gene therapy.
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THE PRELIMINARY REPORT OF A
EUS-GUIDED ENDOSCOPIC
NECROSECTOMY AND TEMPORARY
CYSTOGASTROSTOMY FOR INFECTED
PANCREATIC NECROSIS
A. Krishnan and R. Ramakrishnan
Department of Gastroenterology & Interventional
Endoscopy, Apollo Hospitals, Chennai, India
Introduction: Pancreatic pseudocyst with infected
necrotic tissue is associated with a high rate of compli-
cations and death. Standard treatment is open necro-
sectomy but is associated with significant morbidity,
mortality, and prolonged hospital stay. Endoscopic cyst
drainage with necrosectomy is an alternative and less
invasive technique. Here we report our experience using
pseudocyst drainage with cystogastrostomy and endo-
scopic necrosectomy for infected pancreatic necrosis
with fully covered self-expanding metallic stents
(CSEMS).
Material and Methods: Between 2011 and 2012, 12
patients underwent endoultrsound guided endoscopic
necrosectomy and temporary cystogastrostomy for
infected pancreatic necrosis by using CSEMSs. Patient
details, disease severity scores, scores for severity
assessed at CT, treatment procedures, length of hospi-
tal stay, and outcome for patients undergoing endo-
scopic therapy were recorded. Patients proceed to
intervention if infection is strongly suspected on clinical
and radiological grounds or is confirmed bacteriologi-
cally. After the necrosis cavity had been accessed, with
the assistance of endoscopic ultrasound, a large orifice
was created and necrotic debris was removed using
special short fully covered 15 mm diameter SEMS with
large flares was deployed across the tract under radio-
logical control. Completeness of the necrosectomy
procedure was ascertained by visualization of a clear
pseudocyst cavity on endoscopy.
Results: A total of 12 patients (10 men, 2 women; med-
ian age 39, range 19-76) who were treated successfully.
Median APACHE 2 score on presentation was 11
(range 3  18). Two patients presented with organ fail-
ure and needed intensive care. Necrosis was successfully
treated endoscopically in all patients, requiring a med-
ian of 2 endoscopic interventions (range 1  4). The
tissue samples obtained at the first necrosectomy con-
firmed infection in 12 patients. Complication included
superinfection in patient who made an uneventful
recovery. After median of 5 weeks the metal SEMS
was extracted by endoscopy. The patients have
remained asymptomatic and median follow-up was 4
(2  11) months.
Conclusion: Endoscopic necrosectomy and temporary
cystogastrostomy with self-expanding metallic stent
approach is feasible, safe, and effective in patient with
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infected pancreatic necrosis. The benefits of this
endoscopic approach using fully covered self-expand-
able metallic stent in terms of less morbidity is conceiv-
able and our report demonstrates that such an
approach is feasible.
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DUODENUM PRESERVING
PANCREATIC HEAD RESECTION
VERSUS
PANCREATICODUODENECTOMY FOR
BENIGN PANCREATIC NEOPLASMS
Jia-Zhe Liu, Xin-Yu Huang, Hong-Cheng Wang and
Qi Zhen
Shanghai Sixth People’s Hospital, Shanghai Jiaotong
University School of Medicine, Shanghai, China
Background and aims: The classical duodenopancrea-
tectomy is no longer a standard procedure in benign
pancreatic head neoplasm, and is continuously being
replaced by operations such as the duodenum-preserv-
ing pancreatic head resection. These procedures allow
the preservation of exocrine and endocrine pancreatic
function, and contributes to an improvement in life
quality. The aim of this study was to compare the
safety and efficiency of (duodenum preserving pancre-
atic head resection, DPPHR) and (duodenopancreatec-
tomy, PD) in treatment for benign neoplasm of the
pancreatic head.
Methods: Fifty-seven patients undergoing PD or
DPPHR for benign neoplasm of pancreatic head
between January 2003 and December 2009 were retro-
spectively reviewed. They were followed up for more
than 2 years. The preoperative variables, operation
data, mortality, morbidity and duration of hospital
stay after the two types of surgery were compared.
Quality of life was assessed cross-sectionally using the
standard Chinese version of the EORTC QLQ-C30
(vs. 3.0).
Results: 31 patients underwent PD and 26 underwent
DPPHR for the treatment of benign pancreatic head
neoplasm. The characteristics of patients were similar
between the two groups. Operation time (310  91 min
vs 249  71 min), duration of hospital stay (14.0
 9.8 days vs 9.1  7.4 days) and estimated blood loss
(302  103 mL vs 232  73 mL) were all less for
DPPHR patients (p < 0.05). There was no postopera-
tive death in either group. Mortality (32.26% vs
30.77%, p > 0.05). And quality of life scores was more
excellent in DPPHR group.
Conclusions: DPPHR is as effective as PD in treatment
of the patients with benign pancreatic head neoplasm.
Post-operative mortality and morbidity did not differ
between the two groups. DPPHR resulted in a shorter
hospital stay, less blood loss and less operation time.
DPPHR will be more recommended for some patients
with benign pancreatic head neoplasm.
Key words: Duodenum preserving pancreatic head
resection, duodenopancreatectomy, Benign pancreatic
head neoplasm
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PROTECTIVE EFFECT OF ELECTRO-
ACUPUNCTURE ON LIVER ISCHEMIA-
REPERFUSION INJURY IN RATS
Feng Xu1, Ye-Sheng Li1,2, Xin Lv3, Ping Zhang4,
Xin-Ji Zhang5, Jian Lu5, Yang-Qing Huang1,
Jia-Mei Yang1 and Hong-Hai Li6
1Department of Special Treatment, Eastern
Hepatobiliary Hospital, Second Military Medical
University, Shanghai, China; 2Department of Surgery,
Changhai Hospital, Second Military Medical University,
Shanghai, China; 3Department of Anesthesiology,
Pulmonary Hospital, Tongji University, Shanghai,
China; 4Experimental Research Center, Cancer Hospital,
Fudan University, Shanghai, China; 5Department of
Health Statistics, Second Military Medical University,
Shanghai, China; 6Shanghai Cancer Institute, Shanghai
Jiaotong University, Shanghai, China
Background and Aims: Liver ischemia-reperfusion
injury is an important clinical complication and the
excessive inflammation becomes a key point, whereas
few studies have revealed effective regulation. Recent
studies suggest that electro-acupuncture could control
the excessive inflammation. We aimed to explore the
effects of electro-acupuncture on liver ischemia-reperfu-
sion injury.
Methods: All rats were randomly divided into surgery
and sham groups; both were further divided into four
sub-groups, got non-treatment, non-point acupuncture,
nonselective nicotinic AChR agonist and electro-acu-
puncture. The Alanine aminotransferase, serum cyto-
kines, Myeloperoxidase and tissue pathology were
tested.
Results: This study showed serum Alanine amino-
transferase increased significantly with different pre-
treatments of Non-Treatment, Non-Point
Acupuncture, Nonselective Nicotinic AChR Agonist
or Electro-Acupuncture (n = 12, p < 0.05) and Non-
Treatment or Non-Point Acupuncture group were
much higher concentration than Electro-Acupuncture
or Nonselective Nicotinic AChR Agonist group about
Myeloperoxidase (n = 6, p < 0.05). And showed Elec-
tro-Acupuncture group significantly inhibited the
serum inflammatory cytokines TNF-a, IL-6 (n = 10,
p < 0.05) but has no effect on anti-inflammatory cyto-
kine IL-10 (n = 6, p > 0.05) and had no any effect at
mRNA level (n = 6, P > 0.05). When block the vagus,
there were no signal differences between Non-Point
Acupuncture and Electro-Acupuncture group in Sub-
phrenic Vagotomy or Mecamylamine-Hydrochloride
about Alanine aminotransferase, Myeloperoxidase and
serum cytokines.
Conclusions: Here we shown that the Electro-Acupunc-
ture could effectively protect the liver ischemia-reperfu-
sion and the main mechanism was reduced the pro-
inflammatory cytokines and this role wasn’t accompa-
nied the anti-inflammatory cytokines.
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HEPATIC PERIVASCULAR
EPITHELIOID CELL TUMORS-NOT
OTHERWISE SPECIFIED (HPECOMAS-
NOS)
Xiao-Gang Zhang, Lin Wang, Zhi-Min Geng, Zhen
Wan and Yi Lv
Department of Hepatobiliary Surgery, the First
Affiliated Hospital of Medical College, Xi’an Jiaotong
University, Xian, Shannxi, China
Background and aims: Neoplasms of perivascular epi-
thelioid cells (PEComas) are characterized by epitheli-
oid to spindle cells with eosinophilic to clear
cytoplasm, an intimate relationship with blood vessels,
and coexpression of myoid and melanocytic immuno-
histochemical markers. While most reported hepatic
PEComas, such as angiomyolipoma (AML), behave in
a benign fashion, emerging PEComas cases without
typical characteristics require further clarification.
Methods: We report a case of primary hepatic perivas-
cular epithelioid cell tumors-not otherwise specified
(HPEComas-NOS) with untypical pathological and
immunohistochemical features compared to those of
the benign hepatic AML cases.
Results: A 63 year old female was admitted to the first
affiliated hospital of medical college of Xi’an Jiaotong
university in October 2011 for further examination of
the liver tumor which was detected by computed
tomography (CT). Non-enhanced CT scan revealed a
lower density mass in the right lobe with a well demar-
cated margin and homogeneous density (Fig. 1A). Con-
trast-enhanced CT showed significantly and
heterogeneously patchy enhancement of the lesion on
arterial phase, being slightly hypodense on delayed CT
scan Fig. 1B). The decision was made to resect the liver
neoplasm and in October 2011, the patient underwent a
hepatectomy. The patient did not receive any adjuvant
or neoadjuvant therapy, and she remains alive with no
recurrence or metastases after 10 months of close sur-
veillance. Histologically, the liver tumor was composed
mainly of medium to large epithelioid cells and focal
areas of spindle/elongated cells around numerous small
blood vessels which were arranged in small nests, tra-
beculae or sheet-like patterns with numerous interven-
ing vascular spaces(Fig. 2A, B). The neoplastic cells
were mainly epithelioid but occasionally spindled, with
abundant cytoplasm that varied from eosinophilic and
granular to clear. Immunohistochemically, both the epi-
thelioid and spindle neoplastic cells of the liver tumor
were strong and diffusely positive for HMB-45 (cyto-
plasmic)(Fig. 3A), smooth muscle actin (cytoplasmic
and membranous)(Fig. 3B), CD34 (Fig. 3C) and Vi-
mentin (cytoplasmic and membranous) immunostaining
(Fig. 3D). The tumor cells showed local (< 20% of the
neoplastic cells), strong, immunoreactivity for Ki67
(nuclear)(Fig. 3E). The neoplastic cells failed to express
hepatic carcinoma marker (AFP)(Fig. 3F), S-100 pro-
tein, cytokeratins c-kit/CD117.
Conclusion: HPEComas-NOS may be a special type of
PEComas classified as “malignant potential” or at
“high risk of aggressive behavior”, suggesting further
clarification of Hepatic PEComas and long-term fol-
low-up of patients with HPEComas-NOS.
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RIPC PROTECT LIVER ISCHEMIA
REPERFUSION INJURY VIA HEME
OXYGENASE-1 INDUCED AUTOPHAGY
Yun Wang, Jian Shen, Yong-Hua Xu and
Xiang-Cheng Li
The first affiliated hospital of nanjing medical university,
Nanjing, China
Background and aims: Autophagy has been implicated
in many physiological and pathological processes and
there’s growing evidence linking autophagy to protec-
tive role of preconditioning in liver ischemia/reperfu-
sion (IR). Heme oxygenase-1 (HO-1) is essential to
limit inflammation and prevent cell death or apoptosis
response to IR which was demonstrated to up-regu-
lated in the liver graft after remote ischemic precondi-
tioning (RIPC) in our previous study. The aim of the
present study was to certify the hypothesis that RIPC
protected liver from IR via HO-1 mediated auto-
phagy.
Methods: RIPC was performed with regional ischemia
of limbs before liver ischemia performed in the RIPC
group and the activity of HO-1 was inhibited with
Protoporphyrin IX zinc(II) (ZnPP) preoperation in the
ZnPP group. Autophagy was assessed by the expres-
sion of LC3-II. The HO-1/ERK/ P38/ MAPK path-
way was detected in the mixed model of starvation-
induced autophagy and mineral oil-induced IR in vi-
tro.
Results: In the process of liver IR, the expression of
LC3-II was accordingly increased peaked at 12-24 h
after IR. The ultrstructure of liver after IR also
revealed that there existed abundant autophagosomes
in the liver cells after IR. However, the autophagy
was promptly initiated after RIPC which alleviated the
liver IRI consequently and the expression of HO-1
was also up-regulated simultaneously. The autophagy
was inhibited when the HO-1 was inactivated by Znpp
which would result in the aggravation of liver IRI
subsequently in vivo. In the model of IRI for hepato-
cytes in vitro, the starvation-induced autophagy could
protect rat hepatocytes form IRI which would be dete-
riorated by ZnPP. The phosphorylations of P38
MAPK and ERK1/2 were up-regulated in the starva-
tion-pretreated liver cells and down-regulated after
treatment of ZnPP.
Conclusions: RIPC induced autophagy can protect liver
from IR injury in part via HO-1 p38 MAPK-dependent
signaling.
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565
COMPREHENSION OF DIAGNOSIS
AND TREATMENT OF BILOMA
COMPLICATED BY LIVER TUMOR
AFTER TACE
Gao-Qiang Wang1, Bao-Mu Sun1, Xiao-Xiong Wu1,
Sheng-Bing Wu1, Ting-Song Chen1, Liang-Hui Shi1,
Hong-Ling Yang2 and Ming Luo1
1Department of integrated traditional Chinese and
western medicine, Second military medical universty
eastern hepatobiliary surgery hospital; 2Department of
information, Second military medical universty eastern
hepatobiliary surgery hospital Shanghai, China
Abstract: Objective: To investigate the diagnosis and
treatment of biloma complicated by liver tumor after
treated by transcatherter arterial chemoembolization.
Methods: 1695 patients with liver tumor, from August
2005 to August 2010 in our hospital, treated by TACE
and examined by computed tomography were collected,
33 patients with biloma were found, account for 9.1%.
All 33 patients with biloma were treated by percutane-
ous transhepatic intracavitary duct drainage, 2 cases
were treated by surgery after drainage.
Results: 22 cystic, 8 columnar and 3 cystic and colum-
nar coexisted dilatational bilomas were found, account
for 66.7%, 24.2% and 9.1% respectively. 28 patients
were cured after treated by percutaneous transhepatic
intracavitary duct drainage, 2 patients that ineffectived
were cured by surgery after drainage. 3 patients were
died of concurrent infection, organ function damage.
Conclusions: Biloma is one of the rare complications
by liver tumor after treated by TACE, and there is high
incidence in patients with liver tumor treated by TACE
frequently, in particular among the tumors lack of
blood supply. The effect of percutaneous transhepatic
intracavitary duct drainage and sugery resection is defi-
nite when conservative treatment is not effective.
Keywords: Liver tumor, Chemoembolization, Biloma,
Drainage.
566
CLINICAL APPLICATION OF
LAPAROSCOPIC COMMON BILE DUCT
EXPLORATION THROUGH
TRANSCYSTIC OR A MINI-INCISION
ACCESS
Jing-Hai Song, Zhe Li, Jian Chen, Xiu-Wen He,
Dong-Hui Xie and Jun-Min Wei
Department of General Surgery, Beijing hospital,
Beijing, China
Aims: To summary the clinical experiences on laparo-
scopic common bile duct exploration (LBDE) through
a mini-incision access at the confluence part of CBD
and cystic duct.
Methods: Retrospectively analyze the clinical materials
of 46 cases of LBDE through transcystic or mini-inci-
sion access between Oct 2006 and Dec 2011 in our hos-
pital. An incision of 2-3 mm was made in the point of
CBD and custic duct for exploration. The incision was
directly sewed up after the exploration. Results
sixty-four piece of stones were found in extrahepatic
biliary tract in all patients. The mean duration of post-
operative hospitalization was 6.2  1.7d. All patients
were followed up for a mean of 12 months. Two
patients had residual stones and were cured with endo-
scopic sphincterotomy. One patient suffered from bile
leakage and was cured through open abdominal sur-
gery. No biliary tract stricture were found in all
patients.
Conclusions: LBDE through the mini-incision in the
joint CBD and cystic duct is safe and convenient. If
patients are suitable, it is more in line with the concept
of minimally invasive surgery.
567
EPHA2-MEDIATED AKT/MTOR AND
PYK2/C-SRC ACTIVATIONS
CONTRIBUTE TO TUMOR GROWTH
AND METASTASIS IN
CHOLANGIOCARCINOMA
Hee Chul Yu1, Baik Hwan Cho1, Jae Do Yang1, Xiang
Dan Cui2, Mi Jin Lee2, Gyung Ran Yu2, Seung O.
Lee2 and D. G. Kim2
1Departments of Surgery; 2Division of Gastroenterology
and Hepatology, Internal Medicine, Chonbuk National
University Medical School and Hospital, Jeonju,
Jeonbuk, South Korea
Background and aims: Aberrant expressions of EphA2
was believed to be associated with worse tumor behav-
iors of many carcinomas. This study was to examine
the expression EphA2 in cholangiocarcinoma (CC)
and its biological roles in tumor growth and metasta-
sis.
Methods: EphA2 expressions were investigated in CC
tissues and cells by immunoblot and immunohisto-
chemical analyses, according to CC cell differentiation.
Tumor growth and metastasis were assessed in the ani-
mal model system. Downstream signal pathway of
EphA2 was explored in vitro cell culture system.
Results: Aberrant expression of EphA2 was highly
observed in the CC cells (JCK and SCK) and tissues
with worse differentiation and metastatic ability. In vi-
tro soft agar assay and in subcutaneous tumor model,
EphA2 enhanced colony formation and accelerated
tumor growth, which seemed to be mainly associated
with Akt (T308)/mTORC1 activation. The stable trans-
fectants of EPHA2 showed some morphological
changes of the epithelial mesenchymal transition
(EMT). The ability of metastasis was also enhanced in
mice lung metastasis model, which seemed to be
resulted from Pyk2 (Y402)/c-Src activation. Further-
more, each pathway concurrently effect on the other
pathway.
Conclusion: These results suggested that EphA2 might
be involved in tumor growth and metastasis through
Akt/mTORC1 and Pyk2/c-Src activations. Therapeutic
strategies that target EphA2 may be useful to control
the behaviors of CC.
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ANALYSIS ON PROGNOSIS FACTORS
AND THERAPEUTIC EFFICACY OF 246
UYGHUR PATIENTS WITH PRIMARY
HEPATIC CARCINOMA IN XINJIANG
REGION
Jie Gao, Ya-Qiong Ni and Yong-Xing Bao
Tumor Center, First Affiliated Hospital of Xinjiang
Medical University, Xinjiang, China
Background and aims: Primary hepatic carcinoma(PHC)
is the high incidence of malignant tumors in China, the
prognosis is poor.This study aims to find the prognostic
factors affecting the survival of uyghur patients with pri-
mary hepatic carcinoma and the outcomes of different
therapeutic patterns were compared in this article.
Methods: We retrospectively analyzed the clinical and
follow-up data of 246 uyghur patients with primary hepa-
tic carcinoma.The factors that may influence the progno-
sis and survival were analyzed using the log-rank test.And
multivariate analysis was performed by Cox proportional
hazardmodel to find the independent prognostic factors.
Results: The median survival time for the 246 patients
was 10.7 months. The survival rates at 1,2,3,5 years
were 41.97%, 22.13%, 14.87% and 8.92%.Univariate
analysis by log-rank test showed that the age, hepatic
cirrhosis, tumor staging, tumor number, as cites, portal
vein thrombus,metastasis, lymph node metastasis, Child-
Pugh stage, serum AST, TBIL, ALB, GGT, ALP, TBA,
LDH level were the prognostic factors. While the multi-
factor analysis with Cox proportional hazard model
showed that the age, tumor staging, portal vein throm-
bus, Child-Pugh stage and serum LDH level were inde-
pendent prognostic factors. The therapeutic efficacy of
treatments which include surgery, transcatheter hepatic
arterial chemoembolization(TACE),chemoradiation,
radiofrequency ablation(RFA)was much better than
supporting therapy. The median survival time implied
that integrated therapy was better than single therapy
treatment.For patients treated with TACE and other
treatments,the median survival time was 64.9 months.
Conclusion: The age,tumor staging,portal vein throm-
bus,Child-Pugh stage and serum LDH level were signif-
icant independent factors influencing survival. The
therapeutic efficacy of surgery, TACE, chemoradiation,
RFA was much better than supporting therapy. Inte-
grated therapy is beneficial for improving therapeutic
effect. The therapy combine with TACE and other
treatments is potential for advanced the PHC.
572
SCREEN OF DIFFERENTIAL
EXPRESSION PROTEINS IN RAT LIVER
REGENERATION AFTER PH
Dong-Xun Zhou, Ye-Xiong Tan, Xiao-Hui Xu,
Chao-Xu Yang, Yi Hong, He-Ping Hu, Hong-Yang
Wang and Meng-Chao Wu
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background and aim: It is generally known that the
acceleration of liver regeneration presents some
significant potential clinical benefit for various liver-
associated diseases. However, the molecular mechanism
of liver regeneration remains obscure. Consequently,
we aim to further investigate some functional proteins
or pathways involved in the repair of liver damage
Methods: Adult male Sprague–Dawley rats underwent
approximately 70% partial hepatectomy (PH) and
sham surgery. Liver specimens were collected at 2, 6,
12, 24, 36, 48, 72, and 168 h after PH and sham sur-
gery, respectively. Thereafter, we abstracted the pro-
teins followed by two-dimensional gel electrophoresis
to observe the changes in protein express levels after
PH, then compared these with those in sham-operated
rats. Subsequently, liver specimens from PH rats were
examined by RT-PCR analysis. Western-blotting was
performed to identify prohibitin (PHB) that might play
an important role in liver regeneration.
Results: We found that protein spots began to rise at
2 h, peaked at 36 h, and reduced gradually at 48 h.
This was in accordance with the change in liver DNA
synthesis between 24 h and 36 h. After which, we used
image master software to obtain 938  90 spots in each
gel. Thus, 37 significant proteins were found to be
involved in oxidative stress response, acute reaction,
lipid and energy metabolism, nerve intracellular signal-
ing, and cell proliferation, among others. Prohibitin,
identified as one of significant proteins in gel, was
validated by western-blotting and RT-QPCR.
Conclusion: Liver regeneration following partial hepa-
tectomy affects various signaling and metabolic path-
ways.
573
A NEW FEASIBLE TECHNIQUE OF
CHOLEDOCHOJEJUNOSTOMY BY THE
WAY BEHIND ANTRUE PYLORICUM: A
RETROSPECTIVE CASE-CONTROL
STUDY
Xin-Wei Yang, Jue Yang and Bao-Hua Zhang
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background: Reflux cholangitis was the most common
complication after Roux-en-Y choledochojejunostomy.
In this study we intended to evaluate the perioperative
and long-term efficacy of a new anastomosis method
for choledochojejunostomy.
Methods: The clinical data of 286 eligible patients who
had underwent choledochojejunostomy in Eastern He-
patobiliary Surgery Hospital affiliated Second Military
Medical University, China between January 2005 and
December 2010 were retrospectively analyzed. Among
the patients, consecutive 76 cases were received this
new anastomosis method for choledochojejunostomy
(improved group, IG) and 210 underwent standard
Roux-en-Y choledochojejunostomy (control group,
CG). The changes in incidence of cholangitis, the time
of beginning to eat liquid meals, postoperative delayed
gastric emptying and liver function between two groups
were compared.
Findings: There was no statistical difference in the lev-
els of alaninetransaminase, alkaline phosphomonoester-
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ase and gamma-glutamy transferase between two
groups. The time of beginning to eat liquid meals was
significantly shorter in IG than CG (p < 0.05). The
incidence of delayed gastric emptying was significantly
lower in IG than CG (p = 0.014). Among 18 patients
with different degrees of acute cholangitis in two
groups, two patients (2.6%) in IG and 16 (7.6%) in
CG suffered from acute cholangitis within six months
follow-up after discharge, but with no statistical differ-
ence between two groups (p = 0.126). In long-term fol-
low-up, we have got significantly lower incidence of
chronic cholangitis by the new technique of chol-
edochojejunostomy (p = 0.047).
Conclusions: Consecutive 76 cases in IG had satisfac-
tory perioperative and long-term prognosis with shorter
time of beginning to eat liquid meals and lower inci-
dence of delayed gastric emptying. This new procedure
of choledochojejunostomy by the way behind antrue
pyloricum was feasible and safe with no mortality and
low complication rates.
576
APPLICATION ANALYSIS ABOUT
CORRESPONDING INTENSITY OF
POST END-EXPIRATORY PRESSURE
VENTILATION IN INTRA-ABDOMINAL
HYPERTENSION
Qian He, Yi-Jie Chen, Shao-Bo Zhang, Jian-She Shi
and Cheng-Hua Zhang
General surgery department of the 180th hospital of
PLA, Quanzhou, Fujian, China
Objection: To observe the cardiopulmonary function
affection and analyze the efficacy by giving PEEP
adapted to the different intra-abdominal pressure in
patients with intra-abdominal hypertension.
Methods: We took the patients in our hospital from
Mar 2008 to Jan 2012 with IAP> 20 mmHg, mechani-
cal ventilation and no lung diseases into the study. The
patients with 50% O2 inhalation were given 1 h posi-
tive end-expiratory pressure(PEEP) = 5 cmH2O(conc-
tol),PEEP = 5 cmH2O + 1/5 intra-abdominal pressure
(IAP)(weak PEEP group), PEEP = 5 cmH2O + 1/3
IAP(moderate PEEP group) and PEEP = 5 cmH2O +
1/2IAP(high strength PEEP group), respectively. Car-
diac output (CO) and PaO2 were investigated to
observe the changes under different PEEP, and then
the extra-vascular lung water (EVLW) was observed by
PICCO after 6 h treatments by weak and moderate
PEEP.
Results: The CO of patients treated by weak and mod-
erate PEEP were not significant decreased compared
with control (p = 0.82, 0.63, n = 15), while the PaO2 of
weak, moderate and high PE EP treating increased
12%, 18% and 22%, respectively (P < 0.05). The
EVLW of patients treated by weak and moderate
PEEP for 6 h decreased 12% and 15%, there was no
difference between these two groups(p = 0.71, n = 15),
but there were significance between them and control
(p < 0.05, n = 15).
Conclusion: Appropriate PEEP according to the IAP
can significantly improved PaO2 but have no significant
effect on CO. It is worthy of further clinical applica-
tion.
577
RESECTION WITH PLANNED
HEPATECTOMY CONFERS SURVIVAL
BENEFIT IN HILAR
CHOLANGIOCARCINOMA
Qing-Bao Cheng, Xiao-Qing Jiang, Bin Yi, Xiang-Ji
Luo, Chen Liu and Bai-He Zhang
Department of Biliary Surgey, Eastern Hepatobiliary
Surgery Hospital, Shanghai, China
Background and Aims: Despite more aggressive surgical
therapy, the prognosis of hilar cholangiocarcinoma
(HCCA) patients is still poor. The aim of this study
was to identify prognostic predictors for overall sur-
vival of patients with hilar cholangiocarcinoma with
special focus on survival benefit of planned hepatec-
tomy (PH).
Methods: A total of 136 consecutive patients with
HCBT34 underwent resection from January 2006 to
December 2010 were continually scrutinized. All
parameters were collected from database prospectively
recorded. Cox proportional hazards regression models
were used to determine the association between possible
prognostic variables and survival time.
Results: Negative margins were obtained in 96 patients
(70.5%) and significantly associated with PH (89% vs
41%, p < 0.01). The mean survival time and 5-year sur-
vival rate was 49  6 months and 29% for patients
underwent PH, respectively, compared with
25  3 months and 8% for patients did not (p < 0.01).
Multivariate analysis demonstrated resection without
PH [Relative Risk (RR) 4, 95% CI 2-6] and high pre-
operative serum peak bilirubin level (RR 3, 95% CI 2-
4) as adverse prognostic variables.
Conclusions: Resection with PH offers the best chance
of long term survival. In addition, low preoperative
serum peak bilirubin level showed independent survival
advantage.
579
ROBOTIC VERSUS OPEN MIDDLE
PANCREATECTOMY
Bai-Yong Shen, Qian Zhan, Xia-Xing Deng, Bo Han,
Qin Liu, Cheng-Lei Weng, Cheng-Hong Peng and
Hong-Wei Li
Department of General Surgery, Ruijin Hospital,
Shanghai JiaoTong University Medical colleage,
Shanghai Institute of digestive surgery, Shanghai, China
Background: Middle pancreatectomy (MP) is a recent
skill for the treatment of benign and premalignant cen-
tral panctreatic tumors. Parenchymal preservation is
the most important advantage of this operation. We
used robotic surgical system to carry out minimally
invasive middle pancreatectomy.
Methods: From March 2010 to March 2012, 10
patients (8 females and 2 male), with a mean age of
47.5  12.5(31~62) years, underwent robot-assisted lap-
aroscopic middle pancreatectomy at the Hepato-Bilio-
© 2013 The Authors
HPB © 2013 Americas Hepato-Pancreato-Biliary Association HPB 2013, 15 (Suppl. 2), 85–244
126 CONCURRENT SESSIONS POSTER
Pancreatic Surgical Department of Ruijin Hospital in
Shanghai, China. Perioperative outcome were collected
and compared with 36 open MPs performed in our
institution at the same period.
Results: All 10 surgeries were successfully performed
using the robotic surgical system. There were no mortal-
ities. The mean operation time is 219.0  47.2(150~330)
min, average blood loss is 158.0  107.4(50~400) mL.
Pancreatic fistula occurred(ISGPF definition) in 7 cases
(Grade A 5 cases, Grade B 2 cases), and anastomotic
bleeding in 1. All complications resolved with conserva-
tive management. The mean postoperative hospital stay
was 19.2  9.4(13~41) days. Compared with open sur-
gery, robotic group had a significantly less blood loss
(158.0  107.4 VS 341.1  333.5 mL,p = 0.007), but
the age, mean operation time, pancreatic fistula rate,
complication rate, and tumor size were similar in the
two groups. The robotic group had no transfusion
(0.0  0.0 VS 144.4  329.9 mL,p = 0.013) and stayed
in hospital for a significantly shorter time (19.2  9.4VS
28.6  23.1 days,p = 0.036).
Conclusions: Robotic middle pancreatectomy is a feasi-
ble, less-invasive option for the resection of benign or
borderline tumors of the neck or proximal body of the
pancreas. It provides comparable functional advantages
as well as reduced operative trauma.
581
CLINICAL APPLICATION OF A NOVEL
TECHNIQUE OF
PANCREATICOGASTROSTOMY WITH
DUCT-TO-MUCOSA ANASTOMOSIS: A
REPORT OF 75 CASES
Cai-De Lu, Sheng-Dong Wu, Jin Huang, Feng Qiu,
Wei-Ming Yu, Chang-Jiang Lu, Yong-Fei Hua. Tao
Peng and Zhi-Feng Yang
Department of Hepatobiliary and Pancreatic Surgery,
Lihuili Hospital, Ningbo University, School of Medicine,
Ningbo, China
Objective: To introduce a novel reconstructive tech-
nique of the implanting pancreaticogastrostomy (IPG)
with duct-to-mucosa anastomosis after pancreaticoduo-
denectomy (PD) or local resection of pancreas and
evaluate its feasibility and efficiency.
Methods: The IPG was constructed as follows: An
appropriate seromuscular incision was made in the pos-
terior wall of the stomach, which was dissected from
the layer of mucomuscular/mucosa for about 1.5 cm in
deep. A 2 cm-freed pancreatic stump was implanted
into the pouch between two layers of seromuscular and
mucomuscular/mucosa by a continual suture using 4-0
Prolene from the left (greater curvature) to the right on
the posteriosuperior of the gastric wall and the front
capsule of pancreas stump. A hole was made on the
mucosa close to the pancreatic duct. The duct to
mucosa anastomosis was performed using 5-0 Polydiox-
anone Surture (PDS) by the maneuvers of one point
suturing. A stent tube in duct was remained as inner
drainage. The IPG was finished by the continuing
suture on the posterioinferior wall of gastric to the
posterior of pancreas. The Clinical data of 75 cases
who received IPG from Sep 2009 to may 2012 were
recorded prospectively and obtained from Database.
The statistical analyses of surgical complications,
including pancreatic leakage were performed.
Results: PD or local resection of pancreas were per-
formed for 81 cases in this period, among them 75
cases received IPG as Pancreatoenteric reconstruction.
There were 51 males and 24 females with a mean age
of 61.1  11.6 years (range, 21 to 81 years). Operations
were consisted of 68 PD and 7 local resection of pan-
creas due to malignancy for 64 cases and benign disease
for others. The mean time for IPG was 25.9  3.3 min,
and the median was 26 min (range, 18 to 35). Hospital-
ization days after the surgery were 14.3  7.4 d (range,
7 to 49). Thirty-one complications including pancreatic
fistula were occurred in 26 cases indicating an opera-
tion morbidity of 34.7% (26/75). Total pancreatic leak-
age (fistula) occurred in 4 cases (5.3%), but graded B/C
was occurred only in one case (1.3%). The remaining
complications included 7 cases of delayed gastric emp-
tying, 2 cases of gastrointestinal anastomosis bleeding,
1 case of bile leakage, 5 cases of severe steatorrhea and
others in 8 cases. All of them were healed or relieved
by either reoperation or conservative treatment. The
operation mortality is zero.
Conclusions: The results of this initial application for
IPG indicate that the technique is simple and feasible,
can be performed with very low risk. It may provide a
favorable outcome and could be an alternative method
of pancreatoenteric reconstruction after PD. However,
to determine its superiority over the conventional
procedures, this operative technique should be evalu-
ated more comprehensively in the further clinical study
with larger series of cases.
Key words: Pancreaticoduodenectomy, Pancreaticoga-
strostomy, Pancreatic leakage
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LIVER RESECTION FOR SOLITARY
LARGE HEPATOCELLULAR CANCER –
EARLY OUTCOMES: A REPORT OF 16
CASES
Sadiq S Sikora and Nagaraj Palankar
Manipal Institute of Liver & Digestive Diseases,
Manipal Hospital, Kasturba Medical College Bangalore,
Karnataka, India
Background: Large HCCs are traditionally considered
to be aggressive tumors with poor prognosis and little
benefit from resection. Resection of large HCC is tech-
nically difficult and associated with morbidity and mor-
tality. We describe our early experience with liver
resection for solitary large HCC.
Methods: A retrospective review of 16 patients with
solitary large HCC ( 10 cm) who were operated at 2
related tertiary referral hospitals in South India was
done. Patient demographics, tumour-related factors,
liver function, operative factors, adjunctive procedures,
immediate post-operative outcome and early survival
were analyzed.
Results: Of the 16 patients, 13 were men. The median
age was 55 years (37-78). Four of the 14 patients were
cirrhotic with Child’s score A; 3 were HBV positive.
AFP was elevated in 6 patients with a mean level of
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8890.2 IU/mL (range: 2.9-121000). The mean maximum
diameter of the tumour was 15 cm (10-25). Adjunctive
procedures were used in 3 (18.7%) patients. It included
PVE (2), hepatic artery ligation and neo-adjuvant che-
motherapy in one patient each. Nine patients under-
went hepatectomy by anterior approach and seven by
conventional approach. The average operative time was
8.06 h (4-10) and the average blood loss was 1350 mL
(300-4000 mL). There was one perioperative mortality
(6.25%) as a result of portal vein thrombosis and
progressive liver failure. Two patients suffered serious
intraoperative events viz, air embolism in 1 and bleed-
ing necessitating packing and reoperation in another
patient. Two patients required reoperation; one for
pack removal and another for portal vein thrombosis.
Morbidity was found in 5(31.25%) patients. These
included postoperative ascites in 3 (18.75%), biliary fis-
tula in 1 (6.25%) and portal vein thrombosis in 1
(6.25%). Two patients received postoperative chemo-
therapy. Of the 14 patients who were available for fol-
low-up, at a median follow up of 24 months, 5 patients
had disease recurrence. Four of these patients died due
of recurrent disease; another patient with isolated parie-
tal wall recurrence was treated with reexcision. One
patient died at 39 months due to interstitial lung dis-
ease. Two of these 5 patients presented with very early
recurrence (< 3 months) and they were both large
HCCs in the background of cirrhosis and very high
AFP levels.
Conclusion: Our experience with solitary large HCC
suggests that liver resection can be done safely with
acceptable morbidity and mortality. Solitary large
HCC in a non-cirrhotic liver and low/normal AFP is
associated with good survival when treated by liver
resection.
585
COMBINATION OF ODDD-REGULATED
ADENOVIRUS EXPRESSING RANTES
AND NK-92 EXERTS ANTITUMOR
ACTIVITY IN HEPATOCELLULAR
CARCINOMA
Jiang Li, Hui Liu, Lin-Fang Li, Hong-Ping Wu, Zi
Yan, Ying Wang, Chang-Qing Su, Hua-Jun Jin,
Meng-Chao Wu and Qi-Jun Qian
Laboratory of Viral and Gene Therapy, Eastern
Hepatobiliary Surgery Hospital Department
of bio-treatment, Eastern Hepatobiliary Surgery
Hospital, Shanghai, China
Oncolytic adenoviruses are modified based on adenovi-
rus serotype 5 (Ad5), which belongs to subgroup C and
depends on Coxsackie–adenovirus receptor (CAR) to
recognize target cells. However, expression of CAR is
generally low or lost in certain tumors including HCC.
In contrast, CD46 is highly expressed in various kinds
of malignant tumor cells. Therefore, we constructed an
adenovirus vector expressing the human RANTES/
CCL5 gene regulated by oxygen-dependent degradation
domain (ODD), and analyzed its antitumor effects in
vitro and in vivo. The human RANTES/CCL5 gene
was fused with ODD by PCR and the recombinant
oncolytic adenovirus containing RANTES-ODD,
SG511-CCL5-ODD, was constructed by Gateway
System, which infected cells by binding CD46. Viral
replication experiments were performed to evaluate the
selective replication ability of SG511-CCL5-ODD.
RANTES expression was determined by ELISA. Che-
motactic test was used to analyze the ability of the
expressed RANTES to recruit NK92 cells. The antitu-
mor effects of SG511-CCL5-ODD were examined in
HCC xenografts in nude mice. A chimeric oncolytic
adenovirus, SG511-CCL5-ODD, was constructed
successfully. Cells infected with the recombinant virus
could express RANTES selectively in different environ-
ments controlled by ODD, and the expressed RANTES
could recruit NK92 cells by its chemotactic effect in
vitro and improve the anti-cancer immune response in
HCC xenografts in nude mice. The chimeric adenovirus
SG511-CCL5-ODD highly expressed RANTES-ODD
fusion gene in the hypoxia of HCC under the control
of the ODD and effectively attracted NK92 cells and a
huge number of immunocytes. These factors had com-
plementary advantages and cooperated with each to
exert enhanced antitumor efficacy.
586
CHARACTERIZATION OF TWO NOVEL
CELL LINES WITH DISTINCT
HETEROGENEITY DERIVED FROM A
SINGLE HUMAN BILE DUCT
CARCINOMA
Lin-Fang Li1,5, Jing-Han Wang1,2,5, Ke-Qiang Zhang3,
Yong Yu2, Bin Li2 and Jiang Li1
1Laboratory of Viral and Gene Therapy, Eastern
Hepatobiliary Surgical Hospital, The Second Military
Medical University, Shanghai, China; 2The First
Department of Biliary Surgery, Eastern Hepatobiliary
Surgical Hospital, The Second Military Medical
University, Shanghai, China; 3Department of Molecular
Pharmacology, Beckman Research Institute of the City
of Hope National Medical Center, Duarte, California,
USA; 4Department of Respiratory, Changhai hospital,
The Second Military Medical University, Shanghai,
China; 5Department of Biotherapy, Eastern
Hepatobiliary Surgical Hospital, The Second Military
Medical University, Shanghai, China
Background: Intratumoral heterogeneity reflects subclo-
nal diversity and accounts for a variety of clinically
defined phenotypes including the development of drug
resistance and recurrence. However, intratumoral heter-
ogeneity of bile duct carcinoma (BDC) is rarely stud-
ied.
Methods: Two highly heterogeneous cell lines named
EH-CA1a and EH-CA1b were established from a pri-
mary tumor tissue of a pathologically proven BDC.
Distinct heterogeneity and underlying mechanisms of
two cell lines in karyotype, colony formation, tumorge-
nicity, and sensitivity to chemoradiotherapy were inten-
sively studied.
Results: Both cell lines showed typical morphology of
cancer cells. EH-CA1a cells grew as free-floating aggre-
gates, while EH-CA1b cells grew adherently as a mono-
layer. EH-CA1a cells had higher cloning efficiencies
and were able to keep proliferating under hypoxic
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condition. Coincidentally, hypoxia-induced factor-1a
(HIF1a) and vascular endothelial growth factor
(VEGF) mRNA were significantly higher in EH-CA1a
cells than in EH-CA1b cells. Both cell lines were
tumorigenic in nude mouse, however, EH-CA1a cells
showed more aggressive characteristics. Most impor-
tantly, the EH-CA1a cells showed much more resis-
tance against radiotherapy and chemotherapy with
Gemcitabine. Metastasis-related genes including MMP-
2, MMP-9, epithelial-mesenchymal transition (EMT)
markers, Vimentin, Snail, and Twist, are more highly
expressed in EH-CA1a cells than in EH-CA1b cells.
Moreover, the percentage of cells expressing cancer
stem cell-like marker, CD133, in EH-CA1a cells is
much higher than that in EH-CA1b cells.
Conclusion: Establishment of these two cell lines will
not only shed light on intratumoral heterogeneities of
BDC, but also potentially facilitate the development of
novel therapeutic approaches of BDC.
Key words: bile duct carcinoma (BDC), intratumoral
heterogeneity, epithelialmesenchymal transition (EMT),
cancer stem cell, chemoradioresistance
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LASER LITHOTRIPSY IN A DIFFICULT
CASE OF
HEPATOCHOLEDOCHOLITHIASIS
WITH DISTAL COMMON BILE DUCT
STRICTURE
Billy James Uy, Kristine Trocio and Catherine Teh
National Kidney and Transplant Institute, Philippines,
Chinese General Hospital and Medical Center,
Philippines, Quezon City, Philippines
Introduction: The presence of intrahepatic lithiasis is an
operative dilemma for surgeons. Not all cases are ame-
nable to endoscopic retrograde cholangiography
(ERCP) extraction, and intraoperative biliary extrac-
tion is fraught with difficulties. A usual option is to
insert a t-tube to allow percutaneous choledoscope
extraction post-operatively. Hepatic resection is also
another option but has a higher morbidity. Recent
studies have shown the applicability of laser lithotripsy
in the removal of intrahepatic stones.
Methods: We report a case of intrahepatic lithiasis not
amenable to ERCP and intraoperative biliary extrac-
tion that was done in a center specialized in urologic
cases.
Summmary: A 52 year old male presented colicky
abdominal pain where ultrasound showed calculous
cholecystitis. Patient was initially treated with antibiot-
ics but developed jaundice with acolic stools after a
week. Patient was admitted and repeat ultrasound
revealed calculous cholecystitis with suspicious
obstructing calculus in the proximal CBD, distal CBD
stricture was noted. Ductal dilatation and stone extrac-
tion failed, hence a F10 stent was inserted and sched-
uled for surgery. Intraoperative ultrasound revealed
multiple stones in the CBD and was extracted through
a choledochotomy. A 0.5 cm stone was impacted in the
secondary radicles of the right hepatic duct. A flexible
cysto-nephroscope Fr 8.5 was inserted and stone basket
extraction done but failed. Laser lithotripsy was used
to break the stone into smaller fragments, flushed out
and extracted more proximally. A roux-en-y hepati-
cojejunostomy was done to bypass the distal CBD
stricture. Patient recovered and was eventually dis-
charged.
Conclusion: In intrahepatic stones that have failed
ERCP and biliary extraction, the combination of a
surgical enterotomy, biliary endoscopy, and laser litho-
tripsy could provide a viable option for stone removal.
However, for centers not specialized in hepatobiliary
surgery with lack of equipment, this could pose a
significant challenge on its applicability.
Keywords: Laser lithotripsy, hepatolithiasis, choledo-
cholithiasis, hepatocholedocholithiasis, choledochos-
copy
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TUMOR NECROSIS FACTOR-Α
INDUCES EPITHELIAL-
MESENCHYMAL TRANSITION
THROUGH NF-ΚB IN
HEPATOCELLULAR CARCINOMA.
Xing-Rui Kou, Ying-Ying Jing and Li-Xin Wei
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background: Pro-inflammatory cytokines including
tumor necrosis factor-a(TNF-a) produced in the hepa-
tocellular carcinoma(HCC) microenvironment promote
tumor development and metastatic progression.Inva-
sion of HCC was associated with epithelial–mesenchy-
mal transition (EMT), however, whether TNF-a
promotes invasion through EMT in HCC remains
unclear.
Objective: To study the roles of TNF-a in EMT of
hepatocellular carcinoma(HCC) cells.
Methods: We selected two different HCC cell lines
(Hep3B and SMMC-7721) to treat with TNF-a for
24 h. The invasion was evaluated by Transwell and
Wound healing assay.The morphological change was
observed by microscope and the expression of E-cadh-
erin, Vimentin, Twist and N-cadhetin was observed by
RT-PCR, Western blotting and Immunofluorescent
staining. Luciferase and Western blotting assay were
used to detect the activity of NF-jB. The expression of
Snail was observed by RT-PCR and Western blotting.
Results: Wound healing assay discovered that the
scuffing distance of cells exposed to TNF-a was signifi-
cantly increased compared with no-treatment group,
and Transwell assay showed that the number of cells
penetrated to the membrane was significantly increa-
sed.The phenotype of EMT was significantly upregulat-
ed after treatment of TNF-a. NF-jB was activated by
TNF-a,and the upregulation of EMT was suppressed
by inhibitors of NF-jB. In addition, the activity of
Snail was significantly upregulated after treatment of
TNF-a,and inhibitors of NFjB reduced this
change.Conclusion TNF-a promotes EMT of HCC
through NFjB–mediated Upregulation of snail.
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TWO CASES OF HEPATIC CARCINOMA
POST-HEPATIC RESECTION
PRESENTING WITH CHYLOUS
ASCITES
Billy James Uy and Catherine Teh
Chinese General Hospital and Medical Center,
Philippines, National Kidney and Transplant Institute,
Philippines, Quezon City, Philippines
Background: Chylous ascites is a rare phenomenon
characterized by milky turbid ascitic fluid usually
caused by ruptured lymphatics associated with a variety
of causes. The main causes are usually malignant
tumors, hepatic cirrhosis and tuberculosis. This case
report aims to present two cases of chylous ascites
post-hepatic resection that presented with significantly
different outcomes.
Presentation: Case No. 1. A 53 year old male alco-
holic drinker presented with one month history of
gradual abdominal enlargement, jaundice and dyspnea.
Two years earlier, he underwent segment VII hepatic
resection which revealed hepatocellular carcinoma with
a cirrhotic background. One year after, patient had
left lateral segmentectomy for segment 2-3 metastasis
(Figure 1), and underwent chemoradiotherapy for
mediastinal and left axillary lymph nodes metastasis
6 months after. Abdominal paracentesis done revealed
the presence of chylous ascites. Patient’s ascites was
refractory to diuretics, Octreotide and other medical
management leading to his eventual demise 19 days
after.
Case No. 2. A 48 year male with hepatitis B was diag-
nosed by CT scan with a 19 cm liver tumor involving
segment V, VII and VIII infiltrating the pleura and
right lower lung lobe, and multiple lymphadenopathy
on the peripancreatic and paraaortic area. Right hemi-
hepatectomy with enbloc resection of the diaphragm,
right lower lung resection and radical lymph node dis-
section was done (Figure 2). Patient developed chylous
ascites 8 days post-op but eventually subsided with
NPO, dietary fat restriction and intravenous octreotide
for 7 days. Patient recovered well.
Conclusion: Chylous ascites may present in 0.5-1% of
patients with cirrhosis and ascites. It can occur later as
a consequence of hepatocellular carcinoma. Post-surgi-
cal chylous ascites is rare although post-resectional
hepatocellular carcinoma with lymphatic involvement
could lead to the development of chylous ascites. The
presence of liver cirrhosis with ascites could have led to
liver failure causing intractable ascites that was refrac-
tory to treatment while prolonged multimodal conser-
vative therapy aiming at decreasing lymph production
amidst optimal nutritional supplement may help resolve
post hepatectomy chylous ascites.
Keywords: Chylous ascites, Cirrhosis, Hepatic resec-
tion, Octreotide
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THE EFFECT OF ACTIVE HEPATIC
STELLATE CELL IN
HEPATOCELLULAR CARCINOMA
CHEMORESISTANCE
Guo-Feng Yu, Ying-Ying Jing, Xing-Rui Kou and
Li-Xin Wei
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background: Hepatocellular carcinoma chemoresistance
is a particularly troublesome clinical problem. Active
hepatic stellate cells (HSCs) in tumor microenviron-
ment play a role in HCC invasion, migration and
apoptosis, while its effect in generation of tumor
chemoresistance is still unkown.
Objective: To find out the effect of HSCs in hepatocel-
lular carcinoma chemoresistance and possible mecha-
nism.
Methods: HCC cell lines Hep3b, Huh7 and SMMC-
7721 were incubated in active hepatic stellate cell line
(LX-2) conditioned medium (HSC-CM), rate of apop-
tosis was identified by flow cytometry and proportion
of cell activity was determined via MTT at 12 h and
24 h after HCC treated with cisplatin .RT-PCR and
western blot were used to survey the expression of
EMT signatures. The cytokines expression in HSC-CM
was found out by enzyme-linked immune sorbent assay
(ELISA).
Results: Compared to the cisplatin group, Hep3b,
Huh7 and SMMC-7721 cells in the presence of HSC-
CM expressed higher EMT signatures and performed
lower apoptosis rate,higher cell activity at 12 h and
24 h after treated with cisplatin. The ELISA indicated
that high expression of HGF in the HSC-CM and
HGF neutralizing antibody reversed the effect of
chemoresistance induced by HSC-CM.
Conclusion: Active HSCs could induce HCC cell EMT,
a possible mechanism to promote HCC chemoresis-
tance.
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APPLICATION OF RADIOFREQUENCY-
ASSISTED LIVER RESECTION IN
TREATMENT OF HUGE HEPATIC
TUMOR
Jun-Xi Xiang, Xue-Min Liu, Yi Lv, Jun Xu, Qian-Jin
Zhang, Wan-Quan Wu and Rui Gao
Department of Hepatobiliary Surgery, the First
Affiliated Hospital, Xi‘an Jiaotong University, Xi‘an,
China
Background and aims: Surgical resection is the most
effective therapy for huge hepatic tumor (10 cm or
greater) but a surgical procedure of great challenge
because of the technical complexity, risk of massive
bleeding, and severe intra- or postoperative complica-
tions especially for patients with severe cirrhosis. The
objective of this research is to assess the efficiency of
radiofrequency-assisted liver resection on controlling in-
traoperative blood loss and postoperative complica-
tions.
© 2013 The Authors
HPB © 2013 Americas Hepato-Pancreato-Biliary Association HPB 2013, 15 (Suppl. 2), 85–244
130 CONCURRENT SESSIONS POSTER
Methods: 31 cases with huge hepatic tumor underwent
surgical resections from March 2011 to June 2012 were
researched retrospectively, in which 15 cases adopt ra-
diofrequency-assisted liver resection (RF-LR group)
while 16 cases adopt the clamp-crush liver resection
(CC-LR group). The characteristics including cirrhosis,
prothrombin time, tumor size, intraoperative bleeding,
resection time, blood transfusion, hilar blocking, post-
operative complications, ICU and hospital staying days
were compared. All the measurement data were ana-
lyzed using Mann-Whitney U test and the enumeration
data were analyzed using chi-square test or Fisher
probabilities.
Results: The number of patients with primary liver
carcinoma, metastatic liver tumor and hepatic hemangi-
oma was 10, 2, 3 respectively in RF-LR group and 13,
1, 2 in CC-LR group. Cirrhosis cases were 9 and 8
respectively in RF-LR group and CC-LR group
(p = 0.722). There were no significant differences in
tumor size between RF-LR group (661.5 cm3) and CC-
LR group (600 cm3) (p = 0.874), while the volumes of
intraoperative blood loss (600 mL vs. 1000 mL), the
number of patients who received blood transfusion (6
vs. 13), the ICU staying days (1d vs. 7d) and hospital-
ization days (10d vs 12d) in RF-LR group were signifi-
cantly lower than in CC-LR group (p = 0.005,
p = 0.029, p = 0.037, p = 0.029). The resection time in
RF-LR group was 240 (150-360) min and in CC-LR
group the date was 247.5 (180-420) min (p = 0.511).
Patients underwent hilar blocking were 9 and 14 in two
groups, but there were no significant differences. There
were only one case of bile leakage in RF-LR group
while three cases in CC-LR group (p = 0.060). Referred
to abscess, the date were 0 vs. 1 (p = 1.000). The
amounts of drainage (3 days) in two groups got no sta-
tistical difference (270 mL vs 210 mL, p = 0.362). No
patients died intraoperatively and the hepatic function
of all the subjects recovered to normal in the 7th day
after operation.
Conclusions: Radiofrequency-assisted liver resection
can effectively control intraoperative blood loss, reduce
transfusion cases and ICU/hospital staying time, and it
has great value in liver resection for the treatment of
huge hepatic tumor.
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THE RISK FACTORS OF POOR
PROGNOSTIC IN MASSIVE
HEMORRHAGE HEPATECTOMY
PATIENTS IN MAINLAND CHINA
Li Li1, Fei-Fei Gu2, Yan Liu1 and Zhi-Xia Ye2
1ICU Anesthesia Department of Eastern Hepatobiliary
Surgery Hospital; 2Nursing Department of Eastern
Hepatobiliary Surgery Hospital, Shanghai, China
Background: Massive bleeding during hepatectomy is a
risk for mortality and morbidity. We examined the risk
factors for massive bleeding and their correlations with
poor outcomes.
Methods: The study was a retrospective case series.
The amount of total blood transfusion above 5000 mL
during the operation is the include criteria for patients.
The general data of the patients before and during the
operation were analyzed. The poor prognosis was
defined as died in the hospital or abandoned treatments
and died at home. The paired and unpaired t student
and v2 tests when comparing normal and categorical
variables, respectively. The factors related different
prognostic results were compared by SPSS13.0 software
by a univariate and multivatiate analysis.
Results: In the last five years, 61 patients experienced
massive hemorrhage in our Hospital. 8 patients died in
the hospital and 14 patients died at home and 39
patients recovered. The univariate analysis result shows
that: age, Child Pugh Classification, operation time,
Pringle maneuver time, blood transfusion during the
operation, the value of PH and HGB when transferred
to ICU, acute kidney failure occurs or the mechanical
ventilation time longer than four hours are all risk fac-
tors related to poor prognosis(p < 0.05). The stepwise
multivariate logistic regression analysis was used for
the above nine factors. The result shows that: the
amount of blood transfusion during the operation
higher than 10,000 mL, the Pringle maneuver time
longer than 35 minutes, the value of PH lower than 7.2
when transferred to ICU, acute kidney failure occurs
or mechanical ventilation time longer than four hours.
The amount of drainage and blood transfusion on the
operation day, 1st day and 2nd day of the death group
are higher than that of the survival group.
Conclusion: The risk factors for poor prognostic of
massive hemorrhage in hepatectomy patients includes:
the amount of blood transfusion during the operation
higher than 10,000 mL, the Pringle maneuver time
longer than 35 minutes, the value of PH lower than 7.2
when transferred to ICU, acute kidney failure happens
or mechanical ventilation time longer than four hours.
The amount of drainage higher than 1000 mL on the
operation day or the amount of drainage higher than
500 mL on the 1st day indicate a poor prognosis. The
medical staff should discuss the possibility and neces-
sity of operation for huge liver tumor and make a thor-
ough evaluation and preparation before the operation.
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ROLE OF ADJUVANT TACE IN
PREVENTION OF EARLY
RECURRENCE FOR HCC IN BCLC
STAGE A1 AFTER RADICAL
HEPATECTOMY,A RCT
Feng Xu1, Yang-Qing Huang2, Ye-Sheng Li1, Lu Wu1
and Jia-Mei Yang1
1Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, 200438; 2Shuguang Hospital, 528
Zhangheng Rd, Shanghai, 201204 China
Background and aims: High recurrence rate leads to
poor prognosis of HCC patients after radical hepatec-
tomy. Adjuvant transcatheter arterial chemoemboliza-
tion (TACE) is a controversial therapy to prevent early
recurrence. Published retrospective researches and none
randomized controlled trials have shown contradictory
results of adjuvant TACE for HCC patients in Barce-
lona-Clinic-Liver-Cancer (BCLC) stage A1; therefore,
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we need a strict randomized controlled trial to evaluate
whether adjuvant TACE could reduce early tumor
recurrence of these patients.
Methods: 165 patients, who underwent radical hepatec-
tomy from Jan. 2008 to Dec. 2009 and 160 legal ones
were randomly equally divided into 2 groups. Group A
received adjuvant TACE one month after hepatectomy,
and group B did not receive any adjuvant therapies.
Follow-up was done regularly. Disease free survival
(DFS) time and recurrence rate within two years were
statistically analysed.
Results: Median follow-up duration was 37 months.
Altogether 55 patients recurred. 48 recurrences hap-
pened within 1 year. Mean DFS time of group A and
B were respectively 34.36  1.59 months (5–43 months)
and 32.10  2.02 months (3–46 months) (p = 0.173)
(Fig.1). 0.5, 1 and 2 year recurrence rates of two
groups were 11.1% vs. 17.7%,17.3% vs. 24.1%,23.5%
vs. 36.7%(p = 0.173), respectively. Multivariate COX
regression analysis indicated that AFP(+) (HR:2.702,
95%CI:1.237-5.900, p = 0.013), blood transfusion(yes)
(HR:3.067, 95%CI:1.412-6.664, p = 0.005), tumor
diameter ( > = 3cm) (HR:1.892, 95%CI:1.025-3.493,
p = 0.041), tumor with entire peplos (HR:0.431, 95%
CI:0.244-0.781, p = 0.005) and Edmondson-Steiner
grade (HR:2.575, 95%CI:1.389-4.773, p = 0.003) were
factors related to early recurrence. A stratified analysis
was done according to the result of COX analysis. In
67 patients with tumor diameter > = 3cm, mean DFS
time of group A and B were respectively 30.30  2.72
months (5-43 months) and 19.242.71 months (3-40
months) (p=0.030) (Fig.2). 0.5, 1 and 2 year recurrence
rates of two groups were 15.2% vs. 35.3%,24.2% vs.
52.9%,36.4% vs. 64.7%(p = 0.030), respectively. Multi-
variate COX regression analysis indicated that TACE
(+) (HR: 0.268, 95%CI: 0.118-0.607, p = 0.002) was a
protective factor and blood transfusion (yes)
(HR:7.632, 95%CI:3.116-18.691, p < 0.0001) was a risk
factor. However, in the other 93 patients with tumor
diameter < 3 cm, there was no significant difference
between the two groups of DFS time and within 2-year
recurrence rate (p = 0.501).
Conclusions: Adjuvant TACE is not recommended as a
routine therapy to prevent early tumor recurrence for
HCC patients in BCLC stage A1 after radical resection.
However, these patients with tumor diameter > = 3cm,
adjuvant TACE is also considered for, especially if they
accept blood transfusion perioperative period.
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FOREIGN BODY IN THE COMMON
BILE DUCT -ABSORBABLE GAUZE-A
CASE REPORT
Hao Wang, Xiao-Yan Li and He-Ping Hu
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Absorbable gauze migration into the common bile duct
following operation on liver is an extremely rare com-
plication. Migrated Absorbable gauze into the common
bile duct can cause abdominal pain,obstruction, serve
as a nidus for stone formation, and cause cholangitis.
We report a case of cholangitis due to a migrated
absorbable gauze after operation on liver, which was
successfully treated by endoscopic extraction.
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THE VALUE OF REAL-TIME TISSUE
ELASTOGRAPHY IN THE
DIFFERENTIAL DIAGNOSIS OF FOCAL
NODULAR HYPERPLASIA AND
HEPATIC ADENOMA
Jun-Feng Hong, Jia Gou, Li-Qiong Liang and
Jian-Feng Ji
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background and aims: Focal nodular hyperplasia
(FNH) and hepatic adenoma (HCA) are the most fre-
quently seen non-vascular benign liver tumors. The
importance of differentiating between these lesions is
based on the fact that HCA should be surgically
resected and FNH can be only observed. They are
often asymptomatic, and the diagnosis principally
depends on the enhanced CT, MRI and US by the
arterial phase enhancement, filling direction, stellate
arteries, and portal phase enhancement. Different with
those, the real-time tissue elastography (RTE) can
inspect and measure the stiff of these lesions. We are
aimed to investigate the diagnostic value of real-time
tissue elastography in the differential diagnosis of FNH
and HCA, in expectation to offer a new method.
Methods: Between July 2010 and July 2012, 28 persons
who underwent real-time tissue elastography and were
histologically proved FNH (n = 22) or HCA (n = 9). It
was retrospectively assessed with grade scores (grade 1–
5) and the strain ratio (SR) of the lesions was calcu-
lated.
Results: Majority of lesions with grade 3-4 on elastog-
raphy were identified as FNH on pathology,while most
of masses with grade 1 on elastography were confirmed
as HCA on pathology. The grade scores of FNH and
HCA were significantly different (p = 0.0002). The
strain ratio of FNH was significantly higher than that
of HCA(7.47  4.53 vs. 1.64  0.88, p < 0.0001).
Conclusion: The stiff of FNH is significantly higher
than that of HCA in RTE, which is helpful in differen-
tial diagnosis.
602
STAPLED BILILARY-ENTERIC
ANASTOMOSIS AFTER
PANCREATICODUODENECTOMY FOR
PATIENTS WITH PANCREATIC HEAD
CARCINOMA: A SINGLE-CENTER
STUDY
Bin Zhang, Bin Song, Cheng-Hao Shao, Gang Li and
Yin-Qi Zhou
Department of General Surgery, Changhai Hospital, The
Second Military Medical University, Shanghai, China
Purpose: This study aimed to evaluate the safety and
efficacy of stapled bililary-enteric anastomosis after
pancreaticoduodenectomy, and to analyze the anasto-
motic outcomes 12-month after the operation.
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Methods: A retrospective analysis of a prospectively
collected database was conducted, which included 24
patients with a main bile duct greater than 20 mm who
underwent stapled bililary-enteric anastomosis after
pancreaticoduodenectomy for the treatment of pancre-
atic head carcinoma between September 2007 and
March 2011.
Results: All patients successfully underwent the sur-
gery. Mean operative time for stapled bililary-enteric
anastomosis was 4.56  0.85 min and mean length of
hospital stay was 13.71  3.00 days. There were no
mortalities and morbidities directly related to mechani-
cal anastomosis during hospital stay. Additionally, a
significant decrease of serum biliary enzymes to normal
levels was observed at 1-month after surgery. During a
12-month follow-up period, only one patient developed
cholangitis, and no evidence of anastomotic leakage
and stricture formation in the present series.
Conclusion: Stapled bililary-enteric anastomosis can be
performed more time-saving and easier than traditional
hand-suturing. Moreover, the technique is safe and
effective for bililary-enteric reconstruction after PD
when the caliber of main bile duct is suitable to per-
form it.
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ARE THE FACTORS AFFECTING EARLY
RECURRENCE AND AFFECTING LATE
RECURRENCE AFTER CURATIVE
HEPATECTOMY DIFFERENT?
Kuo-Shyang Jeng M.D., F.A.C.S.1, 2, I-Shyan Sheen
M.D.4, Chien-Chu Lin M.D.2, Chien-Kuan Lin M.D.2
and Kuo-Hsin Chen M.D.1
1Department of Surgery, Far Eastern Memorial
Hospital, Taipei, Taiwan; 2Department of
Gastroenterology, Far Eastern Memorial Hospital,
Taipei, Taiwan; 3Department of Medical Research, Far
Eastern Memorial Hospital, Taipei, Taiwan;
4Department of Hepatogastroenterology, Chang Gung
Memorial Hospital, Taoyuan, Taiwan
Background and aims: Recurrence after curative hepa-
tectomy remains a great challenge for surgeons. Factors
affecting recurrence had been discussed for years.
Whether the factors affecting very early recurrence and
very late recurrence differ remains unclear. The aim of
this study is to elucidate the difference.
Methods: A consecutive series of 352 patients receiving
potentially curative hepatectomy were enrolled into this
study. All were regularly followed up. Recurrence
developed in 189 patients (53.7%) who were divided
into group A (recurrence ≦ 12 months; very early
recurrence), group B (recurrence > 12 to ≦ 24 months;
early recurrence), group C (recurrence > 24 to ≦ 36
months; late recurrence), and group D (recur-
rence > 36 months; very late recurrence).
Results: The significant factors affecting recurrence of
group A (n = 153) included liver cirrhosis (p = 0.033),
high AFP value (p = 0.000), elevated ALT (p = 0.000),
rupture (p = 0.041), stage (p = 0.000), surgical margin
(p = 0.000), incomplete capsule (p = 0.000), satellite
nodule (p = 0.000), multi nodule (p = 0.000), multi cen-
tric (p = 0.000), grade of differentiation (p = 0.000) and
vascular invasion (p = 0.000). These factors affecting
group B (n = 27) are hepatitis (p = 0.033), elevated
ALT (p = 0.027), stage (p = 0.000), satellite nodule
(p = 0.000), multi nodule (p = 0.002), grade of differen-
tiation (p = 0.000) and vascular invasion (p = 0.000).
The factor affecting group C (n = 2) included high
AFP value (p = 0.006) and these affecting group D
(n = 7) are high AFP value (p = 0.044), satellite nodule
(p = 0.000). From survival time points of view, the
multivariate analysis showed significant factors of
group A are multi nodule (p = 0.017) and multi centric
(p = 0.010); group B are grade (p = 0.008) and hepatitis
(p = 0.019) respectively.
Conclusion: The factors affecting early recurrence and
late recurrence are different. Margin, vascular invasion
and grade of cellular differentiation are main determi-
nant for very early or early recurrence, while AFP
value is the key determinant of late or very late recur-
rence.
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SELECTIVE TROPISM OF RAT LIVER
EPITHELIAL CELLS TO
HEPATOCELLULAR CARCINOMA – AN
IN VIVO STUDY OF RAT
Kuo-Shyang Jeng M.D., F.A.C.S.1, 2, Ming-Che Yu2,
Hsin-I Hsiau2, Fang-Yu Chang2, Hsin-Hua Tsai2 and
Shih-Yun Li2
1Department of Surgery, Far Eastern Memorial
Hospital, Taipei, Taiwan; 2Department of Medical
Research, Far Eastern Memorial Hospital, Taipei,
Taiwan
Background and aims: Hepatocellular carcinoma
(HCC), one of the most malignancies worldwide, is pre-
valent in asian counties. For those unsuitable for resec-
tion or transplantation, medical or target therapy is
limited. Progenitor cells may be the “cell of origin” for
cancer because of their capacity for unlimited replica-
tion. Progenitor cells posing a selective migration
capacity to tumor has been reported. However, after
the progenitor cells entering into the tumor, how they
affect the tumor remain unknown.
Methods: Rat liver epithelium cells (RLE cells) were
separated from 10-day-old suckling F344 rats. These
progenitor cells were infected with enhanced green fluo-
rescence protein (EGFP). They were decided into
CD90+ cells and CD90- cells by sorting. To build
C57BL/6 mice model of hepatocellular carcinoma
(HCC), we injected 5 x 106 ML-1 cells into the left lobe
of liver. After 15 days, these 20 mice were injected
CD90+ cells or CD90- cells into liver with 1.5 cm far
from injected HCC around the tumor site. Through the
infection of EGFP, these cells were observed to migrate
to the tumor site. At the 20th day, the rats were sacri-
ficed to analyze the size of tumor and the tropism
effect. The data was analyzed.
Results: After sorting, flow cytometric analysis showed
the purity of CD90+ cells 94.1% and that of CD90-
cells 99.0%. Tropism of both CD90+ cells and CD90-
cells to the tumor was demonstrated from the presence
of EGFP within the tumor after injection. A significant
reduction of the size of the tumor on 20th day after
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injection was also found in both CD90+ cells
(p = 0.035) and CD90- (p = 0.04).
Conclusion: We established a model of rat in vivo of
therapy by progenitor cell upon hepatocellular carci-
noma. Selective tropism of CD90+ and CD90- of the
RLE cells to HCC were demonstrated by the presence
of EGFP. Tumor size may significantly be reduced.
Cell therapy may provide a strategy for unresectable
HCC in the future.
606
ROLE OF Β-CATENIN IN REGULATING
THE BALANCE BETWEEN TNF-Α- AND
FAS- INDUCED ACUTE LIVER INJURY
Shan-Shan Zou1,2, Wen Yang1, He-Xin Yan1, Le-Xing
Yu1, Yu-Qiong Li1, Hui-Lu Zhang1, Fu-Quan Wu1,
Liang Tang1 and Chao Wang1
1International Cooperation Laboratory on Signal
Transduction, Eastern Hepatobiliary Surgery Institute/
Hospital; 2Department of Hepatobiliary Diseases I,
Eastern Hepatobiliary Surgery Institute/Hospital; 3State
Key Laboratory of Oncogenes and Related Genes,
Shanghai Cancer Institute, Renji Hospital, Shanghai
Jiaotong University School of Medicine Shanghai, China
Background & Aims: Acute liver failure is a life threat-
ening clinical syndrome associated with devastating
consequences. b-Catenin, the main component of the
canonical Wnt signaling pathway, plays many critical
roles during various liver physiological and pathologi-
cal processes. However, the role of b-Catenin in acute
liver failure has not been fully investigated.
Methods: This study examined the role of b-Catenin in
D-galactosamine plus LPS (GalN/LPS) and Fas-
induced experimental acute liver failure using hepato-
cyte specific b-Catenin knockout mice. The extent of
liver injury was assessed by histopathology, serum ami-
notransferase levels, TUNEL staining and Western
blot.
Results: Hepatocyte-specific knock-out of b-Catenin
significantly reduced GalN/LPS-induced elevation of
serum alanine aminotransferase levels, liver damage
and hepatocyte apoptosis. Furthermore, mice with b-
Catenin-deficient hepatocytes showed stronger NF-jB
transcription activity, resulting in reduced oxidative
stress level in liver after GalN/LPS treatment. Con-
versely, overexpression of b-Catenin in vitro inhibited
TNF-a mediated NF-jB activation, aggravating TNF-
a-induced oxidative stress and cell death. Interestingly,
hepatocyte-specific knockout of b-Catenin exacerbated
Jo2-mediated liver injury. The mechanism by which b-
Catenin protects against Fas-induced liver injury
involves the role of b-Catenin as a transcriptional
inhibitor of NF-jB signaling, which decreased Fas
expression under injury conditions.
Conclusions: b-Catenin plays an important role in regu-
lating the balance between TNF-a and Fas-induced
liver injury via its effect on NF-jB. These findings
might be useful towards developing strategies for pro-
tection of hepatocytes against different apoptotic trig-
gers.
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THE IMPACT OF TACE BEFORE LIVER
TRANSPLANTATION ON THE
PROGNOSIS OF PATIENTS WITH
HEPATOCELLULAR CARCINOMA
Hai-Lin Li, Wen-Bin Ji, Wei-Dong Duan, Yu-Rong
Liang, Yong-Wei Chen, Ying Luo and Jia-Hong Dong
Hospital & Institute of Department of Hepatobiliary
Surgery, Chinese PLA General Hospital, Beijing, China
Background & aims: The impact of transarterial
chemoembolization(TACE) before liver transplantation
(LT) for hepatocellular carcinoma (HCC) on patient
long survival is unknown. Investigate the impact of
transarterial chemoembolization(TACE) before liver
transplantation (LT) for hepatocellular carcinoma
(HCC) on patient to prolong survival.
Methods: Between Jan 2002 to Dec 2010, 204 patients
with HCC in PLA general hospital liver tansplant cen-
ter were evaluated for LT. Among these 204 patients,
88 patients received transarterial chemoembolization
before LT (TACE group) and 116 patients did not (no-
TACE group). Kaplan-Meier estimates were calculated
5 years after LT and were compared with the log-rank
test.
Results: In TACE group and non-TACE group, the
diseases free survival, with tumor survival time, tumor
recurrence, tumor size, vascular invasion, tumor num-
ber, AFP are significant different. Different classifica-
tion factors preoperative TACE on liver transplant
recipients: Child-Pugh classification, surgical approach,
tumor size, vascular invasion, Edmndson classification
of tumors, the number of tumors, AFP, postoperative
complications are significant different. Patients with
preoperative TACE treatment and no-TACE treatment
,the 1, 3, 5-year cumulative survival rates were 70.5%
vs. 91.4%, 53.3% vs. 83.1%, 46.2% vs. 80.8%, respec-
tively. The median survival time of 51.857  5.042 vs.
80.930  3.308. Log-Rank test v2 value = 22.547,
p = 0.000, p < 0.05. 1, 3, 5-year cumulative disease-free
survival rates were 62.3% vs. 87.9%, 48.7% vs. 82.1%,
48.7% vs. 82.1%, respectively. The median survival
time of 50.386  4.901 vs. 80.281  3.216. Log-Rank
test v2 value = 22.063, p = 0.000, p < 0.05.
Conclusions: TACE before liver transplantation for
hepatocellular carcinoma patients have no positive sig-
nificance on its long-term survival rates and tumor-free
survival rate, however, reduced the long-term survival.
610
LIVER-TO-SPLEEN RATIO AS AN
INDEX OF CHRONIC LIVER DISEASES
AND SAFETY OF HEPATECTOMY
Yang-Qing Huang1, Bin Huang2, Feng Xu2, Hong-Yan
Cheng2, Ton Kan2, Yun-Quan Luo1 and Jia-Mei
Yang2
1.Shuguang Hospital, 528 Zhangheng Rd., Shanghai,
201204; 2.Eastern Hepatobiliary Surgery Hospital, 225
Changhai Rd. Shanghai, 200438, China
Background and aims: Severe complications such as
hepatic failure are the main causes for post-hepatec-
tomy death. Accurate preoperative evaluation of func-
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tional liver reserve is the key to ensure safety of the
operation. The currently available evaluation of func-
tional liver reserve are still not accurate. Former
researches found spleen would gradually enlarge with
liver shrinks when liver chronic disease such as fibrosis
and cirrhosis got worse. So preoperative liver-to-spleen
ratio (LSR) may be an indicator to evaluate severity of
liver disease and may indicate safety of hepatectomy.
Methods: The volumes of liver and spleen were evalu-
ated on computed tomography (CT) scan in 70 patients
who received partial hepatectomy. Preoperative liver-
to-spleen ratio (LSR) was calculated. Statistical analysis
was conducted to examine the relation between LSR
and the grade of chronic liver diseases in 70 patients
and to evaluate the safety of hepatectomy indicated by
LSR.
Results: LSR had a negative correlation with the grade
of chronic liver diseases(liver disease grade: normal,
fibrosis1-4, liver cirrhosis, confirmed by pathological
examine) (r = -0.871, p < 0.0001). Moreover,
LSR = 3.333 was the cut-off point for diagnosing liver
cirrhosis. This ratio had a sensitivity of 94.7% and a
specificity of 90.2% (AUC = 0.963, 95%CI: 0.912–
1.000). LSR was also related to some preoperative
serum chemical test: pre-albumin (r = 0.493,
p < 0.0001), PT (r = -0.335, p = 0.005), INR (r = -
0.338, p = 0.005), PLT (r = 0.435, p < 0.0001). The
evaluation suggested that for patients who received
hepatectomy with LSR > 2.904 the incidence of postop-
erative inadequacy and mortality from liver failure were
significantly reduced than those with LSR  2.904
(3.7% vs. 56.25%, p < 0.0001) with a sensitivity of
90% and a specificity of 88.3% (AUC = 0.880, 95%CI:
0.811–1.000). LSR was still related to some postopera-
tive serum chemical test: total bilirubin (day3,7), pre-
albumin (day1,3,7), PT (day1,3,7), INR (day1,3,7).
Logistic regression indicated that LSR > 2.904 was the
independent factor which affected liver inadequacy or
failure of postoperative safety (B = -4.203, OR = 0.015,
95%CI: 0.002–0.137, p < 0.0001).
Conclusions: Preoperative LSR correlated well with the
grade of chronic liver diseases and it predicted the
safety of major hepatectomy. LSR is also able to indi-
cate liver synthesis function and is correlated with por-
tal hypertension according to the relationship of LSR
and serum chemical test.
611
PORTAL VEIN CLAMPING ONLY
CONFERS PROTECTION AGAINST
HEPATIC ISCHEMIA-REPERFUSION
INJURY IN CIRRHOTIC RATS
Jian-Jun Hu, Chong-Hui Li, Hong-Dong Wang,
Yong-Wei Chen, Ai-Qun Zhang and Jia-Hong Dong
Department of Hepatobiliary Surgery, Institute of
Hepatobiliary Surgery, PLA General Hospital, Beijing,
China
Background and aims: Portal triad blood inflow occlu-
sion during liver surgery is effective in reducing
intraoperative bleeding, whereas cirrhosis weaken the
tolerance of liver to hemorrhage and ischemia reperfu-
sion injury resulted from vascular occlusion. A suitable
vascular occlusion method is vital for a successful oper-
ation. We aimed to explore the protective effects of
portal vein clamping only (PVC) on cirrhotic livers of
rats underwent ischemia and reperfusion injury and
compared with intermittent portal triad clamping (IC).
Methods: Cirrhotic rats induced by carbon tetrachlo-
ride were randomly assigned into 4 groups: sham oper-
ation (SO), portal triad clamping (PTC), PVC and IC
(15 min ischemia alternated with 5 min reperfusion).
After 45, 60 or 75 min of different portal vascular
clamping, the hepatic injury and liver function were
investigated by assessing the 7d survival rate, liver
blood loss, serum alanine aminotransferase (ALT), liver
tissue malondialdehyde (MDA), liver tissue ATP, indo-
cyanine green retention rate at 15 min (ICGR15) and
histopathology changes.
Results: The 7d survival rates of PVC and IC group
were higher than PTC group with 60 or 75 min of
ischemia. The amount of liver blood loss during hepa-
tectomy ranked as follows: group PTC < group IC,
group PVC < group SO(p < 0.01),and there was no dif-
ference between IC and PVC. At 1 h, 6 h and 24 h po-
streperfusion, the ALT and MDA levels of group PTC,
PVC and IC increased significantly compared to SO
(p < 0.01), but PTC was much higher than group PVC
and IC (p < 0.05). The ICGR15 of PTC and IC rats
was similar, which was significantly higher than those
of PVC and SO rats (p < 0.05). Although the ATP lev-
els of all the three clamping groups decreased markedly
after ischemia and reperfusion compared with SO
group, the ATP level of PVC was much higher than
PTC and IC group (p < 0.05). The hepatic injury of
group PVC and IC were similar but both slighter than
those of group PTC according to histopathological
analysis.
Conclusions: The method of portal vein clamping alone
(PVC) could confer protection against hepatic ischemic
reperfusion injury as intermittent portal triad clamping
(IC) in cirrhotic liver of rats. Howerver,the PVC
method is more efficient in retaining the energy and
function of hepatocytes than the method of IC and
suggesting better prognosis.
612
CORRELATION BETWEEN JAUNDICE
AND PROGNOSIS OF GALLBLADDER
CANCER
Fei-Ling Feng, Xiang-Ji Luo, Chen Liu and Xiao-Qing
Jiang
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background: To explore the correlation between the
jaundice and the prognosis of gallbladder cancer.
Methods: We retrospectively analyzed 181 patients with
gallbladder cancer who were treated at our department
from December 2002 to June 2010. Jaundice was found
in 91 patients and 90 patients without jaundice.
Results: The median survival time in patients with
jaundice (8.8  1.6 months) was significantly shorter
than that in one without jaundice (24.8  3.0 months)
(p < 0.01). All patients with jaundice had stage III or
IV gallbladder cancer of whom the median survival
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time was shorter than that in stage III or IV gallblad-
der cancer patients without jaundice (16.3  2.3
months) (p < 0.01). The patients with jaundice had a
lower rate of radical resection (30.8%) than did stage
III or IV gallbladder cancer patients without jaundice
(62.2%). The jaundice group’s median survival
(19.5  4.5 months) was comparable to the survival
(22.1  3.1months) of in-patients without jaundice in
stages III & IV (P > 0.05).
Conclusions: Jaundice is an important factor indicating
the prognosis of patients with gallbladder carcinoma.
Most patients with jaundice have reached stages III &
IV, and the low rate of radical resection also results in
the poor prognosis of these patients. Therefore; an
increased rate of radical resection should improve the
prognosis of patients with jaundice.
Key words: Gallbladder cancer; Radical resection;
Patient survival
614
ANALYSIS ON THE EFFICACY OF
POSTOPERATION RADIOTHERAPY IN
GALLBLADDER CANCER
Liang Yang, Fei-Ling Feng, Hai-Hua Zhou, Yong-Jian
Sun and Yan Meng
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Objective: To summarize the treatment experiences of
gallbladder cancer, evaluate the efficacy of postopera-
tive radiotherapy, and investigate the method of
improving the survival rate of gallbladder cancer
patients.
Method: Retrospectively analyzed the clinical data and
follow-up results of 127 gallbladder cancer patients
among which 84 cases was resected radically alone and
43 cases had an combination of surgery and postopera-
tive radiotherapy between June 2003 to December
2009. According to AJCC staging criteria, compare the
survival time and 1,3,5-year survival rates of the surgi-
cal group and the postoperative radiotherapy group in
the different pathological staging and resection margin
case.
Results: (1)The median survival time of postoperative
radiotherapy group in Stage III was 16.9 months, 1
year, 3 year, 5 year survival rates were 55.7%, 23.5%
and 18.2%, which were higher than that of simple
operation group (median survival time was 14.3
months, 1 year, 3 year, 5 year survival rates were
42.7%, 22.6% and 16.7%), the difference was statisti-
cally significant (p < 0.05). In Stage IV, the median
survival time of postoperative radiotherapy group and
operation group were 9.7 months and 6.3 months, 1
year survival rate were 14.2% and 9.8%, the 3 year
survival rate were 7.2% and 3.9%, the 5 year survival
rate were 7.2% and 1.9%, the difference was statisti-
cally significant (p < 0.05). And there was no statisti-
cally significant difference in stage I, II. (2) R0 or R1
resection, the median survival time and the l,3,5-year
survival rates of postoperative radiotherapy group
was significantly higher than surgery alone group in
III, IV patients (p < 0.05). (3) The main side effects
in postoperative radiotherapy include nausea, vomit-
ing and abdominal pain and to be symptomatic and
supportive therapy may be successful completion of
radiotherapy.
Conclusion: With regard to the gallbladder cancer
patients in III, IVstage, according to the different Stag-
ing,choosing a positive modus operandi and postopera-
tion radiotherapy will enhances the survival rate. ForI,
IIstage gallbladder cancer patients, postoperative radio-
therapy did not significantly improve survival.
615
THE EFFICACY OF RADIATION
THERAPY FOR PATIENTS WITH
ADVANCED GALLBLADDER
CARCINOMA AND ANALYSIS OF
PROGNOSTIC FACTORS
Liang Yang, Yong-Jian Sun, Hai-Hua Zhou, Hong-Bin
Ma and Yan Meng
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Objective: To analyze the efficacy and evaluate the
security of advanced gallbladder cancer radiation ther-
apy retrospectively, in order to improve the prognosis.
Methods: 87 cases of gallbladder carcinoma were
taken with three-dimensional conformal radiation ther-
apy. 81 cases can be evaluated. Nevin ‘staging for IV
was in 23 cases, 58 cases were in V.Male was in 35
cases, 46 cases were of women. Single dose of 1.8 to
2.2Gy, once a day, five times a week, the total dose
was 38 to 65 Gy.
Results: Cox regression analysis showed that: The
serum CA199 value, efficacy and prognosis were with
relation. Patients with advanced gallbladder carcinoma
was in 81 cases, complete remission rate was 12.3% (10
cases), partial remission rate was 42.0% (34 cases), the
efficiency was 54.3%. The survival rate of 3 month was
95.1% (77 cases), survival rate of 6-month period was
69.1% (56 cases), and the survival rates of 1 year, 2
years and 3-year were 24.7%, 3.7%, 1.2%, and the
median survival was 8.5 months. The main response of
Toxicity is the recent gastrointestinal tract returned to
normal after symptomatic treatment. Digestive reaction
of grade Iwas in 31 cases, grade II was in 10 cases, the
rate was 50.6%. The hematological toxicity of leukope-
nia and degree Iwas in 15 cases, II was 5 cases, the rate
was 24.7%. The thrombocytopenia ofIwas in eight
cases, II degree was in 3 cases, the rate was 35.5%. No
one cases was with termination treatment due to severe
radiation reaction.
Conclusions: The three-dimensional conformal radio-
therapy can prolong survival time of patients with
advanced gallbladder, and alleviate the symptoms; most
patients can tolerate side effects.
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616
SURGICAL TREATMENT OF
HEPATOCELLULAR CARCINOMA
WITH INFERIOR VENA CAVA TUMOR
THROMBOSIS
Chang-Hu Duan, Sheng Tai, Chun-Long Li, Zhi-Lei
Su, Hao Wang and Hamza
General surgery department of the second affiliated
hospital of Harbin Medical University, Harbin, China
Background and aims: Hepatocellular Carcinoma
(HCC) with Inferior Vena Cava (IVC) tumor thrombo-
sis is rare, and its prognosis is extremely poor. Non-sur-
gical treatment for these patients causes tumor invasion
to Right Atrium leading to heart failure and sudden
death. The surgical treatment of this disease can prevent
the unfortunate heart failure and invasion of tumor in
the Right Atrium. We report the case of this surgery to
investigate the Preoperative planning, surgical tech-
niques and postoperative efficacy of this disease;
Methods: A 42-year-old man suffered from HCC with
IVC tumor thrombosis invasion, was admitted to our
hospital in MAY 2012. To prevent functional insuffi-
ciency of liver or liver failure at postoperative period,
we decided to reserve the sixth(VI)segment of the liver
via reserving the inferior right hepatic veins (IRHV),
thus the patient underwent Liver resection segment V,
VII, VIII, Cholecystectomy, and Inferior Vena Cava
tumor thrombosis removal Surgery in our hospital;
Results: The patient shows great recovery without any
significant complications with normal AFP value and
liver function, CT scan shows no metastasis. No sign
of recurrence have noticed during the follow-up till
November 2012;
Conclusions: Liver resection and IVC tumor thrombo-
sis removal Surgery can be safely performed on the
case of HCC with Tumor Thrombosis in IVC; surgical
treatment can relieve the patient from the risk of sud-
den death caused by heart failure and pulmonary;
When the IRHV existing, resection the segment V, VII,
VIII, reserving the segment VI of the liver can prevent
functional insufficiency of liver or liver failure at post-
operative period.
617
POTENTIAL RISK FACTORS FOR
INTRAHEPATIC
CHOLANGIOCARCINOMA (ICC) AND
ANALYSE
Hui Wang, Hua-Bang Zhou, Dong-Xun Zhou and
he-Ping Hu
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Aims: To evaluate potential risk factors for intrahepat-
ic cholangiocarcinoma (ICC) and analyse clinicopatho-
logic characteristics of ICC patients with seropositive
hepatitis B surface antigen (HBsAg).
Methods: A retrospective case–control study was con-
ducted. Cases were 317 ICC patients referred to the
Eastern Hepatobiliary Surgery Hospital in China
between 2003 and 2006.Controls were 634 healthy
individuals. Adjusted odds ratios (ORs) were calculated
in logistic regression analysis. Among 317 consecutively
enrolled ICC patients, 154 patients were seropositive
HBsAg (48.6%). We compared clinicopathologic char-
acteristics of these patients (group I) with ICC patients
seronegative for HBsAg (group II; n = 163) and com-
pared the age and sex distributions of patients in group
I with randomly selected hepatitis B virus (HBV)-asso-
ciated hepatocellular carcinoma (HCC) (group III;
n = 1140).
Results: Compared with the controls, ICC patients had
a high prevalence of seropositive HBsAg, cirrhosis, he-
patolithiasis and hepatic schistosomiasis. Compared
with seronegative-HBsAg ICC patients, seropositive-
HBsAg ICC patients were younger, more frequently
male and had a higher proportion of abnormal amino-
transferase and serum alpha-fetoprotein (AFP) level,
histological inflammation and cirrhosis, right-lobe
focus, poor tumour differentiation, tumour encapsula-
tion and microvascular invasion; had a lower propor-
tion of abnormal serum carbohydrate antigen 19-9
(CA19-9) level and lymphatic metastasis. The age and
sex distribution profiles were nearly identical between
seropositive-HBsAg ICC patients and HBV-associated
HCC patients.
Conclusions: The HBV infection, cirrhosis, hepatolithi-
asis and hepatic schistosomiasis may be potential risk
factors for ICC. HBV-associated ICC shares many clin-
icopathological similarities with HBV-associated HCC.
The result indicated HBV-associated ICC and HBV-
associated HCC may hold common disease process for
carcinogenesis.
618
COMBINATION THERAPY OF
MULTIPLE MICRO TRAUMA
TECHNOLOGY ON HEPATOCELLULAR
CARCINOMA
Xin-Feng Li1, Guo-Rong Lu2, De-Xin Liu3,
Gao-Xiong Wang1, Shi-Lin Li2 and Wei Zhuang1
1Second Affiliated Hospital of Fujian Medical
University; 2NO: 34 Zhongshan North Road of
Quanzhow City, Fujian, China
Objective: To compare efficacy of therapy scheme as
Transhepatic Artery Chemoembolization (TACE) +
Radiofrequency Ablation (RFA) + Introportal Vein
Chemotherapy (PVC) + Percutaneous Ethanol Injection
(PEI) therapy (quadruplet group) with TACE + RFA
combinational therapy (diad group) in treating hepato-
cellular carcinoma (HCC).
Methods: 25 cases in quadruplet group were treated by
TACE for 3 weeks, then by RFA, after 2 months, by
PVC + PEI; 23 cases in diad group were treated by
TACE for 3 weeks and then by PEI. After completion
of each treatment course in both groups, Alphafetopro-
tein (AFP) was tested 2 months later, abdomen colorful
doppler, CT and AFP were retested 6 months later.
Results: AFP was significantly decreased in 23 cases of
quadruplet group and 20 cases of diad group among
those with AFP positive results. 6 months later, exam-
inations of CT, colorful Doppler and AFP in two
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groups showed: quadruplet group has significantly
decreased (X2 = 6.81, p < 0.01) blood supply of cancer
tissue and significantly diminished (X2 = 8.29,
P < 0.01) tumor size, few cases with AFP elevation
(X2 = 5.06, P < 0.05); lower 1 year relapse rate and
two years mortality than that in diad group
(X2 = 5.30, P < 0.05).
Conclusion: TACE+RFA+PVC+PEI combinational
therapy is a safe double intervention treatment for
HCC scheme with less side effects, which is better than
TACE+PEI scheme in killing remnant tumor and
reducing relapse.
622
PANCREATICODUODENECTOMY FOR
THE PATIENTS WITH MALIGNANT
CHOLEDOCHAL CYST: REPORT OF 4
PATIENTS AND REVIEW
Chen Liu, Yong Yu, Fei-Ling Feng, Bin Li, Qing-Bao
Cheng, Wei-Feng Tan, Xiang-Ji Luo and Xiao-Qing
Jiang
Department of Biliary Surgery, Eastern Hepatobiliary
Surgical Hospital, Second Military Medical University,
Shanghai, China
Due to easy canceration developed into bile duct can-
cer, congenital bile duct cystic dilatation have usually
been considered a precancerous lesion. Once the malig-
nant transformation occurs, it is difficult to resection
and the prognosis is poor. In the past three years, we
have successively for 4 cases of malignant congenital
cystic dilation of bile duct patients underwent radical
pancreaticoduodenectomy. All of 4 patients were
female, aged 35–46 years old. 1 of the patients died at
11 months after surgery, two cases have survived for
more than two years, the longest surviving more than
31 months, and no signs of recurrence and metastasis,
and 2-year cumulative survival rate was over 50%. The
pancreaticoduodenectomy could make part of patients
with congenital bile duct cystic dilatation of malignant
long-term survival, have a good effect.
623
OCCULT HEPATITIS B VIRUS
INFECTION: AN IMPORTANT RISK
FACTOR FOR DEVELOPMENT OF
INTRAHEPATIC
CHOLANGIOCARCINOMA
Hui Wang, Hua-Bang Zhou and He-Ping Hu
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background/Aims: While some data are available con-
cerning occult hepatitis B virus (HBV) infection (OBI)
in patients with hepatocellular carcinoma (HCC), there
is no information about the cryptic infection in individ-
uals with intrahepatic cholangiocarcinoma (ICC). The
aim of this study was to investigate the correlation of
OBI and ICC development.
Methods: A retrospective case–control study was con-
ducted. Cases were 183 cryptogenic ICC patients (group
I) with referred to the Eastern Hepatobiliary Surgery
Hospital in China between Jan 2003 and Oct 2007. Con-
trols were 549 healthy individuals (group II). The cases
and controls were matched in age, sex and inhabitancy.
Data were analyzed by statistical technique of Chi-
square test and conditional logistic regression. Adjusted
odds ratios (ORs) and 95% confidence interval (95%CI)
were calculated in logistic regression analysis. The intra-
hepatic total HBV DNA in 63 paraffin-samples was col-
lected from group I (n=44), HBV-associated ICC
patients (n = 3) and cavernous hemangioma of liver
patients with seronegative HBsAg (hepatitis B S antigen)
(group III; n = 16). We performed PCR-fluorescence
probing to determine the levels of sera and intrahepatic
HBV DNA, and compared the intrahepatic HBV DNA
of 44 patients in group I with group III.
Results: HBeAg was negative in all of cryptogenic ICC
patients and controls. 26.23% and 31.69% of patients
in group I and group II were negative for all serologi-
cal antibodies of HBV, respectively. Compared to
group II, group I had a lower prevalence of anti-HBs
(antibody of HBsAg) (50.27% vs. 59.93%, p = 0.022),
and had a higher prevalence of anti-HBe (37.16% vs.
8.01%, p<0.001) or anti-HBc (62.30% vs. 20.40%,
p < 0.001). Multivariate analysis confirmed that anti-
HBe and anti-HBc positivity were associated with ICC
(OR, 2.244; 95% CI, 1.070-4.705) and 4.050 (2.141-
7.663), respectively. Compared with group III, crypto-
genic ICC patients were more frequently male and
elder, but no statistical difference in age was found
between two groups. Cryptogenic ICC cases had a
more highly detectable rate of intrahepatic total HBV
DNA than group III (63.64% vs. 18.75%, p = 0.002).
Conclusions: The OBI may be a potential risk factor
for ICC development. HBsAg seroclearance do not
signify eradication of HBV and could not entirely pre-
vent the development of ICC.
625
CONTRAST-ENHANCED
INTRAOPERATIVE
ULTRASONOGRAPHY FOR
DETECTION OF MALIGNANT LIVER
TUMORS: A META-ANALYSIS
Jun Wu, Ya-Min Pan, Tian-Tian Wang and Bing Hu
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background and Study aims: Malignant liver tumors
include primary hepatic carcinomas and secondary
hepatic metastases. Postoperative early recurrence is a
critical problem influencing the life span of patients.
Some early recurrences seem to occur from minor or
inconspicuous tumors which were overlooked during
both preoperative and intraoperative investigations.
Though many detection techniques, such as CT, MRI
and intraoperative ultrasonography(IOUS), have
improved the detection rate of tumors, some lesions
were still neglected. Contrast-enhanced intraoperative
ultrasonography(CE-IOUS) has been reported to
improve the tumors detection rate significantly. We
aimed to assess the accuracy of CE-IOUS in diagnosing
malignant liver tumors by pooling data of existing
trials.
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Methods: A literature search was independently done
by two reviewers to identify all relevant studies. Stud-
ies pertinent to the diagnostic performance of CE-
IOUS for detection of malignant liver tumors were
included without restriction of language. Reviews,
comments, case reports and studies with insufficient
data were excluded. The Quality Assessment of
Diagnostic Accuracy Studied(QUADAS) questionnaire
was used to assess the quality of the selected studies.
The significance and the extent of heterogeneity were
calculated using Q test and I2 index respectively.
Meta-analysis was done using fixed effect model or
random effect model by using Meta-Disc software
(Version1.4).
Results: 9 studies involving 584 patients and 2057
lesions were analyzed. Test of heterogeneity was signifi-
cant for the analysis, meta-analysis was performed
using random effect model. The pooled sensitivity of
CE-IOUS for detection of malignant liver tumors was
92% (95% CI, 0.91-0.94), and the specificity was 81%
(95% CI, 0.76-0.86), the positive likelihood ratio (LR)
was 3.59 (95% CI, 1.64-7.89) and the negative LR was
0.08 (95% CI, 0.03-0.21). The area under the curve
(AUC) under the summary receiver operating charac-
teristic(SROC) was 0.9445.
Conclusions: Contrast-enhanced intraoperative ultraso-
nography improves the ability to detect potential malig-
nant liver tumors, and helps to adjust surgical
approach. Thus, it will be a reasonable and effective
modality for management of liver tumors.
627
BLOCKADE OF STORE-OPERATED
CA2+ ENTRY INHIBITS
HEPATOCARCINOMA CELL
MIGRATION AND INVASION BY
REGULATING FOCAL ADHESION
TURNOVER
Ning Yang1, Ying Tang2, Fang Wang2, Hai-Bin
Zhang1, Dan Xu2, Ji-Hang Yuan2, Ya-Feng Shen2,
Shu-Han Sun2 and Guang-Shun Yang1
1Eastern Hepatobiliary Surgery Hospital, Shanghai,
China; 2Department of Medical Genetics, Second
Military Medical University, Shanghai, China
Background and aim: Store-operated Ca2+ entry
(SOCE) is a main Ca2+ influx pathway controlling the
intracellular Ca2+ concentration in normal hepatocytes
and hepatocellular carcinoma (HCC) cells. Ca2+ influx
has been demonstrated to be involved in liver oncogen-
esis. Stromal interacting molecule (STIM) 1 acts as a
sensor for the level of Ca2+ stored in the endoplasmic
reticulum, and Orai1 protein constitutes the pore-form-
ing subunit of the store-operated channels. Recently,
STIM1 and Orai1 were found critical for breast tumor
cell migration and metastasis. However, the effects of
Ca2+ influx pathway on migration and metastasis have
not been studied in hepatocellular carcinoma.
Results: Here, we found that STIM1 had a higher
expression in hepatoma tissues than in pericancerous
tissues of the same patients. In general, STIM1 expres-
sion is elevated in HCC cell lines compared to a normal
hepatocyte cell line. HCC-LM3 cell, which has a higher
migration ability, expresses five times higher level of
STIM1 than other HCC cell lines.
Conclusions: STIM1 could then be explored as a prog-
nostic marker to screen liver cancer patients with high
metastatic potential. Inhibition of SOCE and STIM1
enhances focal adhesions and decreases the focal adhe-
sion turnover, suggesting the therapeutic potential of
SOCE and STIM1 as new molecular targets for meta-
static HCC.
628
EFFICACY AND SAFETY EVALUATION
OF SIMULTANEOUS SURGICAL
TREATMENT OF PRIMARY
HEPATOCELLULAR CARCINOMA
ASSOCIATED WITH PORTAL
HYPERTENSION
Yong Fu, Ning Yang, Hai-Bin Zhang, Jun-Hua Lu,
Jun Zhao, Hui-Si Ma and Guang-Shun Yang
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background and aims: To evaluate the efficacy and
safety of simultaneous surgical treatment (radical hepa-
tic resection combined with splenectomy and portaazy-
gous devascularization) of primary hepatocellular
carcinoma (HCC) associated with portal hypertension
(PHT).
Methods: The data of 108 primary HCC patients with
and without PHT treated surgically during April 2004
to April 2008 in one single surgical unit of Shanghai
Eastern Hepatobiliary Surgical Hospital were analyzed.
These patients were divided into three groups: simulta-
neous surgical treatment group, control group I, and
control group II. Patients in the simultaneous surgical
treatment group were diagnosed with HCC associated
with severe PHT. Control group A included patients
diagnosed with HCC associated with mild PHT and
treated with radical hepatic resection. Control group II
included patients with HCC without PHT and treated
with radical hepatic resection. The clinical data and fol-
low-up results were examined and compared between
theses three groups.
Results: The average costs and length of hospital stay
were higher in the simultaneous surgical treatment
group comparing to the two control groups. One
patient in control group A had died during the peri-
operation period, 58 patients had died during the 3-
year follow-up period. The occurrence of post-operative
ascites and the levels of post-operative white blood cell
(WBC) and platelet counts were higher in the simulta-
neous surgical treatment group comparing to the two
control groups. Long-term hemorrhage rate in the
simultaneous surgical treatment group is significantly
lower than that of control group I. Long-term survival
rate of simultaneous surgical treatment group is similar
to that of control group II and were both better than
that of control group I.
Conclusions: Treating HCC associated with severe
PHT with simultaneous surgeries is considered effective
and safe. When treating patients with HCC associated
with mild PHT, PHT should also be treated in addition
to radical hepatic resection.
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629
LIVER TRANSPLANTATION IN
PATIENTS WITH COMPLETE SITUS
INVERSUS: CASE REPORT FOR
BILIARY STENOSIS AND
MANAGEMENT
Ning Yang, Hai-Bin Zhang, Jun-Hua Lu, Hui-Si Ma,
Yong Fu and Guang-Shun Yang
Eastern Hepatobiliary Surgery Hospital, Shanghai,
China
Background and aim: Orthotopic liver transplantation
(OLT) in patients with complete situs inversus (CSI)
has been scarcely reported worldwide as the lower inci-
dence of CSI and the serial problems in transplanting
techniques.
Methods and Results: We reported such a case with
hepatocelluar carcinoma who underwent orthotopic
liver transplantation with 90° clockwise rotation of the
normal graft around the median line and end-to-end
anastomosis for all the vessels. The patient had a satis-
factory recovery in the early period after operation,
while 5 months later, an anastomotic stenosis of bile
ducts resulting from the change of original anatomical
position. Fortunately, it was successfully healed
through endoscopic retrograde biliary drainage
(ERBD) and repeated percutaneous transhepatic cho-
langial drainage (PTCD) with favorable liver function
and no tumor recurrence at 72 months post-transplan-
tation.
Conclusions: Patients with CSI undergoing OLT would
similarly yield a good outcome. Stomastenosis of bile
duct is one of the major complications for them, but it
could be well circumvented by prompt endoscopic and
interventional therapy.
630
EFFECT EVALUATION OF VASCULAR
RESECTION FOR PATIENTS WITH
HILAR CHOLANGIOCARCINOMA:
ORIGINAL DATA AND META-
ANALYSIS
Wen-Long Yu, Zong-Ting Gu, Song Shi, Ning-Jia
Shen and Yong-Jie Zhang
Department II of Biliary Tract Surgery, Eastern
Hepatobiliary Surgery Hospital, Shanghai, China
Aim: To evaluate the effect of vascular resection (VR)
in surgical management of hilar cholangiocarcinoma
(HCCA), this report did a clinical analysis and con-
ducted a systematic review,combined other studies,
based on meta-analysis.
Methods: 238 HCCA patients underwent hepatectomy
in the Eastern Hepatobiliary Surgery Hospital. Binary
logistic regression analysis was performed to investigate
the potentially complications associated factors. Kap-
lan-Meier test was employed to compare the long-term
survival of patients in four groups (R0+PVR-free,
R0+PVR, R1 and R2). Meta-analysis was performed
with RevMan 4.3.2 software.
Results: The results suggested that hepatectomy and
HAR were important negative factors from complica-
tions (p < 0.01). Compared with patients in other
groups, survival of patients in R0+PVR group was
worse than R0+PVR-free group, better than R2 group
and similar to R1group with p = 0.001, 0.047 and
0.606 respectively. The results of meta-analysis sug-
gested patients who underwent VR had higher compli-
cations rate and mortality rate than patients who did
not. Moreover, patients with vascular resection had
lower long-term survival rate.
Conclusion: VR used to be considered effective to the
patients with vascular invasion. However our study
suggest that the surgical decision of undergoing VR
should be made cautiously, since VR could diminish
the survival time in some cases.
631
MICRORNA-X PROMOTES
GALLBLADDER CARCINOMA CELL
PROLIFERATION, MIGRATION AND
INVASION BY TARGETING Y
Wen-Long Yu, Zong-Ting Gu, Song Shi, Ning-Jia
Shen and Yong-Jie Zhang
Department II of Biliary Tract Surgery, Eastern
Hepatobiliary Surgery Hospital, Shanghai, China
MicroRNAs (miRs) are conserved small non-coding
RNAs that negatively regulate gene expression. The
miR profiles are markedly altered in cancers and some
of them have a causal role in tumorigenesis. Here, we
report changes in miR-X expression profile in Gallblad-
der carcinoma(GC)and we found that miR-X strongly
affected Gallbladder carcinoma tumorigenesis. The
results showed that the expression level of miR-X was
higher in Gallbladder carcinoma cells and tissues com-
pared with the control. We hypothesized that high level
expression of miR-X was significantly associated with a
more aggressive and/or poor prognostic phenotype of
patients with Gallbladder carcinoma. In this work, up-
regulation of miR-X expression enhanced tumorigenesis
while down-regulation of miR-X expression impaired
tumorigenesis, which showed lower level of cell prolif-
eration and higher level of cell apoptosis. In addition,
colony formation, invasion and migration were also
significantly impaired by miR-X inhibitor. Further
studies showed that miR-X could directly target the
These data highlight an important role for miR-X in
the regulation of invasion and metastasis in the molecu-
lar aetiology of Gallbladder carcinoma, and suggest a
potential application of miR-X in prognosis prediction
and cancer treatment.
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635
IDENTIFICATION OF BIOMARKERS
FOR DISTINCTION BETWEEN
CHOLANGITIS AND
CHOLANGIOCARCINOMA
ASSOCIATED WITH HEPATOLITHIASIS
Wen-Long Yu1, Guang-Zhi Jin2, Xin-Yuan Lu2, Sheng
Xu1, Yong-Jie Zhang1 and Wen-Ming Cong2
1Department II of Billiary Tract Sugery, Eastern
Hepatobiliary Surgery Hospital, Second Military
Medical University, Shanghai, China; 2Department of
Pathology, Eastern Hepatobiliary Surgery Hospital,
Second Military Medical University, Shanghai, China
The mechanism of occurrence and development of cho-
langiocarcinoma associated with Hepatolithiasis remains
unclear. For help to disclosure this process,we screened
immunohistochemical biomarkers using iTRAQ-2DLC-
ESI-MS/MS technique between chronic cholangitis and
cholangiocarcinoma associated with Hepatolithiasis. A
total of 814 proteins were quantified, including 30 pro-
teins up-regulated and 29 proteins down-regulated in
cholangiocarcinoma associated with Hepatolithiasis by
at least 1.25- or 0.8-fold at p < 0.05. The selected candi-
date biomarkers were further verified using Western
blotting and immunohistochemistry. Finally, over
expression of Annexin A3, and L-lactate dehydrogenase
A chain (LDHA) were conformed may serve as diagnos-
tic markers for cholangiocarcinoma associated with He-
patolithiasis. These findings will help to elucidate the
pathogenic mechanism of cholangiocarcinoma associ-
ated with Hepatolithiasis and to develop diagnostic strat-
egies for immunohistochemical diagnosis.
636
DEPTH OF DUODENAL INFILTRATION
AS AN INDICATOR OF LYMPH NODE
METASTASIS IN CARCINOMA OF THE
PAPILLA OF VATER
Wen-Long Yu, Zong-Ting Gu, Song Shi, Ning-Jia
Shen and Yong-Jie Zhang
Department II of Biliary Tract Surgery, Eastern
Hepatobiliary Surgery Hospital, Shanghai, China
Background: Although nodal involvement is one of the
most important prognostic factors for carcinoma of the
papilla of Vater (CPV), a detailed relationship between
clinicopathological factors and nodal involvement has
not been evaluated.
Methods: From January 2005 to December 2010, 94
patients with CPV underwent pancreatoduodenectomy
and dissection of regional lymph nodes at Eastern Hepa-
tobiliary Surgery Hospital. We carefully reviewed nodal
involvement in each patient to investigate clinicopatho-
logical variables in relation to lymph node metastasis.
Results: Forteen of 21 (67%) patients with ulcer for-
mation within the lesion was seen in positive lymph
node metastasis group versus 30 of 73 (41%) in nega-
tive group. No nodal involvement was found in
patients with I layer duodenal invision, or II layer duo-
denal invision. The nodal metastasis rate was 17% (4
of 24) in III layer invision, 50% (10 of 20) in IV layer,
and 68% (30 of 44) in V layer, respectively. The overall
diagnostic accuracy rate in tumor duodenal infiltration:
98% (92 of 94) with intraductal ultrasonography
(IDUS) versus 78% (73 of 94) with endoscopic ultraso-
nography (EUS). Univariate analyses reavealed that the
gross appearance (p = 0.038), duodenal infiltration
(p = 0.000), and pT stage (p = 0.013) were significantly
associated with lymph node metastasis. Subsequently,
multivariate logistic analysis revealed that the strongest
risk factor was duodenal infiltration (p = 0.000), fol-
lowed by gross appearance (= 0.033).
Conclusions: Duodenal infiltration is the most sensitive
indicator of lymph node metastasis in CPV. Preoperative
diagnosis of duodenal infiltration depth conducted by
IDUS can be used to predict lymph node metastasis.
638
FLUFENAMIC ACID REGULATES
ANGIOGENESIS
Rui-Liang Ge1, Lei Hu1, Yi Wang1, Feng Xue1, Yi-Lin
Tai2, Gong-Tian Wei1 and Feng Shen1
1Division of Hepatic Surgery, Eastern Hepatobiliary
Hospital, Second Military Medical University, Shanghai,
China; 2Laboratory of Neural Signal Transduction,
State Key Laboratory of Neuroscience, Institute of
Neuroscience, Shanghai Institutes of Biological Sciences
Shanghai, China
Angiogenesis plays critical roles in development, tumor
growth and metastasis. Flufenamic acid (FFA) is an
anti-inflammatory agent known to alter ion fluxes
across plasma membrane. Its role in angiogenesis has
not been fully addressed yet. Here, we report that FFA
regulates angiogenesis both in vitro and in vivo. Apply-
ing FFA to human umbilical vein cells (HUVECs) for
72 hours attenuates HUVECs growth. The reduction of
cell number is due to disturbance of cell proliferation,
as BrdU incorporation rate is lower in the FFA treat-
ment group than in the control group. However, FFA
promotes tube formation of HUVECs instead of inhi-
bits, not like its role on proliferation. At last, in the
chick embryo chorioallantoic membrane (CAM) assay,
FFA promotes the formation of macroscopic blood
vessels. These results suggest that FFA regulates angio-
genesis at two levels, inhibition of proliferation and
promotion of tube formation.
639
COMBINATION THERAPY OF
MULTIPLE MICRO TRAUMA
TECHNOLOGY ON HEPATOCELLULAR
CARCINOMA
Xin-Feng Li, Guo-Rong Lu, De-Xin Liu, Gao-Xiong
Wang, Shi-Lin Li and Wei Zhuang
Second Affiliated Hospital of Fujian Medical University
Fujian Quanzhow, China
Aims: To compare efficacy of therapy scheme as
Transhepatic Artery Chemoembolization (TACE) +
Radiofrequency Ablation (RFA) + Introportal Vein
Chemotherapy (PVC) + Percutaneous Ethanol Injec-
tion (PEI) therapy (quadruplet group) with TACE +
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RFA combinational therapy (diad group) in treating
hepatocellular carcinoma (HCC).
Methods: From Oct 2005 to Aug 2010,25 cases in
quadruplet group were treated by TACE for 3 weeks,
then by RFA, after 2 months, by PVC + PEI; 23 cases
in diad group were treated by TACE for 3 weeks and
then by PEI. After completion of each treatment course
in both groups, Alphafetoprotein (AFP) was tested 2
months later, abdomen colorful doppler, CT and AFP
were retested 6 months later.
Results: AFP was significantly decreased in 23 cases of
quadruplet group and 20 cases of diad group among
those with AFP positive results. 6 months later, exami-
nations of CT, colorful Doppler and AFP in two
groups showed: quadruplet group has significantly
decreased (X2=6.81, P <0.01) blood supply of cancer
tissue and significantly diminished (X2=8.29, P <0.01)
tumor size, few cases with AFP elevation (X2=5.06, P
<0.05); lower 1 year relapse rate and two years mortal-
ity than that in diad group (X2=5.30, P<0.05).
Conclusion: TACE+RFA+PVC+PEI combinational
therapy is a safe double intervention treatment for
HCC scheme with less side effects, which is better than
TACE+PEI scheme in killing remnant tumor and
reducing relapse.
644
TO IDENTIFY SERUM BIOMARKERS
FROM NMR-BASED METABONOMIC
DATA IN PATIENTS WITH
HEPATOCELLULAR CARCINOMA
Yue Liu1, Guang-Guo Tan1, Liang Zhao2, Zhen-Yu
Zhua1, Zhan-Ying Hong1, Zi-Yang Lou3 and
Guo-Qing Zhang2
1School of Pharmacy, Second Military Medical
University; 2Department of Pharmacy, Eastern
Hepatobiliary Surgery Hospital; 3Shanghai Key
Laboratory for Pharmaceutical Metabolite Research,
Shanghai, China
Background and aims: Hepatocellular carcinoma
(HCC) is one of the most common malignant tumors
in the world. However, current biomarkers for the
diagnosis of HCC cannot meet the need of accuracy
and sensitivity. More reliable biomarkers for HCC
diagnosis are therefore needed.
Methods: Serum from 60 HCC patients and 54 healthy
controls were analyzed using a proton nuclear magnetic
resonance (1H-NMR)-based approach in conjunction
with random forest (RF) analysis to discriminate their
serum metabolic profiles.
Results: 11 potential biomarkers have been identified,
and the feasibility of using these biomarkers for the
diagnosis of HCC was evaluated, where 100% sensitiv-
ity was achieved in detecting HCC patients even with
AFP values lower than 20 ng/mL. The alterations in
these metabolites were associated with perturbations in
lipolysis, Krebs cycle, amino acid catabolism and pur-
ine metabolism in HCC patients.
Conclusions: Our results suggested that these potential
biomarkers identified appear to have diagnostic and/or
prognostic values for HCC, which deserve to be fur-
ther investigated. In addition, it also suggested that
random forest is a classification algorithm well suited
for selection of biologically relevant features in metab-
onomics.
654
EVALUATING IN COMBINATION OF
MODIFIED PERICARDIAL
DEVASCULARIZATION WITH
SPLENORENAL SHUNT FOR PORTAL
HYPERTENSION WITH UPPER
DIGESTIVE TRACT HEMORRHAGE
Xin-Feng Li, Gao-Xiong Wang, Tian-Cong Huang,
Cheng-Zhong Li, Chao-Ping Ye, Chen Ji and
Ling-Yuan Chen
Department of Hepatobilliary Surgery, The Affiliated
Second Hospital, Fujian Medical University, Fujian
Quanzhow, China
Aims: To study the effect of modified pericardial dev-
ascularization (MPCDV) combined with splenorenal
shunt (SRS) for portal hypertension with upper diges-
tive tract hemorrage.
Methods: From September 2005 to May 2010, the clin-
ical and follow-up data of 46 cases with portal hyper-
tension with upper digestive tract hemorrage were
collected. The survival analysis was conducted between
MPCDV+SRS group (n = 24) and MPCDV group
(n = 22) divided by treatment.
Results: There was no difference in baseline clinical
data between the two groups. After treatment, the FPP
in MPCDV+SRS group (37.1  9.7) cm H2O was
higher than in MPCDV group (30.1  8.9) cm H2O
(p < 0.01)). The positive rates of portal hypertensive
gastropathy (PHG), upper digestive hemorrhage and
portal embolism in MPCDV+SRS group were signifi-
cantly lower than in MPCDV group after operation
(X2 = 7.56, p < 0.01, X2 = 4.75, p < 0.01 and X2 =
6.11, p < 0.05 respectively). But there was no differ-
ence in hepatic encephalopathy between the two groups
(p > 0.05).
Conclusion: The clinical effect of combination of
MPCDV with SRS is better than only MPCDV.
655
A CASE OF PORTAL
RECONSTRUCTION USING A
PERICHOLEDOCHAL PLEXUS IN
DIFFUE PORTAL VEIN THROMBOSIS
Joo Seop Kim, Jang Yong Jeon, In-Gyu Kim, Han
Joon Kim, Beong Hoon Sohn and Young Joo Lee
Department of Surgery, Kangdong Sacred Heart
Hospital, Seoul, KOREA
Portal vein thrombosis (PVT) has not been considered
as a contraindication to liver transplantation (LT).
Momost cases of PVT were overcome with eversion
thromboendovenectomy, However, in case of failure of
thrombectomy due to diffuse PVT, other alternative
modalities should be considered such as interposition
vein graft, renoportal anastomosis (RPA), or cavopor-
tal anastomosis(CPA).
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Here, we report our successful experience of reconstruc-
tion of portal flow with collateral vein during deceased
donor LT (DDLT) for a patient who had total occlusion
of portal system. A 60-year-old man who presented with
alcoholic cirrhosis and 28 episodes of variceal bleeding
underwent DDLT. At laparotomy, no portal system vein
was found to be patent, because well organized thrombo-
ses occluded main portal vein, SMV and splenic vein.
Splenorenal shunt did not develop. Only choledochal
vein plexus was found on the ventral part of common
bile duct, even it had occlusion with partial thrombus.
After failing of eversion thromboendovenectomy of
native portal vein, we perfomed the anstomcsis of the
donor PV to patient’s choledochal vein plexus. Postoper-
ative Doppler ultrasound revealed normal blood flow of
portal vein. Patient revealed uneventful course and dis-
charged on 18th postoperative days.
In case of complete occlusion of portal vein system, it is
difficult to decide which methods can be appropriate to
restore portal perfusion. Collateral vein is not used,
because the blood flow is not sufficient and the wall is fri-
able to suture. Furthermore, the long-term results are not
known. A choledochal vein plexus was the only option in
our case. Further discussion and study is needed.
666
PROTECTIVE EFFECTS OF HYDROGEN
ENRICHED SALINE ON LIVER
ISCHEMIA REPERFUSION INJURY BY
REDUCING OXIDATIVE STRESS AND
HMGB1 RELEASE
Yan-Tao Liu, Li-Qun Yang and Wei-Feng Yu
Department of Anesthesia & Intensive Care, Eastern
Hepato biliary Surgical Hospital, the Second Military
Medical University, Shanghai, China
Backgrounds: Hydrogen treatment was recently associ-
ated with down-regulation of the expression of
HMGB1 and pro-inflammatory cytokines during sepsis
and myocardial IRI, but it is not known whether
hydrogen has an effect on HMGB1 in liver IRI. The
objective of the present study was to evaluate the anti-
inflammatory effects of hydrogen-rich saline and deter-
mine any attenuation of liver IRI and its effects on the
HMGB1 pathway.
Method: A rat model of 60 minutes 70% partial liver
ischemia reperfusion injury was used. 1% hydrogen
enriched saline (2.5, 5 or 10 ml/kg) was injected intra-
peritoneally 10 minutes before hepatic reperfusion, and
at 2, 6, 12, and 20 hours post reperfusion. Liver injury
was assessed by serum alanine aminotransferase (ALT)
enzyme levels and histological changes. We also mea-
sured mono di aldehyde (MDA), hydroxy nonenal
(HNE) and 8-hydroxy-guanosine (8-OH-G) levels as
markers of the peroxidation injury induced by reactive
oxygen species (ROS). In addition, pro-inflammatory
cytokines including TNF-a and IL-6, and high mobility
group box B1 protein (HMGB1) were measured as
markers of post ischemia-reperfusion inflammation.
Results: Hydrogen enriched saline treatment signifi-
cantly attenuated the severity of liver injury induced by
ischemia-reperfusion. The treatment group showed
reduced serum ALT activity and markers of lipid per-
oxidation and post ischemia reperfusion histological
changes were reduced. Hydrogen enriched saline treat-
ment inhibited HMGB1 expression and release, reflect-
ing a reduced local and systemic inflammatory response
to hepatic ischemia reperfusion.
Conclusions: These results suggest that, in our model,
hydrogen enriched saline treatment is protective against
liver ischemia-reperfusion injury. This effect may be
mediated by both the anti-oxidative and anti-inflamma-
tory effects of the solution.
668
A RETROSPECTIVE STUDY OF
GENERAL ANESTHESIA COMBINED
WITH EPIDURAL BLOCK USED IN 3858
PATIENTS UNDERWENT
HEPATECTOMY
Li-Qun Yang, Yu-Ming Sun and Wei-Feng Yu
Department of Anesthesia & Intensive Care Eastern
Hepatobiliary Surgical Hospital the Second Military
Medical University Shanghai, China
Backgrounds: Most of patient undergoing hepatic sur-
gery have a long-term cirrhosis history and combined
with pathophysiologic disorders, a better understanding
of anesthetic character about hepatic surgery is perhaps
important and beneficial. The objective of this study is
to investigate the merit and defect of general anesthesia
combined with epidural block used in patients undergo-
ing hepatectomy.
Methods: The Patients were admitted from 1999 to
2004 in Eastern Hepatobiliary Surgery Hospital in
Shanghai, China, and all patients were performed he-
pactotomy, totally 4058 patients’ anethestic records and
postoperative data were analyzed, including patients
underwent general combined with epidural (CGEA,
n = 3858), general anesthesia group (G, n = 100) and
epidural block group (E, n = 100). The intraoperative
stability of vital signs, needs of intravenous anesthetics/
analgesics, muscle relaxants and cardiovascular drugs
were compared. During the postoperative awake phase,
the extubation time, pain relief time and awake related
complications in 3 groups were also be compared.
Results: General anesthesia combined with epidural
block group influenced patient’s heart rate and blood
pressure, but using low dose of cardiovascular activator
(ephedrine) can rectify this effect greatly. CGEA can
markedly reduce needs of atracurium, fentanyl and
inhaled anesthetics. In a weak phase, General anesthesia
combined with epidural block group can awake and ex
tube earlier with lower dysphoria, uroschesis and main-
tains longer-term pain relief than that of other groups.
Conclusion: General anesthesia combined with epidural
block was safe and reasonable for hepatectomy com-
pared with general or epidural anesthesia. The side
effects of the technique were hypotension bradycardia
and to light general anesthesia, which can result in
awareness during surgery, and also, the use of CGEA
in hepatic surgery is increasing because of the favorable
recovery characteristics that facilitate early hospital
discharge
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669
SPLENECTOMY COMBINED
ESOPHAGEAL-GASTRIC
DEVASCULARIZATION AFFECTS
INOSMRNA-EXPRESSING IN PORTAL
HYPERTENSION RAT LIVER CANCER
Ning Yang, Yong Fu, Hai-Bin Zhang, Si-Ma Hui, Nan
Zhu and Guang-Shun Yang
Eastern Hepatobiliary Surgery Hospital, 225 Shanghai
Rd, Shanghai, 200438 China
Background and aims: To investigate the effect of sple-
nectomy combined esophageal-gastric devascularization
on inducible nitric oxide synthase mRNA (iNO-
SmRNA)’s expression in rat liver cancer
Methods: Thirty prehepatic hypertension Sprague-
Dawley rats were randomly divided into three groups:
group A (prehepatic portal hypertension rats with sple-
nectomy combined esophageal-gastric devascularization
with implanted tumor tissue), group B (prehepatic por-
tal hypertension rats with implanted tumor tissue) and
group C (prehepatic portal hypertension rats; control
group). Immunohistochemical staining was used to
detect the expression of iNOSmRNA, and the micro-
vessel density (MVD) was measured by counting
CD34-positive vascular endothelial cells.
Results: The tumor tissue expression levels of iNO-
SmRNA in group A and group B were higher than those
in group C (LSD-t test; iNOSmRNA=2.32  0.24,
2.98  0.28 and 1.06  0.18, respectively; P < 0.05).
The MVD in group A was lower than that in Group B
(18.76  1.21 vs. 19.98  1.28, P < 0.05). Group C was
a negative control. In addition, we also found a positive
correlation between the expression of iNOS mRNA and
the MVD in tumor tissue.
Conclusions: iNOSmRNA and the MVD’s expressions
are involved in the advancement of rat liver cancer.
Splenectomy combined esophageal-gastric devascular-
ization could reduce iNOS mRNA’s expression in rat
liver cancer.
672
PLANNED HEPATECTOMY IN HILAR
CHOLANGIOCARCINOMA:
EXPERIENCE OF PROF. JIANG
XIAOQING’S TEAM DURING 5 YEARS
Xiao-Qing Jiang, Bin Yi, Xiang-Ji Luo, Chen Liu,
Zeng-Qiang Qu, Qing-Bao Cheng and Meng-Chao Wu
Biliary Surgery Department I, Eastern Hepatobiliary
Surgery Hospital, Second Military Medical University
Shanghai, China
Background and aims: Planned hepatectomy (PH) for
hilar cholangiocarcinoma (HCCA) is the standard pro-
tocol in our department in recent years. Percutaneous
trans hepatic biliary drainage (PTBD) and portal vein
embolization (PVE) increasing the volume of the future
liver remnant (FLR) and thereby decreasing the risk of
postoperative liver failure was carried out. We conduct
this study to summarize the experience in surgical treat-
ment of HCCA during the past 5 years.
Methods: Between Jan 2007 and Jan 2012,146 consecu-
tive patients with hilar cholangiocarcinoma who were
scheduled to receive major hepatectomy were involved
in this study. All PVEs were performed in patients with
an estimated FLR of <50%. Hepatic volume and func-
tional changes after PVE were analysed, and operative
outcomes were compared between patients with or
without PVE.
Results: PTBD was performed in 113 patients PVE pro-
cedures in 47 patients. There were three cases of acute
cholangitis following pre-operative PTC catheter drain-
age. There was no mortality following PTCD. PVE-
related complications occurred in 6 patients (12.8%)
and did not preclude hepatectomy, which included bile
leakage (n = 1) and coil displacement (n = 6) inducing
one death. Two weeks after PVE, the FLR to total liver
volume ratio increased statistically (40.7  7.2% vs.
44.8  6.9%; p < 0.001), and the mean increase in FLR
was 4.9  3.4 cm3/day. In the PVE group, 43 patients
(91.5%) underwent radical surgery, and the rest were
precluded because of insufficient hypertrophy of FLR
and tumor dissemination. The PVE group had similar
operative mortality and morbidity compared to the non-
PVE group. The 1- and 2-year survival for PVE group
(radical surgery only) and non-PVE group was 72.5%
and 54.2%; 70.7% and 53.7%, respectively. There was
no significant difference in survival.
Conclusions: PH is a safe and efficacious procedure,
and offers potential benefit for patients with HCCA.
675
HEPATIC EPITHELIOID
HEMANGIOENDOTHELIOMA IN OUR
HOSPITAL: A CLINICAL FEATURES
AND IMAGING FINDINGS STUDY OF 15
CASES
Fan Fei
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, 200433 China
Objective: To study the clinical features, imaging find-
ings and prognosis of hepatic epithelioid hemangio
endo thelioma (HEHE) in Eastern Hepatobiliary Surgi-
cal Hospital, and to improve the level of recognition
and preoperative diagnosis of HEHE.
Methods: Clinical data of 15 pathology-confirmed
HEHE patients, admitted in our hospital from 1999 to
2010 were collected and analyzed retrospectively.
Results: Besides 7 cases of abdominal discomfort, this
cohort of HEHE patients does not show common typical
manifestations. Laboratory examinations found 8 low
ALB/GLB (A/G) cases, 3 mild anemia cases, and 1 high
alanine aminotransferase (ALT) case, but no abnormal
AFP, CEA or CA19-9 cases. Plain computed tomogra-
phy (CT) scanning found uneven multiple low-density
lesions in most cases, and dynamic enhanced CT scan-
ning demonstrated peripheral enhancement in hepatic
arterial (HA) phase and more peripheral enhancement in
portal vein (PV) phase, and ring enhancement were
detected in delayed phase. Magnetic resonance imaging
(MRI) demonstrated low signal intensity and even lower
lesion centers in T1-weighted images (T1WI), but slightly
high signal intensity lesions and higher lesion centers in
© 2013 The Authors
HPB © 2013 Americas Hepato-Pancreato-Biliary Association HPB 2013, 15 (Suppl. 2), 85–244
144 CONCURRENT SESSIONS POSTER
T2-weighted images (T2WI). Enhanced MRI scanning
showed ring enhancements but no obvious enhanced
centers. Lesions were further enhanced in delayed MRI
scanning. Prognosis of this cohort: ten of these 15
patients alive nowadays including four cases alive with
the tumor.
Conclusions: Comprehending the radiological charac-
teristics of HEHE facilitates the level of recognition
and preoperative diagnosis of this disease and avoids
inappropriate surgeries.
676
COMBINATION THERAPY OF
MULTIPLE MICRO TRAUMA
TECHNOLOGY ON HEPATOCELLULAR
CARCINOMA
Xin-Feng Li, Guo-Rong Lu, De-Xin Liu, Gao-Xiong
Wang, Shi-Lin Li and Wei Zhuang
Second Affiliated Hospital of Fujian Medical University,
34 Zhongshan North Rd, Quanzhou City, 362000 Fujian
Quanzhow, China
Due to the unique biological activity of hepatocellular
carcinoma (HCC), single intervention therapy has poor
efficacy. TACE+PEI combinational therapy has achieved
certain effect in improving quality of life and prolonging
life span, however, the incomplete treatment is still the
most important cause for relapse. From Oct 2005 to Aug
2010, the author has chosen Trans hepatic Artery
Chemoembolization (TACE) +Radiofrequency Ablation
(RFA) + Introportal Vein Chemotherapy (PVC) + Percu-
taneous Ethanol Injection (PEIT) combinational method
to treat 25 HCC patients and compared its efficacy with
TACE + PEI method in 23 HCC patients.
Aims: To compare efficacy of therapy scheme as
TACE + RFA +PVC + PEI therapy (quadruplet group)
with TACE + RFA combinational therapy (diad group)
in treating HCC.
Methods: 48 cases with HCC (35 males, 13 females),
within the age range from 27 to 65 years old, with the
mean age at 38.1 years; Cases in both groups were con-
firmed by pathology diagnosis with Doppler guided
puncture; tumor size was between 4.0 cm
9 3.8 cm 9 3.5 cm and 10.1 cm 9 9.1 cm 9 8.7 cm;
40 cases with single nodes, 8 cases with 2~3 nodes,
Alphafetoprotein (AFP) positive in 23 cases in quadru-
plet group and 20 cases in diad group 25 cases in quadru-
plet group were treated by TACE for 3 weeks, then by
RFA, after 2 months, by PVC + PEI; 23 cases in diad
group were treated by TACE for 3 weeks and then by
PEI. After completion of each treatment course in both
groups, AFP was tested 2 months later, abdomen color-
ful doppler, CT and AFP were retested 6 months later.
Results: Patients in both groups were followed up for
2 years. AFP was significantly decreased in 23 cases of
quadruplet group and 20 cases of diad group among
those with AFP positive results. 6 months later, exam-
inations of CT, colorful Doppler and AFP in two
groups showed: quadruplet group has significantly
decreased (X2 = 6.81, p < 0.01) blood supply of cancer
tissue and significantly diminished (X2 = 8.29, p < 0.01)
tumor size, few cases with AFP elevation (X2 = 5.06,
p < 0.05); Fever and transient abdomen were common;
1 case with hemobilia in diad group, 2 cases in quadru-
plet group and 3 cases in diad group had arrest of bone
marrow and recovered after treatment. lower 1 year
relapse rate and two years mortality than that in diad
group (X2 = 5.30, p < 0.05).
Conclusion: TACE+RFA+PVC+PEI combinational
therapy is a safe double intervention treatment for
HCC scheme with less side effects, which is better than
TACE+PEI scheme in killing remnant tumor and
reducing relapse.
677
SIGNIFICANCE OF THE EXPRESSION
OF ENDOSTATIN % CD105 AND KI-67
Xin-Feng Li, Wei Zhuang and Gao-Xiong Wang
Department of Hepatobiliary Surgery, the Second
Affiliated Hospital of Fujian Medical University,
Quanzhou 362000, China, 34 Zhongshan North Road,
Quanzhou, 362000 Fujian Quanzhow, China
Aims: To investigate significance of the expression of
endostatin % endoglin (CD105) and Ki-67 in surgical
specimens of hepatocellular carcinoma (HCC).
Methods: The clinical pathological records of 46 HCC
patients who underwent hepatectomy were retrospec-
tively reviewed. Immunohistochemical staining for
endostatin % CD105 and Ki-67 was performed individ-
ually to each section according to non-biotin two-step
method, so were HE staining and blank control. Slides
were photographed after staining and pictures were
analyzed with computer-aided photochromic picture
analysis system. The relationship among the expression
with the postoperative recurrence of HCC as well as
CD-105-labeled microvessel density (MVD) and Ki-67
proliferation index were determined.
Results: The expression of Endostatin was mainly in
HCC,and was lower in HCC tissue than in its adjacent
tissue. It shows significant difference of MD and IOD in
HCC tissue compared with the adjacent tissue (p
< 0.05, p < 0.01).When compared with normal hepa-
tic tissues, the MD difference was un significant
(p = 0.471), and the IOD difference was significant
(p < 0.05).The expression of Endostatin was positively
correlated with the time for the postoperative recurrence
of PLC(r = 0.669, Py<0.01).However, it was negatively
correlated with MVD and Ki-67 index(r = -0.312, p <
0.05; r = -0.330, p<0.05). CD105 was mainly expressed
in HCC capillary vessels and its adjacent hepatic blood
sinusoids. The CD105-labeled microvessel density
(MVD) was negatively correlated with the time for the
postoperative recurrence of HCC (r = -0.458,
p < 0.05), and was positively correlated with Ki-67
index (r = -0.813, p < 0.01).Ki-67 was mainly expressed
in hepatic nuclei of HCC tissues, while almost none in
its adjacent tissue and nonmalignant tissues. The differ-
ence was significant (P < 0.01).The Ki-67 index was
negatively correlated with the time for the postoperative
recurrence of HCC (r = -0.408, p<0.05), and was posi-
tively correlated with MVD (r = -0.813, p < 0.01).
Conclusions: The expression of endostatin was mainly
in HCC, and was lower in HCC tissue than in its adja-
cent tissue. It was closely correlated with blood vessel
hyperplasia and cellular proliferation, and was contrib-
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uted to the prognosis of HCC .CD105 was mainly
expressed in microvessel endothelial cells, it was a
favorable capillary marker in HCC, which correlated
with the postoperative recurrence of HCC and Ki-67
index. Ki-67 was mainly expressed in hepatic nuclei of
HCC tissues, which reflect tumor cellular proliferation
well, and correlated with the vascular hyperplasia and
prognosis of HCC. The expression of Endostatin %
CD105 and Ki-67 protein may be used as the useful
predictor of prognosis in patients with HCC.
680
HEPATITIS B REACTIVATION AFTER
RFA OR HEPATIC RESECTION FOR
SMALL HCC: A RETROSPECTIVE
STUDY
Jia-Qiang Dan1,2, Yao-Jun Zhang1,2, Jun-Ting
Huang1,2, Min-Shan Chen1,2 and Zhen-Wei Peng1,2
1Department of Hepatobiliary Surgery, Sun Yat-sen
University Cancer Center, 651 Dongfeng Road East,
Guangzhou 510060, China; 2State Key Laboratory of
Oncology in South China, Sun Yat-sen University
Cancer Center, Guangzhou 510060, China
Background and Purpose: Reactivation of hepatitis B
virus (HBV) happens after systemic chemotherapy,
trans arterial chemo embolization (TACE) or hepatic
resection carried out for HBV-related hepatocellular
carcinoma (HCC). The incidence and risk factors of
HBV reactivation after radiofrequency ablation (RFA)
are unclear.
Patients and Methods: From August 2006 to August
2011, 218 consecutive patients with HBV-related small
HCC treated with RFA (n = 125) or hepatic resection
(n = 93) were retrospectively studied. The incidence of
HBV reactivation and risk factors were analyzed.
Results: HBV reactivation developed in 20 (9.2%)
patients after treatment. The incidence of HBV reacti-
vation was significant lower in the RFA group (5.6%,
7/125) than the hepatic resection group (14.0%, 13/93,
p = 0.034). On univariate and multivariate analyses, no
antiviral therapy (OR 11.7; 95% CI 1.52–90.8,
p = 0.018) and treatment with RFA/hepatic resection
(OR 3.36; 95% CI 1.26 – 8.97, p = 0.016) were signifi-
cant risk factors of HBV reactivation. On subgroup
analyses, the incidence of HBV reactivation was lower
in patients who received antiviral therapy than those
did not receive antiviral therapy in both the liver resec-
tion group (2.9% vs. 20.7%, p = 0.027) and the RFA
group (0% vs. 7.6%, p = 0.188), although the differ-
ence was not significant in the latter group.
Conclusion: The incidence of HBV reactivation after
RFA was relatively low when compared with hepatic
resection. Prophylactic antiviral therapy is recom-
mended, especially to patients who are going to receive
hepatic resection for HBV-related HCC to decrease the
incidence of post-treatment HBV reactivation.
681
A MODIFIED TNM-7 STAGING SYSTEM
TO BETTER PREDICT THE SURVIVAL
IN PATIENTS WITH
HEPATOCELLULAR CARCINOMA
AFTER HEPATECTOMY
Jun-Ting Huang1,2, Yao-Jun Zhang1,2, Zhen-Wei
Peng1,2, Heng-Jun Gao1,2, Min-Shan Chen and
Long R. Jiao
1Department of Hepatobiliary Surgery, Sun Yat-sen
University Cancer Center, 651 Dongfeng Road East,
Guangzhou 510060, China; 2State Key Laboratory of
Oncology in South China, Sun Yat-sen University
Cancer Center, Guangzhou 510060, China; 3Department
of Surgery and Cancer, Imperial College, Hammersmith
Hospital Campus, Du Cane Road, London, United
Kingdom, W12 0HS
Purpose: To evaluate the accuracy of the 7th edition of
the American Joint Committee on Cancer staging sys-
tem (TNM-7) for patients undergoing hepatectomy for
hepatocellular carcinoma (HCC) and to propose a
modified TNM system for prediction of survival.
Patients and Methods: Clinico-pathological data for
1313 patients who underwent hepatectomy as initial
treatment for HCC between 2000–2008 were retrieved
from a prospective database. Overall survival (OS) and
disease-free survival (DFS) were analyzed to evaluate
the predictive value.
Results: The 1, 3, 5 year OS and DFS of 1313 patients
were 79.2%, 55.4%, 45.5%, and 52.6%, 36.1%, 31.8%
respectively. Multivariate analysis revealed that major
vascular invasion was the most important prognostic fac-
tor for both OS and DFS, along with tumor number and
size. Patients with stage T1 and T2 disease had signifi-
cantly better OS and DFS than those with T3 disease
(P < 0.001). For stage T3 and T4 disease, there was no
significant difference between T3a and T4 (p = 0.552)
but patients with T3b disease had a worse OS and DFS
than those with T4 disease (p = 0.006 and p < 0.001
respectively). A modified TNM system within the exist-
ing framework was proposed to combine the current T3a
and T4 together as the new T3 and to change T3b to the
new T4. Analysis showed that this modified system had a
better prognostic power than either TNM-6 or TNM-7.
Conclusion: TNM-7 would seem to be inaccurate for
staging advanced HCC. The modified system can
improve both the prognostic accuracy of the current
staging system and the hazard discrimination of disease
to be consistent among subgroups of HCC.
683
IMAGING FINDINGS OF BILIARY
HEMARTOMA WITH PATHOLOGIC
CORRELATION
Yong-Bo Yang, Yu-Fang Chen, Ning-Yang Jia, Dong
Chen, Xing-An Long and Hong-Yan Cheng
Department of Radiology, Eastern Hepatobiliary Surgery
Hospital, 225 Shanghai Rd, Shanghai, 200438 China
Purpose: To evaluate the imaging findings of biliary
hamartomas (von Meyenburg complexes, VMCs) and
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discuss the differential diagnosis with other related dis-
eases.
Methods: Imaging findings of biliary hamartomas on
ultrasonography (US), computed tomography (CT),
magnetic resonance imaging (MRI), MR cholangio
pancreatography (MRCP) and hepatobiliary scintigra-
phy were retrospectively analyzed in six patients.
Results: On ultrasound images, five of the six cases
showed multiple small hyper- and hypo-echoic lesions
with comet-tail echoes, especially when magnified by
US with the usage of zoom function. In all the six
cases, multiple tiny hypo dense lesions less than 10 mm
in diameter were revealed as scattered throughout the
liver with no enhancement on CT. These tiny lesions
were demonstrated to be hyper- and hypo-intensity on
T2- and T1-weighed images, respectively, in three
patients who underwent MRI examinations. MRCP
was performed in two patients, and clearly showed
multiple tiny irregular- and round-shaped hyper-inten-
sity lesions. MRCP and hepato biliary scintigraphy
showed normal appearances of intra- and extra-hepatic
bile ducts in two and one patients, respectively.
Conclusion: Imaging modalities are useful in the diagno-
sis and differential diagnosis of VMCs. A correct diag-
nosis might be obtained when typical imaging findings
are present even without a histological confirmation.
684
HIGH EXPRESSION OF HIGH
MOBILITY GROUP BOX 1 (HMGB1)
PREDICTS POOR PROGNOSIS FOR
HCC AFTER CURATIVE
HEPATECTOMY
Fu-Rong Liu1,2, Yao-Jun Zhang1,2, Zhen-Wei Peng1,2,
Heng-Jun Gao1,2, Li Xu1,2 and Min-Shan Chen1
1Department of Hepatobiliary Surgery, Cancer Centre of
Sun Yat-Sen University, 651 Dongfeng Road East,
Guangzhou 510060, China; 2State Key Laboratory of
Oncology in Southern China, Guangzhou 510060, China
Background: High mobility group box 1(HMGB1)
overexpression has been reported in a variety of human
cancers. However, the role of HMGB1 in hepatocellu-
lar carcinoma (HCC) remains unclear. The aim of pres-
ent study was to analyze HMGB1 protein expression in
tumor, para-tumor and normal tissue and to assess its
prognostic significance for HCC after curative hepatec-
tomy.
Methods: The level of HMGB1 mRNA and protein in
tumor, para-tumor and normal tissue was evaluated in
11 HCC cases by Reverse Transcription-polymerase
chain reaction (RT-PCR) and Western blot. Addition-
ally, HMGB1 protein expression in 161 HCC was ana-
lyzed by immunohistochemistry and correlated with
clinicopathological characteristics and survivals. Stu-
dent’s t-test, spearman’s rank correlation, Kaplan-Me-
ier plots and Cox proportional hazards regression
model were used to analyze the data.
Results: By RT-PCR and Western blot, the levels of
HMGB1 mRNA and protein were significantly higher
in HCC, compared to that in para-tumor (p < 0.001)
and normal tissue (p < 0.001). Immunohistochemical
staining revealed that high expression of HMGB1 was
detected in 42.9% (69/161) HCC cases. High expression
of HMGB1 was significantly associated with incom-
plete encapsulation (p = 0.035) and advanced TNM
stage (p = 0.036). Multivariate analysis showed that
high expression of HMGB1 was an independent prog-
nostic factor for both overall (p = 0.009, HR = 1.834,
95% CI: 1.167–2.881) and disease-free survival
(p = 0.018, HR = 1.622, 95% CI: 1.088–2.419), along
with tumor size. Subgroup analysis revealed that high
expression of HMGB1 predict poorer survival only for
tumor >5 cm (p = 0.031), but not for tumor  5 cm
(p = 0.101).
Conclusions: HMGB1 protein might contribute to the
malignant progression of HCC, high expression of
HMGB1 predicts poor prognosis for patients with
HCC after curative hepatectomy, especially for patients
with tumor > 5 cm.
685
FAMILY HISTORY OF LIVER CANCER
IS NOT ASSOCIATED WITH
PROGNOSIS FOR PATIENTS WITH
HEPATOCELLULCAR CARCINOMA
AFTER HEPATECTOMY
Yao-Jun Zhang1,2, Mei-Xian Chen1,2, Jun-Ting
Huang1,2, Jia-Qiang Dan1,2, Zhen-Wei Peng1,2 and
Min-Shan Chen1
1Department of Hepatobiliary Surgery, Sun Yat-sen
University Cancer Center, 651 Dongfeng Road East,
Guangzhou 510060, China; 2State Key Laboratory of
Oncology in South China, Sun Yat-sen University
Cancer Center, Guangzhou 510060, China
Purpose: Family history of liver cancer is a major risk
factor for hepatocellular carcinoma (HCC). In this
study, we investigated the prognoses of patients with
HCC with a family history.
Methods: Data for 1313 patients who underwent hep-
atectomy as initial treatment for HCC between 2000
and 2008 at a tertiary cancer center hospital were
retrieved from a prospective database. A positive fam-
ily history was defined as a self-reported history of
cancer in first-degree relatives. Clinicopathologic char-
acteristics were compared by family history. Kaplan-
Meier plots and Cox proportional hazards regressions
were applied for overall survival (OS) and disease-free
survival (DFS).
Results: Of 1,313 patients, 169 patients (12.9%) had
first-degree relatives with a history of liver cancer.
There were no significant differences between patients
with or without family history in basic clinicopatho-
logic characteristics. Either in whole group or each
stage according to TNM staging system, first-degree
family history was not associated with survival in all
patients or patients with HBV positive. Multivariate
analysis revealed that first-degree family history was
not a prognostic factor for either OS or DFS.
Conclusion: A first-degree family history of liver cancer
is not associated with prognosis for patients with HCC
after hepatectomy.
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686
TACE AS AN INITIAL TREATMENT
FOR BCLC B HBV-RELATED HCC:
RATIONALITY AND EFFECTIVENESS
AS VERIFIED IN A LARGE CHINESE
COHORT
Heng-Jun Gao1,2, Yao-Jun Zhang1,2 and Min-Shan
Chen1,2
1Department of Hepatobiliary Surgery, Sun Yat-sen
University Cancer Center, 651 Dongfeng Road East,
Guangzhou 510060, China; 2State Key Laboratory of
Oncology in South China, Sun Yat-sen University
Cancer Center, Guangzhou 510060, China
Background and aims: Trans arterial chemo emboliza-
tion (TACE) is recommended as a standard care for
intermediate stage hepatocellular carcinoma (HCC) in
western guidelines. This study aimed to verify the ratio-
nality and effectiveness of TACE as an initial treatment
for BCLC B stage HBV-related HCC in a large Chi-
nese cohort, as there has been little published data to
support such a sue of TACE in the East.
Methods: 1516 patients with BCLC B stage HBV-
related HCC who received TACE as an initial treat-
ments were retrospectively studied. The treatment
response after TACE was assessed by the mRECIST
criteria. The overall survival (OS) was calculated with
life-table method and compared with the Mantel-Cox
test. The prognostic factors of OS were assessed using
multivariate Cox proportional hazards regression anal-
ysis.
Results: The 1, 3, and 5-year OS were 84%, 29%,
and 19% for the whole group of patients. Multivariate
analysis revealed alpha-fetoprotein, Child-Pugh classifi-
cation, tumor size and number to be independent
prognostic factors. Using the mRECIST criteria after
the initial TACE, 328 (21.6%) patients achieved com-
plete response (CR), 589 (38.9%) partial response
(PR), 398 (26.3%) stable disease (SD) and 201
(13.2%) progressive disease (PD). The 5-year OS for
patients with CR, PR, SD and PD were 39%, 19%,
2%, and 0%, respectively (p < 0.0001). Child-Pugh A
liver function (p = 0.002) and smaller tumor
(p < 0.0001) were significantly associated with CR/PR
response. After the initial TACE, the 5-year OS for
patients who received various follow-up treatments
with surgical resection, local ablation, repeated TACE
and other therapies were 52%, 29%, 12%, 10%,
respectively (p < 0.0001).
Conclusion: TACE is a safe and efficacious treatment
for BCLC B stage HBV-related HCC. A low AFP
level, small tumor, few tumor number and good liver
function predicted good survival. Tumor response after
initial TACE, an independent prognostic factor of
overall survival, was associated with tumor extent and
influenced subsequent treatment.
687
ISOLATION TECHNIQUE IN
ABDOMINAL SURGERY-A PRACTICAL
TECHNIQUE
Da-Long Yin, Zhao-Yang Lu, Ying-Jian Liang,
Hong-Chi Jiang and Lian-Xin Liu
Department of General Surgery, the First Affiliated
Hospital of Harbin Medical University; Key Laboratory
of Hepatosplenic Surgery, Ministry of Education
NO23, Youzheng Street, Nangang District, Harbin,
Heilongjiang Province, 150001, P.R.China.
Intraoperative cancer cells or bacteria spreading are
the main contributors to perioperative complications.
We developed isolation technique in abdominal sur-
gery to summarize related technologies and make
them more standardized and continuously enriched
with the importance emphasized at the same time. It
is the clinical practice guided by the concept of mini-
mally invasive surgery and fast track surgery. Isola-
tion technique in abdominal surgery aimed to isolate
one or more intra-abdominal organs as well as one
part or even the entire peritoneal cavity which is a
potential for benefit to reduce the risk of intraopera-
tive or postoperative pollution and protect cancer cells
or bacteria from spreading into vessels, retroperitone-
um or peritoneal cavity. The surgical procedures of
the technique in abdominal surgery can be divided
into three areas of operations, including inside and
outside isolation technique, upper and lower isolation
technique, and anterior and posterior isolation tech-
nique. These procedures can improve the exposure of
operative field, avoid side injury and reduce the inci-
dence of postoperative complications such as abdomi-
nal infection.
688
THE ROLE OF FIBROBLAST GROWTH
FACTOR-INDUCIBLE 14 IN
HEPATOCELLULAR CARCINOMA
Nan Li1, Wen-Jun Hu1, Jie Shi1, Jie Xue1, Wei-Xing
Guo1, Yang Zhang1, Dong-Xian Guan3, Shu-Peng Liu2
and Yu-Qiang Cheng1
1Eastern Hepatobiliary Surgery Hospital, The Second
Military Medical University, Shanghai, China;
2Shanghai Hospital, The Second Military Medical
University, Shanghai, China; 3Institute of Nutrition and
Metabolism, Shanghai Institutes for Biological Sciences,
Chinese Academy of Sciences, Shanghai, China
Background: The prognostic value of the expression of
fibroblast growth factor-inducible 14 (Fn14) in hepato-
cellular carcinoma (HCC) is unknown.
Methods: Real-time PCR (RT-PCR), western blot
assays and immunohistochemistry analysis were per-
formed to detect Fn14 expression in paired liver sam-
ples between HCC and normal liver tissue.
Results: Most of the tumor tissues expressed signifi-
cantly higher levels of Fn14 compared to adjacent
nontumor tissues, with Fn14High accounting for
54.6% (142/260) of all the patients. The Pearson v2 test
indicated that Fn14 expression was closely only associ-
ated with serum Alpha Fetal Protein (AFP) (p = 0.002)
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and tumor number (p = 0.019). Univariate and multi-
variate analysis revealed that along with tumor diame-
ter and portal vein tumor thrombosis (PVTT) type,
Fn14 was an independent prognostic factor for both
OS(HR = 1.398, p = 0.008) and recurrence (HR =
1.541, p = 0.001).
Conclusions: Fn14 overexpression in HCC is strongly
correlated with poor surgical outcome, and this mole-
cule may be a candidate biomarker for prognosis as
well as a target for therapy.
691
BACK PAIN AS AN UNUSUAL
PRESENTATION OF HEPATIC
PECOMA:A CASE REPORT AND
REVIEW OF LITERATURE
Da-Long Yin, Zhi-Cheng Zhang, Lan-Tian Tian,
Hong-Chi Jiang and Lian-Xin Liu
Department of General Surgery, the First Affiliated
Hospital of Harbin Medical University; Key Laboratory
of Hepatosplenic Surgery, Ministry of Education
Heilongjiang Province, China
Background: PEComa is a very rare entity which is
formed by perivascular epithelioid cells and it is charac-
terized by dual melanocytic and myoid differentiation.
An increasing number of reports have documented PE-
Comas arising at various anatomical locations and
uterus is the most common site. Only a very few cases
of PEComa of the liver have been described worldwide
so far.
Case presentation: We herein present a patient suffer-
ing from back pain as an unusual presentation result-
ing from a hepatic tumor which could be suspected as
HCL or hepatic adenoma by preoperative imaging
scanning. A final histopathologic examination revealed
a benign epithelioid tumor with a solid growth pat-
tern, abundant vascularity, poor fat, and frequently
dilated vascular channels without signs of tuberous
sclerosis. Immunohistochemically, the tumor cells were
strongly positive for HMB-45, SMA, Melan-A, CD68
and they were negative for S-100 and LCA, respec-
tively. Because of unpredictable natural history of PE-
Comas, the patient has been closely followed up for
24 months. However, no recurrence has so far been
observed.
Conclusions: Contrast enhancement MRI or CT may
be useful to reduce the risk of preoperative misdiagno-
sis and immunohistochemical findings play a crucial
role in establishing final correct diagnosis on hepatic
PEComa. Surgical resection with an adequate margin
of healthy tissue remains the gold standard of treat-
ment. A long-term periodic follow-up is essential in all
cases presenting with hepatic PEComa.
693
INFERIOR VENA CAVA RESECTION
WITH RIGHT HEPATECTOMY IN CASE
OF CHOLANGIOCARCINOMA WITH
INFERIOR VENA CAVA INVASION.
Bunchaliew Chairat, Chanwat Rawisak and
Khuhaprema Thiravud
National Cancer Institute, 268/1 Rama VI Rd, Bangkok,
Thailand, 10400
Introduction: Involvement of inferior vena cava (IVC)
was considered a contraindication for liver resection.
Advancement of operative technique, vascular prosthe-
sis and neo-adjuvant treatment have enabled surgeons
to performed operation in cases which previously
thought to be unrespectable. We here presented a suc-
cessful resectable case of cholangiocarcinoma with IVC
invasion.
Methods: A 66 year-old female suffered from abdomi-
nal pain with prolonged fever for 1 month. Her
abdominal CT scan revealed 5X7X6 cm mass involving
segment I, VI and VII of liver with IVC invasion. Phys-
ical examination and all laboratories were reported nor-
mal.
Results: Right hepatectomy and IVC resection was per-
formed in this patient. Operation started by mirror-L
incision then right lobe of liver was mobilized. Right
portal pedicle were selective encircled for inflow con-
trol. Supra-hepatic IVC and infra-hepatic IVC were
encircled for outflow control. After right portal pedicle
and infra-hepatic IVC was clamped, right hepatectomy
with caudate lobectomy was done. At this stage, supra-
hepatic IVC was clamped for occlude blood flow from
common trunk then IVC was transected and was
replaced by 20 mm Dacron graft. Operative time was
360 minutes and blood loss was 700 ml. Pathological
report revealed a 7 cm well differentiated cholangiocar-
cinoma of segment I, VI, VII with IVC invasion. Free
all resected margin and negative all 13 lymph nodes.
Post-operative course was uneventful. Patient was dis-
charged on 12th post-operative day. Adjuvant chemo-
therapy was given and disease free survival was
12 months.
Conclusions: En bloc hepatectomy with IVC resection
is the only curative procedure for patients with liver
cancer involving IVC.
695
LAPAROSCOPIC PANCREATIC
DUODENECTOMY VIA REVERSE -
“V” APPROACH WITH FOUR PORTS:
INITIAL EXPERIENCE AND
PERI-OPERATIVE OUTCOMES
Jing-Wang Tan, Jian-Jun Leng, Fei Chen, Wen-Zhi
Zhang and Jia-Hong Dong
Institute of Hepatobiliary Surgery, Chinese PLA General
Hospital Beijing, China
Background: Laparoscopic pancreatic duodenectomy
(LPD) is one of the few remaining sacrosanct areas in
surgery and is not widely accepted to date. To simplify
this surgical procedure and improve its efficacy, we
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performed LPD via reverse –”V” approach with four
ports. The present series aimed to evaluate the feasibil-
ity, safety, and efficacy of the modified LPD.
Methods: This is a retrospective study of selected
patients who underwent laparoscopic pancreatic duo-
denectomy at our center between April 2011 and April
2012. We have described the salient features of our
technique and follow-up protocol. Patient characteris-
tics, tumor histology, operative outcomes, resection
margins, morbidity, and mortality were reviewed.
Results: The procedure could be completed laparoscop-
ically with tumor-free margins in all patients, including
patients with pancreatic ductal adenocarcinoma
(n = 6), ampullary carcinoma (n = 6), intraductal papil-
lary mucinous neoplasm (n = 2), pancreatic cystadeno-
carcinoma (n = 2), pancreatic head adenocarcinoma
(n = 3), and bile duct cancer (n = 2). The mean age of
patients was 65 years (range 42 to 75 years). Median
blood loss was 240 mL (range, 30–1000 mL), and the
mean operating time was 368 minutes (range, 258–
438 minutes). There was no perioperative mortality.
Conclusions: Laparoscopic pancreatic duodenectomy
via reverse –”V” approach can be performed with
safety and good results in properly selected patients.
Localized malignant lesions, irrespective of histopathol-
ogy, are particularly amenable to this approach. The
preliminary experience showed a promising outcome
for LPD via reverse –”V” approach.
697
THE SAFE MINIMAL RESIDUAL LIVER
VOLUME AND UTMOST PORTAL
FLOW IN A STABLE
HEPATOTECTOMY MODEL OF PIG
Jing-Wang Tan, Ai-Qun Zhang, Han-Sheng Liu,
Cong-Hui Li, Xian-Qiang Wang and Jia-Hong Dong
Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Chinese PLA medical School
Beijing, China
Background: Although the history of liver resection has
been over 100 years, it is not clear how much liver vol-
ume excised is too much? This study was aimed to eval-
uate the safe minimal residual liver volume (MRLV)
and the utmost portal vein inflow (PVF) the liver rem-
nant can sustain in a stable hepatectomy model of pig.
Methods: Bench dissection of 10 cadaveric porcine liv-
ers was performed to calculate each liver lobe volumes.
Twenty one pigs were subjected to different liver resec-
tion volumes of 77–82% (20%-R group, n = 7), 83–
87% (15%-R group, n = 7), and 88–92% (10%-R
group, n = 7) using the hilar pedicle suture technique.
The survival rate, hemodynamic change, LPS or
inflammatory response, the injury and regeneration of
the residual liver was observed after surgery.
Results: The liver remnant in 20%-R group with about
4 times baseline PVF per unit volume, subjected to mild
portal overflow injury and regenerate successfully,
whereas in the 15% R-group with about 5.6 times base-
line PVF, 3 animals were alive on postoperative day
(POD) 14; in the 10%-R group with more than 6 times
baseline PVF, subjected to severe portal overflow injury,
none survived to POD 14. The 14d-survival rates were
100%, 42.8%, and 0 respectively in 20 R-group. 15% R-
group 10%-R group, were significantly different.
Conclusions: The deaths of animals in the group with
15% of liver remnant supports the hypothesis that the
15% of liver remnant represents a critical residual liver
parenchyma in pigs, the safe MRLV should beyond
15% of total liver volume, and the utmost PVF the
liver remnant can sustain should less than 5.6 times
baseline.
700
THE CHANGING EPIDEMIOLOGY OF
RECURRENT PYOGENIC
CHOLANGITIS IN SINGAPORE
Adrian Chiow1, Koh Ye Xin1, Chok Aik Yong1, Lim
Jia Xu2, Lee Lip Seng1 and Tan Siong San
1Hepato pancreatico biliary Service, Department of
General Surgery, Shangi General Hospital, 2 Simei
Street 3, Singapore 529889; 2Yong Loo Lin School of
Medicine, National University of Singapore, 21 Lower
Kent Ridge Road, Singapore 119077
Background and aims: Environmental factors are pos-
tulated to be crucial in the pathogenesis of recurrent
pyogenic cholangitis (RPC).We have observed two dis-
tinct groups of patients presenting with RPC in our
institution. The local Singaporeans tend to present at
an older age and the foreign patients from the region
typically present at a younger age. The aim of this
study is to review these two groups of patients, to iden-
tify differences in the disease presentation, characteris-
tics and the subsequent management of these patients
and to relate these differences in the to the changing
landscape of development in Singapore.
Methods: A single-centre retrospective study was
conducted on 80 consecutive RPC patients from 1st
January 2002 to 1st October 2011. The epidemiological
data, clinical presentation, laboratory and imaging
investigations and therapeutic procedures were reviewed
from a prospectively collected department database.
Results: The mean age of onset in locals is 63.1 and
36.0 years for foreigners (p = 0.001). There is a higher
proportion of the foreigners to have lived in rural con-
ditions than the local population. (p = 0.002). Other
than vomiting, serum albumin levels and isolated
organism, the two groups presented largely similarly in
terms of clinical presentation and disease severity.
Discussion: Singapore is uniquely placed after a transi-
tion from a third to first world country. Although Sin-
gapore underwent sanitation improvements and
subsequent eradication of liver flukes, the diet of locals
remained mostly unchanged. Sanitation is thus, a much
more significant factor compared to diet change to a
more western diet. Aggressive management is also rec-
ommended to prevent future complications.
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702
PRIMARY EXTRA-GASTROINTESTINAL
STROMAL TUMOR ARISING IN THE
PANCREAS: REPORT OF A CASE.
Chhabra Deepak
Goel Gautam Dept. of Surgical Oncology, Dr. L.H.
Hiranandani Hospital (Powai), Mumbai. Maharashtra,
India
Background: Gastrointestinal stromal tumors (GIST)
are CD117 (C-Kit) positive mesenchymal neoplasms
considered to originate from the interstitial cells of Ca-
jal. GISTs usually originate in the wall of the stomach
or small intestine. Rarely, GISTs arise primarily in the
omentum, mesentery, or retroperitoneum, at which sites
they are referred to as ‘‘extra gastrointestinal stromal
tumors’’. Pancreatic GISTs are extremely rare and
there have only been eleven previous reports in the lit-
erature.
Case report: A 61-year-old male was incidentally
detected on an MDCT to have a 13 x 9.8 x 7.8 cm
tumor at the retro gastric space during an evaluation
for urinary symptoms. The tumor had a variegated
appearance with solid and necrotic components and
appeared exophytic to the stomach with involvement of
the distal body/tail of pancreas and the splenic hilum.
The splenic vessels were displaced and draped around
the mass. A provisional diagnosis of a gastric GIST
was considered. An OGD scopy showed a diffuse bulge
without any mucosal involvement of stomach. A CT
guided biopsy revealed a stromal tumor. Intra-opera-
tively the tumor was distinctly separate from the stom-
ach but involved the short gastric vessels. It was
inseparable from the body and tail of pancreas. The
patient underwent distal pancreatectomy with splenec-
tomy and a wedge resection of the fundus of stomach.
Histology showed a mixed spindle cell tumor composed
of fascicles of spindle cells amidst loose hyalinoses
stroma with focal calcification. The mitotic count was
02 mitoses per 50 high-power fields. The tumor cells
expressed CD34, C-Kit (weak) and DOG-1 and were
immuno negative for S-100 protein and Desmin. The
sections of the stomach were unremarkable. Based on
these findings, the final pathologic diagnosis was a
GIST of the pancreas.
Conclusion: This case consolidates the possibility that
GIST can involve the pancreas as a primary site.
705
THE INFLUENCE OF EXTERNAL
BILIARY DRAINAGE AND BILE
REINFUSION IN VIVO IN
OBSTRUCTIVE JAUNDICE RATS
Bin Li, Chen Liu, Pei-Ning Yan, Yong Yu and
Xiao-Qing Jiang
Biliary tract surgery Department I, Eastern Hepatic
Biliary Hospital, 225 Shanghai Rd, Shanghai, 200438
China
Background and aims: To study rat liver function,
hepatic energy metabolism, regeneration and apoptosis
on the obstructive jaundice condition before/after
external biliary drainage and bile reinfusion in vivo
combined with hepatectomy.
Methods: 126 male SD rats were in research. 6 male
SD rats were established as sham operation group and
120 male SD rats which underwent common bile duct
ligation for 7 days were randomized into four groups:
external biliary drainage 7 days group, external biliary
drainage 7 days and bile reinfusion in vivo 7 days
group, external biliary drainage 7 days and then reop-
eration with 70% hepatectomy group, external biliary
drainage and bile reinfusion in vivo 7 days before reop-
eration with 70% hepatectomy group. Levels of TB,
ALT, ALB and ALP in serum; HGF, bcl-2 mRNA
and protein; ATP, ADP and AMP in hepatic tissues;
hepatocyte proliferation/ apoptosis index were dynamic
observed after operation (24 h, 72 h and 7d) respec-
tively. Mortality was calculated.
Results: Rats without obstructive jaundice and external
biliary drainage and then infusion of bile in vivo com-
bined with/without hepatectomy groups all would have
an excellent liver regeneration. Compared with it, the
liver function hepatocyte energy metabolism, condition
of HGF、bcl-2 mRNA content of liver tissue and the
hepatocyte proliferation /apoptosis index in external
biliary drainage combined with 70% hepatectomy
group were greatly influenced while recovered slowly
(p < 0.05).
Conclusions: Under the condition of conspicuous
bilirubinemia, the influence of external biliary drainage
combined with hepatectomy on liver hepatocyte energy
metabolism, liver function, hepatocyte regeneration and
apoptosis is severer than that of rats operated external
biliary drainage and then infusion of bile in vivo before
hepatectomy, while also did the rats recovered slowly
in conspicuous bilirubinemia groups. The database sug-
gested that it was more beneficial to operate preopera-
tive external biliary drainage and bile reinfusion in vivo
when performing hepatic resection.
706
INFLOW OCCLUSION DURING LIVER
RESECTION
M. E. Pisetskaya, D. I. Skoryi, A. M. Tyshchenko and
I. V. Volchenko
GI “Institute of General and Urgent Surgery of AMS of
Ukraine”, Kharkov
Background: Significant hemorrhage together with
blood transfusion increases postoperative morbidity
and mortality of hepatic resection. Various methods of
liver transection and vascular occlusion may be used to
minimizing bleeding during hepatic resection. However
intermittent inflow occlusion could also result in hepa-
tic ischemic- reperfusion (I/R) injury, especially in case
of cirrhosis
Objective: Comparative assessment of clinical efficacy
and manifestations of I/R injury during liver resections
with inflow vascular exclusion and without it.
Methods: In 2011 we have carried randomized trial of
the comparative assessing five methods of liver transac-
tion. The analysis showed that the main disadvantage
of the policy clamp crushing (control group, n = 17) is
a large blood loss during dissection.
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In this connection, all patients which has been applied
the technique from 2011 (study group, n = 43), was
used the technique of intermittent hepatic inflow vascu-
lar occlusion (Pringle maneuver).
During every operation we adhere to certain condi-
tions. Anatomic resection performed by standard meth-
ods with preliminary selective devascularization. All
resections were performed with the principles of small-
volume fluid therapy in low numbers CVP (0–50 mm.
H2O). Preoperative examination, technique of surgery,
postoperative therapy did not differ between groups.
For optimal mode clamping was chosen technique
developed by Japanese surgeons: ischemic precondition-
ing for 10 minutes, reperfusion - 5 minutes, the dura-
tion of follow clamping – 15 min.
To determine the expression of the IRS, we performed
a comparative analysis of the level of cytolytic enzymes
before surgery, 1 and 3 day study groups.
Results: Key performance indicators of clamp crushing
technique with and without vascular exclusion of the
liver is shown in Table. 1 and 2.
Conclusions: Thus, the technology the intermittent
clamping had no statistically significant increase in
traumatic dissection method, but significantly reduces
the estimated blood loss on its stage. This increases the
number of patients who do not need an erythrocytic
mass transfusion.
This fact will recommend a method of dissection clamp
crushing together with Pringle maneuver, as an alterna-
tive, and the most technically simple method of modern
methods of liver dissection. However, when the margin
hepatectomies preference is given to the jet or ultra-
sonic methods of dissection without vascular exclusion
that has a minimal injury and preserves maximum
amount of the remaining liver parenchyma.
714
SPONTANEOUS RUPTURE OF
PRIMARY SPLENIC ANGIOSARCOMA:
A CASE REPORT AND LITERATURE
REVIEW
Yun-Fei Duan, Yong Jiang, Chuan-Xing Wu, Gang
She, Dong-Lin Sun and Feng Zhu
Department of Hepatobiliary Surgery, The Third
Affiliated Hospital of Soochow University, Changzhou,
China
Background: Primary angiosarcoma of the spleen is a
rare mesenchymal malignant tumor of vascular origin
often with a very poor prognosis, due to its high meta-
static potential. This disease often presents with a trau-
matic rupture and lethal hemorrhage.
Methods: We report a case of a 65-year-old man who
presented with abdominal pain, anemia, thrombocyto-
penia, and palpable abdominal mass with unstable
blood pressure. After an extensive review of the litera-
ture, we found that less than 200 cases had been
reported since 1879 when Langhans described the first
case of spleen angiosarcoma.
Results: Laparotomy revealed a huge (weight 1650 g,
diameter 19 cm) actively bleeding spleen, so splenec-
tomy was performed. Some liver metastasis foci were
also found during the procedure. Histopathology
diagnosis of the removed spleen was primary splenic
angiosarcoma. The patient was discharged on the tenth
day post operation with no complication.
Conclusion: Splenic angiosarcoma, although rare, must
be considered as one of the differential diagnoses in
patients with spleen parenchymal lesions. Definitive
diagnosis requires laparotomy followed by splenectomy.
Since in the majority patients with spleen angiosarco-
ma, metastatic diseases have already occurred at the
time of laparotomy, the surgical approach of splenec-
tomy is an approach more for diagnosis rather than
treatment purpose.
715
LAPAROSCOPIC HEPATECTOMY AS
THE PREFERRED TREATMENT OF
PRIMARY HEPATIC CARCINOMA
Rong Liu, Ming-Gen Hu, Guo-Dong Zhao and
Zhi-Qiang Huang
Department of Surgical Oncology (HBP), The PLA
General Hospital, Beijing 100853 China
Background and aims;: With the improvement of the
laparoscopic equipment and technique, laparoscopic
hepatectomy (LH) has proven to be a safe minimal
invasive surgery for primary hepatic carcinoma (PHC).
But the typical clinical process of the procedure is still
noncommittal. This study include a serial of 95 cases of
LH for PHC to present the essential characteristics of
the procedure.
Methods: From June 2002 to Dec 2008, % 95 consecu-
tive cases of primary hepatic carcinoma, % included 63
males and 32 Females,with a mean age of 48.7(28-71)
age,underwent LH in our department. All of the opera-
tions were performed by the same surgical team.
Results: Laparoscopic hepatectomies succeeded in 91
cases and the other 4 cases were converted to open
resections included 44 anatomic and 47 un anatomic
hepatectomies. The operative time was 216  87(range:
75–310)minutes. The median intraoperative blood loss
was 250(range: 50–1500) ml. The postoperative hospital
stay was 6.1  1.9 days(range: 3–18). Biliary fistula
occurred in 6 cases and ascites in 9 cases postopera-
tively,which were cured for several days. By 6–
83 months of follow up,recurrence in liver occurred in
9 cases. There was no peritoneum and port metastasis.
Conclusions: Our experience indicates that LH is a safe
and feasible method for the treatment of primary hepa-
tic carcinoma with good short and middle term out-
comes but further prospective study are needed to
evaluate this procedure.
720
CLINICAL ANALYSIS OF GALL
BLADDER CANCER
Seung Ik Ahn, Keon-Young Lee and Woo Young Shin
Department of Surgery, Inha University Hospital
incheon, South Korea
Introduction: Gallbladder cancer is a relatively rare
tumor with a poor prognosis. Surgery still offers the
only chance for cure. The aim of this study was to ana-
lyze the clinical aspect of Gallbladder cancer and
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compare clinical outcomes according to the pathologic
stage.
Method: Between 2002 and 2011, 69 patients with Gall-
bladder cancer underwent surgical treatment at Inha
University Hospital. The data included demographics,
pre-operative diagnosis, diagnostic tools, type of opera-
tion, pathologic stage and survival data. The medical
records were reviewed retrospectively. The statistical
significance was defined when p < 0.05.
Results: Of the 69 patients, 29 men and 40 women,
most prevalent age was the 7th decades of 29 patients
(42.0%). The mean age was 68.85  10.12. The pre-
operative diagnostic tools were ultrasound in 36
patients (52.2%) and computerized tomography in 51
patients (73.9%). According to the pre-operative diag-
nosis, Gallbladder cancer were 45 patients(65.2%),
Gallbladder stone 14 patients(20.3%), and polyp 8
patients(11.6%), respectively.
Radical cholecystectomies were performed in 51
patients (73.9%), simple cholecystectomy in 13 patients
(18.8%) (10 laparoscopic cholecystectomies were
included), pancreatic duodenectomy in 3 patients, and
palliative operation in 2 patients, respectively.
According to the pathology, T1a, T1b, T2, T3 and T4
were observed in 5(7.2%), 6(8.7%), 30(43.5%), 26
(37.7%) and 2(2.9%) cases, respectively.
According to the disease progression, Stage I was 11
cases (15.9%), stage II 18 cases (26.1%), stage IIIA 16
cases (23.2%), stage IIIB 20 cases (29.0%) and stage
IV 3 cases (4.3%), respectively.
For the survival rates, T1 was 90.9%, T2 56.7%, T3
20.0% and all patients were 48.5% (p < 0.05).
According to the disease progression, the survival rate
for stage I was 90.9%, stage II 63.2%, stage IIIA
42.9%, stage IIIB 20.0% and stage IV 0%, respectively
(p < 0.05).
Conclusions: Treatment result of Gallbladder cancer
was dependent on disease progression. The early detec-
tion of disease was seemed to be need for improved
treatment results. Further studies of large number are
needed.
721
THE CLINICAL CHARACTERISTICS OF
NON-B NON-C HEPATOCELLULAR
CARCINOMA IN HAN AND UIGHUR OF
XINJIANG
Sha-Sha Zhou, Rui-Li Zhang and Yong-Xing Bao
First Affiliated Hospital of Xinjiang Medical University,
Urumqi Xinjiang
Background and purpose: The incidence of primary
liver cancer in China is high and has a poor prognosis.
Non-B non-C hepatocellular carcinoma was seldom
discussed,The study was aimed to analyzing the risk
factors, clinical epidemiological characteristics and
prognosis of non-B non-C hepatocellular carcinoma.
Methods: We retrospectively analyzed the clinical data
of 348 cases of NBC-HCC patients from January 2002
to December 2011. Overall survival for patients were
analyzed by Kaplan-Meier method.
Results: Among the 348 Cases, The average age of the
patients was 64 years (1–90 years). The men\women
gender ratio was 2.2:1, The han\Uighur ratio was 3.9:1.
The distribution of population in han and Uighur was
significant (<0.05). Risk factors were gender, age,
smoking, drinking, family history and so on. 0.5-,1-, 3-
and 5-year disease survival rates were
58.30%,24.00%,5.50% and 2.80%.
Conclusion: The distribution of population differ signif-
icantly among different nationalities, disease survival
rates were low than other areas. NBC-HCC in Xinjiang
region has certain regional characteristics and features.
722
THE PROGNOSIS AND INFLUENCING
FACTORS OF NON-B NON-C
HEPATOCELLULAR CARCINOMA IN
HAN AND UIGHUR OF XINJIANG
Sha-Sha Zhou, Rui-Li Zhang and Yong-Xing Bao
Tumor Center, First Affiliated Hospital of Xinjiang
Medical University, Urumqi Xinjiang China
Background and purpose: The incidence o f primary liver
cancer in China is high and has a poor prognosis. Non-B
non-C hepatocellular carcinoma was seldom discussed,
The study was aimed to analyzing the factors that may
influence the prognosis of NBC-HCC patients. Methods
We retrospectively analyzed the clinical data of 348
cases of NBC-HCC patients. Overall survival for
patients were analyzed by Kaplan-Meier method, and
the factors that may influence the prognosis and sur-
vival of NBC-HCC patients were analyzed using uni-
variate (log-rank test) and multivariate Cox
proportional hazard models. The following factors such
as general data,clinic biochemistry parameters, TNM
staging system were analyzed.
Results: 0.5-,1-, 3- and 5-year disease survival rates were
58.30%,24.00%,5.50% and 2.80% for all 348 patients,
respectively. Univariate analysis by log-rank test showed
that,TNM staging system,smoking, family history and
so on, 13 factors in all, were the important factors that
impacted on the survival of NBC-HCC patients. Multi-
variate analysis by Cox model showed that TNM staging
system, portal vein tumor thrombus, smoking, both
smoking and drinking, serum lactate dehydrogenase
family history,the times of therapy were the significant
independent prognostic factors. Conclusion
TNM staging system, portal vein tumor thrombus,
smoking, both smoking and drinking, serum lactate
dehydrogenase family history,the times of therapy are
significant independent factors influencing, and family
history,the times of therapy are protective factors.
NBC-HCC in Xinjiang region has certain regional
characteristics and features.
725
VOLUMETRIC ANALYSIS FOR
SEGMENTAL LIVER RESECTION
Tse Han Loong, Sameer P Junnarkar, Jee Keem Low
and Winston Woon
Tan Tock Seng Hospital, Singapore
Background and aims: Due to better and more regular
follow-up and screening in patients with hepatitis,
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many hepatomas are being identified earlier and conse-
quently liver resections are also becoming more fre-
quent. One of the main criteria for consideration of
liver resections is that there is sufficient functioning
remnant liver. Unfortunately, these patients often have
chronic liver disease with resulting impaired liver func-
tion. As such liver resection volume needs to be care-
fully planned and restricted to ensure adequate
remnant liver. Compounding this issue is the fact that
there are many different formulae that attempt to cal-
culate the liver volume and the associated volume of
liver resected.
Methods: Over a period of one year, patients who were
scheduled to have liver resections had their pre-opera-
tive CT scans analysed and the expected volume of
liver to be resected (based on the surgical plan) was cal-
culated using computer software.
Following liver resection, the volume of the resected
specimen was measured using a volume displacement
technique. Intra-operative pictures were obtained where
possible and the images discussed with the radiologist
and any discrepancy with the predicted resection mar-
gins prompted a repeat calculation of the liver volume.
Results: Over the study period, we identified 13 suit-
able patients that we included into the study. These
patients had surgery for a variety of reasons, ranging
from hepatic metastases from colorectal carcinoma to
hepatocellular carcinoma. From a racial perspective, 12
of the patients were ethnically Chinese whilst 1 was
Indian. The calculated liver volumes tended to correlate
well with the measure resected volumes. However, in a
couple of cases, the amount of resected liver differed
from the initial surgical plan and so required repeat
calculation of the liver volume.
Conclusions: We successfully implemented a workflow
for the measurement of resected liver volumes and in
our small sample of patients there was good correlation
between the predicted resected liver volumes and the
actual specimen. However, the sample size is relatively
small and a larger study needs to be conducted. The
patients in this study were predominantly Chinese, but
in multi-racial Singapore, the accuracy of our results
may not be completely applicable and a larger study
may be able to address this issue as well.
727
THE THREE-DIMENSIONAL
QUALITATIVE EVALUATION OF
SPECT/CT?
Can-Hong Xiang and Jia-Hhong Dong
Hospital & Institute of Hepatobiliary Surgery, Fuxing
road 28, Beijing, 100853 China
Background and aims: As for cirrhosis liver, there is
still no effective assessing method of liver function until
now. Indexes from dynamic SPECT Tc-GSA scintigra-
phy including the hepatic uptake rate (GSA-K), the
functional liver density (FLD) was calculated to evalu-
ate the equality of functional reserve of intrahepatic
anatomic areas.
Method: Twenty patients with cirrhosis liver were
enrolled in this study and CT scan and SPECT scan
were performed in turn using an integrated SPECT/CT
machine. After that the multi-modality image fusion
technique (IQQA-liver, EDDA) was used to carry out
the three-dimension reconstruction, then indexes of the
whole liver and intrahepatic anatomic areas were calcu-
lated, including GSA-K, the functional volume(FLV),
the morphologic volume(MLV) and FLD. The correla-
tion between these indexes and the exited liver function
indexes was analyzed. The difference among patients
and areas were compared. According to whether there
was tumor thrombus in the main branch of the right
portal vein or not, the patients were grouped into Y
group and N group and the influence of portal vein to
the value of GSA-K and FLD was analyzed. Then in
the N group the areas were further divided into tumor-
bearing areas (T+ group) and tumor-free areas (T-
group) and the influence of tumor compression to the
value of GSA-K and FLD was analyzed.
Results: The value of GSA-K correlated well with the
value of GSA-K, CP score and INR, while FLD did
not correlate with them. The gap of GSA-K in patients
was big. The values of GSA-K in areas were almost the
same and not influenced by the portal vein stream and
tumor compression. The gap of FLD in patients was
also big. The difference of FLD among intrahepatic
areas was not significant. The values of FLD of right
liver, S6, S7 and RHVD in Y group were far less than
the figure of corresponding areas in n group and the p
value was 0.007, 0.008, 0.003, 0.048 and 0.000 respec-
tively. Comparing with the T- group, the values of
FLD of section and segment in T+ group decreased
dramatically.
Conclusion: The indexes based on the combination of
dynamic SPECT scintigraphy and three-dimension
reconstruction could assess the regional functional
reserve of cirrhosis liver effectively.
728
SMAC MIMETICS SM-164
POTENTIATES APO22/TRAIL AND
DOXIRUBICIN-MEDIATED
Shui-Jun Zhang1,2, Gong-Quan Li1,2, Bing Yan2 and
Gong Zhang1,2
1Department of Hepatobiliary and Pancreatic Surgery,
the First Affiliated Hospital of Zhengzhou University,
Zhengzhou, Henan, China; 2Key Laboratory of
Hepatobiliary and Pancreatic Surgery & Digestive
Organ Transplantation of Henan Province. Zhengzhou,
China
Background: The members of inhibitors of apoptosis
(IAPs) family are key negative regulator of apoptosis.
Targeting IAPs using small molecule second mitochon-
dria-derived activator of caspases (Smac) mimetics cur-
rently is being evaluated as a novel anticancer therapy
in many human cancer types. Previous studies have
shown that IAPs are aberrantly expressed in hepato
cellular carcinoma (HCC), and caused HCC cells resis-
tant to apoptosis induction by chemotherapeutic
agents. we herein investigated the therapeutic potential
of small molecule Smac mimetics as a single agent and
in combination with chemotherapy in human HCC and
examine the mechanism of anticancer activity of Smac
mimetics.
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Method: Four HCC cell lines, including SMMC-7721,
BEL-7402, HepG2 and Hep3B, and 12 freshly isolated
primary HCC cells were used in this study. SM-164, a
bivalent Smac mimetic, was used to treat HCC cells.
MTT cell viability, cell death induction, and clonal for-
mation assays were used to examine the anticancer
activity. Western blotting analysis and a caspases inhib-
itor were used to investigate the underlying mecha-
nisms.
Results: We found that despite SM-164 is able to
induce complete degradation of cIAP-1/2 in human
HCC SMMC-7721, BEL-7402 and HepG2; SM-164 as
a single agent has minimal effect on cell viability inhibi-
tion at 10 lM in these cell lines. However, SM-164 sig-
nificantly sensitized tumor necrosis factor (TNF)-
related apoptosis-inducing ligand (TRAIL)-resistant
SMMC-7721, HepG2 and TRAIL-sensitive BEL-7402
HCC cell lines to TRAIL-mediated cell viability inhibi-
tion and apoptosis induction. Western blotting analysis
and experiments with pancaspases inhibitors further
showed that TRAIL-sensitization by SM-164 involved
initiator caspase-8 and effector caspase-3 activation and
was blocked by the caspase inhibitor zVAD, indicating
a caspases-dependent pathway. Furthermore, combined
treatment with SM-164 and TRAIL massively reduced
the clonogenic capacity of two TRAIL-resistant HCC
cell lines, suggesting a long-term anticancer activity by
this novel strategy. Importantly, SM-164 efficiently
induced cIAP-1 degradation and significantly enhanced
TRAIL-triggered cell survival inhibition in primary
HCC cells.
Conclusions: Smac mimetics may potentiate TRAIL-
mediated anticancer activity by triggering apoptosis
cascade in HCC cells, and it suggests that small mole-
cule Smac mimetics treatment combined with TRAIL
could be of clinical benefit in human HCC.
733
LAPAROSCOPY ASSISTANT RFA FOR
HEPATOCELLULAR CARCINOMA OF
SPECIFIC SITE
Yue-Si Zhong1, Mei-Hai Deng1, He-Ping Fang1,
Kai Li2 and Rui-Yun Xu1
1Department of Hepatobiliary Surgery, Third Affiliated
Hospital, Sun Yat-Sen University, Guangzhou, 510630,
China; 2Department of Ultra Sonagraphy, Third
Affiliated Hospital, Sun Yat-Sen University, Guangzhou,
510630, China
Background and aims: To prospectively compare lapa-
roscopy assistant radio frequency ablation (RFA) and
percutaneous RFA for hepatocellular carcinoma of spe-
cific site, such as tumors that were  2 cm adjacent to
the gallbladder, the stomach, the diaphragm, the flex-
ura hepatica coli, the right kidney.
Methods: 39 cases with tumors of specific location was
included, all of the tumors of specific site were  2
cm adjacent to organs mentioned above. 25 cases
received laparoscopy assistant RFA while 14 cases
received percutaneous RFA without laparoscopic assist.
In the laparoscopic group, 8 of the 25 cases whose
tumor adjacent to the gallbladder received laparoscopic
cholecystectomy simultaneously. 6 of the 14 cases of
percutaneous group received absolute alcohol injection
immediately after the ablation intraoperatively because
of the incomprehensive ablation. 39 cases were all with
liver cirrhosis, the number of tumors for each case
was  2, and the diameter of each tumor was  3
cm, ultrasound guided and performed with cool-tip
needle technique were used. Laparoscopic ultrasonic
probe was applied in laparoscopic group. The inci-
dences of complications were observed, and the residual
of tumors were observed 3 days after ablation with
contrast-enhanced ultrasonography.
Results: Laparoscopic and percutaneous group were
with no significant difference of age and gender of cases
(p > 0.05).The location and number of tumors were
not significantly different (p > 0.05). There were no
mortality in both groups. In percutaneous group, one
case complicated with gastric perforation, one case
complicated with thermal injury to gallbladder, and
two cases complicated with thermal injury to dia-
phragm, one with diaphragmatic hernia and one with
biliary-bronchi fistula. The incidence of complication of
percutaneous group was 28.57%, however, in laparo-
scopic group, there was no similar complication
(p < 0.002).3 days after ablation, the residual of tumors
were observed. 4 of the 14 cases of percutaneous group
revealed incomprehensive ablation and received abso-
lute alcohol injection after contrast-enhanced ultraso-
nography, while 2 of the 25 cases of laparoscopic
group revealed incomprehensive ablation and received
absolute alcohol injection. The incidence of residual of
tumor of percutaneous group was higher than laparo-
scopic group (p = 0.02).
Conclusions: Laparoscopy assistant RFA is safer and
more effective than percutaneous RFA without laparo-
scopic assist for hepatocellular carcinoma of specific
site. It can help real-time monitoring and minimize the
incidence of complications, so that complete ablation
can be achieved to tumors. laparoscopic ultrasonic
probe should be applied intraoperatively, which can
minimized the affect of pneumoperitoneum.
736
SURGICAL STRATEGY FOR THE
BRANCH DUCT IPMN OF THE
PANCREAS
Nana Ooshima1, Takashi Hatori1, Shuji Suzuki1, Akira
Kimijima1, Toru Furukawa2 and Masakazu
Yamamoto1
1Department of Gastroenterological Surgery; 2Institute
for Integrated Medical Sciences, Tokyo Women’s
Medical University, Tokyo, Japan
Background: Intraductal papillary mucinous neoplasm
(IPMN) of the pancreas is a very distinctive neoplasm
which progresses from adenomas to carcinomas slowly.
Therefore, surgical indication for the branch duct
IPMN is worrisome and controversial. The aim of this
study was to evaluate surgical strategy for the branch
duct IPMN.
Methods: A total of 194 patients who underwent pan-
createctomy for the branch duct IPMN between 1981
and 2011 were reviewed retrospectively.
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Results: The IPMN lesions were histologically classified
based on a pathological evaluation into low-grade dys-
plasia (101), intermediate-grade dysplasia (29), high-
grade dysplasia (40) and associated invasive carcinoma
(24). The incidence rates of malignancy were 46% in
the patients with mural nodules, and 9% in the patients
without mural nodules. The mean tumor size of malig-
nancy was 38 mm in the patients without mural nod-
ules. No lymph node metastasis was observed in
patients with high-grade dysplasia, however lymph
node metastasis was observed in 38% with an associ-
ated invasive carcinoma. Limited pancreatic resection
without lymph node dissection was performed in 63
patients. Although the rate of malignancy was 32%, no
tumor recurrence was seen in the limited pancreatic
resection group. Total pancreatectomy for the multifo-
cal branch duct IPMNs was performed safely in 9
patients, and the rates of malignancy were 22%. How-
ever, the malignant lesions were located in the maxi-
mum lesions with highest oncological risk.
Conclusions: The indications for surgical resection are
the branch duct IPMN with mural nodules or maxi-
mum size more than 40 mm. A pancreatectomy with
lymph node dissection should be performed if the
potential exists for extra pancreatic invasion. A limited
pancreatic resection has a role for non-invasive branch
duct IPMNs, and the treatment approach to the multi-
focal branch duct IPMNs should be mirror that of uni-
focal branch duct IPMN as described in the
international consensus guidelines 2012.
738
THE EFFECT OF 5-FLUOROURACIL
COMBINED WITH TRIPTOLIDE ON
PANCREATIC CANCER IN VITRO
Xiu-Li Xu, Xin-Feng Li and Wei Wang
Department of Hepatobilliary Surgery, The Affiliated
Second Hospital, Fujian Medical University, 34
Zhongshan North Rd, Quanzhou 362000, China Fujian
Quanzhow, China
Aims: To observe the changes of proliferation and
apoptosis in pancreatic cancer cells AsPC-1 after given
the triptolide (triptolide, TPL), and explore the synergy
of (5-fluorouracil,5-FU) combined with TPL on AsPC-
1 cells, and research which TPL could enhance apopto-
sis induced by 5-FU in AsPC-1 cells or not.
Methods: AsPC-1 cells were cultured in high glucose
DMEM+ 10% fetal calf serum in the culture medium;
Inhibited proliferation effect of 5-FU,TPL, IC30 dose
of TPL combined with 5-FU and constant proportion
of 5-FU combined with TPL on AsPC-1 cells was
determined by MTT assay; The expression changes of
PARP and caspase-3 were detected by Western Bloting;
The differences of cell apoptosis ratios were analyzed
by flow cytometer.
Results: AsPC-1 cells were inhibited proliferation by
TPL and 5-FU, with dose and time related. After 24
hours, TPL combined with 5-FU on AsPC-1 cells, the
differences of expression amount of activated caspase3
had statistically significant when 5-FU alone group
compared with other groups (p < 0.01). After 48 hours,
the differences of expression amount of activated
caspase-3 had statistically significant when combination
group compared with other groups (p < 0.01); Single
drug group compared with control group, with signifi-
cant difference (p < 0.01). After 48 hours, the cleavaged
PARP expression of combination group compared with
single drug group and control group, with significant dif-
ference (p < 0.01); TPL single group compared with con-
trol group, with significant difference (p < 0.01); After
24 hours, compared combination group, TPL monother-
apy group, 5-FU monotherapy group with control
group, the differences of cells apoptosis rates were statis-
tically significant (p < 0.01); Combination group com-
pared with 5-FU alone group and TPL monotherapy
group, with significant difference (p < 0.01). After 48
hours, the cells apoptosis rates of combination treatment
group, TPL monotherapy group, 5-FU alone group
compared with control group, with significant difference
(p < 0.01); Combination group compared with 5-FU
alone group and TPL monotherapy group, with signifi-
cant difference (p < 0.01).
Conclusions: TPL had significant effects of inhibiting
proliferation and inducing apoptosis on AsPC-1 cells,
and no significant inhibitory effect of IC30 concentra-
tions of TPL could significantly enhance 5-FU in pro-
liferation inhibition on AsPC-1 cells. TPL and 5-FU
had highly synergistic effects on inhibiting proliferation
of AsPC-1 cells. TPL could significantly enhance 5-FU
inducing apoptosis on AsPC-1 cells.
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HEPATITIS B VIRUS (HBV) INDUCES
DIFFERENT RESPONSES OF
HEPATOCYTES AND OVAL CELLS
DURING HBV-RELATED
HEPATOCARCINOGENESIS
Lei Zhang1, Yan Chen2, Dong-Lei Chang3, Hui-Fang
Liang3, Bi-Xiang Zhang1, Wei-Wei Wan3, Wei Zhang1
and Xiao-Ping Chen1
1Hepatic Surgery Center, Tongji Hospital, Tongji
Medical College, Huazhong University of Science and
Technology, Wuhan 430030, People’s Republic of China;
2Department of Pediatrics, Union Hospital, Tongji
Medical College, Huazhong University of Science and
Technology, Wuhan 430022, People’s Republic of China;
3Laboratory of Hepatic Surgery, Tongji Hospital, Tongji
Medical College, Huazhong University of Science and
Technology, Wuhan 430030, People’s Republic of China
Wuhan, China
Chronic infection with hepatitis B virus (HBV) is a
high risk factor for hepatocellular carcinoma (HCC) in
humans. Mechanisms of HBV-related HCC are not
very well understood. To investigate whether HBV may
induce oval cell response in mice and induce different
responses of hepatocytes and oval cells, we used Immu-
nohistochemistry to identify oval cell response in HBV
transgenic mice. Flow cytometry, immunohistochemis-
try and microarray were applied to detect different
responses of the hepatocytes and oval cells to HBV
expression. The data of microarray were validated in
human HCC. Our data showed that HBV expression
stimulated oval cell responses in mice. HBV induced a
significant increase of cell death in HBV hepatocytes,
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but had minimal effects on oval cells. We identified the
genes and signaling pathways differently expressed in
oval cells from hepatocytes, showed that HBV affected
them in oval cells to a greater extent than in hepato-
cytes. In particular, the expressions of oncogenes in
HBV hepatocytes were downregulated and tumor sup-
pressor genes were upregulated. Expression patterns in
oval cells were in contrast to those in hepatocytes.
Thus, HBV transgenic mice is a useful model for study
the biological behaviors of oval cells affected by HBV
and stem/progenitor-derived HCC. We identified the
genes and pathways, which might be new progenitor
markers and play roles in HBV-related stem/progeni-
tor-derived HCC. These results provide new evidences
that support the stem cell theory of carcinogenesis, and
the methods used serve as a potential platform to facili-
tate study of the mechanisms underlying HBV-related
hepatocarcinogenesis.
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20 CASES OF DIAGNOSIS AND
TREATMENT FOR
PREUDOPAPILLARY-SOLID
EPITHELIAL NEOPLASM
Xiao-Gang L, Ping Lu, Rong Yang, Bo Li, Ming-Chun
Wang, Wen-Yuan Mao and Kai-Yuan Luo
General Surgery Department, The Second People’s
Hospital of Yunnan Province & Abdominal Surgery
Center of Yunnan Province, Kunming 650021, Kunming,
Yunnan Province, China
Objective: We summarized our experiences on the sur-
gical treatment for preudopapillary-solid epithelial neo-
plasm (PSEN) in the body or trail of the pancreas.
Methods: Distal pancreatectom had been operated on
20 cases of preudopapillary-solid epithelial neoplasm
(PSEN) in the body or trail of the pancreas from May
2008 to February 2010.
Results: All of 20 cases were be operated by distal pan-
createctom, which were successfully performed. The
mean operation time was 3.2h (range: 5–5 h), and the
average intraoperative blood loss was 270ml (range:
100–500 ml).19 cases had pancreatic fistula, death or
surgery related infection. After post operative follow-
up for 6 to 24 months with an average of 15.5 months,
there was no recurrence.
Conclusions: The surgical resection is the best effective
treatment for PSEN, which has satisfying prognosis.
743
CURATIVE EFFECTS OF PERMANENT
INTERSTITIAL 125I SEEDS
BRACHYTHERAPY COMBINED WITH
PALLIATIVE OPERATION FOR LARGE
HEPATOCELLULAR CARCINOMA
Xiao- Gang Li, Bo Li, Wen-Yuan Mao, Rong Yang
and Kai-Yuan Luo
Department of General Surgery of The Second People’s
Hospital of Yunnan Province Kunming, China
Background: Large hepatocellular carcinoma is primary
malignancies of the liver, and current treatment
methods are inadequate. We reported 80 cases of large
hepatocellular carcinoma successfully managed by cus-
tom-designed permanent interstitial 125I seeds brachy-
therapy combined with palliative operation.
Methods: Between 2009 and 2011, 80 patients with
large hepatocellular carcinoma in The Second People’s
Hospital of Yunnan Province were enrolled in the
study. They all underwent palliative operation plus
Permanent interstitial 125I seeds brachytherapy and
chemotherapy. All patients were followed up on
6,12,24,36 months postoperatively.
Results: Our study showed that clinical symptom
remission rate was 95.3% (61/64). Alanine aminotrans-
ferase and aspartate aminotransferase were lowered to
a normal level in 80% of the patients (50/60) and 75%
of the patients (45/60) respectively. in 80% of the
patients (40/50),The value of Alpha fetoprotein
decreased by 50% after the therapy. The effective rate
of therapy was 80% (76/95) for 95 tumor nodules
(diameter 5cm–10cm), and 78.6% (33/42) for 42 tumor
nodules (diameter >10cm). The 3-year disease-free sur-
vival was 66.6%.
Conclusions: Palliative operation plus Permanent inter-
stitial 125I seeds brachytherapy appears to be a reason-
able alternative for treating large hepatocellular
carcinoma.
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LAPAROSCOPIC COMMON BILE DUCT
EXPLORATION IN THE PATIENTS
WITH PREVIOUS UPPER ABDOMINAL
OPERATIONS
Hae Won Lee, Young Joon Ahn and Keong Won Yun
Department of Surgery, Seoul National University
College of Medicine, Seoul National, Seoul, South Korea
Background and aims: Laparoscopic common bile duct
exploration (LCBDE) is technically difficult and chal-
lenging in patients who have undergone upper abdomi-
nal operations. The purpose of the present study was
to investigate the safety and feasibility of LCBDE in
patients with upper abdominal surgical histories.
Methods: LCBDE was attempted in 44 patients
between Jan 2000 and Mar 2012. Among them, 39
patients were enrolled in the present study excluding 5
patients with previous lower abdominal operation his-
tories. The patients were divided into two groups
according to presence of previous upper abdominal
operation; Group A: patients without history of
abdominal operation (n = 27), Group B: patients with
history of upper abdominal operation (n = 12). The
two groups were compared with respect to demo-
graphic data, operating time, postoperative hospital
stay, open conversion rate, postoperative complication,
duct clearance rate and mortality.
Results: After common bile duct (CBD) exploration,
T-tube was placed in CBD on 38 patients (97.4%) and
primary closure was performed on only one patient.
Two groups were statistically similar in terms of gen-
der, mean age and presence of comorbidity. Conversion
to open surgery was made in 4 cases of Group A
(14.8%) and 1 case of Group B (8.3%) (p = 0.312).
Mean operating time was 164.48  63.07 min for
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Group A and 134.83  45.23 min for Group B, which
was not statistically different (p = 0.18). Duct clearance
and complication rates were comparable (p  0.05)
and postoperative hospital stay was also similar
(12.59  5.71 days for Group A, 9.83  2.92 days for
Group B, p = 0.158) between two groups. There was
no Trocar-related complication in both groups.
Conclusions: LCBDE was performed safely and effec-
tively even in the patients with previous upper abdomi-
nal operation. Thus, LCBDE by experienced
laparoscopic surgeons could be considered as one of
the best alternatives to failed ERCP for difficult choleli-
thiasis.
Key words: Laparoscopic common bile duct explora-
tion, previous upper abdominal operation
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EXPRESSION OF RKIP AND HPA IN
HEPATOCELLULAR CARCINOMA AND
THEIR CLINICAL SIGNIFICANCE
Yue-Shan Zhang, Shun-Xiang Wang and Xiao-Hui Wu
Department of Hepatobiliary Surgery, the Fourth
Hospital of Hebei Medical University Shi Jia Zhuang,
China
Background: Hepatocellular carcinoma is one of the
most common malignant tumors in China, which has
high degree of malignancy, insidious onset, recurrence,
metastasis. All of these are related to biological charac-
teristic of HCC which is easy invasion and metastasis.
But the exact mechanism remains unclear, so the regu-
latory mechanism of HCC?s invasion and metastasis
has become a hot topic of the present study.
Objective: To investigate the expression of Raf kinase
inhibitor protein (RKIP) and heparanase (HPA) in
Human hepatocellular Carcinoma tissues, tumor-sur-
rounding tissues and normal liver tissues. To discuss
their correlation with clinical pathological factors and
to analysis correlation between RKIP and HPA.
Methods: We collected 42 cases of hepatocellular Car-
cinoma tissues, 36 cases of tumor surrounding tissues
and 23 cases of normal liver tissues which were from
surgical resection in our hospital. All cases were con-
firmed by pathology. Immunohistochemistry was used
to detect the expression of RKIP and HPA in all of tis-
sues. and then analysis software SPSS13.0 was deter-
mined to access their relationship with clinical
pathological factors and the correlation between them.
Expression differences of RKIP and HPA among HCC
tissues, tumor-surrounding tissues and normal liver tis-
sues use Kruskal-Wallis rank-sum test. Using Spear-
man,s rank correlation test to analysis correlation
between RKIP and HPA.Using ? 2 test to analysis
correlation between RKIP, HPA and clinical pathologi-
cal factors.
Results: 1. Positive rates of RKIP in HCC tissues,
tumor-surrounding tissue and normal liver tissues were
28.57%, 80.56% and 95.65%, and the difference had
statistical significance (?2 = 26.597; p = 0.000).
2. Positive rates of HPA in HCC tissues, tumor-
surrounding tissue and normal liver tissues were
83.33%,72.22% and 8.69%, and the difference also had
statistical significance(?2 = 36.722, p = 0.000).
3. Both RKIP and HPA was irrelevant with age, gen-
der, AFP and the size of tumor, while was relevant
with having liver inside or the lymph node metastasis
and pathological grade.The expression of RKIP in
HCCs with intrahepatic or lymph node metastasis was
lower than that without intrahepatic or lymph node
metastasis, which in well differentiated group was
higher than in poorly differentiated group. However,
the expression of HPA in HCCs was just the opposite.
4. There was a significantly negative relationship
between the expression of RKIP and HPA in HCCs
(r = -0.409, p = 0.007).
Conclusions: 1. RKIP was related to the invasion and
metastasis of HCC and may inhibit HCC?s metastasis.
2. HPA was related to the invasion and metastasis of
HCC and may promote HCC?s metastasis.
3. RKIP may through the Raf-1- MEK1/2-ERK1/2 or
the NF-?B pathway to inhibit expression of HPA.
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MIR-143 SUPPRESSES PROLIFERATION
AND MIGRATION OF
HEPATOCELLULAR CARCINOMA BY
TARGETING MACC1 SIGNALING
PATHWAY
Sheng Gao1,2, Zhe Yang1,2,3, Zhi-Yun Zheng1,2, Jia
Yao1,2, Feng Zhang1,2, Li-Ming Wu1,2,3, Hai-Yang
Xie1,2,3 and Lin Zhou1,2
1Key Laboratory of Combined Multi-organ
Transplantation, Ministry of Public Health; 2Key
Laboratory of Organ Transplantation, Zhejiang
Province; 3Division of Hepatobiliary and Pancreatic
Surgery, Department of Surgery, First Affiliated
Hospital, Zhejiang University School of Medicine,
Hangzhou, China
Background and aims: Studies have been shown that
miR-143 plays an important role in carcinogenesis,
however, the role of miR-143 in hepatocellular carci-
noma (HCC) remains undefined.
Methods: The expression of miR-143 in HCC cell lines
and paired HCC tissues was measured by Real time-
PCR (qRT-PCR) and in situ hybridization (ISH). Ecto-
pic expression of miR-143 was used to test the influ-
ences of miR-143 on proliferation and metastasis of
HCC cells in vitro and in vivo. Predicted target genes
of miR-143 were determined by dual-luciferase report-
ing, qRT-PCR, and western blot (WB) analyses. The
correlations and prognostic values of miR-143 and its
target genes were also investigated.
Results: Decreased miR-143 was observed in both
HCC tissues and cell lines, and associated with
patients’ aggressive pathologic features. Up-regulating
miR-143 significantly inhibited the malignant pheno-
types by repressing the expression of metastasis associ-
ated in colon cancer 1 (MACC1) both in vitro and in
vivo. Inhibiting miR-143 could increase MACC1
expression, and RNA interference targeting MACC1
mRNA could rescue the loss of miR-143 functions.
MiR-143 inhibits the proliferation and metastasis of
HCC by directly targeting MACC1.
Conclusions: MiR-143 exerts tumor suppressive
functions by targeting MACC1 signaling pathway.
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Up-regulation of miR-143 might be a promising
approach and a prognostic marker for HCC.
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CLINIC COMPARATIVE STUDY ON
LEFT SEMI-HEPATECTOMY BY
PRINGLE’S MANEUVER AND
ANATOMICAL LEFT SEMI-
HEPATECTOMY FOR LEFT SEGMENT
BILE DUCT STONE
Yong-Peng Wei, Ying-He Qiu and Bin Yi
Eastern Hepatobiliary Surgery Hospital Shanghai, China
Background and aims: To explore feasibility and safety
of anatomical left semi-hepatectomy in the treatment of
left segment bile duct stone.
Methods: 80 patients with left segment bile duct stone
undergoing elective semi-hepatectomy were randomly
divided into two groups, including 40 cases of treat-
ment group, 40 cases of control group. The treatment
group was treated with anatomical left semi-hepatec-
tomy, and the control group was treated with left semi-
hepatectomy by pringle’s maneuver. The operation
time, blood loss in operation, improvement of liver
function after operation and complications after opera-
tion were compared.
Results: There were no significant difference on the
operation time, blood loss and blood transfusions in
operation (p > 0.05), while the stay-in-hospital time
after operation in treatment group was significantly
shorter than that in control group (p < 0.05). After
treatment for 5 days, the level of ALT, AST and TB in
treatment group were significantly lower than those in
control group (p < 0.05). For 5 days, the PT, APTT in
treatment group at 1st and 3rd after treatment were
significantly shorter than those in control group
(p < 0.05), while the difference was no longer signifi-
cant at 5th after treatment(p > 0.05). The incidence of
post-operative complications in treatment group was
10.0%, and 25.0% in control group, the difference was
significant (p < 0.05).
Conclusions: It is a safe and feasible of anatomical left
semi-hepatectomy for treating left segment bile duct
stone, it has relative small damage to liver of uninjured
sides, and it can contribute to control blood loss in
operation, reduce post-operative complications.
762
THE CLINICAL APPLICATION OF
INTRAOPERATIVE ENBD TUBE
PLACEMENT WITH TRI-SCOPY
COMBINED IN CBD EXPLORATION
WITH PRIMARY SUTURE
Ya-Hong Yu, Song-Qi Wen and Guang-Yao Yan
Department of Pancreatic-Biliary Surgery, Affiliated
Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, Wuhan, China
Background and aims: With the maturity and develop-
ment of biliary surgery minimally invasive techniques,
laparoscopic common bile duct exploration of T-tube
drainage in the treatment of common bile duct stones
have been gradually replaced laparotomy. Postopera-
tive T-tube drainage exist various disadvantages, espe-
cially a long period of T tube drainage time
inconvenience to the patient’s life. To investigate the
safety,feasibility and effectiveness of the common bile
duct primary suture after tri-scopy(Laparoscope、cho-
ledochoscopy and duodenoscopy)combined choledo-
chotomy.
Methods: Retrospective analysis from February 2009
to December 2011, a case-control study was performed
on 67 patients undergoing this new procedure and 40
patients receiving laparoscopic choledochotomy T—
tube drainage after surgery in a same period of time.
Results: There was no mortality and no convert to
open surgery in two groups,the new procedures with a
success rate was 97% (65/67). The difference of two
groups in operative time,removal tube time, postopera-
tive complications and the hospital costs was not statis-
tically significant (p > 0.05), but the difference in bowel
function recovery time (30.6  5.2 h/48.3  6.4 h),
postoperative hospital stay time (7.2  1.3 d/
13.7  1.7 d), the bile loss time (6  2.7 d/28  3.9 d)
between 2 groups was statistically significant (p < 0.05),
the nasobiliary duct group was shorter than T-tube
drainage group. Two groups were followed up during 1
to 3 years, average 1.5 years, no retained stones and
biliary stricture complications were found in any
patient.
On the basis of strictly surgical indications and place
the Nasobiliary duct drainage as usual, the primary
suture of common bile duct after tri-scopy combined
common bile duct exploration is safe, feasible and
effective.
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RE-RESECTION FOR METACHRONOUS
COLORECTAL LIVER METASTASIS: IS
IT JUSTIFIED?
KSH Chok1, TT Cheung1, ACY Chan1, WC Dai1, SC
Chan1,2, ST Fan1,2, RTP Poon1,2 and CM Lo1,2
1Department of Surgery, The University of Hong Kong,
Hong Kong SAR, China; 2State Key Laboratory for
Liver Research, The University of Hong Kong, SAR,
China
Background and aims: Data on re-resection for colorec-
tal liver metastases is scare and long-term outcome is
unclear. The aim of the present study is to investigate
whether re-resection is justified in this group of
patients.
Methods: Prospectively collected data of all adult
patients who diagnosed with colorectal liver metastases
at Department of Surgery, the University of Hong
Kong, Queen Mary Hospital, Hong Kong SAR, China,
in the period between December 1989 and December
2011 were reviewed. 14 patients having re-resection
(Group R) with curative intent for metachronous colo-
rectal liver metastases were compared with those of 307
patients having primary resection (Group P) in the
same period. There was no overlap of patient and all
had gross tumour-free resection margin.
Results: The two groups had comparable demograph-
ics. Although not reached statistical significance, more
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patient in Group P received major resection (55.6% vs.
30.8% p = 0.079). Median blood loss was comparable.
Tumour size was significantly smaller in Group R (2.5
cm vs. 3.5 cm, =0.02) and resection margin was sig-
nificantly closer in Group R (0.3 cm vs. 0.7 cm,
p = 0.037). Univariate analysis showed that re-resection
was not a significant risk factor in overall survival.
Multivariate analysis showed that presence of postoper-
ative complication (HR:1.66, 95% CI: 1.15-2.39;
p = 0.007), resection margin (HR:1.95, 95% CI: 1.26-
3.04; p = 0.003) and number of tumour nodules
(HR:1.58, 95% CI: 1.17-2.14; p = 0.003) were signifi-
cant risk factors associated with overall survival. The
two groups displayed no significant differences in dis-
ease-free and overall survivals.
Conclusions: Re-resection for metachronous colorectal
liver metastasis can achieve favorable survival outcome.
766
PATHOLOGICAL COMPLETE
REMISSION WITH LONG TERM
SURVIVAL AFTER HEPATIC ARTERIAL
CHEMOTHERAPY IN ADVANCED
HEPATOCELLUAR CARCINOMA
Sung Su Yun1, Hwa Kyung Jung1, Jong Ryul Eun2,
Dong Shick Lee1 and Hong Jin Kim1
1Department of Surgery; 2Department Internal
Medicine, Yeungnam University Hospital Daegu, Korea
Background: The prognosis of advanced hepatocellular
carcinoma (HCC) patients with portal vein thrombosis
is very poor even after surgery.
Aim: We report a case of pathologically confirmed
complete remission of HCC induced by hepatic arterial
infusion chemotherapy (HAIC).
Methods: A 45-year-old male patient had a massive
HCC in the right and main portal veins. He achieved a
partial response after two cycles of HAIC with 5-fluo-
rouracil (750 mg/m2) and cisplatin (25 mg/m2).
Results: After completion of six cycles he received a
curative partial hepatectomy, and histopathology
revealed complete necrosis without any viable tumor
cell. He has been in good health without recurrence at
40-month follow-up.
Conclusions: This result suggests that this regimen is a
promising therapeutic modality for the treatment of
advanced HCC with portal vein tumor thrombosis.
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A CASE OF GALLBLADDER CANCER
COMBINED WITH ECTOPIC
INDIVIDUAL OPENING OF COMMON
BILE DUCT AND PANCREATIC DUCT
CY Jeong, JK Cho, YT Ju, YJ Lee, EJ Jung, WS Ha,
SK Choi and SC Hong
Department of Surgery, Gyeongsang National University
Hospital Jinju, Korea
Background and aims: The common bile duct (CBD)
typically enters the posteromedial aspect of the second
portion of the duodenum. Ectopic opening of the com-
mon bile duct (CBD) into the duodenal bulb is an
extremely rare congenital anomaly. The clinical impli-
cations and frequency of this anomaly are not clearly
known. This article presents a case of ectopic opening
of the CBD into duodenal bulb and incidental gallblad-
der cancer and discuss clinicopathological features of
this condition.
Methods: A 57-year-old man was referred to our hospi-
tal presenting intermittent right upper abdominal pain
two years ago. ERCP showed the individual ectopic
opening of the CBD and pancreatic duct in the duode-
nal bulb and there was no evidence of a papilla-like
structure in the second or third portion. Magnetic reso-
nance cholangiopancreatography (MRCP) demon-
strated that independent insertion of CBD and
pancreatic duct into duodenal bulb and a hook-shaped
configuration of the distal CBD. Also, focal fundal
nodular lesion of gallbladder was identified. However,
there were no further endoscopic or surgical treatment.
Recently, CT scan showed that this lesion was slightly
increased. Under suspicion of GB cancer, laparoscopic
cholecystectomy was performed.
Results: Frozen biopsy indicated the nodular lesion
was adenocarcinoma of gallbladder and extension to
perimuscular connective tissue. Grossly, the adenocarci-
noma infiltrated serosa of gallbladder. After Open con-
version, radical cholecystectomy and hepatic
ojejunostomy was performed. This was because of
extension of cancer to cystic duct and CBD junction
and intent to treat biliary obstruction due to acute
angulation of the distal CBD.
Conclusions: Ectopic opening of the CBD in the duo-
denal bulb is not an incidental finding but a pathologic
condition with cholangitis and carcinogenesis. The
absence of a sphincter permits reflux of intestinal bacte-
ria and food materials into the biliary system, which
could cause recurrent cholangitis, resulting biliary
malignancy. In conclusion, it should be kept in mind
that although an ectopic opening of the CBD into the
duodenal bulb is extremely rare, it may cause severe
pancreatic obiliary disease, even malignancy.
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LAPAROSCOPIC DISTAL
PANCREATECTOMY WITH OR
WITHOUT SPLENIC PRESERVATION: A
RETROSPECTIVE STUDY OF 39 CASES
Chao Jiang, Guo-Yue Lv, Ying-Chao Wang, Xue-Yan
Liu and Guang-Yi Wang
Department of Hepatobiliary & Pancreatic Surgery,
First Hospital of Jilin University Changchun, China
Background and aims: Laparoscopic distal pancreatec-
tomy (LDP) has gained large popularity in recent
years, although the choice of whether to preserve the
spleen has remained inconsistent. Distal pancreatec-
tomy with splenectomy is an effective technique for
management of benign or low-grade malignant diseases
in the body or tail of the pancreas. However, the spleen
participates in various immune functions there is a sig-
nificantly increased risk of sepsis associated with sple-
nectomy, and a negative influence on long-term
survival. The aim of our study was to report our expe-
riences with laparoscopic distal pancreatectomy, to
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provide evidence for the safety of the operative tech-
nique and an evaluation index of splenic function.
Methods: We retrospectively evaluated all LDPs per-
formed at our institution between March 2008 and
October 2012. Cases were divided into a laparoscopic
spleen-preserving distal pancreatectomy (LSPDP) group
(n = 17) and an LDP with splenectomy (LDPS) group
(n = 22). Perioperative data (blood loss, operative time,
length of hospital stay, and blood transfusion), and
procedure-specific complications (pancreatic fistula,
splenic infarction, and hemorrhage) were compared
between the two groups. Parametric and nonparametric
statistical analyses were used to compare perioperative
and oncologic outcomes.
Results: Demographic characteristics, perioperative
data and complication rate were similar between
groups. Patients who underwent LDPS tended to have
larger masses and lower pancreatic fistularates, but
these differences were not significant. White blood cell
(WBC) counts were significantly higher in the LDPS
group than in the LSPDP group on postoperative days
-1 and 7.
Conclusions: To avoid splenectomy-associated compli-
cations, preservation of the spleen and especially the
splenic vessels is preferred. Our data suggest that
LSPDP can be performed safely and feasibly. Lower
postoperative WBC counts may imply better splenic
function.
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RATIONALE AND SURGICAL
TECHNIQUE OF LAPAROSCOPIC LEFT
LATERAL SECTIONECTOMY WITH
ENDOSCOPIC STAPLE
Sung Su Yun, Lee Dong Hyun, Lee Dong Shick, Hwa
Kyung Jung and Hong Jin Kim
Department of Surgery, HBP Division, Yeungnam
University Hospital Daegu, Korea
Background and Aims: Laparoscopic left lateral sec-
tionectomy (LLLS) has been accepted with popularity
in its benefits related to minimally invasive surgery.
Some surgeons like to isolate glissonian pedicles to seg-
ment 2 and 3 and control individual pedicles with sur-
gical clips. But others like to control glissoinan pedicles
to segment 2 and 3 at once with endoscopic stapling
device without isolating each pedicles..The aim of this
study is to find rationale (safety, outcomes, learning
curve) of LLLS with endoscopic staples.
Methods: We retrospectively analyzed and compared
the clinical outcomes(operation time, blood loss, hospi-
tal stay, learning curve, complication rate, etc) in 33
patients who underwent LLLS between April 2004 and
December, 2011 depending on surgical technique
whether isolate each glissonian pedicles (individual
group, n = 20) or not (batch group, n = 13). To see the
learning curve, we arbitrarily divided first and second
half period (before and after December, 2009) depend-
ing on case number 17.
Results: There was one open conversion in individual
group. Mean operative time was 265.3  21.3 min
(Mean  SE) in the individual group and 170.0  22.9
min in batch group. Operation time in batch group was
significantly shorter than individual group (p = 0.007).
There was no blood transfusion in batch group, but 4
out of 20 patients in individual group needed blood
transfusion during surgery. Mean post-operative hospi-
tal stay were 10.7  1.1 and 9.4  0.8 days in individ-
ual and batch group (p = 0.46). Mean operative time in
the first and second half of individual and batch group
were 271.9  28.9/254.3  32.2 min and 209.0  29.1/
142.1  30.7 min (first half/second half). In batch
group, we could save operation time significantly
(p = 0.027) in second half period without morbidity
and mortality.
Conclusions: The LLLS with endoscopic staple (batch
group) was easy and safe technique with short learning
curve and better outcomes without mortality and mor-
bidity. We will show schematic pictures and video to
support rationale for LLLS with endoscopic staples
(batch group).
773
SELECTIVE PORTAL VEIN
EMBOLIZATION IN THE TREATMENT
OF LIVER CANCER
Jun-Hui Sun, Yue-Lin Zhang, Chun-Hui Nie, Li-Ming
Chen, Jian-Di He, Wei-Lin Wang and Shu-Sen Zheng
Hepatobiliary and Pancreatic Intervention Center,
Division of Hepatobiliary and Pancreatic Surgery,
Department of Surgery, The First Affiliated Hospital,
College of Medicine, Zhejiang University Hangzhou,
Zhejiang Province, China
Objective: To evaluate the clinical feasibility and effec-
tiveness of transcatheter portal vein embolization
(PVE) and transcatheter arterial chemoembolization
(TACE) in the treatment of hepato cellular carcinoma.
Methods: PVE was performed in 22 patients with unre-
sectable advanced hepatocellular carcinoma1 Right
portal vein were embolized with percutaneous transhe-
patic approach through the ultrasound guidance. Left
hepatic lobe volume was measured with CT scans
before and after PVE. Liver function, and coagulation
function were also measured before and after PVE.
Results: Right portal vein was embolized successfully
in all patients. Right liver resection was performed in
12 patient. The left hepatic lobe volume was
(315  101) cm3 before PVE, and (628  121) cm3,
(740  103)cm3 and (678  132) cm3, respectively 2
weeks, 4 weeks, and 8 weeks after PVE. Left hepatic
lobe volume increased (44.1  21.1)%, (47.1  22.1)%
and (49.3  23.1)%, respectively. There was statistical
difference in left hepatic lobe volume before and 2
weeks after PVE (p < 0.05). Liver function damage
after PVE was minimal. No patient had complication
after PVE.
Conclusions: PVE is clinically feasible, safe and effec-
tive in inducing the compensatory hypertrophy of the
remnant liver. It can increase the resection rate and
safety of operation.
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LOW EXPRESSION OF ASPARAGINE
SYNTHETASE IN HEPATOCELLULAR
CARCINOMA IS ASSOCIATED WITH
WORSE SURGICAL OUTCOME
Bo Zhang1,2, Yu-Fei Pan1, Ye-Xiong Tan1, Min-Hong
Li1, Jian Zhang1, Zhi-Wen Ding1, Yang-Jia He2,
Li-Wei Dong1 and Hong-Yang Wang1,3
1International Cooperation Laboratory on Signal
Transduction, Eastern Hepatobiliary Surgery Institute,
the Second Military Medical University, Shanghai, P. R.
China; 2Department of Laparoscopic Surgery, Eastern
Hepatobiliary Surgery Hospital, Second Military
Medical University, Shanghai, P.R. China; 3State Key
Laboratory of Oncogenes and related Genes, Shanghai
Cancer Institute, Renji Hospital, Shanghai Jiaotong
University School of Medicine, P.R. China. Shanghai,
China
Background and aims: Asparagine synthetase (ASNS)
is known to be associated with drug resistance in leu-
kemia and its function is not clear yet, especially in
hepatocellular carcinoma (HCC). By proteomics
approach, we previously identified ASNS is overex-
pressed in HCC tumor tissues compared with normal
liver specimens. The expression of ASNS and its prog-
nostic value in HCC remains unclear. This study
aimed to investigate the relationship between ASNS
expression, tumor recurrence, and patient survival
after surgery resection.
Methods: A cohort of 269 HCC patients who under-
went surgical resection from 2002 to 2006 were retro-
spectively reviewed. By real-time PCR and
immunohistochemistry assay, the expression of ASNS
was evaluated. The correlation between ASNS expres-
sion and clinicopathological factors were investigated.
Potential clinicopathological prognostic factors were
examined by univariate and multivariate survival analy-
sis.
Results: The expression of ASNS was significantly
correlated with tumor size (p = 0.002), microscopic
vascular invasion (p = 0.003), tumor encapsulation
(p = 0.007), TNM stage (p = 0.039) and BCLC stage
(p = 0.039). Patients with low ASNS expression had a
poorer prognosis in survival than those with high
ASNS expression (P<0.01). Patients with ASNS high
or low expression, the survival rates were statistically
different (52.6%, 29.2% and 25.3% versus 37.4%,
20.0% and 13.9% in 1-, 3- and 5-year survival rates).
Multivariate survival analysis indicated that the
expression of ASNS was an independent factor affect-
ing survival (HR 0.744, 95% CI 0.565–0.979,
p = 0.035).
Conclusions: ASNS expression was an independent fac-
tor affecting survival. Low ASNS expression in HCC is
correlated with worse surgical outcome, and this mole-
cule might be useful in predicting post-surgical outcome
in patients with HCC.
778
SEGMENT IVB AND V HEPATIC
RESECTION WITH
LYMPHADENECTOMY IN EARLY
STAGE GALLBLADDER CANCER
Moungthard Hathaiwan1, Bunchaliew Chairat2,
Chanwat Rawisak2 and Khuhaprema Thiravud2
1Chulabhorn Cancer Center, 54 Khampangphet6 Road,
Laksee, Bangkok, Thailand 10210; 2National Cancer
Institute, 268/1 Rama VI Road, Rachathewe, 10400
Bangkok, Thailand
Introduction: Gallbladder Cancer (GBC) is one of the
very poor prognostic cancer. At the symptomatic time,
it has usually no longer curable stage. Early stage diag-
nosis with extensive surgical resection are the appropri-
ated management for selected patients. We here
presented one patient from our series which received
this approach in our institute.
Methods: A 55 year-old man had no abnormal symp-
tom who was investigated by abdominal ultraso-
nography for yearly checkup which was reported a
infiltrative lesion at neck of gallbladder. Subsequently
CT abdomen suspected early stage GBC without lymph
node enlargement. Surgical management was advised
but patient denied surgery and loss follow up. 4 months
later, patient returned to our hospital and MRI abdo-
men was reported slightly enlarge of lesion at neck of
gallbladder and no lymph node involvement or distant
metastasis.
Results: Segment IVb and V hepatic resection with
lymphadenectomy was performed in this patient. Dur-
ing operation, frozen section of cystic duct margin was
reported negative. Pathological report revealed well-dif-
ferentiated adenocarcinoma which involved muscular
layer (T1b), free all resection margin and lymph node
positive 1 in 23 nodes. Post-operative course was
uneventful. Patient was discharged on 5th post-opera-
tive day. Now, he is doing well at 16 months after
operation and adjuvant chemotherapy.
Conclusions: Radical resection including cholecystec-
tomy with en-bloc hepatic resection and lymphadenec-
tomy is only potentially curative treatment for early
stage GBC.
780
RISK FACTORS AND
COUNTERMEASURES FOR
ENDOTRACHEAL REINTUBATION
DURING POSTOPERATIVE CARE
FOLLOWING LIVER
TRANSPLANTATION
Cui Chen1, Li Li2, Zhi-Xia Ye1, Zhi-Hui Zou1, Fei-Fei
Gu1 and Li Fu1
1Nursing Department, Eastern Hepatobiliary Surgery
Hospital, 225 Shanghai Rd, Shanghai; 2ICU,Eastern
Hepatobiliary Surgery Hospital, 225 Changhai Rd,
Shanghai China
Background and aims: In patients receiving mechanical
ventilation, reintubation was associated with increased
incidence of nosocomial pneumonia, length of ICU stay
© 2013 The Authors
HPB © 2013 Americas Hepato-Pancreato-Biliary Association HPB 2013, 15 (Suppl. 2), 85–244
162 CONCURRENT SESSIONS POSTER
and mortality. This study is aim to explore risk factors
of endotracheal reintubation for patients after liver
transplantation.
Methods: The data of 237 patients with liver transplan-
tation from January, 2004 to December, 2009 in East-
ern Hepatobiliary Surgery Hospital were collected,
including clinical data, laboratory results and complica-
tions during and after operation. The data were ana-
lyzed by SPSS PASW (18.0), and method of Logistic
regression analysis was used to investigate the risk fac-
tors of endotracheal reintubation of patients after liver
transplantation.
Results: 30 of 237 patients (12.7%) required one or
more episodes of reintubation after liver transplanta-
tion. The overall mortality rate in patients with reintu-
bation was 53.3%, comparing with 4.3% in patients
without reintubation (p < 0.001). According to Logistic
regression analysis, the risk factors for reintubation
after liver transplantation include preoperative grade of
liver function(Child-pugh C), (OR = 12.597, 95%CI
2.686–41.814,p = 0.001), intraoperative hypotension,
(OR = 15.916, 95%CI 2.340–108.229, p = 0.005), post-
operative complications such as pulmonary infection
(OR = 28.641, 95% CI: 2.561–320.328, p = 0.006) and
renal function failure(OR = 8.159, 95% CI:1.320–
50.447, P = 0.024), high volume of sputum in 3 days
after operation, (OR = 2.002, 95% CI 1.135–3.532,
p = 0.017).
Conclusions: To improve the preoperative liver func-
tion, to control the intraoperative bleeding, to promote
the expectoration after extubation and to prevent the
postoperative complications such as pulmonary infec-
tion and renal failure are helpful to decrease the inci-
dence of tracheal retintubation in patients after liver
transplantation.
782
SPLENECTOMY PRIOR TO ANTIVIRAL
THERAPY IN PATIENTS WITH HCV
RELATED DECOMPENSATED
CIRRHOSIS
Fan-Pu Ji, Zong-Fang Li, Hong Deng, Zhi-Fang Cai,
Na Huang, Jian Zhang, An Jiang, Shu Zhang,
Zhi-Dong Wang and Rui Zhou
The Second Affiliated Hospital, College of Medicine,
Xi’an Jiaotong University, 157 Xi Wu Road Xi’an,
China
Background and Aims: Patients with hepatitis C virus
related decompensated cirrhosis had been reported to
benefit from interferon-based therapy. However, the
majority of patients cannot receive such treatment due
to cytopenia. We aimed to investigate the safety of
splenectomy and the efficacy of antiviral therapy after
splenectomy in this population.
Methods: From January 2008 to January 2011, thir-
teen HCV decompensated cirrhotic patients underwent
splenectomy prior to antiviral therapy was included in
this prospective study. All patients (39–62 years, Child
–Pugh A 9 and B 4) were interferon naive, one to
three months after surgery, receivd pegylated IFN a-
2a/ IFN a-2b or standard IFN a-2b plus ribavirin for
48 weeks.
Results: There were no severe operative and postopera-
tive complications except for minor portal vein throm-
bosis were detected in two patients and 8 patients
experienced transient ascites postoperatively. Platelet
(48.23  15.92 v.s 186.0  70.629103/lL, p < 0.001)
and leukocyte (2.102  0.492 v.s 5.695  1.4239103/
lL, p < 0.001) counts significantly increased at one
month after splenectomy. All patients completed 72
weeks administration. One case required transient IFN
interruption for severe intestinal infections, one and
two patients required reduction of IFN and ribavirin
dose respectively. A sustained viral response was
achieved for 4 patients with genotype 2a (4/4, 100%)
and 4 with genotype 1b (4/9, 44%). No patients
occurred variceal bleeding or encephalopathy during
antiviral treatment and follow-up.
Conclusions: Splenectomy is safe in the setting of por-
tal hypertension and hypersplenism associated with
HCV infection. Splenectomy for severe leukocytopenia
and thrombocytopenia with the intent to apply inter-
feron therapy can be beneficial.
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EFFFICACY AND SAFETY OF
RADIOFREQUENCY ABLATION IN THE
MANAGEMENT OF HEMANGIOMAS OF
THE LIVER: A SYSTEMATIC REVIEW
Xiao-Wu Zhang, Lu-Nan Yan and Jia-Yin Yang
Department of Hepatic and Vascular Surgery, Liver
Transplantation Center, West China Hospital of Sichuan
University, No. 37 Guo Xue Xiang, Chengdu 610041,
Sichuan Province, China
Background and aims: To systematically review the cur-
rent status of radiofrequency ablation (RFA) in the
management of systematic-enlarging hepatic hemangio-
mas (HCHs).
Methods: We conducted a comprehensive review from
January 1998 to August 2012 to retrieve all relevant
articles.
Results: A total of 11 studies with 176 patients under-
going RFA for the management of 228 systematic-
enlarging HCHs were reviewed. Diameter of the
lesions ranged from 2.2 to 22 cm. A total of 174
patients (98.9%) with 226 lesions were successfully
treated by RFA independently or in combination with
suture and ligation surgery. Range of ablation time
for each lesion and estimated blood loss were 8 to 160
minutes and 50 to 400 ml, respectively. Of the 226
HCHs successfully managed by RFA, 223 lesions
(98.7%) were ablated completely, including 188 of 188
(100%) lesions < 10 cm and 35 of 38 (92.1%) lesions
 10 cm. All the 104 patients who had obvious
symptoms related to HCHs had a complete disappear-
ance of their symptoms (89.4%) or significantly symp-
tomatic amelioration (10.6%) after RFA. The most
frequent complication was fever observed in 53 cases
(30.5%; 23.5% [< 10 cm] vs 55.3% [ 10 cm]), fol-
lowed by hemoglobinuria (11.5%; 2.9% [< 10 cm] vs
42.1% [ 10 cm]) and jaundice (8.0%; 2.9% [< 10
cm] vs 26.3% [ 10 cm]). Two patients with HCHs
over 10 cm developed serious complications including
lower esophageal fistula and acute respiratory distress
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syndrome. All of these complications were successfully
managed by conservative treatment and no patient
required reoperation.
Conclusions: RFA is a minimally invasive, safe and
curative therapy in the management of symptomatic-
enlarging HCHs smaller than 10 cm.
795
QUALITY OF DAY-CARE
LAPAROSCOPIC CHOLECYSTECTOMY
PATIENTS’ LIFE: THE CHINESE
EXPERIENCE
Yang Liu1, Mu-Chuan Yu2, Bo Liu1, Xian-Qiang
Wang1, Xiang-Fei Meng1 and Jia-Hong Dong1
1Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Beijing, 100853; 2Department of
Hepatobiliary Surgery, Traditional Chinese Medicine
Hospital of Zhangqiu City, Shangdong, China
Objective and aims: To compare of the short term clini-
cal efficacy and quality of life in day-care laparoscopic
cholecystectomy (DCLC) group and conventional lapa-
roscopic cholecystectomy (CLC) group. To assess the
feasibility of extending DCLC in China.
Methods: Retrospectively analyzed the clinical data of
this operation in 167 cases between September 2009 and
Match 2010, DCLC group 106 cases and CLC group 61
cases. Recorded the quality of life by using SF-36 and
GIQLI scale at 1 day before the operation, 2 weeks after
the operation and 1 month after the operaion.
Results: There two were no statistically difference in
age, sex, body mass index, ASA score, operation indi-
cation, operation time, bleeding volume and postopera-
tive complications. No conversion admission during
this period. No statistic difference in SF-36 and GIQLI
of this 2 groups. Hospital stay length of DCLC group
was significantly lower than that of CLC group (days,
1.2  0.7 vs. 4.5 1.2, p = 0.00). DCLC group costs
were less than CLC group after deducting the cost of
supplies ( , 9045  755.2 vs. 9274.3  557.4, p = 0.03).
Conclusions: DCLC is safe and effective, it can reduce
the length of hospital stay and reduce hospital charges.
No significant difference in terms of quality of life ver-
sus CLC. To promote DCLC is feasible in China.
800
A CASE OF PRIMARY MALIGNANT
GASTROINTESTINAL STROMAL
TUMOR (GIST) OF THE LIVER
PRESENTING MULTIPLE METASTATIC
NODULES IN THE ABDOMINAL
CAVITY
Chi Young Jeong, Jin Kyu Cho, Young Tae Ju, Eun
Jung Jung, Young Joon Lee, Sang Kyung Choi, Woo
Song Ha, Soon Tae Park and Soon Cha
Department of Surgery, Gyeongsang National University
Hospital Jinju, Korea
Background and aims: GISTs found mostly in the gas-
trointestinal origin, but outside origins are extremely
unusual. The primary GIST of the liver are very rare.
We report a case of primary malignant GIST of the
liver and multiple metastatic nodules in the abdominal
cavity.
Methods: We present a case of primary hepatic GIST
in a 71 year-old patient, who was diagnosed early gas-
tric cancer. About 7cm sized low-attenuating solid mass
in the left lateral sector of the liver on computed
tomography (CT) was incidentally identified in the pro-
cess of workup. Magnetic resonance imaging revealed a
well defined mass with internal multiple cystic compo-
nent, initially diagnosed as biliary cystadenocarcinoma.
On PET CT imaging, a intense hot lesion in segment 3
was identified. Laparoscopic distal gastrectomy and
laparoscopic left lateral sectionectomy were performed
simultaneously. However, during operation, we identi-
fied multiple intra-abdominal nodules, which were
diagnosed as GIST through frozen biopsy.
Results: The tumor of the stomach was diagnosed as
signet ring cell carcinoma. The liver tumor showed the
ultrastructural features compatible with GISTs. Immu-
nohistochemical stains showed reactivity to CD117 and
DOG-1 in liver tumor cells, which were unreactive to
desmin, cytokeratin, smooth muscle actin, and S100.
The extensive histopathologic examination of the gas-
tric specimens failed to point out any other GIST. We
carefully reviewed previously CT examined five years
ago, we identified 1.9 cm sized mass in segment 2 of
the liver. In view of the fact that most previously
described malignant GIST were metastases from vari-
ous gastrointestinal sites, we carefully looked for a
potential primary site on the review of previously
scanned radiologic finding. Since no other primary site
could be found, we finally concluded that the liver
tumor was indeed malignant and the only GIST in this
patient rather than hepatic metastasis. Imatinib was
administrated after surgery, however, fifteen months
later, a routine follow-up CT scans revealed that
masses in left upper and lower quadrant abdominal
mass enlarged to respectively 8.4 cm and 3.4 cm.
Conclusions: Primary GIST of the liver was hypothe-
sized to originate from progenitors of mesenchymal
cells capable of differentiation toward a pacemaker cell
phenotype. This case shows that GIST can occur as a
primary liver tumor, so we indicated that not all GIST
of the liver are metastases. Primary hepatic GISTs may
be malignant and show poor outcome.
802
DO WE NEED A BETTER PROGNOSTIC
SCORING SYSTEM FOR SEVERE
ACUTE PANCREATITIS?
Sivaraj G, Jinzeng Du, Shelat V, Low JK, Woon W
and Junnarkar SP
Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng,
308433 Singapore
Introduction: Severe pancreatitis has been associated
with significant morbidity and mortality. Initial goals
in the management of severe pancreatitis involve
aggressive supportive care. Several scoring systems have
been used classically to prognosticate the severity of
pancreatitis in an attempt at early identification of
patients who may require intensive care and high
dependency monitoring and support. Two of the most
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commonly used scoring systems are the Glasgow and
Ranson’s score. The aim of our study is to review the
efficacy of the latter two scoring systems in prognosti-
cating the severity of acute pancreatitis.
Methods: A retrospective review of all patients who
were admitted for acute pancreatitis from January 2011
to December 2011. Acute pancreatitis was diagnosed
based upon characteristic clinical symptoms, serum
amylase and/or lipase levels more than three times the
upper limit of normal and characteristic findings on
imaging. All patients were prognosticated using both
the Ranson’s and Glasgow prognostic scoring systems
at admission. This data was then correlated with their
final severity outcome upon discharge. Atlanta classifi-
cation was used for evaluation of clinical outcomes at
discharge.
Results: From Jan 2011 to Dec 2011 109 patients were
admitted with a diagnosis of acute pancreatitis out of
which 13 patients had eventual severe pancreatitis. All
patients admitted and treated for acute pancreatitis
during the study period were taken in the analysis.
Severe pancreatitis occurred in 12% patients. Morbid-
ity and mortality of severe pancreatitis in our study is
11% and 2.8% respectively. Glasgow prognostic scor-
ing in our patients had a sensitivity of 53.9%, specific-
ity of 76%, positive predictive value (PPV) of 23.3%
and negative predictive value (NPV) of 92.4%. Ran-
son’s prognostic scoring showed a sensitivity of 84.6%,
specificity of 71.9%, PPV of 29% and a NPV of 97.2%
in predicting the final severity outcome.
Conclusions: Both the Ranson’s and Glasgow score
have strong NPV in the classification of pancreatitis
severity, but their sensitivity and specificity is limited.
Ranson’s scoring system is more sensitive than the
Glasgow system. We suggest alternate criteria for sever-
ity prognostication. We are studying if SOFA score is
more accurate in predicting severity.
805
SYNCHRONOUS DIAPHRAGMATIC
EXCISION DURING LIVER RESECTION
IS SAFE AND FEASIBLE
Bergamin P, Chang J, Links DJR, Stavrakis T and
Haghighi KS
Prince of Wales Hospital, Department of Surgery,
Barker St, Randwick, 2031 Sydney, Australia
Background and Aims: Diaphragmatic involvement by
tumour during liver resection can provide a difficult
challenge to the surgeon. We describe a simple tech-
nique for closure of the diaphragmatic defect after
resection and report a single surgeon’s experience of
synchronous excision with hepatic resection.
Methods: We retrospectively reviewed our prospec-
tively collected database of 337 liver resections per-
formed by a single surgeon (Haghighi KS) over 6 years
for patients undergoing concurrent diaphragmatic exci-
sion. We recorded patient characteristics, operative
data, histopathology, perioperative complications,
transfusion requirement, length of stay and survival.
Results: The indications for resection were 7 colorectal
liver metastases, 2 hepatocellular carcinoma, a benign
liver cyst and 1 renal cell cancer. All resections included
en bloc removal of the involved diaphragm with a 1cm
macroscopic margin where feasible. There was no inpa-
tient mortality, mean operative time was 188 minutes
and mean tumour size was 77mm. There were no pne-
umathoraces on CXR. Mean ICU stay was 1.3 days.
Mean length of hospital stay was 10 days. There was
one positive resection margin (non-diaphragmatic).
Four patients required blood transfusions (one unit).
The only complication was CVA secondary to atrial
fibrillation in one patient. There were no bile leaks or
collections. Three patients have had recurrence to date.
Two of the eleven patients have died of metastatic dis-
ease. Two patients required IVC resection concurrently
with the diaphragm resection. One patient required a
mesh repair to the diaphragm rather than primary
repair. Surgical technique: En bloc primary resection
with primary closure of the diaphragm. Closure is per-
formed left to right with continuous 2-0 Prolene suture.
At the lateral edge a purse string is formed with the
final two suture passes around a Yanker sucker placed
through this defect into the pleural space. A valsalva is
performed and the sucker turned on. The sucker is
removed whilst tightening the purse string enabling an
airtight closure of the defect with complete evacuation
of intrapleural air. There is no requirement for a chest
drain.
Conclusions: Synchronous diaphragmatic resection dur-
ing liver surgery can be performed safely with low peri-
operative morbidity. Diaphragmatic involvement by
tumour should not be considered a contraindication to
potentially curative liver resection.
807
PRETRANSPLANT SERUM ALPHA-
FETOPROTEIN HAS NO PROGNOSTIC
VALUE FOR TUMOR RECURRENCE
AFTER LIVER TRANSPLANTATION
FOR HEPATOCELLULAR CARCINOMA
WITHOUT VASCULAR INVASION
DETECTED BY PREOPERATIVE
IMAGING EXAMINATION
Gu-Ying Wang, Jian Zhang, Yang Yang, Qi Zhang
and Gui-Hua Chen
Liver Transplantation Center of the Third Affiliated
Hospital, Sun Yat-sen University, Guangzhou, 510630
China
Background and aims: Alpha-fetoprotein (AFP) has
been proposed to correlate with vascular invasion of
hepatocellular carcinoma (HCC) and predict tumor
recurrence after liver transplantation (LT). However,
the prognostic value of AFP in patients with HCC
without vascular invasion during the waiting list for LT
has not been clearly defined. In this study, we deter-
mined the prognostic role of preoperative AFP in
patients who underwent LT for HBV-associated HCC
without vascular invasion.
Methods: We analyzed the outcome of 80 patients who
underwent LT for HBV-associated HCC without vascu-
lar invasion. Vascular invasion was defined as the
presence of tumor emboli within the lobar or segmental
branches of the portal or hepatic veins, which was
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diagnosed or highly suspected by preoperative imaging
examination. Patients were divided into two groups
according to different AFP cut-off level (20 ng/ mL,
100 ng/mL, 200 ng/mL, and 400 ng/mL).
Results: The 1-, 3- and 5-year disease-free and overall
survivals were 97.1%, 89.1%, and 79.9%, and 92.1%,
81.5%, and 72.7%, respectively. Ten patients developed
tumor recurrence and 13 patients died during 6 years
of follow-up. Univariate analysis revealed that multiple
tumor number was the only preoperative predictor of
disease-free survival (DFS). Surprisingly, there was no
significant difference in DFS with regard to the tumor
size, AFP level, preoperative tumor therapy, histologic
grade, Milan criteria, and UCSF criteria. All four
patients with tumor size greater than 8 cm had no
tumor recurrence during 3 years of follow-up. The 3-,
and 5-year DFS for patients with AFP or > 400 ng/mL
were 86.8%, 82.4%, and 86.8%, 72.4%, respectively
(P > 0.05). The disease-free and overall survivals were
not significantly different among the five AFP classes
( 20 ng/mL; 21–100 ng/mL; 101–200 ng/mL; 201–400
ng/mL; >400 ng/mL).
Conclusions: Preopertative serum AFP level has no
prognostic role in patients who underwent liver trans-
plantation for HBV-associated HCC without vascular
invasion. Although the accuracy and objectivity of the
radiological imaging remains a problem, carefully
studying the radiologic imaging is still regarded as a
first-line test for selecting appropriate candidates for
liver transplantation and predicting tumor recurrence
following liver transplantation in patients with HCC.
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SYNERGISTIC INHIBITING EFFECT OF
PARP-1 INHIBITOR PJ34 AND HDAC
INHIBITOR SAHA ON HUMAN LIVER
CANCER
Bin-Yong Liang, Zhi-Yong Huang and Xiao-Ping
Chen
Research Laboratory and Hepatic Surgery Center,
Department of Surgery, Tongji Hospital, Tongji Medical
College, Huazhong University of Science and
Technology, Wuhan, China 430030 Wuhan, China
Background and aims: Poly (ADP-ribose) polymerase-1
(PARP-1) inhibitor PJ34 and Histone deacetylase
(HDAC) inhibitor Subcroylanilide hydroxamic acid
(SAHA) were respectively reported to have inhibiting
effect on human cancer cells. This study aims to
explore whether there exists a synergistic inhibiting
effect between PARP-1 inhibitor PJ34 and HDAC
inhibitor SAHA on human liver cancer.
Methods: PARP-1 expression was confirmed in human
liver cancer cell lines HepG2, Hep3B, HCC-LM3 and
also the human normal liver cell line L02. These cell
lines were administered with different inhibitors or its
combination (PJ34, SAHA, PJ34+SAHA), respectively.
Cell proliferation assay was employed to investigate cell
proliferation of each cell line following drug adminis-
tration. Flow cytometry was used for cell apoptosis
analysis. Moreover, HepG2 cells were inoculated sub-
cutaneously into nude mice. The nude mice bearing
subcutaneous tumors were grouped randomly and
administered with different inhibitors or its combina-
tion (PJ34, SAHA, PJ34+SAHA), respectively. The
inhibition rates of the individual inhibitors and its com-
bination on tumor growth were compared.
Results: Both PJ34 and SAHA inhibited the prolifera-
tion of HepG2 cells in a dose-dependent manner. There
was no significant cell cytotoxicity on human normal
liver cell line L02 with the concentrations of 8lmol/L
PJ34 and 1lmol/L SAHA. Furthermore, the combina-
tion of PJ34 (8lmol/L) and SAHA (1lmol/L) have a
synergistic inhibiting effect on the proliferation of
HepG2, Hep3B and HCC-LM3, the coefficient of drug
interaction (CDI) were 0.67, 0.81 and 0.76, respectively
(CDI<1 means synergy). The apoptosis rates of the
combined application of PJ34 and SAHA on HepG2
cells were significantly higher than those of separate
application of PJ34 or SAHA. In vivo, the tumor inhi-
bition rates of PJ34 alone (10mg/kg), SAHA alone
(25mg/kg) and PJ34 combined with SAHA (10mg/kg
PJ34+25mg/kg SAHA) were 53.5%, 61.4% and 82.6%,
respectively. The combined application of PJ34 and
SAHA had significantly inhibiting effect on xenograft
tumor growth comparing to PJ34 or SAHA alone.
Conclusions: The combination of PARP-1 inhibitor
PJ34 and HDAC inhibitor SAHA have a synergistic
inhibiting effect on human liver cancer. This study pro-
vides preliminary evidence for combined use of PARP-
1 inhibitor PJ34 and HDAC inhibitor SAHA for liver
cancer therapy in the future.
Key words: Poly (ADP-ribose) polymerase-1; PJ34;
Histone deacetylase; SAHA; Liver cancer
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THE EFFICACY OF RADIATION
THERAPY FOR PATIENTS WITH
ADVANCED GALLBLADDER
CARCINOMA AND ANALYSIS OF
PROGNOSTIC FACTORS
Liang Yang, Yong-Jian Sun, Hai-Hua Zhou, Hong-Bin
Ma and Yan Meng
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, 200438 China
Objective: To analyze the efficacy and evaluate the
security of advanced gallbladder cancer radiation ther-
apy retrospectively, in order to improve the prognosis.
Methods: 87 cases of gallbladder carcinoma were taken
with three-dimensional conformal radiation therapy. 81
cases can be evaluated. Nevin ‘staging for IV was in 23
cases, 58 cases were in V. Male was in 35 cases, 46
cases were of women. Single dose of 1.8 to 2.2Gy, once
a day, five times a week, the total dose was 38 to 65
Gy.
Results: Cox regression analysis showed that: The
serum CA199 value, efficacy and prognosis were with
relation. Patients with advanced gallbladder carcinoma
was in 81 cases, complete remission rate was 12.3% (10
cases), partial remission rate was 42.0% (34 cases), the
efficiency was 54.3%. The survival rate of 3 month was
95.1% (77 cases), survival rate of 6-month period was
69.1% (56 cases), and the survival rates of 1 year, 2
years and 3-year were 24.7%, 3.7%, 1.2%, and the
median survival was 8.5 months. The main response of
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Toxicity is the recent gastrointestinal tract returned to
normal after symptomatic treatment. Digestive reaction
of grade 1 was in 31 cases, grade II was in 10 cases, the
rate was 50.6%. The hematological toxicity of leukope-
nia and degree 1 was in 15 cases, II was 5 cases, the
rate was 24.7%. The thrombocytopenia of 1 I was in
eight cases, II degree was in 3 cases, the rate was
35.5%. No one cases was with termination treatment
due to severe radiation reaction.
Conclusions : The three-dimensional conformal radio-
therapy can prolong survival time of patients with
advanced gallbladder, and alleviate the symptoms; most
patients can tolerate side effects.
Key words: Gallbladder cancer, Three-Dimensional
Conformal Radiotherapy
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A REPORT OF FOUR CASES IN A VHL
FAMILY IN SHAANXI, CHINA
Jing–Yao Zhang and Chang Liu
Department of Hepatobiliary Surgery, The First
Affiliated Hospital of Xi’an Jiaotong University Medical
College, Xi’an, Shaanxi, China
Background: Von Hippel-Lindau (VHL) disease a rare,
inherited neoplastic disease characterized by multi-
organ involvement of tumors, with the incidence of 1/
36,000–1/52,000. There are a lot of reports about VHL
disease in the world but a few about Chinese, especially
the particular subtype just like the pancreatic endocrine
tumors (PETs). We encountered four members of the
same family who had the VHL disease of which two of
them were diagnosed the PETs at last, so we review the
clinical data of cases and evaluate the clinical features
of the disease.
Aims: To report four cases of VHL disease came from
the same VHL family in Shaanxi, China.
Cases: Four patients (37, 42, 33 and 24 years old)
came from a same family were admitted to hospital in
2011. The first patient had a bilateral adrenectomy in
1999, and was detected pancreas lesions in the physical
examination. The second patient came for the high
blood temperature and the neoplasm of the pancreas,
the bilateral adrenal gland and the spleen. The third
patient is related to the headache and the lesions in the
left cerebellar, then she was found he neoplasm of the
right adrenal when she took the CT in the hospital.
And the fourth was admitted for the lesions in the
bilateral adrenal.
Results and Conclusions: Four patients were diagnosed
the VHL disease in the clinical. The first patient’s pan-
creas lesions was confirmed the multiple endocrine pan-
creatic tumors with the metastases in the Spleen, and
the paraganglioma at the junction of Inferior vena cava
and left renal vein. The second patient was finally diag-
nosed the diffuse pancreatic endocrine tumors, meta-
static in the left adrenal gland and hiluslienis, right
pheochromocytoma. The third patient was the heman-
gioblastoma in the left cerebellar and the right pheo-
chromocytomas. And the fourth was diagnosed the
bilateral pheochromocytomas after the operation. They
were all discharged after an uneventful recovery.
835
OUTCOME FOR HILAR
CHOLANGIOCARCINOMA REMAINS
POOR DESPITE AGGRESSIVE
TREATMENT
Moon-Tong Cheung
Department of Surgery, Queen Elizabeth Hospital, Hong
Kong SAR, China
Background: Treatment for hilar cholangiocarcinoma is
a challenge to surgeons, endoscopists and radiologists.
More aggressive approach including liver resection and
biliary reconstruction has been advocated in recent dec-
ades. Palliative stenting for hilar cancer carries poor
quality of life with at least 1 to 2 catheters inserted for
relieve of jaundice.
Methods: We review those patients with cholangiocar-
cinoma within 1 cm from liver hilar, some may
extended to 2nd branch intrahepatic ducts or duode-
num. Some intrahepatic cholangiocarinoma within
1 cm from the liver hilar were also included. All
patients under these categories with operations done
from 1st January 1996 to 30th October 2012 in our
hospital are retrospectively studied, particularly the
long term outcome and the need for further interven-
tion.
Results: There were 42 patients (24 males) with 43
operations. Mean age at operation was 66.1 years
(range 40–79). Ten had excision of extrahepatic bile
duct only, and all performed on or before year 2003;
20 had left hepatectomy, 8 right hepatectomy with bili-
ary reconstruction; 1 with right hepatectomy & Whip-
ple operation, 3 with Whipple only. Among those 29
hepatectomy, 16 had concomitant caudal lobe resection
and 4 had portal vein (PV) resection. One patient with
history of right hepatectomy had margin recurrent and
wedge re-resection performed 7 years later. There were
3 operative deaths, 2 before year 2000, and the other
was the re-resection patient died of post-operative
sepsis in 2010. Twenty-three patients had postoperative
complications. Microscopic margin involvement
occurred in 11 cases. These patients were follow-up for
a mean of 32.2 months (range 1–115). All except those
with early T1 tumor died after 10 years. Overall 5 year
survival was 38%, significantly worse in those patients
with excision of extrahepatic bile duct only. The 5 year
survival for those with hepatectomy was 43%, and the
recurrence did not affect by concomitant caudate lobe
or PV resection. The overall disease free survival for
those with hepatectomy and without hepatectomy was
42% and 21% respectively. Common sites of recur-
rence were peritoneum, liver, paraaortic lymphadenopa-
thy. The need for intervention for recurrence was 6 out
of 29 post-hepatectomy cases and 8 out of 13 cases for
those with excision or Whipple only.
Conclusion: Overall prognosis for hilar cholangiocarci-
noma remains gloomy. However, most of them are
slow-growing. Aggressive treatment consisting of hepa-
tectomy appears to be justified as it provides better
quality of life without requiring much intervention
despite its recurrence.
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849
IVB-STAGE (T4N2M0) WELL-
DIFFERENTIATED GALLBLADDER
CANCER PATIENT ACCEPTED LIVER
TRANSPLANTATION AND SURVIVED
MORE THAN 5 YEARS
Wei-Feng Tan1, Bing Yi1, Xiang-Ji Luo1, Yue-Qin
Zhou2, Li Cheng3, Bai-He Zhang1, Feng Shen1,
Xiao-Qing Jiang1 and Meng-Chao Wu1
1Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, 200438, China; 2Department of Forensic
Medicine, Medical College of Fudan University,
Shanghai, 200032, China; 3Shanghai Criminal
Investigation Corps Criminal Technology Research
Institute, Shanghai, 200083, China
Background and aims: IV-stage gallbladder carcinoma
is considered a contraindication for liver transplanta-
tion, but this rule is worth discussing according to IV-
stage well differentiated gallbladder carcinoma without
distal metastasis patient.
Methods: A severe liver cirrhosis patient (male, 70-
year-old) with gallbladder carcinoma without distal
metastasis is described.
Results: The patient accepted liver transplantation
(LT) and hepatoduodenal ligament lymph node exhaus-
tive dissection. During operation the patient had been
given a blood transfusion. The pathological examina-
tion indicated well-differentiated gallbladder adenosqu-
amous carcinoma (see picture 1) with liver infringed
approximately 4 cm and gallbladder neck lymph node,
hepatic artery lymph node metastasis. Postoperative
diagnosis was IV-stage (T4N2M0). About three weeks
later he suffered a serious acute transfusion-associated
graft-versus-host disease (TA-GVHD) but eventually
obtained a cure. 22 days after the surgery peripheral
blood test indicated leucopenia, 26 days the patient
presented with oral ulcers, 29 days the patient’s chest,
abdomen and back appeared lots of red rashes (see pic-
ture 2,3), and 31 days the patient presented with diar-
rhea and high fever. The human short tandem repeat
sequences-polymerase chain reaction (STR-PCR) test
was used to check the patient’s leukocyte extraction
which collected from the receptor’s peripheral blood,
liver tissue extraction and the donor’s liver tissue
extraction. STR-PCR test revealed: comparing with the
result of patient’s liver tissue, peripheral blood leuko-
cyte extraction was found to have abnormal allele
genes at three loci; further comparing with the test
result of donor’s liver extraction, the abnormal alleles
did not come from the donor (detailed in table 1).
Thus, the acute TA-GVHD was diagnosed. After a
comprehensive treatment to stop using the immunosup-
pressive agents, apply the anti-IL-2 receptor monoclo-
nal antibody, enhance the patient’s immunity and
symptomatic treatment, the patient was recovered. The
STR-PCR re-test indicated gene chimeric phenomenon
disappeared. The patient survived more than 5 years
without tumor recrudescence.
Conclusions: The case indicated that the STR-PCR test
was very useful for the early diagnosis of the liver trans-
plant recipients’ acute TA-GVHD, and under this basis,
early effective treatment conducive to cure acute TA-
GVHD. The case also prompted that according to a well-
differentiated gallbladder carcinoma without distal metas-
tasis patient, liver transplantation plus hepatoduodenal
ligament lymph node dissection might be worth to try
850
RISK FACTORS FOR
PANCREATOGENIC DIABETES AFTER
PANCREATICODUODENECTOMY
Yoo-Seok Yoon M.D., Ho-Seong Han M.D., Ji Hoon
Kim M.D., Jai Young Cho M.D., Dae-Wook Hwang
M.D. and Young Ki Kim M.D.
Seoul National University College of Medicine, Seoul
National University Bundang Hospital, 300 Gumidong,
Bundang-gu, Seongnam-si/Gyeonggo-do, South Korea
Background: Postoperative diabetes mellitus (DM)
after pancreaticoduodenectomy (PD) may compromise
the long-term quality of life in survivors after this oper-
ative procedure due to treatment difficulty and its
related complications. The aim of this study is to deter-
mine the incidence of new-onset pancreatogenic DM
after PD and investigate the risk factors for this com-
plication.
Methods: Among 170 patients who underwent PD
between November 2003 and September 2009, 98
patients were selected for this study. The selected patients
were non diabetic prior to the operation and had under-
gone follow-up tests for glucose metabolism and an
abdominal computed tomography (CT) scan 1 year after
the operation. The clinical data of these patients were
retrospectively analyzed by reviewing their medical
records, radiologic images, and pathologic reports.
Results: Postoperative pathology confirmed malignant
tumors in 91 patients, borderline malignancy in 5, and
benign tumor in 2. Tumor locations included the pan-
creatic head (n = 30), the common bile duct (CBD)
(n = 30), ampulla of Vater (n = 30), and the duodenum
(n = 8). New-onset diabetes occurred in 17 (17.4%) of
the 98 patients during the first year after the operation.
The comparative analysis between postoperative DM
(+) and DM (-) groups revealed that the atrophy of the
remaining pancreas was the only significant risk factor
for development of postoperative DM after PD.
Conclusion: This study suggests that the atrophy of the
remaining pancreas increases the risk of pancreatogenic
DM after PD, and various efforts to prevent pancreatic
atrophy are needed to decrease this complication.
852
RADIOFREQUENCY-ASSISTED VERSUS
CLAMP-CRUSH TECHNIQUE FOR
LIVER PARENCHYMAL TRANSACTION:
A META-ANALYSIS OF RANDOMIZED
CONTROLLED TRIALS
Yun-Hong Tian, Hai Ma, Hong-Chun Yang and Yu
Wang
Department of Hepato-biliary Surgery, Nanchong
Central Hospital, Nanchong, Sichuan, China
Background: Radiofrequency-assisted technique and
clamp-crush technique has been used widely in liver
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parenchymal transaction. We compared radiofrequen-
cy-assisted (RF) and clamp-crush (CC) liver resection
technique using a meta-analysis.
Methods: Literature on Radiofrequency-assisted versus
Clamp-crush technique for liver parenchymal transac-
tion published in public was retrieved.
Results: Five randomized controlled trials with a total
of 451 patients were included. 236 treated with RF
resection and 215 treated with CC resection. The infec-
tive complication and bile leakage were greater with the
RF than with the CC group. There was no significant
difference between the two groups in total blood loss,
Blood loss during transaction, Transaction time, Blood
loss/transaction area, Transected area/time, Operation
time.
Conclusions: The clamp-crush technique is more safe
and is associated with lower bile leakage when com-
pared with radiofrequency-assisted of liver parenchymal
transaction.
854
SUPPRESSION OF CB1 CANNABINOID
RECEPTOR BY LENTIVIRUS
MEDIATED SMALL INTERFERING RNA
AMELIORATES HEPATIC FIBROSIS IN
RATS
Si-Wen Chen, Ben-Yan Wu, Shi-Ping Xu, Jun-Bao
Wen and Dao-Hong Wu
Department of Gastroenterology, NanLou Clinic,
General Hospital of PLA, Beijing 100851, China
It is recognized that endogenous cannabinoids, which
signal through CB1 receptors in hepatic stellate cells
(HSCs), exert a profibrotic effect on chronic liver dis-
eases. In this study, we suppressed CB1 expression by
lentivirus mediated small interfering RNA (CB1-RNAi-
LV) and investigated its effect on hepatic fibrosis in vi-
tro and in vivo. Our results demonstrated that CB1-
RNAi-LV significantly inhibited CB1 expression, and
suppressed proliferation and extracellular matrix pro-
duction in HSCs. Furthermore, CB1-RNAi-LV amelio-
rated dimethylnitrosamine induced hepatic fibrosis
markedly, which was associated with the decreased
expression of mesenchymal cell markers smooth muscle
a-actin, vimentin and snail, and the increased expres-
sion of epithelial cell marker E-cadherin. The mecha-
nism lies on the blockage of Smad signaling
transduction induced by transforming growth factor b1
and its receptor TGF-b RII. Our study firstly provides
the evidence that CB1-RNAi-LV might ameliorate
hepatic fibrosis through the reversal of epithelial-to-
mesenchymal transition (EMT), while the CB1 antago-
nists AM251 had no effect on epithelial-mesenchymal
transitions of HSCs. This suggests that CB1 is impli-
cated in hepatic fibrosis and selective suppression of
CB1 by small interfering RNA may present a powerful
tool for hepatic fibrosis treatment.
855
MIR-526B IS INVOLVED IN DOWN-
REGULATING KU80 EXPRESSION AND
TUMOR PROGRESSION OF
HEPATOCELLULAR CARCINOMA
Zun-Yi Zhang, Zhi-Yong Huang and Xiao-Ping Chen
Research Laboratory and Hepatic Surgery Center,
Department of Surgery, Tongji Hospital, Tongji Medical
College, Huazhong University of Science and
Technology, 1095 Jie Fang Da Dao 430030, Wuhan,
China
Objective: Ku80 is a component of the protein complex
called DNA-dependent kinase, which is involved in
DNA double-strand break repair and multiple other
functions. Previous study has revealed that Ku80 is fre-
quently down-regulated in HCC compared with the
adjacent liver tissue, suggesting that ku80 functions as
tumor suppressor gene in HCC. But the mechanism for
the down-regulation of Ku80 is still unknown. MicroR-
NA (miRNA) is a new class of small, noncoding RNAs
that can bind target mRNAs and down-regulate pro-
tein expression in many species. What microRNAs are
involved in regulation of Ku80 expression is still
unknown.
Methods: Based on 5 released databases named miR-
anda, miRDB, miRWalk, RNA22, Target scan that
can be used to predict the relationship between micr-
oRNA and target protein, miR-31, miR-340, miR-188,
miR-297, miR-520, miR-524, miR-526b and miR-623
were predicted to be involved in the regulation of ku80
expression with highest possibility. All these microR-
NAs were transfected into HepG2 and PLC cell lines,
respectively, and the expression of Ku80 was detected
by Western blot. After the stable cell lines were chosen,
and the antagomir corresponding to the most effective
microRNA was transfected into the cell lines with the
higher expression of this microRNA. The cell growth
and apoptosis were studied in vivo. And the microR-
NA expression was further investigated in human HCC
and its adjacent liver tissue. The relationship between
the micro RNA expression and biological features of
the tumors were analyzed in 46 different patients with
HCC.
Results: miR-526b down-regulated the expression of
Ku80 in HepG2 and PLC cell lines. After inhibiting the
function of miR-526b by the antagomir, the expression
of Ku80 was up-regulated in PLC cells. The down reg-
ulation of the expression of miR-526b in PLC cells
resulted in growth inhibition and apoptosis. Mir-526b
was found up-regulated in HCC with adjacent liver tis-
sue in 41% patients. And the up-regulation of miR-
526b was significantly correlated with poor differentia-
tion of the tumor.
Conclusion: miR-526b is involved in down-regulation
of Ku80, and increased miR-526b expression is associ-
ated with tumor progression of HCC.
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MIDDLE-PRESERVING
PANCREATECTOMY WITH REVERSED-
PANCREATOGASTROSTOMY
Bibek Aryal, Teruo Komokata, Jun Kadono, Hiroyuki
Motodaka, Hidetaka Kawamura, Yuichi Shimamoto,
Koto Yoshikawa and Iwao Kitazono
Department of Cardiovascular and Gastroenterological
Surgery, Kagoshima University Graduate School of
Medical and Dental Science, Arata 2-53-13, Dai ichi
kawaji Biru- 401, Kagoshima, Japan
Background: Middle-preserving pancreatectomy (MPP)
is a parenchyma-preserving procedure when the pancre-
atic body is spared from disease. Variability exists in
the method of anastomosis with the remnant pancreas.
Aim: To show the surgical technique for MPP and an
alternative method for the pancreatic anastomosis, so-
called reverse-pancreaticogastrostomy (RPG).
Methods: A 79-year-old woman was diagnosed for a
carcinoma of the lower bile duct and a branched-type
IPMN in the tail of the pancreas by CT-scan, MRI/
MRCP, and ERCP. A subtotal stomach preserving
pancreaticoduodenectomy was performed followed by a
pancreatic tail resection with a splenectomy. Mobiliza-
tion of the proximal stump of the pancreas was impos-
sible because of an inadequate length of the pancreatic
remnant and fixation of the pancreatic remnant to the
surrounding vasculature and tissues. The distal (left
side) stump with a lost stent was anastomosed to the
stomach by invagination method.
Results: The patient developed pancreatic fistula on
Grade B at the proximal stump of the pancreatic rem-
nant, and recovered with conservative management.
After a year of surgery patient had normal endocrine
and exocrine functions.
Conclusions: MPP is a useful procedure for resecting
multifocal lesions in the head and tail of the pancreas.
RPG is a feasible method for pancreatic reconstruction
after MPP.
870
MEASUREMENT OF KL-6 IN BILE: A
NEW APPROACH FOR DIAGNOSIS OF
BILIARY MALIGNANCIES
Yang Shen, Dao-Jian Gao, Ya-Min Pan, Tian-Tian
Wang, Xiao-Ming Yang, Jun Wu, Xin Ye, Rui Lu,
Zhi-Mei Shi, Shu-Ping Wang and Hui Huang
Department of Endoscopy, Eastern Hepatobiliary
Hospital, The Second Military Medical University, 225
Changhai Rd, Shanghai 200438, China
Background and aims: The early diagnosis of malignant
biliary strictures can be clinically challenging. Serum
Krebs von den Lungen-6 (KL-6), classified as human
mucin-1 (MUC1), is used as a marker of some malig-
nancies including biliary tumors. However, there is lim-
ited literature on the level of KL-6 in human bile. We
hypothesize that measurement of KL-6 in bile could
improve diagnosis in patients with indeterminate biliary
strictures.
Patients and Methods: A total of 57 patients with bili-
ary obstruction, who received Endoscopic retrograde
cholangio-pancreatography (ERCP) between December
2011 and July 2012 in the Eastern Hepatobiliary Hospital
were retrospectively reviewed. The etiologies of patients
included malignant tumors in 41 cases (cholangiocarci-
noma 16, hepatocellular ca. 10, pancreatic ca. 4, papilla
ca. 4, gallbladder ca. 3, and metastasis 4) and benign
lesions in 16 (bile duct stones 10, strictures 6). Each
patient’s bile and serum were obtained and KL-6 levels
were measured using ELISA method. The serum KL-6
was also assessed in another 14 healthy adult volunteers
for control. Receiver operating characteristics (ROC)
was used to calculate the diagnostic accuracy of KL-6.
Results: The mean (SD, ng/ml) of serum KL-6 in
malignant, benign and healthy persons were
46.074  9.76, 42.563  13.529 and 23.180  14.604
respectively (p < 0.05). ROC curves showed the optimal
diagnostic cutoff of KL-6 in serum was 45.541 ng/ml
and the area under curve (AUC) was 0.601 (95% CI
0.415–0.786), with sensitivity of 58.5% and specificity
of 62.5%. The level of KL-6 in bile was significantly
higher in patients with biliary malignancy
(65.841 15.845) than with benign diseases (51.947
 9.624), (p = 0.004). The optimal cutoff of KL-6 in
bile was 57.942, with AUC 0.749 (95% CI 0.621–
0.878), sensitivity 63.4% and specificity 81.2%.
Conclusions: KL-6 level is much higher in patients with
malignant biliary disorders both in serum and bile,
which is a promising biomarker for biliary tumors.
Measurement of KL-6 in bile showed more sensitive
and specifically than in serum and can serve as early
diagnostic approach for the biliary malignancies.
871
CLINICAL APPLICATION OF A NOVEL
TECHNIQUE OF
PANCREATICOGASTROSTOMY WITH
DUCT-TO-MUCOSA ANASTOMOSIS: A
REPORT OF 75 CASES
Cai-De Lu, Sheng-Dong Wu, Jin Huang, Feng Qiu,
Wei-Ming Yu, Chang-Jiang Lu, Yong-Fei Hua. Tao
Peng and Zhi-Feng Yang
Department of Hepatobiliary and Pancreatic Surgery,
Lihuili Hospital, Ningbo University, School of Medicine,
Ningbo 315041, China
Background and aims: To introduce a novel reconstruc-
tive technique of the implanting pancreaticogastrosto-
my (IPG) with duct-to-mucosa anastomosis after
pancreaticoduodenectomy (PD) or local resection of
pancreas and evaluate its feasibility and efficiency.
Methods: The IPG was constructed as follows: An
appropriate seromuscular incision was made in the pos-
terior wall of the stomach, which was dissected from
the layer of mucomuscular/mucosa for about 1.5 cm in
deep. A 2 cm-freed pancreatic stump was implanted
into the pouch between two layers of seromuscular and
mucomuscular/mucosa by a continual suture using 4–0
Prolene from the left (greater curvature) to the right on
the posteriosuperior of the gastric wall and the front
capsule of pancreas stump. A hole was made on the
mucosa close to the pancreatic duct. The duct to
mucosa anastomosis was performed using 5–0 Polydi-
oxanone Suture (PDS) by the maneuvers of one point
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suturing. A stent tube in duct was remained as inner
drainage. The IPG was finished by the continuing
suture on the posteroinferior wall of gastric to the pos-
terior of pancreas. The Clinical data of 75 cases who
received IPG from Sep 2009 to May 2012 were
recorded prospectively and obtained from Database.
The statistical analyses of surgical complications,
including pancreatic leakage were performed.
Results: PD or local resection of pancreas were per-
formed for 81 cases in this period, among them 75
cases received IPG as Pancreatoenteric reconstruction.
Operations were consisted of 68 PD and 7 local resec-
tion of pancreas due to malignancy for 64 cases and
benign disease for others. The mean time for IPG was
25.9  3.3 min, and the median was 26 min (range, 18
–35). Hospitalization days after the surgery were
14.3  7.4 d (range, 7–49). Thirty-one complications
including pancreatic fistula were occurred in 26 cases
indicating an operation morbidity of 34.7% (26/75).
Total pancreatic leakage (fistula) occurred in 4 cases
(5.3%), but graded B/C was occurred only in one case
(1.3%). The operation mortality is zero.
Conclusions: The results of this initial application for
IPG indicate that the technique is simple and feasible,
can be performed with very low risk. It may provide a
favorable outcome and could be an alternative method
of pancreatoenteric reconstruction after PD. However,
to determine its superiority over the conventional pro-
cedures, this operative technique should be evaluated
more comprehensively in the further clinical study with
larger series of cases.
873
LAPAROSCOPIC APPROACH FOR
RIGHT-SIDED IHD STONES: A
COMPARATIVE STUDY OF OPEN
VERSUS LAPAROSCOPIC TREATMENT
Young Ki Kim, Ho-Seong Han, Yoo-Seok Yoon, Jai
Young Cho, Dae Wook Hwang and Kyu Whan Jung
Seoul National University Bundang Hospital, College of
Medicine, 166 Gumi-ro, Bundang-gu, Seongnam-si,
Gyeonggi-do, Korea, Seongnam, South Korea
Aims: The aim of this study is to evaluate the thera-
peutic effectiveness and safety of laparoscopic approach
for right-sided intrahepatic duct (IHD) stones by com-
paring it with open approach for the disease.
Background: The treatment of IHD stones is known to
be difficult because of high rate of incomplete elimina-
tion and recurrence. Despite several attempts to treat
this disease entity by laparoscopy, most of cases have
been limited to left-sided IHD stones. There have been
few reports on the application of laparoscopy for right-
sided IHD stones.
Methods: This retrospective comparative study
included 34 patients who underwent the laparoscopic
(n = 17) and open treatment (n = 17) for right-sided
IHD stones from March 2003 to December 2011, Clini-
cal data including operation time, intraoperative blood
loss, postoperative hospital stay days, postoperative
complication, stone clearance and recurrence rate were
retrospectively analyzed and compared between the two
groups.
Results: The operation time of laparoscopic group was
longer than open group (432  38 vs. 335  20 min,
p = 0.03). The laparoscopic group showed lower
postoperative complication rate than open group (30%
vs. 58% p = 0.04) There are no significant difference in
intraoperative blood loss (1294  267 vs.
908  228 mL), postoperative hospital stay (16  3 vs.
22  3 days). There was no perioperative mortality in
both groups. The laparoscopic group showed signifi-
cantly better stone clearance rate than open group (17
vs. 10 patients, p = 0.03). After a median follow-up of
31 months, the recurrence rate of laparoscopic group
was lower than that of open group (0 vs. 7 patients,
p = 0.03).
Conclusion: This study demonstrates that laparoscopic
treatment, including liver resection and IHD explora-
tion is can be an effective and safe therapeutic modality
in selected patients with right-sided IHD stones.
880
RISK FACTORS FOR LIFE –
THREATENING (ISGPF GRADE C)
PANCREATIC FISTULA FOLLOWING
PANCREATICODUODENECTOMY
Simon H. Tsang, K. S. H. Chok, T. T. Cheung,
W. K. Yuen, A. C. Chan, T. C. L. Wong, W. Sharr,
R. T. P. Poon, S. T. Fan and C. M. Lo
Division of Hepatobiliary and Pancreatic Surgery,
Department of Surgery, The University of Hong Kong,
Queen Mary Hospital, 102 Pokfulam Road, Hong Kong,
Hong Kong S.A.R., China
Background and aim: Postoperative pancreatic fistula
(POPF) remains a major complication after pancreati-
coduodenectomy. The International Study Group on
Pancreatic Fistula (ISGPF) in 2005 stratified the impact
of POPF on the patient’s hospital course into grades
A, B and C. The fact that the less severe forms of fis-
tula can be managed conservatively further highlights
the importance of early recognition of patients who are
at increased risk of grade C POPF, i.e. those who
require percutaneous drainage or reoperation. The risk
factors for grade C POPF are not well documented in
the literature. This study is to identify any potential
preoperative and intraoperative risk factors for the
development of grade C POPF following pancreatico-
duodenectomy.
Methods: A retrospective study of 160 consecutive
pancreaticoduodenectomies performed at a single insti-
tution between 1 April 2004 and 31 July 2012. Preoper-
ative, intraoperative, and postoperative data of patients
who developed grade C POPF were compared with
those who had no POPF or who suffered from milder
grades of POPF. Their respective perioperative
outcomes were analyzed.
Results: Adenocarcinoma of the pancreas was the com-
monest diagnosis with 61 patients (38.1%). 71 patients
(44.4%) developed POPF of whom 20 (12.5%) suffered
from grade C fistula. 8 patients out of a total of 10 in-
hospital deaths in the series suffered from grade C
POPF, whereas there were no deaths in patients with
fistula grades A or B. Patients with a soft pancreatic
consistency had a higher incidence of grade C POPF
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compared with those who had a hard pancreas (18.8%
vs. 3.2%, p = 0.006). Pancreaticoduodenectomies car-
ried out for conditions other than adenocarcinoma of
the pancreas had significantly higher occurrence of
grade C POPF (19.2% vs. 1.6%, p = 0.001). Patients’
age, comorbidities, preoperative renal function, serum
albumin, bilirubin, preoperative biliary drainage, opera-
tive blood loss, pancreatic duct diameter, or the use of
an external pancreatic stent showed no significant effect
on the incidence of grade C POPF.
Conclusion: A soft pancreas found at operation and
the diagnosis of a condition other than adenocarci-
noma of the pancreas are risk factors for postoperative
grade C pancreatic fistula formation following pancrea-
ticoduodenectomy.
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THE RELATIONSHIP BETWEEN
MAGNETIC FORCE WITH
ANASTOMOSIS EFFECT IN
INTESTINAL MAGNETIC
COMPRESSION ANASTOMOSIS: AN
ANIMAL TRIAL
Jia Ma, Xiao-Peng Yan, Ding-Hui Dong, Hao-Hua
Wang, Xiao-Hai Cui, Peng Lei, Shi-Qi Liu and Yi Lv
1Department of Hepatobiliary Surgery, the First
Affiliated Hospital, Medical School of XI’AN Jiaotong
University, 227 Yanta Rd, XI’AN 710061, Xi’an, China
Background & aim: Magnetic compression anastomosis
(MCA) is a kind of novel technology without suture
which has been widely used in digestive tract recon-
struction. However, at present there is a lack of
detailed study on the relationship between magnetic
force with anastomosis effect which determines the suc-
cess or failure of this technology. In this study, we
explored the relationship between magnetic force and
anastomosis effect.
Method: A total 15 mongrel canines underwent side-to-
side anstomosis in small intestine using MCA and each
animal was subjected to five intestinal anastomosises
meanwhile the five magnetic anastomats were separated
with resin holder to against attracted each other. The
maximum magnetic force were 10 N/15 N/20 N/30 N/
40 N, respectively. The postoperative complications,
gross appearance, tensile testing, pathology and
hydroxyproline quantitative were compared between
each groups at each time-point (1st day, 3rd day and
7th day).
Results: There are 4 cases not forming compression in
10 N group (3 cases in the 1st day, 1 case in the 3rd
day), 1 case in 15 N group (in the 1st day). Only 1 ani-
mal revealed anastomotic leakage in 40 N group (in the
7th day). Because the greater momentum adhesion,
there is no celiac infection. The pathology testing
revealed that there was inflammatory reaction and
hemorrhage around the anastomotic in the 1st day,
especially in the 40 N group. Granulation tissue could
be observed in the 3rd day in each groups, and a small
amount of new mucosal tissue could be observed in the
7th day. Tensile testing showed that breaking strength
enhanced with the time and magnetic force gradually.
Hydroxyproline quantitative also revealed significantly
more in stronger magnetic groups (p < 0.05).
Conclusion: This study revealed that anastomotic can-
not be completely against intestinal canal peristalsis in
10 ~ 15 N (73% ~ 93%), and has the risk of intestinal
leakage in 40 N (6.7%) because of necrosis too fast.
20 N and 30 N are more safe and effective in mongrel
canines’ small intestinal magnetic ananstomosis.
Because the radius of round cake shaped anastomat is
0.5 cm, the most suitable magnetic force range was
from 0.256 MPa to 0.382 MPa.
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PANCREATICODOUDENECTOMY FOR
COMMON BILE DUCT CANCER IN A
PATIENT WITH MALROTATION AND
SITUS AMBIGUOUS
Han Gi Lim and Yoo Shin Choi
Department of Surgery, College of Medicine, Chung-Ang
University, 224-1, Heuk Seok-Dong, Dongjak-Ku, Seoul,
Korea
Background: Situs inversus indicates mirror image loca-
tion of the internal organ. The incidence of situs inver-
sus is approximately 1 in 10,000. Situs ambiguous is
defined as the abnormal location of organs and vessels
which are not clearly lateralized. The estimated mini-
mal incidence of situs ambiguous is 1 in 40,000 in live
births. We present a case of CBD cancer patient who
has malrotation and isolated levocardia with particular
disposition of abdominal viscera and lack of a splenic
or cardiac anomaly which is a rare form of situs ambig-
uous.
Case: A 59-year-old male patient presented with epi-
gastric pain and jaundice. SGOT/SGPT, total/direct
bilirubin, alkaline phosphatase, gamma-glutamyltrans-
peptidase and CA 19–9 were elevated. CT showed seg-
mental concentric wall thickening in distal CBD with
biliary tree dilatation and abnormal disposition of
intra-abdominal organs. Liver was located in the mid-
dle of upper abdomen. The spleen was in the right
upper quadrant. In addition, stomach and pancreas
were laid reversely. Chest X-ray showed no specific
abnormality. Under the diagnosis of isolated levocardia
with situs ambiguous and distal CBD cancer, we
decided to explore. In the operative field, right lobe of
liver was located in the middle of upper abdominal cav-
ity resting and GB sat just beneath the right lobe of
liver as common. Left lobe of liver was located below
the left diaphragm but it was as big as right lobe.
Stomach and spleen was found in the right upper abdo-
men under the right lobe of liver. We could find first
and second portion of duodenum, but below third por-
tion, duodenum and jejunum were not clearly identified
due to the lack of treitz ligatment. This causes the third
and fourth portion of duodenum and pancreas did not
locate in the retroperitoneum, but in the peritoneal
space. The uncinate process of pancreas was not devel-
oped. Small intestine was totally gathered right side of
abdomen. And whole large intestine was on left; espe-
cially ascending colon was not fixed with gastrocolic
and duodenocolic ligament so it was freely movable.
We performed PPPD as usual manner. Total operation
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time was 605 min. And blood loss was about 500 ml.
Histopathologic outcome was moderately differentiated
adenocarcinoma of common bile duct and the tumor
invaded to pancreas and duodenum (T3N0M0). He
recovered without any complications and CCRT were
started at 15st post operative day.
886
THE CLINICOPATHOLOGICAL
ANALYSIS OF CENTRAL
PERIVENULITIS-BASE ACUTE
REJECTION AFTER LIVER
TRANSPLANTATION
Xin-Yuan Lu and Wen-Ming Cong
Department of Pathology, Eastern Hepatobiliary
Surgery Hospital, Second Military Medical University,
225# Changhai road, Shanghai, China
Background: Clinicopathological staging of complica-
tions after liver transplantation (LT) has not been fully
described. The aim of the current study was to propose
a clinicopathological staging for post-LT complications
based on a larger series of liver biopsies.
Materials and Methods: We retrospectively analyzed
1,245 needle liver biopsies after LT in a single center
followed by proposing a clinicopathological staging for
post-LT complications.
Results: In 444 cases of the liver biopsy pathology
diagnosed as acute rejection, the portal-based AR (PB-
AR) was identified in 236 (53.15%) cases; while the
central perivenulitis-based AR (CP-AR) was 27(6.08%)
cases and portal + central perivenulitis-based AR
(PB + CP-AR) was 47 (10.59%) cases. In the first liver
biopsies, PB-AR occurred mainly in stage I
( 1 month) after OLT, accounting for 75.16%;
41.67% of CP-AR and 45.16% of PB + CP-AR
occurred in the Stage II and III (>1 month), was much
later than PB-AR (p < 0.05). In consecutive liver biop-
sies, PB-AR in stage I accounted for 61.02%, which is
much earlier than CP-AR (25.93%) and PB + CP-AR
(38.30%) (p < 0.01). The Interval of two times PB-AR
(52  214.24 days) was shorter than CP-AR
(353  662.12) and PB + CP-AR (322.04  633.70)
(p < 0.05). Evaluation of liver function showed that
total bilirubin (TB) was different between non-AR and
AR groups (PB-AR, BACR, CP-AR, PB + CP-AR
and CR) (p < 0.05), but no difference between no-AR
and I/R or biliary lesions (p > 0.05).
Conclusions: The occurrence of PB-AR was most fre-
quently in the early stage after liver transplantation;
but CP-ACR which occurred in middle or late stage
lasted long time and was not easy to restore. There
were no difference in liver function between groups of
AR, we cannot divide the type of acute rejection by
liver function test, eventually need to clear by patholog-
ical diagnosis. Some test was useful to whether rejec-
tion was happened, such as TB.
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OSTEOPONTIN HAS A CRUCIAL ROLE
IN VASCULOGENIC MIMICRY
FORMATION BY HEPATOCELLULAR
CARCINOMA THROUGH REGULATION
OF MMP-2 AND UPA
Wen-Bin Liu, Ge-Liang Xu, Wei-Dong Jia and
Jian-Sheng Li
Department of Hepatic Surgery, Provincial Hospital
affiliated to Anhui Medical University, Anhui Province
Key Laboratory of Hepatopancreatobiliary Surgery, No.
17, Lujiang Road, Hefei 230001, Anhui Province, P. R.
China, Heifei, China
Background and aims: Osteopontin (OPN), which is
over expressed in a variety of cancers including hepato-
cellular carcinoma (HCC), is likely involved in vasculo-
genic mimicry (VM) formation by few some tumor
cells. We explored whether OPN had a crucial role in
VM formation by HCC cells in this study.
Methods: The abilities of highly metastatic MHCC97-
H cell line and non-metastatic Hep3B cell line to dis-
play VM in vitro were compared. Real-time RT-PCR
arrays were used to detect gene expression profiles of
the two HCC cells in three-dimensional culture. Small
interfering RNA (siRNA) was employed to investigate
whether OPN knockdown could inhibit proliferation,
invasiveness, migration, VM formation, and the
expression of matrix metalloproteinase (MMP)-2,
MMP-9 and plasminogen activator (uPA) in
MHCC97-H cells. Human HCC tissue samples were
studied by immunohistochemistry to analyze the corre-
lations between VM and the expression of OPN,
MMP-2 and uPA.
Results: MHCC97-H but not Hep3B cells possessed
the ability to form VM. Real-time RT-PCR array
analyses revealed increased expression of some genes
including OPN in MHCC97-H cells forming VM
compared with Hep3B. OPN knock down resulted in
a significant decrease in migration, invasion, and VM
formation capacity of MHCC97-H cells, which was
accompanied by down-regulation of MMP-2 and uPA
expression. Furthermore, there existed significant
positive correlations between VM and the expression
of OPN, MMP-2 and uPA in HCC tissue samples.
Conclusions: These results strongly suggest that OPN
acts to regulate VM formation by HCC cells, and its
action is associated with alteration of MMP-2 and uPA
expression by OPN.
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EXPRESSION AND CLINICAL
SIGNIFICANCE OF EXTRACELLULAR
MATRIX PROTEIN 1 IN
HEPATOCELLULAR CARCINOMA
Hao Chen, Jian-Sheng Li, Wei-Dong Jia and Ge-Liang
Xu
Department of Hepatic Surgery, Provincial Hospital
affiliated to Anhui Medical University, Anhui Province
Key Laboratory of Hepatopancreatobiliary Surgery, No.
17, Lujiang Road, Hefei 230001, Anhui Province, P. R.
China, Heifei, China
Background and aims: To elucidate the expression of
extracellular matrix protein 1 (ECM1) in hepatocellular
carcinoma (HCC) and its association with clinicopatho-
logical characteristics and prognosis, including explor-
ing the biological function and mechanism of ECM1 in
the process of metastasis and recurrence of HCC.
Methods: (1) RT-PCR and Western blotting was used
to evaluate ECM1 expression in HCC and correspond-
ing adjacent tissues, and three HCC cell lines with vari-
ous metastatic potentials. (2) The preoperative serum
ECM1 levels in a hospital-based cohort of patients with
HCC by ELISA to elucidate the serum levels of ECM1
in HCC and its association with clinicopathological
characteristics and prognosis. (3) In addition, it is also
to evaluate the ECM1 and matrix metalloproteinase 9
(MMP-9) expressions in a hospital-based cohort of
patients with HCC by immunohistochemistry.
Results: (1) Among the four cell lines, the expression
level in HCCLM3, which with the highest metastatic
potential, was significantly higher than that with lower;
while ECM1 expression was not detected in normal
liver cell line L02. Expression level of ECM1 was sig-
nificantly increased in HCC compared with adjacent
and normal liver tissues. (2) ECM1 was detected in all
the samples of 117 HCC patients and 53 healthy volun-
teers. The median serum ECM1 level in HCC patients
was significantly higher than that in healthy volunteers.
Median serum ECM1 levels were significantly higher in
patients with invasive phenotypes. On Cox propor-
tional-hazard model multivariate analysis, high serum
ECM1 level (>180 pg/ml) was found to be an indepen-
dent prognostic factor for overall survival and disease
free survival of HCC patients. (3) The positive rates of
ECM1 and MMP-9 expression in HCC tissues immu-
nohistochemically were 73.3% (88/120) and 65.0% (78/
120), significantly higher than that in normal liver tis-
sues, respectively. The expression of ECM1 in HCC tis-
sues was significantly correlated with vascular invasion
and TNM stage. The patients with both ECM1 and
MMP-9 positive have significantly poorest overall and
disease-free survival rate. There was a significant posi-
tive correlation between ECM1 and MMP-9.
Conclusions: ECM1 level in HCC patients are signifi-
cantly associated with invasive phenotypes; it may pres-
ent a diagnostic marker for predicting the prognosis
and recurrence of HCC patients after surgery, and may
via correlated with MMP-9 to promote the invasion of
HCC.
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STAT3 ACTIVATION MEDIATES
EPITHELIAL-TO-MESENCHYMAL
TRANSITION IN HUMAN
HEPATOCELLULAR CARCINOMA
Chuan-Hai Zhang, Ge-Liang Xu and Wei-Dong Jia
Department of Hepatic Surgery, Provincial Hospital
affiliated to Anhui Medical University, Anhui Province
Key Laboratory of Hepatopancreatobiliary Surgery, No.
17, Lujiang Road, Hefei 230001, Anhui Province, P. R.
China
Background and aims: Hepatocellular carcinoma
(HCC) is one of the most aggressive malignant tumors
highly prevalent in Asia and Africa [1]. The long-term
prognosis of HCC patients is dismal even after surgi-
cal resection because of a high recurrence rate, which
is usually associated with a high propensity for vascu-
lar invasion and metastasis [2]. Nevertheless, to date,
the molecular mechanisms for HCC invasion and
metastasis remains obscure, and the approaches to
inhibit invasion and metastasis are still limited. Epithe-
lial-to-mesenchymal transition (EMT) is critical for the
development of the invasion and metastasis in human
tumors [3]. Recently, signal transducer and activator
of transcription 3 (STAT3) activation has been linked
to EMT program in cancers. However, the actual
association of STAT3 activation with EMT, and its
mediated tumor invasion and metastasis remains elu-
sive in HCC. The aim of this study was to investigate
the correlation between STAT3 activation and EMT,
as well as the underlying mechanism involved in HCC
progression.
Methods: We treated SMMC-7721 cells with a known
STAT3 activator in the absence or presence of a selec-
tive STAT3 inhibitor. The EMT-associated morpho-
logic and molecular changes of cells were analyzed. The
EMT-mediated HCC cell invasion, migration and adhe-
sion were evaluated. Moreover, these in vitro findings
were further verified in HCC clinical samples.
Results: In this study, we found that STAT3 activation
was associated significantly with morphologic changes,
cytoskeleton rearrangement and molecular changes
consistent with EMT in SMMC-7721 cells; STAT3 acti-
vation-mediated EMT may be transcriptionally induced
by Twist. STAT3 activation-mediated EMT also pro-
moted HCC cell invasion, migration and adhesion sig-
nificantly. By analysis of clinical samples, we found
that activated STAT3 was significantly correlated with
the expression of EMT markers and was positively
associated with HCC invasion and metastasis, which
was also confirmed by detection of HCC cell lines with
different metastatic potentials.
Conclusion: In summary, our study show for the first
time that STAT3 activation may induce invasion and
metastasis through the mediation of EMT in HCC.
Activated STAT3 and EMT markers can serve as
molecular targets for clinical HCC treatment.
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PREDICTIVE VALUE OF REVISED
MELD FOR CLINICAL RESULTS IN
THE EARLY STAGE AFTER LIVER
TRANSPLANTATION
Jian-Wei Chen, Yong-Fa Tan, Jie Zhou and He-Ping
Kan
Department of Hepatobiliary Surgery, Nanfang
Hospital, Southern Medical University, Guangzhou,
510515, China
Background and aims: To evaluate the prediction of
revised model for end-stage liver disease (MELD) for
the clinical results in the early stage after liver trans-
plantation.
Methods: The clinical data of 218 patients were retro-
spectively analyzed. After calculated the MELD score,
ReFit MELD score and ReFit MELDNa score before
transplantation, we compared the predictive accuracy
of MELD, ReFit MELD and ReFit MELDNa by ana-
lyzing area under curve (AUC) of the receiver operat-
ing characteristic (RUC). Groups were categorized with
the cut-off of MELD, ReFit MELD and ReFit
MELDNa and the early-stage complications and mor-
tality in different group were analyzed.
Results: The AUC for MELD, ReFit MELD and
ReFit MELDNa was 0.737 (95% CI 0.621 ~ 0.854),
0.727 (95% CI 0.663 ~ 0.785) and 0.735 (95% CI
0.671 ~ 0.792). There was no statistical difference of
the AUC among MELD, ReFit MELD and ReFit
MELDNa. All three elevated scores predicted higher
rates of pulmonary infection, abdominal infection and
acute renal dysfunction, including higher mortality.
Conclusions: The ReFit MELD score and ReFit
MELDNa score are relatively useful predictors of
short-term survival rates after liver transplantation, of
which predictive accuracy is similar to MELD score.
Value of the score above its cutoff value indicates
higher rates of complication and poorer prognosis.
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DOCOSAHEXAENOIC ACID REDUCES
PROLIFERATION AND INHIBITS
INVASION OF HUMAN
HEPATOCELLULAR CARCINOMA
CELL LINES
Si-Nan Sun, Jian-Sheng Li, Wei-Dong Jia and
Ge-Liang Xu
Department of Hepatic Surgery, Provincial Hospital
affiliated to Anhui Medical University, Anhui Province
Key Laboratory of Hepatopancreatobiliary Surgery, No.
17, Lujiang Road, Hefei 230001, Anhui Province, P. R.
China
Background and aims: To investigate the cellular and
molecular mechanism of docosahexaenoic acid (DHA)
induces apoptosis and inhibits invasion of hepatoma
cells.
Methods: The time- and dose-dependent effect of DHA
on the proliferative activity of hepatocellular carcinoma
(HCC) cell lines SMMC-7721 and Bel-7402 were
assessed by using the MTT staining method and cell
viability was estimated using the Trypan blue dye
exclusion assay. Quantitation of apoptotic cells under
different concentration of DHA-intake conditions was
obtained by flow cytometric analysis. The expression of
bim gene was selected for qRT-PCR analysis. We
detected the level of the antiapoptotic protein Bcl-2
and proapoptotic proteins Bax by Western blotting
assays. Measurement of caspase-3 activity was detected.
Cell invasion and migration assays were measured by
transwell and wound scratch assay. Immunohistochemi-
sty and Gelatin zymography were employed to deter-
mine the expression of MMP-9 in HCC cells which
pretreated with different concentrations of DHA for
48 h.
Results: 1) The longer exposure and higher concentra-
tions of DHA were more effective than shorter expo-
sure and lower DHA concentrations on cell
proliferation and cell viability. 2) DHA activates the
mitochondrial pathway of apoptosis and increases cas-
pase-3 activity. 3) DHA inhibits invasion and migration
of HCC cell.4) DHA decreases MMP-9 expression of
HCC cell.
Conclusions: DHA induced HCC cells apoptosis
through activating the mitochondrial pathway of apop-
tosis. DHA may reduce the invasion and metastasis of
HCC cells via decreasing the expression of MMP-9.
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OMEGA-3 POLYUNSATURATED FATTY
ACIDS PREVENT PROGRESSION OF
LIVER FIBROSIS AND PROMOTE
LIVER REGENERATION AFTER
PARTIAL HEPATECTOMY IN
CIRRHOTIC RATS
Yue Yang, Fei Duan, Xiao-Jie Bian, Hao Cai, Liang
Chen, Jian-Yu Lin and Yu-Dong Qiu
Department of Hepatobiliary Surgery, Affiliated Drum
Tower Hospital, Medical College of Nanjing University,
Jiangsu Province’s Key Medical Center for
Hepatobiliary Disease, No. 321 Zhongshan Road,
Nanjing 210008, Jiangsu Province, China
Background: Liver regeneration after the loss of hepa-
tic tissue is a fundamental parameter of liver response
to injury. x-3 PUFA could promote liver regeneration
and attenuate the progression of liver cirrhosis in cir-
rhotic rats.
Aims: To evaluate the effect of omega-3 polyunsatu-
rated fatty acids (n-3 PUFA) on liver regeneration after
hepatectomy and antifibrosis under conditions of liver
cirrhosis in rats.
Methods: Omega-3 polyunsaturated fatty acids were
intravenously injected in n-3 PUFA group 3 days
before operation to 1 day after partial hepatectomy.
Seventy precent hepatectomy was carried out in rats,
which were subsequently divided into 4 groups: (1)nor-
mal and hepatectomy group(PH), (2)liver cirrhosis and
hepatectomy group(LC + PH), (3)liver cirrhosis, n-3
PUFA (1 ml/kg) and hepatectomy group (LC + n-3
PUFA + PH),(4) liver cirrhosis, n-3 PUFA (2 ml/kg)
and hepatectomy group (LC + n-3 PUFA* + PH).
Body/liver weight ratios, Serum parameters, histopath-
ological examination, immunostaining, inflammatory
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cytokine and quantification of mRNA expression were
also investigated.
Results: Liver regeneration was significantly delayed
compared with PH group 7 days after hepatectomy in
LC + PH group. On the other hand, liver regeneration
of LC + n-3 PUFA* + PH group increased signifi-
cantly compared with LC + PH group 7 days after
hepatectomy. In LC + PH group, liver cirrhotic was
significantly higher compared with LC + n-3
PUFA + PH group 7 days after hepatectomy. Mean-
while, liver cirrhosis of LC + n-3 PUFA* + PH group
was significantly reduced compared with LC + n-3
PUFA + PH group 7 days after hepatectomy. Anti-
inflammatory cytokine IL-10 were increased and pro-
inflammatory cytokine IL-6 were decreased in LC + n-
3 PUFA* + PH group compared with LC + PH group.
N-3 PUFA also suppressed increments in mRNA
expression for transforming growth factor-b and matrix
metalloproteinase-1, and increased matrix metallopro-
teinase-9 expression in the liver.
Conclusion: These results clearly show n-3 PUFA that
reduce liver fibrosis and promote liver regeneration,
even under cirrhotic conditions. This could be a poten-
tially useful treatment for liver cirrhosis.
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CASE REPORT OF MESENCHYMAL
CHONDROSARCOMA ARISING FROM
THE PANCREAS
Jin Go and Chul-Nam Kim
Departments of General surgery, Ilsan Paik Hospital,
Inje University, School of Medicine, Goyangsi,
Gyeonggi-do 411-706, Korea Bu-cheon city, South Korea
Background: In worldwide, mesenchymal chondrosar-
coma is a very rare and has more aggressive prognosis
than other chondrosarcoma. Just 2 cases of metastatic
chondrosarcomas in the pancreas have been reported in
the literature.
Methods: A 41-year-old man presented with a 1-month
history of abdominal pain. His previous medical and
familial histories were unremarkable. CT scan of the
abdomen revealed an ill defined, lobulated mass that
measured about 13 9 12 9 7 cm in size and it
appeared as a heterogeneously low attenuated mass
with numerous areas of coarse calcification. Hemipan-
createctomy (involved splenectomy) and T-colectomy
was done.
Results: The pathological diagnosis was extraskeletal
mesenchymal chondrosarcoma arising from the pan-
creas with invasion to the splenic vein. 6th cycles of
Chemotherapy [Adriamycin + Ifosfamide + Mesna]
were done. 3 years later, the patient complained back
pain, vertebral metastasis and op. site recurrence were
confirmed by operative biopsy.
Conclusions: Mesenchymal chondrosarcoma almost dis-
plays a lethal clinical course, as radical excision of the
tumor is the optimal treatment methods.
902
STRUCTURED TRIGLYCERIDES WERE
WELL TOLERATED AND INDUCED
AFTER HEPATECTOMY IN PATIENTS
WITH HEPATOCARCINOMA
Wei-Dong Jia and Ge-Liang Xu
Department of Hepatic Surgery, Provincial Hospital
affiliated to Anhui Medical University, Anhui Province
Key Laboratory of Hepatopancreatobiliary Surgery, No.
17, Lujiang Road, Hefei 230001, Anhui Province, P. R.
China
Background and aims: There is a direct correlation
between the progression of the liver disease and the
severity of malnutrition. Malnutrition and cirrhosis can
cause high rates of morbidity and mortality in patients
with resection of hepatocellular carcinoma (HCC).
Since structured-lipid emulsion seems to induce less ele-
vation in serum liver function values, have no detri-
mental effect on the reticuloendothelial system, showed
a greater gain in body weight and a greater positive
nitrogen balance, we performed a prospective study to
investigate whether nutrition support with structured
triglycerides could have the effect of STG on liver func-
tions, biochemical variables, postoperative complica-
tions, and the overall safety in adult patients with
HCC.
Methods: 49 consecutive patients with HCC whose
HCC was considered to be respectable on the basis of
radiologic studies and hepatic-function tests were ran-
domly assigned into 2 groups: STG group (n = 25),
receiving peripheral parenteral nutrition support with
1.3 9 REE and nitrogen 0.20 (0.19 ~ 0.21) g/kg/d in
regular “3 L bag”, and the control group (n = 24)
receiving regular fluid supplement, with same amount
of nitrogen and glucose. The parenteral nutrition was
expected to be required for at least 5 d. Check postop-
erative liver functions, biochemical variables and post-
operative complications. Demographic data were
compared with an unpaired Student’s t tests or a Fish-
er’s exact test. Tolerance and efficacy were tested by a
two-way analysis of variance for repeated measures and
Tukey in posttest.
Results: The two groups of patients were similar in
terms of all basal values (age, sex, BMI, Child Grade,
and so on), and operative data (operate type, blood
loss, the results of the preoperative assessment). As
shown in Table 1 and 2, there were significant differ-
ences in blood serum values (prealbumin, RBP). Liver
function was found to be improved. As shown in Table
3, there were significant differences in blood C-reactive
protein.
Conclusions: The structured triglycerides was well toler-
ated and induced, and nutrition therapy with STG is
an effective method for postoperative support in
patients after hepatectomy with liver cancer.
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EXPRESSION AND CLINICAL
SIGNIFICANCE OF HEPATOCYTE
GROWTH FACTOR IN SERUM OF
PATIENTS WITH HEPATOCELLULAR
CARCINOMA
Wei-Dong Jia, Ge-Liang Xu and Jian-Sheng Li
Department of Hepatic Surgery, Provincial Hospital
affiliated to Anhui Medical University, Anhui Province
Key Laboratory of Hepatopancreatobiliary Surgery, No.
17, Lujiang Road, Hefei 230001, Anhui Province, P. R.
China
Background and aims: To investigate the expression of
hepatocyte growth factor (HGF) in patients with hepa-
tocellular carcinoma (HCC) and its clinical significance.
Methods: Enzyme-linked immunosorbent assay was
used to determine the circulating serum levels of HGF
in HCC patients and normal healthy people. Student’s
t-test was taken to compare the levels of HGF between
different clinical characteristics of patients with HCC.
The Kaplan-Meier method with log-rank test was
employed for survival analysis. Univariate and multi-
variate analyses were performed to identify the prog-
nostic factors in HCC patients.
Results: The median levels of HGF were significantly
higher in peripheral blood of patients with HCC than
in normal healthy people (1.17 [0.81 ~ 1.63] vs. 0.18
[0.12 ~ 0.54] ng/ml, p < 0.01). According to the patho-
logical features of HCC compared HGF levels between
different groups, we found that the levels of HGF were
significantly higher in male, tumor size >5 cm, vascular
invasion and with cirrhosis HCC patients than in
female, tumor size  5 cm, no vascular invasion and
without cirrhosis HCC patients (all p < 0.01). The HCC
patients were divided into two groups according to the
median level of HGF (group A was HGF  1.17 ng/
ml, and group B was HGF < 1.17 ng/ml). The overall
survival of group A was significantly lower than group
B (14.3%, 73.7%, respectively, p < 0.01). The disease-
free survival of group A was also lower than group B
(47.6%, 78.9%, respectively, p < 0.05). Univariate and
multivariate analyses for the survival rate showed that
the HGF and nodules were independent prognostic fac-
tors for overall survival.
Conclusion: HGF promote the development of male
patients with HCC, play a catalytic role in HCC inva-
sion and metastasis, and serve as a biological factor for
prognosis of HCC patients, which is also a dependent
prognostic factor for overall survival.
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CASE REPORT OF MESENCHYMAL
CHONDROSARCOMA ARISING FROM
THE PANCREAS
Jin Go and Chul Nam Kim
Departments of General surgery, Ilsan Paik Hospital,
Inje, University, School of Medicine, Goyangsi,
Gyeonggi-do 411-706, Korea Bu-cheon city, South Korea
Background: In worldwide, mesenchymal chondrosar-
coma is a very rare and has more aggressive prognosis
than other chondrosarcoma. Just 2 cases of metastatic
chondrosarcomas in the pancreas have been reported in
the literature.
Methods: A 41-year-old man presented with a 1-month
history of abdominal pain. His previous medical and
familial histories were unremarkable. CT scan of the
abdomen revealed an ill defined, lobulated mass that
measured about 13 9 12 9 7 cm in size and it
appeared as a heterogeneously low attenuated mass
with numerous areas of coarse calcification. Hemipan-
createctomy (involved splenectomy) and T-colectomy
was done.
Results: The pathological diagnosis was extraskeletal
mesenchymal chondrosarcoma arising from the pan-
creas with invasion to the splenic vein. 6th cycles of
Chemotherapy [Adriamycin + Ifosfamide + Mesna]
were done. 3 years later, the patient complained back
pain, vertebral metastasis and op. site recurrence were
confirmed by operative biopsy.
Conclusions: Mesenchymal chondrosarcoma almost dis-
plays a lethal clinical course, as radical excision of the
tumor is the optimal treatment methods.
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ESTROGEN MODULATE
INFLAMMATORY
MICROENVIRONMENT THROUGH IL-6
AND HGF TO SUPPRESS
TUMORIGENESIS AND METASTASIS
OF HCC
Wei-Dong Jia and Ge-Liang Xu
Department of Hepatic Surgery, Provincial Hospital
affiliated to Anhui Medical University, Anhui Province
Key Laboratory of Hepatopancreatobiliary Surgery, No.
17, Lujiang Road, Hefei 230001, Anhui Province, P. R.
China
Background and aims: The gender disparity in morbid-
ity of HCC provides an opportunity to investigate the
main etiology and predominant mechanisms leading to
HCC. Clinic and epidemiology data as well as animal
experiment rightly attaches to that estrogen may
involved in the development of HCC, but there is not a
definitive conclusion for their relationship and the
mechanisms involved in it are not clear. Our aim was
to explore the influence of estrogen on HCC and in
depth analyzing the mechanism of estrogen suppresses
hepatocarcinogenesis in a rat model.
Methods: First, 160 female SD rats were randomly dis-
tributed into four groups: ovariectomy (OVX), sham
operation (Sham), ovariectomy followed by 30 lg/kg
body weight/day 17a-Ethynylestradiol (EE2) supple-
mentation (OVX + E), and sexually intact control
(Ctrl) groups. All rats were treated intraperitoneally
with diethylnitrosamine (DEN) at a dose of 100 mg/kg
body weight and following N-nitrosomorpholine
(NMOR) (100 ppm) in drinking water for 20 weeks to
establish SD rat HCC model. Then, in depth analyzing
the mechanism of protective role of estrogen in the ini-
tiation, development and metastasis of HCC from pro-
tein and nucleic acid two aspects by using ELISA,
immunohistochemistry (IHC), RT-PCR based on the
findings of above.
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Results: Physiological doses of estrogen, no matter
endogenous E2 or exogenous EE2, can strongly reduce
the initiation, development and metastasis of HCC and
an increase in the survival time of animals dead before
the termination of experiment. OVX rats exhibit
decreased production of estrogen and a consistent
expression of estrogen receptor alpha (ERa) and phos-
phorylated estrogen receptor alpha (P-ERa); OVX
group express higher hepatocyte growth factor (HGF)
and interleukin-6 (IL-6) level in circulating and hepatic
tissues of rats at the end point of experiment; OVX
group exhibited increased expression of HGF and IL-6
than the other three groups in rat’s HCC at the end
point of experiment.
Conclusion: Our study showed that estrogen can modu-
lating the inflammatory hepatic and tumor microenvi-
ronment with one of the main mechanism by
suppressing HGF and IL-6 production, and this may
be response to gender differences that are detectable in
the occurrence of HCC.
906
BENEFICIAL EFFECTS OF S-
ADENOSYL-L-METHIONINE ON POST-
HEPATECTOMY RESIDUAL LIVER
FUNCTION: A PROSPECTIVE,
RANDOMIZED, CONTROLLED
Wei-Dong Jia, Ge-Liang Xu, Jin-Liang Ma and
Jian-Sheng Li
Department of Hepatic Surgery, Provincial Hospital
affiliated to Anhui Medical University, Anhui Province
Key Laboratory of Hepatopancreatobiliary Surgery, No.
17, Lujiang Road, Hefei 230001, Anhui Province, P. R.
China
Background and aims: Hepatectomy is associated with
high rates of postoperative live dysfunction in patients
with cirrhosis [1]. Since S-adenosyl-L-methionine
(SAMe) can be used to treat liver disease [2, 3], we per-
formed a prospective clinical trial to investigate
whether it could be used after hepatectomy to benefit
residual liver function.
Methods: We studied 79 hepatitis related chronic
patients who underwent resection of hepatocellular car-
cinoma. 39 patients were randomly assigned to receive
postoperative intravenous SAMe treatment, and 40
were randomly assigned to a control group. The post-
operative SAMe treatment consisted of SAMe 1000 mg
given intravenously for seven days. The other treatment
was standardized.
Results: At inclusion into the trial no significant dif-
ferences were observed between the two groups with
respect to sex, age, Child classification, preoperative
liver function tests, blood lose, total time of hepatic
pedicle occlusion and the extent of liver resection. The
overall frequency of postoperative liver insufficiency
decreased from 42% in the control group to 31% in
the SAMe group, although the difference was not sta-
tistically significant (p = 0.121). When the patients
who underwent hepatic pedicle occlusion by Pringle’s
maneuver over 15 min were analyzed, the frequency of
postoperative liver insufficiency (p = 0.028), serum
total bilirubin levels on days 5 (p = 0.025) and 7
(p = 0.032) preoperatively and the maximum value of
postoperative serum total bilirubin (p = 0.040) were
significantly greater in the control group than in the
SAMe group.
Conclusions: The results indicate that the postoperative
SAMe therapy can benefit residual liver function of the
patients with cirrhosis, especially in those suffered
greater ischemia reperfusion injury.
908
HEPATIC FUNCTIONAL RESERVE
ASSESSMENT FOR HEPATECTOMY IN
HEPATOCELLULAR CARCINOMA
PATIENTS WITH HBV-RELATED
CIRRHOSIS
Wei-Dong Jia, Ge-Liang Xu, Jin-Liang Ma and
Jian-Sheng Li
Department of Hepatic Surgery, Provincial Hospital
affiliated to Anhui Medical University, Anhui Province
Key Laboratory of Hepatopancreatobiliary Surgery, No.
17, Lujiang Road, Hefei 230001, Anhui Province, P. R.
China
Background and aims : Hepatocellular carcinoma
(HCC) is the third cause of cancer-related death world-
wide and the top two in China. Postoperative liver fail-
ure is still the major cause of postoperative death,
particular in patients with cirrhosis or underwent major
liver resection. In this case, a correct estimation of
hepatic functional reserve is essential to prevent it.
However, there is no standard hepatic functional
reserve assessment method for chronic hepatitis B
(HBV) related chronic patients. The aim was to assess
the predictive values of four classical hepatic functional
reserve assessment methods mainly based on indocya-
nine green (ICG) test for surgery on HCC patients with
HBV-related cirrhosis.
Methods: 153 patients with HBV-related cirrhosis who
underwent liver resections for HCC were enrolled in
this study. Indocyanine green (ICG) retention rate at
15 min (ICGR15) clearance (K) and effective hepatic
blood flow (EHBF) were measured by using a pulse
spectrophotometry before surgery. The volume of
whole liver, tumor and resected liver were measured.
The liver resection rate and the remnant ratio were cal-
culated. The predictive of four classical hepatic func-
tional reserve assessment methods were compared
included a prediction score by Okamoto et al, a criteria
by Van et al, a decision tree by Makuuchi et al and a
criteria by Ohwada et al.
Results: Twelve patients (7.8%) suffered liver failure
and two (1.4%) died in hospital. In a logistic regression
model, the remnant liver ratio (p = 0.027) and the rem-
nant K (p = 0.035) were significant predictors of post-
operative liver failure. Three of the four classical
hepatic functional reserve assessment methods
compared in this study showed the predictive value for
postoperative liver failure (p = 0.020; p < 0.001;
p < 0.001).The sensitivity and sensitivity of decision
tree method were the highest (75%, 92.9%).
Conclusions: The decision tree which based on ascites,
total bilirubin level and ICGR15 value can be used to
guide hepatobiliary surgeons in tailoring the correct
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timing and extent of liver resection for HBV-related
chronic patients.
910
PRELIMINARY RESEARCH OF
BIOLOGICAL CHARACTERISTICS ON
SIDE POPULATION CELLS SORTED
FROM HEPATOCELLULAR
CARCINOMA CELL LINE HEPG2
Yang Lv, Ge-Liang Xu and Wei-Dong Jia
Department of Hepatic Surgery, Provincial Hospital
affiliated to Anhui Medical University, Anhui Province
Key Laboratory of Hepatopancreatobiliary Surgery, No.
17, Lujiang Road, Hefei 230001, Anhui Province, P. R.
China
Background and aims: Emerging evidence indicate that
cancer stem cells (CSCs) are an essential targets for
cancer therapy because CSCs drive tumor growth,
chemo-resistance, tumor relapse, and metastasis. How-
ever, as lack of specific hepatocellular carcinoma stem
cell (HCSC) surface markers, HCSCs are very difficult
to be separated from hepatocellular carcinoma cells,
which becomes the key handicap of functional studies
of HCSCs. Side population cells (SP) sorting method
lays a solid foundation for in-depth study of HCSCs.
To identify the existence of SP in hepatocellular carci-
noma cell lines and to sort side population cells from
hepatocellular carcinoma cell line HepG2, besides to
analysis the biological characteristics different between
SP cells and original cell line HepG2.
Methods: Fluorescence-activated cell sorting (FACS)
was used to sort side population (SP) cells from
HepG2 cell lines. We defined SP cells as experimental
group and same generation HepG2 cells which didn’t
go through FACS as control group. Soft agar cloning
methods were applied to measure the tumor formation
ability of SP cell in vitro and Non-obese diabetic/
severe combined immunodeficiency (NOD/SCID)
xenograft transplant experiments was performed to
test the tumorigenicity of the two groups. The two
groups tumor cells adhesion ability were detected by
cell-matrix adhesion experiment. The distinction
between the two groups in proliferation growth curve,
migration capability and metastatic potential were
evaluated by MTT assay, Matrigel invasion assay and
migration assay. Suspension sphere formation assay
were used to test the ensphere capacity with Seru-free
medium.
Results: Soft agar cloning assay showed that SP cells
had significantly higher clonogenicity. NOD/SCID
xenograft transplant experiments demonstrated that
2 9 10 4 SP cells were sufficient to form tumor as to
control group 2 9 10 6 cells couldn’t form tumor.
There was no significantly difference in adhesion abil-
ity, metastatic potential and cell proliferation growth
curve between the two groups. Meanwhile migration
assay and sphere formation assay give evidence that SP
cells were more capable at migration and ensphere.
Conclusions: SP cells sorted from HepG2 cell lines have
cancer stem cell-like property and function, indicating
that they may rich in hepatocarcinoma stem cells.
913
HEPARIN-BINDING EPIDERMAL
GROWTH FACTOR-LIKE GROWTH
FACTOR PROTECTS RAT INTESTINE
AFTER PORTAL TRIAD CLAMPING
Xin-Xin Liao, Wen-Guang Fu, Li-Yan Chen and Jie
Zhou
Nanfang Hospital, No 1838 North Guangzhou Avenue,
Guangzhou, 510515 China
Background and aims: Heparin-binding epidermal
growth factor-like growth factor (HB-EGF) is a potent
mitogen and chemotactic factor. Previous studies have
demonstrated that HB-EGF attenuates the intestinal
ischemia/reperfusion injury caused by superior mesen-
teric artery occlusion. The current study examined
whether HB-EGF has protective effects in intestinal
congestion/reperfusion injury, which is caused by portal
triad clamping.
Methods: A total of 30 male Sprague-Dawley rats were
divided into three equal-sized groups randomly: I sham-
operated; II. portal triad clamping (Pringle maneuver)
for 30 min followed by reperfusion for 6 h; III II + in-
traluminal administration of HB-EGF 15 min after the
initiation of portal triad clamping. Intestine injury was
evaluated by histopathologic examinations. The expres-
sion of serum pro-inflammatory cytokines, such as
tumor necrosis factor-a and interleukin-1b was measured
by enzyme-linked immunosorbent assay (ELISA). Mye-
loperoxidase (MPO) activity and malonaldehyde (MDA)
levels of intestine samples were spectrophotometrically
measured. Apoptotic cells were assessed by terminal
deoxynucleotidyl transferase-mediated deoxyuridine
triphosphate nick end labeling technique (TUNEL).
Results: Compared with sham-operated rats, all rats
subjected to clamping of portal triad for 30 min fol-
lowed by reperfusion for 6 h had significantly increased
intestinal histologic injury, pro-inflammatory cytokine
expression, MPO activity, MDA levels and apoptosis
indices. Intraluminal administration of HB-EGF in
group III significantly reduced these indicators when
compared with group II (p < 0.05).
Conclusions: The clamping of portal triad which is fol-
lowed by reperfusion causes intestinal congestion/reper-
fusion injury. HB-EGF, given intraluminally, reduces the
severity of intestinal congestion/reperfusion injury in rats.
914
SPONTANEOUS RUPTURE OF
HEPATOCELLULAR CARCINOMA: A
TEACHING HOSPITAL
RETROSPECTIVE STUDY OF 87
PATIENTS
Ping Sun, Zi-Fang Song, Qing-Gang Hu, Jun Xiong,
Shao-Bo Hu and Qi-Chang Zheng
Hepatobiliary Surgery Centre, Union hospital, Huazhong
University of Science and Technology, 1277 Jiefang
Ave., Wuhan, Hubei, 430022, China
Background: Spontaneous rupture is not rare but a cat-
astrophic complication of hepatocellular carcinoma
(HCC) with high in-hospital mortality.
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Objective: To review the management of ruptured
HCC in a single teaching hospital over 13-year period;
to determine the prognostic factor of in-hospital mor-
tality and evaluate the safety and efficacy of liver resec-
tion.
Method: A retrospective collection of medical records
of 87 patients with spontaneous ruptured HCC was
carried out. All patients were in accordance with fixed
treatment strategy.
Results: 28 patients underwent emergency intervention
including transarterial chemoembolization (TACE) and
laparotomy with/without liver resection. Conservative
treatment was performed in 59 patients and 16 of
which underwent delayed hepatectomy or TACE
(Figure 1). The overall in-hospital mortality and med-
ian survival time was 54% and 22 days respectively.
Albumin level (OR = 0.874, 95% CI: 0.778–0.973,
p = 0.024), number of tumors (OR = 5.011, 95% CI:
1.015–24.750, p = 0.048) and laparotomy (OR = 0.069,
95% CI: 0.012–0.406, p = 0.003) were all independent
factors affecting overall in-hospital mortality (Table 1),
but for patients undergone laparotomy, only total bili-
rubin level (OR = 1.138, 95% CI: 1.024–1.264,
p = 0.016) was (Table 2). Age, total bilirubin level,
maximum tumor size, number of tumors, portal vein
tumor thrombosis and extra-hepatic metastasis were all
significantly different between group with laparotomy
and without. There was no significant difference
between emergency and delayed liver resection groups
in in-hospital mortality (0 vs. 0), median survival time
(788 vs. 750 days respectively) as well as 1-year and 3-
year survival rates (66.7%, 44.4% vs. 70%, 30%,
respectively) (p = 0.763, log-rank test) (Figure 2).
Conclusions: Spontaneous rupture is a catastrophic
complication of HCC, with in-hospital mortality
around 50%. Both underlying chronic liver disease and
tumor stage could affect the in-hospital mortality, but
for patients undergone laparotomy, only total bilirubin
level was independent factor. Surgeons were more
prone to choose patients with younger age, better liver
function and earlier tumor stage to do surgery, which
could achieve better survival. In well selected patients,
both emergency and delayed liver resections were safe
and could achieve prolonged survival.
915
HEPARIN BINDING EGF-LIKE
GROWTH FACTOR ATTENUATES
TOTAL HEPATIC ISCHEMIA-
REPERFUSION INJURY INDUCED BY
LIVER TRANSPLANTATION
Xin-Xin Liao, Wen-Guang Fu, Li-Yan Chen and Jie
Zhou
Nanfang Hospital, No 1838 North Guangzhou Avenue,
Guangzhou, 510515, China
Background and aims: Hepatic ischemia-reperfusion (I/
R) injury is associated with both local damage to the
liver and systemic inflammatory responses. Heparin
binding epidermal growth factor-like growth factor
(HB-EGF) is a biologically active protein that acts as
an intestinal cytoprotective agent. The current study
examined whether intraluminal administration of HB-
EGF has protective effects in total hepatic ischemia-
reperfusion injury induced by liver transplantation in
rats.
Methods: Thirty male Sprague-Dawley rats were ran-
domly divided into three equal-sized groups: I. sham-
operated; I. orthotopic autologous liver transplantation
model with anhepatic phase for 25 min followed by
reperfusion for 6 h (I/R);III. I/R with intraluminal
administration of HB-EGF 15 min after the initiation
of anhepatic phase (I/R + HB-EGF). Blood and liver
tissue samples were obtained and compared. Serum
level of ALT was measured. Liver was sampled for his-
topathological examination and TdT-mediated dUTP
nick end labeling (TUNEL) aasay. Myeloperoxidase
(MPO) activity of liver samples was spectrophotometri-
cally measured. The expressions of tumor necrosis
factor-alpha and interleukin-1beta in serum and liver
tissue were measured respectively. Liver nuclear factor
kappa B (NF-jB) p65 was detected by Western blot
analysis.
Results: Compared with sham-operated rats, all rats
subjected to anhepatic phase for 25 min followed by rep-
erfusion for 6 h had significantly increased serum ALT
level, hepatic histologic injury, apoptosis index, MPO
activity, pro-inflammatory cytokine expression and NF-
jB p65 nuclear translocation. Intraluminal administra-
tion of HB-EGF in group III significantly reduced these
indicators when compared with group II (p < 0.05).
Conclusions: HB-EGF, given intraluminally, attenuates
the severity of total hepatic ischemia-reperfusion injury
in rats. The protective mechanism may be related to its
anti-inflammatory function.
916
THE INVENTION AND ANIMAL
EXPERIMENTAL RESEARCH OF RAPID
VENO-VENOUS BYPASS
Peng Lei1, Yi Lv2 and Shi-Qi Liu2
1XJTU Research Institute of Advance Surgical
Technology and Engineering. The Department of
Hepatobiliary Surgery of Ningxia Medical University
Affiliated General Hospital, Ningxia Province, China;
2XJTU Research Institute of Advance Surgical
Technology and Engineering, Department of
Hepatobiliary Surgery, First Affiliated Hospital of Xi’an
Jiaotong University, The Yanta west road 76, Xi’an,
Shaanxi, China
Background: Ex-situ liver resection is an important
treatment alternative for unresectable liver tumors. This
surgical procedure requires a lengthy operation time,
during which blood dynamics must be carefully main-
tained to avoid venous congestion. However, an effec-
tive veno-venous bypass (VVB) may resolve this issue.
We invent a set of novel veno-venous bypass (VVB)
device with magnetic anastomosis technique which can
be used in ex situ liver resection, verify the clinical
value and the performance of them through canine
experiment.
Methods: 1. Invention and testing of the novel VVB
device. The construction and relevant parameters was
designed according the data of canine anatomic struc-
ture. Each VVB device was constructed from three
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magnetic rings and an inverted Y-shaped tube with
magnetic rings on its each end. The magnetic ring was
made of N52 sintered NdFeB with processing steps of
electrode cutting, titanium nitride (TiN) coating and
magnetizing. The tube was made of polyvinyl chloride
(PVC) and preconditioned with heparin coating on the
surface of lumen. The magnetic force of magnetic ring,
the tensile strength and pressure intensity of anasto-
motic stoma was tested respectively. The surface of
tube lumen was coated with heparin and low molecular
weight heparin (LMWH) with the H-G-PEI coating
technique. 2. Eight canines underwent the ex situ liver
resection, veno-venous bypass was established by mag-
netic anastomosis technique with the novel VVB device
in the operation. The time for establishing VVB was
recorded, and the hemodynamic indexes which include
venous flow velocity, carotid pressure, CAP and portal
pressure was detected. The change of intestinal canal
and kidney was also observed.
Results: 1. The magnetic force of magnetic ring, the
tensile strength and pressure intensity of anastomotic
stoma was satisfying. 2. It only took 6–10 min to estab-
lished VVB by the novel VVB device in the operation,
the hemodynamics stability was maintained smoothly
during the anhepatic phase. The shunt index of IVC
and PV was 76.2% and 75.5%, respectively. The
congestion of intestinal canal and kidney was also alle-
viated during the anhepatic phase.
Conclusions: 1. VVB is a key technique in ex situ liver
resection. 2. It can spend less time to establish VVB
with magnetic anastomosis technique in ex situ liver
resection. The experiment showed utilizing the novel
VVB device for introabdominal venovenous bypass
during the anhepatic phase could be helpful to
maintain hemodynamics stability.
918
STUDY OF THE RELATIVITY BETWEEN
LIVER METABOLISM AND ISCHEMIA-
REPERFUSION INJURY.
Li-Yan Chen, Jie Zhou, Zhen-Chao Luo, Xin-Xin
Liao, Jian-Wei Chen and Wang Kai
Nanfang Hospital, No. 1838 North Guangzhou Avenue,
Guangzhou, 510515, China
Background and aims: Taking GC/MS (gas chromatog-
raphy-mass spectrometry) as a new method to assess
ischemia and reperfusion injury (I/R) after liver surgery.
Methods: Through Sprague-Dawley rats to constructed
pringle maneuver, use pringle maneuver for 30 min,
test its urine for metabolisms, serums for nzymologies
and HE.
Results: The routine tests can lead to the same ten-
dency of the variety from injury to recover. Find the
typical and common markers as homologous markers
from liver metabolism like lipid metabolism, glycome-
tabolism and proteometabolism in testing urine by GC/
MS. GC/MS also have higher sensitive.
Conclusions: GC/MS is valuable for the assessments of
I/R after surgery on liver, it have not any reports yet.
The innovation of this experiment is to assess about I/
R anterior-posterior liver surgery, using GC/MS to
analysis urine. Although the test result inside the group
and interblock has higher disparity and most of the
markers have no significant, the typical and common
markers are still have higher sensitive. It is also have
higher value in clinical exploration of clinical research
and practices.
927
RETROSPECTIVE ANALYSIS OF 353
CASES OF UIGHUR AND HAN
NATIONALITY PANCREATIC CANCER
CLINICAL MATERIAL IN XINJIANG
yan-Na Sun, Hua Zhang, Rui-Li Zhang and
Yong-Xing Bao
Tumor Center, First Affiliated Hospital of Xinjiang
Medical University Xinjiang 830054, Urumqi, China
Purpose: Research and analysis the clinical features of
pancreatic cancer, living status and influence factors of
prognosis.
Methods: This paper retrospectively analyzes the Xinji-
ang medical university first affiliated hospital from
January 1, 2002 to December 31, 2010 of 353 cases of
hospitalized Uighur and han patients with pancreatic
cancered clinical data, the application of Kaplan–Meier
method for calculation of survival, and may the prog-
nosis of patients with image factors are single factor
analysis (log-rank test), the application of Cox pro-
portional risk model for multiple factors statistical
analysis.
Results: 353 cases of pancreatic cancer had a median
surial of 167 days, and the six months, 1, 2 and
5 years survival rates were 47.1%, 23.6%, 11.4%,
4.2% respectively, but Uighur han 1 year survival rate
were 22.0% and 23.4%, did not find significant differ-
ences in survival (p = 0.86). Single factor analysis
found that ECOG physical condition (ZPS) score,
clinical stage, surgery or not, tumor site and size,
chemoradiation or not, before treatment serum carci-
noembryonic antigen (CEA), cancer antigen 242
(CA242), cancer antigen 199 (CA199), numeration of
leukocyte (WBC), hemoglobin (HGB), platelet count
(PLT), albumin, lactate dehydrogenase level and clo-
sely related to the prognosis, Multiple factors analysis
shows that ECOG physical condition (ZPS) score, clin-
ical stage, surgery or not, tumor size, chemoradiation
or not, before treatment serum carbohydrate antigen
242, carbohydrate antigen 199, albumin, lactic acid
dehydrogenase levels can be used as independent prog-
nostic determining factor.
Conclusion: ECOG physical condition (ZPS) score,
clinical stage, surgery or not, tumor size, chemoradia-
tion or not, before treatment serum carbohydrate anti-
gen 242, carbohydrate antigen 199, albumin, lactic acid
dehydrogenase levels can be used as pancreatic cancer
independent prognostic determining factor.
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IMMUNOLOGIC ANALYSIS AND RISK
FACTORS FOR EARLY ACUTE
REJECTION IN LIVING DONOR LIVER
TRANSPLANTATION
Ho Joong Choi, Dong Goo Kim, Eun Young Kim,
Gun Hyung Na, Jae Hyun Han, Tae Ho Hong and
Young Kyoung You
Hepatobiliary-pancreas surgery & Liver Transplantation
division, Department of Surgery, Seoul St. Mary’s
Hospital, The Catholic University of Korea, Seoul,
South Korea
Background and aims: Orthotopic liver transplantation
(OLT) is the therapeutic option for hepatic failures or
HCC. Acute rejection is one of the main causes of early
graft failure. The purpose of this study is to evaluate
the factors associated with acute rejection by examining
the various factors.
Methods: From September 2010 to July 2012, we retro-
spectively analyzed 121 patients who had undergone
OLT at Seoul St. Mary’s Hospital of the Catholic Uni-
versity of Korea. Rejection activity index (RAI) 3
points or more, experienced within 12 months after
liver transplantation was defined as early acute rejec-
tion. We evaluated HLA (A, B, DR) typing, cross
matching (T cell, B cell) test, panel reactive antibody
(PRA) test, CD4, CD25, interleukin (IL)-2, IL-6, IL-
12, IL-17, interferon-c and TNF-a to identify factors
associated with rejection. We also compared survival
according to the presence of acute rejection. The med-
ian follow-up was 15 (3 ~ 25) months.
Results: 19 patients (15.7%) had experienced at least
one acute rejection episode within 12 months after
transplantation. Acute rejection occurred within 1, 6
and 12 months was 1 (5.2%), 14 (73.7%) and 4
(21.1%) patients. Acute rejection group revealed more
percentage of patients with non-identical HLA-A typ-
ing (p = 0.038). But, the incidence of rejection revealed
no statistical differences according to HLA-B, -DR typ-
ing and cross matching test. PRA class I, PRA class II,
CD4 & CD25 did not affect the incidence of acute
rejection. In the acute rejection group, but only IL-2
and IL-6 levels showed statistical difference (p = 0.011
and p = 0.006). Preoperative IL-10, IL-12, IL-17, inter-
feron-c and TNF-a levels showed no statistically signifi-
cant difference. Overall survival rates were no
relationship between acute rejection and no rejection
group (p = 0.815).
Conclusions: Our study shows that HLA-A typing, pre-
operative IL-2 and IL-6 levels are associated with acute
rejection occurred within 12 months. Further verifica-
tion of these findings by a large volume or prospective
study is required to determine the risk factor of rejec-
tion.
931
AGO1 PROMOTES HEPATOCELLULAR
CARCINOMA METASTASIS AND
ANGIOGENESIS THROUGH THE P53
AND VEGF PATHWAYS AND IS
CORRELATED TO POOR P
Miao Wang1,2, Jia-Min Zhou1,2 and Lu Wang1,2
1Liver Cancer Institute and Zhongshan Hospital, Fudan
University, Shanghai, People’s Republic of China; 2Key
Laboratory for Carcinogenesis and Cancer Invasion, The
Chinese Ministry of Education, Shanghai, People’s
Republic of China, 136 Yi Xue Yuan Road, Shanghai,
China
Background and aims: AGO1 is a major component of
RNA-induced silencing complexes and plays a crucial
role in solid tumors. The aim of our study was to
investigate AGO1 functions in HCC.
Methods: AGO1 expression was measured in
HCCLM3, MHCC97L, and HepG2 cell lines. Immuno-
histochemistry in tissue microarrays consisting of 200
HCC patients was used to analyze the associations
between AGO1 expression with prognosis and micro-
vessel density (MVD). Using small interfering RNA,
AGO1 functions and its effects on P53 and vascular
endothelial growth factor (VEGF) expression were
investigated in HCCLM3 and HepG2 cell lines.
Results: AGO1 expression increased in parallel with
the metastatic potential of the HCC cell lines. Cell pro-
liferation, invasion, and P53 and VEGF expression
were significantly decreased after AGO1 depletion in
the HCC cell lines. Intratumoral AGO1 was correlated
with younger age (p = 0.039), higher a-fetoprotein
(p = 0.002), HBeAg-positive status (p = 0.049), liver
cirrhosis (p = 0.045), intrahepatic and extrahepatic
recurrence (p < 0.001), higher MVD (p = 0.009), and
was an independent risk factor for overall survival
(p = 0.008) and recurrence-free survival (p < 0.001).
Conclusions: These findings indicate that AGO1 may
promote HCC metastasis and angiogenesis through the
P53 and VEGF pathways, and AGO1 may be a reliable
prognostic factor in HCC.
933
SURGICAL OUTCOME OF BILIARY
TRACT CANCER: SINGLE INSTITUTION
EXPERIENCE
Ryusei Matsuyama1, Ryutaro Mori1, Michio Ueda2,
Kuniya Tanaka1, Jiro Maekawa3 and Itaru Endo1
1Department of Gastroenterological Surgery, Yokohama
City University Graduate School of Medicine, 1-2-1-
E1401 Maruyamadai Kounandai Yokohama, Kanagawa,
Japan; 2Yokohama City University Medical Center,
Gastroenterological Center, 1-2-1-E1401 Maruyamadai
Kounandai Yokohama, Kanagawa, Japan; 3Department
of Plastic and Reconstructive Surgery, Yokohama City
University Hospital, 1-2-1-E1401 Maruyamadai
Kounandai Yokohama, Kanagawa, Japan
Introduction: Biliary tract cancer is a rare entity and its
prognosis varies depending on location of tumor. Sur-
gical resection remains the only potentially curative
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treatment. Aim of this study is to review our surgical
experience with biliary tract cancer.
Patients and Methods: Between 1992 and 2010, 352
patients with biliary tract cancer who underwent surgi-
cal resection at Department of Gastroenterological Sur-
gery, Yokohama City University Hospital, were
retrospectively reviewed. Site of cancer was the hilar
bile duct in 86 patients, the distal bile duct in 99
patients, the gallbladder in 92 patients, and the papilla
of Vater in 75 patients. Hepatectomy was performed in
119 patients, and Pancreaticoduodenectomy was per-
formed in 163 patients. Local resection such as bile
duct resection and cholecystectomy was performed in
70 patients.
Results: Morbidity and mortality rates were 48.8 and
3.1%, respectively. Curative resection was achieved in
295 patients (83.8%). The overall 5-year survival rate
of all patients was 48.5%. The 5-year survival rate was
97.1% for fStage I patients, 77.5% for fStage II
patients, 44.8% for fStage III patients, 21.3% for
fStage IVa patients and 10.1% for fStage IVb patients.
The 5-year survival rate was 37.5% for hilar bile duct
cancer, 40.0% for distal bile duct cancer, 50.3% for
gallbladder cancer, and 66.9% for cancer of the papilla
of Vater. Operative culpability, hospital death and 5-
year survival rates were improved significantly during
the period from 1992 to 2001 and from 2002 to 2010
from 75.4%, 4.9%, 42.2% to 91.0%, 1.5%, and 54.3%,
respectively.
Conclusions: Surgical outcome of biliary tract cancer is
still poor but have been improved year by year with
improved surgical techniques, new chemotherapeutic
agents, 3D-CT technology and development of surgical
devices.
945
PANCREATIC ASCITES- A CASE
REPORT
Borgaonkar Vijay, Deshpande Sushil and Rathod
Mukesh
Seth Nandlal Dhoot Hospital, A-1 M.I.D.C.
Chikalthana, Jalana Road, Aurangabad 431210,
Maharashtra, India
Pancreatic Ascites is an uncommon complication of
Acute Pancreatitis. The development of massive ascites
in a patient of Acute Pancreatitis should give rise to
suspicion of pancreatic cause. There is a disruption of
main pancreatic duct. This leads to rapid feeling of
abdominal cavity with ascetic fluid. The rise in intra-
abdominal pressure may give rise to difficulty in respi-
ration.
The diagnosis of pancreatic ascites is made by detection
of raised Serum Amylase with very high levels of Ascit-
ic fluid amylase and raised ascetic fluid proteins.
The treatment of this rare condition must be done ener-
getically. Various options are available depending on
patient’s condition and availability of resources at the
center.
When the disruption of the duct is suspected to be
minor, then only treatment with Injection Octreotide
helps some times. In other patients therapeutic Endo-
scopic Retrograde Cholangio Pancreatography
(E. R. C. P.) and selective pancreatic stenting gives dra-
matic results.
Presenting herewith our experience of managing suc-
cessfully a case of Pancreatic Ascites at our institute.
Patient was managed with therapeutic E. R. C. P. with
very good result.
947
RISK FACTORS OF PORTAL VEIN
THROMBOSIS AFTER SPLENECTOMY
IN PATIENTS WITH LIVER CIRRHOSIS
Mu-Xing Li, Xu-Feng Zhang and Yi Lv
Department of Hepatobiliary Surgery, The 1st Affiliated
Hospital, School of Medicine, Xi’an Jiaotong University,
No. 277, Yanta West Road, Xi’an, 710061, P.R. China
Background and aims: Portal vein thrombosis (PVT) is
a potential lethal complication after splenectomy in the
context of liver cirrhosis. The independent risk factors
of PVT have not been clearly defined yet. And disputa-
tion over the prophylaxis regiment for the PVT forma-
tion still exists. Our study aims to investigate risk
factors as well as our anti-platelet prophylactic strategy
of PVT.
Methods: From January 2008 to December 2010, 472
non-neoplastic liver cirrhosis patients underwent sple-
nectomy in our institution. Excluding 28 patients who
were diagnosed as PVT before or in the operation, the
clinical and surgical characteristics of 80 (80/444, 18%)
patients who developed PVT and 364 (364/444, 82%)
patients who did not develop PVT were reviewed and
analyzed. Prophylactic anti-platelet therapy was admin-
istrated when postoperative PLT count exceeded
300 9 109/L. The univariable and multivariable analy-
sis of risk factors were performed. The prognosis of the
two groups were later valued.
Results: There were no significant differences between
PVT group and non-PVT group in terms of hemoglo-
bin, WBC count, bilirubin, albumin, International nor-
malized ratio (INR), fibrinogen, Child-pugh
classification, MELD score (p > 0.05, respectively).
Operation time, Intraoperative blood transfusion,
acquired thrombophilic factors in patients’ history and
spleen volume exhibited no significant relationship with
PVT formation (p > 0.05 respectively). However, in
multivariable analysis, the preoperative portal vein
diameter (PVD) and postoperative thrombocytosis
(POD5 PLT count- preoperative PLT count) shown
significant differences between PVT group and non-
PVT group (p < 0.001, p = 0.001, respectively). And
patients underwent periesophagogastric devasculariza-
tion were prone to develop PVT (p < 0.001). Incidence
of PVT in patients who took anti-platelet drugs was
not lower than that in patients who didn’t in our insti-
tution (p = 0.722). Compared with non-PVT group,
gastrointestinal bleeding occurred more often in PVT
group in the follow up (p = 0.044).
Conclusions: PVT may be related with danger of gas-
trointestinal hemorrhage. Preoperative portal vein
diameter (PVD), postoperative thrombocytosis and per-
iesophagogastric devascularization are independent risk
factors of PVT. We strongly recommend that preopera-
tive PVD and perioperative PLT count should be mea-
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sured in every patient. For patients whose above fac-
tors are prominent, close surveillance after the opera-
tion is highly suggested. Prophylactic protocol which
gains both safety and high efficiency should be further
studied.
950
USING NOVEL MAGNETIC
COMPRESSIVE TECHNIQUE TO
CREATE PORTACAVAL SHUNT IN
DOG: AN EXPERIMENTAL STUDY
Xiao-Peng Yan1, Jia Ma1, Jian-Hui Li2, Ding-Hui
Dong1, Hao-Hua Wang2, Shi-Qi Liu1, Zhen Wan1,
Shan-Pei Wang1, Feng Ma2 and Yi Lv1
1Department of Hepatobiliary Surgery, First Affiliated
Hospital, College of Medicine, Xi’an Jiaotong
University, 277 Yantaxi Rd, Xi’an, 710061, China;
2XJTU Research Institution of Advanced Surgical
Technology and Engineering, Xi’an Jiaotong University,
277 Yantaxi Rd, Xi’an, 710061, China
Background and aims: The traditional portosystemic
shunts is technically complicated, and the incidence of
thrombosis and hepatic encephalopathy has remained
high. TIPS remain relatively safe procedure, but com-
plications of stenosis and hepatic encephalopathy that
may result from it. In order to achieve a minimally
invasive surgery with long-term shunting effects, a set
of novel magnetic compression technique (MCT) was
introduced to the shunting procedure.
Methods: Two Nd-Fe-B permanent magnets which
coated polyurethane/heparin/taxol were accepted. The
parent magnet was applied to inferior vena cava guided
by a catheter through the incision on the femoral vein.
The daughter magnet was moved to the anastomosis
position on portal vein by the balloon catheter through
the incision on the splenic vein. After the daughter
magnet reached the target position, the 2 magnets
attracted, compressed the vessel wall to hold it in place.
5–7 days later, under X-ray guidance, the magnets were
detached from the vessel wall with the needle of RUPS-
100 set. One month after that portal venography were
performed.
Results: A large number of fibrous connective tissue
can be observed around the adventitial of anastomosis
position, 5–7 days after the first surgery. During the
second surgery, when the magnets were detached, the
contrast media can be observed flowing from portal
vein into the inferior vena cava. 1 month after the sec-
ond surgery, portal venography revealed that the porto-
systemic shunt still exists. H.E. staining revealed a mild
intimal hyperplasia in the portal vein and the inferior
vena cava, a continuity of the vascular adventitial from
the portal vein to the inferior vena cava. Masson stain-
ing revealed a large quantity of tidily arranged collagen
surrounding the adventitial.
Conclusions: By using a unique magnet device, MCT
was successfully used to establish a portacaval shunt in
dog, which may be used as a novel surgical therapy
without the risk of stenosis in the portosystemic shunts.
955
NOTCH PATHWAY IS ACTIVATED IN
MASS-FORMING INTRAHEPATIC
CHOLANGIOCARCINOMA POSSIBLY
DERIVED FROM HEPATIC
PROGENITOR CELLS
Masayuki Nakajima, Masayuki Ohtsuka, Hiroaki
Shimizu, Hiroyuki Yoshidome, Atsushi Kato,
Hideyuki Yoshitomi and Masaru Miyazaki
Department of General Surgery, Graduate School of
Medicine, Chiba University, 337-1 sonno-cho inage-ku
Chiba, Japan
Background/Aims: The Notch2/Jagged1 signaling path-
way is implicated in normal biliary development, as
well as in neovascularization. We investigated the possi-
bility that Notch2 and Jagged1 are also involved in
differentiation into cholangiocellular phenotypes in
mass-forming intrahepatic cholangiocarcinoma (ICC),
possibly originating from hepatic progenitor cells.
Methods: The expression of Notch2, Jagged1, a-feto-
protein, c-Kit and CD44 were examined immunohisto-
chemically in 32 surgically resected cases with mass-
forming ICC. Furthermore, tumor vascularity was
assessed by intratumoral microvessel density deter-
mined by CD31 immunostaining.
Results: Positive Notch2 expression was observed in 18
(56%) of cases and positive Jagged1 in 10 (31%).
Notch 2 protein was frequently localized to the cyto-
plasm and nucleus of cancer cells. C-Kit, a-fetopro-
tein, and CD44 expression was noted in 16 (50%), 1
(3.1%), and 14 (44%), respectively. C-Kit expression
was significantly associated with Notch2, but not Jag-
ged1, expression, whereas CD44 expression was inver-
sely correlated with Notch2 expression. As compared
with cases with negative Notch2 expression, cases with
positive Notch2 expression showed significantly lower
levels of preoperative serum carbohydrate antigen 19–
9, and a histological cancer-negative resected margin
was achieved more frequently. ICC with positive
Notch2 expression was related to high intratumoral
microvessel density. Survival among patients with
positive Notch2 expression was significantly better
than that among patients with negative Notch2 expres-
sion.
Conclusion: Notch pathway is activated in mass-form-
ing intrahepatic cholangiocarcinoma, which may be
important for the development and the maintenance of
the cholangiocellular features or phenotype of malig-
nant transformed hepatic progenitor cells. ICC was less
aggressive in such cases than in cases with negative
Notch2 expression.
958
1 YEAR EXPERIENCE OF PENG’S
BINDING
PANCREATICOGASTROSTOMY AFTER
PPPD
Insang Song, Kwangsik Chun, Younghoon Sul and
Byungsoon Park
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Department of surgery, college of medicine, Chungnam
National University, 33 Munhwa-ro, Jung-gu Daejeon,
301–721, Korea
Background and aims: Pancreatic fistula after PPPD
remains a significant cause of morbidity and mortality.
The aim of this study was to assess the operative results
of a new technique; Peng’s binding pancreaticogastros-
tomy (PG) after PPPD, in which the stump of pancreas
inserted into the posterior gastric wall with only two
purse-string sutures.
Methods: Recently, for 1 year, consecutive 20 cases of
PPPD were performed using binding pancreaticoga-
strostomy.
Results: Indications for surgery included 16 malignant
neoplasms, including 5 cases of multivisceral resections
and 4 benign diseases. There was 1 case of grade A,
POPF (postoperative pancreatic fistula) according to
definition by ISGPS grading system. The overall mor-
bidity was 55% as 11 cases in 7 patients (1 case of pan-
creatic fistula, 2 cases of DGE, 1 case of wound
hematoma, 1 case of wound infection, 1 case of ascites,
1 case of liver abscess, 1 case of UGI bleeding, 1 case
of abdominal abscess, 1 case of not removal of drain, 1
case of ICH). But, there were no complications related
to POPF. Perioperative mortality was nil.
Conclusion: By early term observation after PPPD,
Peng’s binding PG might be superior to the other pan-
creatico-enteric anastomotic techniques in order to min-
imize POPF.
959
SYNERGISTIC EFFECT OF 5-
FLUOROURACIL COMBINED WITH
TRIPTOLIDE ON PANCREATIC
CANCER IN VITRO BASED ON TWO-
DIMENSIONAL ELECTROPHORESIS
Lin Chai, Xin-Feng Li and Wei Wang
Department of Hepatobilliary Surgery, The Affiliated
Second Hospital, Fujian Medical University, NO:34
Zhongshan Norty Rd, Quanzhou 362,000, China
Aims: To investigate the5fluorouracil (5-fluorouracil,
5-FU and TPL act on ASPC-1 cells synergistic effect,
further explore TPL enhanced 5-FU on pancreatic
carcinoma cell apoptosis and human pancreatic cancer
cell ASPC-1 drug resistance mechanism.
Methods: Using DMEM high glucose cultured ASPC-1
cells; MTT method for the detection of 5-FU, TPL,
IC30dosage and concentration of TPL combined with
5-FU on pancreatic cancer cell proliferation inhibition
effect of ASPC-1, Western Bloting method for the
detection of apoptosis related protein PARP; flow
cytometry analysis in each experimental group the
apoptosis ratio difference, extraction of each protein
for two-dimensional electrophoresis. ImgemMster
image software to analyze the differentially expressed
proteins between the groups, the application of MS
analysis identified by screening the differentially
expressed proteins. PCR validation control group and
TPL group and TPL and5-FU combined group of Vi-
mentin mRNA expression difference.
Results: TPL,5-FU to ASPC-1has the obvious inhibi-
tory action, and the dose and time correlation;5-FU
and TPL combination of the two drugs in pancreatic
cancer ASPC-1pro-apoptotic have synergistic effects.
48 h after, single-agent TPL,5-FU and IC30TPL doses
combined group PARP expression quantity is star TPL
difference; treatment of human pancreatic cancer cells
Aspc-1, extracting collected after treatment of cellular
proteins, for two-dimensional electrophoresis, scanning
by ImgeMster image analysis software analysis.
IC30TPL combined with 5-FU treatment dosage and
concentration of human pancreatic cancer cells Aspc-1,
extracting collected after treatment of cellular proteins,
for two-dimensional electrophoresis, scanning by Im-
geMster image analysis software analysis. Compared
with the control group, TPL group and TPL and 5-FU
combined group of vimentin (Vimentin) mRNA levels
have obvious differences in expression quantity.
Conclusion: TPL, 5-FU single drugs in vitro on
human pancreatic cancer cell Aspc-1proliferation inhi-
bition, and inhibition of the effect was dose and time
dependent. No significant role on the proliferation of
IC30 concentration of TPL can improve 5-FU on
human pancreatic cancer cell Aspc-1proliferation inhi-
bition effect. Vimentin (Vimentin) may be one of
targets for TPL and 5-FU combination of human pan-
creatic carcinoma cell apoptosis of Aspc-1.TPL on
human pancreatic cancer cell Aspc-1proliferation inhi-
bition targets may be associated with vimentin (Vimen-
tin) or its product related. Human pancreatic
carcinoma cells to chemotherapy drugs (such as Aspc-
1TPL and5-FU) of resistance may be associated with
Annexin A3 related.
960
FEVER AFTER TRANSARTERIAL
CHEMOEMBOLIZATION FOR
HEPATOCELLULAR CARCINOMA
Tracy R. C. Ramos, Shelat V. G., Woon W.,
Junnarkar S. P. and Low J.K.
Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng,
Block 117, Ang Mo Kio Avenue 4, 10-467, Singapore
Purpose: Transcatheter arterial chemoembolization
(TACE) is a procedure to restrict a tumor’s blood sup-
ply. Hepatocellular Carcinoma can be treated in many
ways and TACE is one of the ways of treating it espe-
cially for non-resectable Hepatocellular carcinoma.
TACE is an invasive procedure, it has potential compli-
cations that would range from being mild fever to mor-
tality. One of its most common complications is fever.
Fever is due to tumour necrosis and almost always self
resolving with supportive management. We conducted
a retrospective study to examine the patients who
underwent TACE at our institution with special
emphasis on patients experiencing fever after TACE.
Aim: To determine the incidence of fever after TACE
and identify secondary causes of post TACE pyrexia.
Methods: A retrospective review the medical records of
39 patients is done. The incidence and possible risk fac-
tors associated with post-TACE fever on their first ses-
sion were analyzed.
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Results: Of the 39 patients, nineteen patients experi-
enced fever after TACE. Of these 19 patients, thirteen
had a septic work-up done. Five patients were noted to
have urinary tract infection and one patient developed
hospital acquired pneumonia. Of the nineteen patients
who had fever, eleven had a solitary liver lesion. One
patient died because of post-TACE renal failure. Of the
nineteen pyrexial patients, sixteen patients received
therapeutic antibiotic therapy.
Conclusion: Post-TACE fever is one of the most com-
mon complications of TACE. Our data suggests that
its incidence is 49%. After ruling out other infections,
with the aid of a septic work-up, it was noted that the
incidence of primary post-TACE pyrexia is only 33%
(13 out of 39).
963
REAPPRAISAL OF THE RIGHT
ANTERIOR LOBE BASED ON THE
INTRAHEPATIC PORTAL VEINS BY
USING 3-D IMAGES
Yu Xie1 and Jia-Hong Dong2
1Department of Hepatobiliary Surgery,Chinese PLA
Second Artillery General Hospital, Beijing, 100088;
2Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Beijing, 100853
Objective and aims: To evaluate the intrahepatic portal
veins and hepatic veins of right anterior lobe of liver,
put up a new concept of the classification of hepatic
segment for the imaging and liver surgery.
Methods: Using 100 successive sections of the upper
abdomen of adult MRI enhanced images of living
donor for liver transplantation and transform the 2-
dimesional images into 3-dimensional images. By using
3-D images, we investigated the course and division
pattern of the intrahepatic portal vein and the hepatic
veins,and also the relationship between them.
Results: Among the 100 cases, the branches of segment
8 may be divieded into four types: monopodium, two
branches, three branches and four branches and the pec-
centage is 16%、72%、8% and 4% respectivly. About
84% of the intrahepatic portal veins of segment 8 can be
mainly divided into ventral branches and dorsal branches
and the dorsal branches of P8 supplied the dorsocranial
area of the right lobe posterior to the right hepatic vein,
which belong to segment 7 according to Couinaud’s
classification. About 93% branches of P5 were branching
off the portal veins of the right anterior trunk or the ven-
tral branches of P8. And also,we found that the hepatic
vein of segment 8 running ventral to P8v joining the mid-
dle hepatic vein while the hepatic vein of segment 8
running dorsal to P8d joining the right hepatic vein;
most drainage veins of S5 joined to the middle hepatic
vein. So, we divided the right anterior lobe into S8v+S5
(ventral segment) and S8d(dorsal segment).
Conclusion: This new concept of hepatic segment divi-
sion will be helpful not only to the precise allocation of
lesion in the liver, but also to the development of new
and safer surgical procedures.
964
SUSTAINED METHYLENE BLUE
STAINING TO GUIDE ANATOMICALLY
PRECISE HEPATECTOMY
Shou-Wang Cai, Shi-Zhong Yang, Weng-Ping Lv,
Wei-Dong Duan, Wei-Yi Wang, Wan-Qing Gu and
Zhi-Qiang Huang
Hospital&Institute of Hepatobiliary Surgery, Chinese
PLA, General Hospital, Beijing, 100853. China, Fuxing
road 28, Beijing China
Background and aims: To describe a novel methylene
blue staining technique for guiding anatomic resection
of hepatocellular carcinoma (HCC). The boundary of
the target hepatic segment within the liver parenchyma
cannot be marked using a conventional anatomic hepa-
tectomy approach.
Methods: Between February 2009 and June 2010, ana-
tomic hepatectomy was performed in 43 HCC patients
using a novel sustained methylene blue staining tech-
nique. Sustained staining was achieved by injecting
methylene blue into the distal aspect of the portal vein
after exposing Glisson’s sheath. The hepatic pedicle
was immediately ligated, and the hepatic parenchymal
transection was performed along the interface between
methylene blue stained tissue and unstained tissue.
Results: Anatomic hepatectomies were subsegmentecto-
my (n = 7), monosegmentectomy (n = 21), multiseg-
mentectomy (n = 10), and hemihepatectomy (n = 5).
The portal vein was successfully injected with methy-
lene blue in 100% of cases, and complete staining of
the target hepatic segment was achieved in 41/43
(95.3%) cases. Mean intraoperative bleeding was
300  50 mL, and the postoperative complication rate
was 18.6% (8/43). All complications were successfully
managed via conservative treatment. Surgical margins
were all negative on pathologic examination. Mean
duration of postoperative follow-up was 19 mo (range,
12–28 mo). Eleven patients had intrahepatic recurrence,
but no local recurrence (around the surgical margin)
occurred.
Conclusions: This novel technique of achieving sus-
tained staining by injecting methylene blue then imme-
diately ligating the hepatic pedicle is simple and
feasible. It can guide the selection of the surgical mar-
gin during hepatic parenchyma transection to improve
the accuracy of anatomic hepatectomy for the treat-
ment of HCC.
965
A CASE OF PENG’S BINDING
PANCREATICOGASTROSTOMY FOR
THE PROXIMAL PANCREATIC
TRANSECTION
Young Hoon Sul, Youn Ju Lee, Kwang Sik Cheon and
In Sang Song
Department of Surgery, Chungnam National University,
College of Medicine, Munhwa-ro 33, Jung-Gu, Daejeon,
Korea
Various treatment for the proximal pancreatic transec-
tion following blunt trauma have been attempted. But,
none of these has yet been clearly established. The
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proximal pancreatic transection is usually managed by
distal pancreatectomy with or without splenectomy.
However, pancreatic insufficiency and the risk of post-
splenectomy infection remain significant problems. To
avoid these problems in the patient with proximal pan-
creatic transection, pancreaticoenteric anastomosis can
be a treatment option, but pancreatic fistula form pan-
creaticoenteric anastomosis remains a significant cause
of morbidity and mortality. Recently, Dr. Peng pro-
posed the binding pancreaticogastrostomy to minimize
the postoperative pancreatic fistula after pancreatic sur-
gery. So, we report a case of proximal pancreatic tran-
section successfully treated with Peng’s binding
pancreaticogastrostomy.
966
ISOLATION AND IDENTIFICATION OF
SIDE POPULATION CELLS FROM A
HEPATOCELLULAR CARCINOMA
CELL LINE HEPG2 AND FRESH
TUMOR TISSUES
Hong-Hai Xia, Ge-Liang Xu, Wei-Dong Jia,
Jian-Sheng Li and Wen-Bin Liu
Department of Hepatic Surgery, Provincial Hospital
affiliated to Anhui Medical University, Anhui Province
Key Laboratory of Hepatopancreatobiliary Surgery, No.
17, Lujiang Road, Hefei 230001, Anhui Province, P.R.
China
Background and aims: The recurrence of Hepatocellular
carcinoma(HCC) limits the outcoming to a low level.
Cancer stem cells(CSCs) has been proved contribute to
recurrence. The side population(SP) is thought enriched
with hepatocellular cancer stem cells (HCSCs), how-
ever, it has not been fully explored.
Methods: To study the characters of HCSCs, a Hoe-
chst33342 dye was uesed to isolate the SP cells from a
HCC cell line Hepg2 and fresh tumor tissues of 21
HCC patients by flow cytometry. Properties of the SP
cells were established by cell proliferation assay, capac-
ity to form spheroids in the serum-free medium, inva-
sion and migration assays, tumorigenicity in NOD/
SCID mice and mRNA microarray analysis.
Results: SP cells were observed in HCC cell line Hepg2
and 18 of the 21 fresh tissues. SP cells showed higher
abilities of forming spheroids, invasion and migration,
and there was no significant difference in cells prolifera-
tion between the two groups. Tumours could generate
from SP but not non-SP(NSP) cells in a low dose of
subcutaneous injection to the NOD/SCID mice
(59102cells/mouse). The mRNA microarray analysis
revealed that 2057 gene expressions were up-regulated
and 3189 down-regulated.
Conclusions: HCC SP cells have properties of HCSCs
which may be the origin of recurrenc. Further investga-
tions on HCSCs are warranted to provide insights into
our understanding of tumor biology.
967
ASSISTANT INFUSION TECHNIQUE
FOR PERCUTANEOUS
RADIOFREQUENCY ABLATION OF
LIVER CANCER IN SPECIAL POSITION
Yue Han, Shan Liu, Min Yang, Bao-Hua Zou, Lei Yu,
Yu-Zhi Hao and Jian-Qiang Cai
Cancer Institute&Hospital, Chinese Academy of Medical
Sciences, Chaoyang District, Beijing Panjiayuan South
17 Beijing, China
Objective: To assess the value of assistant infusion
technique which can separated the liver from the adja-
cent organs or structures for ultrasound-guided percu-
taneous radiofrequency ablation of liver cancer in
special position.
Methods: 27 cases with malignant liver cancer in spe-
cial position received assistant US-guided puncture and
infusion. When the liver was separated from the adja-
cent organs or structures by saline solution, percutane-
ous radiofrequency ablation was performed. Technical
efficacy and complications were evaluated.
Results: Among the 27 cases, the target tumor was
adjacent to the right kidney in 6cases, to the colon in 7
cases, to the stomach in 5 cases, to the pericardium in
4 cases, to the gallbladder in 3 cases, to the right kid-
ney and colon in 1 case and to the stomach, gallbladder
and main branch of the right portal vein trunk in 1
case. 25 patients received US-guided puncture through
the hepatic tissue to the abdominal cavity near the tar-
get tumor, with a 22-G needle, and assistant infusion
with 80~390 mL saline solution created a space(range
0.8~2.5 cm) between the liver and adjacent organs or
structures. 5 cases with tumor adjacent to the stomach
or colon received further infusion during the ablation.
2 cases failed in assistant infusion, because of the post-
operative adhesion, and received palliative radiofre-
quency ablation. The mean hospital stay post operation
was 4 days. No adjacent organs or structures injury,
hemorrhage or needle track implantation was observed.
Only one case died because of liver function failure. 2-
week of 1-month follow-up CT/MRI showed the tech-
nical success rate was 96.0%(24/25) in the 25 cases who
received complete ablation.
Conclusion: Assistant infusion for percutaneous radio-
frequency ablation creates protective space between the
liver and adjacent organs or structures in patients with
liver cancer in special position. The safe and effective
technique can widen the indication and significantly
increase the cure rate of percutaneous radiofrequency
ablation.
968
INTRA PERITONEAL BUPIVACAINE
WASHING IN LAPAROSCOPIC
CHOLECYSTECTOMY PATIENTS
Maria Mayasari1,2, Emerson Masli2 and Shabrina
Rizky Putri1
1Faculty of Medicine University of Indonesia, Jakarta,
Indonesia; 2Medistra Hospital, Jakarta, Indonesia
Background and aims: Laparoscopic cholecystectomy
has been known and became standard treatment for
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gall bladder stone diseases. In many countries, this pro-
cedure was carried out as a day surgery case. The main
problem of adopting this practice in our country is the
remaining post operative pain occurred early in post-
surgery that necessitates hospitalization. Intra perito-
neal low dose bupivacaine washing is hypothesized to
potentially reduce pain after laparoscopic cholecystec-
tomy, so that oral administration of analgesia would be
sufficient in the post operative setting. The aim of this
pilot study is to determine the feasibility of this method
in surgical practice in Indonesia, and its correlation
with shorter hospitalization.
Method: Medical records from patients receiving lapa-
roscopic cholesistectomy from a single surgeon in a pri-
vate hospital in Jakarta, Indonesia were collected
retrospectively from January 2012 to September 2012.
Data on hospital length of stay, frequency of intrave-
nous analgesia, time to early mobilization and side
effects were collected retrospectively. Patients who
received intraperitoneal bupivacaine washing were com-
pared with patients who did not receive it.
Results: In this pilot study, a total of 16 patients were
included, male to female ratio is 1:1, and mean age is
55.19 years old, ranging from 28 to 82 years old, with
31.3% of the patients receiving intra peritoneal bupiva-
caine washing. Although the non bupivacaine group
were slightly older than the receiver group (57 to
51 years old), statistically, the use of intra peritoneal
bupivacaine showed shorter length of stay post opera-
tively, from 3 days to 1 day (p = 0.018). Whereas there
were no significant difference for the IV analgesic use
(p = 0.473), oral analgesic use (p = 0.533) and early
mobilization time (p = 0.951). In this study, no side
effects possibly related to the use of bupivacaine wash-
ing of the abdomen were encountered.
Conclusion: Intra peritoneal bupivacaine washing is
safe and feasible to be performed in Indonesian prac-
tice of laparoscopic cholecystectomy. The usage of this
practice can contribute to the implementation of day
surgery laparoscopic cholecystectomy for Indonesian
patients.
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RBBP4 ACTIVATION RESULTING
FROM MIR-199A-5P LOSS ARE
ASSOCIATED WITH POOR PROGNOSIS
OF HEPATOCELLULAR CARCINOMA
BY AKT PATHWAY.
Zhen Lv1,2, Jian Wu1,2, Sun-Yi Ye1,2, Jun Cheng1,2,
Chao-Feng Ding1,2, Hai-Yang Xie1,2, Lin Zhou1,2 and
Shu-Sen Zheng1,2
1Department of Surgery, Division of Hepatobiliary and
Pancreatic Surgery, The First Affiliated Hospital, School
of Medicine, Zhejiang University, Hangzhou, China;
2Key Laboratory of Combined Multi-organ
Transplantation, Ministry of Public Health, Key
Laboratory of Organ Transplantation, Zhejiang
Province, Hangzhou, Zhejiang, China, Room 407,
Building 11, NO. 79 Road Qingchun Hangzhou, China
Background: Retinoblastoma binding protein 4
(RBBP4) was reported to participate in several protein
complexes, which had been implicated in chromatin
remodeling and transcriptional repression. In our previ-
ous study, RBBP4 was found upregulated in hepatocel-
lular carcinoma (HCC) patients with recurrence via
proteomics analysis. The aim of the present study is to
examine the expression pattern of RBBP4 in HCC and
its clinical significance as well as its potential role in
tumor progression.
Methods: The expression of RBBP4 and was examined
in 30 HCC samples using real-time PCR reaction, and
further validated by western blotting in 16 of the 30
HCC samples. We next analyzed its correlation with
clinical parameters and prognosis in 70 HCC patients
that have undergone liver transplantation(LT). RBBP4
overexpression vector and RBBP4 siRNA vector were
constructed to examine its role and mechanism in
tumor progression. The expression of mir-199a-5p was
performed by real time PCR in 30 HCC samples, and
luciferase assays was used for target validation. The
alteration of pathway proteins was examined by wes-
tern blot.
Results: RBBP4 expression significantly increased in
HCC tissues compared with para-cacer tissues. Clinico-
pathological analysis showed that RBBP4 expression
was significantly correlated with vascular invasion
(p = 0.027), tumor size (p = 0.001), pTNM stage
(p=0.002) and tumor recurrence (p = 0.000). Patients
with high RBBP4 expression had poorer recurrence free
survival (p = 0.000) and overall survival (p = 0.003)
after LT than those with low RBBP4 expression. Multi-
variate analys was showed RBBP4 expression was an
independent predictor of recurrence free survival (Haz-
ard ratio 5.425, p = 0.003). Moreover, the overexpres-
sion of RBBP4 significantly promoted the malignant
phenotypes of HCC cell lines, including cell prolifera-
tion, invasion and migration and anti-apoptosis. Above
all, our further research showed that RBBP4 was a tar-
get of mir-199a-5p and mir-199a-5p/RBBP4/AKT posi-
tive loop was a potential mechanism involved in HCC
progression.
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SHORT-TERM EFFICACY OF
PERCUTANEOUS RADIOFREQUENCY
ABLATION ON COLORECTAL HEPATIC
METASTASES
Yue Han, Min Yang, Bao-Hua Zou, Lei Yu, Yu-Zhi
Hao and Jian-Qiang Cai
Cancer Hospital, Chinese Academy of Medical Sciences,
Beijing 100021, Beijing, China
Background and aims: Percutaneous radiofrequency
ablation is a newly developing technique which has a
small wound and exact effect. The NCCI clinic guide-
line suggests that for the patients with colorectal hepa-
tic metastases should accept radiofrequency ablation in
the hepatic metastases,which could be cleared com-
pletely. The aim is to discuss the value of ultra-guided
percutaneous radiofrequency ablation in colorectal
hepatic metastases.
Methods: 34 cases of percutaneous radiofrequency
ablation in the hepatic metastases between December,
2009 to June, 2012 were retrospective analyzed. All of
the patients with 78 liver metastases accepted totally 39
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percutaneous radiofrequency ablations. Among them 2
patients accepted three times, 1 patients accepted twice,
23 patients had synchronous liver metastases, while 11
patients had metachronous liver metastases. The effec-
tion of the operation was analyzed by Liver contract
CT/MRI one month later. Local recurrence rate, entop-
ic relapse rate and One-year survival rate were followed
up and concluded.
Results: There was no treatment related death. The
postoperative complications rate was 10.3%. 38 among
39 cases got the completely ablations. the effective rate
was 97.4%. The local recurrence rate, entopic relapse
rate and One-year survival rate was 5.12%, 30.7,
90.5% respectively.
Conclusions: Percutaneous radiofrequency ablation in
colorectal hepatic metastases was worthy of application
and dissemination, because of low complication rate
and local exact effect.
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CLINICAL ANALYSIS OF 15 CASES
CATHETER ABLATION OF THE
CHOLANGIOCARCINOMA
Rui Liang, Ke-Xin Ma, De-Guang Sun, Qin-Long Liu,
Zhen-Ming Gao and Li-Ming Wang
The Second Affiliated Hospital of Dalian Medical
University, 467 Zhongshan Road, Dalian, 116000, China
Cholangiocarcinoma is a common malignant tumor of
biliary tract.The insidious onset and slow progression
of symptoms usually result in delayed diagnosis and
treatment.Most of the patients with advanced cancer
that usually go to see the docotor because of the jaun-
dice have already lost the chance of operation. Conser-
vative treatment to alleviate the symptoms of jaundice
is the main choice but has poor prognosis.The catheter
ablation of the cholangiocarcinoma is a relatively new
therapeutic measure which not only alleviate the
jaundice but also partly eradicate the mass.This new
measure gained satisfied clinic efficacy in the patients’
survival time and the life quality.By studying some
cases of catheter ablation of cholangiocarcinoma pat-
iens in our hospital,We conclude some experience and
perception of this new therapeutic measure.
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SURGICAL TREATMENT OF PRIMARY
LIVER CANCER WITH EMBOLUS IN
INFERIOR VENA CAVA: OPERATION
OR CONSERVATIVE TREATMENT
Song Ye, Wei-Lin Wang, Feng Zhu, Jian Wu and
Shu-Sen Zheng
The First Affiliated Hospital, Zhejiang University School
of Medicine, 79 Qingchun Rd, Hangzhou, 310003
HangZhou, China
Background and aims: Primary liver cancer (PLC) with
embolus in Inferior Vena Cava (IVC) is an advanced
type of the PLC with poor prognosis. It is a contraindi-
cation for operation in traditional idea. But this concept
is challenged now because of the progress in surgical
skills. The aims of this article is to investigate the surgi-
cal treatment of PLC with embolus in IVC. Analyse the
prognosis after the operation or other therapies.
Methods: Thirteen cases of PLC with embolus in IVC
who received therapies in our department during Apr
2009 to Sept 2010 were investigated retrospectively.
Nine of the thirteen (9/13) underwent resection of PLC,
embolectomy of IVC and/or right atrium. And one
patient of the nine (1/9) received cardiac arrest and
extracorporeal circulation during the operation. Two of
the thirteen (2/13) received transcatheter arterial
chemoembolization (TACE). And the other two (2/13)
refused all of the treatment and discharged.
Results: All of the operated group were successful and
without perioperative mortality. The survival time of
the operated group was 2~23 months, 13.7 months in
average. Five of nine patients (5/9) were still surviving
on investigated time, including four disease-free and
one survived with recurred tumor. The survival time of
TACE group (2/13) were 6 and 9 months. And the
patients who refused treatment were survival with
tumors for 2 and 6 months.
Conclusions: PLC combined with the IVC tumor em-
boli isn’t the absolute contraindication of surgical
resection. The operation is safe and effective by experi-
enced surgeons. And the survival time of the operation
group is longer than the other treatments. So we con-
cluded that the patients of PLC with IVC emboli
should receive operation if the patients can tolerate it.
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COX-REGRESS ANALYSIS OF
PRIMARY LIVER CANCER
PROGNOSTIC FACTORS
Hui-Cai Wang, Chang Liu, Jing Ma, Mei-Xin Wang,
Yong-Xing Bao, Fang-Ping He and Hao Wen
The first affiliated hospital of Xinjiang medical
university, Urumqi, 830054 china
Objective: To explore the influence factors of prognosis
of primary hepatic carcinoma, including gender, age,
nationality, serum AFP, serum ALT, serum HBsAg,
liver function classification (Child hierarchical), tumor
number, tumor size, pathological types etc, Screening
for prognostic factors.
Method: According to the first affiliated hospital of
Xinjiang medical university from July 2009 to August
2012 consecutive patients for hepatic carcinoma diag-
nosed by pathological examination and 102 cases of
hepatic carcinoma patients were included according to
strict inclusion criteria. The patients’ clinical datas were
entried with excel and followed up by visiting the
patients in hospital or outpatients or calling with tele-
phone and other forms. Combined the results of
follow-up with clinical datas to analysis. The Log-rank
test and Breslow inspection were used to compare with
vary survival rate. A multivariate analysis was per-
formed by Cox regression for variables significant on
univariate analysis. Result
The nationality, serum AFP, serum ALT and liver
function classification (Child hierarchical), tumor size
and tumor number identified by survival analysis
(P < 0.05). Cox regression analysis confirmed that
serum AFP, liver function classification (Child hierar-
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chical) and tumor size were the independent prognostic
factors.
Conclusion: The independent prognostic factors of pri-
mary hepatic carcinoma were liver function classifica-
tion (Child hierarchical), serum AFP and tumor size in
turn.
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REAPPRAISAL OF SEQUENTIAL
PREOPERATIVE IPSILATERAL
HEPATIC VEIN EMBOLIZATION AFTER
PORTAL VEIN EMBOLIZATION
Bo Hyun Jung, Shin Hwang, Hyung Woo Park, Chun
Soo Park, Yo Han Park, Chul Soo Ahn, Ki Hun Kim,
Deok Bog Moon and Tae Yong Ha
Department of Surgery, Division of Hepatobiliary
Surgery and Liver Transplantation Asan Medical Center,
University of Ulsan College of Medicine, 388-1
Poongnap-dong, Songpa-gu Seoul, Korea
Background and aim: Portal vein embolization (PVE)
induces shrinkage of the embolized lobe and compensa-
tory enlargement of the non-embolized lobe, but it does
not always induce sufficient liver regeneration. There
was no effective method to accelerate liver regeneration
in addition to PVE yet. The preliminary experience of
first 12 cases on the effect of ipsilateral hepatic vein
embolization (HVE) performed after PVE was pre-
sented before, but no large-volume study was presented
yet. We herein present our 29 cases of experience
regarding on PVE-HVE.
Methods: During a 5-year study period, preoperative
HVE were performed on 29 patients who had shown
limited liver regeneration after PVE awaiting major
hepatectomy (right hepatectomy, n = 28; left hepatec-
tomy, n = 1). The right or left hepatic vein was embol-
ized with multiple coils after insertion of vascular
plugs.
Results: The primary diseases were hilar bile duct can-
cer in 22, hepatocellular carcinoma in 4, intrahepatic
cholangiocarcinoma in 2, and gallbladder cancer in 1.
No HVE procedure-related complications occurred, but
embolization of the wrong hepatic vein trunk occurred
in 2 patients, in whom intended operation was can-
celled in 1 and additional right HVE was performed in
1. The increase in blood liver enzymes after HVE was
comparable to that after PVE alone. In 24 patients
who underwent right hepatectomy, the proportions of
future liver remnant volume to total liver volume
increased further after HVE. Cirrhotic livers showed
lower regeneration rates following HVE after PVE.
Preplanned surgery intending curative resection was
successfully performed in 25, but 4 patients underwent
palliative surgery (n = 1) and no operation (n = 3).
Conclusions: This study confirmed that preoperative
sequential application of PVE and HVE is safe and
effective in facilitating contralateral liver regeneration
by inducing more severe liver damage than PVE alone.
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OUTCOME OF VARIOUS TREATMENTS
FOR POST-TRANSPLANT HEPATITIS B
VIRUS RECURRENCE
Nam Joon Yi1, Kwang Woong Lee1,2, Sun Young
Kong3, Kyoung Woon Park4, Kyoung Bun Lee5, Geun
Hong1, Sung Sik Han2 and Sang Jae Park2
1Department of Surgery, Seoul National University
College of Medicine, Seoul, Republic of Korea; 2Center
for Liver Cancer, National Cancer Center, Goyang-si,
Gyeonggi-do, Republic of Korea; 3Laboratory Medicine,
National Cancer Center, Goyang-si, Gyeonggi-do,
Republic of Korea; 4Laboratory Medicine, Seoul
National University Bundang Hospital, Seongnam-si,
Gyeonggi-do, Republic of Korea; 5Department of
Pathology, Seoul National University College of
Medicine, Seoul, Republic of Korea, 101 Daehak-ro,
Chongro-gu Seoul, South Korea
Background and aims: Currently, no treatment guide-
lines are available for post-transplant hepatitis B virus
(HBV) recurrence. We retrospectively evaluated the rate
of clearance of hepatitis B surface antigen (HBsAg)
from the sera according to the various types of treat-
ment regimen in two large Korean liver transplantation
centers.
Methods: Between 1996 and 2008, HBV recurrence
occurred in 59 patients among 933 HBV liver recipients
(6.3%). Patients with HBV recurrence were divided into
four groups according to the type of treatment: Group
L (lamivudine based therapy n = 21) and Group N
(new nucleos(t)ide analogue (NA) based therapy,
n = 38). In detail, intravenous Hepatitis B immuno-
globulin (ivHBIG) had been simultaneously adminis-
tered in 10 patients in Group L and in 26 patients in
Group N. The mean post-transplant follow-up duration
and time to HBV recurrence was 69 (14-152) and 37(3-
120) months.
Results: Overall, 22 patients (37.3%) showed sero-neg-
ative conversion of HBsAg for median 8 months after
treatment (range 1-15 months). The rate of seroclea-
rance was significantly higher in Group N (n = 20,
52.6%) than in Group L (n = 2, 9.5%) (p < 0.000).
The time to seroconversion did not differ between
Group L (7 months, range 5-16) and Group N
(7 months, range 1-15) (p = 0.428). In subgroup analy-
sis, the rate of HBsAg seroconversion was much higher
in combined ivHBIG and new NAs (15 out of 26
patients, 58.0%) than the others (p = 0.006).
Conclusion: Seroclearance of HBsAg could be achieved
using new NAs in a half of patients after post-trans-
plant HBV recurrence. Combined ivHBIG may add
synergistic effect to new NAs for clearing HBsAg.
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SALVAGE LIVING DONOR LIVER
TRANSPLANTATION AFTER PRIOR
LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA
Shin Hwang, Chu Soo Ahn, Ki Hun Kim, Deok Bog
Moon, Tae Yong Ha, Gi Won Song, Dong Hwan
Jung, Gil Chun Park and Jung Man Namgoong
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Division of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, Asan Medical
Center, University of Ulsan College of Medicine, 388-1
Poongnap-dong, Songpa-gu Seoul, Korea
Background: Salvage liver transplantation has been
performed for recurrent hepatocellular carcinoma
(HCC) or deterioration of liver function after primary
liver resection. Since prior liver resections in these
patients are usually minor in extent, performing
deceased-donor whole liver graft implantation is not
regarded as a contraindication. In contrast, prior per-
formance of a major liver resection, such as right lobec-
tomy, makes subsequent recipient hepatectomy
technically difficult. Living-donor liver transplantation
(LDLT) can also be performed for salvage purpose. To
assess the technical feasibility and indication of salvage
LDLT for recurrent HCC, we assessed our experience
performing these surgical procedures over 15 years.
Methods: From our institutional database of LDLT
having more than 3000 cases, we selected 87 cases of sal-
vage LDLT after prior hepatectomy for HCC. Twelve
patients underwent LDLT due to progressive hepatic
failure without recurrent HCC, thus excluded from this
study. The medical records of 75 patients who followed
up more than 6 months were retrospectively reviewed.
Results: Male patients were 65. Mean patient age was
53.1  7.4 years. The extents of prior hepatecomy were
sectionectomy or less in 58 and hemihepatectomy or bi-
sectionectomy in 17. Graft types were right liver grafts
in 64, dual-grafts in 8 and left liver grafts in 3. Mean
graft-recipient weight ratio was 1.09  0.24. Periopera-
tive mortality cases within 3 months were 4 (5.3%), in
whom hemihepatectomy had been performed in 3. The
Milan and Asan criteria were met in 48 (64%) and 60
(80%), respectively. Five-year patient survival rates
were 88.1% in within-Milan and 38.7% in beyond-
Milan (p<0.001) as well as 79.8% in within-Asan and
34.4% in beyond-Asan (p = 0.003). Five-year HCC
recurrence rates were 7.3% in within-Milan and 81.8%
% in beyond-Milan (p < 0.001) as well as 10% in
within-Milan and 61.5% (at 3 years) in beyond-Asan
(p = 0.000). Preoperative alpha-fetoprotein cutoff at
200 ng/mL and microvascular invasion did not show
survival difference (p > 0.7).
Conclusions: Overall patient survival rates following
salvage LDLT were similar to those following primary
LDLT, especially when the extent of recurrent tumor
satisfies the Milan or Asan criteria. Therefore, the
results of this study strongly support that every combi-
nation of prior hepatectomy and living donor liver
graft is feasible for patients undergoing salvage LDLT
and the acceptable extent of HCC for salvage LDLT is
equivalent to that for primary LDLT.
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RHUEPO PROTECTS THE LIVER FROM
ISCHEMIA-REPERFUSION INJURY
Wen-Guang Fu1,2, Xin-Xin Liao1, Jian Ruan3, Xiang-
Hong Li1, Li-Yan Chen1, Biao Wang1, Kai Wang1 and
Jie Zhou1
1Department of Hepatobiliary Surgery, Nanfang
Hospital, Southern Medical University, Guangzhou
510515, China; 2Department of Hepatobiliary Surgery,
the Affiliated Hospital, Luzhou Medical College, Luzhou
646000, China; 3Department of Oncology, Nanfang
Hospital, Southern Medical University, Guangzhou
510515, China
Background: The exact mechanism by which erythro-
poietin protects the liver from ischemia/reperfusion (I/
R) injury is not yet known. In the present study, we
examined the role of Akt and endothelial nitric oxide
synthase (eNOS) in the protective effect of recombinant
human erythropoietin(rHuEPO) on I/R injury of the
liver.
Materials and methods: We employed a liver auto-
transplantation model of liver ischemia and reperfu-
sion. One hundred and twenty adult male Sprague-
Dawley rats were divided randomly into six groups.
rHuEPO and LY294002 were injected in the tail vein
before the operation, and its effect was assessed by
measuring the serum levels of AST, ALT, LDH, NO,
and ET-1 and by histological analysis. The expression
of EPOR and eNOS was measured by Q-PCR. Total
AKT and eNOS and phosphorylated Akt and eNOS
were examined by western blot analysis. We examined
the biliary epithelial cells in the hilar bile duct by TUN-
EL staining.
Results: rHuEPO dramatically attenuated the func-
tional and morphological injuries. The serum levels of
ALT and LDH were significantly decreased, but the
amount of NO in the serum was increased in the I/
R+rHuEPO group. Accordingly, rHuEPO administra-
tion significantly ameliorated the histological damages,
including biliary epithelial cell apoptosis in the hilar
bile duct at 6 h after reperfusion. rHuEPO significantly
stimulated the phosphorylation of Akt and eNOS in
the rats after liver auto-transplantation.
Conclusions: The protective effect of rHuEPO in I/R
injury following liver auto-transplantation is mediated
via the activation of the PI3K/AKT/eNOS signaling
pathway, at least in part, by increasing p-Akt and p-
eNOS, and leads to the maintenance of an elevated
level of NO.
998
ESTROGEN RECEPTOR AND THE
ROLE OF THE ESTROGEN RECEPTOR
IN THE BILIARY TRACT TUMOR
Ling-Qiang Zhang, Chang Liu, Kai Qu, Jia Xu, Lei
Zhou, Ji-Chao Wei, Fan-Di Meng, Ming-Hui Tai,
Jin-Yao Zhang and Zhi-Xin Wang
Department of Hepatobiliary Surgery, The First
Affiliated Hospital, School of Medicine, Xi’an Jiao tong
University, Xi’an, China
Background and aims: Estrogen receptor (ESR), which
mediates the effect of estrogen, has a wide range of tissue
distribution. Recent studies have found that ESR may be
correlated to the carcinogenesis. According to the epide-
miology, biliary tract tumor is more prevalent in women
than men. Therefore, ESR may play an important role
in the biliary tract tumor. This study was to discuss the
ESR and role of ESR in the biliary tract tumor.
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Methods: Search literatures in the pubmed with the
key word “estrogen receptor, gallbladder cancer, cho-
langiocarcinoma”, and review and summary them.
Result: 1. ESR has three subtypes, ERa, ERb and
ERc. Most of present studies about estrogen have
mainly focused on ERa and ERb. ERa may promote
the development of the tumor, but the ERb can inhibit
the growth of the tumor. 2. ESR has been detected in a
variety of human tumor tissues, including biliary tract
tumor. 3. overexpression of ESR in the biliary tract
tumor is associated with the differentiation of the
tumor and the prognosis of patients. 4. The detection
of the ER may guide the endocrine therapy of gallblad-
der cancer, that is ER-positive gallbladder cancer has a
better response to anti-estrogen therapy compared with
ER-negative gallbladder cancer. 5. ESR may take part
in the formation of biliary tumor through vascular
endothelial growth (VEGF), interleukin-6(IL-6).
Conclusion: ESR plays an important role in the biliary
tract tumor although the mechanism is not clear at
present. Detecting the expression of ESR in the biliary
tract tumor has clinical significance. ESR may be a
potential target to cure the biliary tract tumor.
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PRESERVING HEPATIC ARTERY FLOW
DURING PORTAL TRIAD BLOOD
INFLOW OCCLUSION REDUCES THE
OUTGROWTH OF
HEPATOCARCINOMA IN MICE AFTER
Bin Shi, Chong-Hui Li, Yong-Wei Chen, Shi-Zhong
Yang, Ai-Qun Zhang, Fei Chen and Jia-Hong Dong
Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Fuxing road 28, Beijing 100853
China
Background and aims: To investigate the effects of dif-
ferent hepatic vascular occlusion maneuvers on the
growth of hepatocellular carcinoma after liver ischemia
reperfusion injury.
Methods: Kunming mice were randomly divided into
four groups, including SO (sham operation), group
OPT(occlusion of portal triad), group OPV (occlusion
of portal vein) and group INT (intermittent clamping).
Three days after an hepatocellular carcinoma model
was established using portal vein injection, mice under-
went either simultaneous clamping of both the portal
vein and the hepatic artery or selective clamping of the
portal vein to the median and left liver lobules for
60 min. Sham-operated mice served as controls. The
ischemia-reperfusion (I/R), pathological changes of
liver tissue, hepatic replacement area (HRA) and the
positive expression rate of the proliferative cell nuclear
antigen in hepatocellular carcinoma tissues were mea-
sured 5 days after reperfusion.
Results: The OPV group showed significantly lower
ALT, AST value in the restoration of blood flow after
five days than the OPT group and INT group. Hepato-
cytes in the OPV group were much less injured than in
the OPT group and the INT group in histopathology.
The levels of hepatic replacement area in occlusion of
the hepatic lobule in group sham operation, group
occlusion of portal triad, group occlusion of portal vein
and group intermittent clamping were 7.658  2.552%,
35.612  4.234%, 9.02  3.006% and 19.946 
4.098% respectively (p < 0.01). The positive expression
rate of the proliferative cell nuclear angiten in hepato-
cellular carcinoma tissues was 30% in group SO and
78% in group OPT and 45% in group OPV and 60%
in group INT.
Conclusion: Preserving hepatic artery flow during
portal triad blood inflow occlusion reduces liver ische-
mia-reperfusion injury, while slow dowm growth and
metastasis of liver cancer in mice.
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PRESERVING HEPATIC ARTERY FLOW
DURING PORTAL TRIAD BLOOD
INFLOW OCCLUSION REDUCES THE
OUTGROWTH OF
HEPATOCARCINOMA IN MICE AFTER
LIVER ISCHEMIA REPERFUSION
INJURY
Bin Shi, Chong-Hui Li, Yong-Wei Chen, Shi-Zhong
Yang, Ai-Qun Zhang, Fei Chen and Jia-Hong Dong
Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Fuxing road 28, Beijing 100853
China
Background and aims: To investigate the effects of dif-
ferent hepatic vascular occlusion maneuvers on the
growth of hepatocellular carcinoma after liver ischemia
reperfusion injury.
Methods: Kunming mice were randomly divided into
four groups, including SO (sham operation), group
OPT (occlusion of portal triad), group OPV (occlusion
of portal vein) and group INT (intermittent clamping).
Three days after an hepatocellular carcinoma model
was established using portal vein injection, mice under-
went either simultaneous clamping of both the portal
vein and the hepatic artery or selective clamping of the
portal vein to the median and left liver lobules for 60
minutes. Sham-operated mice served as controls. The
ischemia-reperfusion (I/R), pathological changes of
liver tissue, hepatic replacement area (HRA) and the
positive expression rate of the proliferative cell nuclear
antigen in hepatocellular carcinoma tissues were mea-
sured 5 days after reperfusion.
Results: The OPV group showed significantly lower
ALT, AST value in the restoration of blood flow after
five days than the OPT group and INT group. Hepato-
cytes in the OPV group were much less injured than in
the OPT group and the INT group in histopathology.
The levels of hepatic replacement area in occlusion of
the hepatic lobule in group sham operation, group
occlusion of portal triad, group occlusion of portal vein
and group intermittent clamping were 7.658  2.552%,
35.612  4.234%, 9.02  3.006% and 19.946 
4.098% respectively (p < 0.01). The positive expression
rate of the proliferative cell nuclear angiten in hepato-
cellular carcinoma tissues was 30% in group SO and
78% in group OPT and 45% in group OPV and 60%
in group INT.
Conclusion: Preserving hepatic artery flow during
portal triad blood inflow occlusion reduces liver ische-
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mia-reperfusion injury, while slow down growth and
metastasis of liver cancer in mice.
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DOWN-REGULATION OF BECLIN 1 IN
PANCREATIC CANCER CELLS
INHIBITS CELL GROWTH AND
ENHANCES CHEMOSENSITIVITY
Xu-Bo Wu1, Dong-Feng Cheng2, Ran Tao2 and
Cheng-Hong Peng2
1Central Hospital of Minhang District, Ruijin Medical
Group, 170 Xinsong Rd,Shanghai, 201199; 2Ruijin
Hospital. Shanghai Jiaotong University School of
Medicine, 197 2nd Rui Jin Rd, Shanghai,200025, China
Background and aims: Pancreatic cancer (PC) is a kind
of malignant tumor which is resistent to current chemo-
therapies. Autophagy is a catabolic process in cells,
which was observed in tumor cells treated with chemo-
therapy drugs recent years, including in pancreatic can-
cer cells. Autophagy gene Beclin 1, as a tumor
suppressor gene, plays a key role in autophagy, but its
role in pancreatic cancer is unclear. In this study, we
observed the growth status and reaction to chemother-
apy drugs of pancreatic cancer cells by down-regulation
of Beclin 1.
Methods: Construct and culture Beclin 1 down-regu-
lated PC cell lines (Bxpc-3, Panc-1) via transfecting
ShRNA expression vectors with lentiviral transfection
technology. Real time-PCR and Western blot were used
for detecting the expression of mRNA and protein of
Beclin 1 in PC cells. Cell proliferation and invasion
were analyzed by MTT assay and transwell assay
respectively.
Results: Beclin 1 expression in PC cells was down-regu-
lated by ShRNA. After treated with chemotherapy
drugs (5-FU and/or Gemcitabine) for 48H, expression
of Beclin 1 mRNA and LC3 mRNA increased signifi-
cantly in normal PC cells (Control) (P < 0.01), other-
wise, their mRNA expression maintained low levels in
Beclin-1 down-regulated PC cells. Western blot showed
protein levels of Beclin 1 and LC3 elevated in control
PC cells after chemotherapy (P < 0.05), but it could
not be found in Beclin-1 down-regulated PC cells. It
was showed that autophagy was inhibited in Beclin 1
down-regulated PC cells. The MTT assay showed that
the proliferation of Beclin 1 down-regulated PC cells
was inhibited in vitro (P < 0.05), compared with the
control PC cells. But there was no significant difference
on proliferation after chemotherapy. The transwell
invasion assay showed that there was no significant
difference on the capacity of invasion between Beclin 1
down-regulated and control PC cells. But after treated
with chemotherapy drugs, the invasive ability of Beclin
1 down-regulated PC cells was markedly reduced
(P < 0.05).
Conclusions: Our data suggest that Beclin 1 plays an
important role in autophagy of PC cells. The capacity of
proliferation and invasion was inhibited in Beclin 1
down-regulated PC cells and down-regulation of Beclin 1
could enhance chemosensitivity. Beclin 1 maybe a novel
target for antitumor therapy of pancreatic cancer.
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ATROPHY OF THE LEFT GRAFT
SECONDARY TO ARTERIAL INFLOW
FAILURE IN DUAL LIVER
TRANSPLANTATION
Zhen Wan1,2, Yi Lv1,2, Liang Yu1,2, Chang Liu1,2,
Xue-Min Liu1,2, Bo Wang1,2 and Xiao-Gang Zhang1,2
1Department of Hepatobiliary Surgery, The First
Affiliated Hospital, Medical School of Xi’an Jiaotong
University, No.76 Yanta West Road, Xi’an, Shaan Xi,
710061, China; 2XJTU Research Institution of Surgical
Advanced Technology and Engineering, No.76 Yanta
West Road, Xi’an, Shaan Xi, 710061, China
Background and aims: Adult-to-adult living donor liver
transplantation (LDLT) using dual grafts was devised
elegantly by Lee et al. with potential benefits. To date,
the study about the impact of hepatic arterial inflow on
the regeneration and outcome of dual grafts is rare.
Furthermore, the mutal relationship (competitive or
synergistic) between the two grafts under the metabolic
demand stimulus, remains unelucidated.
Methods: A 52-year-old male received a full right liver
lobe including middle hepatic vein and a left lobe
simultaneously. Hepatic hemodynamic changes espe-
cially hepatic arterial inflow and regeneration response
in both grafts were assessed with serial ultrasonography
(US) and computed tomography (CT), respectively.
Liver function was also monitored.
Results: The total graft volume amounted to 830 mL,
corresponding to 58.9% of SLV. After reperfusion, in-
traoperative US showed regular portal, venous and
arterial flow in both grafts except the left hepatic
artery. As vessel size mismatch, a vein graft procured
from the recipient’s great saphenous vein was placed
between the left hepatic artery of the graft and the
common hepatic artery of the recipient. On postopera-
tive day 14, US revealed left hepatic artery inflow
disappeared. Following computed tomography angiog-
raphy (CTA) confirmed that the left hepatic artery was
absent and the density of the left graft was significantly
decreased. Meanwhile, the right graft showed normal
triangle-shaped regeneration. Live function did not
deteriorated. Follow-up CT demonstrated that the left
graft grew atrophy gradually while the right graft
became compensatory hypertrophy. The recipient has
been well for 4.5 years and laboratory tests including
liver function parameters are normal.
Conclusion: The regenerating liver requires an enor-
mous amount of oxygen supply to meet the increased
metabolic load and DNA synthesis. Increased hepatic
arterial inflow arising from splenectomy or in the set-
ting of heterotopic auxiliary liver transplantation, led
to enhanced hepatocyte proliferation and improved
liver regeneration. In the case reported herein, left
hepatic arterial flow failure resulted in hypoxia
response in the left-sided graft and impaired its early
regeneration. The right graft regenerated effectively and
outcompeted the left one significantly. Furthermore,
the coexistence of two separated grafts is likely to
induce inter-graft functional inhibition. Thus, we sup-
pose under the metabolic demand stimulus of the reci-
© 2013 The Authors
HPB 2013, 15 (Suppl. 2), 85–244 HPB © 2013 Americas Hepato-Pancreato-Biliary Association
CONCURRENT SESSIONS POSTER 193
pient the right-sided graft became further hypertrophy
while the left one gradually grew atrophy.
1014
SURGICAL OUTCOME OF CAUDATE
LOBE RESECTION FOR
HEPATOCELLULAR CARCINOMA-
SINGLE INSTITUTE EXPERIENCE
Chih-Po Hsu, Tsung-Han Wu, Ming-Chin Yu,
Chen-Fang Lee, Kun-Ming Chan, Wei-Chen Lee and
Miin-Fu Chen
Department of Surgery, Division of General Surgery,
Chang Gung Memorial Hospital, 7F., No.136,
Changgengyihu Vil., Guishan Township, Taoyuan County
333, Taiwan
Aim: Hepatocellular carcinoma (HCC) originating in
the caudate lobe is rare. We reviewed the clinicopatho-
logic findings and outcomes of liver resection for cau-
date lobe hepatocellular carcinoma (HCC) in Linkou
branch of Chang Gung Memorial Hospital.
Methods: We retrospectively analyzed 35 consecutive
patients with HCC, originating from the caudate lobe,
who underwent resection between April 2002 and Janu-
ary 2011. Univariate and multivariate analyses were
performed to determine the factors affecting the out-
come.
Results: The mean age was 56.3 years old and 29
patients were male. Thirty patients were hepatitis B or
C carrier. Thirty-four patients were Child A. The clini-
copathologic showed tumor characters: mean total bili-
rubin (T-Bil) 0.9 mg/dL, glutamate oxaloacetate
transaminase (AST) 41.3 mg/dL, glutamic pyruvic
transaminase (ALT) 56.2 mg/dL, alkaline phosphatase
95.3 mg/dL, albumin 4.2 mg/dL and apha-fetoprotein
(AFP) 1711.3 mg/dL. The mean operative time was
305.6 minutes. The mean blood loss was 825.0 mL.
The mean tumor size was 6.7 cm. Twenty-six tumors
had capsule. Eighteen tumors had capsule invasion.
Two tumors was rupture. Thirteen tumors had vascular
invasion. The mean resection weight was 373.1 g.
Sixteen, seven and twelve patients were TNM stage I,
II and III or IV respectively. The mean disease-free
and overall survival rate was 24.9 and 33.2 months
respectively. Univariate analysis showed that non-B
and non-C hepatitis status, patients with symptoms,
positive physical examination findings, T-Bil more than
2 mg/dl, AST more than 68 U/L, albumin less than 4
g/dL, tumor size more than 5 cm, vascular invasion
and T staging were related to disease-free survival rate.
Vascular invasion, T staging and major resection were
related to overall survival. Multivariate analysis showed
that non-B and non-C status and tumor size more than
5 cm were elated to disease-free survival rate. Vascular
invasion was related to overall survival rate.
Conclusion: The most prognostic factors for surgical
treatment for caudate lobe HCC was vascular invasion
and tumor size.
1015
GENOME-WIDE REPROGRAMMING OF
TREG CELLS INTO EFFECTOR T
CELLS AFTER SPONTANEOUSLY LOSS
OF FOXP3
Hai-Qi He1, Bing Ni3, Yong Zhang2 and Yi Lv1
1Department of Hepatobiliary Surgery; 2Department of
Thoracic Surgery, The First Affiliated Hospital of
Medical Collage, Xi’an Jiaotong University, Xi’an
710061, Shanxi Province, China; 3Institute of
Immunology, PLA, Third Military Medical University,
Chongqing 400038, China
Background and aims: Natural CD4+FOXP3+ regula-
tory T (Treg) cells constitute a unique T-cell lineage
that plays a pivotal role in the maintaining immune
homeostasis and inducing transplantation tolerance.
However, recent studies provide evidence for functional
heterogeneity and lineage plasticity with Treg cells. To
extend our understanding of Treg cell instability and
analyze the fate of Treg cells that lose FOXP3, we
compared the gene expression patterns of expanded
FOXP3+ Treg cells and FOXP3-losing cells.
Methods: Natural CD4+CD25highCD127low Treg cells
were isolated from peripheral blood mononuclear cells
by FACS and expended in vitro with repeated stimula-
tion via CD3 and CD28 in the presence of high-dose
interleukin 2. The percentage of FOXP3+ cells was
analyzed every week by flow cytometry. The expanded
cells were then sorted into FOXP3+ and FOXP3- sub-
populations, and RNA was extracted and analyzed
using genome-wide mRNA sequencing.
Results: Natural Treg cells rapidly down-regulate
expression of their lineage-defining transcription factor
FOXP3 during in vitro expansion. Whole-transcriptom-
e analysis showed that 809 genes were down-regulated
whereas 1034 genes were up-regulated after loss of
FOXP3 expression. What’s more, FOXP3-losing cells
loss Treg cell gene expression patterns, such as down-
regulated CTLA4, CTLA4, LGALS3 and LRRC32
and up-regulated CD40LG. More strikingly, FOXP3-
losing Treg cells started to express a number of Th-spe-
cific genes, especially Th2 signature genes, such as
GATA3, IL-13 and IL-4.
Conclusions: Our results demonstrated that Treg cells
can reprogrammed to effector-like cells upon loss of
FOXP3 expression, which elucidate the plasticity of
human Treg lineage.
1017
PROSPECTIVE CASE-CONTRAL STUDY
FOR TABLET-AND LIPOSOME-
ALBENDAZOLE IN TREATING
HEPATIC CYSTIC ECHINOCOCCOSIS
Hai-Tao Li1,2, Ta Song1,3, Ying-Mei Shao1,2, Erganaili
Tu1,2, Yifuhanahan1,2, Bo Ran1,2 and Hao Wen1,3
1State Key Lab Incubation Base of Xinjiang Major
Diseases Research (2010DS890294) and Xinjiang Key
Laboratory of Echinococcosis, First Affiliated Hospital
of Xinjiang Medical University; Urumqi, Xinjiang,
China. 830000; 2Hepatobiliary & Hydatid Department,
Digestive and Vascular Surgery Centre, First Teaching
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Hospital, Xinjiang Medical University; Urumqi,
Xinjiang, China. 830000; 3Department of
Ultrasonography, First Affiliated Hospital, Xinjiang
Medical University, Urumqi, Xinjiang, China. 830000
Background: Echinococcosis is a zoonotic parasitic dis-
ease, which is widely distributed all over the world.
Surgery is the best choice for the treatment of human
echinococcosis, but chemotherapy is absolutely neces-
sary as an auxiliary treatment. At present, benzimidaz-
oles are the primary medical therapy in the treatment
of hydatid cystic echinococcosis(HCE), and albendazole
is from the benzimidazoles family and is effective medi-
cine acknowledged in the word. Even so that, the evi-
dence-based medical evaluation is still difficult to carry
out owing to the lack of randomized controlled trials
(RCTs) to evaluate medical effect for treating HCE in
the world by now. Liposomal albendazole(L-ABZ) is a
new form of albendazole, the clinical effect has been
reported as good. Our study tended to investigate the
safety and efficacy of the two forms of albendazole
which are tablet albendazole(T-ABZ) and liposomal
albendazole(L-ABZ) by clinical trial in treating HCE.
Aims: Using the non-randomized case-control study,
taking albendazole tablet as positive control, We try to
evaluate the safety and effect for two forms of albe-
ndazol, in treating HCE.
Methods: By prospective study, in total of 60 out-
patients with HCE including single cyst(CE1) and
daughter cyst(CE2) treated with T-ABZ and L-ABZ.
Based on including and excluding criteria, all cases
were not randomly divided two groups. By continuous
chemotherapy, the effect and safety of the two drugs
were compared by analyzing the clinical symptoms,
imaging examination and serologic test results.
Results: In all following cases, Group T-ABZ lost one
case in following period, one case choose to treat by
operation. Group L-ABZ lost two cases in following
period. By blinding statistic analyzing, in short-term effect
evaluation(3 months), the total effective rates of L-ABZ
group and T-ABZ group were 33.3%(10/30) and 76.7%
(23/30).There was significant difference between the two
groups in total effective rates (= 11.38, p = 0.001). In
long-term effect evaluation of the two(6 months), the total
effective rates of L-ABZ group and T-ABZ group were
66.7%(20/30) and 93.3%(28/30).There was significant
difference between the two groups in total effective rates
( = 6.67, p = 0.01). Drug-related adverse effect being same
were 10%(3/30), without difference(= 0.18, p = 0.66).
Conclusions: Tablet albendazole and liposomal alben-
dazole are all safe and effective drug for treating HCE,
while, it seems that the effect of liposomal albendazole
is superior to tablet albendazole.
1021
ESTROGEN RECEPTOR EXPRESSION
IN NORMAL AND MALIGNANT
PANCREAS
V. G. Shelat, Ho Bernard, Low J. K., Junnarkar S. P.
and Woon W
Tan Tock Seng Hospital, 11, Jalan Tan Tock Seng
308433 Singapore
Background: Estrogen receptors are expressed in
normal and malignant pancreas. This provides an
opportunity for hormonal therapy for pancreatic can-
cer. There have been conflicting results of hormonal
therapy in pancreatic cancer. Enthusiasm in this con-
cept has faded and clinical application of hormonal
therapy is unexpected in near future. Due to reports
and encouraging results of tamoxifen therapy by some
centers, we would like to re-explore this concept. We
herewith report a pilot study to expression of estrogen
receptor in normal and malignant pancreas. Once con-
firmed, we would like to test a pure anti-estrogen
medicine to test efficacy of hormonal therapy, first in
animal model and then as a part of controlled clinical
trial.
Aim: To study the expression of estrogen receptor in
normal and malignant pancreas.
Hypothesis: 1. Estrogen receptors are expressed in nor-
mal pancreas.
2. Estrogen receptors are over-expressed by 25% in
malignant pancreas.
Results: Will be disclosed at the presentation, study is
ongoing. Study is expected to complete by Jan 2013.
Conclusion: Will be disclosed at the presentation, study
is ongoing. Study is expected to complete by Jan 2013.
Acknowledgement:
Ms Wang Bei, Hepato-biliary nurse clinician:
Disclosures and Conflict: This study is funded from a
research grant for Master in Clinical Investigation to
Mr Shelat VG from National Medical Research Coun-
cil, Singapore.
1023
HEPATOBILIARY TUBERCULOSIS-
CASE SERIES FROM A SINGLE
INSTITUTION
Terence Huey, M. H. A. Jayathilaka, J. P. Sameer, W.
Woon and J. K. Low
Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng
Singapore
Introduction: Tuberculosis is common especially in
underdeveloped and developing nations and yearly 7-
8 million new cases are detected worldwide. However,
hepatobiliary tuberculosis is uncommon and presents
with non-specific symptoms mimicking malignancies
and other infections. We present a case series of hepa-
tobiliary tuberculosis in a single centre.
Case Presentations: The first case was a 49 years old
Filipino lady who presented with epigastric pain and
on CT scan found to have focally dilated right intrahe-
patic ducts with ill-defined hypodense lesions surround-
ing the ducts and several foci of clacifications
associated with capsular retraction suggestive of hepatic
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granulomas; MRCP confirmed these findings and cho-
langiocarcinoma remained a differential. Colonoscopy
performed for investigation of anaemia revealed a cae-
cal ulcer, for which the biopsy showed acid fast bacilli.
Biopsy of the hepatic lesions showed granulomas with
Langhan’s type giant cells, central necrosis and PCR
was positive for Mycobacterium tuberculosis DNA.
The second case was a 71 years old man who presented
also with abdominal pain and had a CT scan done
showing a 4.5 cm mass in segment 4a of the liver. It
was hypermetabolic on PET scan, suggestive of intra-
hepatic cholangiocarcinoma. Left hemihepatectomy was
performed which revealed granulomatous inflammation
with caseous necrosis and no evidence of malignancy.
The patient recovered uneventfully with anti-tubercu-
lous medication. The third case was a 25 year old FiIli-
pino lady presenting with progressive jaundice with
upper abdominal pain for a month. The chest x ray
showed military tuberculosis .CT scan showed multiple
calcified hepatic granulomas with multiple hypodense
lesions. MRCP showed dilated intrahepatic biliary
ducts, no stones, likely secondary to fibrosis from long-
standing infection and suggestive of hepatic tuberculo-
sis in view of the concurrent pulmonary findings. She
was also started on anti-tuberculous medication.
Discussion: Tuberculosis of the hepatobiliary system is
a rare condition and the common presentations include
fever, weight loss, abdominal pain and jaundice. Imag-
ing often yields findings that are more commonly
attributed to more sinister pathologies such as cholan-
giocarcinomas, which are more common in our centre.
However the treatment modalities and prognosis of
these two groups are vastly different. Diagnosis needs
to start with a strong index of suspicion depending on
patient’s immune status, geographical background and
comorbid conditions, especially other sites of concur-
rent tuberculosis. Appropriate diagnosis may obviate
need for major surgery and achieve cure.
Conclusion: Hepatobiliary tuberculosis manifest in a
variety of presentations. Timely and accurate diagnosis
is vital in order to avoid unnecessary surgical interven-
tions.
1026
THE DIFFERENTIAL DIAGNOSIS AND
CLINICAL SIGNIFICANCE OF GOLGI-
PROTEIN 73 IN PATIENTS WITH LIVER
CIRRHOSIS AND HEPATOCELLUAR
CARCINOMA
Ying Yang, Rui Mao, Lei Xiao, Hua-Rong Zhao,
Yue-Fen Zhang and Yong-Xing Bao
Cancer Center of the First Affiliated Hospital in
Xinjiang Medical University, Urumqi, China
Background: Recent data and our previous study have
showed Golgi-protein 73 (GP73) as a potential serum
marker for diagnosing hepatocelluar carcinoma (HCC).
However, serum GP73 value in the differential diagno-
sis between liver cirrhosis and HCC and its clinical sig-
nificance in patients with HCC remain largely
unknown. Thus, it prompted us to further examine
whether serum GP73 was superior to AFP in differenti-
ating liver cirrhosis from HCC and its correlation
between tumor characteristics and liver impairment.
Methods: GP73 (total 249serum samples) in 80 HCC,
65 liver cirrhosis, 54chronic hepatitis B and 50 healthy
controls were detected using enzyme-linked immunosor-
bent assay (ELISA) and AFP was also measured by
clinical chemiluminescence.
Results: 1. The serum GP73 in HCC group282.0
(163.6-366.7) lg/L, was significantly higher than that in
liver cirrhosis group 211.8 (107.5-295.7) lg/L, chronic
hepatitis group100.3 (61.8-191.3) lg/L and control
group 58.3 (43.4-83.6) lg/L (H = 106.6, P < 0.001).
2. The critical values of GP73 and AFP were 318.1 lg/
L and 13.4 lg/L respectively determined by ROC
curves in differentiating patients with HCC and liver
cirrhosis. The sensitivity of GP73 45.0% (36/80) was
lower than AFP 65.0% (52/80), v2 = 8.02, P<0.05; the
specificity of GP73 83.1% (54/65) was either lower than
AFP 87.7(57/65)%, v2 = 0.27, P > 0.05, but no signifi-
cance was found. The area under ROC curves was 0.75
(95%CI 0.67 0.83) for AFP, 0.65(95%CI 0.54 0.72)
for GP73(Z = 1.88, p > 0.05). 3. GP73 was correlated
with liver cirrhosis, portal vein thrombus, clinical TNM
staging (correlation coefficient r was 0.265, 0.294, 0.267
respectively, all P < 0.05), but was not with sexuality,
age, AFP >13.4 lg/L, the diameter of tumor, distant
metastasis (correlation coefficient r was 0.130, 0.100,
0.038, 0.175, 0.040, all p > 0.05). 4. The level of GP73
was positively correlated with ALT, AST and nega-
tively correlated with ALB, A/G (correlation coefficient
r was 0.368, 0.425, -0.408, -0.360 respectively, all
P < 0.05), with no correlation of TBLB, DBLB, IBLB,
GGT (correlation coefficient r was 0.043, 0.046, 0.066,
0.049, all p > 0.05).
Conclusion: The diagnostic efficiency of serum GP73
was comparable with AFP, but its sensitivity was
inferior to AFP in differentiating liver cirrhosis from
HCC patients. The elevation of serum GP73 may be
correlated with tumor load, tumor aggression and
hepatocytes injury.
1027
GROOVE PANCREATITIS
Sadiq Sikora and Nagaraj Palankar
Manipal Hospital, HAL Airport Road, Bangalore
560017. India, Bangalore, Karnataka, India
Background: Groove Pancreatitis is a rare form of
focal chronic pancreatitis involving the groove between
the pancreatic head and the C-loop of the duodenum.
It is a rarely reported condition and hence frequently
under diagnosed.
Objective:
We report a series of 3 cases of groove pancreatitis:
Methods: 3 patients were diagnosed to have groove
pancreatitis. The demography, symptomatology, associ-
ated co morbidities, history of alcohol abuse, diagnostic
workup, treatment options and outcome were reviewed.
Results: 2 of the 3 patients were male. They were of
the age 38, 49 and 64 years. 2 of the 3 patients pre-
sented with vomiting and loss of weight. Another
patient presented with features of mild acute pancreati-
tis including elevated amylase and lipase. 2 patients
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had associated diabetes. None of the patients consumed
alcohol. All the 3 patients had normal liver function
tests. All patients had normal Ca 19-9 levels. CT scan
in all the 3 patients showed features of inflammation in
the groove between the head of the pancreas and the c-
loop of the duodenum. None of the patients had bile
duct dilatation. Multiple cystic lesions were found in
duodenal wall/groove in 2 patients. One patient showed
features of atrophic pancreatitis with pancreatic ductal
dilatation and multiple ductal calculi. 2 patients who
had persistent vomiting and weight loss underwent
Whipple’s pancreaticoduodenectomy. Both had an
uneventful postoperative course. Histopathology
revealed in both cases groove fibrosis, Brunner gland’s
hyperplasia, ectopic pancreatic acini and cystically
dilated ducts in the duodenal wall. Another patient
who presented with recurrent acute flare-up of pancrea-
titis was managed expectantly.
Conclusion: Groove Pancreatitis is commonly mistaken
for pancreatic head cancer. Awareness of this is neces-
sary to make a correct diagnosis and appropriate man-
agement.
1028
ISOLATED CHOLECYSTO-RIGHT
HEPATIC DUCT FISTULA - A VARIANT
MIRIZZI SYNDROME ?: REPORT OF A
CASE
Kyu Hee Her
Jeju National University Hospital, Ara 1, Jeju city, Jeju,
Korea, Jeju, South Korea
Backgrounds and aims: Mirizzi syndrome is character-
ized by obstruction of common hepatic duct and even-
tually evolving into a cholecystobiliary fistula by
impacked gallbladder stone.
Recent classification divided Mirizzi syndrome into
four or five types according to the pathophysiology.
But even though different types of Mirizzi syndromes
had been added, cholecystobiliary fisutula between gall-
bladder and intrahepatic duct was never been men-
tioned. We experienced a fistula formed between
infundibulum of gallbladder and right hepatic duct.
Methods: A 39-year-old women with recurrent epigas-
tric discomfort after meal was determined to have
symptomatic gallbladder stones underwent laparoscopic
cholecystectomy. Preoperative computed tomography
revealed diffuse wall thickening of gallbladder with mul-
tiple stones and mild right hepatic duct dilatation with-
out demonstable obstructive lesion. Because laboratory
studies including liver function test were totally normal,
operation was performed without further studies.
Results: While dissecting infundibulum of gallbladder
body from the liver, a large stone impacked in the
liver parenchyme was found and removed, followed by
bile leakage through a small defect of the liver. Inra-
operative cholangiography through the defect showed
a main branch of right hepatic duct. Operation was
converted to open cholecystectomy. Partial cholecys-
tectomy and 10Fr. T-tube insertion through the defect
was done. T-tube was removed after 8 weeks later
successfully.
Conclusions: We insisted that our case was unique and
this type of cholecystobiliary fisutula might be consid-
ered as a variant form of Mirizzi syndrome.
1029
INHIBITORY EFFECT AND
MECHANISM OF THE RAF KINASE
INHIBITOR PROTEIN EXPRESSION IN
HEPARANASE ON HCCLM3 CELL
Ning-Ning Feng and Shun-Xiang Wang
Department of Hepatobiliary Surgery, the Fourth
Hostipal of Hebei Mediccal University, 12 jiankang Rd,
Shijiazhuang, 050000 China
Background: Hepatocellular carcinoma is the 5th com-
monest malignancy worldwide and is the third most
common cause of cancer-related death.The RKIP
involved in regulation of multiple signal transduction
pathways, including inhibition of Raf-MEK1/2-ERK1/
2 and NF-jB signal transduction pathways.
Objective: To HCCLM3 liver cancer cells and stable
transfection of RKIP gene HCCLM3 liver cancer cells
of RKIP in the detection of liver cancer cells Hpa, P-
ERK expression to further clarify the RKIP inhibited
the expression of liver cancer cells Hpa whether the
Raf-MEK1/2-ERK1/2 signal transduction pathway.
Methods: 1 HCCLM3 liver cancer cells, RKIP cells
extract protein, BCA Protein Assay. Western blotting
detection of RKIP, P-ERK and Hpa protein expression
observed expression of RKIP inhibition of Hpa and
Raf-MEK1/2-ERK1/2 signal transduction pathway.
2 HCCLM3 liver cancer cells, RKIP cells by adding
EGF to activate the ERK pathway, cell protein was
extracted after 15 minutes, the BCA Protein Assay.
Western blotting detection of RKIP, P-ERK and Hpa
protein expression, further validate RKIP inhibition of
the expression of Hpa and inhibition Raf-MEK1/2-
ERK1/2 signal transduction pathway activation.
Results: 1 RKIP expression in RKIP transfected the
group HCCLM3 cells was significantly higher than the
blank control group (P <0.05), while the expression of
P-ERK and Hpa was significantly lower than the blank
control group (P <0.05); With HCCLM3 cells of RKIP
expression increased, the P-ERK and Hpa expression
decreased.
2 The EGF (+) control Group HCCLM3 cells, P-ERK
expression was significantly higher than that of EGF
(+) of RKIP transfected group (p < 0.05), EGF (+)
control group HCCLM3 cells Hpa expression was sig-
nificantly higher than that of EGF (+)RKIP transfer
dye group (p < 0.05); RKIP expression as HCCLM3
cells increased ERK pathway activation, the P-ERK
and Hpa expression is still down.
Conclusions: 1 In HCCLM3 cells RKIP low expression,
while the P-ERK and Hpa high expression, while high
expression of RKIP in RKIP transfected HCCLM3
cells, the P-ERK and Hpa low expression. RKIP may
be via ERK pathway to inhibit the expression of Hpa.
2 Control of RKIP the group HCCLM3 cells with low
expression, the P-ERK and Hpa high expression of
EGF (+), and in the EGF (+)RKIP transfected cells
high expression of RKIP, the P-ERK and Hpa low
expression, indicating that the RKIP expression inhibit
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the expression of Hpa and inhibition of ERK signaling
pathway activation.
1031
OUTCOMES OF INTRAHEPATIC
CHOLANGIOCARCINOMA AFTER
LIVER RESECTION
TCL Wong, KS Chok, TT Cheung, AC Chan,
SH Tsang and RT Poon
Queen Mary Hospital, The University of Hong Kong,
L340, Queen Mary Hospital, Hong Kong Hong Kong
S.A.R., China
Background and aims: The optimal surgical manage-
ment for intrahepatic cholangiocarcinoma (IHC) is
controversial especially in regard to the need for radical
lymphadenectomy. Evidence to demonstrate oncologi-
cal significance of radical lymphadenectomy is limited.
Radical lymphadenectomy is not a routine practice in
our centre. The aim of this study is to evaluate the out-
comes of these patients who underwent liver resection
without radical lymphadenectomy.
Method: This is a retrospective review of all consecu-
tive patients who underwent hepatectomy for IHC in a
university centre in Hong Kong from 1990 to 2011.
Results: Ninety seven patients underwent surgery dur-
ing study period. The median age was 61 year old.
Around one third of them are hepatitis B or C carrier
and 18 patients (18.6%) have background of recurrent
pyogenic cholangitis. Most of our patients were Child’s
A and the median indocyanine green retention rate at
15mins was 9.85 (0.8-82.5). Seventy two patients
(74.2%) underwent major and 25 patients (25.8%) had
minor resection. None had radical lymphadenectomy.
Hospital mortality was 9.3% and complication rate
was 33.0%. Forty-four (45.4%) patients were free from
recurrence, 14 patients (14.4%) had intrahepatic recur-
rence, 19 patients (19.6%) had extrahepatic recurrence
and 20 patients (20.6%) had both intrahepatic and
extrahepatic disease. Among the 39 patients with extra-
hepatic disease, majority (38.5%) of them suffered from
lung metastasis. The overall survival at 3-year and 5-
year was 42.7% and 32.7% while the 3- and 5-year dis-
ease free survival was 37.1% and 27.8%. Multivariate
analysis showed survival was poorer in those with
background of recurrent pyogenic cholangitis
(HR = 2.0, p = 0.04), those with multiple primary
tumors (HR = 2.9, p = 0.001), tumors with vascular
permeation (HR = 2.23, p = 0.007) and patients who
had perioperative complications (HR = 2.39,
p = 0.001).
Conclusion: Our survival data is comparable to those
reported in the literature. The question whether radical
lymphadenectomy, besides staging relevance, could
improve overall survival of patients with IHC remains
unknown. The primary site of metastasis of these
patients was in the lung rather than in lymph node and
lymphadenectomy itself is not without risk. Routine
radical lymphadenectomy might not lead to additional
survival advantage.
1038
SIMPLE TECHNIQUE OF
LAPAROSCOPIC
PANCREATICOJEJUNO ANASTOMOSIS
DURING LAPAROSCOPIC
PANCREATICODUODENECTOMY FOR
PANCREATIC CANCER
Pavel Tyutyunnik1, V. V. Tsvirkun2, R. E. Izrailov1
and P. S. Tyutyunnik1
1Chair of faculty surgery № 2, Moscow State Medical
Dentistry University; 2FMBA № 119, Clinical Hospital,
Moscow, Russia
Pancreaticojejuno anastomosis is the most difficult and
important stage during totally laparoscopic pancreati-
coduodenectomy (TLPDE). The insufficiency of pan-
creaticojejunal anastomosis may lead to serious
postoperative morbidity and mortality. For today tech-
nique of pancreaticojejunal anastomosis is not stan-
dardized in different hospitals. Standardize the
technical details of performing TLPDE to improve
long-term outcomes and quality of life after such sur-
geries.
Objectives: To create the most safe technique of pan-
creaticojejunal anastomosis during TLPDE.
Methods: From January 2007 to August 2009 20
pancreaticoduodenectomy were performed by totally
laparoscopic approach. In all patients we use nonab-
sorbable Prolen sutures and for formation end-to-sight
pancreaticojejunal anastomosis. In 13 patients (65%)
two-roll duct-to-mucosa pancreaticojejuno anastomosis
with 3.0 internal running sutures and 5.0 interrupted
sutures for the pancreatic duct. In 7 patients (35%)
one-roll 3.0 interrupted sutures invagination pancreat-
ojejunal anastomosis without separate suture of the
pancreatic duct. We did not use any tubes when per-
forming the pancreaticojejunostomy.
Results: From January 2007 to August 2009 24
patients were taken for laparoscopic pancreaticoduo-
denectomy at the single center among them 20 patients
by totally laparoscopic approach. Insufficiency of duct-
to-mucosa pancreaticojejunal anastomosis was observed
in 2 patients (10%). Insufficiency of invagination pan-
creaticojejunal anastomosis was observed in 1 patient
(5%). The mean time of performing of duct-to-mucosa
pancreaticojejunal anastomosis was 55.8 min (34–
75 min). The mean time of performing of invagination
pancreatojejunal anastomosis was 45.5 min (31–
68 min).
Conclusion: TLPDE is a safe procedure. The invagina-
tion pancreaticojejunal anastomosis provides more
safety and less time for performing.
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1040
APPLICATION OF
GASTRODEUDENTAL ARTERY GRAFT
IN RECONSTRUCTION OF TUMOR
INVASIVE HEPATIC ARTERY IN HILAR
CCA
Yu-Rong Liang, Xian-Jie Shi, Shou-Wang Cai, Jing
Wang and Jia-Hong Dong
Hospital & Institute of Hepatobiliary Surgery, Chinese
PLA General Hospital, Beijing 100853
Abstract: Hilar cholangiocarcinoma (CCA) have in
recent decades been managed with a more aggressive
surgical approach to achieve R0 resection and satisfac-
tory results of 5-year survival. However, artery inva-
sion in hilar cholangiocarcinoma is still the
contraindication for numbers of the surgeries. Whether
the invasive hepatic artery be reconstructed or not after
resection is also controversial. This study is designed to
use gastrodeudental artery grafts to reconstruct the
resected hepatic arteries, which were involved in hilar
CCA. From June 2008 to October 2011 total 6 cases
of hilar CCA (Type Bithmuth IIIa) were conducted
hemihepatic resection plus hepatic artery reconstruction
using gastrodeudental artery grafts and none of them
were found to araise artery thrombosis or stenosis.
Neither of them appeared problems of gastrointestinal
or liver dysfunction. We concluded that gastrodeuden-
tal artery graft might be the perfect candidate for
reconstruct the resected hepatic artery that involved by
hilar CCA.
Keywords: Hilar cholangiocarcinoma; Hepatic artery,
Artery graft; Reconstruction
Correspondence author: Jiahong Dong, MD, PhD.
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SERUM PEPTIDOME PROFILING FOR
PANCREATIC CANCER
Pei Li, Zheng Wang and Zheng Wu
Department of Hepatobiliary Surgery, First Affiliated
Hospital of Xi’an Jiaotong University, 277 West Yanta
Rd, Xi’an, Shaanxi, 710061 China
Background and aims: Considering the early diagnosis
of pancreatic cancer will significantly improve the prog-
nosis of patients. It’s urgent to find a minimally inva-
sive and efficient method of detecting early pancreatic
cancer. Seeking a biomarker in serum by the mass spec-
trometry (MS)-based screening methods such as
matrix-assisted laser desorption/ionization time-of-flight
(MALDI-TOF) MS has become a mature technology.
Methods: 40 serum samples of pancreatic cancer
patients (preoperative and postoperative) and healthy
controls were collected from the First Affiliated Hospi-
tal of Xi’an Jiaotong University from 09/2010 to 03/
2012. Magnetic bead-based weak cation-exchange chro-
matography(MB-WCX) was used for peptidome sepa-
ration of samples. Air-dried targets were measured
immediately using a calibrated Autoflex III MALDI-
TOF MS (Bruker), FlexControl software (version 3.0;
Bruker). The Flex analysis soft-ware (version 3.0; Bru-
ker) was applied for data analysis. Clinprotools
software (version 2.2; Bruker) was used for the recogni-
tion of peptide patterns.
Results: MB-WCX magnetic beads were used on serum
samples and MALDI-TOF MS revealed 49 peaks, of
which 33 significant m/z peaks with a P value for the
Wilcoxon rank sum test of< 0.001 were detected
between the preoperative pancreatic cancer patients
and the healthy controls (Table 1). The preoperative
patients (red), postoperative patients (blue) and healthy
controls (green) demonstrated protein profiles from 1
to 10 kDa (Fig. 1). The two proteins (m/z = 1866.83
and 4055.17) were both down-regulation in pancreatic
cancer which screen out by software can distinguish the
preoperative or postoperative pancreatic cancer patients
and the healthy controls (Fig. 2).
Conclusions: We made a preliminary exploration for
the pancreatic cancer patients and normal controls’
serum proteomics and found that there are differences
among the three groups. The two proteins (m/
z = 1866.83 and 4055.17) from the 33 significant m/z
peaks almost have little sample distribution overlap
region which confirm the two proteins can distinguish
the preoperative patients group and normal control
group wonderful, and may be a new biomarker in diag-
nosis of pancreatic cancer. Clarifying the proteomics
characteristics of pancreatic cancer serum is crucial for
a better understanding of the tumor biology in order to
develop novel diagnostic strategy. Their potential
involvement and biological significance in pancreatic
cancer may open up a new horizon to the molecular
mechanisms underlying pancreatic cancer.
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EXPRESSION OF SPECIAL AT-RICH
SEQUENCE- BINDING PROTEIN AND
ITS CLINIC SIGNIFICANCE IN
HEPATOCELLULAR CARCINOMA
Ding-Hua Yang, Xiao Liu, Huang Yu, Xiang-Hong Li,
Jian-Kun Liang, Liang Lin, Ke-Bo Zhong, Hua He, Bo
Liang, Jia-Lu Li and Jie Zhou
Department of Hepatobiliary Surgery, Nanfang
Hospital, Southern Medical University, Guangzhou,
510515, China
To investigate the expressions of Special AT-rich
Sequence- binding Protein(SATB1) and its significance
in hepatocellular carcinoma (HCC).
Methods: The mRNA and protein expression of
Special AT-rich Sequence-binding Protein(SATB1)in
hepatocellular carcinoma(HCC) and adjacent tissues
were detected with real-time fluorescence quantitative
PCR(qRT-PCR), western blotting methods and immu-
nohistochemical method. The relationships between
SATB1 expression and the clinical pathological param-
eters, recurrence or metastasis, the survival time were
analyzed.
Results: The expression of SATB1 mRNA in HCC tis-
sues was 3.27-fold higher than its adjacent tissues
(p < 0.001) y real-time fluorescence quantitative PCR.
The positive rate of SATB1 protein in HCC tissues
(75%) was higher than its adjacent tissues (12.5%)
(p < 0.001) immunohistochemistry. Western blotting
showed that the expression of SATB1 in HCC tissues
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was higher than its adjacent tissues (p < 0.001). The
expression of SATB1 in HCC tissues is associated with
AFP, tumor size, tumor thrombus, histological differ-
entiation, TNM classification, recurrence and metasta-
sis after surgical resection (p < 0.05). There is no
relationship between the expression of SATB1 and gen-
der, age, HBsAg positive, tumor number, liver cirrho-
sis, envelope (p > 0.05). The recurrence rate of HCC
patients with high expression of SATB1 was higher
than that with low expression of SATB1, and the sur-
vival time of HCC patients with high expression of
SATB1 was shorter than that wit low expression of
SATB1.
Conclusion: The expression of SATB1 may be associ-
ated with the degree of malignancy and prognosis of in
hepatocellular carcinoma (HCC).
Key words: Hepatocellular carcinoma(HCC);SATB1;
Real-time fluorescent quantitative RT-PCR;mRNA;
Protein;Western blotting;Immunohistochemistry
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SIROLIMUS (SRL) MONOTHERAPY
VERSUS CONTINUED FK506 IN LIVER
ALLOGRAFT RECIPIENTS: A
RETROSPECTIVE ANALYSIS
Ding-Hua Yang, Xiang-Hong Li, Yu Huang, Liang
Lin, Ke-Bo Zhong, Yi-Xiong Lin, Sheng Yu, Hua He,
Xiao Liu and Jie Zhou
Department of Hepatobiliary Surgery, Nanfang
Hospital, Southern Medical University, Guangzhou,
510515, China
To assess the feasibility, safety and adverse events of si-
rolimus (SRL)monotherapy in long-term follow-up in
the early postoperative period after liver transplanta-
tion (LT), and the affect sirolimus (SRL)monotherapy
on the patient survival with hepatocellular carcinoma
(HCC) post transplantation.
Methods: A retrospective analysis of 118 consecutive
patients, who had undergone LT for late-stage hepatitis
B virus (HBV) cirrhosis or HCC was conducted. 119
patients were divided into two groups: SRL group
(n = 61, 15 HBV cirrhosis, 46 HCC) who received sirol-
imus (SRL) monotherapy in the early postoperative
period after liver transplantation (LT), FK506 group
(n = 57, 14 HBV cirrhosis, 43HCC) who received
FK506-based immunosuppression post transplantation.
The acute rejection rates and adverse events of siroli-
mus (SRL),were used in the assessment. The survival
time and recurrence of HCC in two group patients with
HCC were analysed.
Results: The incidence of acute rejection was not signif-
icantly different for patients treated with SRL
(p > 0.5). The level of Creanine (Cr) and CCR in SRL
group was significantly higher than that in FK506
group (p < 0.5). Compared with FK506 group, there
was significantly difference found for time to recur-
rence, survival time for patients with HCC treated with
SRL (p < 0.01). The common adverse events of siroli-
mus included mouth ulceration, rash, hyperlipidemia,
bone marrow suppression, and there was not found for
hepatic artery thrombosis (HAT), proteinuria, pneumo-
nitis and incision diorders in SRL group.
Conclusion: The present study shows that sirolimus
(SRL)monotherapy can be safely used in patients
undergoing LT for late-stage hepatitis B virus (HBV)
cirrhosis or HCC;forthermore, SRL did significantly
affect the timing of post-transplant HCC recurrence
and patients survival.
Key words: Liver transplantation; Sirolimus; Cirrhosis
or HCC; FK506
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IMAGING DIAGNOSIS OF HEPATIC
VASCULAR MALIGNANCY TUMOR
Ning-Yang Jia, Hong-Yan Chen, Dong Chen, Xian-An
Long, Lun Lu and Xue-Xue Wang
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, 200438 China
To investigate the imaging appearance of hepatic vas-
cular malignancy tumor.
Material and Method: Thirteen cases (eight females
and five male, age from 5 years to 80 years) of hepatic
vascular malignancy tumor confirmed by pathologically
were retrospectively analyzed between 2009–2010 in our
hospital. Six cases were diagnosis of hepatic epithelioid
hemangioendothelioma (EHE), four case of hepatic an-
giosarcoma (AS), three cases of hepatic Hemangioperi-
cytoma (HPC). Tumor markers including Ca 19-9, alfa
feto protein and CEA levels were within normal limits
in twelve patients. These patients were scanned by 1.5
T MR (GE) or CT(GE). Single breath-hold FSPGR
sequence was used for the T1WI in axial orientation.
FSE with fat suppression sequences was used for the
T2WI in axial orientation. Both un-enhancement and
enhancement scan were also used for CT exam proce-
dure. The contrast medium was intravenous injected.
Three phases dynamic exam was scanned at 20–25 s, 55
–65 s and 120–140 s after injected the contrast med-
ium.
Result: Hepatic epithelioid hemangioendothelioma
appeared as single nodule and multiple nodules, lesions
likely located at subcapsular with clearer boundary,
multiple nodules usually tend to fusion. Typical appear-
ance of hepatic epithelioid hemangioendothelioma
showed “halo” sign, “capsular retraction” sign. Hepatic
epithelioid hemangioendothelioma may show intra-tu-
moral necrosis and coexistence with hemorrhage. After
contrast medium injected, tumor edge appeared mild
enhanced on arterial phase and slightly expanded
enhancement without tumor center filling on delay
phase. Typical imaging appearance of hepatic Hemang-
iopericytoma present with” fried-egg” sign, which the
center of the tumor were haemorrhage surrounded by
peritumoral rich vascular tissue. After contrast medium
administration, rich vascular tissue located at the edge
of the lesion showed heterogeneous enhancement on
arterial phase and still appeared enhancement on delay
phase, haemorrhage located at the center of the lesion
appeared no enhancement. Hepatic angiosarcoma may
also appear as single nodule and multiple nodules,
lesions located at subcapsular tend to broken. Typical
imaging appearance of hepatic angiosarcoma present
with isolated huge nodular or diffuse invasion with
rapid progression and also prone to metastasis.
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Conclusion: Imaging technique such as CT and MR
are important technique for the diagnosis of these
hepatic vascular malignancy tumor. Although these
hepatic vascular malignancy tumors are rare, we also
found that each hepatic vascular malignancy tumor has
its own typical imaging appearance which would be
helpful for pre-operation diagnosis.
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CASE REPORT: ONCOCYTOMA AT
ECTOPIC ADRENAL GLAND IN LIVER
Young Lae Jung, Hyun Il Seo and Sung Pil Yun
Department of Surgery, Pusan National University
Postgraduated School of Medicine, Busan, Korea
Adrenal oncocytomas are very rare tumors. Most of
them are benign and nonfunctioning. Oncocytic cells
were marked by the increased number of hypertrophied
mitochondria. The etiology remained unknown. We
report a case of an ectopic adrenal gland located at
liver(S6) in a 57 year old woman. The patient was
tested because of dyspepsia and found hepatic mass by
CT examination. Before surgery, the reading was he-
patocecellular carcinoma, and laparotomy was done for
liver resection. After surgery, the pathology report con-
firmed oncocytoma at ectopic adrenal gland in liver.
The patient is still alive after 1 year without recurrence
or metastasis. Adrenal oncocytoma, although extremely
rare, should be considered in the differential diagnosis
of indeterminate tumors.
1056
ENDOSCOPIC TREATMENT FOR
SPHINCTER OF ODDI DYSFUNCTION
(SOD): A RESULT OF LONG TERM
FOLLOW UP OVER 12 YEARS
Tian-Tian Wang
Endoscopic center, Shanghai, China
Background: SOD is a benign disease caused by a
sphincter of Oddi dysfunction. Important causes of
acute recurrent pancreatitis, common female and gall-
bladder resection patients, but the efficacy of endo-
scopic treatment is not exact.
Objective: To understand the long-term efficacy of
endoscopic treatment of SOD.
Method: Select SOD patients in our hospital 2000.1.1-
2012.3.31 with ERCP procedure. A total of 131 people
attending this research. Includeding criteria: pancreati-
cobiliary type pain, AST and ALT and ALP > 2x NL,
CBD diameter > 12 mm, bile duct emptying delay.
Exclusion criteria: acute or chronic pancreatitis, pan-
creas divisum, benign stricture of bile duct, common
bile duct stones. Record the patient’s age, gender, SOD
typing, preoperative and postoperative laboratory data,
common bile duct diameter, ERCP treatment, preoper-
ative and postoperative VAS pain scores. The chi-
square test statistic is used.
Results: ERCP pancreatitis and 36 patients(27%), no
ERCP related complications patients who died. The
pain 56 people complete remission, partial remission in
65, and 9 lost. Endoscopic treatment efficiency is
92.4%. EST was accounted for 57.1% in patients with
pain relief, columnar balloon dilatation accounted for
10.7%, 7.1% did not undergo endoscopic therapy,
endoscopic therapy for SOD can release symptoms
effectively than did not undergo endoscopic therapy,
(p < 05), EST best effect (p < .05).
Conclusion: Long-term follow-up endoscopic treatment
of SOD can effectively alleviate the patient’s symptoms,
and to reduce the incidence of postoperative complica-
tions and mortality.
1062
THE MECHANISM OF EPITHELIAL TO
MESENCHYMAL TRANSITION IN
HEPATOCELLULAR CARCINOMA
Bin Sun and Zheng-feng Yin
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, 200438 China
Metastasis is the main cause of hepatocellular carci-
noma-related death. The epithelial mesenchymal transi-
tion (EMT) plays a key role in the embryonic
development, tissue regeneration, cancer progression
and metastasis. During the past decade, EMT has been
increasingly concerned during the progression of vari-
ous carcinoma such as hepatocellular carcinoma
(HCC). Recent study revealed that EMT is associated
with both tumor invasiveness and metastasis in HCC.
To study the mechanism of EMT in HCC is extremely
important which leads to more accurate pathological
assessments and therapeutic concepts for individuals to
efficiently combat HCC progression. Here we reviewed
the relevant study for EMT in HCC, discussed the rele-
vance to the diagnosis and treatment of HCC, and ana-
lyzed the research area in the future.
1068
NEUROENDOCRINE TUMORS OF THE
AMPULLA OF VATER
Hiradava H Nag, Neeraj Goel, Amit Javed, Nikhil
Gupta, S. Saluja, P K Mishra and Anil K Agarwal
Department of GI Surgery, GB Pant Hospital & MAM
College, Delhi University, New Delhi, India
Background: Neuroendocrine tumors of the ampulla of
Vater account for less than 0.3% of all gastrointestinal
neuroendocrine tumors (NET) and have been mostly
reported as isolated case reports. The purpose of this
article was to report our experience in managing these
rare neoplasms.
Patients and Methods: A retrospective analysis of pe-
riampullary tumor database between January 2006 and
July 2012. Patients with NET arising from the Ampulla
formed the study group and were assessed for clinico-
pathological variables and tumor biology.
Results: During the study period, 154 periampullary
tumors were surgically resected by classical or pylorus
preserving pancreaticoduodenectomy. Of these, 6
patients had NET arising from the ampulla of Vater
and formed the study group. The mean age of the
patients was 43 years with 3 males and 3 females. Jaun-
dice was the commonest presenting symptom (in all
patients) followed by abdominal pain (3/6). All patients
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were resectable and underwent a Whipple’s pancreati-
coduodenectomy. The majority of the tumors were well
differentiated NET (4/6); one was poorly differentiated
neuroendocrine carcinoma and one was mixed endo-
crine-exocrine tumor. One tumor was associated with
multiple GISTs and another had a synchronous duode-
nal NET. All the tumors were chromogranin and
synaptophysin +ve and all were T3 lesions. Lymph
node metastases was present in 4 of the 6 patients. At a
median follow up of 24 (12–36) months all patients are
alive and free from disease.
Conclusion: The ampullary NETs are rare tumors. They
present with jaundice and therefore present early and are
usually non-functional. Most patients are resectable with
reasonable outcomes after surgical resection.
1069
PERIAMPULLARY CARCINOMA - ARE
HISTOLOGIC SUBTYPES IMPORTANT?
Rajneesh Kumar Singh, H H Nag, Neeraj Goel, Amit
Javed, Nikhil Gupta, S.Saluja, P K Mishra and Anil K
Agarwal
Sanjay Gandhi Post Graduate Institute of Medical
Sciences, Lucknow, India
Aims: The term periampullary carcinoma is used for
heterogeneous group of tumors that are often difficult
to classify with certainty. Pathologists have classified
periampullary tumours, based on morphologic criteria
and immunohistochemical markers on histology, into
intestinal (I) or pancreatobiliary (PB) types. I type
tumours have been shown to have favorable prognosis
compared to PB type. We aimed to study these histo-
logic subtypes (I and PB) and their clinicalcopathologi-
cal correlation.
Methods: All patients with periampullary carcinoma
who underwent pancreaticoduodenectomy over a 3 year
period were the subjects of the study. These were histo-
logically classified into I, PB and other types initially
based on microscopic morphological criteria only. Then
the same patients were reclassified based on combina-
tion of microscopic morphology and immunohistochem-
ical markers. These groups were correlated with various
clinicopathological factors to ascertain the value of each
classification using Chi square & Kaplan Meir tests.
Results: There were 109 patients who underwent pan-
creaticoduodenectomy for periampullary adenocarci-
noma. Using microscopic morphologic criteria only, 42
cases were classified as I type and 54 cases as PB type.
Upon reclassification using a combination of IHC and
microscopic morphological criteria, 48 cases were clas-
sified as I type and 50 cases as PB type. Using morpho-
logic classification, I type adenocarcinoma were of a
lower grade (81%), lower stage (90% stage I & II), had
a lower incidence of perineural invasion (19%) and
lymphovascular invasion (4.7%). Lymph node metasta-
sis was seen in 50% of PB type cases and 30.9% in I
type cases. Reclassification of cases did not make any
difference to the correlation to these factors. However,
classification without using IHC showed a better differ-
ence in median survival (I and PB type–30 and 13
months, p = 0.03) than reclassification using IHC (I
and PB types – 28 and 16 mths, p = 0.15).
Conclusions: Periampullary carcinoma can be classified
into I and PB types using microscopic morphologic cri-
teria. Intestinal type cases have a better prognosis and
survival. In the present study, immunohistochemical
staining did not add much to the classification and its
role needs to be studied further.
1070
LAPAROSCOPIC RADICAL RESECTION
FOR HEPATIC HYDATID DISEASE
Nikhil Gupta, Amit Javed, R. Kalayarasan and Anil
Agarwal
Department of GI Surgery, GB Pant Hospital & MAM
College, Delhi University, New Delhi, India
Introduction & Aim: Radical surgery (cystopericystec-
tomy or formal resection) is the treatment of choice as
it reduces the incidence of recurrence and also
decreases the incidence of cavity related complications.
This is often performed by conventional open surgery.
To analyze our experience of radical resectional sur-
gery for hydatid disease of the liver performed laparo-
scopically.
Method: We analyzed the prospectively collected data
on hydatid cyst of the liver who were managed at our
centre with laparoscopic radical surgery (cystopericys-
tectomy, formal liver resection).
Results- Fourteen patients were planned for laparo-
scopic radical resection. There were 11 females. Mean
age was 34.14 years (19–56 years). In 5 patients, the
cysts were located in the right lobe, in 6 patients, the
cysts were located in the left lobe and in 3 patients,
the cyst was involving both the lobes. Four patients
had Gharbi type I cysts, 4 patients had type II cysts
and 6 patients had type III cysts. Average size of the
cysts was 6.96 cm x 6.85 cm. Nine patients underwent
successful radical resection (4 left lateral hepatectomy
and 5 cystopericystectomy) and 5 patients were con-
verted to open surgery. Mean intra-operative blood
loss was 111.11 mL (50–250 mL) and mean operating
time was 243.33 min (180–300 min). Bile leak did not
occur in any of the patients. There were no wound
infections or post operative cavity related complica-
tions. Four out of five patients who were converted
had cysts located in the posterior segments of liver.
Anteriorly placed cysts had higher chances of being
completed laparoscopically compared to posteriorly
placed cysts (66.6% vs. 12.5%). There has been no
recurrence till date.
Conclusion: Laparoscopic radical resection is a feasible
option with excellent post operative outcomes for
selected cases of hydatid cyst of liver. Anteriorly placed
cysts are better suited for laparoscopic radical surgery.
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TUMOR EXISTENCE AND TUMOR SIZE
AS PROGNOSTIC FACTORS IN HBV-
RELATED CIRRHOSIS UNDERWENT
LIVER TRANSPLANTATION
Xin-Sen Xu, Yan-Zhou Song, Kai Qu, Jun Liu, Peng
Zhang and Chang Liu
Department of Hepatobiliary Surgery, The First
Affiliated Hospital of Medical College, Xi’an Jiaotong
University, Xi’an Shaanxi 710061, China
Background and Aims: HBV-related chronic liver dis-
ease is one of the most common indications for liver
transplantation (LT). Patient data in our unit was used
to evaluate the impact of liver tumor on outcomes in
HBV-related cirrohis who underwent liver transplanta-
tion.
Methods: HBV transplanted patients in our hospital
from August 2002 to March 2012 were analysed and
compared according to indication for LT: decompen-
sated cirrhosis (DEC) or hepatocellular carcinoma
(HCC). As for HCC patients, receiver-operating char-
acteristic (ROC) curve analysis was used to determine
the appropriate cutoff value for tumor size, which was
measured as maximum tumor diameter. According to
the cutoff value, patients were divided into two groups:
large size tumors (LST) and small size tumors (SST).
The correlations between other clinicopathologic fac-
tors and tumor size were investigated. Potential prog-
nostic factors were evaluated by Cox’s proportional
hazard model analysis.
Results: The 1-, 3-, 5-year OS rate in the 111 HBV-
related patients was 76.2%, 43.2%, 32.9%, respectively,
with the background patient data shown in table 1.
Patients with liver tumors had a significantly poorer
overall survival than those with only decompensated
cirrhosis (p < 0.05) (Figure 1). The mean tumor size
was 5.97 cm, and ROC analysis indicated that the
appropriate tumor size cutoff point for prognosis was
4.25 cm, with the sensitivity and specificity of 62.8%
and 81.0%, respectively (AUC = 0.760, 95%CI: 0.644-
0.877, p = 0.000) (Figure 2). Using this cutoff point, 31
patients had large tumor size (  4.25 cm) and 33 had
small tumor size ( < 4.25 cm). Patients with small
tumor size had a significantly better overall survival
than those with large tumor size (p < 0.05) (Figure 3).
Univariate analysis showed that only the tumor size
(RR = 1.14, P < 0.001) was significantly associated
with the overall survival.
Conclusions: Tumor existence and tumor size are prog-
nostic factors in HBV-related cirrhosis. Using a tumor
size cutoff value of 4.25 cm, patients with large size
tumors have significantly poorer overall survival than
those with small size tumors.
Key words: HBV; transplantation; cirrhosis; cancer;
size
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SIGNIFICANCE OF COMBINED
RESECTION OF THE PORTAL VEIN
AND/OR THE INFERIOR VENA CAVA
IN PATIENTS WITH LOCALLY
ADVANCED INTRAHEPATIC
CHOLANGIOCARCINOMA
Masayuki Ohtsuka, Hiroaki Shimizu, Hiroyuki
Yoshidome, Atsushi Kato, Hideyuki Yoshitomi, Dan
Takeuchi and Katsunori Furukawa
Department of General Surgery, Graduate School of
Medicine, Chiba University, Chiba, Japan
Background/Aims: Recently, there has been a world-
wide increase in the incidence and mortality from intra-
hepatic cholangiocarcinoma (ICC). Although aggressive
surgical treatment seems to afford hope for long-term
survival, ICC remains difficult to resect with curative
intent because of advanced loco regional extension,
such as the extension to the portal vein and the inferior
vena cava, at the time of diagnosis. In order to achieve
complete surgical resection in such cases, hepatic resec-
tion with combined resection of the portal vein and/or
the inferior vena cava is required, but the significance
of these procedures is not clarified. The aim of this
study is to evaluate the outcome of aggressive surgical
treatment with combined resection of the portal vein
and/or the inferior vena cava for ICC patients.
Patients: December 1984 and April 2011, 114 patients
with ICC underwent surgical resection. Among these
114 patients, 32 (28%) underwent combined resection
of the portal vein and/or the inferior vena cava. Ten
patients had portal vein resection alone, 8 patients had
the resection of both portal vein and inferior vena cava,
and 14 patients had the resection of the inferior vena
cava only.
Results: Positive cancer invasion to the portal vein
beyond the adventitia was present in 72% of 18
patients undergoing combined portal vein resection,
while invasion to the inferior vena cava beyond the
adventitia was pathologically evidenced in 73% of 22
patients undergoing the resection of the inferior vena
cava. Although one patient with combined resection of
the inferior vena cava had the stenosis at the site of
anastomosis with thrombosis, no operative mortality
was encountered. The 1-, 3-, and 5-year survival rates
for patients with portal vein resection alone, the resec-
tion of both portal vein and inferior vena cava, and the
resection of the inferior vena cava only were 47, 31,
and 16%, 58, 22, and 22%, and 70, 31, and 23%,
respectively. These survival outcomes were not signifi-
cantly different from the survival in ICC patients with-
out any vascular resection.
Conclusion: Hepatic resection with combined resection
of the portal vein and/or the inferior vena cava might
have some beneficial effects on the prognosis without
leading to an increase of surgical risk for patients with
locally advanced ICC.
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INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASM OF THE BILE
DUCT: REPORT OF FIVE CASES
Jian-Ying Lou, Ting-Bo Liang, Xeu-Li Bai,
Shun-Liang Gao, Liang Wang, Yun Zhang and
Chun-Hui Cao
The Second Affiliated Hospital, Medical College of
Zhejiang University, 88 Jiefang Rd, Hangzhou 310009,
Zhejiang Province, China
Purpose: To evaluate the clinical, radiological, and his-
topathological characteristics of intraductal papillary
mucinous neoplasm of the bile duct (IPMN-B) that has
the histopathological similarity to intraductal papillary
mucinous neoplasm of the pancreas (IPMN).
Methods: The medical records of five patients with
IPMN-B, who underwent surgical resection of the
lesions, were retrospectively reviewed. The clinical,
radiological, surgical, endoscopic and histopathological
findings were analyzed. All patients were followed up
for 5 to 9 months.
Results: Four of the five cases of IPMN-B in this paper
were associated with intrahepatic lithiasis. Recurrent
episodes of fever and jaundice are the most common
clinical manifestations. The diffused or localized dilata-
tion of intra or extrahepatic duct and intrahepatic
lesions were found radiologically in all patients. Abun-
dant mucin and myriad frond-like papillary or villous
projections in the bile duct that was confirmed by cho-
ledochoscope during the surgeries. All patients under-
went a partial liver resection with or without an Roux-
en-Y hepaticojejunostomy and discharged uneventfully.
One patient was found recurrence three months after
the surgery during the follow-up and confirmed chole-
dochoscopically. Postoperative pathological diagnosis
of intraductal papillary adenoma was established in
four patients (with local canceration in two patients)
and intraductal papillary adenocarcinoma in one
patient.
Conclusions: Preoperatively identifying the location of
intraductal lesions that is the resource of excessive
mucin in biliary duct is the key point to cure the con-
dition. Radical resection of the involved biliary ducts
with tumor-free histologic margins is the first option
for patients with IPMN-Bs. The prognosis and sur-
vival rates for patients with IPMN-Bs are significantly
favorable than those for patients with other biliary
tumors.
1076
MITOFUSIN-2 RESTRAIN INTIMAL
HYPERPLASIA AND RESTENOSIS OF
ABDOMINAL AORTA BY PROMOTING
APOPTOSIS IN RAT CHRONIC
REJECTION
Wei-Lin Wang1, Qiang Sun1, Ze-Hui Wu1, Dong-Kai
Zhou1, Jian-Feng Wei1, Hai-Yang Xie1,2, Lin Zhou1,2
and Shu-Sen Zheng1,2,3
1Division of Hepatobiliary and Pancreatic Surgery,
Department of Surgery, First Affiliated Hospital, School
of Medicine, Zhejiang University; Key laboratory of
Combined Multi-organ Transplantation, Ministry of
Public Health; Key Laboratory of Organ
Transplantation, Hangzhou, 310003, Zhejiang Province,
China; 2Department of General Surgery, First Affiliated
Hospital, School of Medicine, Zhejiang University,
Hangzhou, 310003, Zhejiang Province, China;
3Correspond to Shusen Zheng, Department of
Hepatobiliary and Pancreatic Surgery, First Affiliated
Hospital, School of Medicine, Zhejiang University, 79#
Qingchun Road, Hangzhou, 310003, China
Background: Mitofusin-2(Mfn2) is a novel suppressor
of cell proliferation. It has been demonstrated that
expression of Mfn2 is obviously reduced in hyper-pro-
liferative vascular smooth muscle cells(VSMCs) from
spontaneously hypertensive rat arteries. Angiostenosis
is an important performance of chronic rejection, which
will influence graft survival .
Methods: In this study, we evaluated the effect of
Mfn2 in prevention of chronic rejection through the
model of rat abdominal aorta transplantation from
Lewis to BN. The aortae got from Lewis rats were
transfected in vitro with Mfn2-GFP or GFP by soaking
in the mixed liquor(volume ratio 1:1) of (Mfn2-GFP or
GFP)lentivirus(1*10E8 TU/ml) and UW organ preser-
vation fluid for four days at 4ºC. Then we transplanted
the aortae to BN rats. Recipient rats were killed on
day 30, day 60 and day 90 after transplantion to get
the graft aortae.
Results: With hematoxylin-eosin staining, we found
that the intima ratios of aortae(day 60 and day 90)
transfected with Mfn2-GFP were much smaller than
the ones transfected with GFP. While the intima ratios
of aortae (day 30) had no significant difference.
Through immunohistochemistry and RT-PCR, we also
found aortae(day 60 and day 90) transfected with
Mfn2-GFP had a low expression of apoptotic factor
bcl-2,Vascular Endothelial Growth Factor(VEGF) and
proliferation marker ki67. But expressions of bcl-2,
VEGF and ki67 of aortae(day 30) did not change obvi-
ously.
Conclusion: These results indicate that overexpression
of Mfn2 will restrain intimal hyperplasia and restenosis
of abdominal aorta, which will subsequently improve
graft survival. Mfn2 may play an important role as an
apoptotic factor by interaction with bcl-2, ki67, VEGF
in the process of chronic rejection, which provides valu-
able information for further studies on organ trans-
plantation.
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CAN COMMON BILE DUCT
RESECTION INCREASE THE SURVIVAL
IN ADVANCED GALLBLADDER
CANCER?
Jin Hong Lim1, Sung Hoon Kim2, Seoung Woo Park3,
Chang Moo Kang1, Woo Jung Lee1, Jae Bock Chung3,
Byoung Ro Kim1 and Kyung Sik Kim1
1Dept. of Surgery, Severance Hospital, Yonsei University
College of Medicine1; 2Dept. of Surgery, WonJu
christian Hospital, Yonsei University College of
medicine; 3Dept. of Internal Medicine, Severance
Hospital, Yonsei University College of Medicine, Seoul,
South Korea
Introduction: In advanced gall bladder cancer, the sur-
gical resection is the only treatment for cure. However,
there is no consensus for common bile duct resection
during radical surgery. The aims of this study were to
identify predictors of survival and assess the necessity
of common bile duct(CBD) resection in advanced gall-
bladder cancer.
Methods: We reviewed the medical records of 131
patients with advanced gallbladder cancer who under-
went cholecystectomy except R2 resection and D0
lymph node dissection from March 2000 through Dec
2011 at Severance hospital, Yonsei University College
of Medicine, Seoul, Korea. The survival outcomes and
clinicopathological characteristics were reviewed
between the CBD resection group and the non-CBD
resection group.
Results: Of the 131 patients, 52 patients (39.7%)
underwent common bile duct resection. Overall survival
rates of non-CBD resection group was longer than
CBD resection group. (at 1 year: 74.6% vs. 67.3%, at 3
years: 63% vs. 52.8% and at 5 years: 53% vs. 33.5%
respectively; p = 0.05). The numbers of acquired lymph
nodes, tumor invaded lymph nodes and Lymph nodes
around hepatoduodenal ligament were more in CBD
resection group. Because the pathological staging was
higher (p = < 0.01), the survival was poorer in CBD
resection group.
Conclusion: Although CBD resection didn’t increase
the survival, CBD resection may be needed for more
accurate nodal status evaluation
1083
SURGICAL MANAGEMENT
ACCORDING TO PREOPERATIVE
IMAGING STUDY IN PATIENTS WITH
GALLBLADDER CANCER.
Jin Hong Lim M.D.1, Sung Hoon Kim M.D.2, Ho
kyung whang M.D.1, Gi Hong Choi M.D.1, Chang
Moo Kang M.D.1 and Woo Jung Lee
1Dept. of surgery, severance Hospital, Yonsei University
Health System, Seoul, South Korea; 2Dept. of surgery,
Wonju College of Medicine, Yonsei University, Wonju,
Seoul, South Korea
Introduction: Incidentally found gallbladder cancer
(GBC) has been dramatically increased because of
advancement of imaging technology. The curative
aimed treatment for GBC is a complete surgical resec-
tion. But optimal surgical managements were depen-
dent on tumor stage. This study was undertaken to
investigate relationship between preoperative imaging
study and tumor stage in patients with GBC.
Methods: From Jan. 2000 to Dec. 2011, 121 patients
underwent R0 resection of GBC. The clinicopathologi-
cal characteristics and survival outcomes were reviewed
retrospectively. Preoperative Imaging studies were
reviewed by well experienced radiologists.
Results: Tumor locations were classified as fundus,
body, neck and wide lesion (n = 46, 35, 16, 21 respec-
tively). Tumor sides of location were classified as peri-
toneum, liver bed and encircling (n = 37, 37, 47
respectively). Gross types were classified as infiltrative,
polypoid and mass replacing GB fossa (n = 69, 46, 5
respectively). Except wide lesion, tumor location did
not have relation with tumor stage. (p = 0.360). How-
ever, more advanced tumor stage was confirmed at
patients with liver bed side located GBC or infiltrative
gross type. (p = 0.047, 0.001 respectively). Especially,
all patients with tumor replacing GB fossa had
advanced tumor stage. Lymph node metastases were
more observed in infiltrating gross type (p = 0.007).
However, the rate of lymph node metastases had no
difference in tumor location or side (p = 0.100, 0.194,
respectively). Except wide lesion, overall survival and
disease free survival also did not show difference in
tumor location or side. Polypoid gross type show better
overall survival and disease free survival than other
gross types.
Conclusions: Although tumor location did not have
relation with tumor stage, in patients with liver bed
side located GBC, combined hepatic resection w con-
sidered for achievement of R0 resection. A aggressive
lymph node dissection was also needed in patients with
infiltrative gross type.
1085
HEMORRAGIC SHOCK CAUSED BY
RUPTURE OF CYSTIC ARTERY
PSEUDOANEURYSM SECONDARY TO
CALCULUS CHOLECYSTITIS: A CASE
REPORT AND REVIEW
Xiao Liang, Jie-Min Lv, Ning Meng, Re-Nan Jing and
Xiu-Jun Cai
Sir Run Run Shaw Hospital, School of Medicine,
Zhejiang University, No. 3, East Qingchun Road,
Hangzhou, China 310016
Cholecystitis is a kind of common diseases in the East
Asia. Some of these patients will have Cystic artery
pseudoaneurysm as a rare complication following cho-
lecystitis. No more than 20 patients with cystic artery
pseudoaneurysm have been reported in the English lit-
erature, but only 3 of them presented with gallbladder
perforation which lead to hemorrhagic shock. We
report a 88-year-old woman who developed a cystic
artery pseudoaneurysm following an episode of acute
cholecystitis. And the cystic artery pseudoaneurysm
ruptured quickly after its formation. She presented with
severe abdominal pain and hemorrhagic shock. abdom-
inal ultrasonography (US) showed echogenic material
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within the gallbladder which weren’t seen one day ago.
A contrast enhanced computed tomography scan
(CECT scan) reveales high-density material in the
lumen of the gallbladder and small volume ascites
within the upper abdomen. Finally cholecystectomy
with common bile duct exploration was done in an
emergency surgical exploration. Finally we get a con-
clusion that cystic artery pseudoaneurysm is a rare
complication of cholecystitis. Cystic artery pseudoaneu-
rysm has prone to rupture which has an association
with a high incidence of hypovolaemic shock and can
be fatal. We should be aware of this relatively rare
cause of hypovolaemic shock .CT and Angiography are
helpful in both diagnose and treatment of these
patients.
1086
PRIMARY HEPATIC
NEUROENDOCRINE CARCINOMA
WITH BRAIN METASTASIS
Il Young Park1, Jina Kim1, Ki Hwan Kim2, Ho Jung
Choi1 and Kwang Wook Cho1
1Bucheon St. Mary Hospital, Catholic University of
Korea, Bucheon, South Korea; 2Euijungbu St. Mary
Hospital, Catholic University of Korea, Bucheon, South
Korea
A 67-year-old male presented with progressive left hem-
iparesis from 1 month ago. A contrast–enhanced mag-
netic resonance image of the brain revealed measuring
about 4.5 x 3.5 x 5.0 cm sized rim enhancing mass with
central necrosis and associated edema located in left
occipital lobe. A craniotomy was performed to remove
tumor and confirm of the pathology. The histological
features and immunochemical staining showed meta-
static neuroendocrine carcinoma. The Positron emission
tomography(PET) and abdominal computed tomogra-
phy(CT) were checked for meatastatic origin evalua-
tion. CT revealed about 9 cm sized mass with poor
enhancement in right hepatic lobe. Hepatitis B antigen
was positive and hepatitis B antibody was negative.
Tumor markers such as AFP and CEA were within
normal range. Serum CA19-9 was elevated at 74.82 u/
ml. Serum 5-HT, serum and urine level of 5-HIAA
were normal. The levels of serum Gastrin, Glucagon,
C-peptide were within normal limits. Right hepatec-
tomy with cholecystectomy was performed 1 month
after craniotomy. The specimen showed same patho-
logic findings with brain lesion. Immunohistochemical
stains with CD56a, Snaptophysin and Cytokeratin were
positive. There was tumor necrosis with 60% of Ki-67
labeling index.
Four months later, tumor recurred at brain and liver.
Re-operation underwent to reduce mass effect in the
brain and followed radiation therapy and chemother-
apy with etophoside and cisplatin. However, two
month later after re-operation, PET showed spinal cord
and liver metastasis.
Bone metastasis, lymph node metastases and lung
metastases were reported. This brain metastatses of
neuroendocrine tumor from liver is the first case. This
case is an aggressive primary hepatic neuroendocrine
carcinoma with brain metastasis.
1087
APPROPRIATE TRAINING MODULE OF
SINGLE INCISION LAPAROSCOPIC
CHOLECYSTECTOMY FOR SURGICAL
TRAINEE
Kee Hwan Kim, Chang Hyeok An, Jeong Soo Kim, Il
Young Park and Dong Gu Kim
Department of Surgery, Uijeongbu St. Mary’s Hospital,
College of Medicine, The Catholic University of Korea,
Uijeongbu, South Korea
Purpose: Laparoscopic cholecystectomy is the gold-
standard procedure for gallbladder removal. The
advantages of this procedure over the open approach
include better cosmetic result, less postoperative pain,
and shorter recovery time. Recently, in order to
reduce operative trauma and improve cosmetic result
following laparoscopic cholecystectomy, new operative
techniques have been developed. Single-incision laparo-
scopic surgery (SILS) was developed with the aim of
reducing the invasiveness of traditional laparoscopy,
But, Limited retraction has been an obstacle in the
advancement of pure single incision cholecystectomy.
Adequate retraction is necessary to perform a safe
cholecystectomy. We reviewed the results of a single
institution with respect of single incision cholecystec-
tomy with a single 2 mm needlescopic instrument and
snake retractor to aid in obtaining a critical view of
safety to identify the ideal surgical strategy of single
incision laparoscopic cholecystectomy in disease of bil-
iary tree.
Methods: Between October 2010 and October 2012,
291 patients underwent single incision laparoscopic
cholecystectomy with needle scopic infundibular retrac-
tion for gallbladder disease in single institute by one
surgeon, Uijeongbu St. Mary’s hospital. 291patients
with a mean age 48.8  14.6 years (range 12 to 82)
were identified. We used a hand-made Glove port or
SILSTM (Covidien, Tyco health Medical) single-port
device for operation. Single port device was placed
through umbilicus. A(2 mm) needlescopic retractor
(Stryker, San Jose, CA) was placed in the right flank
region directly through the abdominal wall for retrac-
tion of the gallbladder infundibulum in an anterior and
cephalad direction. And snake retractor was used for
liver retraction
Results: Patient all had a pathologic diagnosis of acute
and chronic cholecystitis. ASA class averaged 1.62
(range 1 to 2). Operative times(skin to skin) averaged
62.9  49.6 min (range 25 to 313 min): in simple chole-
cystectomy averaged 53.2  21.7 min and in difficult
cholecystectomy 92.3  51.4 min (range 28 to 313
min). Postoperative hospital stays averaged 2.5 days.
There were three open conversion cases: one bile duct
injury, one uncontrolled bleeding and one difficult dis-
section. No major morbidity and mortality cases
Conclusions: Single incision cholecystectomy with a sin-
gle needlescopic instrument is safe for acute and
chronic cholecystitis even in gallbladder empyema.
Liver retraction using a snake retractor is very useful
module during single incision laparoscopic cholecystec-
tomy in easy and difficult gallbladder disease.
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T TUBE SINUS TRACT DUODENAL
FISTULA: A RARE COMPLICATION OF
POSTOPERATIVE
CHOLEDOCHOSCOPY FOR TREATING
HEPATOLITHIASIS
Jian-Ying Lou, Ting-Bo Liang, Xeu-Li Bai,
Shun-Liang Gao, Liang Wang, Yun Zhang and
Chun-Hui Cao
The Second Affiliated Hospital, Medical College of
Zhejiang University, Hangzhou, China
Backgrounds: Postoperative percutaneous choledochos-
copy via T tube sinus tract is a common modality for
treating retained intrahepatic stones in China. We
report a rare complication of postoperative choledo-
choscopy for treating retained hepatolithiasis: T tube
sinus tract duodenal fistula.
Methods: From January 2003 to December 2011, 2583
postoperative percutaneous choledochoscopy sessions
were performed in 847 patients with T tubes in situ.
Intrahepatic duct stones with or without common bile
duct (CBD) stones were detected in 526 patients. Eight
of the 526 patients with intrahepatic stones developed a
T tube sinus tract duodenal fistula that was diagnosed
by cholangiography and choledochoscopy. The causes,
manifestations, diagnosis, treatment and methods of
prevention were retrospectively analyzed.
Results: The incidence of T tube sinus tract duodenal
fistula in patients with retained intrahepatic stones
being treated by postoperative choledochoscopy is
1.52% (8/526) in this series. After a mean duration of
2.2 weeks, occlusions of the distal channel of T Tube
were developed in five patients and resulted in failure
to get access to CBD for further stones extraction cho-
ledochoscopically. The fistula accounted for 20% (5/25)
of all causes of residual stones after being treated by
postoperative choledochoscopy in this series. All cuta-
neous fistulas healed in a mean time of 4.9 days after
removal of the T tubes. Two patients underwent reo-
perations for recurrent cholangitis.
Conclusions: Long time placement of T tube in situ is
probably the main cause of the T tube sinus tract duo-
denal fistula. Placement of T tube in correct way and
finishing the whole choledochoscopic stones extraction
procedure in short time are the key points to prevent T
tube sinus tract duodenal fistula formation.
1089
MFN2 TRIGGERS APOPTOSIS OF
HEPATOCELLULAR CARCINOMA
CELLS MEDIATED BY ACTIVATION OF
THE MITOCHONDRIAL APOPTOTIC
PATHWAY
Wei-Lin Wang, Qing-Song Xie, Jian-Feng Wei, Qiang
Sun, Dong-Kai Zhou, Peng-Fei Huang, Hai-Yang Xie
and Shu-Sen Zheng
Key lab of combined Multi-organ Transplantation,
Ministry of Public Health, Key Lab of Organ
Transplantation, Department of Hepatobiliary and
Pancreatic Surgery, First Affiliated Hospital, Zhejiang
University School of Medicine, Hangzhou, Zhejiang
310003, China
Background and aim: The mitochondrial GTPase mi-
tofusin-2 gene, which has the function of hyperplasia
suppressor, was first found in vascular smooth muscle
cells of spontaneously hypertensive rats. The mecha-
nism of apoptosis of hepatocellular carcinoma(HCC)
cells triggered by Mfn2 remains unknown. We attempt
to investigate the effect of Mfn2 on HCC cells apopto-
sis and the mechanism.
Methods: Adenovirus carrying Mfn2 (Ad-mfn2)
infected HCC cells used as experimental group and
zero load adenovirus as controls. The post infectionem
expression of Mfn2 was observed by Western blot. The
effect of Mfn2 on the apoptosis of HCC cells was
investigated by using flow cytometry (FCM). The
expression of Bcl-2, Bax, cytochrome-c, caspase-8, cas-
pase-3, caspase-9 and AIF was detected by using Wes-
tern blot. The mitochondrial transmembrane potential
and reactive oxygen species (ROS), labeled by fluores-
cent probe of JC-1 and DCFH-DA, respectively, were
measured by using FCM.
Results: Overexpression of Mfn2 gene promoted the
apoptosis of HCC cells, the remarkably decreased expres-
sion of mitochondrial Bcl-2 protein and the increased
expression of mitochondrial Bax protein. Overexpression
of Mfn2 gene also induced cytochrome c, active caspase-
3, caspase-9 and AIF to release to cytoplasm, however
the level of active caspase-8 was no different. There are
also reduction of mitochondrial transmembrane potential
and augmentation of ROS in experimental group.
Conclusions: Mfn2 triggers apoptosis of HCC cells
mediated by activation of the mitochondrial apoptotic
pathway.
1094
EXPERIENCES OF LAPAROSCOPIC
LIVER RESECTION IN VARIABLE
LIVER DISEASE
Kwangsik. Chun and Insang Song
Department of Surgery, Research Institute for Medical
Sciences, College of Medicine, Daejeon, South Korea
Chungnam National University, Daejeon, Korea
Purpose: To review and investigate the experiences of
laparoscopic liver resection in variable liver disease.
Method: From April 2008 to December 2010 in
Chungnam national university, 49 cases of laparoscopic
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liver resection were performed among 157 liver resec-
tions. During formal one year, mainly laparoscopy
assisted liver resections were performed and during
later two years totally laparoscopic liver resections were
main operative type. Surgery type is decided preopera-
tively by intension to treatment. Clinical data were col-
lected retrospectively and comparatively analyzed by
surgery type.
Result: Mean age was 60.0(35–85), sex ratio (M:F) was
1:1.3. Preoperatively 28 patients were diagnosed intrahe-
patic duct stone with recurrent pyogenic cholangitis, 9
patients were hepatocellular carcinoma, 5 patients were
colorectal cancer with liver metastasis and 7 patients
were benign hepatic tumors. Laparoscopy assisted liver
resection was 16 cases (32.7%) and totally laparoscopic
liver resection was 33 cases (67.3%). Anatomical major
liver resection was 40 cases (81.6%) and 9 cases
(18.4%) were nonanatomical resection. Mean operation
time was 264.3 min (75–570 min) and intraoperative
transfusion was done in 7 patients (14.3%). Mean post-
operative hospital stay was 10.2 days (4–32 days).
Except preoperative planned laparosocopy assisted liver
resection, open conversion was happened in two cases.
Complications were happened in 4 cases, two cases were
bile leakage. Pulmonary atelectasis and indigestion were
happened in one case each. All of them were solved by
conservative managements. Mean malignant tumor size
was 2.4 cm (1.8–5.0 cm) and mean tumor free margin
was 1.9 cm (0.7–5.0 cm). But tumor recurrence was
happened in 5 cases (35.7%). Two cases (22.2%) were
hepatocellular carcinoma and three cases (60%) were
colorectal cancer liver metastasis.
Conclusion: In this study, we conclude laparoscopic liver
resection is feasible operation but it needs to be carefully
conducted when it comes to malignant tumors.
1095
CIRCULATING TUMOR CELLS IN
HEPATOCELLULAR CARCINOMA:
DETECTION TECHNIQUES, CLINICAL
IMPLICATIONS, AND FUTURE
PERSPECTIVES
Yu Zhang, Jun Li, Lu Cao, Wen Xu and Zheng-Feng
Yin
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, 200438 China
Hepatocellular carcinoma (HCC) is a primary liver can-
cer with a huge challenge in terms of its complex etiol-
ogy and its management. The fact that the most
common site of early tumor recurrence in liver trans-
plantation for HCC is the transplanted allograft
strongly suggests that circulating tumor cells (CTCs)
are really an active source of HCC metastasis or recur-
rence. In the past decade, with the tremendous progress
in the technology of CTC detection, there is convincing
evidence that CTCs have great potential as a marker
for metastatic disease and poor prognosis in patients
with a malignancy. Currently some interesting and
encouraging results have been achieved in HCC CTC
detection, although the knowledge about its clinical
relevance in HCC is lagging behind other major tumor
types. Here we will review existing and developing
methodologies for CTC detection, discuss future per-
spectives, and describe the potential clinical impact of
the identification and molecular characterization of
CTC subset or circulating cancer stem cells in HCC
patients. Particular attention is given to the results
based on the HCC CTC study.
1097
OUTCOMES OF VASCULAR
RECONSTRUCTION WITH CRYO-
PRESERVED VEIN GRAFT IN HEPATO-
BILIARY AND PANCREATIC SURGERY
Sumhito Tamura1,5, Yasuhiko Sugawara1,2,4, Taku
Aoki2, Junichi Kaneko1, Yoshihiro Sakamoto2, Kiyoshi
Hasegawa2 and Osamu Hattori5
1Artificial Organ and Transplantation Division,
Department of Surgery, Graduate School of Medicine,
The University of Tokyo; 2Hepato, Biliary, Pancreatic
Surgery Division, Department of Surgery, Graduate
School of Medicine, The University of Tokyo;
3Department of Gastroenterology, The University of
Tokyo Hospital; 4Organ Transplantation Service, The
University of Tokyo Hospital; 5University of Tokyo
Tissue Bank, The University of Tokyo Hospital;
6Department of Cardiac Surgery, The University of
Tokyo Hospital, Tokyo, Japan
Background and aims: Resectability of malignant tumor
is a significant factor affecting outcomes in hepato-bili-
ary and pancreatic surgery. However, the procedure
may become faced with difficulties due to its anatomi-
cal location, especially in those adhering to major
vessels. We have aggressively applied the use of cryo-
preserved vein [CP-v] grafts for various types of
abdominal surgery including liver transplantation and
extensive hepato-biliary and pancreatic surgery. CP-v
grafts do not require anticoagulation, is resistant to
infection, possess superior flexibility with variety of size
and length available, and therefore considered valuable
in major hepato-biliary and pancreatic surgery at our
institution. Studying the outcomes of cases with CP-v
graft usage may suggest useful approach in the coming
era of advanced adjuvant therapy.
Method: Outcomes of major hepato-biliary and pancre-
atic surgery performed between 2001 and 2011 at the
Tokyo University Hospital requiring vascular recon-
struction were studied. Data were collected retrospec-
tively. Patency rates of the reconstructed vessels,
assessed by CT/US were compared between cases
reconstructed with auto-grafts and with CP-v grafts.
Results: During the studied period, hepatic vein and
portal vein reconstruction with CP-v grafts were per-
formed in 18 and in 20 cases, and reconstruction with
auto grafts were performed in 11 and in 10 cases
respectively. Patency rates at 6 months, one-year, and
two-year post operation were, 44%, 29% and 29% for
cases with CP-v grafts and 72%, 60%, and 32% for
cases with auto grafts hepatic vein reconstruction. Like-
wise, patency rates were, 89%, 79%, and 79% with
CP-v grafts and 100%, 100%, and 86% with auto
grafts in cases requiring portal vein reconstruction,
respectively. There were no statistical differences
between the outcomes of CP-v grafts and auto grafts.
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Conclusion: Use of CP-v graft for vascular reconstruc-
tion in hepato-biliary and pancreatic surgery is feasible
and may enhance the numbers of surgically resectable
cases.
1103
END-TO-END SUTURELESS VASCULAR
ANASTOMOSIS WITH MAGNETIC
RINGS
Shi-Qi Liu, Yi Lv, Peng Lei, Jian-Hui Li and Xiao-Hai
Cui
Department of Hepatobiliary Surgery, The First
Affiliated Hospital, Xi’an Jiaotong University, Xi’an,
China
Objective: The present study was to investigate the new
type magnetic vascular anastomosis device for non-
suture vascular anastomosis.
Material and methods: This device consists of paired
Nd-Fe-B magnetic rings and alternately spaced holes
and titanium pins, which are coated by titanium oxide
coating with PCVD technique and are embedded in
photosensitive resin shell that was made by rapid pro-
totyping technology. Sixteen mongrel dogs underwent
the vascular anastomoses with a novel magnetic pin-
ned-ring device and traditional hand-sewing, respec-
tively. In situ end-to-end anastomoses were performed
in femoral artery and inferior vena cava. Patency was
confirmed with ultrasound scans and angiographic
images at different time-points 4 weeks, 12 weeks and
24 weeks postoperatively. Gross observation, histologi-
cal staining and scanning electron microscopy were per-
formed at 24 weeks postoperatively.
Results: The operation time required for vascular anas-
tomosis was significantly shorter in magnetic device
than in hand-sewing. A continuity of re-endothelializa-
tion was confirmed in all anastomostic stomas after
4 weeks, 12 weeks and 24 weeks, neither formation of
aneurysms and thickening of vascular wall was noted.
The re-endothelialization was smooth at the anastomo-
stic site of magnetic device after 4 weeks, whereas
suture was observed under rough and uneven re-endo-
thelialization after hand-sewing. The endothelial cells
were regularly arranged at the anastomostic site of
magnetic device; nevertheless, there were different-sized
and irregularly aligned endothelial cells at the anasto-
mostic site of hand-sewing. Magnetic device was associ-
ated with the significantly decreased deposition of
fibrotic collagen and depressed infiltration of inflamma-
tory cells as compared with hand-sewing.
Conclusions: All anastomoses stomas were patent
under direct observation and palpation or duplex
ultrasound scanning. 8 IVC and 9 of 10 femoral artery
anastomoses stomas were clearly patent on duplex
scans, and patency of 1 artery anastomosis stomas
was questionable. The magnetic vascular anastomosis
device offers a simple, faster, reliable and efficacious
technique for non-suture vascular anastomosis. This
technique shortens operation time, maintains the high
patency rate, and improves the healing of vascular
tissue.
1104
THE CURATIVE RESECTION ON THE
INTRAHEPATIC BILIARY
PAPILLOMATOSIS AFTER
PHOTODYNAMIC THERAPY
Jin Ock Chung1, Jee Ye Kim1, Jin Hong Lim1, Jun
Seong Park1, Seung Woo Park2 and Kyung Sik Kim1
1Department of Surgery; 2Department of Internal
Medicine, Severance Hospital, Yonsei University College
of Medicine, Seoul, South Korea
A healthy 56-year-old man was diagnosed CBD steno-
sis by CT study during his lifelong checkup on April
2012. An ERCP revealed a suspicious papillomatosis
involving CHD in both proximal intrahepatic bile duct
and Rt. posterior intrahepatic bile duct. A papillary
dysplasia of common hepatic duct was confirmed. An
endoscopic nasobiliary drainage was performed for bili-
ary decompression. Then, the patient was transferred
to Severance Hospital for a surgery.
Before the surgery, a photodynamic therapy was
applied to avoid extensive liver resection and recur-
rence. The point of hilum to mid CBD, Lt. intrahepatic
duct and Rt. intrahepatic duct were initially treated at
180 J for 450 sec. The second photodynamic therapy
was only performed at the point of hilum to mid CBD
site, because Lt. and Rt. intrahepatic duct sites had
shown improvements.
During the follow-up, jaundice was developed. On the
PTCS, there was no obstruction or severe stricture on
CBD and IHD. The entire sites of previously men-
tioned papillomatosis lesions had improved.
After two months, the patient underwent extensive Rt.
Hemihepatectomy. A total necrotic change of intrahe-
patic bile duct with chronic cholangitis, hepatolithiasis
and foreign body reaction were reported, and there
were no lymphatic metastasis (0/8).
After four months of operation, there were no other
complications, local recurrences and distant metastases.
1105
THE EFFECTIVENESS OF
BIOIMPEDANCE ANALYSIS IN
PERIOPERATIVE BODY FLUID
VOLUME ESTIMATION
Kuk Hwan Kwon1, Jee Ye Kim2, Chang Ik Yoon2, Jae
Geun Lee2, Jin Hong Lim2, Ho Sun Lee2, Jae Gil
Lee2,3 and Kyung Sik Kim2,3
1Department of Surgery, National Health Insurance
Corporation Ilsan Hospital, Koyang, Kyunggido, Korea;
2Department of Surgery, Severance Hospital, Yonsei
University College of Medicine; 3Nutritional support
team, severance hospital3, Seoul, South Korea
Different body fluid monitoring methods for postopera-
tive patients include physical examination, laboratory
tests and hemodynamic parameters. However, these
techniques are not direct markers of volume status and
do not provide sufficient evidence.
Bioimpedance Analysis (BIA) is a useful method for
assessing the change in body fluid in hemo-dialysis
patient. The objective of this study is to examine the
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effectiveness of BIA in estimating volume status in
postoperative patients.
Forty patients with history of hepatopancreaticobiliary
disease from a single center were enrolled. Body fluid
composition was measured with BIA, and laboratory
tests for lymphocyte, albumin, cholesterol, creatine,
CRP were conducted on the day before, immediately
after and the day after the operation.
There were 25 male and 15 female participants. Their
median age was 60.5 years, and their age ranged from
28 to 78. Patients received different treatments. Nine-
teen patients underwent major hepatectomy. Seven
patients underwent minor hepatectomy. Five patients
underwent PPPD. Three patients underwent segmental
resection of bine duct, and there were six patients who
received other treatments.
The mean operation time was 247.85 min, and it ran-
ged from 89 to 527 min. For the preoperative patients,
the mean lymphocyte count, albumin, cholesterol, crea-
tine, crp were 1470 ul, 3.96 mg/dl, 178.1 mg/dl,
0.81 mg/dl, 6.80 mg/dl respectively. Preoperative intra-
cellular water (ICW), extracellular water (ECW), total
body water(TBW), fat free mass(FFM) and body cell
mass(BCM) were 22.53 L, 13.6 L, 36.15 L, 49.31 L and
32.28 L respectively.
For immediate postoperative patients, the mean lym-
phocyte count, albumin, cholesterol, creatine, crp were
930 ul, 2.91 mg/dl, 132.8 mg/dl, 0.76 mg/dl, 2.97 mg/dl
respectively. Immediate postoperative ICW, ECW,
TBW, FFM and BCM were 22.73 L, 13.92 L, 36.65 L,
49.89 L and 32.54 L respectively.
Forpostoperativeday1, themean lymphocyte count, albu-
min, cholesterol, creatine, crp were 910 ul, 3.26 mg/dl,
121.6 mg/dl, 0.86 mg/dl and 47.21 mg/dl. Postoperative
day 1 ICW, ECW, TBW, FFM and BCM were 23.18 L,
14.07 L,37.25 L,50.81 Land33.21 Lrespectively.
Preoperative and postoperative change pattern analysis
revealed an L-shaped alteration of lymphocyte and
cholesterol; however, the data was not statistically sig-
nificant. Albumin and creatine both showed a decreas-
ing V-type alteration with only albumin only being
statistically significant. CRP data showed an increasing
trend and was statistically significant.
No statistical significancewas found for different body flu-
ids. It is speculated that patients have generalized edema.
In this study, BIA was found to be an effective method
for assessing the change in perioperative body composi-
tion. Further replicated studies will to confirm its
effectiveness on body fluid estimation.
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COMPREHENSIVE MANAGEMENT OF
VASCULOBILIARY INJURY AFTER
LAPAROSCOPIC CHOLECYSTECTOMY:
A CASE REPORT AND REVIEW OF
LITERATURE
Adianto Nugroho and Benny Philippi
Digestive Division, Cipto Mangunkusumo Hospital,
University of Indonesia, Jl. Diponegoro 71, Jakarta,
Indonesia
Introduction: Biliary injury is the most common severe
complication of cholecystectomy, and the introduction
of laparoscopic approach has led to a sharp rise in its
incidence. It is commonly associated with vascular inju-
ries, especially arterial injuries.
Case Illustration: We report a case of a 48 years old
female patient who recently had laparoscopic cholecys-
tectomy, which was converted to open surgery due to
bleeding. The initial surgeon reported a bleeding from
the liver bed without subsequent bile leak. A drain was
placed at subhepatic region. Patient came with sepsis,
jaundice and shock, with bile came out from the drain.
An emergency arteriography revealed an extravasation
of contrast material at the proper hepatic artery, which
was treated by coil embolization. The drain production
continue to show bile leaking with a trend toward mini-
mization, even when the patient was still jaundiced.
ERCP failed to be done because of difficult cannula-
tion. MRCP showed a Strasberg type E3 bile duct
injury. Because of a prolonged sepsis and a subsequent
organ failures, a re-laparotomy was done only to find a
massive adhesion near the hepatic hilum. Abdominal
lavage was done and two drains were left intra-abdomi-
nally. After surviving from lung infection, acute renal
failure and septic shock in Intensive care unit, this
patient gradually improved. The jaundice disappear
3 weeks after the second laparotomy with minimal
drain production and good abdomen condition. The
patient went home 1 month after surgery in good con-
dition.
Discussion and Summary: A vasculobiliary injury is an
injury to both a bile duct and a hepatic artery and/or
portal vein. Patient with vasculobiliary injury often
gone into life threatening septic condition early after
the initial surgery. This condition is devastating, both
to the initial surgeon and the consultant surgeon who
dealt with the management of the injury. A good diag-
nosis, prompt treatment and a optimal critical care are
the key concepts in the management
1108
DIAGNOSTIC AND PROGNOSTIC
VALUES OF AMINOACYLASE-1,
SEQUESTOSOME-1, AND GLYPICAN-3
IN HEPATOCELLULAR CARCINOMA
Guang-Zhi Jin1, Hui Dong1, Wen-Long Yu2, Xin-Yuan
Lu1, Hua Yu1, Zhi-Hong Xian1, Wei Dong1,
Wen-Ming Cong1 and Meng-Chao Wu3
1Department of Pathology; 2Department II of billiary
tract Surgery; 3Department of Surgery, Eastern
Hepatobiliary Hospital, Second Military Medical
University, Shanghai, 200438, China
Background: To investigate diagnostic values of Ami-
noacylase-1 (ACY1), Sequestosome-1 (SQSTM1) and
Glypican-3 (GPC3) in distinction of small well-differen-
tiated hepatocellular carcinoma (WDHCC) from dys-
plastic nodules (DN) and their prognostic values.
Methods: The expression profiling of ACY1, SQSTM1
and GPC3 in low grade DN (LGDN), high grade DN
(HGDN) and small WDHCC were assessed by immu-
nohistochemistry. The differential diagnostic perfor-
mances of 3 markers or their combinations in HGDN
and WDHCC were investigated by using logistic regres-
sion models (HGDN = 21, WDHCC = 32) and vali-
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dated in an independent testing set (HGDN = 21,
WDHCC = 24). Postoperative overall survival and time
to recurrence were evaluated by univariate and multi-
variate analyses in an independent set of 500 patients.
Results: ACY1, SQSTM1 and GPC3 were expressed
differentially in each group. For differential diagnosis
of WDHCC from HGDN, the sensitivity and specificity
of ACY1 + SQSTM1 + GPC3 combination for
WDHCC detection was 93.8% and 95.2% in the train-
ing set, respectively, which was much higher than 3
kind of 2 marker-combinations. The validity of 4 diag-
nostic models was further confirmed in an independent
testing set and the corresponding good sensitivity and
specificity were observed. Interestingly, GPC3 expres-
sion in HCC tissues combined with serum AFP was
found to be an independent predictors for overall sur-
vival and time to recurrence.
Conclusions: ACY1 + SQSTM1 + GPC3 combination
could make substantial contributions to distinguish
between WDHCC and HGDN using immunohisto-
chemistry. Meanwhile, low GPC3 staining combined
with positive serum AFP may play a practical role in
predicting poor postoperative outcome and high tumor
recurrence risk.
References: 1. Di Tommaso L, Franchi G, Park YN,
Fiamengo B, Destro A, Morenghi E, Montorsi M,
Torzilli G, Tommasini M, Terracciano L et al: Diag-
nostic value of HSP70, glypican 3, and glutamine syn-
thetase in hepatocellular nodules in cirrhosis.
Hepatology 2007, 45(3):725-734.
2. Jin GZ, Li Y, Cong WM, Yu H, Dong H, Shu H,
Liu XH, Yan GQ, Zhang L, Zhang Y et al: iTRAQ-
2DLC-ESI-MS/MS Based Identification of a New Set
of Immunohistochemical Biomarkers for Classification
of Dysplastic Nodules and Small Hepatocellular Carci-
noma. J Proteome Res 2011, 10(8):3418-3428.
3. Shirakawa H, Suzuki H, Shimomura M, Kojima M,
Gotohda N, Takahashi S, Nakagohri T, Konishi M,
Kobayashi N, Kinoshita T et al: Glypican-3 expression
is correlated with poor prognosis in hepatocellular car-
cinoma. Cancer Sci 2009, 100(8):1403-1407.
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SINGLE INCISION LAPAROSCOPIC
CHOLECYSTECTOMY IN PATIENT
WITH SEVERELY DISTORTED
HEPATIC ANATOMY BY PRIOR
CONGENITAL ABDOMINAL WALL
DEFECT
Yong OonYooHan, Yong OonYoo andDong Lak Choi
Division of Hepato-Biliary-Pancreas Surgery and Liver
Transplantation, Department of Surgery, College of
Medicine Catholic University of Daegu, Daegu Catholic
University Medical Center, Daegu, Republic of Korea,
South Korea
Congenital abdominal wall defects (gastroschisis or
omphalocele) may be associated with structural anoma-
lies. But, there is little information on the position and
size of the liver later in life in patients with giant
abdominal wall defect. In case the liver is ventrally or
medially located, acute abdominal operations, espe-
cially hepatic or biliary tract surgery, can cause a very
difficult operation and increase complications.
Twenty-five years old woman with recurrent epigastric
abdominal pain and dyspepsia visited in our hospital
for cholecystectomy. On physical examination, an
abdominal skin deformity was detected. Abnormality
of hepatic anatomy due to congenital abdominal wall
defects (r/o omphalocele) was identified by ultrasonog-
raphy and computed tomography. Liver was located in
center of abdomen, and Gallbladder was also located
in dorsal side of liver. On operation, we had tried a
perihepatic adhesiolysis through 2–3 cm right parame-
dian incision, a single incision laparoscopic cholecystec-
tomy(SILC) was decided. Cholecystectomy was
completed after about 3 h and immediate postoperative
course was uneventful except a paralytic ileus and she
discharged on postoperative day 5.
In conclusion, if we don’t have laparoscopic or SILC
experiences, she might have an additional large wound
scar with prior huge and ugly abdominal scar. Also,
she would have undergone a long hospital stay and
more severe abdominal pain compared with laparo-
scopic surgery.
1110
INITIAL EXPERIENCE WITH
LAPAROSCOPIC COMMON BILE DUCT
EXPLORATION FOR CHOLEDOCHO-
CHOLECYSTOLITHIASIS
MANAGEMENT IN GOVERNMENT HO
Adianto Nugroho, Wifanto S Jeo, Maria Mayasari,
Yarman Mazni and Toar Lalisang
Digestive Division, Cipto Mangunkusumo Hospital,
University of Indonesia, Jakarta, Indonesia
Introduction: The management of choledocho-cholecysto-
lithiasis has evolved in recent years. A laparoscopic
approach has gaining acceptance worldwide. The aim of
our study was to evaluate the use of LC/LCBDE as one
of the treatment option for bile duct stones in our center.
Methods: A retrospective study of patients with chole-
docho-cholecystolithiasis who had undergone Laparo-
scopic Cholecystectomy (LC) with subsequent
Laparoscopic Common Bile Duct Exploration (LCBDE)
between 2011–2012 in Cipto Mangunkusumo, a govern-
ment hospital. Data regarding the demographics, type of
procedure, duration of operation, length of stay, conver-
sion rate as well as difficulties that were commonly found
during procedure was describe.
Result: A total of 25 LC/LCBDE was done in two
years period, the median age was 35 (Range 24–50)
with a relatively same sex distribution (M:F = 13:12).
The median operating time was 183 min (Range 120–
240 min). Twenty patients undergone transcholedochal
approach while 5 had transcystic exploration. The
exploration was carried out with the help of choledo-
choscope and intra operative cholangiogram. T-tube
was placed in 17 patients. Conversion rate in our series
were 0.28%, mostly due to large and multiple stone
which was difficult to be extracted.
Discussion: LC/LCBDE is an excellent choice for the
treatment of choledocho-cholecystolithiasis, but its use
should be accompanied by proper armamentarium to
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crush and take out the stone. In the case where it is
unavailable, one should adopt this technique only with
a good patient’s selection, in order to gain an added
value to this procedure over a more established proce-
dures such as CBD exploration or ERCP.
Conclusion: A good patient’s selection is very impor-
tant in the management of choledocho-cholecystolithia-
sis in center with limited options for LC/LCBDE.
1111
AUTOPHAGY IS INDUCED BY SITU OR
REMOTE ISCHEMIC
PRECONDITIONING AND PROTECT
AGAINST LIVER IR INJURY IN A MICE
MODEL
Yong-Hua Xu, Chang-He Zhang, Yun Wang, Hai
Zhang, Chang-Jun Huang, Xue-Hao Wang and
Xiang-Cheng Li
Liver Transplantation Center, First Affiliated Hospital of
Nanjing, Medical University, Key Laboratory of Living
Donor Liver Transplantation, Ministry of Public Health,
Guanzhou Road 300, Nanjing 210029, P.R. China
Background and aims: Ischemic preconditioning,
induced by pre-exposure to one or more brief periods
of hypoxia followed by reoxygenation, triggers an
endogenous protective mechanism towards subsequent
ischemia-reperfusion injury. However, the accurate
mechanism that how IP works during the ischemia rep-
erfusion injury was not clear. Autophagy is an evolu-
tionarily conserved mechanism of cellular self-digestion
that maintains intracellular homeostasis by degrading
and removing the damaged organelles and protein
aggregates.We hypotheis that autophagy may play a
critical role in the protective mechanism of ischemic
preconditioning of liver ischemia reperfusion injury.
Materials and methods: We examined autophagy in
two types of preconditioning in C57BL6 mice. After a
midline laparotomy, the portal triad to the left and
median lobes of the liver were occluded with an atrau-
matic microaneurysm vascular clamp for 60 min. Rep-
erfusion was initiated by removal of the clamp. For
situ ischemic preconditioning model, Ischemic precondi-
tioning (IPC)group received 10 min of ischemia and 10
min of reperfusion prior to the prolonged ischemic
insult. While the remote ischemic preconditioning
(RIPC)group involved 5 min of ischemia followed by 5
min of reperfusion of hind limb; this process was
repeated for four cycles before prolonged liver ische-
mia.
Results: In animals subjected to 60 min of hepatic
ischemia, ALT levels were significantly lower in the
IPC and RIPC group when compared with the control
group .Meanwhile, Hepatocytes oncosis was less fre-
quent in livers in IPC and RIPC groups than controls.
The increased expression of light chain 3 type II (LC3-
II) was observed in preconditioned livers by Western
Blot. The increased number of autophagic vacuoles
detected by transmission electron microscopy also con-
firmed an association of autophagy in livers pretreated
with IPC or RIPC. The induction of autophagy was
correlated with enhanced cell survival and decreased
serum ALT levels.
Conclusions: In conclusion, the results of this study
indicate that autophagy is essential for the protective
effects of ischemia preconditioning on liver IR injury.
1113
COMMON HEPATIC ARTERY ARISING
FROM THE LEFT GASTRIC ARTERY
DETECTED DURING LEFT HEPATECT
Yong oon Yoo, Dong Lak Choi and Yong Oon Yoo
Division of Hepato-Biliary-Pancreas Surgery and Liver
Transplantation, Department of Surgery, College of
Medicine, Catholic University of Daegu, Daegu Catholic
University Medical Center, Daegu, Republic of Korea,
South Korea
Anatomical variations of the hepatic artery supply are
common. However, the common hepatic artery arising
from the left gastric artery is far less common. We pres-
ent a rare case in which the common hepatic artery
arose from left gastric artery, detected during left hepa-
tectomy. This case admitted for treatment of liver inva-
sion by periportal node metastasis from ovarian cancer.
The usual common hepatic artery along the portal vein
was not identified during operation. The left, middle
and right hepatic arteries were derived sequentially from
left gastric artery. Postoperatively, this anatomical vari-
ation was confirmed by preoperatively checked com-
puted tomography.
In conclusion, early recognition and knowledge of this
anatomical variation can prevent a hepatic injury by
vascular damage during hepatectomy or liver transplan-
tation.
1114
COMPOSITE PARAGANGLIOMA WITH
NEUROBLASTOMA IN RETROHEPATIC
RETROPERITONEUM MIMICKING
HEPATOCELLULAR CARCINOMA
DEVELOPED IN THE ADULT
Chol kyoon Cho, Seung Hyun Cho, Choong Young
Kim, Byung Gwan Choi, Hee Joon Kim, Young Hoi
Hur and Hyun Jong Kim
Chonnam National University Medical School, 160
Baekseo-ro, Gwangju, South Korea
Background and Aims: Pheochromocytoma arising from
outside the adrenal glands is called paraganglioma.
Paraganglioma is more common in the head and neck
region than in the retroperitoneum. Neuroblastoma is
one of the most common tumors derived from the
embryonal sympathetic nervous system usually devel-
oped in children. Composite paraganglioma with neuro-
blastoma consists of a neuroendocrine component
mixed with a neural component. The composite para-
ganglioma with neuroblastoma has been reported in the
children, but in the adult the tumor developed extre-
mely rarely.
Methods: A 62-year-old man visited outpatient depart-
ment with a complaint of right upper quadrant pain.
Abdominal CT and MRI demonstrated a
11 x 11 x 16 cm sized multiseptated cystic mass that
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contained hemorrhagic fluid in right hepatic lobe. All
routine laboratory finding with tumor markers includ-
ing CA 19-9, CEA and AFP were within normal range.
His past clinical history was non-specific except medica-
tion for hypertension with well controlled state. The
elective operation was planned under the impression of
hepatocellular carcinoma in right lobe of liver with
questionable retroperitoneal invasion. In operation
finding, about 20 x 15 cm sized huge mass was detected
in the area between posterior portion of right hepatic
lobe and retrohepatic retroperitoneum with invasion of
right adrenal gland. Right hepatectomy and right adre-
nalectomy with resection of retroperitoneal tissue was
performed.
Results: The tumor was tightly adhered to the poster-
ior portion of liver and right adrenal gland. On section-
ing, the tumor was composed with both cystic and
solid component, and the tumor was well marginated
and demarcated from the liver. Pathological result of
cystic lesion was paraganlglioma with CD56(+), synapt-
ophysin(+) and Ki-67(+, 2–3%) on immunohistochemi-
cal stain. On the other hand, the result of solid
component was anaplastic neuroblastoma with CD56
(+), synaptophysin(-), Ki-67(+, 10–15%). The final
pathological diagnosis was confirmed by composite
paraganglioma and anplastic neuroblastoma in retro-
peritoneum.
Conclusions: Composite paragaglioma with neuroblas-
toma of the retropeitoneum is rare and especially extre-
mely rarely developed in the adult. Here in, we report a
case of retroperitoneal composite paraganglioma with
anaplastic neuroblastoma mimicking hepatocellular car-
cinoma developed in the adult.
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SURVIVAL OF PERIAMPULLARY
MALIGNANCY: SINGLE TEAM
EXPERIENCE
Adianto Nugroho and Toar Lalisang
Digestive Division, Cipto Mangunkusumo Hospital,
University of Indonesia, Jakarta,Indonesia
Background: Simple prognostic criteria for pancreatico-
duodenectomy would be helpful in assessing prognosis
and evaluating the need for adjuvant treatment. This
study analysed the clinical and surgical factors influenc-
ing outcome following pancreaticoduodenectomy for
peri ampullary malignancy.
Methods: A total of 127 pancreaticoduodenectomies
for periampulary cancers were performed from 1995 to
2012. The median age of patients was 50 years (range
17–73 years). The median follow-up was 2 years. Of
the location, 50 were pancreatic adenocarcinoma and
the rest were ampullary (54), duodenal (20) and others.
Statistical analysis was performed using log-rank and
Cox regression multivariate analyses.
Results: Patients who underwent resection had 1-, 3-
and 5-year survival rates of 95%, 38% and 25%,
respectively. The 1-, 3- and 5-year survival rates for pe-
riampullary are better than pancreatic adenocarcinoma,
but not statistically significant Surgery done after 2005
has a better survival than those done before 2005,
reflecting an earlier diagnostic effort, better periopera-
tive care and a more experience team.
Conclusion: A solid and experienced team with a rea-
sonably high case load is needed for a the management
of patient with periampullary malignancy
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FATTY LIVER DISEASE IN SINGAPORE
– A HEAVY BURDEN TO BEAR
Cherlynize-mae Ong1 and Stephen Kin Yong Chang2,3
1Yong Loo Lin School of Medicine, National University
of Singapore, 21 Lower Kent Ridge Road, Singapore
119077; 2Dept of Surgery, Yong Loo Lin School of
Medicine, National University of Singapore, 21 Lower
Kent Ridge Road, Singapore 119077; 3Div of
Hepatobiliary & Pancreatic Surgery, Dept of General
Surgery, University Surgical Cluster, National University
Health System, 1E, Kent Ridge Road, Singapore 119228
Singapore
Background and Aims: The burden of fatty liver disease
(FLD) has increased with greater affluence and modern
day lifestyles. Yet very often, because patients are
asymptomatic, this is picked up incidentally during
investigations for other problems. The silent FLD can
develop into steatohepatitis and eventually cirrhosis,
unless it is managed appropriately. This study aims to
find out the prevalence of FLD, identify demographic
and other risk factors associated with FLD, as well as
determine the proportion of patients with FLD who
are managed and followed up for it.
Methods: Retrospective review was performed on 553
Singaporean patients (aged between 58 and 100) without
any pre-existing liver parenchymal pathologies who under-
went ultrasonography (U/S) of the liver in 2010. The
participants’ medical records were then used to determine
the fatty liver status, demographics, presence of risk fac-
tors for FLD, as well as whether they were followed up
for it.
Results: 34.4% of the participants were found to have
a fatty liver on U/S. Of the various associated co-mor-
bidities investigated, fatty liver was more prevalent in
patients with pre-existing DM (PR 1.99, 95% CI 1.30–
3.06). The prevalence of FLD in patients also increased
as their BMI increased, with a prevalence ratio of 9.39
[2.52, 38.09] in patients with BMI > 30 compared to a
BMI of < 23.0. On bivariate analysis, BMI and DM
were shown to be an independent predictors of fatty
liver disease (p < 0.001 and p = 0.04 respectively).
Only 33.2% of the patients with FLD are currently
being followed up. Among these patients, 2 of them
who underwent follow-up scans were shown to have
developed liver cirrhosis.
Conclusions: Fatty liver disease is extremely common
in Singapore nowadays, especially in overweight
patients and those with DM. These patients are at risk
of liver failure and cancer, and do require regular
follow ups for early detection, which is not currently
done in many patients.
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REEXAMINING THE ROLE OF
PANCREATIC COMPOSITION IN
SHORT TERM OUTCOMES AFTER
PANCREATICODUODENECTOMY FOR
MALIGNANCY
Hariharan Ramesh, Bejoy Abraham, K P Manjuraj, S
Mahesh, B Venugopal, A Venugopal, V Lekha and H
Ramesh
Department of Surgical Gastroenterology, Lakeshore
Hospital & Research Center, Cochin, Kerala, India
Aim: To assess the influence of pancreatic histology on
early outcomes (pancreatic anastomotic leakage) after
pancreaticoduodenectomy for malignancy and its rela-
tion with texture.
Materials & methods: Prospective study enrolling
patients who underwent Whipple’s pancreaticoduodenec-
tomy for malignant lesions of the periampullary and
pancreatic head region from March 2009 to March 2011.
68 patients had undergone Whipple’s PD as curative pro-
cedure for malignancy in two years and 54 were included
in the study. There were 42 men and 12 women. The
median age of the sample population was 57 (36–83). Of
the 54 patients, surgical indications were ampullary carci-
noma in 33, pancreatic cancer in 15, Distal common duct
growth in 3 patients and Duodenal tumour in 4. The
median BMI of the study population was 21.16 range
(15.1–27.51). Representative slices of nontumorous
pancreatic tissue located at pancreatic neck margin and
uncinate margin were sampled for each patient. These
specimens were analyzed independently by two blinded
pathologists. Pancreatic fistula was graded as per ISGPF
criteria and post operative complications were graded
according to the Clavien Dindo system.
Results: There were 19 post operative pancreatic fistulae.
Univariate analysis of factors affecting pancreatic fistula
showed significant difference between mean fibrosis score
(3.0 vs. 0.42, p = 0.0001) and mean inflammation score
(0.69 vs. 0.21, p = 0.012) between fistula and no fistula
group. Fat score has no implication on post operative
pancreatic fistula on univariate analysis (1.69 vs. 1.21,
p > 0.05). Firm texture of pancreas significantly correlates
with increasing inflammation and fibrosis scores
(p = 0.03). Soft texture however did not correlate with
steatosis scores. Several other clinical and intraoperative
factors like diabetes (p = .011), weight loss (p = 0.05), pre-
operative biliary drainage (p = .016), soft consistency of
neck (p = .011), ampullary and pancreatic origin of
tumour (p = .059) were found to be significantly related
to postoperative complications as well as post operative
pancreatic fistula on univairate analysis. Preoperative bili-
ary drainage alone was associated with higher complica-
tion rate on multivariate analysis.
Conclusion: Firmness of pancreatic neck is a good indi-
cator of histological fibrosis and inflammation. Fibrosis
and inflammation of non tumourous pancreas seems to
be a protective factor for post operative pancreatic fis-
tula. Steatosis correlates poorly with softness and also
does not seem to have a strong relationship with fistula
and is probably a poor indicator due to the low BMI
in the sample population.
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THE EFFECT OF A NEW
BIODEGRADABLE STENT ON WOUND
HEALING OF BILIARY-ENTERIC
ANASTOMOSIS
Jian-Hua Shi, Yi Lv, Liang Yu, Bin-Bin Zhang,
Xu-Feng Zhang and Chao Fan
Department of Hepatobiliary Surgery, The First
Affiliated Hospital of Medical College, Xi’an Jiaotong
University, Xi’an, P.R. China
Background and Aim: Benign biliary stricture of anas-
tomotic stoma is frequent after biliary reconstruction.
In order to prevent such a complication, a new paclit-
axel coated Poly-L-Lactide acid (PLLA) biodegradable
biopolymer stent was designed. This original device was
intended both to exert adequate mechanical support
properties and to allow controlled drug delivery from
the coating, with the goal of favoring wound healing
after biliary reconstruction.
Methods: PLLA stents coated with three different pac-
litaxel concentrations were implanted in the biliary
anastomosis of mongrel dogs (defining groups A, B and
C, respectively). Liver function tests and residual dosage
of paclitaxel from each stent were measured. Histologi-
cal and a-smooth muscle actin immunohistochemical
staining of biliary-enteric anastomosis were examined.
Results: There were no significant differences in liver
function all along the study between the 3 groups and no
bile leakage was observed. Stents were fixed from the eight
week after stent placement. The paclitaxel-coated stents
were able to slowly release the paclitaxel for 9 weeks. In
groups B and C, histological examinations showed less
granulation tissue and glandular hyperplasia in biliary-
enteric anastomosis than in group A. Submucosal collagen
deposition was reduced and a-smooth muscle actin posi-
tive cells decreased significantly, reflecting the inhibition of
myofibroblast proliferation in groups B and C.
Conclusions: PLLA paclitaxel coated stents reduced the
proliferation of granulation tissue and glandular hyper-
plasia, and inhibited the myofibroblast proliferation
and extracellular matrix over deposition during the
healing process of biliary-enteric anastomotic stoma.
This original device may offer a new way for prevent-
ing benign biliary structure.
1121
POSITIVE CONTRIBUTION OF PD
WITH PV/SMV RESECTION IN THE
TREATMENT OF PANCREATIC
CANCER WITH VENOUS INVASION
Wei-Lin Wang, Song Ye, Dong-Kai Zhou, Qiang Sun
and Shu-Sen Zheng
The First Affiliated Hospital, Zhejiang University School
of Medicine, 79 Qingchun Rd, Hangzhou, 310003 China
Background and aims: Vascular invasion has been a
conventional contraindication to operation of pancre-
atic cancer (PC). In 1970’s to 1990’s, the resection and
reconstruction of SMV and portal vein(PV) were asso-
ciated with poor results in advanced PC. But this con-
cept is challenged in recent decades because of the
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progress in surgical skills. The aims of this article is to
investigate the effection of pancreatoduodenectomy
(PD) with PV/SMV resection and reconstruction in
treatment of pancreatic cancer with venous invasion.
Compare the prognosis between the PD with PV/SMV
resection(PD + PV) and simple PD.
Methods: A consecutive series of 322 patients with
pathological diagnosis of pancreatic cancer undergoing
PD/PD + PV between March 2010 and May 2012 in
our department were investigated retrospectively in this
research. 265 patients underwent simple PD and the
other 57 patients underwent PD + PV because of
venous invasion. In the PD group, 239 cases were R0
resection and 26 cases were R1 resection. In the
PD + PV group, 29 cases were R0 resection and 28
cases were R1 resection. The postoperative morbidity,
mortality, 1 and 2 year survival rate were examined.
Results: All of the operated group were successful and
without perioperative mortality. There were no statisti-
cal differences in the postoperative morbidity such as
pancreatic leakage, bile leakage, intraabdominal bleed-
ing between the two groups. In R0 resection series: the
1 year survival rate of PD and PD + PV groups were
70.2% versus 72.4% (p > 0.05) and the 2 year survival
rate of PD and PD + PV groups were 61.1% versus
51.7% (p > 0.05). In R1 resection series: the 1 year sur-
vival rate of PD and PD + PV groups were 38.5% ver-
sus 42.8% (p > 0.05) and the 2 year survival rate of
PD and PD + PV groups were 23.1% versus 35.7%
(p > 0.05). There were no Statistics difference between
the survival rate of PD and PD + PV groups of 1 and
2 year survival rate.
Conclusions: The resection and reconstruction of SMV
and PV is safe and effective. This operation will not
increase the morbidity and mortality of PD. And the
survival rate of 1 and 2 years is just like the simple PD
for pancreatic cancer. So PD + PV is a beneficial oper-
ation when the case has the PV/SMV invasion.
1126
LAPAROSCOPIC RADICAL
CHOLECYSTECTOMY FOR T2
GALLBLADDER CANCER
Chi young Jeong, Jin Kyu Cho, Young Tae Ju, Eun
Jung Jung, Young Joon Lee, Sang Kyung Choi, Woo
Song Ha, Soon Tae Park and Soon Cha
Department of Surgery, Gyeongsang National University
Hospital, Jinju, Korea, jinju/GyeongSang nam do, South
Korea
Background and aims: Minimally approach to gallblad-
der cancer is controversial. But recently laparoscopic
surgery was done in patients with early-stage gallblad-
der cancer by the increasing of experience in laparo-
scopic surgery.
Patients found to have a T1a gallbladder cancer in lap-
aroscopic cholecystectomy, no further surgery is
needed. But the patients with T1b and T2 tumors
should be treated by simple colecystectomy or by the
radical surgery remains under debate.
Methods: From December 2009 to July 2012, 6
patients diagnosised T2 gallbladder cancer underwent
totally laparoscopic cholecystectomy with hepatoduode-
nal lymphnode dissection or laparoscopic radical chole-
cystectomy at the Department of Surgery, Gyeongsang
National University Hospital. Clinicopathological char-
acteristics were retrospectively reviewed in this study.
Results: Three of the six patients have undergone lapa-
roscopic cholecystectomy with hepatoduodenal lymphn-
ode dissection and 3 patients have undergone
laparoscopic radical cholecystectomy with hepatoduo-
denal lymphnode dissection.
One of six patients with T2 gall bladder cancer had
lymph node metastasis.
The average operative time was 293 min (range, 170–
375 min), average estimated blood loss was 625 ml
(range, 200–1100 ml), and average hospital stay was
9 days (range, 4–15 days). The average number of
lymph nodes was 9 (range, 2–26) and median follow up
was 8.8 months (range, 1–23 months). No locoregional
recurrence, morbidity or mortality was observed.
Conclusions: The role of laparoscopic surgery of gall-
bladder cancer is remain controversy. But in our study,
laparoscopic radical cholecystectomy is useful in T2
gallbladder cancer. More large, randomized controlled
studies about oncologic result are needed.
1134
RUPTURE OF HEPATOCELLULAR
CARCINOMA FOLLOWING
TRANSARTERIAL EMBOLIZATION/
CHEMOEMBOLIZATION: TWO CASES
REPORT AND SYSTEMATIC REVIEW
Ping Sun, Rui-Qing He, Zi-Fang Song, Qing-Gang Hu,
Jun Xiong, Shao-Bo Hu and Qi-Chang Zheng
Hepatobiliary Surgery Centre, Union hospital, Huazhong
University of Science and Technology. 1277 Jiefang
Ave., Wuhan, Hubei, China
Abstract: Background: Rupture of hepatocellular carci-
noma (HCC) following transarterial embolization/
chemoembolization (TAE/TACE) is a rare but life-
threatening complication.
Objective: To review information available on the inci-
dence, risk factors, clinical characteristics, treatment,
and outcomes of this complication.
Methods: We described two cases and reviewed all
cases of ruptured HCC after TAE/TACE reported in
the literature.
Results: Our search yielded 32 cases of ruptured HCC
after TAE/TACE. The overall incidence was 0.45% per
patient and 0.21% per session. The mean age was
57.4 years (range 28–90 years, N = 26, No. of cases
with available information). Males accounted for 81%
of cases (21/26). 50% of the cases had histories of pri-
mary hypertension, diabetes or peripheral artery disease
(6/12). Mean diameter of the tumor was 11.4 cm (range
3–20 cm, N = 27). 100% of cases had superficial or ex-
ophytic tumors (23/23). Portal vein thrombosis was
presented in 61.5% of patients (8/13). The median
interval between TAE/TACE and rupture was 2 days
(range 0 h-30 days, N = 31). Management choice
included emergency TAE, surgery, or conservative
treatment. The overall median survival time was 7 days
(N = 19).
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Conclusion: Rupture of HCC following TAE/TACE is
relatively rare but potentially life-threatening. The man-
agement is difficult and prognosis is poor. Large tumor
size, superficial or exophytic tumors as well as portal
vein thrombosis and comorbidities such as primary
hypertension, diabetes or peripheral artery disease may
be predisposing factors for rupture. This complication
may happen during or immediately after the procedure
as well as several weeks later. Doctors should be aware
of such an extraordinary and fatal complication of
TAE/TACE to provide effective management.
1136
LIVER AUTOTRANSPLANTATION FOR
THE TREATMENT OF HEPATIC
ALVEOLAR ECHINOCOCCOSIS: FOUR
CASES REPORT
Hao Wen, Jia-Hong Dong, Jin-Hui Zhang, Jin-Ming
Zhao, Ying-Mei Shao, Wei-Dong Duan, Yu-Rong
Liang, Xue-Wen Ji and Qin-We Tai
1Department of Liver and Laparoscopy Surgery, First
Affiliated Hospital of Xinjiang Medical University,
Xinjiang Organ Transplantation Research Institute,
Urumqi 830000, China; 2Department of Hepatobiliary
Surgery, General Hospital of Chinese People’s
Liberation Army, Beijing 100853, China
Objective: To summarize the clinical experience of liver
autotransplantation (LA) for the treatment of advanced
hepatic alveolar echinococcosis (HAE).
Methods: Four patients with advanced HAE under-
went LT in the First Affiliated Hospital, Xinjiang Med-
ical University from August 2010 to October 2012 were
retrospectively analyzed.
Results: Four LA were successfully performed for
advanced HAE. The overall medium time of the four
LA procedures and unhepatic phrase were 700.0 min
(range, 580–1080 min) and 245.0 min (range, 135–
344 min), respectively. The medium transfusion
requirement was 8.0 u (range, 4–15 u). The medium
follow-up was 12 months (range, 1–18 min). Bile leak-
age appeared early in all the cases and was recovered
spontaneity within six months with extraperitoneal
drainage. Three patients were recovering well except for
one died of severe fever of unknown origin six months
postoperatively.
Conclusion: LA is the optimal method of treating
advanced HAE. Strict compliance with the LA indica-
tions, deliberate operative skill and careful postopera-
tive management are key factors for radical treatment
of advanced HAE. Systemic administrations of L-ABZ
are necessary to prevent from the recurrence of alveolar
echinococcosis and ensure a long-term survival.
Keys: Liver autotransplantation; Hepatic alveolar
echinococcosis; Liver three-dimensional image recon-
struction
1137
CLINICOPATHOLOGICAL
CHARACTERISTICS IN COMBINED
HEPATOCELLULAR-
CHOLANGIOCARCINOMA: A SINGLE
CENTER STUDY
Jae do Yang, Hong Pil Hwang, Hee Chul Yu and Baik
Hwan Cho
Department of Surgery, Chonbuk National University
Medical School and Hospital, Jeonju si, South Korea
Backgrounds: Combined hepatocellular carcinoma and
cholangiocarcinoma (cHCC-CC) is an uncommon sub-
type of primary liver cancer that has rarely been
reported in detail. This study was done to evaluate the
clinicopathological characteristics and prognostic fac-
tors of cHCC-CC.
Methods: The clinicopathological features of patients
diagnosed and operated with cHCC-CC at Chonbuk
National Hospital between January 1998 and Decem-
ber 2007 were retrospectively studied by comparing
them with patients with hepatocellular carcinoma
(HCC) alone who had undergone a hepatic resection
during the same period.
Results: Ten of the 152 patients who were undergone a
hepatic resection were diagnosed with cHCC-CC and
included in this study (M: F = 8: 2, median age:
51.9  11.1 years). According to the parameters of the
7th American Joint Committee on Cancer T staging,
there were 76 (50.0%), 44 (28.9%), 9 (5.9%), 18
(11.8%) and 5 (3.3%) patients with T stages I, II, IIIa,
IIIb and IV cancer, respectively. Overall survival period
was better in the HCC only group
(67.9  40.4 months) than in the combined cHCC-CC
group (22.7  40.1 months). 5-year survival rate was
20% in the cHCC-CC group and 60% in the HCC
group. The disease free survival for patients with
cHCC-HCC and HCC were 16.3 and 50.9 months,
respectively. The only significant clinicopathological
factor identified by multivariate analysis was T staging.
(p = 0.05).
Conclusion: Even after curative hepatic resection, the
presence of a cholangiocellular component appeared to
be a poor prognostic indicator in patients with primary
liver cancer.
T stage is the only independent significant prognostic
factor associated with patient survival in our study.
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1138
TOTALLY LAPAROSCOPIC
PANCREATODUODENECTOMY IN
TREATMENT FOR PERIAMPULLARY
CARCINOMA: EXPERIENCE WITH 16
CASES
Yue-Ming Sun and Chun-Hua Xi
Department of General Surgery, the First Affiliated
Hospital of Nanjing Medical University, Nanjing, China
Aims: To evaluate the efficacy and feasibility of totally
laparoscopic pancreatoduodenectomy (TLPD) in man-
agement of periampullary carcinoma.
Methods: We retrospectively analyzed 16 cases that
underwent TLPD between Apr. 2004 and Sep. 2012 in
our hospital. Clinical records of intraoperative data
and postoperative complications were studied, with sur-
gical skills summarized.
Results: TLPDs were successfully performed in all 16
patients, with no conversion to open surgery. Mean
operation time was 543  49.9 min, and mean intraop-
erative blood loss was 444  352.02 mL. Pancreatic
fistula occurred in five patients, four of which were
treated successfully with conservative therapy, except
one underwent reoperation for subsequent intra-
abdominal abscess. Chyle leakage occurred in one
patient and healed after drainage and medical treat-
ment. Post-operative pathology confirmed 8 cases of
biliary carcinoma, 5-duodenal carcinoma, 1 duodenal
endocrine carcinoma, 1 periampullary adenocarcinoma
and 1 gastric cancer. The 3-year overall survival rate
for this group of patients is 81.2%.
Conclusions: In our case series, we performed TLPD
with uncinate process completely resected which we
think is vitally important in the treatment for periam-
pullary carcinoma. It is our conclusion that, in manag-
ing of early-stage periampullary carcinoma, TLPD
performed by senior surgeons with advanced laparo-
scopic skills and profound experience in open pancre-
atic surgery is a feasible and minimally invasive
approach, which is expected to have wider clinical
application.
1140
THE PROXIMAL LEINORENAL SHUNT
AS A ONE TIME TREATMENT OPTION
FOR SELECTED PATIENTS WITH
PORTAL HYPERTENSION
Virandera pal Bhalla, JC Vij, R Vats and D Goel
Centre for Digestive & Liver Diseases, BLK Super
Speciality Hospital, New Delhi, India
Background: Portal hypertension (PHT) and its mani-
festations present a management challenge. Surgery has
traditionally been considered as an option only in
patients who are beyond endoscopic therapy such as in
those with persisting GI bleed from gastric or ectopic
varices and congestive enteropathy or those compli-
cated with primary or secondary portal biliopathy.
Surgical porto systemic shunts are effective in lowering
portal pressures, and in patients of PHT with good
liver function e.g. Extra Hepatic Porto Venous
Obstruction (EHPVO) and Non Cirrhotic Portal Fibro-
sis (NCPF) post shunt hepatic encephalopathy is not a
significant problem. Indian experience has suggested
that patients of PHT with good liver function are more
likely to die of bleeding than encephalopathy and
shunts may be a good option in patients who have lim-
ited access to facilities for blood transfusion for manag-
ing variceal bleeds. Developments during the last two
decades have prompted a reassessment of the role of
surgery in PHT.
Better facilities for blood transfusion has led to a
greater awareness of the problems of blood transfusion.
Transfusion associated infection, immunosuppression
and concerns over costs of repeated transfusion .Also
the popularity of the Rex Mesenterico Portal Shunt in
transplant units is bringing shunt surgery back into
perspective. Finally insurance companies and health
care funding agencies are increasingly inclined to sup-
port one time definitive treatment options in preference
to prolonged endoscopic treatment programs.
Aim: To place in perspective the proximal leino renal
shunt as a onetime treatment option in the manage-
ment of PHT in patients with good liver function.
Patient methods: From 1993 to 2012, 91 patients
underwent surgical shunting for PHT. The commonest
causes of PHT were EHPVO and NCPF in 72/91 cases
and the commonest indication for surgery was GI
bleeding in 66/91 patients. The preferred procedure was
splenectomy with a Proximal leino Renal Shunt. No
routine post shunt anticoagulation was used. No post
shunt hepatic encephalopathy was encountered in this
group. Shunt patency rate was 86% at one year follow
up.
Conclusion: The Proximal Leino Renal Shunt is a non
selective shunt which is relatively easy to learn and per-
form with no post shunt encephalopathy when per-
formed for patient with good liver function. It may
infact be a more rational alternative to the complex
Rex Shunt and in selected patients it offers a onetime
treatment option and relief from the need of repeated
hospital admission, endotherapy and recurring treat-
ment costs of GI bleeding due to PHT.
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THE DEVELOPMENT OF
BIODEGRADABLE MAGNETIC
COMPRESSION ANASTOMOSIS
DEVICES WITH NANO-NDFEB
COMPOSITE MATERIALS TOHEPATIC
VASCULAR SUTURELESS
Shan-Pei Wang1, Jian-Hui Li1, Jun-Min Qian2, Wei-Jie
Yao1, Shi-Qi Liu1, Shi Huang1 and Yi Lv1,3
1Department of Hepatobiliary Surgery, First Affiliated
Hospital, Medical School of Xi’an Jiaotong University,
Xi’an, China; 2Surgical Dream Works, Institute of
Advanced Surgical Technology and Engineering, Xi’an
Jiaotong University, Xi’an 710061, Shaanxi Province,
China; 3State Key Laboratory for Mechanical Behavior
of Materials, School of Materials Science and
Engineering, Xi’an Jiaotong University, Xi’an 710061,
Shaanxi Province, China
Correspondence to: Yi Lv, Professor, Doctoral
supervisor, Department of Hepatobiliary Surgery, First
Affiliated Hospital, Medical School of Xi’an Jiaotong
University, Xi’an, China
Background and aims: Magnetic compression anasto-
mosis (MCA) caused surgeons’ attention recently for
its manipulate easily, anastomosis quickly, better con-
sistent quality and a wide range of applications. In this
study we developed a new biodegradable MCA devices
which bonded with nano-NdFeB magnetic particles
and biodegradable polymer material PLGA (poly-L-
lactide-co-glycolide). This new biodegradable MCA
devices can be used in the anastomosis of hepatic vas-
cular. It can provide enough magnetic force to make
sure it is safe while anastomosis. With the degradation
of degradable polymer biomaterials, nano-magnetic
materials can be gradually excreted to invitro when
anastomotic stoma healed. Then we can achieve the
aim of sutureless anastomosis by MCA in hepatobiliary
system.
Methods: 1. To product nano-NdFeB magnetic parti-
cles with high energy ball milling and modifying it sur-
face with silica gel.
2. The nano-SiO2-NdFeB magnetic particles were
bonded with biodegradable polymer material PLGA by
solvent evaporation method.
3. Biodegradable nano-NdFeB composite materials fab-
rication by warm compaction process.
4. New biodegradable MCA rings were developed and
the portal vine end-to-end sutureless reconstruction in
canine.
Results: 1. The diameter of nano-NdFeB magnetic par-
ticles is about 20-150 nm and the silica surface is 7 nm.
MTT test indicated that the cytotoxicity degree of
nano-particles was 1. TEM show that the nanoparticles
could be observed intra-cellular and distribution in the
cytoplasm without nucleus. The acute toxicology
research show that the liver and kidney functions are
stable and the histological sections of liver, kidney
there no significant pathological changes.
2. The best temperature and pressure of warm compac-
tion process is 120°C and 12 MPa. The best composi-
tion is 95% nano-NdFeB particles with 5% PLGA.
The maximum magnetic energy product is 45 kj/m3.
3. The degradation time of biodegradable MCA rings
is closely related to molar ratios of PLGA. The degra-
dation peak of molar ratios of PLGA (90 L /10 G),
(70 L /20 G), (50 L /50 G) is at the 8th, 6th, 4th week.
4. The portal vine end-to-end sutureless reconstruction
in canine show that the operation time were signifi-
cantly shortened. TEM show that MCA anastomotic
intimal was smoothly, with endothelial cells arranged
regularly.
Conclusions: Developed a new type of biodegradable
MCA devices with nano-NdFeB composite materials.
The MCA devices have good magnetic energy product,
degradation property, biocompatibility, and low cyto-
toxicity. It can offer a fast, convenient, and safety
approach sutureless anastomosis of hepatic vascular
anastomosis. Also it can reduce the influence of human
factors and the difficulty of surgical operation and
complications.
1145
INFLUENCE OF RESECTION MARGIN
WIDTHS ON OUTCOMES OF HEPATIC
RESECTIONS FOR COLORECTAL
LIVER METASTASES
Chen hui Lionel raphael1, Teo Jin Yao2, Lee Ser Yee2
and Wong Jen San2
1Yong Loo Lin School of Medicine, National University
of Singapore, Singapore; 2Department of Surgery,
Singapore General Hospital, Singapore
Purpose: Hepatic resection is the most effective therapy
for patients with colorectal liver metastases (CLM)
with 5 year survival of up to 58%. Traditionally, clear
margins of at least 1 cm were considered a prerequisite
for better survival. However, recent studies have ques-
tioned the prognostic importance of the 1 cm rule. This
study’s aim is to evaluate the effect of the resection
margin width on patients’ outcomes.
Methods: From 2001 to 2011, all patients who under-
went liver resection for CLM were selected from the
Singapore General Hospital. Patients with extrahepatic
metastases prior to resection of CLM were excluded.
Results: Overall median survival, recurrence free sur-
vival (i.e. intra and extrahepatic recurrence) and intra-
hepatic recurrence free survival were 25, 10 and
14 months respectively. 165 (85.1%) and 36 (17.9%)
underwent R0 and R1/2 resection respectively. Kaplan–
Meier (KM) univariate survival analysis suggests
patients with R0 resection had better survival as com-
pared to R1/2 resection (HR = 0.635, 95% CI = 0.39–
1.04, p = 0.067). Among the R0 resections, 48 (29.1%),
48 (29.1%) and 69 (41.8%) had margin width of  1, 1
to 5 and >5 mm respectively. On univariate analysis,
multiple liver metastases, bilobar distribution and  3
segments resected were associated with narrower mar-
gin width. Multivariate analysis showed  3 segments
resected was independently associated with  1 as com-
pared to >5 mm resection margin (OR = 2.85, 95%
CI = 1.26–6.43, p = 0.012).
Wider margins of >5 as compared to  1 mm were
associated with better intrahepatic recurrence free sur-
vival (HR = 0.544, 95% CI = 0.32–0.93, p = 0.027).
However, margin width effect on overall survival and
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recurrence free survival was not statistically significant
with p values of 0.298 and 0.484 respectively.
Conclusion: Wider resection margins are associated
with lower intrahepatic recurrence. However, it has no
influence on overall survival and recurrence free sur-
vival. Achieving a 1.0 cm margin is not necessary when
resecting CLMs.
1150
NF-ΚB REGULATES PHAGOCYTOSIS
IN SPLENIC MACROPHAGE IN
HYPERSPLENISM DUE TO LIVER
CIRRHOSIS
Song Ren1, Zong-Fang Li1, Fan-Pu Ji1, An Jiang1,
Hai-Tao Zhu1, Ke Li2, Shu Zhang1, Jun Yang2 and
Chen Huang2
1Department of General Surgery, the Second Affiliated
Hospital, Medical College, Xi’an Jiaotong University,
Xi’an, Shaanxi province, China; 2Biotherapy &
Translational Medicine Engineering Research Center of
Shaanxi Province, Second Affiliated Hospital, Xi’an
Jiaotong University, P. R. China, Xi’an, China
Background: Nuclear factor-kappaB (NF-jB) tran-
scription factors have a key role in various biological
processes. In this study, we explore the role of NF-jB
in dysfunction of splenic macrophage in hypersplenism
due to liver cirrhosis.
Methods: NF-jB activation was examined in hypersp-
lenism splenic macrophage. To inhibit NF-jB activa-
tion, we used NF-jB p65 activation inhibitor JSH-23,
p65 siRNA and c-Rel siRNA to treat normal and hy-
persplenism splenic macrophage. Phagocytosis and
secretion were evaluated in untreated and treated cells.
NF-jB p65 and c-Rel downstream target genes were
evaluated by quantitative real-time polymerase chain
reaction (qRT-PCR).
Results: NF-jB p65, p52 and c-Rel are constitutively
activated in hypersplenism splenic macrophages. NF-
jB activation inhibitor JSH-23 and siRNA-mediated
p65 and c-Rel gene silencing significantly suppressed
phagocytosis and secretion in hypersplenism splenic
macrophage. We identified phagocytosis regulators
interferon-c (IFN-c) was regulated by NF-jB in hy-
persplenism splenic macrophages.
Conclusions: These results demonstrate that NF-jB
p65 and c-Rel may be critical factors in phagocytosis in
hypersplenism splenic macrophage. Selective targeting
of different NF-jB dimers may become potential thera-
peutic targets for treatment of hypersplenism and liver
cirrhosis
1151
COMPARATIVE LIVER UTILIZATION
RATE IN CADAVERIC LIVER
TRANSPLANTATION- PRE AND POST-
UTILIZATION OF MARGINAL DONORS
IN SINGAPORE
Tay Kon voi and Iyer Shridhar
Hepatopancreaticobiliary division, Department of
Surgery, National University of Hospital, Singapore
Introduction: Liver transplantation is becoming stan-
dard of care for selected patients with HCC and cirrho-
sis. Scarcity of donor pool remained limiting factor as
a routine treatment. We show the significant increase in
liver utilization rate after using marginal liver donors.
Materials and Methods: All donor referrals between
2004 and 2012 were studied. Reasons for rejection as
potential donors were documented. We compare donor
referrals utilization rate in the era of pre- and post uti-
lization of marginal donors.
Results: From 2004 to 2007, liver utilization rate
remained very low (mean: 15%). This is because there
are strict criteria in prevention of primary non-func-
tioning liver post transplantation. However, starting
from 2008, marginal donors are used to increase the
donor pool utilization to overcome the demands (mean:
65%). Marginal donors such as Hep BcAb +ve, history
alcohol use, macrovesicular steatosis >40%, transient
hypotension, transient abnormal liver function test,
donor requirement of >2 inotropes, possible sepsis, and
ICU stays >5 days. There are significant increase 330%
rate of liver utilization and no significant survival out-
comes of patients who received marginal donor grafts.
Conclusion: Acceptance of marginal donor has success-
fully increased the liver transplant rate in Singapore for
the past 5 years. More studies need to be following up
to include more potential donor referrals in future.
1155
REVERSAL EFFECTION OF BAICALEIN
ON MULTIDRUG RESISTANCE IS
ASSOCIATED WITH SUPPRESSING
THE EXPRESSION OF P-GP AND
BCL-XL
Jun Li2, Rong-Rui Liang1, Ju-Nan Qi3, Peng An2,
Hai-Tao Zhu1, Yan-Song Pu1, Bao-Hua Li2,
Yuan-Yuan Ji2, Jun Yang2 and Zong-Fang Li1,2
1Department of General Surgery, the Second Affiliated
Hospital, Medical College, Xi’an Jiaotong University,
Xi’an, Shaanxi province, China; 2Biotherapy &
Translational Medicine Engineering Research Center of
Shaanxi Province, Second Affiliated Hospital, Xi’an
Jiaotong University, P. R. China; 3Baoji Central
Hospital, Baoji, Xi’an, Shaanxi province, China
Background and objective: Multidrug resistance (MDR)
led a major cause to failure of chemotherapy. To date,
few MDR reversal agents illustrated satisfied effect.
This investigation aimed to observe the reversal effect
and the potential mechanism of Baicalein on multidrug
resistance in human hepatocarcinoma MDR cell line in
vitro.
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Methods: Human hepatocarcinoma MDR cell line
BEL-7402/5-FU was cultured in vitro. There are five
groups including 5-FU, Epirubicin, Baicalein, 5-
FU + Baicalein and Epirubicin + Baicalein. The inhibi-
tion rate and resistance fold of 5-FU and EPI, the
reversal effection of Baicalein were determined by MTT
assay. The introcellular concentration of Rho123 and
EPI were detected by FACS. The expression pattern of
P-gp and Bcl-xl were observed via Realtime-PCR,
immunohistochemistry assay and FACS.
Results: Combined with Baicalein, the IC50 of 5-FU
were significant lower than that of 5-FU single usage.
Epirubicin added with Baicalein illustrated the same
result; The intracellular average fluorescence intensity
of Rho 123 in treatment group were significantly
enhanced versus the control group, the EPI demon-
strated the same phenomenon; The mRNA and protein
of P-gp and Bcl-xl were reduced than that of the con-
trol group after the treatment of baicalein. FACS
showed the positive rate of P-gp reduced 1.23 and 1.63
fold and the average fluorescence intensity of Bcl-xl
reduced 1.44 and 2.08 fold than that of the control
group.
Conclusions: Baicalein can reverse the MDR of BEL-
7402/5-FU partly in vitro, the reversal effection of Ba-
icalein on the MDR of BEL-7402/5-FU is associated
with suppressing the expression of P-gp and Bcl-xl in
vitro.
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TH17 DYNAMIC CHANGES EFFECTS IN
THE DEVELOPMENT OF HCC WITH
PVTT
Sun Baomu, Zeng-Hui Xu, Rong Li, Ming Luo and
Ping-Kang Wei
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, China
Aim: To observate dynamic changes of Th17 cell cyto-
kines and IL-17mRNA among healthy volunteers, pri-
mary hepatocellular carcinoma (HCC) patients and
HCC patients with portal venous tumor thrombus
(PVTT) in peripheral venous blood and/or portal
venous blood, to further clarify role of portal vein
microenvironment Th17 dynamic changes during PVTT
formation and provide a new target for clinical diagno-
sis, treatment.
Method: Control group, HCC group and PVTT group,
30 male cases in each group, liver function was in the
range as Child-Pugh grade A or B, patients in HCC
group and PVTT group were confirmed by B ultra-
sound and CT or MRI, parallelled with liver pathology
testing. Liver pathology, biochemical were performed
respectively, AFP, flow cytometry and RT-PCR detec-
tion were performed respectively.
Result: Serum GGT level, HCC group was significantly
higher than control group (p < 0.01), and there was a
significantly higher level in PVTT group than control
group too(p < 0.01), PVTT group in comparison with
HCC group, Level of Serum GGT was significantly
higher (p < 0.05); Th17: In HCC group and PVTT
group, ratio of patients peripheral blood CD4 + IL-
l7 + cells and CD4 + T cells was much higher than
control group (p < 0.01), and the same result in portal
venous blood(p < 0.01), and higher in PVTT group
than which in HCC group in portal venous blood
(p < 0.01); Serum IL-17 mRNA detection: whether in
HCC group, or PVTT group, expression level of
peripheral monocyte blood cells IL-17mRNA was sig-
nificantly higher than that in control group (p < 0.01),
whether in peripheral blood or portal venous blood, in
PVTT group was higher level than which in HCC
group, and the difference was different (p < 0.01); IL-
17Mrna level in PVTT group was higher in portal
venous monocyte blood cells than that in peripheral
venous monocyte blood cells, and the difference was
significantly(p < 0.05); correlation of Serum GGT con-
tent and portal venous Th17 cytokine expression level:
It was obviously positive correlation between them.
Conclusion: In peripheral venous blood/portal vein
microenvironment, expression levels of Th17 cytokine
was rise in line with genesis of liver tumors and forma-
tion of portal venous tumor thrombus. There was sig-
nificantly positive correlation between GGT content
and expression of Th17; Peripheral venous blood/portal
venous blood Th17 cell levels may be able to be used
as a new target in the prognosis of HCC patients’
development in the near future.
1158
NANOSECOND PULSED ELECTRIC
FIELD (NSPEF) INHIBITS TUMOR
GROWTH VIA INHIBITING THE MAIN
HALLMARKS OF CANCERS IN VITRO
AND IN VIVO
Zhi-Gang Ren1, Xin-Hua Chen1, Guang-Ying Cui2,
Jian-Wen Jiang1, Hai-Yang Xie1, Shu-Sen Zheng1 and
Lin Zhou1
1Key Laboratory of Combined Multi-organ
Transplantation, Ministry of Public Health, Department
of Hepatobiliary and Pancreatic Surgery, First Affiliated
Hospital, School of Medicine, Zhejiang University,
Hangzhou 310003, China; 2State Key Laboratory for
Diagnosis and Treatment of Infectious Disease, First
Affiliated Hospital, School of Medicine, Zhejiang
University, Hangzhou 310003, China
Objective: Cancer was a leading cause of death and
deaths from cancer worldwide are projected to rise to
over 11 million in 2030. Nanosecond pulsed electric
field (nsPEF) as a new technology has emerged from
military into biomedicine. In this study, we want to
explore whether nsPEF could inhibit cancer and how it
functions in vitro and in vivo.
Materials and Methods: PANC-1 cells were prepared
for in vitro experiment, and treated by nsPEF in differ-
ent intensities. After incubation for different hours, cell
viability was determined and cell proliferation was mea-
sured by CCK-8 assay. Cell apoptosis was identified by
DNA ladder assay, cell TUNEL, TEM and flow-
cytometry. Cell cycle was analyzed by flow cytometry.
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Cell migration and invasion were detected by Tran-
swell. Apoptosis relative Bcl-2 family proteins, NF-KB
pathway proteins, Wnt pathway proteins and MMPs
proteins were ascertained by Western-blot. In addition,
HepG2 cells were injected into nude mice to perform in
vivo experiment. Tumor growth was observed per
week. MRI of tumor-bearing mouse was performed to
observe in vivo tumor size. All mice were sacrificed to
compare tumor volume. Tumor H&E, TUNEL and
TEM were performed to explore the possible mecha-
nisms of tumor shrinkage.
Results: NsPEF could significantly decrease cancer cells
number and viability in vitro. It induced cell apoptosis,
expressed by forming DNA fragmentation, increasing
TUNEL positive cells, presenting mitochondria degener-
ation and apoptotic body. With increased intensity of
nsPEF, cells presented from early apoptosis to late
apoptosis and necrosis, with high expressions of pro-
apoptotic proteins such as Bax, Bak, Bim etc, cyto-
chrome C, and caspase-3, and low expressions of anti-
apoptotic proteins Mcl-1, Bcl-2. NsPEF could inhibit
cell proliferation and stop cell cycle at G1 phase, which
might be through inhibiting NF-KB pathway to reduce
protein expressions of Cyclin-A and Cyclin-D1. It also
decreased migration and invasion ability of cancer cells
via suppressing Wnt pathway including beta-Catenin
and c-Myc proteins to reduce MMPs family proteins
and VEGF expressions. In addition, In vivo experiments
via tumor MRI and visual comparison provided vigor-
ous evidences that nsPEF significantly inhibited tumor
growth. Tumor cell shrinkage, vessels damage, and leu-
cocytes infiltration were observed by H&E stain. Tumor
cell apoptosis was found by tumor TUNEL and TEM.
Conclusion: nsPEF could inhibit cancer growth in vitro
and in vivo via inducing apoptosis, inhibiting prolifera-
tion, inactivating invasion and metastasis, and destroy-
ing tumor microenvironment, which will provide a
novel and effective therapeutic strategy for cancers.
1159
THE CO-CULTURE OF KUPFFER CELL
AND HEPATIC STELLATE CELLS
UNDER THE DIFFERENT
STIMULATING FACTORS
Fan-Pu Ji3, Na Huang2, Hai-Yan Chen2, Rong-Rui
Liang1, Rui Zhou1, Shu Zhang1, Song Ren1, Hai-Tao
Zhu1, Chen Huang2 and Zong-Fang Li1,2
1Department of General Surgery, the Second Affiliated
Hospital, Medical College, Xi’an Jiaotong University,
Xi’an, Shaanxi province, China; 2Biotherapy &
Translational Medicine Engineering Research Center of
Shaanxi Province, Second Affiliated Hospital, Xi’an
Jiaotong University, P. R. China; 3Department of
Infectious Disease, the Second Affiliated Hospital,
Medical College, Xi’an Jiaotong University, Xi’an,
Shaanxi province, China
Background: The relation of hypersplenism due to por-
tal hypertention and hepatic fibrosis become a hot spot.
In this study, we simulate the environment of portal
hypertension in vivo by co-culture to investigate molec-
ular mechanism and effect of spleen affecting the for-
mation of hepatic fibrosis.
Methods: Isolate hepatic kupffer cell (KC) and splenic
macrophage (MΦ) from SD rats. Culture HSC-T6 cell
lines. Prepare culture fluid of kuffer cell and splenic
macrophage with LPS stimulating or not. According to
the different stimulant conditions and cultural methods,
we can divide culturing HSC into six groups: A1
(HSC), A2 (HSC + LPS), B1 (HSC + KCCM), B2
(HSC + KCCM-L), C1 (HSC + MΦCM), C2
(HSC + MΦCM-L). We can divide co-culturing HSC
and into four groups: a1 (HSC + KC), a2
(HSC + KC + LPS), c1 (HSC + KC + MΦCM), c2
(HSC + KC + MΦCM-L). The expression of HSC
TGF-b, PDGF-R and CD38 is detected by laser scan-
ning confocal microscope and flow cytometry. And the
expression of IL-6 is detected by ELISA.
Results: After adding LPS, the expression of HSC
TGF-b, PDGF-R, CD38 and culture liquid IL-6 in
co-culture group(a1, a2, c1, c2) are significantly higher
than in control group(A1, A2, C1, C2). The expression
in the stimulant liquid of splenic macrophage group is
highest in all. The changing trend of various index is
c2 > a2 > B2 > C2.
Conclusion: MΦCM-L could activate the HSC by its
direct or indirect stimulation. And the indirect action
which is realized with the stimulation of KC has the
dominant position. When the MΦCM-L is present, it is
more activated. Spleen could promote the formation of
hepatic fibrosis.
1164
COMPARISON OF RADIOFREQUENCY
ABLATION AND SURGICAL
RESECTION IN PATIENTS WITH
SOLITARY HEPATOCELLULAR
CARCINOMA WITHIN 5 CM: A ME
Hao Cai, Tie Zhou and Yu-Dong Qiu
Department of Hepatobiliary Surgery, Nanjing Drum
Tower Hospital, The Affiliated Hospital of Nanjing
University Medical School, Zhongshan Road 321,
Nanjing 210008, China
Background and aims: Tumor size, tumor number and
liver function were important prognostic factors in
patients with hepatocellular carcinoma (HCC). It is
widely accepted that for HCC  3 cm, radiofrequency
ablation (RFA) is equivalent to surgical resection (SR),
in spite of tumor number and liver function. And it
remains controversial for HCC  5 cm.
Methods: Databases were searched for comparative
studies on RFA versus SR published from 2005 to
2012. A Meta-analysis was performed using a random-
ized or fixed effect model to compare the treatment effi-
cacy between RFA and SR.
Results: 5 studies fulfilled our criteria and were
included. For patients with solitary HCC  5 cm,
RFA was equivalent to SR for 1-, 3- and 5-year overall
survivals (OS) (p > 0.05). However, SR was superior to
RFA for 1-, 3- and 5-year disease-free survivals (DFS)
(p < 0.05). Higher local recurrence rate was associated
with RFA than SR.
Conclusions: For solitary HCC  5 cm, RFA can
achieve comparable overall survival as SR, though with
higher recurrence rate and lower disease-free survival.
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HEPATOCELLULAR CARCINOMA
PRESENTED AS SPONTANEOUS
RETROPERITONEAL BLEEDING-
IMAGING
Tay Kon voi and Iyer Shridhar
Hepatopancreatobiliary division, Department of Surgery,
National University Hospital, Singapore
Introduction: HCC can have various clinical presenta-
tions. We present one case of locally advanced segment
VI HCC which caused right retroperitoneal bleed.
History: 52 year old gentleman who presented with
non specific right sided abdomen pain and progressive
drop of haemoglobin found to have right sided large
retroperitoneal hematoma. CT scan showed large retro-
peritoneal hematoma 5 9 6 9 7 cm with bleeding. Fur-
ther angiogram showed multiple blood supply of the
hematoma region with no active bleeding hence angi-
oembolisation withheld. Initial impression was ruptured
retroperitoneal tumor such as adrenal. Patient was trea-
ted conservatively as his Hb and haemodynamic stable.
Patient subsequently underwent staged elective surgery
to remove the ruptured tumour and final histology
showed poorly differentiated HCC.
Imaging: Figure 1 and 2: Large right retroperitoneal
haematoma
1166
THE ALTERATION OF SPLEEN IN
MURINE TRANSPLANTABLE LIVER
CANCER
Baohua Li2, An Jiang1, Zong-Fang Li1, Rong-Rui
Liang1, Hong-Tao Ren3, Yuan-Yuan Ji2, Kun-Lun
Chen1 and Jing-Sen Shi2
1Department of General Surgery, the Second Affiliated
Hospital, Medical College, Xi’an Jiaotong University,
Xi’an, Shaanxi province, China; 2Biotherapy &
Translational Medicine Engineering Research Center of
Shaanxi Province, Second Affiliated Hospital, Xi’an
Jiaotong University, P. R. China; 3Department of
Oncology, the Second Affiliated Hospital, Medical
College, Xi’an Jiaotong University, Xi’an, Shaanxi
province, China
Background/Aims: Splenectomy can either promote or
inhibit tumor growth; the role and the mechanism of
spleen in tumor immunology are still unclear. In the
present study, we aimed to describe the alteration of
spleen and discuss the significance of alteration during
tumor growth.
Methods: H22 transplantable liver cancer was estab-
lished in BALB/c mice. Spleen weight and index as well
as the histology were observed, and the percentage of
myeloid-derived suppressor cell (MDSC) in spleen was
also detected by flow cytometry in 1 week, 2 weeks and
3 weeks after tumor challenge.
Results: The mean survival time of tumor-bearing mice
was 21 day. Spleen weight and index increased 1 week
after tumor challenge, then declined in 2 weeks later,
and were significantly lower than that in the control
group after 3 weeks (p < 0.05). The hematoxylin and
eosin (H&E)-stained spleen sections from tumor-bear-
ing mice also revealed an abnormal splenic architecture
including red pulp hyperplasia and no boundary
between white pulp and red pulp. The percentage of
splenic MDSC was elevated in the course of tumor
growth. It reached to 16.0, 3.58% after 3 weeks of
tumor challenging compared to 2.55, and 0.07% in the
control group (p < 0.05).
Conclusions: Our data demonstrated spleen weight and
index were decreased and the percentage of immune
inhibitory cell MDSC increased in the late stage of
tumor, indicating spleen may play a negative immune
function and promote tumor progression.
Acknowledgements: This work was supported by a
grant from Program for changjiang Scholars and Inno-
vative Research Team in University (PCSIRT: 1171)
and the Kwang-Hua Education Foundation of Xi’an
Jiaotong University.
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BAICALEIN-INDUCED ENHANCEMENT
ON MMC-RELATED CYTOTOXICITY IN
HEPATOMA CANCER CELLS VIA DNA
DAMAGE REPAIR PATHWAY
Rong-Rui Liang1, Peng An2, Kun-Lun Chen1, Ju-Nan
Qi3, Yuan-Yuan Ji2, Yan-Song Pu1, Chen Huang2 and
Zong-Fang Li1,2
1Department of General Surgery, the Second Affiliated
Hospital, Medical College, Xi’an Jiaotong University,
Xi’an, Shaanxi province, China; 2Biotherapy &
Translational Medicine Engineering Research Center of
Shaanxi Province, Second Affiliated Hospital, Xi’an
Jiaotong University, P. R. China; 3Baoji Central
Hospital, Baoji, Xi’an, Shaanxi province, China
Background/Aims: Causing DNA damage in the form
of DNA cross-links as well as a variety of DNA mono-
adducts, which is a serious damage to chromosomal
DNA that blocks key DNA metabolisms including DNA
replication and transcription is the major mechanism of
mitomycin (MMC)-induced cytotoxicity. Activation of
DNA damage repair (DDR) signaling is a common con-
sequence in cancer cells underwent MMC treatment.
Hence, inhibiting key proceeds in DNA repair-related
cell cycle checkpoint could enhance DNA damage-related
chemotherapy. Baicalein is a flavonoid derived from the
root of Scutellaria baicalensis. Our previous investigation
suggested that Baicalein could enhance the cytotoxicity
effect induced by MMC, leaving the mechanism uncle-
ared. This study was aimed to investigate the mechanism
of Baicalein-induced chemo-sensitising effect.
Methods: HepG2 cells were treated with MMC along
or combine Baicalein, MTT assay and Annexin V/PI
staining was executed to detect Baicalein-induced
chemo-sensitise effect in MMC treatment. Western-Blot
was performed to investigate the alteration of key
moleculars in DDR pathway caused by Baicalein.
Result: The combined treatment of Baicalein and
MMC inhibits proliferation of HepG2 cells in a syner-
gistic manner. MMC could increase Rad51 protein
level in HepG2 cells while Baicalein could decline the
expression of Rad51 in a dose-dependent way. More-
over, Baicalein suppresses MMC-elicited phosphory-
lated ATR and Rad50 protein levels.
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Conclusions: Our study reported that Baicalein
enhanced MMC-induced cytotoxicity on HCC cancer
cells. Furthermore, our data indicated that the mecha-
nism of Baicalein-induced chemo-sensitise effect was
based on suppressing DDR activity in HCC cancer
cells.
Acknowledgements: This work was supported by a
grant from Program for changjiang Scholars and Inno-
vative Research Team in University (PCSIRT: 1171)
and the Kwang-Hua Education Foundation of Xi’an
Jiaotong University.
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THE PREVENTION AND TREATMENT
OF INTRA-ABDOMINAL
HEMORRHAGE POST SPLENECTOMY
AND LINEAR STAPLER PERICARDIAL
DISCONNECTION ON PORTAL
HYPERTENSION
Zong-Fang Li1,2, An Jiang1, Shu Zhang1, Zhi-Dong
Wang1, Rui Zhou1, Jian Zhang1, Rong-Rui Liang1,
Zhen-Gan Yang1 and Bao-Tai Wang1
1Department of General Surgery, the Second Affiliated
Hospital, Medical College, Xi’an Jiaotong University,
Xi’an, Shaanxi province, China; 2Biotherapy &
Translational Medicine Engineering Research Center of
Shaanxi Province, Second Affiliated Hospital, Xi’an
Jiaotong University, P. R. China, Xi’an, China
Aim: To introduce a self-designed method, the linear
stapler pericardial disconnection in treating portal
hypertension, and to evaluate the prevention and treat-
ment of intra-abdominal hemorrhage post operation.
Method: The clinical data from 142 patients with por-
tal hypertension undergoing linear stapler pericardial
disconnection from Nov 1998 to Oct 2012 were ana-
lyzed retrospectively.
Results: All the patients had liver cirrhosis due to viral
hepatitis; 27 patients belonged to Child’s classification
degree A (19.0%), 94 to degree B (66.2%), and 21 to
degree C (14.8). Emergency operation was performed in
9 cases, 36 cases were submitted to prophylactic surgery,
and the rest to selective operation. The operations were
performed smoothly, without operative mortality. There
were 7 cases suffer Intra-abdominal Hemorrhage post
the operation. 3 cases suffer errhysis from drainage tube,
3 cases have a hematocele in abdominal cavity. 1 case
haemorrhage from drainage tube incision. 1 case expired
because of hepatic failure; other cases were cured (4
cases conservative treatment, 2 cases operation).
Conclusions: The “linear stapler pericardial disconnec-
tion” is a convenient and effective procedure for the
treatment of portal hypertension. It deserves further
study in order to be popularized in clinical practice.
The main reasons of Intra-abdominal Hemorrhage post
the operation were the patients have thrombocytopenia,
lesser clotting factors and higher portal vein pressure.
The main prevention method was correct hypercoagula-
ble state according thrombelastography before opera-
tion; exact hemostatic at easy bleeding site (spleen
pedicle, gastric short blood vessels, gastric coronary
veins and splenorenal ligament). Conservative
treatment was available to intra-abdominal errhysis
(<50 ml/h) and operation should be performed in intra-
abdominal hemorrhage (>50 ml/h). Vascular emboliza-
tion or laparotomy hemostatic should be selected, and
individualized treatment was advocated.
Acknowledgements: This work was supported by a
grant from Health industry special scientific research
(201002015).
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RETRIEVING A LARGE HCC
LAPAROSCOPIC LIVER RESECTION
SPECIMEN THROUGH A SMALL
PERIUMBILICAL INCISION: HOW WE
DID IT!
Anil K Agarwal
Department of GI Surgery, GB Pant Hospital & MAM
College, Delhi University, New Delhi, India
Video Abstract: Traditionally hepatectomy specimen
needs an incision congruous with the resected specimen
to retrieve the specimen without mutilating and com-
promising on the pathological examination. The video
depicts a large 8–10 cm lesion in the segment III of the
Liver in an elderly gentleman. The tumor was resected
with an adequate margin. The specimen was then put
in a bag and retrieved through a small periumbilical
incision without mutilation and compromising on the
resected edge for histopathological examination.
1176
SURGICAL TREATMENT FOR
CHRONIC RELAPSING PANCREATITIS
Shunichi Takahata, Takao Otsuka, Junji Ueda and
Masao Tanaka
Department of Surgery and Oncology, Kyushu
University, Fukuoka, Japan
Background: Chronic relapsing pancreatitis often needs
surgical treatment. We report the series of patients need
surgery for chronic pancreatitis especially focused on
patients needed repeated surgical treatment.
Patients: Ninety-four patients diagnosed as chronic
pancreatitis and underwent pancreatic surgery from
1992 to 2010 were included.
Results: Thirty four decompression surgery were per-
formed including 34 pancreato-jejunostomies and 17
cysto-enterostomies. As a pancreatic resection, 17 pan-
creatic head resections and 22 distal pancreatectomies
were chosen. Most of the cases had scheduled opera-
tion for chronic pain; however, We had 3 emergent
operation for hemorrhagic shock, and 7 quasi-emergent
case for enlarged pseudocyst or pseudoaneurysm. As a
less invasive surgery, duodenum preserving pancreatic
head resection or pancreas head resection with second
portion duodenectomy were performed. 3 distal pan-
createctomies and 4 cysto-enterostomies were laparo-
scopically operated. Among 34 patients had
pancreatojejunostomy, 4 cases needed additional treat-
ment including 3 reoperative surgery.
Conclusions: Patients with chronic pancreatitis have
various etiology or clinical course and need careful
evaluation to be operated.
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SUCCESSFUL EN-BLOC RESECTION OF
METASTATIC HCC WITH IVC
REPLACEMENT AND LEFT RENAL
VEIN RE-IMPLANTATION
Deok-bog Moon, Sung Gyu Lee, S Hwang, Cheol Soo
Ahn, Ki Hun Kim, Tae Yong Ha, Gi Won Song,
Dong Hwan Jung and Gil Chun Park
Hepato Biliary Surgery and Liver Transplantation, Asan
Medical Center, University of Ulsan College of
Medicine, Seoul, South Korea
Background: Surgical resection of metastatic HCC can
be indicated in selective patients. The most important
life threatening cause in HCC patient is not the extra-
hepatic metastasis but the status of liver tumor or liver
function. Hence, regardless of extensive extrahepatic
metastasis, better outcome can be expected after surgi-
cal resection if complete resection resection is secured
under well-controlled liver tumor and well-preserved
liver function. Herein we report successful en-bloc
resection of metastatic HCC involving right adrenal
gland and kidney, IVC and massive adjacent para-arot-
ic lymph node with IVC replacement and left renal vein
re-implantation.
Patient and method: The patient was 54 year-old male
patient with HBV-related chronic hepatitis. 21 months
before admission, HCC occurred in the liver and
successfully treated with radiofrequency ablation.
11 months before admission, metastasis of HCC was
suspected at right adrenal gland and adjacent para-
arotic lymph node, but HCC was absent in the liver.
Radiotherapy was performed, but the tumor enlarged
and invaded right kidney and renal vein. Additionally
IVC thrombus and conglomerated para-aortic lymph
nodes enlargement was noted on admission. AFP and
PIVKA II level and liver function were normal
range. For en-bloc removal of the metastatic tumor,
Kocherization was performed first, and then IVC was
isolated at supra- and infra-renal side, and left renal
vein was also isolated. Right adrenal vein was
divided after right-side mobilization of the liver.
Under veno-venous bypass, en-bloc removal of the
conglomerated metastatic tumors were possible and
resected IVC was replaced with 25 mm diameter.
Dacron graft and left renal vein was re-implanted to
the replaced IVC.
Result: The operation time was 13 h 40 min and the
3 units of packed RBC was transfused. Urine output
and serum creatinine level were maintained well during
operation and postoperative recovery. Pathology of
the resected specimen revealed metastatic HCC. He
was discharged without complication on postoperative
20 days. Follow-up CT scan on postoperative
4 months showed patent vasculature and absence of
tumor.
Conclusion: Favorable outcome could be expected after
en-bloc resection of metastatic HCC when the patient
had well controlled HCC in the liver and preserved
liver function.
1180
APPLICATION OF TOTALLY
LAPAROSCOPIC ROUX-EN-Y
ANASTOMOSIS FOR THE TREATMENT
OF BILIARY TRACT OR PANCREATIC
DISEASES
Chun Hua, Yue-Ming Sun, Jian-Feng Bai, Zan Fu,
Wen-Xiong Lu, Chun-Hua Xi, Yi Shi and Yong Wang
Department of Minimally Invasive Surgery, the First
Affiliated Hospital of Nanjing Medical University,
Jiangsu Province, Nanjing, China
Objective: To explore the application of totally laparo-
scopic Roux-en-Y anatomosis for the treatment of bili-
ary tract or pancreatic diseases.
Method: 50 cases with choledochal cyst and 6 cases
with pancreatic pseudocyst were analyzed retrospec-
tively, who underwent laparoscopic total cyst excision
with Roux-en-Y hepatojejunostomy and Roux-en-Y
anastomosis of pancreatic pseudocyst with jejunum
between May. 2004 and Feb. 2012 in our hospital.
Results
All operations were completed successfully with totally
laparoscopic surgery. Mean duration of operation was
110 min, and average introperative bleeding was 45 ml.
All cases were recovered smoothly without stenosis of
anastomotic stoma, biliary fistula or pancreatic fistula.
Average stay was 9 days. Fever, jaundice, pancreatitis,
ankylenteron and other complications were never
occurred in patients in postoperative follow-up. There
was no intra-or postoperative complication.
Conclusion: Totally laparoscopic Roux-en-Y anastomo-
sis was effective, practical, safe and minimally invasive
procedure. Familiarity of intro-operative anatomic
structure, exposure of operative field and perfect tech-
nique of suture are the key points to operational
success.
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THE COMMON CAUSES OF
HYPERSPLENISM AND
PERIOPERATIVE MANAGEMENT OF
SPLENECTOMY
Zong-Fang Li1, An Jiang1, Fan-Pu Ji2, Rong-Rui
Liang1 and Shu. Zhang1
1Department of Surgery, the Second Affiliated Hospital,
School of Medicine, Xi’an Jiaotong University, Xi’an,
China; 2Department of Infectious Disease, the Second
Affiliated Hospital, School of Medicine, Xi’an Jiaotong
University, Xi’an, China
Abstract: According to the causes of hypersplenism, it
can be divided into primary and secondary categories.
The primary hypersplenism are found in some hemopa-
thy (congenital hemolytic anemia, thrombocytopenic
purpura, primary splenic granulocytopenia, et al). Most
of hypersplenism was secondary hypersplenism, for
example: the infectious diseases (typhia, rubella, septi-
cemia, virus hepatitis, et al), silting hemorrhagic disease
(portal hypertension, hemosiderosis, congestive heart-
failure, et al), metabolic disease (Gaucher’s disease,
Niemann-Pick disease, et al), malignant tumor diseases
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(Hodgkin’s disease, chronic granulocytic leukemia, lym-
phoma, et al), and some other diseases (Vaqueez-Os-
ler’s disease, splenic artery aneurysm, primary
myelofibrosis, et al). In our country, the most common
cases of hypersplenism were cirrhotic portal hyperten-
sion. Splenectomy is still the preferred method for the
treatment of hypersplenism. The perioperative manage-
ment of splenectomy has its own characteristics: preop-
erative assessment and preparation include liver
function, coagulation function, anemia, hypoprotein-
emia, and thrombocytopenia, et al. The disease had a
higher complication rate and the correct intraoperative/
postoperative treatments can reduce the incidence of
complications. Surgical procedures should been selected
based on portal venous pressure and some pathologic
change. The most common postoperative complications
include: intraperitoneal hemorrhage, humoral imbal-
ance, portal vein thrombosis, refractory thrombopenia,
upper gastrointestinal hemorrhage et al. In brief, strict
preoperative assessment, careful preoperative prepara-
tion, skillful surgery operation, timely postoperative
treatment, and individual treatment are the keys to get
the best efficacy in patients with hypersplenism.
Acknowledgements: This work was supported by a
grant from Health industry special scientific research
(201002015).
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PRELIMINARY QUANTITATIVE STUDY
ON OBSTRUCTIVE JAUNDICE BY
REAL-TIME ULTRASOUND
ELASTOGRAPHY
Yin-Xia Li, Jun-Feng Hong and Jia Guo
The ultrasound department of Eastern Hepatobiliary
Surgery Hospital, 225 Changhai Rd, Shanghai, China
Background: Obstructive jaundice can cause the change
of liver stiffness, and real-time ultrasound elastography
with Strain Histogram Measurement Function is a
promising quantitative method for detecting liver dif-
fuse disease.
Objective: To investigate the preliminary quantitative
application value of obstructive jaundice by real-time
ultrasound elastography with Strain Histogram Mea-
surement Function.
Methods: 86 patients with obstructive jaundice were
enrolled and divided into mild, moderate, high levels of
jaundice according to the clinical total bilirubin (TB)
index, besides, 35 patients without jaundice or with
invisible jaundice as control group. ALL of them were
underwent real-time ultrasound elastography and the
liver MEAN and blue area percentage (% AREA) were
measured by Strain Histogram Measurement Function.
Results: The liver MEAN and %AREA had statistical
differences among the control group, the research
group and all levels of jaundice; a negative correlation
between the MEAN and the jaundice levels (Spearman,
s correlation coefficient r = 0.5, p < 0.000) and a
positive correlation between the %AREA and the jaun-
dice levels (Spearman, s correlation coefficient r = 0.5,
p < 0.000) were detected.
Conclusion: Real-time ultrasound elastography with
Strain Histogram Measurement Function could reflect
the degree of obstructive jaundice, the MEAN and %
AREA can be used as quantitative reference index of
evaluating obstructive jaundice degree.
Key words: Real-time ultrasound elastography;
Obstructive jaundice; MEAN; %AREA
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THE DIAGNOSTIC VALUE OF PET/CT
IMAGING IN HEPATIC ALVEOLAR
ECHINOCOCCOSIS AND ITS BIOLOGY
BOUNDARY
Yong-De Qin
Department of nuclear medicine, the first affiliated
hospital, Xinjiang Medical University, Urumqi, China
The diagnostic value of PET/CT imaging in hepatic
alveolar echinococcosis and its biology boundary
Abstract: Objective: To analysis the biology boundary
of the hepatic alveolar echinococcosis with PET/CT
and improve the diagnostic value of PET/CT compared
with pathology.
Methods: The patients who were certified hepatic alve-
olar echinococcosis, 13 cases in our hospital (male: 5
cases, female: 8 cases, the age is between 41  24 years
old) 17 lesions in total have taken the PET/CT examin-
ations. All the patients underwent surgical treatment.
Makes the analysis to the performance of PET/CT
imaging, and then compared with the pathology.
Results: The distribution of radiotracer is Non-uni-
form in the liver, and sometimes, there is no uptake
of radiotracer in the lesion, but around the lesion, the
uptake is obvious, so, 18F-FDG can draw the biology
boundary of the lesion, and then to show the charac-
teristics of radiopharmaceuticals uptake in the bound-
ary. SUVmax values between 3.5  1.1, showing the
characteristics of biological activity. 2 h later, the
delayed phase showed that the up-taking of radiophar-
maceuticals is increased, SUVmax values between
4.6  0.9, the SUV values of every lesion increase
than initial phase. Do the Statistical analysis between
the biology boundary of hepatic alveolar echinococco-
sis and the Pathology, Sensitivity: 83.33% (10/12)
specificity: 60% (3/5) accuracy: 76.47% (13/17),
positive: 83.33% (10/12), negative: 60% (3/5)
Conclusions: Not only can be detected the lesion loca-
tion, shape, number, border, calcification and the sur-
rounding tissue but also can be s diagnostic value for
the activity characteristics of the lesions development
process, the prognosis. The diagnosis of around metas-
tases of echinococcosis, screening and diagnosis of dis-
tal metastasis of echinococcosis, can be provided earlier
and effective diagnostic value.
Key words: Echinococcosis; Radiopharmaceuticals;
Biology boundary; Positron
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ROLE OF TRYPSIN-PROTEASE
ACTIVATED RECEPTOR-2 PATHWAY
IN PANCREATIC CANCER PAIN
Zhi-Jie Lu1, Xue-Rong Miao1, Hai Zhu1, Xue-Feng
Sun2, Da-Wei Yu1, Hai-Bo Qiu1 and Wei-Feng Yu1
1Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Road, Shanghai 200438, China; 2First Affiliated
Hospital to PLA General Hospital, Beijing 100037,
China
Background and aims: Rapid and effective treatment of
pain in pancreatic cancer remains a clinical challenge.
The protease activated receptor-2 (PAR-2) plays a criti-
cal role in many aspects of nociceptor function. There-
fore, we investigated the potential role of trypsin-PAR-
2 pathway in pancreatic cancer pain.
Methods: Pancreatic carcinoma specimens (n = 22)
and matched control samples (n = 28) were obtained
from patients with pain who underwent surgery at
Eastern Hepatobiliary Surgery Hospital. Supernatants
from pancreatic carcinoma specimens were used for
activation of cultured DRG neurons and for evocation
of peripheral nociception in rats after intra-paw injec-
tion. The animal model by orthotopic injection of
SW1990 cells in nude mice was used for determination
of the role of trypsin-PAR-2 in pancreatic cancer
pain.
Results: Pancreatic carcinoma specimens from release
increased levels of trypsin compared to normal con-
trols. Specimens from pancreatic cancer patients (but
not controls) released mediators that sensitized rat sen-
sory neurons in culture. Sensitization was prevented by
a serine protease inhibitor FUT-175 and PAR-2 antag-
onist peptide. Specimens from pancreatic cancer
patients, but not controls, also caused somatic hyperal-
gesia and allodynia in mice, when administered into the
paw. These pronociceptive effects were inhibited by
FUT-175 and a PAR-2 antagonist. Pain behaviors in
pancreatic cancer pain mice induced by SW1990 cells
were alleviated by PAR-2 antagonist peptide.
Conclusions: These findings suggest that trypsin-PAR-2
pathway plays a role in the development and mainte-
nance of pancreatic cancer pain.
1207
DECREASED EXPRESSION OF TH17
TYPE CYTOKINES CONTRIBUTES TO
SUPPRESSION OF ACUTE REJECTION
FOLLOWING ORTHOTOPIC LIVER
TRANSPLANTATION IN A
SUBCUTANEOUS ALVEOLAR
ECHINOCOCCOSIS RAT MODEL
Jiang Wu1,3, Tao Li2, Ren-Yong Lin1, Jin-Min Zhao2,
Jun-Hua Wang1, Ling Wang3, Rui Ling3, Jun Yi3,
Shi-Fang Yuan3 and Hao Wen1,2
1Xinjiang Key Laboratory of Echinococcosis and
Medical Research Center, First Affiliated Hospital of
Xinjiang Medical University, Urumqi, Xinjiang, China;
2Department of Vascular Endocrine Surgery, Xijing
Hospital, Fourth Military Medical University of Chinese
PLA, Xi’an 710033, Shaanxi Province, China;
3Department of Digestive-Vascular Surgical center, The
First Affiliated Hospital of Xinjiang Medical University,
Urumqi, Xinjiang China
Background: For end-stage hepatic alveolar echinococ-
cosis (HAE) patients, orthotopic liver transplantation
(OLT) is the best scheme to save lives. Rejection of
allograft for HAE patients have been found to be dif-
ferent from general allograft after liver transplantation
(LT). Th17 cytokines have been associated with
immune rejection in the study of LT.
Methods: The recipient BN rats were divided into two
groups (for E.m + ROLT group and E.m  ROLT
group). Half rats (30 rats) were injected subcutaneously
with protoscoleces, and underwent injecting 3 months
later. Six recipient rats of each group were euthanized
randomly at the 1st, 3rd, 5th and 7th days post-trans-
plant. Interleukin-17 (IL-17) mRNA of liver allografts
was measured by SYBR Green I real-time RT-PCR,
IL-17 positive cell ratio of liver by immunohistochemis-
try, IL-17 expression in serum by ELISA. Serumal
interleukin-23 (IL-23) and transforming growth factor
beta (TGF-b) also were detecting.
Results: Allograft rejection, as evaluated by liver func-
tion, survival time of liver allograft and RAI score of
histology, proved that the model of ROLT was success-
ful and E.m + ROLT recipients prolonged the survival
of liver allograft, compared with E.m  ROLT group.
Real-time RT-PCR, immunohistochemical staining and
serumal detecting showed that the expression of IL-17
was lower in E.m + ROLT group, and escalate more
tardily compared with E.m  ROLT group. Experi-
mental results of serumal IL-23 level which was similar
to IL-17 have been detected by ELISA. Relational
serumal TGF-b deficiently showed promotional role in
facilitating IL-17 expression.
Conclusions: The present study data showed Echinococ-
cus multilocularis (E.m) prolongs the survival of liver
allograft. Explanation of this scientific phenomena is
probably due to the minor expression of IL-17 and IL-
23, and insufficient promotion of IL-17 expression by
TGF-b may be implicated in the mechanism
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1211
EMERGENCY PROXIMAL
LIENORENAL SHUNT (LRS) FOR
VARICEAL BLEEDING IN PATIENTS
WITH EXTRAHEPATIC PORTAL
VENOUS OBSTRUCTION (EHPVO)
Nihar Ranjan Dash1, Vivek Mangla2, Sujoy Pal1,
Peush Sahni1, S. K. Acharya1, Tushar Kanti
Chattopadhyay2 and Samiran Nundy3
1All India Institute of Medical Sciences, New Delhi,
India; 2Institute of Liver and Biliary Sciences, New
Delhi, India; 3Sir Gangaram Hospital, New Delhi, India
Background: We have previously shown that that LRS
is a safe and effective (95% 15-year survival) one-time
procedure for variceal bleeding in patients with
EHPVO. While endotherapy is preferred for the man-
agement of acute variceal bleeding, patients who fail to
respond to endotherapy need emergency surgical inter-
vention. We analyzed our results of emergency LRS in
this cohort.
Methods: All patients with EHPVO who had under-
gone emergency LRS for acute variceal bleed not
responding to conservative measures including endo-
therapy were included.
Results: Between 1975 and 2010 we operated upon 965
patients with EHPVO of whom 55 underwent emer-
gency surgery. Fifty of these patients had an LRS
done, 32 were males and their mean (SD) age was 17.3
(8.9) years (range 3–42). They had been symptomatic
for 3 months to 25 years and had had a mean of 3.9
episodes of bleeding (range 1–18) requiring a mean of
9.5 units of blood transfusion (range 2–30 units). 3
(6%) patients had associated gastropathy and 3 (6%)
had biliopathy. Preoperative endotherapy was done in
19 of them while 31 were taken up for surgery without
any endoscopic intervention. Three patients died (6%),
4 had an early re-bleed (8%) and 1 a late re-bleed
(2%). Five patients were re-explored, one for an early
re-bleed and the four others for other surgical compli-
cations. The mean postoperative hospital stay was
12 days and none of the patients developed encepha-
lopathy over a mean follow up period of 109 months
(range 24–364).The liver function was normal. In com-
parison to elective setting the emergency rescue proce-
dure carried higher mortality (1.1 vs. 6%), re-bleed rate
(7.6% vs. 10%), need for transfusion (6.5 vs. 18.96%)
and need for further endotherapy (8.4 vs. 10%). The
reduction in varices was similar to the outcome of elec-
tive procedure.
Conclusion: Compared with our published experience
with elective LRS, the emergency LRS for control of
acute variceal bleeding has a higher operative mortality,
an almost similar re-bleed rate. Hence, the LRS is a
safe and effective therapeutic option for control of
acute variceal bleeding in patients with EHPVO.
1218
TREATMENT EXPERIENCE OF
ASYMPTOMATIC COMMON BILE
DUCT STONE IN LAPAROSCOPIC
CHOLECYSTECTOMY
Hai-Bo Yu, Lei Chen and Xiao-Dao Jin
Department of Hepatobiliary Surgery, Dingli Clinical
College, Wenzhou Medical College, Wenzhou 325000,
China
Objective: To summarize and discuss the experience of
asymptomatic common bile duct stone in laparoscopic
cholecystectomy.
Methods: The clinical data of 26 patients who were
found asymptomatic common bile duct stone in laparo-
scopic cholecystectomy were retrospective analyzed.
Results: Laparoscope operation was successfully com-
pleted in 24 cases (92.3%), whereas a conversion to
open surgery was required in 2 cases (7.7%). There was
no significant postoperative complication such as bile
leakage, bleeding or infection.
Conclusions: Good command of operative technique,
combined with endoscope and intraoperative cholangi-
ography, laparoscope operation for treating asymptom-
atic common bile duct stone in laparoscopic
cholecystectomy is safe and feasibility.
1220
CDKN1A AND CDKN1B
POLYMORPHISMS AND
HEPATOCELLULAR CANCER RISK IN
A CHINESE HAN POPULATION
Fei Liu, Yong-Gang Wei, Wen-Tao Wang, Lv-Nan
Yan, Tian-Fu Wen, Ming-Qing Xu, Jia-Yin Yang and
Bo Li
Department of Liver Surgery, West China Hospital,
Sichuan University, 37 Guo Xue Road, Chengdu,
Chengdu/Sichuan Province, China
Background: CDKN1A and CDKN1B are members of
the Cip/Kip family of cyclin-dependent kinase inhibi-
tors, which can arrest cell proliferation and serve as
tumor suppressors. We hypothesized that genetic vari-
ants in CDKN1A and CDKN1B may modify individ-
ual susceptibility to hepatocellular carcinoma (HCC).
Methods: To test this hypothesis, we evaluated the
associations of the polymorphisms of Ser31Arg and
C+20T in CDKN1A and C-79T and Gly109Val in
CDKN1B, as well as their combinations, with HCC
risk in a case-control study of 476 HCC cases and 526
cancer-free controls in a Chinese population. The
matrix-assisted laser desorption ionization time-of-flight
(MALDI-TOF) mass spectrometry method was per-
formed to detect these polymorphisms.
Results: We found that the variant genotypes of
CDKN1A Ser31Arg and CDKN1B C-79T were indi-
vidually associated with a significantly increased risk of
HCC, but no associations were observed for other vari-
ant genotypes. Moreover, the combined variant geno-
types of the four loci were associated with a
significantly increased HCC risk (adjusted OR = 2.24,
95% CI = 1.72, 2.91 among subjects carrying three or
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more variant alleles), especially among HbsAg-positive
individuals (adjusted OR = 3.09, 95% CI = 1.86, 5.14).
Furthermore, the combined variant genotypes of the
four loci (carrying three or more variant alleles)
increased a 1.93-fold (95% CI = 1.20, 3.09) and 1.76-
fold (95% CI = 1.17, 2.64) risk of HCC among smok-
ers and nonsmokers. The variant genotypes of the two
genes in this study have negative correlation with the
clinicopathologicals observed.
Conclusion: These results suggest that CDKN1A poly-
morphisms individually or in combination with
CDKN1B polymorphisms increases risk of HCC, par-
ticularly among HbsAg-positive individuals.
1223
EFFECT OF REPRESSOR EXPRESSION
OF MIR-155 ON APOPTOSIS AND
PROLIFERATION OF HUMAN
PANCREATIC CANCER CELL LINE SW-
1990
Xin Zhao1, Liang Yu2 and Hua Zhao1
1Department of General Surgery, The First Affiliated
Hospital of Soochow University, Suzhou 215006, China;
2Department of General Surgery, The Second People’s
Hospital of Changshu City, Changshu 215000, China
Background and aims: To detect and analyze the
impact on proliferation and apoptosis of SW-1990 cells
in vitro by inhibiting the expression of the miR-155,
and the effect of the expression of predict target pro-
teins TP53NP1 to this cell lines on proliferation and
apoptosis.
Methods: (1) To detect the expression of miR-155 in
four pancreatic cancer cell lines PANC -1, SW-1990,
BxPc3, Patu8988 by use of stem-loop primers SYBR-
GREE I real-time quantitative PCR. The lipofecta-
mineTM 2000 and FAM-NC-inhibitor were mixed in dif-
ferent proportions then transfected into SW-1990 cells.
Transfection efficiency was detected by flow cytometry.
(3) The inhibition of miR-155 expression was measured
by stem-loop primers SYBR-GREE I real-time quantita-
tive PCR. The expression of predict target proteins
TP53NP1 was measured by Western blot. (4) Cell viabil-
ity in different time was assayed by CCK-8. The apopto-
sis and cell cycle of SW-1990 cells on each group was
measured by flow cytometry in 48 h after transfection.
Results: (1) Among pancreatic cancer cell line PANC-
1, SW-1990, BxPc3, Patu8988, the expression of miR-
155 in SW-1990 is relatively high. (2) After experimen-
tal exploration, the best transfection efficiency was
98.6%. (3) The expression of miR-155 of miR-155-
inhibitor repressor group, was significantly downregu-
lated (p < 0.05), and the predicted target proteins
TP53NP1 significantly increased (p < 0.05). (4) Com-
pared with the control group, and NC-inhibitor group,
SW-1990 cells proliferation rate of mir-155-inhibitor
group obviously slowed down. The apoptosis rates of
experimental groups were 15.7  0.52(miR-155-inhibi-
tor group), 2.47  0.45(control group), 3.17 0 .35
(NC-inhibitor group), respectively. The apoptosis rate
of miR-155-inhibitor group was significantly higher
than other groups (p < 0.05). The cells of miR-155-
inhibitor group most stranded in G0/G1 phase by the
cell cycle detection with the cell flow cytometric.
Conclusion: The proliferation of SW-1990 cell
decreased and the apoptosis of SW-1990 cell increased
after downregulation of miR-155. The expression of
predicted target protein TP53NP1 upregulation and the
cell cycle most stranded in G0/G1 phase after downre-
gulation of miR-155. The inhibition of targeting
miR-155 can be seen a potential measure in pancreatic
cancer.
1225
EFFECT OF RNAI-MEDIATED GENE
SILENCING OF MCL-1 ON APOPTOSIS
OF HUMAN PANCREATIC CANCER
CELL LINE PANC-1
Xin Zhao, Xu Zhang and Hua Zhao
Department of General Surgery, The First Affiliated
Hospital of Soochow University, Suzhou 215006, China
Background and aims: By RNAi technology Mcl-1 in
human pancreatic cancer cell line PANC-1 was specifi-
cally knocked down with siRNA, then detect and ana-
lyze the impact on proliferation and apoptosis of
PANC-1 cells in vitro. From this research we hope to
provide the experimental foundation for gene treatment
of the pancreatic cancer.
Methods: 1 The lipofectamineTM 2000 and FAM-NC-
siRNA were mixed in different proportions then trans-
fected into PANC-1 cells. Transfection efficiency was
detected by flow cytometry, and then select the best
transfection conditions. 2 The inhibition of Mcl-1
expression was measured by reverse transcription PCR
(RT-PCR) and Western blot after transfecting siRNA
(Mcl-1). 3 Cell viability in different time after transfec-
tion was assayed by MTT and then drew the growth
curve of each experimental group. The apoptosis of
PANC-1 cells each experimental group was measured
by flow cytometry in 48 h after transfection.
Results: 1 After experimental exploration, the best
transfection efficiency was 87.5%. 2 The Mcl-1 mRNA
and protein of siRNA (Mcl-1) group were significantly
downregulated (p < 0.05). This effect reached a peak at
48 h after transfection then declined. 3 Compared with
the control group, liposome group and NC-siRNA
group, PANC-1 cells proliferation rate of siRNA (Mcl-
1) group obviously slowed down. 4 The apoptosis rates
of experimental groups 48 h after transfection were
measured by flow cytometry. The apoptosis rates of
experimental groups were 14.6  0.36% (siRNA (Mcl-
1) group), 4.1  0.35 (control group), 4.2  0.41 (lipo-
some group), 4.4  0.26 (NC-siRNA group), respec-
tively. The apoptosis rate of siRNA (Mcl-1) group was
significantly higher than other groups (p < 0.05).
Conclusions: Liposome-mediated siRNA (Mcl-1) can
efficiently inhibit the expression of Mcl-1 in PANC-1.
The proliferation of PANC-1 cell decreased after down-
regulation of Mcl-1 and the apoptosis of PANC-1 cell
increased after downregulation of Mcl-1. The RNAi
targeting Mcl-1 can be seen a potential measure in
pancreatic cancer.
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1226
SURGICAL OUTCOMES AND
PROGNOSTIC FACTORS OF
INTRAHEPATIC
CHOLANGIOCARCINOMA
Shao-Jun Zhou, Zhi-Yong Huang and Xiao-Ping Chen
Department of Surgery, Research Laboratory and
Hepatic Surgery Center, Tongji Hospital, Tongji
Medical College, Huazhong University of Science and
Technology, Wuhan, China
Objective: Although curative resection was the only
chance of cure in patients suffering from intrahepatic
cholangiocarcinoma (ICC), the prognostic factors of
ICC following resection remains controversial. The pur-
pose of this study was to analyze the surgical outcomes
and prognostic factors of a cohort of patients with ICC
undergoing resection.
Methods: The clinicopathological data of 93 patients
with ICC undergoing resection between January 2003
and November 2009 were retrospectively reviewed. The
variables including age, sex, hepatitis B virus infection,
cirrhosis, tumor marker, tumor size, number of tumors,
vascular invasion, bile duct thrombi, lymph node
metastasis, perineural invasion, tumor cell differentia-
tion, AJCC staging and resection margin were analyzed
by using the Kaplan–Meier method and Cox hazard
models. The correlation between CA19-9 expression
and clinicopathological factors was analyzed using the
v2 test and a logistic regression model.
Results: The cumulative 1-, 3- and 5-year survival rates
of the entire cohort were 67.7%, 40.2% and 30.2%,
respectively. Univariate analysis revealed that curative
resection, high preoperative CA19-9 level ( 200 U/
mL), AJCC staging, tumor size (> 5 cm) and lymph
node metastasis were statistically significant factors.
Multivariate analysis further showed that curative
resection (RR: 3.3; p < 0.001), high preoperative CA19-
9 level ( 200 U/mL) (RR: 2.825; p < 0.001), and
AJCC staging (RR: 1.56; p = 0.007) were independent
prognostic factors. Among 69 patients who underwent
curative resection, the 1-, 3- and 5-year disease-free sur-
vival rates were 62.3%, 40.0% and 30.7%, respectively,
and the 1-, 3- and 5-year overall survival rates were
84.1%, 48.7% and 38.1%, respectively, with a median
survival of 36 months. High preoperative CA19-9 level
( 200U/mL) was an independent dismal prognostic
factor for recurrence (RR: 3.038; p = 0.001) and overall
survival (RR: 3.433; p < 0.001) after curative resection.
The rate of lymph node metastasis in the CA19-9
( 200 U/mL) group was significantly higher than that
in the CA19-9 (< 200 U/mL) group (OR: 4.538;
p = 0.008).
Conclusions: Curative resection is the most effective
treatment for ICC. High preoperative CA19-9 level
( 200 U/mL) is significantly associated with lymph
node metastasis and poor surgical outcomes.
1227
HEPATIC RESECTION FOR MULTIPLE
HEPATOCELLULAR CARCINOMA LESS
THAN 5 CM: A PROSPECTIVE
COMPARATIVE STUDY
Wei-Feng Shen1, Lu Wu2, Hui Dong3, Cheng-Jun Sui1,
Bing-Hua Dai1, Rong-Xi Shen1 and Jia-Mei Yang1
1Department of Special Treatment, Eastern
Hepatobiliary Surgery Hospital, Second Military
Medical University, Shanghai, China; 2The First
Department of Interventional Radiology, Eastern
Hepatobiliary Surgery Hospital, Second Military
Medical University, Shanghai, China; 3Department of
Pathology, Eastern Hepatobiliary Surgery Hospital,
Second Military Medical University, Shanghai, China
Background: Treatment of multiple hepatocellular car-
cinoma (HCC) remains a critical issue. In addition, the
prognosis and prognostic factors of multiple HCC after
hepatic resection are not well documented, especially
prospectively.
Methods: The clinicopathologic and follow-up data of
81 patients who underwent curative resection of HCC
between January 2008 and January 2009 were prospec-
tively collected. These patients were categorized accord-
ing to the size of the largest tumor: group A (n = 40,
two or three HCCs with maximum tumor diameter
>3 cm and  5 cm) and group B (n = 41, two or three
HCCs with maximum tumor diameter  3 cm). The
two groups were compared for clinicopathologic data
and survival results.
Results: The 1-, 2-, 3-, and 4-year survival rates of
group A were 75.0%, 58.0%, 50.0%, and 44.0%,
respectively, while the survival rates of group B were
93.0%, 80.0%, 66.0%, and 47.0%, respectively. The 1-,
2-, 3-, and 4-year disease-free survival rates of group A
were 43.0%, 30.0%, 23.0%, and 15.0%, respectively,
comparing to 71.0%, 54.0%, 44.0%, and 36.0% in
group B, respectively. The median overall cumulative
survival time of group A and group B were 36.0 and
44.5 months, respectively (p = 0.322). The median dis-
ease-free survival time of group A was 10.0 months
and was significantly shorter than that of group B
(30.0 months, p = 0.011).
Conclusions: Resection may provide comparative sur-
vival benefits even for patients with multiple HCCs
with maximum tumor diameter > 3 cm and  5 cm.
1230
TOTAL LAPAROSCOPIC
MANAGEMENT OF RECURRENT
PYOGENIC CHOLANGITIS
Jain Amit, Gupta Nikhil, Javed Amit and Anil K
Agarwal
Department of GI Surgery, GB Pant Hospital & MAM
College, Delhi University, New Delhi, India
Background: Recurrent pyogenic cholangitis (RPC) is a
common disease in East Asia. The treatment of intrahe-
patic duct (IHD) stones in these patients is challenging,
as their complete removal is difficult. Reports of lapa-
roscopic surgery for IHD stones have, until now, been
rare with most studies including patients with stones
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confined to the common bile duct and up to the biliary
bifurcation. We present our experience of two patients
of IHD stones operated laparoscopically with stones
beyond the secondary biliary radicles
Methods: Two patients with a diagnosis of recurrent
pyogenic cholangitis were operated laparascopically.
Longitudinal choledochotomy (infrahilar) done, CBD
and intrahepatic duct stones were retrieved using stone
holding forceps, IHD stones were retrieved using flush-
ing, balloon fogartization and the use of choledocho-
scope. A complete cholangiogram was performed intra-
op to confirm completion of procedure and roux limb
hepatico-jejunostomy was performed laparoscopically
with a subcutaneous access loop.
Results: Both patients were females of age 35 and
36 years, with chief complaint of pain abdomen with
two episodes of jaundice in one patient. MRI was sug-
gestive of diffuse stone disease with multiple CBD
stones and diffuse IHD stones beyond the secondary
biliary radicles. None of the patients had liver atrophy
or biliary cirrhosis. IHD stones were retrieved using
flushing, balloon fogartization and choledochoscopy.
Roux en Y hepatico-jejunostomy was performed in
both the cases with an access loop. The entire proce-
dure including HJ and JJ was completed laparoscopi-
cally. Average duration of surgery was 4 h and mean
blood loss was 200 mL. There was no postoperative
bile leak with an average hospital stay of 4 days.
Conclusion: Laparoscopic hepaticolithotomy and hepa-
tico-jejunostomy with an access loop is a safe and effec-
tive method for the management of patients with
recurrent pyogenic cholangitis with intrahepatic calculi.
1235
RAT HEPATIC STELLATE CELLS
ALTER THE GENE EXPRESSION
PROFILES AND PROMOTE THE
GROWTH, MIGRATION, INVASION OF
HEPATOCELLULAR CARCINOMA
CELLS IN VITRO
Zhi-Ming Wang and Sheng-Long Ye
Zhongshan Hospital, Institute of Liver Cancer, 180
Fenglin Road, Shanghai 200032, Shanghai, China
Background and aims: Recently, studies suggested that
hepatic stellate cells (HSCs) play a great role in the
progression of hepatocellular carcinoma (HCC). This
part was to investigate the induction-activated HSCs
(iHSC) with tumor-conditioned medium (CM) alter the
gene expression profiles and promote the growth,
migration, invasion of HCC cells in vitro through the
mechanisms including release of paracrine factors.
Methods: Rat HSCs were isolated from rat livers by
perfusion of collagenase and pronase, followed by cen-
trifugation over percoll density gradient. We prepared
rat McA-RH7777 hepatoma cells CM and induced
HSCs activation in vitro. The iHSCs were collected and
co-cultured with McA-RH7777 cells in transwell
systems. We compared the gene expression profiles of
co-cultured McA-RH7777 cells with the control McA-
RH7777 cells. 28,728 gene expression was analyzed by
cDNA microarray, and confirmed by real time poly-
merase chain reaction and Western blot analysis. We
prepared iHSC CM, and investigated wether iHSC CM
promote the growth, migration, invasion of HCC cells
in vitro through the experiments, such as CCK-8 (cell
count kit-8), scratch repair, transwell invasion. The
cytokines of supernatant in the co-cultured McA-
RH7777 cells and the control McA-RH7777 cells were
assayed by ELISA and compared.
Results: 573 genes were differentially expressed in the
co-cultured McA-RH7777 cells and control McA-
RH7777 cells with more than two-fold up/down-regu-
lated (among them, 432 genes were up-regulated and
141 genes were down-regulated), including cell surface
receptors, metabolic process, cell adhesion moleculars,
signal transduction molecules, chemokines and immu-
nity factors. By the release of paracrine factors from
iHSC, some genes in the co-cultured McA-RH7777
cells were up regulated such as Tapbp, Ccl2, Cxcl1,
Cxcl10, Junb, Igf1, Stat1, Irf1, Irf7, Irf9 and Csf1, and
some genes including 4-Sep, Cck, Pdgfra, Itgae, Cd36
were specifically down-regulated. iHSC also promote
the growth, migration, invasion of hepatocellular carci-
noma cells in vitro through release of paracrine factors.
Compared with the control McA-RH7777 cells, some
cytokines of supernatant were increased in the co-cul-
tured McA-RH7777 cells, such as HGF, IL-6, MMP-2,
MMP-9.
Conclusions: iHSCs can alter the gene expression pro-
files and promote the growth, migration, invasion of
HCC cells in vitro through the release of paracrine fac-
tors. The above suggested that iHSC play a major role
in HCC during growth, and metastasis.
1240
CLONAL ORIGIN OF RECURRENT
HEPATOCELLULAR CARCINOMA
DETERMINED BY LOSS OF
HETEROZYGOSITY OF
MICROSATELLITES
Wen-Ming Cong1, Bin Wang1, Hui Dong1, Xin-Yuan
Lu1 and Meng-Chao Wu2
1Department of Pathology, Eastern Hepatobiliary
Surgery Hospital, Second Military Medical University,
Shanghai, China; 2Department of Surgery, Eastern
Hepatobiliary Surgery Hospital, Second Military
Medical University, Shanghai, China
Background and aims: Recurrent hepatocellular
carcinoma (RHCC) is a major challenge to current
practice of hepatic surgery. The present study is aimed
to determine the clonal origin of and its clinical signifi-
cance.
Methods: By using tissue microdissection-based DNA
extraction and PCR-single strand conformation poly-
morphism (PCR-SSCP) assay, 15 high-frequency of
loss of heterozygosity of DNA microsatellites were
determined on 60 matched pairs of RHCC from 40
patients who underwent liver re-resections. The rela-
tionship between the origin of clonal patterns of the
tumors and the surgicopathological features was evalu-
ated.
Results: Of the 60 pairs of RHCC, a total of 19 pairs
(31.7%) showed varied LOH patterns, and the clonal
origin of the tumors was multicentric occurrence (MO-
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type) in 14 pairs (23.3%) and intrahepatic metastasis
(IM-type) in 46 pairs (76.7%). In the 14 pairs of MO-
type RHCC from 12 patients, 8 patients had one and
four patients had two recurrent nodules at the second
operation. All patients who had  3 recurrent nodules
were IM-type. LOH was detected in all the 15 selected
microsatellites with a mean frequency of 37.5% (26.8–
47.9%). Overall, there were six sub-molecular clonal
patterns of RHCC revealed in this study. The clinico-
pathological features, including the recurrent time,
tumor size, vascular invasion, histological grading, and
associated chronic liver diseases in patients with MO-
type RHCC were significantly different from those with
IM-type RHCC (p < 0.05–0.001). There was a signifi-
cant difference in disease-free survival between patients
with MO-type and IM-type RHCC (33.8  4.5 vs.
14.2  2.5 months, p = 0.001).
Conclusions: The disease-free survival for patients with
MO-type RHCC was better than those with IM-type
RHCC. The current study proposed that RHCC exists
six kinds of subtypes in the clonal origin by microsatel-
lite-based LOH detection, which we think has the
advantages of being specific and reliable, and is suitable
to be used as a routine approach for clonal analysis.
Our results supported that liver re-resection, if techni-
cally possible, is the first-line treatment of choice for
MO-type RHCC. As the clonal subtypes of RHCC can
only be determined by molecular approaches, we rec-
ommend that microdissection-based microsatellite LOH
protocol be made routinely in surgical pathology to
assess the clonal origin of recurrent HCCs and to
evaluate the clinical outcome and mode of treatment of
patients with RHCC more accurately.
1241
MIDDLE-PRESERVING
PANCREATECTOMY FOLLOWED BY
REVERSED-
PANCREATOGASTROSTOMY
Bibek Aryal, Teruo Komokata, Jun Kadono, Hiroyuki
Motodaka, Hidetaka Kawamura, Yuichi Shimamoto,
Kota Yoshikawa and Iwao Kitazono
Department of Cardiovascular and Gastroenterological
Surgery, Kagoshima University Graduate School of
Medical and Dental Science, Kagoshima, Japan
Background: Middle-preserving pancreatectomy (MPP)
is a parenchyma-preserving procedure when the pancre-
atic body is spared from disease. Variability exists in
the method of anastomosis with the remnant pancreas.
Aim: To show the surgical technique for MPP and an
alternative method for the pancreatic anastomosis,
so-called reversed-pancreatogastrostomy (RPG).
Methods: A 79-year-old woman was diagnosed for a
carcinoma of the lower bile duct and a branched-type
IPMN in the tail of the pancreas by CT-scan, MRI/
MRCP, and ERCP. A subtotal stomach preserving
pancreaticoduodenectomy was performed followed by a
pancreatic tail resection with a splenectomy. Mobiliza-
tion of the proximal stump of the pancreas was impos-
sible because of an inadequate length of the pancreatic
remnant and fixation of the pancreatic remnant to the
surrounding vasculature and tissues. The distal (left
side) stump with a lost stent was anastomosed to the
stomach by invagination method.
Results: The patient developed pancreatic fistula on
Grade B at the proximal stump of the pancreatic rem-
nant, and recovered with conservative management.
After a year of surgery patient had normal endocrine
and exocrine functions.
Conclusions: MPP is a useful procedure for resecting
multifocal lesions in the head and tail of the pancreas.
RPG is a feasible method for pancreatic reconstruction
after MPP.
1250
PROSPECTIVE RANDOMIZED STUDY
OF GLUCOCORTICOIDS IN THE
IMPACT OF THE LIVER FUNCTION
AND THE PROGNOSIS AFTER
HEPATECTOMY OF
HEPATOCELLULAR CARCINOMA
Jian Zhai, Xiong Cai, Shu-Ping Qu, Yi-Jun Zhang,
Xu-Tao Chen and Dong Wu
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Road, Shanghai, China
Background: Liver ischemia-reperfusion injury occurs
in a number of clinical settings, including liver surgery,
transplantation, and circulatory shock, leading to sig-
nificant morbidity and mortality. Perioperative steroid
administration has been advocated to reduce liver dam-
age. The aim of this prospective, randomized study was
to determine whether steroid administration can reduce
liver injury and impact the prognosis.
Methods: Sixty patients of the primary liver cancer
undergoing liver resection were randomized to steroid
group or control group. Patients in the steroid group
received 100 mg of hydrocortisone sodium succinate
postoperatively once a day for 5 days, Serum levels of
alanine aminotransferase (ALT), aspartate aminotrans-
ferase (AST) and total bilirubin were compared
between the two groups. Length of stay and type and
number of complications were recorded as well. On the
other hand, the rate of disease-free survival was
compared between the two groups by follow-up.
Results: The total bilirubin level on postoperative day
3, 5 was significantly lower in the steroid group than in
control group (p = 0.016, p = 0.032, respectively).
However, the postoperative time courses of the ALT
level and the AST level were no significant difference
between the two groups. There was no significant dif-
ference between the two groups in the proportion of
patients with complications (26.7% vs. 36.7%,
p = 0.405) or the rate of the disease-free survival
(p = 0.965).
Conclusion: The hydrocortisone sodium succinate may
reduce the lever of total bilirubin, and the steroid has
protective effect during the liver resection. The gluco-
corticoid has no affect on the recurrence of the hepato-
cellular carcinoma.
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1253
APPLICATION OF LIVER GRAFTS
FROM MARGINAL DONOR
Yi-Tao Ding1,2 and Chun-Ping Jiang1,2
Department of Hepatobiliary Surgery, The Affiliated
Drum Tower Hospital of Nanjing University Medical
College, Nanjing, China
Aims: To discuss the effect of marginal donor on post-
operative liver function and prognosis in liver trans-
plantation and to share our experience of perioperative
care in these cases.
Methods: We analyzed 37 marginal donor liver trans-
plantation cases (steatosis: 16 cases, aged donors: 3
cases, prolonged ischemia: 5 cases, HBV positive: 8
cases, ABO incompatible: 3 cases and donation after
cardiac death: 2 cases) carried out in our center and
compared with 31 control cases of normal donor liver
transplantation. Postoperative liver function, prothrom-
bin time (PT), ICU stay days, the incidence of donor
liver initial poor function/primary nonfunction(IPF/
PNF) and 1 year survival rate were summarized and
compared between marginal donor cases and control
cases.
Results: We found no significant deviation between
marginal donor cases and control cases in all of ana-
lyzed parameters (p > 0.05).
Conclusions: With proper perioperative care, the appli-
cation of marginal donor liver in the situation of organ
shortage may have similar therapeutic efficacy with
normal donor liver transplantation.
1257
STUDY ON THE PHENOTYPIC
IDENTIFICATION AND
TUMORIGENICITY OF ABCG2+
HEPATOCARCINOMA
Chun-Ping Jiang, Hong-Buo Jiao and Yi-Tao Ding
Department of Hepatobiliary Surgery, The Affiliated
Drum Tower Hospital of Nanjing University Medical
College, Nanjing, China
Objective: Using the axenic flow sorting method
selected ABCG2 positive and negative cells after mark-
ing by ABCG2 antibody, and testing two by stem cell
phenotype of CD44, CD90, CD133 differences
ABCG2-positive and ABCG2-negative cells isolated
from the human hepatoma cell line, culture will be two
groups of cells cross-reference to a certain concentra-
tion of cells inoculated into nude mice armpit, observ-
ing two tumor differences.
Methods: (1) By flow cytometry detection of ABCG2
expression in hepatoma cell line SMMC-7721 level, to
assess whether flow cytometry sorting; (2) SMMC-7721
cells of the human ABCG2 monoclonal antibody logo,
elected to the sterile flow sorting method ABCG2-posi-
tive and ABCG2-negative cells, sub-elect cells were cul-
tured until the cells have a certain number were
detected ABCG2-positive and-negative cells ABCG2
expression rates; (3) detection of ABCG2-positive and-
negative cells in the stem cell phenotype of CD44,
CD90 and CD133 expression rates; (4) the sorting of
cells to cross-reference, respectively, according to a cer-
tain concentration of inoculation to nude armpit, regu-
lar observations of tumor formation time, tumor size,
time of death and whether the transfer.
Results: (1) Human hepatoma cell line SMMC-7721
cell lines in the ABCG2 positive expression rate of
about 8.8%, and optional for flow cytometry sorting;
(2) after sorting by flow cytometry culture passaged 3–
4 times ABCG2-positive cells ABCG2 expression rate
of about 12.7%, while the negative cells ABCG2
positive expression rate of less than 2%; (3) of CD44
expression in positive cells and negative cells no differ-
ence; about 5.2% of the expression of CD90-positive
cells; about 0.2% of the expression of CD90-negative
cells; approximately 14.3% of the expression of CD133
positive cells in the expression of negative cells is about
2.9%; (4) sorting after the cells were inoculated to nude
armpit of ABCG2-positive cells in tumor formation
than negative cells as early as the high rate of tumor
formation, tumor volume greater.
Conclusion: SMMC-7721 cell line expression of
ABCG2, stem cell markers of CD90 and of CD133
negative cells in the ABCG2-positive cells compared
with enrichment of ABCG2-positive cells in the tumor
was significantly higher than ABCG2-negative cells.
Tip ABCG2 positive cells with stem cell properties.
Thus, ABCG2 may be a sign of liver cancer stem cells
1261
THE EXPRESSION OF ABCG2 IN
HUMAN LIVER CANCER CELL LINES
AND ITS RELATED FUNCTIONS
Qiang Guang, Chun-Ping Jiang and Yi-Tao Ding
Department of Hepatobiliary Surgery, The Affiliated
Drum Tower Hospital of Nanjing University Medical
College, Nanjing, China
Methods: 1) The expression of ABCG2 in four liver
cancer cell lines – PLC/PRF/5,7721,7402,7701 was
detected by flow cytometry. The cell line which
expressed the highest ABCG2 was investigated further.
2) The growth inhibiting to 5-FU and adriamycin of
the four cell lines were examined by MTT. 3) To detect
the location and expressed rate of the ABCG2 expres-
sion in the cell line by using the immunofluorescence
staining. 4) To observe the shape of the ABCG2 cells
by using the immunohistochemical staining. 5) Using
the axenic flow sorting method selected ABCG2 posi-
tive and negative cells after marked much more cells by
ABCG2 antibody, then subcultured. When the two
subpopulations increased much more, we detected the
expression of ABCG2 of the two subpopulations and
clone formation ability in the common media. We
observed the difference of function between the
ABCG2 positive and negative cells with the growth
curve, the inhibitory rate to 5-FU and adriamycin and
the cell cycles.
Results: 1) The expression of ABCG2 was highest in
7721, the positive rate of ABCG2 ranged from 15% to
30%, and the ABCG2-positive and-negative cells have
clear bimodal; 2) IC50 of the cell line 7721 to 5-FU
and adriamycin is higher; 3) fluorescence microscopy
revealed the ABCG2 expressed green fluorescent in the
membrane, the expressed rate is about 5–12%; 4) after
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immunohistochemical staining, the ABCG2 was located
in the membrane and cytoplasm as brown. The shape
of cells was round, and smaller; 5) culture and passage
3–4 times after sorting by flow cytometry, the expres-
sion rate of ABCG2-positive cells about 30%, whereas
the negative cells ABCG2 expression rate was about
2–5%. the rate of drugs inhibited of positive cells
were lower than the negative cells. Cell cycle analysis
showed that the ABCG2 positive cells had more
quiescent cells.
Conclusion: Different liver cancer cell lines have differ-
ent ABCG2 expressed rates, the 7721 cell line has sig-
nificantly higher expression, and the ABCG2-positive
and-negative cells have clear bimodal. The IC50 value
of 5-FU and doxorubicin in the 7721 cell line is slightly
higher. Suggest that the ABCG2 positive cells may con-
tain the liver stem cells. The ABCG2-positive and nega-
tive cells have slightly different in colony formation
assay, growth curve, and the drugs inhibited, but no
statistical significance. It prompted that some of
ABCG2 cells with stem cell characteristics. ABCG2
may be one of liver cancer stem cell marker.
1278
PARTIAL HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA IN
ELDERLY PATIENTS: A
RETROSPECTIVE CASE-CONTROL
STUDY
Kui Wang, Zhen-Lin Yan, Le-Hua Shi, Yong Xia,
Jun Li, Guang-Hua Liu, Yang Liu, Feng Shen and
Meng-Chao Wu
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, China
Background and Aims: The outcome of partial hepatec-
tomy in cirrhotic patients has improved remarkably in
recent years; however, the role of age is still uncertain.
The aim of this study was to elucidate surgical out-
comes of hepatectomy in eldly patients.
Methods: Data from 16915 consecutively patients who
underwent curative resection for hepatocellular carci-
noma were retrospectively collected and analyzed:
patients were divided into 2 groups according to the
age whether  (n = 718) or < (n = 16197) 70 years old
at the time of surgery. To overcome biases owing to
the different distribution of covariates throughout the 2
groups, a one-to-one match was created: after match,
intraoperative, and postoperative course and survival
rates were analyzed.
Results: The eldly patients experienced better preopera-
tive liver function p < 0.05) and similar survival rates
(p = 0.051) in comparison to those younger: after one-
to-one matching, patients with (n = 412) and without
portal hypertension (n = 412) had the same preoperative
characteristics and showed the same intraoperative
course, postoperative occurrence of liver failure, morbid-
ity, length of in-hospital stay and survival rates (p = ns
in all cases). The only predictors of postoperative liver
failure were liver function (p < 0.001), comorbidities
(p < 0.001) and extent of hepatectomy (p = 0.006).
Conclusions: Eldly HCC patients showed less inflam-
mation and better preservation of liver function,
indicating that facing with the same hepatic function
and extent of hepatectomy planning, the eldly should
not be considered as a contraindication for hepatic
resection in HCC patients.
1280
ONE CENTER’S EXPERIENCE:
SURVIVAL ANALYSIS OF 194 CASES OF
LIVER TRANSPLANTATION FOR
PRIMARY HEPATOCELLULAR
CARCINOMA
Jia-Bin Zhang, Zhen-Hua Bi, Yue-Bo Ren, Lin Wang,
Min Zhang and Zhen-Wen Liu
The Liver Transplantation Center of 302 Hospital of
PLA, Beijing, China
Background and aims: To investigate the significance of
orthotopic liver transplantation in the management of
primary hepatocellular carcinoma (PHC); To evaluate
the survival and prognostic factors of liver transplanta-
tion for PHC.
Methods: The clinical data from 194 consecutive PHC
patients who underwent OLT were retrospectively ana-
lyzed.
Results: The 1-year, 3-year and 5-year cumulative sur-
vival rates of the 194 patients were 92.78%, 78.07%
and 64.29%. The integrality of tumor TNM stage
(p = 0.026667), tumor diameter (p = 0.0045), tumor
number (p = 0.0318), vascular invasion (p = 0.006059),
and AFP level before transplantation (p = 0.003426)
were significantly related with tumor recurrence; Multi-
variate analysis revealed that tumor diameter
(p = 0.0081, OR = 0.789, 95% CI wei[2.1233, 6.124]),
vascular invasion (p < 0.001, OR = 5.928, 95% CI wei
[1.173, 86.789]), and AFP level before transplantation
(p = 0.019, OR = 2.601, 95% CI wei[2.196, 5.658]) were
independent risk factors for tumor recurrence. The dif-
ferences in survival rate, tumor-free survival rate were
statistically significant between Milan criteria group
and beyond-UCSF criteria group (p < 0.01), and
between UCSF criteria group and beyond-UCSF crite-
ria group (p < 0.01). The differences in survival rate,
tumor-free survival rate were not statistically significant
between Milan criteria group and UCSF criteria group
(p > 0.05).
Conclusion: Liver transplantation is an effective treat-
ment for PHC; The tumor diameter>8 cm, vascular
invasion and AFP level significantly affect the survival
of PHC patients.
1281
ROLE OF Β-CATENIN IN REGULATING
THE BALANCE BETWEEN TNF-Α- AND
FAS- INDUCED ACUTE LIVER INJURY
Shan-Shan Zou, Wen Yang, Le-Xing Yu, He-Ping Hu
and Hong-Yang Wang
Eastern Hepatobiliary Surgery Institute/Hospital, 225
Changhai Rd, Shanghai, 200438 Shanghai, China
Background and Aims: Acute liver failure is a life
threatening clinical syndrome associated with devastat-
ing consequences. B-Catenin, the main component of
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the canonical Wnt signaling pathway, plays many criti-
cal roles during various liver physiological and patho-
logical processes. However, the role of B-Catenin in
acute liver failure has not been fully investigated.
Methods: This study examined the role of B-Catenin in
D-galactosamine and LPS (GalN/LPS) and Fas-
induced experimental acute liver failure using hepato-
cyte specific B-Catenin knockout mice. The extent of
liver injury was assessed by histopathology, serum ami-
notransferase levels, TUNEL staining and Western
blot.
Results: Hepatocyte-specific knock-out of B-Catenin
significantly reduced GalN/LPS-induced elevation of
serum alanine aminotransferase levels, liver damage
and hepatocyte apoptosis. Furthermore, mice with B-
Catenin?deficient hepatocytes showed stronger NF-?B
transcription activity, resulting in reduced oxidative
stress level in liver after GalN/LPS treatment. Con-
versely, overexpression of B-Catenin in vitro inhibited
TNF-A mediated NF-?B activation, aggravating TNF-
A-induced oxidative stress and cell death. Interestingly,
hepatocyte-specific knockout of B-catenin exacerbated
Jo2-mediated liver injury. The mechanism by which ?
1284
A PROSPECTIVE CLINICAL STUDY
FOR THE SURGICAL RETRACTOR
MADE OF THE POLYMER MATERIALS
FOR MEDICINE
Fang-Rui Wang, Jian-Min Qian, Qian-Wei Wang and
Zhen-Yu Ma
Huashan Hospital Affiliated to Fudan University, 12
Wulumuqizhong Rd, Shanghai, 200032, China
Background and aims: Exposure is half of the battles,
but the current used surgical retractors are with compli-
cated structures and also with the risks of cross-infec-
tion since they are repeated used. Now we invented the
one-time used surgical retractor made of the polymer
materials for medicine. This study is to observe the
mechanic characteristics and clinical results of self-help
surgical retractor.
Methods: Use tensile testing device to do the mechanic
test with the self-help surgical retractor and the medal
abdominal retractor, measuring the change of traction
and displacement when the two kinds of tractor were
under different initial traction, and received continuous
traction. We also compare the clinical results of the
two retractors.
Results: The mechanic test show that the left traction
of self-help surgical retractor decreased with time, the
average left traction decreased by 10%–13% after 1 h.
In the clinical test, there were 120 patients in total, with
60 in experimental group and 60 in control group. In
the experimental group, surgeons gave 50/60 (83.3%)
very good evaluation. In the analysis of perioperative
clinical results, there were no difference between the
two groups. The VAS paining score of the experimental
group and the control group was 2.6  0.65 and
4.1  0.45 (p < 0.05), 6 months after operation, the
incidence of chronic paining was 20/60 (33.3%) and 44/
60 (73.3%), and duration was 1.8  1.19 months
and 3.7  1.84 months (P < 0.01). The spending of
instrument cleaning of the experimental group was sig-
nificantly less.
Conclusions: The self-help surgical retractor was evalu-
ated well in the clinical use, and it was similar with the
abdominal retractor in clinical profits, but it reduced
the incidence of wound infection and significantly
reduced the extent and duration of paining.
1285
PIVOTAL ROLE OF ANTISECRETORY
FACTOR PROTEIN IN
HEPATOCELLULAR CARCINOMA
DEVELOPMENT
Wen Sun, Tao Han, Dai-Min Xiang, Huan-Lin Sun,
Xue Wang, Heng-Yu Li, Jin Ding and Hong-Yang
Wang
International Cooperation Laboratory on Signal
Transduction, Eastern Hepatobiliary Surgery Hospital,
Second Military Medical University, 225 Changhai Rd,
Shanghai, China
Background/aims: Liver cancer is a malignant tumor
with dismal prognosis, and half patients with HCC
reside in China. Up to now, surgical resection remains
as the primary treatment for patients with HCC. For
those with severe liver cirrhosis, however, alternative
therapy is desirable due to poor physical condition.
Recent findings suggested that aberrant expression of
oncogenes and growth factors were closely related with
malignant tranformation and metastatic invasion of
hepatoma cells, but effective therapeutic targets of
HCC remain obscure. Therefore, it is urgent to illus-
trate the mechanism underlying hepatocarcinogenesis
and elicit target for prevention therapies as well as
prognostic markers. AF (antisecretory factor protein) is
an important protein involved in ubiquitin-proteasome
system. Our previous studies on mRNA expression
microarray of 70 cases of para-tumor tissues and tumor
samples of HCC patients demonstrated that AF was
aberrantly over-expressed in HCC tissues. However, the
mechanism underlying AF-mediated hepatocellular car-
cinoma (HCC) remains elusive. This study aims to
investigate the role of AF in the malignance of hepato-
mas, and evaluate the effect of AF interference in the
suppression of HCC cells.
Methods: Tissue microarray was utilized to evaluate
the correlation between AF expression and HCC malig-
nant status in HCC patients. Changes of HCC malig-
nance was detected by cck8, colony formation and flow
cytometry assay using AF interference.
Results: AF was remarkably overexpressed in human
HCCs. The levels of AF protein expression closely cor-
related with the malignant status of hepatoma in HCC
patients. Down-regulation of AF protein in hepatoma
cells significantly inhibited their malignancy.
Conclusions: AF plays important role in HCC develop-
ment, and AF interference could be a novel strategy
for HCC therapy.
1288
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1293
THE CLINICOPATHOLOGICAL
SIGNIFICANCE AND CLONAL ORIGIN
OF COMBINED HEPATOCELLULAR-
CHOLANGIOCARCINOMA
Qian Zhao, Wen-Long Yu, Wen-Ming Cong and Chao
Wu
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, China
Background and aims: Combined hepatocellular cho-
langiocarcinoma (CHC) is a rare form of primary liver
cancer, showing a mixture of hepatocellular and biliary
features. Data suggest that most CHC arise from hepa-
tic progenitor cells (HPCs). The aim was to investigate
the origin of CHC.
Methods and results: We microdissected multiple HCC
and CC foci and studied frequency of loss of heterozy-
gosity (LOH), Of the 16 cases studied, 16 cases showed
identical allelic losses between HCC and CC foci, indi-
cating the single clonal derivation. The cumulative
recurrence rates and survival rates in the CHC group
were lower than those in the HCC group and higher
than those in the CC group.
Conclusions: The HCC-CC group has distinct clinico-
pathologic features compared with the HCC or CC
groups. In addition, the CHC group has a prognosis
that is better than the CC group but worse than the
HCC group. They potentially derive from HPCs.
1303
REPORT OF 2 CASES OF
CONVENTIONAL INSTRUMENTS
TRANSUMBILICAL SINGLE PORT
LAPAROSCOPIC SPLENECTOMY
Zhi-Wei Sun, Zhen-Hao Fei, Du-Fu Kang and
Jian-Zhong Tang
Department of Hepatobiliary Surgery, The First
Hospital of Yunnan Province, KunMing, China
Explore the clinical feasibility of transumbilical
approach single port laparoscopic splenectomy.
Methods: Implementation of a transumbilical single
hole laparoscopic splenectomy on two cases of idio-
pathic thrombocytopenic purpura patients. 3 cm skin
incision in the umbilical doinga long right-to-left, side
by side, were placed in 12 mm, 10 mm trocar and a
5 mm trocar core. The spleen periodontal ligament lig-
asuer cutting off, splenic pedicle GIA 60-3.5 mm
straight.
Results: The successful completion of the 200–240 min
splenectomy, bleeding 150–200 mL 10 days after hospi-
tal discharge, and follow-up with no complications.
Conclusions: The umbilical single hole laparoscopic
spleen removal is safe and feasible, less invasive,
recover faster beauty and other advantages.
1304
SOLID-PSEUDOPAPILLARY TUMOR
OF THE PANCREAS: A CASE REPORT
Ye-Sheng Chen, Zhi-Wei Sun and Chun-Cheng Meng
Department of Hepatobiliary Surgery, The First
Hospital of Yunnan Province, KunMing, China
We report a case of the solid-pseudopapillary tumor of
the pancreas (SPTP), which is considered to be a rare
pancreatic tumor. In contrast to other pancreatic
tumors, SPTP has a favorable prognosis, it has a low
malignant potential. These tumors are typically present
in women in 20–30 years. Ultrasound, computed
tomography and magnetic resonance imaging are
widely used in diagnosis. It is very important to make
the diagnosis preoperatively because with an adequate
surgical resection the prognosis is good.
1311
ASSOCIATION OF MITOCHONDRIAL
DNA CONTENT IN PERIPHERAL
BLOOD LEUKOCYTES WITH RISK OF
HBV-RELATED HCC IN A CHINESE
HAN POPULATION
Nai-Jian Ge1, Ye-Fa Yang1, Lu Wu1, Shu-Qun Shen1,
Jun Liang1, Yi-Jun Zhang1, Si-Yuan Zhao2,
Han-Qiang Liu2 and Jin-Liang Xing2
1Department of Interventional Radiology 1, Eastern
Hepatobiliary Surgery Hospital, The Second Military
Medical University, Shanghai 200438, China; 2Biology &
Department of Cell Biology & Cell Engineering Research
Center, Fourth Military Medical University, Xi’an
710038, China
Increasing epidemiological evidence has indicated that
inherited variations of mitochondrial DNA (mtDNA)
content could affect the genetic susceptibility of many
malignancies in a tumor-specific manner. However, the
association between mtDNA content and hepatocellular
carcinoma (HCC) risk remains undetermined. In this
study, we measured mtDNA content of peripheral
blood leukocytes (PBLs) using quantitative real-time
polymerase chain reaction (PCR) in a case-control
study consisting of 274 HCC cases, 126 non-cancer
patient controls with chronic liver diseases (CLD) and
258 healthy controls. We found that HCC cases had a
significant lower mtDNA content than CLD controls
[median (range): 0.77 (0.17–2.30) vs. 0.84 (0.32–3.37);
p = 0.012] and healthy controls [0.77 (0.17–2.30) vs.
0.84 (0.35–3.44); p = 0.035]. There was no difference in
mtDNA content between CLD and healthy controls
[0.84 (0.32–3.37) vs. 0.84 (0.35–3.44); p = 0.261]. We
further assessed the association between mtDNA con-
tent and HCC risk and found that compared to indi-
viduals with high mtDNA content, those with low
mtDNA content had a significantly increased risk of
HCC when health controls [adjusted OR (aOR) = 1.64,
95% CI = 1.06–2.55], CLD controls (aOR = 1.57, 95%
CI = 1.10–2.25) or combined controls (aOR = 1.55,
95% CI = 1.12–2.14) was used as reference. In addi-
tion, stratified analyses showed that the significant
association was only evident in younger individuals,
male individuals, ever-smokers and never-drinkers.
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Collectively, our findings provided the first epidemio-
logical evidence that low mtDNA content in PBLs is
significantly associated with increased HCC risk, which
warrants further validation in prospective studies.
1312
LONGER LEUKOCYTE TELOMERE
LENGTH PREDICTS INCREASED RISK
OF HBV-RELATED HEPATOCELLULAR
CARCINOMA: A CASE-CONTROL
ANALYSIS
Nai-Jian Ge, Ye-Fa Yang, Lu Wu, Shu-Qun Shen, Jun
Liang and Yi-Jun Zhang
Department of Interventional Radiology 1, Eastern
Hepatobiliary Surgery Hospital, The Second Military
Medical University, Shanghai 200438, China
Background: Convincing evidence indicated that alter-
ation of telomere length was involved in the tumorigen-
esis. Consistently, epidemiological studies also observed
strong correlations between relative telomere length
(RTL) in peripheral blood leukocytes (PBLs) and the
susceptibility of many cancers. However, whether leu-
kocyte RTL can be used as a risk predictor for hepato-
cellular carcinoma (HCC) remains to be determined.
Methods: RTL in PBLs was measured using a PCR-
based method in a case-control study, consisting of 240
HCC cases, 240 healthy controls and 120 non-cancer
controls with chronic liver diseases (CLD).
Results: HCC cases exhibited a significantly longer
RTL [median (range): 0.57 (0.21–3.3)] than CLD [0.46
(0.15–1.99); p < 0.001] or healthy controls [0.39 (0.13–
2.69); p < 0.001]. Compared to individuals with short
RTL, those with long RTL had a significantly
increased risk of HCC when either the health (adjusted
OR = 7.28, 95% CI = 4.46–11.8) or CLD controls
(adjusted OR = 2.86, 95% CI = 1.74–4.70) was used as
reference. A significant dose-response relationship was
observed between HCC risk and long RTL (p for
trend < 0.001 in both controls). Additionally, there was
a significantly positive RTL correlation between PBLs
and normal (r = 0.78, p < 0.001) or cirrhotic liver tis-
sues (r = 0.67, p = 0.001). Furthermore, a significant
joint effect on HCC risk was noted between RTL and
smoking status or alcohol use.
Conclusion: Our findings for first time provide the epi-
demiological evidence linking long RTL in PBLs to
increased HCC risk, which warrants further investiga-
tion in other population.
1318
SURGICAL TREATMENT OF
IATROGENIE TRAUMATIC STRICTURE
OF BILE DUCT: THE EXPERIENCES OF
A SINGLE TREATMENT GROUP
Wen-Long Yu, Song Shi, Ning-Jia Shen and Yong-Jie
Zhang
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, 200438 China
To summarize the experiences of a single treatment
group in surgical treatment of iatrogenie traumatic
stricture of bile duct during the past 14 years. A retro-
spective summarization was made for 173 cases of iat-
rogenic traumatic biliary stricture operated by a single
surgery team in the Eastern Hepatobiliary Surgery
Hospital from 1998 to 2011. There were 61 males and
112 females, their ages ranged from 12 to 77 years old
(47 years on average). According to Bismuth classifica-
tion of injured restricture of bile duct, 10 patients were
type I, 22 patients were type II, 87 patients were type
III, 38 patients were type IV and 16 patient was type
V. Excision of the traumatic stricture with end-to-end
anastomosis were performed on 19 patients. 154
patients were treated by Roux-en-y duodenojejunosto-
my, among them 8 patients were performed hemihepa-
tectomy or partial hepatectomy also. In the patients
available through this follow-up, the total excellent and
good rate was 94.8% after operation. Surgery is the
most effective therapy for iatrogenic bile duct trauma.
Optimal timing of surgery, reasonable surgical meth-
ods, following the principle of bile duct surgery strictly,
prefect operative skills are the key to the treatment of
traumatic biliary stricture.
1319
A NEW APPROACH OF
GALLBLADDER-PROTECTED
LITHOTOMY FOR HEPATOLITHIASIS
Fu-Zhou Tian1, Zhu-Lin Luo1, Li-Guo Chen2,
Rui-Feng Wang1, Li-Jun Tang1, Jian-Dong Ren1 and
Long Chen1
1PLA General Surgery Center, Chengdu General
Military Hospital, Chengdu 610083, China; 2General
Surgery Department, the 452 Hospital of PLA, Chengdu
610021, China
The usually treatment of choledochojejunostomy for
hepatolithiasis, reconstruction of the digestive tract and
abolished the Oddi function, also abolished the gall-
bladder, brought a lot of complications. We design a
new operation: subcutaneous tunnel and hepat-
ocholangioplasty with the use of gallbladder (STHG).
The strictured bile ducts in the hilus was opened after
removal of stones or resection of the damaged liver seg-
ments. The gallbladder, instead of usually used jeju-
num, was anastomosed to the widely opened bile duct
in the hilus to form a widened pass way through intra-
hepatic to extrahepatic ducts. The fundus of gallblad-
der was mobilized and pulled to abdominal wall to
form a subcutaneous tunnel which could be used for
reentry to biliary tree at any time, even many years
later. The disadvantages of traditional choledochojejun-
ostomy was avoided by the new operation.
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1322
THE APPLICATION OF GRADUAL
DILATATION WITH BILIARY BALLOON
DILATORS ON ONE STAGE REPAIR
FOR BILE DUCT INJURY
Fu-Zhou Tian
Hepatobiliary Surgery of PLA General Surgery Center,
Chengdu General Military Hospital, PRC, 610083
Chengdu, China
Objective: To summarize our 5 years’ experience on
management of bile duct injury with gradual biliary
balloon dilator dilatation, and the prophylactic effect
of this method on traumatic biliary stricture after
instant hepatojejunastomy.
Methods: 31 patients with bile duct injury were studied
during the time from Jan 2005 to Jan 2010, their mean
age is 49 years (28–64) with 18 were male and 13
female. All the cases were done hepatojejunastomy
instantly after the injuries were found, with the biliary
balloon dilators set within the anastamosis. The bal-
loon dilator was dilated with air infusion from the 7th
postoperative day, 4 times/day and 2–3 hours per time.
The balloon dilator was pulled out 3 months after
operation and all the cases were followed up.
Result: All the 31 patients had been done hepatojejun-
astomy successfully. The mean follow-up time is
2.8 years (from 0.5 year to 5 years). There was 1 case
which has complication of cholanggitis and was stric-
ture diagnosed by MRCP examination. The other 30
cases was found were no complications of cholangitis
and stricture such as recurrent abdominal pain, fever,
icterus and itching. There’s also no stricture diagnosed
by ultrasonography, cholangioscopy and MRCP exami-
nation.
Conclusion: When bile duct injury accured, instant he-
patojejunastomy and biliary balloon dilator setting
accompanied with gradual balloon dilatation after-
wards can prevent anastamotic stricture successfully.
1323
LAPAROSCOPIC TREATMENT OF
MIRIZZIS SYNDROME
P. P. Rao and Bhagwat Sonali
Mamata Hospital Mumbai India, Dombivli east, India
Mirrizzis Syndrome is of three types and in the later
stages, the gall bladder and common hepatic duct have
a common wall with the stone having partly eroded
into the hepatic or bile duct. This coupled with the
acute nature of the disease make surgical and particu-
larly laparoscopic treatment of this disease particularly
difficult. In fact a few authors also advice open surgery
for this kind of pathology. We present a simple way to
tackle Mirizzis syndrome laparoscopically and at the
same time remove the CBD stones and clear the bile
duct. With experience all such cases can be managed la-
paroscopically and this technique is aptly demonstrated
with a video.
1326
THE ROLE OF PRE-LIGATION OF
BLOOD VESSELS AND TACE IN THE
PREVENTION OF TUMOUR
DISSEMINATION DURING
HEPATECTOMY
Zhe-Fu Li, Hong Li and Ming-Hui Ding
Qingdao municipal hospital, Qingdao medical college of
Qingdao University, 1 Jiao Zhou Rd, Qingdao 266011,
China
To study the efficacy of pre-ligation of hepatic inflow
and outflow blood vessels of lesioned liver lob as well
as postoperative transcatheter arterial chemoemboliza-
tion (TACE) in the prevention of tumour dissemination
during liver resection for hepatocellular carcinoma
(HCC).
Methods: A case-control study was carried out on 160
patients who underwent liver resection for HCC
between January 2005 and January 2012. 60 patients
underwent hepatic resection using pre-ligation blood
vessels and TACE (group A), 50 patients using pre-
ligation blood vessels (group B) and 50 using Pringle
maneuver (group C). The postoperative 1-, 2-, 3 year
rates of intrahepatic recurrence and lung metastasis,
and the overall disease-free survivals were compared
between the three groups.
Results: The incidence of lung metastasis at 1 year
after operation was significantly lower in group A than
group B and C respectively (8.1% vs. 14.6% and
16.8%, p = 0.042, 0.038). There were no significant dif-
ferences in the incidences of lung metastasis at postop-
erative year 2 and 3 between the three groups. The
differences in the postoperative 1-, 2, 3 year intrahepat-
ic recurrence rates were not significant among the three
groups. The median survivals of the three groups were
30.5 months, 22.3 months and 21.4 months respec-
tively. Patients in group A had a significantly higher
overall disease-free survival rate than patients in group
B and C respectively (p = 0.041, 0.036).
Conclusion: Pre-ligation of blood vessels of lesioned
liver lob and postoperative TACE was efficacious in
reducing the incidence of lung metastasis and in
improving the overall disease-free survival in patients
after liver resection for HCC. CHVE contributed in
preventing intraoperative tumour dissemination and in
improving prognosis.
1329
NEEDLESCOPIC CLIPLESS
CHOLECYSTECTOMY – A STUDY OF
463 CASES
Kai Lu
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, 200438, China
To investigate the value of needlescopic clipless chole-
cystectomy in the early benign gallbladder disease.
Methods: Four hundred sixty-three consecutive patients
who underwent needlescopic clipless cholecystectomy
were analyzed. Surgical technique: after performing the
pneumoperitoneum at the umbilical site, 3 trocars were
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inserted; 2 of 3 mm and 1 of 10 mm in diameter,
through which a laparoscope was inserted. Neither the
3-mm laparoscope, nor clips were used. The cystic
artery and duct were safely ligated near the gallbladder
neck with surgical knots. Removal of the gallbladder
was carried out in an adapted endobag through the 10-
mm umbilical site.
Results: Four hundred sixty-three consecutive patients
had undergone needlescopic clipless cholecystectomy
successfully. No complications were observed, and
postoperative results are superior to conventional lapa-
roscopic surgery.
Conclusion: The incision of needlescopic clipless chole-
cystectomy was nearly invisible, and postoperative
recovery was faster; free titanium clip eliminate adverse
effects on the human body; Our results indicate that
this procedure could be performed successfully and
safely by experienced surgical teams.
1331
REEXAMINING THE ROLE OF
PANCREATIC COMPOSITION IN
SHORT TERM OUTCOMES AFTER
PANCREATICODUODENECTOMY FOR
MALIGNANCY
Manjuraj K. Paulose, Bejoy Abraham and Hariharan
Ramesh
Lakeshore Hospital & Research Center, Cochin/Kerala,
India
To assess the influence of pancreatic composition on
early outcomes pancreatic anastomotic leakage after
pancreaticoduodenectomy for malignancy and its rela-
tion with texture.
Material and method: In this prospective study patients
enrolled were those who underwent Whipple’s pancrea-
ticoduodenectomy for malignant lesions of the periam-
pullary and pancreatic head region from March 2009
to March 2011. 68 patients had undergone Whipple’s
PD as curative procedure for malignancy in two years
and 54 were included in the study. There were 42 men
and 12 women. The median age of the sample popula-
tion was 57 (36–83). Of the 54 patients, surgical indica-
tions were ampullary carcinoma in 33, pancreatic
cancer in 15, Distal common duct growth in 3 patients
and Duodenal tumour in 4. The median BMI of the
study population was 21.16 range (15.1–27.51). Repre-
sentative slices of nontumorous pancreatic tissue
located at pancreatic neck margin and uncinate margin
were sampled for each patient. These specimens were
analyzed independently by two blinded pathologists.
Pancreatic fistula was graded as per ISGPF criteria and
post operative complications were graded according to
the Clavien Dindo system.
Results: There were 19 post operative pancreatic
fistulae. Univariate analysis of factors affecting pancre-
atic fistula showed significant difference between mean
fibrosis score (3.0 vs. 0.42, p = 0.0001) and mean
inflammation score (0.69 vs. 0.21, p = 0.012) between
fistula and no fistula group. Fat score has no implica-
tion on post operative pancreatic fistula on univariate
analysis (1.69 vs. 1.21, p > 0.05). Firm texture of
pancreas significantly correlates with increasing
inflammation and fibrosis scores (p = 0.03). Soft texture
however did not correlate with steatosis scores. Several
other clinical and intraoperative factors like diabetes
(p = 0.011), weight loss (p = 0.05), preoperative biliary
drainage (p = 0.016), soft consistency of neck
(p = 0.011), ampullary and pancreaticorigin of tumour
(p = 0.059) were found to be significantly related to
postoperative complications as well as post operative
pancreatic fistula on univairate analysis. Preoperative
biliary drainage alone was associated with higher com-
plication rate on multivariate analysis.
Conclusion: Firmness of pancreatic neck is a good indi-
cator of histological fibrosis and inflammation. Fibrosis
and inflammation of non tumourous pancreas seems to
be a protective factor for post operative pancreatic fis-
tula. Steatosis correlates poorly with softness and also
does not seem to have a strong relationship with fistula
and is probably a poor indicator due to the low BMI
in the sample population.
1335
ENDOSCOPIC TREATMENT OF
BILIARY COMPLICATIONS AFTER
CADAVERIC OR LIVING DONOR LIVER
TRANSPLANTATION
Ya-Min Pan, Bing Hu, Jun Wu and Tian-Tian Wang
Department of Endoscopy, Eastern Hepatobiliary
Hospital, Second Military Medical University, Shanghai
200438, China
Background and Aims: Biliary complications occur in
5% to 34% patients after orthotopic liver transplanta-
tion (OLT), and constitute an important cause of mor-
bidity and mortality. The traditional method for
treatment of biliary complications is surgical interven-
tion. We aimed to characterize the features of biliary
complications after liver transplantation and to evalu-
ate the efficacy of endoscopic treatment of biliary com-
plications.
Patients and Methods: From January 2006 to Septem-
ber 2012, Post-OLT patients who underwent endo-
scopic treatment of biliary complications in our
hospital were reviewed retrospectively. The biliary stric-
ture was treated by endoscopic placement of multiple
plastic stents or removable fully covered self-expand-
able metal stent (FCSEMS). Leakage was treated by
nasobiliary drainage or platic stent placement. The
strategy of endoscopic intervention was “treating leak-
age firstly, and then stricture”. If biliary stricture
recurred, patients would undergo endoscopic reinter-
vention. Success of endoscopic treatment was defined
as the resolution of the cholangiographic findings.
Results: Total 635 patients (female = 93; male = 542)
after liver transplantation [cadaveric donor (565), living
donor (70)] underwent endoscopic treatment. The med-
ian age of patients was 48 years (range, 9–72 years).
Biliary strictures were diagnosed in 601 patients and
biliary leakages were in 34 patients. 505 of 601 patients
(84%) were anastomotic strictures and 96 patients
(16%) were non-anastomotic strictures. 516 of 601
patients (81.25%) achieved resolution of strictures after
endoscopic stenting, of which multiple plastic stents
(Mean, 3 stents [range, 2–6 stents]) placement was
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performed in 471 patients, and removable FCSEMS
placement was performed in 45 patients. The mean
stents duration was 5.5  1.5 months with plastic
stents and 6.2  1.6 months with metal sten respec-
tively. Both plastic stents and metal stents were
removed successfully without further surgery interven-
tion. The median follow-up period after stent removal
was 10 months (2–25.5 months) and there was no bili-
ary stricture recurrence during follow-up. In 34 patients
with biliary leakages, 24 patients (70.59%) combined
with biliary stricture concurrently. 30 of 34 patients
(88.24%) were treated successfully without leakage
recurrence. The main complications included pancreati-
tis (9 patients), bleeding (8 patients), cholangiolitis (5
patients), stent migration (3 patients), all complications
were treated conservatively.
Conclusion: Endoscopic treatment of biliary complica-
tions after OLT is a effective approach with high suc-
cess rate and low risk, and avoids unnecessary surgical
intervention, deserving wide clinical use.
1337
SORAFENIB COMBINED WITH
CYBERKNIFE IN PRIMARY LIVER
CANCER
Fang-Rui Wang, Jian-Min Qian, Qian-Wei Wang and
Zhen-Yu Ma
Huashan Hospital Affiliated to Fudan University, 12
Wulumuqizhong Rd, Shanghai, 200032 China
Background and aims: In the treatment of liver carci-
noma, the role of sorafenib has been confirmed today,
but still it has its limitations, especially in hilar tumors
or tumors with lymph node metastasis. Meanwhile, cy-
berknife has been proved efficient for abdominal
tumors. But the efficacy and safety of cyberknife in
combination with sorafinib as adjuvant therapy for he-
patocellularcarcinoma (HCC) remains unclear. This
study was to evaluate the safety and initial curative
effect of sorafenib combined cyberknife in primary liver
cancer which were unresectable.
Methods: Ten patients with advanced HCC who are
not eligible for surgery received sorafini as standard
treatment (800 mg/day, if adverse events occurred, then
400 mg/day). Patients underwent cyberknife after sor-
afinib was introduced. Tumor response was assessed
every eight weeks.
Results: Median time of overall survival is
15.5  5.3 months, median time of progression free
survival is 7 months. By Aug 2011, average survival of
BCLC B grade patients is 16.7  6.56 months, average
survival of BCLC C grade patients is
13.8  2.87 months (p = 0.433). Average total tumor
diameter is 6.96  2.75 cm before treatment and
6.55  3.04 cm after six months of treatment. Average
AFP is 933.8  1333.72 ng/mL before treatment and
119.2  182.76 ng/mL after (p = 0.082).
Conclusions: Cyberknife in combination with sorafinib
can improve overall survival for advanced HCC
patients. Safety profile is acceptable with similar
adverse events of sorafinib aloneor cyberknife alone.
1342
TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION COMBINED
WITH Γ-RAY THREE-DIMENSION
CONFORMAL RADIOTHERAPY FOR
HEPATOCELLULAR CARCINOMA
Zeng-Qiang Qu, Xiao-Xia Chen, Ning Ding, Sui-Ling
Zhng, Ji-Mimg Zhong and Hi-Hu Zhou
Eastern Hepatobiliary Surgery Hospital, Second
Military Medical University, Shanghai, China
Objective: To evaluate the effects and safety of Trans-
catheter arterial chemoembolization (TACE) combined
with c-ray three-dimension conformal radiotherapy
(3DCRT) in the treatment for the unresectable hepato-
cellular carcinoma with portal vein thrombus (PVTT).
Methods: from 2006 to 2011, 132 patients of unresec-
table hepatocellular carcinoma with PVTT were treated
with TACE and 3DCRT. The 3DCRT was performed
followed by TACE. The planed target was PVTT only,
the dose was 3.0 Gy to 4 Gy per fraction, the total
does ranging from 30 Gy to 40 Gy. The objective
responses were analyzed and the survival rates were
assessed using Kapkan–Meier method.
Results: The total efficacy rate after 3-month treatment
was 71.2% (94/132), the remission rate of PVTT was
77.3(102/132), the 1, 2, 3 year survival rate was 54.5%,
34.1% and 19.7% respectively. The median survival
time was 15.3 months.
Conclusion: TACE combined with 3DCR is aneffective
method in the treatment for the hepatocellular carci-
noma with portal vein tumo thrombus.
1343
PHENACETIN O-DEETHYLATION IS A
USEFUL TOOL FOR EVALUATION OF
HEPATIC FUNCTIONAL RESERVE IN
RATS WITH CCL4-INDUCED CHRONIC
LIVER
Zeng-Qiang Qu and Ping He
Eastern Hepatobiliary Surgery Hospital, Second
Military Medical University, Shanghai, China
Background: Mortality of liver resection is as high as
3.1% to 25% in patients with chronic liver disease.
Evaluation of hepatic functional reserve is critical for
the prediction of risk of post-operation death. Phenace-
tin O-deethylation is a marker reaction of cytochrome
P4501A2 (CYP1A2) activity. In this study, our aim is
to investigate whether phenacetin O-deethylation is a
useful tool for the evaluation of hepatic functional
reserve in rats with chronic liver injury.
Materials and methods: Rat model for chronic liver
injury was established by subcutaneous administration
of 50% CCl4, 1 mL/kg twice per week for 12 weeks.
Hepatic CYP1A2 activity, content and mRNA expres-
sion were determined (n = 10). Effects of 15%, 30%
and 45% hepatectomy on phenacetin O-deethylation
were evaluated in the rats (n = 5 in each group). Addi-
tionally, the correlation of risk of death after 70% hep-
atectomy with phenacetin O-deethylation was studied
in 27 rats with chronic liver injury.
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Results: Compared with normal controls, CYP1A
activity, content and mRNA expression decreased
33%, 60% and 50% in the rats with chronicliver injury
(p < 0.05), respectively. Following the increasing of
liver-resected size, CYP1A2 activity decreased propor-
tionally (rs = 0.877, p < 0.05). Six of 27 rats with
chronic liver injury died within 7 days after 70% hepa-
tectomy. Phenacetin metabolism was impaired more
severely in 6 dead rats than in 21 living rats (p < 0.05).
Conclusions: Phenacetin O-deethylation is a useful tool
for the evaluation of hepatic functional reserve in the
rats with CCl4-inducedchronic liver injury.
1344
THE IMPACT OF SPHINGOSINE
KINASE 1 ON THE PROGNOSIS OF
PATIENTS WITH PORTAL VEIN
TUMORTHROMBUS
Jie Shi, Yong-Yong He and Ju-Xian Sun
Eastern Hepatobiliary Surgery Hospital, 225 Changhai
Rd, Shanghai, 200438 China
There is considerable evidence that sphingosine kinases
1(SPHK1) play a key role in cancer progression, which
is essential in several biologic processes, such as
enhanced cell migration, invasion and angiogenesis.
However, the prognostic value of SPHK1 expression in
hepatocellular carcinoma (HCC) remains unclear. The
purpose of this study was to investigate the relationship
between SPHK1 expression, tumor recurrence, and
patient survival. We identified SPHK1 as the most
overexpressed gene in portal vein tumor thrombus
(PVTT) by way of gene expression profiling. A pro-
spective study of 256 patients undergoing curative
resection indicated that SPHK1 expression was an inde-
pendent factor affecting survival (hazard ratio [HR]
1.799, 95% confidence interval [CI] 1.337–2.368,
p < 0.001) and recurrence (HR 1.451, 95% CI 1.087–
1.935, p = 0.011). Patients with SPHK1 overexpression
had a poorer prognosis than those with SPHK1 under-
expression (p < 0.001 and p = 0.011 for survival and
recurrence). According to portal vein tumor thrombus
(PVTT) classification, overexpression of SPHK1 could
have shorter time to recurrence and survival than those
whose tumors had decreased expression of this mole-
cule in PVTT I and II stage, respectively.
Conclusion: SPHK1 might represent a novel and useful
prognostic marker for hepatocellular carcinoma and
play a role during the development and progressionof
the disease.
1346
THE CLINICAL CHARACTERISTICS OF
THE TERMINAL STAGE BILIARY
TRACT DISEASES PERFORMED LIVER
TRANSPLANTATION
Xiang-Ji Luo, Xiao-Bin Chi, Bin Yi, Fei-Lin Feng,
Wei-Feng Tan, Qing-Bao Chen, Bin Li, Yong Yu,
Chen Liu, Bai-He Zhang and Xiao-Qing Jiang
Eastern Hepatobiliary Surgery Hospital, Second
Military Medical University, Shanghai 200438, China
The terminal stage biliary tract diseases are the primary
or secondary ones which can’t be cured by internal and
surgical means. During the hazardous course, the com-
plications occur repeatedly within the “hospital depen-
dent stage”.
Objection: Summarize the clinical characteristics of 11
cases of terminal stage biliary tract diseases.
Method: Retrospectively study the clinicopathologic
characteristics of 11 cases of terminal stage biliary tract
diseases performed liver transplantation during 2004–
2008.
Results: OLT has been performed in 4 cases with the
hepatolithus in our department. Among the 4 cases, the
exploration of biliary tract lithotomy and biliary intes-
tinal anastomosis have ever been done repeatedly in the
two quarters hepatolithus cases. The CT images of the
2 cases show bilateral hepatic duct stone with appar-
ently unilateral atrophy and fibrosis of the liver, 2 cases
accompanying with the caudate lobe and diffuse intra-
hepatic bile duct dilatation and stone. The common
hepatic duct and left hepatic duct in 1 case with HCC
is injured by radio frequency therapy, with progressive
aggravating jaundice, with repeatedly futile treatment
of bile duct injury. 1 case with biliary tract complica-
tion after the liver transplantation, who has ever expe-
rienced a liver transplantation in other hospital in
2002, whose jaundice appeared after 1 year. Further
investigation shows the hepatic arteriostenosis, intrahe-
patic bile ducts stenosis, and repeate cholangitis. 1 case
in sclerosing cholangitis with upper gastrointestinal
hemorrhage and liver function failure. 1 case in diffuse
type Caroli disease with liver decompensation. 1 case of
advanced the gallbladder carcinoma with liver failure. 2
cases in advanced hilarcholangiocarcinoma with portal
vein invasion and liver failure.
Conclusion: Liver transplantation can be selectively
applied for the terminal stage biliary tract diseases
except advanced Hilarcholangiocarcinoma and gall-
bladder carcinoma.
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1353
TREATMENT STRATEGY OF SURGICAL
PATIENTS WITH LARGE
HEPATOCELLULAR CARCINOMA
(>10 CM)
Shigeki Wakiyama, Hiroaki Shiba, Yasuro Futagawa,
Takeyuki Misawa, Yuichi Ishida and Katsuhiko
Yanaga
Department of Surgery, The Jikei University School of
Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo,
Japan
Background: Despite significant improvement in the
management of hepatocellular carcinoma (HCC), it is
often difficult to manage patients with large HCC
(>10 cm). Hepatic resection is the only curative treat-
ment for large HCC, but there are some problems
regarding operation, postoperative complications, and
tumor recurrence.Aim
To review the clinicopathological features and the out-
comes of surgical patients with large HCC and to clar-
ify treatment strategy for these patients.
Patients and Methods: From January 2000 through
March 2010, 14 patients underwent elective hepatic
resection for primary large HCC in our hospital (group
I: n = 14). 1) Clinical data of group I were compared to
those of surgical patients with HCC (<5 cm) (group II:
n = 104). Clinical data consisted of overall (OS) and
disease-free survival (DFS), complications, patients-,
tumor-, and operative related factors including gender,
age, BMI, diabetes mellitus (DM), hypertension, serum
aspartate aminotransferase (AST), alanine aminotrans-
ferase (ALT), total bilirubin (T-bil), albumin (Alb),
alkaline phosphatase (ALP), gamma-glutamyl transpep-
tidase (c-GT), white blood cell count (WBC), platelet
count (Plt), ICGR15, AFP, PIVKA-II, maximum tumor
size (maxTS), number of tumors (solitary or multiple)
and blood transfusion (RC, FFP). 2) In group I, prog-
nostic factors were investigated. 3) In group I, the sig-
nificance of preoperatibe TACE (preTACE) was
evaluated (TACE (+): n = 4, TACE (-): n = 10).
Results: 1) In group I compared with group II, nonB-
nonC (NBNC) was significantly more frequent, and in
group II HCV positivity was more frequent (p < 0.01).
In group I compared with group II, the value of BMI,
Plt, AFP, and PIVKA-II were significantly higher
(p < 0.01), and that of ICGR15 was significantly lower
(p < 0.01). In group I, vp (pathological portal vein
invasion) positivity was more frequent (p < 0.01). In in-
traoperative factors, operation time in group I was sig-
nificantly longer, and blood loss and transfusion
volume were significantly larger (p < 0.01). In group I
compared with group II, OS and DFS were signifi-
cantly worse (p < 0.01), while the rate of complications
was comparable between group I and II. 2) Prognostic
factor in group I was blood transfusion (FFP)
(p < 0.05). 3) In group I, preTACE might be beneficial
for survival.
Conclusion: The characteristic features of large HCC
seems to be NBNC, good liver function, and high
malignant potential. In order to improve prognosis of
large HCC, it is important to control operative blood
loss, reduce blood transfusion, and employ other
measures to reduce tumor recurrence. Also, preTACE
might be beneficial for survival.
1356
ANALYSIS OF HIGH RISK FACTORS
AND CLAVIEN CLASSIFICATION FOR
BILIARY COMPLICATION AFTER
LIVER TRANSPLANTATION
Hai-Bin Zhang, Dong-Yu Li, De-Jun Yang, Ning
Yang and Guang-Shun Yang
The 5th Department of Liver Surgery, Eastern
Hepatobiliary Surgery Hospital, Second Military
Medical University, Shanghai, China, 200438
To explore the value of Clavien classification of biliary
complication (BC) after liver transplantation (LT).
Methods: The clinical data of 181 patients who under-
went LT between Jan. 2004 and Dec. 2008 were col-
lected retrospectiely. The mean follow-up time was
656.44  452.75 days. Cases of BC were classified by
Clavien system. The risk factors of BC above Clavi-
enIIIb were evaluated by using a binary forward step-
wise logistic regression analysis.
Results: Among the 181 patients, 26 (14.4%, BC
group) recipients developed BC after LT (1/Clavien I,
2/Clavien II, 4/ Clavien IIIa, 14/Clavien IIIb, 5/Clavien
IV). Stepwise logistic regression analysis revealed that
the abnormal hepatic arterial resistance index (HARI)
on the 1st and 7th day after the surgery, placement of
“T” tube were the risk factors of BC after LT. The
abnormal HARI was also the independent risk factor
of BC above ClavienIIIb.
Conclusion: Clavien system may be important to the
classification of BC. Patients of lower grade BC seem
to have a better survival rate and quality than the
higher grade. Hepatic arterial insufficiency (HAI) was
an independent risk factor of BC above ClavienIIIb.
1359
FUNCTION CONSERVATION
SURGICAL STRATEGY FOR
TREATMENT OF SOLID
PSEUDOPAPILLAY TUMOR OF
THEPANCREAS: A RETROSPECTIVE
STUDY OF 23
Ying-Fei Zhang, Jian-Long Zhang, Zhi-Yu Xiao,
Jian Sun, Chuan-Chao He and Jie Wang
Department of Hepatobiliopancreatic Surgery, Sun
Yat-Sen Memorial Hospital of Sun Yat-Sen University,
Guangzhou, 510120, China
Purpose: The purpose of this study was to investigate
effectiveness and safety of surgical treatment for the
patients with solid pseudopapillary tumors of the pan-
creas (SPTP) by summarizing and analyzing clinical
information of them.
Methods: A single-institution, retrospective evaluation
of a database of 23 SPTP patients treated from Octo-
ber 2006 to May 2011 was performed.
Results: In this study, 21 females and 2 males were
including, median age was 32.5 (range, 10–66). The
tumor was most commonly located in the body and
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tail of the pancreas. The median operative time was
255 min (range, 200–386), median Intraoperative
bleeding was 289 mL (range, 100–500), median post-
operative hospital stay of the patients was 22 days
(range, 18–28) are decreased compare with other surgi-
cal proceduce for SPTP and pancreatic fistula rate was
12.5% by Middle segment pancreatectomy. In a com-
parative study pancreaticoduodenectomy group there
only one patient developed a low-output pancreatic
fistula, median operative time was 340 min, median
Intra-operative bleeding was 150 and median postoper-
ative hospital stay of the patients was 23 days. There
is no new-onset diabetes and no patient developed
clinical signs of exocrine pancreatic insufficiency in
MSP group.
Conclusion: According to the data of our results, the
surgical approaches such as MSP, the parenchyma-
sparing resection is an available and safe operation for
SPTP which may reduce the risk of exocrine/endocrine
insufficiency. Duct-to-mucosa anastomois will lower the
risk of operative complication.
1365
EXPERIENCE IN DIAGNOSIS AND
SURGICAL TREATMENT OF
ABERRANT RIGHT POSTERIOR
HEPATIC BILE DUCT INJURY
Zula Pai, Yusufu Yimit and Hao Wen
First Affiliated Hospital of Xinjiang Medical University,
Liyushan Road, Urumqi, China
Objective: To explore the diagnosis and surgical man-
agement of aberrant right posterior hepatic bile duct
injury.
Methods: Twenty eight cases with aberrant right pos-
terior hepatic bile duct injury were analyzed retrospec-
tively; according to injury type and diagnostic time, 28
patients divided into three groups; the first group is
comprised of 10 patients in whom the injury was recog-
nized and repaired at the time of original surgery; the
second group is consisted of 10 patients in whom the
injured aberrant right posterior hepatic bile duct was
ligated and diagnosed after operation; third group is
comprised of 8 patients with external bile fistula after
aberrant right posterior hepatic bile duct injury; com-
pare with short and long term complication after surgi-
cal repair in three groups.
Results: In first group, 1 patient was abdominal hyd-
ropsy, no one has the bile duct stricture; in second
group, 1 patient was bile fistula, 2 cases were abdomi-
nal hydropsy, case was incisional infection, 1 case was
bile duct stricture. In third group, 2 cases were bile fis-
tula, 1 patient was intestinal obstruction, 2 cases were
incisional infection, 1 patient has intra-abdominal hem-
orrhage, 2 cases were bile duct stricture and 1 case has
incisional hernia at follow-up period.
Conclusion: Finding and repairing the aberrant right
posterior hepatic bile duct injury at original operation
are the precious time to success. It can use different
surgical repairemental method for aberrant right pos-
terior hepatic bile duct injury according to its type and
diagnostic time
1368
HEPATITIS B VIRUS X PROTEIN
ENHANCES CISPLATIN-INDUCED
HEPATOTOXICITY VIA A MECHANISM
INVOLVING DEGRADATION OF MCL-1
Lei Chen, Liang Hu and Hong-Yang Wang
International Cooperation Laboratory on Signal
Transduction, Eastern Hepatobiliary Surgery Institute,
Shanghai 200438, China
Hepatitis B virus X protein (HBx) is implicated in the
pathogenesis of hepatitis B virus (HBV)-associated liver
diseases. However, whether HBx has the ability to dis-
turb the susceptibility of hepatocytes to common che-
motherapeutic agents remains incompletely understood.
Here we demonstrate that HBx enhances cisplatinin-
duced hepatotoxicity by a mechanism involving degra-
dation of Mcl-1, an antiapoptotic member of the Bcl-2
family. Ectopic expression of HBx sensitized hepato-
cytes to cisplatin-induced apoptosis, which was accom-
panied by a marked down regulation of Mcl-1 but not
of Bcl-2 or Bcl-xL. Overexpression of Mcl-1 prevented.
HBx-induced proapoptotic and proinflammatory effects
during cisplatin treatment both in vitro and in vivo.
HBx-induced dysregulation of Mcl-1 resulted mainly
from posttranslational degradation rather than tran-
scription repression. Moreover, a caspase-3 inhibitor
effectively abrogated HBx-enhanced Mcl-1 degradation
and cell death. Importantly, antioxidants blocked acti-
vation of caspase-3 and acceleration of Mcl-1 loss, as
well as cell death, in HBx-expressing hepatocytes upon
cisplatin exposure in vitro and in vivo. Collectively,
these data implicate oxidative stress-dependent caspase-
3-mediated degradation of Mcl-1 as a mechanism con-
tributing to HBx-mediated sensitization of cisplatin-
induced hepatotoxicity. A combination of cisplatin and
antioxidants might provide more advantage than cis-
platin alone in the treatment of cancer patients with
chronic HBV infection.
1369
DETECTION AND DIAGNOSTIC VALUE
EVALUATION OF SERUM
FUCOSYLATED FETUIN-A IN
HEPATOCELLULAR CARCINOMA AND
LIVER CIRRHOSIS
Li Li, Meng Fang, Chang-Hong Yi, Jun Ji and
Chun-Fang Gao
Department of Laboratory Medicine, Eastern
Hepatobiliary Surgery Hospital, Second Military
Medical University, Shanghai 200438, PR China
Background and aims: To establish a new lectin
enzyme-linked immunosorbent assay (lectin-ELISA) to
detect the fucosylated level of serum fetuin-A. And to
investigate the diagnostic value of fucosylated fetuin- in
hepatocellular carcinoma (HCC) and liver cirrhosis.
Method: We established a lectin-ELISA method using
the lectin-fetuin A antibody sandwich method to deter-
mine serum fucosylated fetuin-A level. A total of 122
cases of HCC, 66 cases of liver cirrhosis, 118 asymp-
tomatic HBV carriers and 117 cases of normal control
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were collected for serum fetuin-A protein fucosylated
level detection. The diagnostic value of fetuin-A fucosy-
lated level in HCC and cirrhosis was analyzed with
receiver operating characteristic (ROC) curve.
Result: The fucosylated level of serum fetuin-A in
HCC and cirrhosis groups were significantly higher
than that in asymptomatic HBV carriers and healthy
control groups, (p < 0.05). The difference between the
Asymptomatic HBV carriers and healthy control group
was not statistically significant. Using Cutoff value of
1.122 to identify cirrhotic patients from asymptomatic
HBV carriers and the healthy control group, the area
under the ROC curve was 0.906, the 95% confidence
interval was 0.861 to 0.951. Using Cutoff value of
0.976 to identify HCC from asymptomatic carriers of
HBV and healthy control group, the area under the
ROC curve was 0.831, the 95% confidence interval was
0.787 to 0.876. The fucosylated level of serum fetuin-A
of liver cirrhosis group was above HCC group, the dif-
ference was statistically significant (p < 0.05).
Conclusion: Fucosylated level of serum fetuin-A is a
potential maker of liver cancer and liver cirrhosis, it is
expected to afford an new serum reference for labora-
tory diagnosis of liver cancer, and cirrhosis. A larger
cases could be needed to validate its value in further
studies.
1417
EXPRESSION AND SIGNIFICANCE OF
SHH, E-CADHERIN AND IL-6 IN
HUMAN CHRONIC CHOLECYSTITIS
Qing-Ping Lu, Shi-Bo Sun, Wei-Guo Hu, Feng-Bo
Wang and De-Zhong Li
Wuhan General Hospital of Guangzhou Military, Wuluo
Road 627, Wuhan, China
Aim: To investigate the expression of sonic hedgehog
(SHH), E-cadherin and IL-6 in human chronic chole-
cystitis.
Methods: 120 post-operation specimens of cholecystitis
and 36 post-operation specimens of gallbladder carci-
noma were selected in Wuhan General Hospital of Gu-
angzhou Military from February 2005 to May 2010.
The expression of SHH and E-cadherin protein in 45
specimens of mild cholecystitis, 45 specimens of moder-
ate cholecystitis, 30 specimens of severe cholecystitis
and 36 specimens of gallbladder carcinoma were
assessed by immunohistochemistry, they all signed the
informed consent.
Results: There was significant difference between the
four groups in average gray scale and positive unit of
SHH. E-cadherin and IL-6 (p < 0.01). There was signif-
icant difference between the groups of stone size
(d  3 cm vs. <3 cm) (p < 0.01). However, there was
no significant difference between age groups, gender
groups in SHH. E-cadherin and IL-6 expression value
(p > 0.05, respectively). The expression of SHH or IL-6
was inversely correlated with E-cadherin (p < 0.01),
positive correlation were observed among SHH and IL-
6(p < 0.01).
Conclusion: Sonic hedgehog signaling pathway and
E-cadherin is activated in the tissue of chronic chole-
cystitis and gallbladder carcinoma, it may play an
important role in the development and transformation
of gallbladder carcinoma.
1418
EXPRESSIONS OF GRP78 AND GRP94
DURING THE PERIODS OF HEPATIC
ISCHEMIA REPERFUSION IN RAT
Qiu-Guo Du, Qi-Ping Lu, Zhi-Guang Xu and Jian-Hu
Gao
Wuhan General Hospital of Guangzhou Military, Wuluo
Road 627, Wuhan, China
Objective: To evaluate the changes of GRP78, GRP94,
p-Akt1 and Caspase-12 expression during the periods
of hepatic ischemia reperfusion in rat.
Methods: Fifty-five Wistar rats were randomly divided
into three groups: normal group(n = 5), sham operated
group(n = 25)and ischemia reperfusion group(n = 25).
The rat model of hepatic ischemia reperfusion was
established by clamping hepatic pedicle for 45 min with
no damage artery clamp and then reperfusion. The
expression of GRP78, GRP94 and Caspase-12 was
detected by immunohistochemistry SABC at 0, 3, 12,
24, 72 h after ischemia reperfusion. The expression of
p-Akt1 was detected by Western-blot at the same time.
Results: The expression level of GRP78, GRP94 and
Caspase-12 in ischemia reperfusion group was signifi-
cantly higher than in normal group and sham operated
group (p < 0.01). In ischemia reperfusion group,
expressions of GRP78, GRP94 and Caspase-12 were
increased at 0–3 h after reperfusion, peaked at 12 h,
and began to decline at 24–72 h, but still significantly
higher than the other two groups. In ischemia reperfu-
sion group, the tide of expression of p-Akt1 resembled
GRP78, and significantly higher than the other two
groups.
Conclusion: GRP78 and GRP94 played an important
role during the periods of hepatic ischemia reperfusion
in rat by reducing the burden of endoplasmic reticulum
and promoting gluconeogenic pathway. p-Akt1 proba-
bly was an important signal molecule in the PI3K/Akt
signal path which raised the expression of GRP78.
1419
EFFECTS OF RADIX SALVIA
MILTIORRHIZA FOR EXPRESSION OF
ACTIVATING TRANSCRIPTION
FACTOR 6Α(ATF-6Α) DURING THE
PERIODS OF HEPATIC
Zhi-Guang Xu, Qi-Ping Lu, Qiu-Guo Du and Jian-Hu
Gao
Wuhan General Hospital of Guangzhou Military, Wuluo
Road 627, Wuhan, China
Objective: To investigate the expressions of activating
transcription factor-6a(ATF-6a) and cysteinylasparate
specific proteinase-12(Caspase-12) during the periods of
hepatic ischemia-reperfusion injury and the effect of
radix salvia miltiorrhiae (RSM) in this process.
Methods: A total of 80 Wistar rats were randomly
divided into four groups: normal group, sham-
operation group, ischemia-reperfusion group and Radix
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Salvia Miltiorrhiza (RSM)-pretreated group. The model
of hepatic ischemia-reperfusion injury was established
by occlusion of hepatic pedicle, the expressions of
ATF-6a and Caspase-12 were detected by Western blot
method and immunohistochemistry method at 45 min
after ischemia and 0,3,12,24 and 72 h after reperfusion.
Results: There was no significant difference between
the normal group and the sham-operation group
(p>0.05). In the ischemia-reperfusion group,the expres-
sions of ATF-6a and Caspase-12 were higher than the
normal group and the sham-operation group
(p < 0.01); ATF-6a and Caspase-12 expressed nearby
the central veins and the portal area (0–3 h), strong
positive expressions of ATF-6a and Caspase-12 diffused
distribution in the hepatic lobule(12–24 h), the range of
ATF-6a and Caspase-12 expressed around the central
veins(24—72 h). In the RSM-pretreated group, the
expressions of ATF-6a and Caspase-12 around the cen-
tral veins and portal area were higher than the normal
group and the sham-operation group (p < 0.01), but
lower than the ischemia-reperfusion group (p < 0.01).
The degree of liver tissue injury was relieved.
Conclusions: The protective effect of RSM-pretreat-
ment may be regulate hepatocyte endoplasmic reticu-
lum stress steady state, reduce the apoptosis during the
periods of hepatic ischemia/reperfusion by maintaining
the proper expression of ATF-6a and down-regulating
the over expression of Caspase-12 in rats.
1420
THE EFFECTS OF RADIX SALVIAE
MILTIORRHIZAE PRECONDITION FOR
EXPRESSIONS OF PHOSPHORYLATED
EUKARYOTIC INITIATION FACTOR 2A
(EIF-2A)
Jian-Hu Gao, Qi-Ping Lu, Qiu-Guo Du and
Zhi-Guang Xu
Wuhan General Hospital of Guangzhou Military, Wuluo
Road 627, Wuhan, China
Objective: In order to research the expression of
phosphorylated eukaryotic initiation factor 2a on rat
hepatic ischemic-reperfusion injury after radix salviae
miltiorrhizae (RSM) precondition, and to explore RSM
pretreatment on hepatic ischemia reperfusion injury in
endoplasmic reticulum steady state regulation.
Methods: We used the model of rat hepatic ischemia
reperfusion injury. Wistar rats were randomized into
four groups: control group, sham group, hepatic ische-
mia-reperfusion group and RSM group, and sham
group, hepatic ischemia-reperfusion group and RSM
group were, respectively, divided to five subgroups: 0,
3, 12, 24 and 72 h. Liver tissues were sampled at 0, 3,
12, 24 and 72 h after reperfusion for detection of
phosphorylated eukaryotic initiation factor 2a(eIF-2a)
and Caspase-12, and phosphorylated eIF-2a and
Caspase-12 protein expressions were examined by
western blot.
Results: The expressions of the phosphorylated eIF-2a
and Caspase-12 were not statistical significance
between control group and sham group (p > 0.05). In
the hepatic ischemia-reperfusion group, the expressions
of phosphorylated eIF-2a began to increase at 3 h
after reperfusion, which reached peak at 12 h, then
gradually reduced, and were close to control group
and sham group at 72 h (p > 0.05); and the expres-
sions of Caspase-12 gradually increased at 0 h after
reperfusion, which reached peak at 12 h, then gradu-
ally reduced, but it also kept higher level than control
group and sham group at 72 h (p < 0.01). Compared
with the different reperfusion time of hepatic ischemia-
reperfusion group, there were higher level of the
expressions of phosphorylated eIF-2a in RSM group
(p < 0.01); the expressions of Caspase-12 were higher
than control group and sham group, but were
obviously lower than hepatic ischemia-reperfusion
group (p < 0.01).
Conclusion: RSM can increase of eIF-2a phosphoryla-
tion level, which alleviate unfolded protein response,
stabilize endoplasmic reticulum internal environment,
eventually protect liver from damage in the hepatic
ischemia-reperfusion injury.
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